Citrus Sinensis ID: 040910
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.945 | 0.552 | 0.458 | 1e-121 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.911 | 0.530 | 0.477 | 1e-120 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.965 | 0.565 | 0.446 | 1e-119 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.909 | 0.541 | 0.456 | 1e-119 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.965 | 0.563 | 0.442 | 1e-118 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.907 | 0.532 | 0.471 | 1e-117 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.965 | 0.568 | 0.442 | 1e-117 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.937 | 0.570 | 0.467 | 1e-115 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.826 | 0.482 | 0.477 | 1e-113 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.915 | 0.539 | 0.443 | 1e-112 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 235/513 (45%), Positives = 338/513 (65%), Gaps = 44/513 (8%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
+F+ +++PD E+ + V+ ++C CL+NC+C AY + GG GC++W D++
Sbjct: 356 EFLTLKSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLV 410
Query: 69 DMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVLIALPV-VILPAFF--IFYGRKRKLKE 125
D+++ G S+++R S++G+ + I V++A+ V VIL F + + KRK
Sbjct: 411 DLQQFEAG--GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDV 468
Query: 126 KG--------------NMTRAKEFCEGDSAA-----KGKS-KESWFIFFSLASISTATHN 165
G ++T++KE S + +GK+ S FSL +I+ AT++
Sbjct: 469 SGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATND 528
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
F +EN+LG GGFGPVYKG L +G E+AVKRLS KSGQGV+EFKNE+ILIAKL HRNLVRL
Sbjct: 529 FCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRL 588
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC E EK+L+YEYMPNKSLDFFLFD + ++DW R IIEGIA
Sbjct: 589 LGCCFEGEEKMLVYEYMPNKSLDFFLFD------------ETKQALIDWKLRFSIIEGIA 636
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLH+ SRLR+IHRDLK SNVLLD +MNPKISDFG+AR+FGG++ ++N R+VGTYG
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405
YMSPEYA+ GLFS+KSDV+SFGVLLLE +S K+NT + + +L+G+AW L+ R+ +
Sbjct: 697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEE 756
Query: 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465
L+DP ++ R I VA+LCVQ++AA+RP M+ V+ M++++ L +P+QP F+
Sbjct: 757 LVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTS 816
Query: 466 VR--IVEKSVLLENSEAEASSGNCLTLSMVDAR 496
R ++ + L++S+ S N +T ++V R
Sbjct: 817 TRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 238/498 (47%), Positives = 311/498 (62%), Gaps = 46/498 (9%)
Query: 31 NLKECEAECLKNCTCRAYG--NSNLIGGGSGCLMWFGDMIDMKRTLGNLTGQSIYLRAPA 88
N KEC AECL NC C+AY +++ + C +W D+ ++K G L +++++R
Sbjct: 369 NEKECRAECLNNCQCQAYSYEEVDILQSNTKCWIWLEDLNNLKE--GYLGSRNVFIRVAV 426
Query: 89 SQLG-------------KKKTLWIVVLIALPVVIL-----PAFFIFYGRKRKLKEKGNMT 130
+G K + I+V+ IL A ++F R++ KE G++
Sbjct: 427 PDIGSHVERGRGRYGEAKTPVVLIIVVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIP 486
Query: 131 RAKEFCEGD-------SAAKGKSKESWFI---FFSLASISTATHNFSEENKLGEGGFGPV 180
R C+ + + + K +S I F L +I AT NFS NKLG+GGFGPV
Sbjct: 487 RGVHLCDSERHIKELIESGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPV 546
Query: 181 YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240
YKG +E+AVKRLS SGQG+EEFKNE++LIAKL HRNLVRL G C+ EK+L+YE
Sbjct: 547 YKGMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYE 606
Query: 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVI 300
YMP+KSLDFF+FD K LDW R II GIA+GLLYLHQ SRLR+I
Sbjct: 607 YMPHKSLDFFIFDRKLCQR------------LDWKMRCNIILGIARGLLYLHQDSRLRII 654
Query: 301 HRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIK 360
HRDLK SN+LLD +MNPKISDFG+AR+FGG E +N NR+VGTYGYMSPEYAL GLFS K
Sbjct: 655 HRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFK 714
Query: 361 SDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPM 419
SDVFSFGV+++ET+S K+NT F+ + SL+LLGHAW+LWK +R +LLD LQ
Sbjct: 715 SDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEG 774
Query: 420 VKRYIKVALLCVQENAADRPTMSEVVSMI-KNEIVNLPSPQQPAFSYVRIVEKSVLLENS 478
+ + V LLCVQE+ DRPTMS VV M+ +E LP+P+QPAF R S ++
Sbjct: 775 FLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSST 834
Query: 479 EAEASSGNCLTLSMVDAR 496
+ E S N LT+++ D R
Sbjct: 835 KPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 231/517 (44%), Positives = 325/517 (62%), Gaps = 38/517 (7%)
Query: 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C F++ M++PD E +++ + LKECE CLK C C A+ N+++ GGSGC++W
Sbjct: 345 CDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIW 404
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVL---IALPVVILPAFFIFYGRK 120
G + D++ GQ +Y+R A L K+ ++ I + +++L +F IF+ K
Sbjct: 405 SGGLFDIRNYAKG--GQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWK 462
Query: 121 RKLKEK-------GNMTRAK-----EFCEGDSAAKGKSKESWFIFFSL---ASISTATHN 165
RK K ++ R++ E + + K ++ ++ L +++ AT+N
Sbjct: 463 RKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNN 522
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
FS +NKLG+GGFG VYKG LL+G+E+AVKRLS S QG +EF NE+ LIAKL H NLVRL
Sbjct: 523 FSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 582
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC+++GEK+LIYEY+ N SLD LFD SS L+W R II GIA
Sbjct: 583 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN------------LNWQKRFDIINGIA 630
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR+FG +E ++N R+VGTYG
Sbjct: 631 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYG 690
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAW 404
YMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN + L LLG W WK+ +
Sbjct: 691 YMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKEL 750
Query: 405 KLLDP----TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460
+++DP L +E + R I++ LLCVQE A DRP MS V+ M+ +E +P P++
Sbjct: 751 EIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKR 810
Query: 461 PAFSYVRIVEKSVLLENSEA-EASSGNCLTLSMVDAR 496
P F R + +++ + + N +TLS++DAR
Sbjct: 811 PGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 221/484 (45%), Positives = 311/484 (64%), Gaps = 33/484 (6%)
Query: 2 SDCKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNS--NLIGGGSG 59
S C F+K M++PD + ++ ++ LKEC+ CLKNC+C AY ++ G G
Sbjct: 336 SICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGAIG 395
Query: 60 CLMWFGDMIDMKRTLGNLTGQSIYLRAPASQL---------GKKKTLWIVVLIALPVVIL 110
CL W G M+D + L +GQ Y+R +L GK++ L I++ + V++L
Sbjct: 396 CLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVMLL 453
Query: 111 PAFFIFYGRKRKLKEKGNMTRAK------EFCEGDSAAKGKSKESWFIFFSLASISTATH 164
R+R+ + + A +F E + K++ F L +I AT+
Sbjct: 454 TVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVAATN 513
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
NFS +NKLG GGFGPVYKG L N E+AVKRLS SGQG+EEFKNE+ LI+KL HRNLVR
Sbjct: 514 NFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVR 573
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ GCC+E EK+L+YEY+PNKSLD+F+F + + LDW R+ I+ GI
Sbjct: 574 ILGCCVELEEKMLVYEYLPNKSLDYFIFHEE------------QRAELDWPKRMEIVRGI 621
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+G+LYLHQ SRLR+IHRDLKASN+LLD +M PKISDFG+AR+FGG++++ +R+VGT+
Sbjct: 622 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 681
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404
GYM+PEYA+ G FSIKSDV+SFGVL+LE ++ KKN+ F+ +S L+GH W+LW++ A
Sbjct: 682 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE-ESSNLVGHIWDLWENGEAT 740
Query: 405 KLLDPTLQNEALYPM-VKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAF 463
+++D + E V + I++ LLCVQENA+DR MS VV M+ + NLP+P+ PAF
Sbjct: 741 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 800
Query: 464 SYVR 467
+ R
Sbjct: 801 TSAR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 229/518 (44%), Positives = 325/518 (62%), Gaps = 39/518 (7%)
Query: 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C G F++ M++PD ++ + +KECE +CL++C C A+ N+++ G GSGC+ W
Sbjct: 347 CGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTW 406
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVL---IALPVVILPAFFIFYGRK 120
G++ D++ GQ +Y+R A+ L K+ ++ I + V++L +F IF+ K
Sbjct: 407 TGELFDIRNYAKG--GQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWK 464
Query: 121 RKLKEK--------GNMTRAKEFCEGD---SAAKGKSKES-----WFIFFSLASISTATH 164
RK K + R+++ + S+ + S+E+ ++ AT+
Sbjct: 465 RKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATN 524
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
NFS NKLG+GGFG VYKGKLL+G+E+AVKRLS S QG +EFKNE+ LIA+L H NLVR
Sbjct: 525 NFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVR 584
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L CC++ GEK+LIYEY+ N SLD LFD +S L+W R II GI
Sbjct: 585 LLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK------------LNWQMRFDIINGI 632
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+GLLYLHQ SR R+IHRDLKASN+LLD M PKISDFG+AR+FG DE ++N ++VGTY
Sbjct: 633 ARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTY 692
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRA 403
GYMSPEYA+ G+FS+KSDVFSFGVLLLE +SSK+N FYN D L LLG W WK+ +
Sbjct: 693 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKG 752
Query: 404 WKLLDPTLQNEA---LYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460
+++DP + + + + R I++ LLCVQE A DRPTMS V+ M+ +E +P P+
Sbjct: 753 LEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKA 812
Query: 461 PAFSYVR--IVEKSVLLENSEAEASSGNCLTLSMVDAR 496
P + R + S + + E+ + N +T+S++DAR
Sbjct: 813 PGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 423 bits (1088), Expect = e-117, Method: Compositional matrix adjust.
Identities = 231/490 (47%), Positives = 319/490 (65%), Gaps = 40/490 (8%)
Query: 2 SDCKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNS--NLIGGGSG 59
S C F K +++P+ V ++ ++ LKECE CLKNC+C AY ++ G G
Sbjct: 339 SICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGAKG 398
Query: 60 CLMWFGDMIDMKRTLGNLTGQSIYLRAPASQL---------GKKKTLWIVVLIALPVVIL 110
CL W G+M+D + L +GQ YLR S+L GKK+ + I++ + V++L
Sbjct: 399 CLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVMLL 456
Query: 111 PAFFIFYGRKRKLKEKGNMTRAKEFCEGDSA-----------AKGKSKESWFIFFSLASI 159
F Y RKR+ + + N R S+ + KS+ F L++I
Sbjct: 457 LISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELSTI 516
Query: 160 STATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH 219
+TAT+NF+ +NKLG GGFGPVYKG L NG E+AVKRLS SGQG+EEFKNE+ LI+KL H
Sbjct: 517 ATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQH 576
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
RNLVR+ GCC+E EK+L+YEY+PNKSLD+F+F + + LDW R+
Sbjct: 577 RNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEE------------QRAELDWPKRMG 624
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
II GI +G+LYLHQ SRLR+IHRDLKASNVLLD +M PKI+DFG+AR+FGG++++ + NR
Sbjct: 625 IIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNR 684
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
+VGTYGYMSPEYA+ G FSIKSDV+SFGVL+LE ++ K+N+ FY +SL L+ H W+ W+
Sbjct: 685 VVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-ESLNLVKHIWDRWE 743
Query: 400 DDRAWKLLDPTLQNEALYP--MVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPS 457
+ A +++D L E Y V + + + LLCVQEN++DRP MS VV M+ + ++LPS
Sbjct: 744 NGEAIEIID-KLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPS 802
Query: 458 PQQPAFSYVR 467
P+ PAF+ R
Sbjct: 803 PKHPAFTAGR 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 229/517 (44%), Positives = 325/517 (62%), Gaps = 38/517 (7%)
Query: 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C F + M++PD +++ + LK C+ CL++C C A+ N+++ GGSGC++W
Sbjct: 341 CDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIW 400
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVL---IALPVVILPAFFIFYGRK 120
+++DM+ GQ +Y+R A++L K+ ++ I + +++L +F IF+ K
Sbjct: 401 TREILDMRNYAKG--GQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWK 458
Query: 121 RKLKE-------KGNMTRAKEFC--------EGDSAAKGKSKESWFIFFSLASISTATHN 165
RK K + R+++ G ++ + KS+ L +++TAT+N
Sbjct: 459 RKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNN 518
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
FS +NKLG+GGFG VYKG+LL+G+E+AVKRLS S QG +EF NE+ LIAKL H NLVRL
Sbjct: 519 FSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 578
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC+++GEK+LIYEY+ N SLD LFD SS L+W R II GIA
Sbjct: 579 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN------------LNWQKRFDIINGIA 626
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR+FG +E ++N R+VGTYG
Sbjct: 627 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYG 686
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAW 404
YMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN + L LLG W WK+
Sbjct: 687 YMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNEL 746
Query: 405 KLLDP----TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460
+++DP +L ++ + R I++ LLCVQE A DRP MS V+ M+ +E +P P++
Sbjct: 747 EIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKR 806
Query: 461 PAFSYVRI-VEKSVLLENSEAEASSGNCLTLSMVDAR 496
P F R +E + + N +TLS++DAR
Sbjct: 807 PGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-115, Method: Compositional matrix adjust.
Identities = 235/503 (46%), Positives = 321/503 (63%), Gaps = 38/503 (7%)
Query: 2 SDCKSGSQFIKFDDMQVPDLLEVLLN--ESVNLKECEAECLKNCTCRAYGNSNLIGGGSG 59
++C+ F+KF +++PD + + L++C+ +C NC+C AY N+++ GG G
Sbjct: 343 TNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKG 402
Query: 60 CLMWFGDMIDMKRTLGNLTGQSIYLRAPASQL---GKKKTLWIVVLIALPVVILPAFFIF 116
CL+WFGD++DM+ + GQ +Y+R +++ G++ +V + V+L F
Sbjct: 403 CLLWFGDLVDMREY--SSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFAC 460
Query: 117 YGRKRKLKEKGNMTRAKEFCEGDSAAKGKSKESWFI-FFSLASISTATHNFSEENKLGEG 175
+ RK+ +K G++ KG +E + F +IS AT +FS N LG G
Sbjct: 461 F-RKKIMKRY----------RGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRG 509
Query: 176 GFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235
GFGPVYKGKL +G+E+AVKRLS SGQGVEEFKNE+ LIAKL HRNLVRL GCCI+ E
Sbjct: 510 GFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEEC 569
Query: 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS 295
+LIYEYMPNKSLDFF+FD + S+ LDW R+ II G+A+G+LYLHQ S
Sbjct: 570 MLIYEYMPNKSLDFFIFDERRSTE------------LDWKKRMNIINGVARGILYLHQDS 617
Query: 296 RLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG 355
RLR+IHRDLKA NVLLD DMNPKISDFG+A+ FGGD+ +S+ NR+VGTYGYM PEYA+ G
Sbjct: 618 RLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDG 677
Query: 356 LFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRA-WKLLDPTLQN 413
FS+KSDVFSFGVL+LE ++ K N F + D L LLGH W +W +DR + L+
Sbjct: 678 HFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEE 737
Query: 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSV 473
++ P V R I VALLCVQ+ DRPTM+ VV M ++ +LP P QP F ++V
Sbjct: 738 TSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSD-SSLPHPTQPGF----FTNRNV 792
Query: 474 LLENSEAEASSGNCLTLSMVDAR 496
+S S N ++++M+ R
Sbjct: 793 PDISSSLSLRSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 225/471 (47%), Positives = 300/471 (63%), Gaps = 61/471 (12%)
Query: 34 ECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMIDMKRTLGNLTGQSIYLRAPASQLGK 93
+C +CL+NC+C AY ++N G G+GC +W D + + ++IY+R S+L
Sbjct: 366 DCYVKCLQNCSCVAYASTN--GDGTGCEIWNTDPTN--ENSASHHPRTIYIRIKGSKLAA 421
Query: 94 KKTLWIVVLIALPVVILPAFFIFYGRKRKLKEKGN--MTRAKEFCEGDSAAKGKSKESWF 151
W+VV+ +L ++I + I Y RK K KG ++ + + S + + S
Sbjct: 422 T---WLVVVASLFLIIPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCSLTNKRLSTL 478
Query: 152 ----------------------------------IFFSLASISTATHNFSEENKLGEGGF 177
FS S++ AT FS+ NKLGEGGF
Sbjct: 479 RVGSTIDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGF 538
Query: 178 GPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237
GPVYKG+L++GEEVA+KRLS SGQG+ EFKNE +LIAKL H NLV+L GCC+E+ EK+L
Sbjct: 539 GPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKML 598
Query: 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRL 297
IYEYMPNKSLD+FLFD P K +LDW R RI+EGI QGLLYLH+YSRL
Sbjct: 599 IYEYMPNKSLDYFLFD------------PLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRL 646
Query: 298 RVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF 357
+VIHRD+KA N+LLD DMNPKISDFG+AR+FG E ++N R+ GT+GYMSPEY GLF
Sbjct: 647 KVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLF 706
Query: 358 SIKSDVFSFGVLLLETLSSKKNTRFYNIDS---LTLLGHAWNLWKDDRAWKLLDPTLQNE 414
S KSDVFSFGVL+LE + +KN F++ DS L L+ H WNL+K++R +++DP+L +
Sbjct: 707 SAKSDVFSFGVLMLEIICGRKNNSFHH-DSEGPLNLIVHVWNLFKENRVREVIDPSLGDS 765
Query: 415 AL-YPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN-LPSPQQPAF 463
A+ P V R ++VALLCVQ+NA DRP+M +VVSMI + N L P++PAF
Sbjct: 766 AVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 221/498 (44%), Positives = 305/498 (61%), Gaps = 44/498 (8%)
Query: 10 FIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMID 69
F+K M+VP E + + C CL NC+C AY G GC++W GD++D
Sbjct: 367 FLKLQKMKVPISAE---RSEASEQVCPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVD 419
Query: 70 MKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVLIALPVV----ILPAFFIFYGRKRKLKE 125
M+ LG +G +++R S+L L V+IA PV+ I + RK K +
Sbjct: 420 MQSFLG--SGIDLFIRVAHSELKTHSNL--AVMIAAPVIGVMLIAAVCVLLACRKYKKRP 475
Query: 126 KGNMTRAKEF--------CEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGF 177
R+ E + +A + K F ++T+T +FS NKLG+GGF
Sbjct: 476 APAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGF 535
Query: 178 GPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237
GPVYKGKL G+E+AVKRLS KSGQG+EE NE+++I+KL HRNLV+L GCCIE E++L
Sbjct: 536 GPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERML 595
Query: 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRL 297
+YEYMP KSLD +LFD P + ILDW TR I+EGI +GLLYLH+ SRL
Sbjct: 596 VYEYMPKKSLDAYLFD------------PMKQKILDWKTRFNIMEGICRGLLYLHRDSRL 643
Query: 298 RVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF 357
++IHRDLKASN+LLD ++NPKISDFG+AR+F +E ++N R+VGTYGYMSPEYA+ G F
Sbjct: 644 KIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFF 703
Query: 358 SIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAWKLLDPTLQNEAL 416
S KSDVFS GV+ LE +S ++N+ + + +L LL +AW LW D A L DP + ++
Sbjct: 704 SEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCF 763
Query: 417 YPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVLLE 476
+++ + + LLCVQE A DRP +S V+ M+ E ++L P+QPAF IV +
Sbjct: 764 EKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAF----IVRRGA--- 816
Query: 477 NSEAEASSGNCLTLSMVD 494
SEAE+S + +S+ D
Sbjct: 817 -SEAESSDQSSQKVSIND 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | ||||||
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.937 | 0.671 | 0.527 | 1e-144 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.941 | 0.539 | 0.539 | 1e-141 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.941 | 0.733 | 0.536 | 1e-140 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.879 | 0.219 | 0.539 | 1e-139 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.933 | 0.547 | 0.513 | 1e-135 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.939 | 0.561 | 0.529 | 1e-134 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.939 | 0.691 | 0.533 | 1e-133 | |
| 359493709 | 894 | PREDICTED: receptor-like serine/threonin | 0.911 | 0.505 | 0.538 | 1e-133 | |
| 296090091 | 674 | unnamed protein product [Vitis vinifera] | 0.895 | 0.658 | 0.541 | 1e-132 | |
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.925 | 0.561 | 0.506 | 1e-132 |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-144, Method: Compositional matrix adjust.
Identities = 270/512 (52%), Positives = 358/512 (69%), Gaps = 47/512 (9%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
+F+K +++ P ++L E+ +++ C+ CL C+C AY ++ CLMW ++
Sbjct: 204 KFLKMANVKFPQSPQIL--ETQSIETCKMTCLNKCSCNAYAHN------GSCLMWDQILL 255
Query: 69 DMKR-TLGNLTGQSIYLRAPASQLGK----KKTLWIVVLIALPVVILPAF-FIFYGRKRK 122
++++ + + G+++YL+ AS+L K W++ ++ + V++L +I Y + ++
Sbjct: 256 NLQQLSKKDPDGRTLYLKLAASELQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKR 315
Query: 123 LKEKGNMTRAK----------------EFCEGDSAAKGKSKESWFIFFSLASISTATHNF 166
++++ MT ++ E EG+ K K+K++W FS AS+S AT +F
Sbjct: 316 VQDREEMTTSQDILLYEFGMGSKATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHF 375
Query: 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
S ENKLG+GGFGPVYKG+L NG+E+AVKRLS SGQG+EE KNE +L+A+L HRNLVRL
Sbjct: 376 STENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLL 435
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
GCCIEQGEKILIYEYMPNKSLD FLFD P +G LDW RV IIEGIAQ
Sbjct: 436 GCCIEQGEKILIYEYMPNKSLDSFLFD------------PNKRGQLDWAKRVSIIEGIAQ 483
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GLLYLH+YSRLR+IHRDLKASN+LLD DMNPKISDFG+ARMFGG+E +N NRIVGTYGY
Sbjct: 484 GLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGY 543
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKL 406
MSPEYAL GLFS KSDVFSFGVL+LE LS KKNT FYN D+L L+G+AW LWK D A L
Sbjct: 544 MSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINL 603
Query: 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYV 466
+DP L+ ++ M+ RYI V LLCV+E AADRPT+SEVVSM+ NE+ LPSP+ PAFS V
Sbjct: 604 MDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFSTV 663
Query: 467 RIVE--KSVLLENSEAEASSGNCLTLSMVDAR 496
R +E +S + S E S N L++S+++AR
Sbjct: 664 RSMENPRSSM---SRPEIYSANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-141, Method: Compositional matrix adjust.
Identities = 271/502 (53%), Positives = 344/502 (68%), Gaps = 35/502 (6%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
QF + ++++PD L + +CE++CL NC+C AY C +W GD++
Sbjct: 385 QFYRVSNVRLPDYPLTL--PTSGAMQCESDCLNNCSCSAYSYYM-----EKCTVWGGDLL 437
Query: 69 DMKR-TLGNLTGQSIYLRAPASQLGKK--KTLWIVVLIALPVVILPAFFIFYGRKRKLKE 125
++++ + N GQ YL+ AS+L K + W V LI + + + F+ +G +R+L+
Sbjct: 438 NLQQLSDDNSNGQDFYLKLAASELSGKVSSSKWKVWLIVTLAISVTSAFVIWGIRRRLRR 497
Query: 126 KG-----------NMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGE 174
KG ++ E E G+ KE FS AS+S AT+NFS ENKLGE
Sbjct: 498 KGENLLLFDLSNSSVDTNYELSETSKLWSGEKKEVDLPMFSFASVSAATNNFSIENKLGE 557
Query: 175 GGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234
GGFGPVYKGK G EVAVKRLS +SGQG EE KNE++LIAKL H+NLV+LFG CIE+ E
Sbjct: 558 GGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDE 617
Query: 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY 294
KILIYEYMPNKSLDFFLFD P GIL+W TRV II+G+AQGLLYLHQY
Sbjct: 618 KILIYEYMPNKSLDFFLFD------------PTKHGILNWKTRVHIIKGVAQGLLYLHQY 665
Query: 295 SRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH 354
SRLR+IHRDLKASN+LLD DMNP+ISDFG+AR+FGG+E ++ N IVGTYGYMSPEYAL
Sbjct: 666 SRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKAT-NHIVGTYGYMSPEYALE 724
Query: 355 GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE 414
GLFS KSDVFSFGVLLLE LS KKNT FY DSL LLG+AW+LWKD R +L+DP L+
Sbjct: 725 GLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLEET 784
Query: 415 ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVL 474
++ RYI + LLCVQE+A DRPTMS+VVSM+ NE V LPSP+QPAFS +R + +
Sbjct: 785 LPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHI 844
Query: 475 LENSEAEASSGNCLTLSMVDAR 496
+N + + S N +TLS+++AR
Sbjct: 845 SQN-KPKICSLNGVTLSVMEAR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 504 bits (1298), Expect = e-140, Method: Compositional matrix adjust.
Identities = 271/505 (53%), Positives = 344/505 (68%), Gaps = 38/505 (7%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
QF + ++++PD L + +CE++CL NC+C AY C +W GD++
Sbjct: 154 QFYRVSNVRLPDYPLTL--PTSGAMQCESDCLNNCSCSAYSYYM-----EKCTVWGGDLL 206
Query: 69 DMKR-TLGNLTGQSIYLRAPASQLGKK-----KTLWIVVLIALPVVILPAFFIFYGRKRK 122
++++ + N GQ YL+ AS+L K + W V LI + + + F+ +G +R+
Sbjct: 207 NLQQLSDDNSNGQDFYLKLAASELSGKGNKISSSKWKVWLIVTLAISVTSAFVIWGIRRR 266
Query: 123 LKEKG-----------NMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENK 171
L+ KG ++ E E G+ KE FS AS+S AT+NFS ENK
Sbjct: 267 LRRKGENLLLFDLSNSSVDTNYELSETSKLWSGEKKEVDLPMFSFASVSAATNNFSIENK 326
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231
LGEGGFGPVYKGK G EVAVKRLS +SGQG EE KNE++LIAKL H+NLV+LFG CIE
Sbjct: 327 LGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIE 386
Query: 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYL 291
+ EKILIYEYMPNKSLDFFLFD P GIL+W TRV II+G+AQGLLYL
Sbjct: 387 KDEKILIYEYMPNKSLDFFLFD------------PTKHGILNWKTRVHIIKGVAQGLLYL 434
Query: 292 HQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEY 351
HQYSRLR+IHRDLKASN+LLD DMNP+ISDFG+AR+FGG+E ++ N IVGTYGYMSPEY
Sbjct: 435 HQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKAT-NHIVGTYGYMSPEY 493
Query: 352 ALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTL 411
AL GLFS KSDVFSFGVLLLE LS KKNT FY DSL LLG+AW+LWKD R +L+DP L
Sbjct: 494 ALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGL 553
Query: 412 QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEK 471
+ ++ RYI + LLCVQE+A DRPTMS+VVSM+ NE V LPSP+QPAFS +R +
Sbjct: 554 EETLPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVE 613
Query: 472 SVLLENSEAEASSGNCLTLSMVDAR 496
+ +N + + S N +TLS+++AR
Sbjct: 614 PHISQN-KPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1294), Expect = e-139, Method: Compositional matrix adjust.
Identities = 258/478 (53%), Positives = 338/478 (70%), Gaps = 42/478 (8%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
+F+K +++ P ++L E+ +++ C+ CL C+C AY ++ CLMW ++
Sbjct: 621 KFLKMANVKFPQSPQIL--ETQSIETCKMTCLNKCSCNAYAHN------GSCLMWDQILL 672
Query: 69 DMKR-TLGNLTGQSIYLRAPASQLGK----KKTLWIVVLIALPVVILPAF-FIFYGRKRK 122
++++ + + G+++YL+ AS+L K W++ ++ + V++L +I Y + ++
Sbjct: 673 NLQQLSKKDPDGRTLYLKLAASELQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKR 732
Query: 123 LKEKGNMTRAK----------------EFCEGDSAAKGKSKESWFIFFSLASISTATHNF 166
++++ MT ++ E EG+ K K+K++W FS AS+S AT +F
Sbjct: 733 VQDREEMTTSQDILLYEFGMGSKATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHF 792
Query: 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
S ENKLG+GGFGPVYKG+L NG+E+AVKRLS SGQG+EE KNE +L+A+L HRNLVRL
Sbjct: 793 STENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLL 852
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
GCCIEQGEKILIYEYMPNKSLD FLFD P +G LDW RV IIEGIAQ
Sbjct: 853 GCCIEQGEKILIYEYMPNKSLDSFLFD------------PNKRGQLDWAKRVSIIEGIAQ 900
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GLLYLH+YSRLR+IHRDLKASN+LLD DMNPKISDFG+ARMFGG+E +N NRIVGTYGY
Sbjct: 901 GLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGY 960
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKL 406
MSPEYAL GLFS KSDVFSFGVL+LE LS KKNT FYN D+L L+G+AW LWK D A L
Sbjct: 961 MSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINL 1020
Query: 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFS 464
+DP L+ ++ M+ RYI V LLCV+E AADRPT+SEVVSM+ NE+ LPSP+ PAFS
Sbjct: 1021 MDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFS 1078
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1252), Expect = e-135, Method: Compositional matrix adjust.
Identities = 266/518 (51%), Positives = 340/518 (65%), Gaps = 55/518 (10%)
Query: 10 FIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMID 69
F+K + +P+ + + V++ C C+KNC C AY ++ SGC +W GD+I+
Sbjct: 353 FLKMSILTLPENSKAY--QKVSVARCRLYCMKNCYCVAYAYNS-----SGCFLWEGDLIN 405
Query: 70 MKRT--LGNLTGQSIYLRAPASQLGK-----KKTLWIVVLIALPVVILP-AFFIFYG--R 119
+K++ G IY+R AS+L K + + +A+PV ++ F ++ R
Sbjct: 406 LKQSEIAAGRAGAEIYIRLAASELEPQIGNIKWKIRTTLAVAVPVTLITLGLFTYFSCLR 465
Query: 120 KRKLKEKGNMTRAK-------------------EFCEGDSAAKGKSKESWFIFFSLASIS 160
K KL KG ++ + E D+ K SK F FS S+S
Sbjct: 466 KGKLIHKGTSSKERTGHNLLRFDFDADPNSTTNESSSVDNRKKRWSKNIEFPLFSYESVS 525
Query: 161 TATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR 220
AT FS+ KLGEGGFGPVYKGKL G E+AVKRLS +SGQG+EEF+NE LIAKL HR
Sbjct: 526 VATGQFSD--KLGEGGFGPVYKGKLPTGLEIAVKRLSERSGQGLEEFRNETTLIAKLQHR 583
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG-ILDWTTRVR 279
NLVRL G CIE+ EK+LIYEYMPNKSLDFFLFD A++G ILDW TR+R
Sbjct: 584 NLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFD-------------ANRGQILDWGTRIR 630
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
IIEGIAQGLLYLH+YSRLR+IHRDLK SN+LLD +MNPKISDFG+AR+FGG+E Q++ NR
Sbjct: 631 IIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGGNETQAHTNR 690
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
IVGTYGYMSPEYA+ GLFSIKSDVFSFGVL+LE +S KKNT FY+ D+L LLGHAW LW
Sbjct: 691 IVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSDTLHLLGHAWKLWN 750
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
++A L+DP L + + RYI + LLCVQE+ ADRPTMS+V+SMI NE V LP P+
Sbjct: 751 SNKALDLMDPILGDPPSTATLLRYINIGLLCVQESPADRPTMSDVISMIANEHVALPEPK 810
Query: 460 QPAFSYVR-IVEKSVLLENSEAEASSGNCLTLSMVDAR 496
QPAF R + E+ L+ S + S N +T++ +D R
Sbjct: 811 QPAFVACRNMAEQGPLM--SSSGVPSVNNMTITAIDGR 846
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1245), Expect = e-134, Method: Compositional matrix adjust.
Identities = 266/502 (52%), Positives = 334/502 (66%), Gaps = 36/502 (7%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
QF+ ++++P L S ECE+ CL C+C AY C +W GD++
Sbjct: 351 QFLLVSNVRLPKYPVTLQARSA--MECESICLNRCSCSAYAYKR------ECRIWAGDLV 402
Query: 69 DMKRTL-GNLTGQSIYLRAPASQLGKK--KTLWIVVLIALPVVILPAFFIFYGRKRKLKE 125
++++ G+ G+S Y++ AS+L K+ + W V LI + L + F+ YG + +
Sbjct: 403 NVEQLPDGDSNGRSFYIKLAASELNKRVSSSKWKVWLIITLAISLTSAFVIYGIWGRFRR 462
Query: 126 KG-----------NMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGE 174
KG + + E E + +G+ +E FS AS+S +T+NFS ENKLGE
Sbjct: 463 KGEDLLVFDFGNSSEDTSYELDETNRLWRGEKREVDLPMFSFASVSASTNNFSIENKLGE 522
Query: 175 GGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234
GGFG VYKGK EVAVKRLS +S QG EE KNE +LIAKL H+NLV++ G CIE+ E
Sbjct: 523 GGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDE 582
Query: 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY 294
KILIYEYM NKSLDFFLFD P GIL+W TRV IIEG+AQGLLYLHQY
Sbjct: 583 KILIYEYMSNKSLDFFLFD------------PTKHGILNWKTRVHIIEGVAQGLLYLHQY 630
Query: 295 SRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH 354
SRLR+IHRDLKASN+LLD DMNPKISDFG+AR+FGG+E + N IVGTYGYMSPEYAL
Sbjct: 631 SRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKVT-NHIVGTYGYMSPEYALE 689
Query: 355 GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE 414
GLFS KSDVFSFGVLLLE LS KKNT FY DSL LLG+AW+LWKD R +L+DP L+
Sbjct: 690 GLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEET 749
Query: 415 ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVL 474
++ RYI V LLCVQE+A DRPTMS+VVSM+ NE V LPSP+QPAFS +R + +
Sbjct: 750 LPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHI 809
Query: 475 LENSEAEASSGNCLTLSMVDAR 496
+N E S N +TLS+++AR
Sbjct: 810 SQN-RPEVCSLNGVTLSVMEAR 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-133, Method: Compositional matrix adjust.
Identities = 269/504 (53%), Positives = 336/504 (66%), Gaps = 38/504 (7%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
QF+ ++++P L S ECE+ CL C+C AY C +W GD++
Sbjct: 193 QFLLVSNVRLPKYPVTLQARSA--MECESICLNRCSCSAYAYKR------ECRIWAGDLV 244
Query: 69 DMKRTL-GNLTGQSIYLRAPASQL---GKKK-TLWIVVLIALPVVILPAFFIFYGRKRKL 123
++++ G+ G+S Y++ AS+L GKKK + W V LI + L + F+ YG +
Sbjct: 245 NVEQLPDGDSNGRSFYIKLAASELNKRGKKKDSKWKVWLIITLAISLTSAFVIYGIWGRF 304
Query: 124 KEKG-----------NMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKL 172
+ KG + + E E + +G+ +E FS AS+S +T+NFS ENKL
Sbjct: 305 RRKGEDLLVFDFGNSSEDTSYELDETNRLWRGEKREVDLPMFSFASVSASTNNFSIENKL 364
Query: 173 GEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232
GEGGFG VYKGK EVAVKRLS +S QG EE KNE +LIAKL H+NLV++ G CIE+
Sbjct: 365 GEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIER 424
Query: 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH 292
EKILIYEYM NKSLDFFLFD P GIL+W TRV IIEG+AQGLLYLH
Sbjct: 425 DEKILIYEYMSNKSLDFFLFD------------PTKHGILNWKTRVHIIEGVAQGLLYLH 472
Query: 293 QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA 352
QYSRLR+IHRDLKASN+LLD DMNPKISDFG+AR+FGG+E + N IVGTYGYMSPEYA
Sbjct: 473 QYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKVT-NHIVGTYGYMSPEYA 531
Query: 353 LHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQ 412
L GLFS KSDVFSFGVLLLE LS KKNT FY DSL LLG+AW+LWKD R +L+DP L+
Sbjct: 532 LEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLE 591
Query: 413 NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKS 472
++ RYI V LLCVQE+A DRPTMS+VVSM+ NE V LPSP+QPAFS +R +
Sbjct: 592 ETLPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEP 651
Query: 473 VLLENSEAEASSGNCLTLSMVDAR 496
+ +N E S N +TLS+++AR
Sbjct: 652 HISQN-RPEVCSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 263/488 (53%), Positives = 322/488 (65%), Gaps = 36/488 (7%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
QF+ ++++P L S ECE+ CL C+C AY C +W GD++
Sbjct: 354 QFLLVSNVRLPKYPVTLQARSA--MECESICLNRCSCSAYAYEG------ECRIWGGDLV 405
Query: 69 DMKRTL-GNLTGQSIYLRAPASQLGKK--KTLWIVVLIALPVVILPAFFIFYGRKRKLKE 125
++++ G+ +S Y++ AS+L K+ + W V LI + L + F+ YG K +
Sbjct: 406 NVEQLPDGDSNARSFYIKLAASELNKRVSSSKWKVWLIITLAISLTSAFVIYGIWGKFRR 465
Query: 126 KGNM------------TRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLG 173
KG T E E + +G+ KE FS S+S +T+NF ENKLG
Sbjct: 466 KGEDLLVFDFGNSSEDTSCYELGETNRLWRGEKKEVDLPMFSFVSVSASTNNFCIENKLG 525
Query: 174 EGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233
EGGFG VYKGK G EVAVKRLS +S QG EE KNE +LIAKL H+NLV++ G CIE+
Sbjct: 526 EGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERD 585
Query: 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293
EKILIYEYM NKSLDFFLFD PA +GIL+W TRVRIIEG+AQGLLYLHQ
Sbjct: 586 EKILIYEYMSNKSLDFFLFD------------PAKRGILNWETRVRIIEGVAQGLLYLHQ 633
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
YSRLRVIHRDLKASN+LLD DMNPKISDFG+AR+FGG+E ++ IVGTYGYMSPEYAL
Sbjct: 634 YSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKAT-KHIVGTYGYMSPEYAL 692
Query: 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413
GLFS KSDVFSFGVLLLE LS KKNT FY DSL LLG+AW+LWKD R +L+DP L+
Sbjct: 693 EGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLEE 752
Query: 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSV 473
++ RYI V LLCVQE+A DRPTMS+VVSM+ NE V LPSP+QPAFS +R
Sbjct: 753 TLPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGTHKS 812
Query: 474 LLENSEAE 481
L N + E
Sbjct: 813 LSSNPDLE 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1231), Expect = e-132, Method: Compositional matrix adjust.
Identities = 259/478 (54%), Positives = 323/478 (67%), Gaps = 34/478 (7%)
Query: 34 ECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMIDMKRTL-GNLTGQSIYLRAPASQLG 92
ECE+ CL +C C AY G C +W GD++++++ G+ G+S Y++ AS+L
Sbjct: 216 ECESICLNSCPCSAYAYE-----GEECRIWGGDLVNVEQLPDGDSNGRSFYIKLAASELN 270
Query: 93 KK--KTLWIVVLIALPVVILPAFFIFYGRKRKLKEKGNM------------TRAKEFCEG 138
K+ + W V LI + L + F+ YG + + KG T E E
Sbjct: 271 KRVSSSEWKVWLIVTLAISLTSAFVIYGIWGRFRRKGEDLLLFDFGNSSEDTSCYELGET 330
Query: 139 DSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSN 198
+ +G+ KE FS AS+S +T+NF ENKLGEGGFG VYKGK EVAVKRLS
Sbjct: 331 NRLWRGEKKEVDLPMFSFASVSASTNNFCNENKLGEGGFGSVYKGKSQRRYEVAVKRLSK 390
Query: 199 KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS 258
+S QG EE KNE +LIAKL H+NLV++ G CIE+ EKILIYEYM NKSLDFFLFD
Sbjct: 391 RSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFD----- 445
Query: 259 GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
P GIL+W T V IIEG+AQGLLYLHQYSR+R+IHRDLKASN+LLD DMNPK
Sbjct: 446 -------PTKHGILNWKTWVHIIEGVAQGLLYLHQYSRMRIIHRDLKASNILLDKDMNPK 498
Query: 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
ISDFG+AR+FGG+E ++ N IVGTYGYMSPEYAL GLFS KSDVFSFGVLL+E LS KK
Sbjct: 499 ISDFGMARIFGGNEPKAT-NHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLMEILSGKK 557
Query: 379 NTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR 438
NT FY DSL LLG+AW+LWKD R +L+DP L+ + ++ RYI V LLCVQE+A DR
Sbjct: 558 NTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLEETSPTHILLRYINVGLLCVQESADDR 617
Query: 439 PTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVLLENSEAEASSGNCLTLSMVDAR 496
PTMS+VVSM+ NE V LPSP+QPAFS +R + + +N S N +TLS+++AR
Sbjct: 618 PTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPG-IYSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1230), Expect = e-132, Method: Compositional matrix adjust.
Identities = 255/503 (50%), Positives = 331/503 (65%), Gaps = 44/503 (8%)
Query: 9 QFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
+F+K ++ +P + +E+ N CE +CL +C+C + +N SGC +W GD++
Sbjct: 345 EFLKMSNLTLPTNSKA--HEAANATRCELDCLGSCSCTVFAYNN-----SGCFVWEGDLV 397
Query: 69 DMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVLIALPVVILP-AFFIF--YGRKRKLKE 125
++++ G G +Y+ Q+G K+ ++ + +PV ++ FI+ Y RK KL
Sbjct: 398 NLQQQAGE--GYFLYI-----QIGNKRRTRAILAVVIPVTLITFGLFIYCCYLRKSKLHH 450
Query: 126 KGNMTRAKEFCEGD------------SAAKGKSKESWFIFFSLASISTATHNFSEENKLG 173
KG ++ D S+ + K FS S+S T FS +KLG
Sbjct: 451 KGEEDTSENLLFFDFDTCPNSTNNVPSSVDNRRKNVELPLFSYESVSAVTEQFS--HKLG 508
Query: 174 EGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233
EGGFGPVYKGKL NG EVAVKRLS +SGQG+EEF+NE ++IA+L HRNLVRL GCCIE+
Sbjct: 509 EGGFGPVYKGKLSNGVEVAVKRLSKRSGQGLEEFRNETMVIARLQHRNLVRLLGCCIERD 568
Query: 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293
EKILIYEYMPNKSLDFFLFD + ILDW +RVRIIEGIAQGLLYLH+
Sbjct: 569 EKILIYEYMPNKSLDFFLFDAN------------KRQILDWGSRVRIIEGIAQGLLYLHR 616
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
YSRLR+IHRDLK SN+LLD +MNPKISDFG+AR+FG E ++N +I GTYGYMSPEYA+
Sbjct: 617 YSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGDSETEANTKKIAGTYGYMSPEYAM 676
Query: 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413
GLFSIKSDVFSFGVLLLE +S +KNT FY+ DSL LLGHAW W RA L+DP L +
Sbjct: 677 DGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDSLNLLGHAWKSWNSSRALDLMDPVLGD 736
Query: 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSV 473
++ R+I + LLCVQE+ ADRPTMS+V SMI NE LP+P+QPAF+ R + +
Sbjct: 737 PPSTSVLLRHINIGLLCVQESPADRPTMSDVFSMIVNEHAPLPAPKQPAFATGRNMGDTS 796
Query: 474 LLENSEAEASSGNCLTLSMVDAR 496
S A S N +T++M+DAR
Sbjct: 797 -SSTSSAGFPSVNNVTVTMMDAR 818
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 496 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.683 | 0.432 | 0.526 | 3.1e-108 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.691 | 0.403 | 0.557 | 3.5e-107 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.957 | 0.560 | 0.445 | 2.2e-105 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.945 | 0.552 | 0.446 | 2.8e-105 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.963 | 0.567 | 0.442 | 3.6e-105 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.965 | 0.563 | 0.436 | 7.5e-105 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.941 | 0.550 | 0.446 | 6e-103 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.935 | 0.551 | 0.430 | 2.9e-96 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.925 | 0.553 | 0.434 | 1.6e-95 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.655 | 0.485 | 0.541 | 3.8e-94 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 191/363 (52%), Positives = 253/363 (69%)
Query: 140 SAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK 199
S+ K + ++ F L ++S AT FS NKLG+GGFGPVYKG L G+EVAVKRLS
Sbjct: 439 SSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRT 498
Query: 200 SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG 259
S QGVEEFKNE+ LIAKL HRNLV++ G C+++ E++LIYEY PNKSLD F+FD +
Sbjct: 499 SRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKE---- 554
Query: 260 FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319
+ LDW RV II+GIA+G+LYLH+ SRLR+IHRDLKASNVLLD DMN KI
Sbjct: 555 --------RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKI 606
Query: 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379
SDFG+AR GGDE ++N R+VGTYGYMSPEY + G FS+KSDVFSFGVL+LE +S ++N
Sbjct: 607 SDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRN 666
Query: 380 TRFYNID-SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPM--VKRYIKVALLCVQENAA 436
F N + L LLGHAW + +D+A++++D + NE+ + V R I + LLCVQ++
Sbjct: 667 RGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAV-NESCTDISEVLRVIHIGLLCVQQDPK 725
Query: 437 DRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVLLENSEA---EASSGNCLTLSMV 493
DRP MS VV M+ +E++ L P+QP F E+++L ++ + E S N T+S++
Sbjct: 726 DRPNMSVVVLMLSSEMLLL-DPRQPGF----FNERNLLFSDTVSINLEIPSNNFQTMSVI 780
Query: 494 DAR 496
D R
Sbjct: 781 DPR 783
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 3.5e-107, Sum P(2) = 3.5e-107
Identities = 204/366 (55%), Positives = 264/366 (72%)
Query: 138 GDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLS 197
G +A+ + E FS S++ AT FS+ NKLGEGGFGPVYKG+L++GEEVA+KRLS
Sbjct: 501 GKRSARNNNNE--LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLS 558
Query: 198 NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYS 257
SGQG+ EFKNE +LIAKL H NLV+L GCC+E+ EK+LIYEYMPNKSLD+FLFD
Sbjct: 559 LASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFD---- 614
Query: 258 SGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317
P K +LDW R RI+EGI QGLLYLH+YSRL+VIHRD+KA N+LLD DMNP
Sbjct: 615 --------PLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNP 666
Query: 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
KISDFG+AR+FG E ++N R+ GT+GYMSPEY GLFS KSDVFSFGVL+LE + +
Sbjct: 667 KISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGR 726
Query: 378 KNTRFYNIDS---LTLLGHAWNLWKDDRAWKLLDPTLQNEALY-PMVKRYIKVALLCVQE 433
KN F++ DS L L+ H WNL+K++R +++DP+L + A+ P V R ++VALLCVQ+
Sbjct: 727 KNNSFHH-DSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQ 785
Query: 434 NAADRPTMSEVVSMIKNEIVN-LPSPQQPAFSYVRIVEKS--VLLENSEAEASSGNCLTL 490
NA DRP+M +VVSMI + N L P++PAF Y S + +E E E S N +T+
Sbjct: 786 NADDRPSMLDVVSMIYGDGNNALSLPKEPAF-YDGPPRSSPEMEVEPPEMENVSANRVTI 844
Query: 491 SMVDAR 496
++++AR
Sbjct: 845 TVMEAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
Identities = 232/521 (44%), Positives = 316/521 (60%)
Query: 4 CKSGSQFIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C F++ M++PD KECE CLK C C A+ N+++ GGSGC++W
Sbjct: 345 CDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIW 404
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWXXXXXXXXXXXXX---XFFIFYGRK 120
G + D++ GQ +Y+R A L K+ F IF+ K
Sbjct: 405 SGGLFDIRNYAKG--GQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWK 462
Query: 121 RKLKEK-------GNMTRAKEFCEGD--SAAKG-KSKESWFIFFSLA-----SISTATHN 165
RK K ++ R+++ + A++ SKE+ + L +++ AT+N
Sbjct: 463 RKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNN 522
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
FS +NKLG+GGFG VYKG LL+G+E+AVKRLS S QG +EF NE+ LIAKL H NLVRL
Sbjct: 523 FSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 582
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC+++GEK+LIYEY+ N SLD LFD SS L+W R II GIA
Sbjct: 583 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN------------LNWQKRFDIINGIA 630
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR+FG +E ++N R+VGTYG
Sbjct: 631 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYG 690
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAW 404
YMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN + L LLG W WK+ +
Sbjct: 691 YMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKEL 750
Query: 405 KLLDPTLQNEAL---YPM--VKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
+++DP + +AL +P + R I++ LLCVQE A DRP MS V+ M+ +E +P P+
Sbjct: 751 EIVDP-INIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPK 809
Query: 460 QPAFSYVRIVEKSVLLENSEAEASSGNC----LTLSMVDAR 496
+P F R S+ +++S + C +TLS++DAR
Sbjct: 810 RPGFCVGR---SSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 2.8e-105, P = 2.8e-105
Identities = 229/513 (44%), Positives = 327/513 (63%)
Query: 9 QFIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMI 68
+F+ +++PD ++C CL+NC+C AY +L+GG GC++W D++
Sbjct: 356 EFLTLKSVKLPDFEIPEHNLVDP-EDCRERCLRNCSCNAY---SLVGG-IGCMIWNQDLV 410
Query: 69 DMKRTLGNLTGQSIYLRAPASQLGK-KKTLWXXXXXXXXXXXXXXFF--IFYGRKRKLKE 125
D+++ G S+++R S++G+ +KT F + + KRK
Sbjct: 411 DLQQFEAG--GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDV 468
Query: 126 KG--------------NMTRAKEFCEGDSAA-----KGKS-KESWFIFFSLASISTATHN 165
G ++T++KE S + +GK+ S FSL +I+ AT++
Sbjct: 469 SGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATND 528
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
F +EN+LG GGFGPVYKG L +G E+AVKRLS KSGQGV+EFKNE+ILIAKL HRNLVRL
Sbjct: 529 FCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRL 588
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC E EK+L+YEYMPNKSLDFFLFD + ++DW R IIEGIA
Sbjct: 589 LGCCFEGEEKMLVYEYMPNKSLDFFLFD------------ETKQALIDWKLRFSIIEGIA 636
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLH+ SRLR+IHRDLK SNVLLD +MNPKISDFG+AR+FGG++ ++N R+VGTYG
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405
YMSPEYA+ GLFS+KSDV+SFGVLLLE +S K+NT + + +L+G+AW L+ R+ +
Sbjct: 697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEE 756
Query: 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465
L+DP ++ R I VA+LCVQ++AA+RP M+ V+ M++++ L +P+QP F+
Sbjct: 757 LVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTS 816
Query: 466 VR--IVEKSVLLENSEAEASSGNCLTLSMVDAR 496
R ++ + L++S+ S N +T ++V R
Sbjct: 817 TRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 3.6e-105, P = 3.6e-105
Identities = 229/518 (44%), Positives = 317/518 (61%)
Query: 4 CKSGSQFIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C F + M++PD K C+ CL++C C A+ N+++ GGSGC++W
Sbjct: 341 CDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIW 400
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKK-----KTLWXXXXXXXXXXXXXXFFIFYG 118
+++DM+ GQ +Y+R A++L K K + F F+
Sbjct: 401 TREILDMRNYAKG--GQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWK 458
Query: 119 RKRKLK---EKGNM--TRAKEFCEGDSAA--KG---KSKESWFI---FFSLASISTATHN 165
RK+K + N+ R+++ D +G K K+S ++ L +++TAT+N
Sbjct: 459 RKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNN 518
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
FS +NKLG+GGFG VYKG+LL+G+E+AVKRLS S QG +EF NE+ LIAKL H NLVRL
Sbjct: 519 FSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 578
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
GCC+++GEK+LIYEY+ N SLD LFD SS L+W R II GIA
Sbjct: 579 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN------------LNWQKRFDIINGIA 626
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GLLYLHQ SR R+IHRDLKASNVLLD +M PKISDFG+AR+FG +E ++N R+VGTYG
Sbjct: 627 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYG 686
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRAW 404
YMSPEYA+ G+FS+KSDVFSFGVLLLE +S K+N FYN + L LLG W WK+
Sbjct: 687 YMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNEL 746
Query: 405 KLLDPTLQNEAL---YPM--VKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
+++DP + ++L +P + R I++ LLCVQE A DRP MS V+ M+ +E +P P+
Sbjct: 747 EIVDP-INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPK 805
Query: 460 QPAFSYVRI-VEKSVLLENSEAEASSGNCLTLSMVDAR 496
+P F R +E + + N +TLS++DAR
Sbjct: 806 RPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 226/518 (43%), Positives = 313/518 (60%)
Query: 4 CKSGSQFIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C G F++ M++PD KECE +CL++C C A+ N+++ G GSGC+ W
Sbjct: 347 CGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTW 406
Query: 64 FGDMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWXXXXXXXXXXXXX---XFFIFYGRK 120
G++ D++ GQ +Y+R A+ L K+ F IF+ K
Sbjct: 407 TGELFDIRNYAKG--GQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWK 464
Query: 121 RKLKEK--------GNMTRAKEFCEGD---SAAKGKSKES-----WFIFFSLASISTATH 164
RK K + R+++ + S+ + S+E+ ++ AT+
Sbjct: 465 RKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATN 524
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
NFS NKLG+GGFG VYKGKLL+G+E+AVKRLS S QG +EFKNE+ LIA+L H NLVR
Sbjct: 525 NFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVR 584
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L CC++ GEK+LIYEY+ N SLD LFD +S L+W R II GI
Sbjct: 585 LLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK------------LNWQMRFDIINGI 632
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+GLLYLHQ SR R+IHRDLKASN+LLD M PKISDFG+AR+FG DE ++N ++VGTY
Sbjct: 633 ARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTY 692
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGHAWNLWKDDRA 403
GYMSPEYA+ G+FS+KSDVFSFGVLLLE +SSK+N FYN D L LLG W WK+ +
Sbjct: 693 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKG 752
Query: 404 WKLLDPTL-QNEALYPM--VKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460
+++DP + + + + + R I++ LLCVQE A DRPTMS V+ M+ +E +P P+
Sbjct: 753 LEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKA 812
Query: 461 PAFSYVRIV--EKSVLLENSEAEASSGNCLTLSMVDAR 496
P + R + S + + E+ + N +T+S++DAR
Sbjct: 813 PGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 6.0e-103, P = 6.0e-103
Identities = 231/517 (44%), Positives = 310/517 (59%)
Query: 5 KSGSQFIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMWF 64
+SG F+ +++ PD C CL NC+C AY + +GCL W
Sbjct: 357 QSGDGFLPMGNIKWPDFSYWVSTVGDE-PGCRTVCLNNCSCGAY----VYTATTGCLAWG 411
Query: 65 GDMIDMKRTLGNLTGQ-SIYLRAPASQLGKKKTLWXXXXXXXXXXX---XXXFFIFYGRK 120
++IDM TG ++ L+ PAS+L +W +++
Sbjct: 412 NELIDMHELQ---TGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHG 468
Query: 121 RKLKE--------KGNMTRAKEFCE----------GDSAAKGKSKESWFIFFSLASISTA 162
R +K+ + + T++++ D GKS E +SL I TA
Sbjct: 469 RNIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGKSHE--LKVYSLDRIRTA 526
Query: 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
T NFS+ NKLGEGGFGPVY G L GEEVAVKRL SGQG+EEFKNE+ILIAKL HRNL
Sbjct: 527 TSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNL 586
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL GCCI + EKIL+YEYMPNKSLD FLF+ P + +LDW R IIE
Sbjct: 587 VRLLGCCIPREEKILVYEYMPNKSLDAFLFN------------PEKQRLLDWKKRFDIIE 634
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
GIA+GLLYLH+ SRLRV+HRDLKASN+LLD DM PKISDFG+ARMFGGD+ Q N NR+VG
Sbjct: 635 GIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVG 694
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY-NIDSLTLLGHAWNLWKDD 401
T+GYMSPEYA+ G+FS+KSDV+ FGVL+LE ++ K+ F+ + DSL + G+AW W +D
Sbjct: 695 TFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNED 754
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQP 461
A +L+DP ++ V R I +ALLCVQ++A +RP + V+ M+ N+ +LP+P+ P
Sbjct: 755 NAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPP 814
Query: 462 AFSYV-RIVEKSVLLENSEAEAS-SGNCLTLSMVDAR 496
R +E S ++SE + S S +T++ + R
Sbjct: 815 TLMLRGREIESS---KSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 217/504 (43%), Positives = 303/504 (60%)
Query: 10 FIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMID 69
F ++VPD + C+ C ++C+C+AY L+ G GC++W D+ID
Sbjct: 362 FTVLKGIKVPDFGSVVLHNNS--ETCKDVCARDCSCKAYA---LVVG-IGCMIWTRDLID 415
Query: 70 MKRTLGNLTGQSIYLRAPASQLGKKK---TLWXXXXXXXXXXXXXX-FFIFYGRKRKLK- 124
M+ G SI +R S+LG K TLW +I + K+ LK
Sbjct: 416 MEHF--ERGGNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKA 473
Query: 125 ---EKGNMTRAKEFCEG----DSAAK---GKSKESWFI-FFSLASISTATHNFSEENKLG 173
+K ++T + E S K G ++ + FS S+++AT +F+EENKLG
Sbjct: 474 FLWKKKDIT-VSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLG 532
Query: 174 EGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233
+GGFG VYKG G E+AVKRLS KS QG+EEFKNE++LIAKL HRNLVRL GCCIE
Sbjct: 533 QGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDN 592
Query: 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293
EK+L+YEYMPNKSLD FLFD + +G LDW R +I GIA+GLLYLH+
Sbjct: 593 EKMLLYEYMPNKSLDRFLFD------------ESKQGSLDWRKRWEVIGGIARGLLYLHR 640
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
SRL++IHRDLKASN+LLD +MNPKISDFG+AR+F + +N R+VGTYGYM+PEYA+
Sbjct: 641 DSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAM 700
Query: 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413
G+FS KSDV+SFGVL+LE +S +KN F D +L+G+AW+LW + +++DP +++
Sbjct: 701 EGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKD 760
Query: 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAF-SYVRIVEKS 472
R I V +LC Q++ RP M V+ M++++ LP P+QP F S++
Sbjct: 761 TRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLN--SGD 818
Query: 473 VLLENSEAEASSGNCLTLSMVDAR 496
+ L + +S N +T + + R
Sbjct: 819 IELNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 219/504 (43%), Positives = 299/504 (59%)
Query: 10 FIKFDDMQVPDXXXXXXXXXXXXKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMID 69
F++ M+VP ++C CLKNC+C AY G GCL+W G+++D
Sbjct: 355 FVRVQKMKVPHNPQRSGANE---QDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMD 407
Query: 70 MKRTLGNLTGQSIYLRAPASQLGKKKTLWXXXXXXXXXXXXXXFFIFYG-------RKRK 122
M+ G TG Y+R S+ KK+T F+F G + K
Sbjct: 408 MQEFSG--TGVVFYIRLADSEF-KKRT---NRSIVITVTLLVGAFLFAGTVVLALWKIAK 461
Query: 123 LKEKGNMTRA-KEFCEG----DSAA----KGKSKESWFIFFSLASISTATHNFSEENKLG 173
+EK TR E E D A + K KE F ++ AT+NFS NKLG
Sbjct: 462 HREKNRNTRLLNERMEALSSNDVGAILVNQYKLKE--LPLFEFQVLAVATNNFSITNKLG 519
Query: 174 EGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233
+GGFG VYKG+L G ++AVKRLS SGQGVEEF NE+++I+KL HRNLVRL G CIE
Sbjct: 520 QGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGE 579
Query: 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293
E++L+YE+MP LD +LFD P + +LDW TR II+GI +GL+YLH+
Sbjct: 580 ERMLVYEFMPENCLDAYLFD------------PVKQRLLDWKTRFNIIDGICRGLMYLHR 627
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
SRL++IHRDLKASN+LLD ++NPKISDFG+AR+F G+E + + R+VGTYGYM+PEYA+
Sbjct: 628 DSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAM 687
Query: 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI-DSLTLLGHAWNLWKDDRAWKLLDPTLQ 412
GLFS KSDVFS GV+LLE +S ++N+ FYN + L +AW LW L+DP +
Sbjct: 688 GGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIF 747
Query: 413 NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKS 472
E ++R + V LLCVQ++A DRP+++ V+ M+ +E NLP P+QPAF R +
Sbjct: 748 EECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEV 807
Query: 473 VLLENSEAEASSGNCLTLSMVDAR 496
S+ AS N ++L+ + R
Sbjct: 808 ESSGQSDPRASINN-VSLTKITGR 830
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
Identities = 183/338 (54%), Positives = 241/338 (71%)
Query: 158 SISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL 217
+I TAT +F E NK+G+GGFG VYKG L +G EVAVKRLS SGQG EFKNE++L+AKL
Sbjct: 340 TIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKL 399
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
HRNLVRL G C++ E++L+YEY+PNKSLD+FLFD PA KG LDWT R
Sbjct: 400 QHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFD------------PAKKGQLDWTRR 447
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
+II G+A+G+LYLHQ SRL +IHRDLKASN+LLD DMNPKI+DFG+AR+FG D+ + N
Sbjct: 448 YKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENT 507
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLGHAWN 396
+RIVGTYGYMSPEYA+HG +S+KSDV+SFGVL+LE +S KKN+ FY D L+ +AW
Sbjct: 508 SRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWG 567
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456
LW + R +L+DP + V R + + LLCVQE+ A+RPT+S +V M+ + V LP
Sbjct: 568 LWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLP 627
Query: 457 SPQQPAFSYVRIVEKSVLLENSEAEASSGNCLTLSMVD 494
P+QP + + K L ++ +++ G+ S+ D
Sbjct: 628 VPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITD 665
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 496 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-57 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-28 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-25 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-22 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 7e-57
Identities = 98/288 (34%), Positives = 141/288 (48%), Gaps = 34/288 (11%)
Query: 170 NKLGEGGFGPVYKGKLLNGE----EVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVR 224
KLGEG FG VYKGKL + EVAVK L + S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L G C E+ L+ EYM L +L + K L + I
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPE------KSTLSLKDLLSFAIQI 114
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQSNMNRIVGT 343
A+G+ YL + +HRDL A N L+ D+ KISDFG++R ++ D + +
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
+M+PE G+F+ KSDV+SFGVLL E TL + T + + + +L + L K
Sbjct: 172 R-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA---TPYPGLSNEEVLEY---LRKGY 224
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
R L P + LY ++ L C Q + DRPT SE+V ++
Sbjct: 225 R---LPKPEYCPDELY-------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 6e-54
Identities = 93/286 (32%), Positives = 133/286 (46%), Gaps = 38/286 (13%)
Query: 169 ENKLGEGGFGPVYKGKLL-----NGEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
KLGEG FG VYKGKL EVAVK L + S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V+L G C E+ ++ EYM L +L ++ L + +
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--------------RKNRPKLSLSDLLSFAL 109
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA+G+ YL IHRDL A N L+ ++ KISDFG++R D+ +
Sbjct: 110 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL- 165
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE G F+ KSDV+SFGVLL E + + + + + +L + L R
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE-QPYPGMSNEEVLEY---LKNGYR 221
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+ P LY + L C E+ DRPT SE+V ++
Sbjct: 222 LPQ---PPNCPPELY-------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 96/286 (33%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNG-----EEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
KLGEG FG VYKG L EVAVK L + S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V+L G C E+ +++ EYMP L +L + L + +
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-------------PKELSLSDLLSFAL 110
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA+G+ YL IHRDL A N L+ ++ KISDFG++R D+ +
Sbjct: 111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL- 166
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE G F+ KSDV+SFGVLL E + + + + + +L + L K R
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE-EPYPGMSNAEVLEY---LKKGYR 222
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
K P LY K+ L C E+ DRPT SE+V ++
Sbjct: 223 LPK---PPNCPPELY-------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 75/205 (36%), Positives = 112/205 (54%), Gaps = 23/205 (11%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
LGEGGFG VY + G++VA+K + S +EE E+ ++ KL+H N+V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
++ L+ EY SL L + +G L +RI+ I +GL
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--------------EGKLSEDEILRILLQILEGLE 106
Query: 290 YLHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
YLH +IHRDLK N+LLD + K++DFG++++ D+ S + IVGT YM+
Sbjct: 107 YLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAYMA 161
Query: 349 PEYALH-GLFSIKSDVFSFGVLLLE 372
PE L G +S KSD++S GV+L E
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 91/294 (30%), Positives = 125/294 (42%), Gaps = 57/294 (19%)
Query: 171 KLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVR 224
KLGEG FG VYKG L +VAVK L + + EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L G C + ++ EYMP L FL L +++ I
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--------------RKHGEKLTLKDLLQMALQI 111
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+G+ YL +HRDL A N L+ ++ KISDFG++R D+ G
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGK 165
Query: 345 G---YMSPEYALHGLFSIKSDVFSFGVLLLETLS-------SKKNTRFYNIDSLTLLGHA 394
+M+PE G F+ KSDV+SFGVLL E + N
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL----------- 214
Query: 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
L +D +L P + LY ++ L C + DRPT SE+V +
Sbjct: 215 -ELLEDGY--RLPRPENCPDELY-------ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 74/226 (32%), Positives = 105/226 (46%), Gaps = 28/226 (12%)
Query: 171 KLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFK---NEMILIAKLHHRNLVRLF 226
KLG G FG VYK K G+ VAVK L K + ++ + E+ ++ +L H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
++ L+ EY L +L + G L +I I +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---------------SRGGPLSEDEAKKIALQILR 109
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GL YLH +IHRDLK N+LLD + KI+DFG+A+ S++ VGT Y
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWY 164
Query: 347 MSPE-YALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
M+PE + K DV+S GV+L E L+ F + L L
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQL 208
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 77/281 (27%), Positives = 116/281 (41%), Gaps = 35/281 (12%)
Query: 166 FSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
+ KLGEG FG VY + G+ VA+K + K + E E+ ++ KL H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL+ ++ + L+ EY L L +G L +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---------------KKRGRLSEDEARFYLRQ 105
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L YLH ++HRDLK N+LLD D + K++DFG+AR E + VGT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
YM+PE L + D++S GV+L E L+ K F D L L + +
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLEL---FKKIGKPKP 214
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ ++++ LL + R T E
Sbjct: 215 PFPPPEWDISPEAKDLIRK-----LLVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-37
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 170 NKLGEGGFGPVYKGKLL-NGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG G FG VY GE +AVK LS S + +E + E+ +++ L H N+VR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 227 GCCIEQGEK-ILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G ++ + + I+ EY+ SL L + I +T + I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPV------IRKYTRQ------I 110
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+GL YLH ++HRD+K +N+L+D D K++DFG A+ G E + GT
Sbjct: 111 LEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+M+PE + +D++S G ++E + K
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 79/230 (34%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 159 ISTATHNFSEENKLGEGGFGPVYKGKL--LNGEE----VAVKRL-SNKSGQGVEEFKNEM 211
I + F EE LGEG FG VYKG+L N VA+K L N + +EF+ E
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLF------DYKYSSGFDMVTD 265
L++ L H N+V L G C ++ +++EY+ + L FL D SG + V
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 266 PASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325
LD + + I IA G+ YL S +HRDL A N L+ + KISDFG++
Sbjct: 120 S-----LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
R + ++ + +M PE L+G F+ +SD++SFGV+L E S
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 78/209 (37%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFG 227
E KLG G FG V+ G +VAVK L K G E F E ++ KL H LV+L+
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 228 CCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
C + E I I EYM SL FL + K L V + IA+
Sbjct: 69 VC-SEEEPIYIVTEYMSKGSLLDFL-----------KSGEGKK--LRLPQLVDMAAQIAE 114
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT--- 343
G+ YL IHRDL A N+L+ ++ KI+DFG+AR+ DE + G
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFP 167
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ +PE A +G F+IKSDV+SFG+LL E
Sbjct: 168 IKWTAPEAANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
F+ E KLG G FG V++G N VA+K L + ++F+ E+ + +L H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
F C +I E M SL FL P + +L + + + +A
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL------------RSPEGQ-VLPVASLIDMACQVA 114
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+G+ YL + IHRDL A N+L+ D+ K++DFG+AR+ D S+ +I Y
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYK 169
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE A HG FS KSDV+SFG+LL E +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 170 NKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLV 223
+LGEG FG V + GE+VAVK L++ Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 224 RLFGCCIEQGEKI--LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ G C + G + LI EY+P+ SL +L + ++ +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--------------QRHRDQINLKRLLLFS 115
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNR 339
I +G+ YL R IHRDL A N+L++ + KISDFG+A++ D
Sbjct: 116 SQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ Y +PE FS SDV+SFGV L E +
Sbjct: 173 ESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 172 LGEGGFGPVYKGKLLNGEE------VAVKRLSNKSGQGVEE-FKNEMILIAKLHHRNLVR 224
LGEG FG V+ G+ + E VAVK L + + F+ E L+ H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFD---MVTDPASKGILDWTTRVRII 281
+G C E I+++EYM + L+ FL S G D + + + G L + ++I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL----RSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
IA G++YL + +HRDL N L+ D+ KI DFG++R D ++ R+
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVG 181
Query: 342 GT----YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
G +M PE ++ F+ +SDV+SFGV+L E + K
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 74/281 (26%), Positives = 134/281 (47%), Gaps = 38/281 (13%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
F K+G+GGFG VYK + G+EVA+K + +S + E+ NE+ ++ K H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+G +++ E ++ E+ SL D++ ++ L + + + +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLK------------DLLK--STNQTLTESQIAYVCKEL 107
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM--NRIVG 342
+GL YLH +IHRD+KA+N+LL D K+ DFG++ +L N +VG
Sbjct: 108 LKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMVG 159
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
T +M+PE + K+D++S G+ +E L+ K + + + L +
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIE-LAEGKPP-YSELPPMKALFKI----ATNG 213
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
L +P ++ +K+ C+Q+N RPT +
Sbjct: 214 PPGLRNPEKWSDEFKDFLKK-------CLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 68/211 (32%), Positives = 116/211 (54%), Gaps = 26/211 (12%)
Query: 172 LGEGGFGPVYKGKLL-NGE----EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRL 225
LG G FG VYKG + GE VA+K L ++ + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 226 FGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G C+ ++ LI + MP L ++ ++K + G S+ +L+W + I
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIG--------SQYLLNWCVQ------I 118
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+G+ YL + R++HRDL A NVL+ + KI+DFG+A++ DE + +
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+ E LH +++ KSDV+S+GV + E ++
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (297), Expect = 3e-30
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHRN 221
+ ++G+G FG VY + +G+ +K LSN S + E+ NE+ ++ KL+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGF---DMVTDPASKGILDWTTRV 278
+++ + E+G+ ++ EY L + K + ILDW +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ--------ILDWFVQ- 111
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM- 337
+ L YLH SR +++HRD+K N+ L + K+ DFGI+++ L S +
Sbjct: 112 -----LCLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD 158
Query: 338 --NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+VGT Y+SPE + ++ KSD++S G +L E
Sbjct: 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 4e-30
Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 32/313 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKL-HHR 220
++ KLGEG FG VY + + + VA+K L+ + VE F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V+L+ ++G L+ EY+ SL D++ KG L + + I
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL------------EDLLKKIGRKGPLSESEALFI 106
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN-PKISDFGIARMFGGD----ELQS 335
+ I L YLH +IHRD+K N+LLD D K+ DFG+A++ + +
Sbjct: 107 LAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
Query: 336 NMNRIVGTYGYMSPEYALHGLF---SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
+ VGT GYM+PE L S SD++S G+ L E L+ F + +
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATS 221
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
+ + L L + K + + ++ +R + S +S
Sbjct: 222 QTLKIILELPT-PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 453 VNLPSPQQPAFSY 465
+ L
Sbjct: 281 LKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 165 NFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLS--NKSGQGVEEFKNEMILIAKLHHRN 221
N+ + +G G FG VYKG L G+ VA+K++S + ++ E+ L+ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V+ G +I EY N SL K F P S +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---RQIIKKFGPF-----PESLVA-------VYV 105
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+ QGL YLH+ VIHRD+KA+N+L D K++DFG+A +V
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVV 160
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GT +M+PE S SD++S G ++E L+
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231
LG G FG V+ GK +VA+K + + ++F E ++ KL H NLV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYL 291
Q ++ EYM N L +L + K G + + D S + + + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD--------------VCEAMEYL 116
Query: 292 HQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YGYMS 348
IHRDL A N L+ D K+SDFG+AR D+ S+ GT +
Sbjct: 117 ESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS----QGTKFPVKWAP 169
Query: 349 PEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLD 408
PE + FS KSDV+SFGVL+ E S K + + ++ ++L
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESV------SAGYRLYR 222
Query: 409 PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
P L +Y ++ C E DRP +++S +
Sbjct: 223 PKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 41/218 (18%)
Query: 166 FSEENKLGEGGFGPVYKGKLLN-GEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ K+GEG G VYK G+EVA+K RL ++ + + NE++++ H N+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V + + E ++ EYM SL TD I+ VR+ E
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSL----------------TD-----IITQN-FVRMNE 115
Query: 283 G-IA-------QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
IA QGL YLH VIHRD+K+ N+LL D + K++DFG A + +
Sbjct: 116 PQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEK 170
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
S N +VGT +M+PE + K D++S G++ +E
Sbjct: 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 89/299 (29%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 170 NKLGEGGFGPVYKGKLL--NGEE--VAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVR 224
+LG G FG V KG L +G+E VAVK L G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 225 LFGCCIEQGEK-ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L G C +GE +L+ E P L +L + + + + +V
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRR---------EIPVSDLKELAHQV----- 104
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM--FGGDELQSNMNRIV 341
A G+ YL +HRDL A NVLL KISDFG++R G D ++
Sbjct: 105 -AMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----- 155
Query: 342 GTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS--SKKNTRFYNIDSLTLLGHA 394
T G + +PE +G FS KSDV+S+GV L E S +K + + +L
Sbjct: 156 -TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214
Query: 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453
L + P + +Y + L C + DRPT SE+ S + +
Sbjct: 215 ERLPR---------PEECPQEIYS-------IMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 44/276 (15%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCC 229
KLG G FG V++G N VAVK L K G ++F E ++ KL H L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 230 IEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
E I I E M SL +Y + P + + +A G+
Sbjct: 71 T-LEEPIYIVTELMKYGSL----LEYLQGGAGRALKLP---------QLIDMAAQVASGM 116
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSNMNRIVGT---Y 344
YL + IHRDL A NVL+ G+ N K++DFG+AR+ D ++ G
Sbjct: 117 AYLEAQN---YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAR----EGAKFPI 168
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404
+ +PE AL+ FSIKSDV+SFG+LL E ++ Y + +A L + D+ +
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVT-------YGRMPYPGMTNAEVLQQVDQGY 221
Query: 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440
++ P + LY + L C +E+ DRPT
Sbjct: 222 RMPCPPGCPKELY-------DIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 39/275 (14%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
++G G FG V+ G L +VA+K + + E+F E ++ KL H LV+L+G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
E+ L++E+M + L +L A +G T + + + +G+ Y
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--------------RAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YGYM 347
L + VIHRDL A N L+ + K+SDFG+ R D+ S+ GT +
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS----TGTKFPVKWS 168
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407
SPE +S KSDV+SFGVL+ E S K T + N + ++ + ++L
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK-TPYENRSNSEVVETI------NAGFRLY 221
Query: 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS 442
P L ++++Y +++ C +E DRP+ S
Sbjct: 222 KPRLASQSVYELMQH-------CWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 62/298 (20%)
Query: 171 KLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH------HRNLV 223
LG+G G VYK + G+ A+K++ + + L+ +L +V
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI-----HVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G ++GE ++ EYM SL L + +P I R
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVG------KIPEPVLAYI----AR-----Q 107
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIV 341
I +GL YLH + +IHRD+K SN+L++ KI+DFGI+++ D+ + V
Sbjct: 108 ILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----V 161
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
GT YMSPE +S +D++S G+ LLE K + +
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK-----FPFLPPGQPS--F------ 208
Query: 402 RAWKLLD-------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS--MIKN 450
++L+ P+L E P + +I C+Q++ RP+ +E++ IK
Sbjct: 209 --FELMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 80/225 (35%), Positives = 118/225 (52%), Gaps = 13/225 (5%)
Query: 159 ISTATHNFSEENKLGEGGFGPVYKGKLLN---GEE---VAVKRLSNKS-GQGVEEFKNEM 211
I+ +T F EE LGE FG VYKG L GE+ VA+K L +K+ G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKG 270
++ ++L H N+V L G ++ +I+ Y + L +F + +S D K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330
L+ V I+ IA G+ +L S V+H+DL NVL+ +N KISD G+ R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 331 DELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ M + +MSPE ++G FSI SD++S+GV+L E S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 19/226 (8%)
Query: 165 NFSEENKLGEGGFGPVYKGK---LLNGEE---VAVKRLSNK-SGQGVEEFKNEMILIAKL 217
N +G+G FG V++ + LL E VAVK L + S +F+ E L+A+
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYK-------YSSGFDMVTDPASKG 270
H N+V+L G C L++EYM L+ FL S +
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFG 329
L T ++ I + +A G+ YL S + +HRDL N L+ +M KI+DFG++R ++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
D +++ N + +M PE + ++ +SDV+++GV+L E S
Sbjct: 183 ADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 82/286 (28%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 171 KLGEGGFGPVYKGKLLN--GE--EVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLVRL 225
KLG+G FG V +G+ G+ VAVK L + +++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+G + ++ E P SL D + A G +T IA
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSL------------LDRLRKDA-LGHFLISTLCDYAVQIA 107
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIVGT 343
G+ YL R IHRDL A N+LL D KI DFG+ R D + V
Sbjct: 108 NGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-P 163
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
+ + +PE FS SDV+ FGV L E + Y + L + L K D+
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKE 216
Query: 404 WKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+ L+ P + +Y ++ + C N ADRPT + + +
Sbjct: 217 GERLERPEACPQDIYNVMLQ-------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 85/293 (29%), Positives = 125/293 (42%), Gaps = 30/293 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEE------VAVKRLSNKSGQGVE-EFKNEMILIAKL 217
N E LG G FG V+ K EE V VK L + ++ EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H+N+VRL G C E +I EY L FL + + D P L +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL---RATKSKDEKLKPPP---LSTKQK 119
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
V + IA G+ +L S R +HRDL A N L+ K+S +++ E
Sbjct: 120 VALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397
N ++ +++PE FS KSDV+SFGVL+ E + + FY + +L L
Sbjct: 177 NALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-LPFYGLSDEEVLN---RL 231
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ + LY ++ R C N DRP+ SE+VS +
Sbjct: 232 QAGKLELPVPEGC--PSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231
+G+G FG V G G++VAVK L + S + F E ++ L H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGI-LDWTTRVRIIEGIAQGLLY 290
++ EYM SL DY S G ++T G LD + +G+ Y
Sbjct: 72 GNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFALD----------VCEGMEY 117
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY--GYMS 348
L + +HRDL A NVL+ D+ K+SDFG+A+ +++ + G + +
Sbjct: 118 LEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTA 167
Query: 349 PEYALHGLFSIKSDVFSFGVLLLETLS 375
PE FS KSDV+SFG+LL E S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 87/288 (30%), Positives = 138/288 (47%), Gaps = 45/288 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFG 227
KLG G FG V+ G +VA+K L K G E F E L+ +L H LVRL+
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ Q +I EYM N SL FL K G + +K ++D + IA+G
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFL---KTPEGIKL---TINK-LIDMAAQ------IAEG 114
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ ++ R IHRDL+A+N+L+ + KI+DFG+AR+ +E + +
Sbjct: 115 MAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWT 170
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKK-----NTRFYNIDSLTLLGHAWNLWKDDR 402
+PE +G F+IKSDV+SFG+LL E ++ + T I +L +R
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL------------ER 218
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+++ P E LY +++ C +E +RPT + S++++
Sbjct: 219 GYRMPRPDNCPEELYELMRL-------CWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 87/304 (28%), Positives = 139/304 (45%), Gaps = 66/304 (21%)
Query: 169 ENKLGEGGFGPVYKGKL-LNGEE---VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
E +G G FG V +G+L L G++ VA+K L + S + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL G + ++I EYM N SLD FL + + G V ++ G
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE--------------NDGKFTVGQLVGMLRG 114
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
IA G+ YL S + +HRDL A N+L++ ++ K+SDFG++R E T
Sbjct: 115 IASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---------AT 162
Query: 344 YGYMS---------PEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394
Y PE + F+ SDV+SFG+++ E +S + R Y
Sbjct: 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE--RPY----------- 209
Query: 395 WNLWKDD------RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
W++ D ++L P ALY ++ L C Q++ +RPT S++VS +
Sbjct: 210 WDMSNQDVIKAVEDGYRLPPPMDCPSALY-------QLMLDCWQKDRNERPTFSQIVSTL 262
Query: 449 KNEI 452
I
Sbjct: 263 DKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 86/285 (30%), Positives = 133/285 (46%), Gaps = 47/285 (16%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
+LG G FG V GK +VA+K + S +EF E ++ KL H LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
+Q ++ EYM N L +L ++ F + + + + +G+ Y
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQ------------LLEMCKDVCEGMAY 115
Query: 291 L--HQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YG 345
L Q+ IHRDL A N L+D K+SDFG++R DE S+ VG+
Sbjct: 116 LESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVR 166
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
+ PE L+ FS KSDV++FGVL+ E +L RF N +++ + L++
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---- 222
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
P L +E +Y + C E A +RPT +++S I
Sbjct: 223 -----PHLASEKVY-------AIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 73/220 (33%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 172 LGEGGFGPVYKGKLLN----GEE---VAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
LG G FG VY+G + G VAVK L + G +E K E L++ +H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V+L G C+ + +I E M L +L D + P +L + I
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVER-----FGPP---LLTLKELLDIC 112
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLL-----DGDMNPKISDFGIAR-MFGGDELQS 335
+A+G +YL Q + IHRDL A N L+ D D KI DFG+AR ++ D +
Sbjct: 113 LDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
++ +M+PE L G F+ +SDV+SFGVL+ E L+
Sbjct: 170 EGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 88/284 (30%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
KLG G FG V+ G N +VAVK L + V+ F E L+ L H LVRL+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
++ +I EYM SL D+ S V P +D++ + IA+G+ Y
Sbjct: 72 KEEPIYIITEYMAKGSL----LDFLKSDEGGKVLLPKL---IDFSAQ------IAEGMAY 118
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
+ R IHRDL+A+NVL+ + KI+DFG+AR+ +E + + +PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPE 174
Query: 351 YALHGLFSIKSDVFSFGVLLLETLSSKK--NTRFYNIDSLTLLGHAWNLWKDDRAWKLLD 408
G F+IKSDV+SFG+LL E ++ K N D ++ L + +
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------- 223
Query: 409 PTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
P ++N + LY ++K C +E A +RPT + S++ +
Sbjct: 224 PRMENCPDELYDIMK-------TCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 40/284 (14%)
Query: 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+G G VY L N E+VA+KR+ K V+E + E+ +++ +H N+V+ +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ E L+ Y+ SL D++ +G LD +++ + +G
Sbjct: 67 SFVVGDELWLVMPYLSGGSL------------LDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIVGTYG 345
L YLH + IHRD+KA N+LL D + KI+DFG++ GGD + VGT
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 346 YMSPE--YALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY---NIDSLTLLGHAWNLWKD 400
+M+PE +HG + K+D++SFG+ +E + Y + LTL
Sbjct: 172 WMAPEVMEQVHG-YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP------ 224
Query: 401 DRAWKLLDPTLQNEALY-PMVKRYIKVALLCVQENAADRPTMSE 443
P+L+ A Y K + K+ LC+Q++ + RPT E
Sbjct: 225 --------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 76/277 (27%), Positives = 135/277 (48%), Gaps = 33/277 (11%)
Query: 169 ENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
++KLG G +G VY+G VAVK L + VEEF E ++ ++ H NLV+L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
C + +I E+M +L +L + ++ ++ + + I+
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRE-------------CNRQEVNAVVLLYMATQISSA 116
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ YL + + IHRDL A N L+ + K++DFG++R+ GD ++ +
Sbjct: 117 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWT 172
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407
+PE + FSIKSDV++FGVLL E +++ + + ID L + L ++ +++
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWE-IATYGMSPYPGID----LSQVYELL--EKGYRME 225
Query: 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
P +Y +++ C Q N +DRP+ +E+
Sbjct: 226 RPEGCPPKVYELMRA-------CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEF----KNEMILIAKLHHRNLVR 224
++GEG +G VYK + GE VA+K++ + E F E+ L+ KL H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 225 LFGCCIE--QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
L +G +++EYM + D F T+ K + +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKF---TESQIKCYM---------K 107
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+ +GL YLH ++HRD+K SN+L++ D K++DFG+AR + NR++
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 343 TYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377
T Y PE L + + D++S G +L E K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 41/285 (14%)
Query: 174 EGGFGPVYKGKLLNG-----EEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFG 227
EG FG ++ G L++ EEV VK + + + + V E L+ L H+N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 228 CCIEQGEK-ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR--VRIIEGI 284
CIE GE ++Y YM +L FL + + +T+ V + I
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA---------LSTQQLVHMAIQI 126
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDE--LQSNMNRIV 341
A G+ YLH + VIH+D+ A N ++D ++ KI+D ++R +F D L N NR V
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
+M+ E ++ +S SDV+SFGVLL E L + T + ID + KD
Sbjct: 184 K---WMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEM----AAYLKD- 234
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
++L P + L+ V C + +RP+ S++V
Sbjct: 235 -GYRLAQPINCPDELF-------AVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 80/280 (28%), Positives = 127/280 (45%), Gaps = 37/280 (13%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
+LG G FG V+ GK +VA+K + N+ E+F E ++ KL H LV+L+G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
+Q ++ E+M N L +L + DM+ + + + + +G+ Y
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--------------LSMCQDVCEGMEY 115
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
L + S IHRDL A N L+ K+SDFG+ R DE S+ + PE
Sbjct: 116 LERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPE 171
Query: 351 YALHGLFSIKSDVFSFGVLLLETLSSKKN--TRFYNIDSLTLLGHAWNLWKDDRAWKLLD 408
+S KSDV+SFGVL+ E + K + N + + ++ R ++L
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---------SRGFRLYR 222
Query: 409 PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
P L + +Y +V C E RPT +E++ I
Sbjct: 223 PKLASMTVY-------EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 9/214 (4%)
Query: 171 KLGEGGFGPVYKGK---LLNGEE---VAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+LGEG FG V+ + LL ++ VAVK L S ++F+ E L+ L H+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+G C E ++++EYM + L+ FL + + + + G L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A G++YL + L +HRDL N L+ + KI DFG++R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
+M PE L+ F+ +SD++SFGV+L E + K
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 88/296 (29%), Positives = 141/296 (47%), Gaps = 39/296 (13%)
Query: 171 KLGEGGFGPVYKGKLLNGEE-----------------VAVKRL---SNKSGQGVEEFKNE 210
KLGEG FG V+ + E+ VAVK L +NK+ + +F E
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR--NDFLKE 69
Query: 211 MILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG 270
+ ++++L N++RL CI +I EYM N L+ FL ++ + A
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA----AEKADVV 125
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFG 329
+ ++T + + IA G+ YL S L +HRDL N L+ + KI+DFG++R ++
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389
GD + R V +MS E L G F+ SDV++FGV L E L+ K + +
Sbjct: 183 GDYYRIQ-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 390 LLGHAWNLWKDD-RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
++ + ++D R L P L ++LY K+ L C + NA +RP+ E+
Sbjct: 242 VIENTGEFFRDQGRQVYLPKPALCPDSLY-------KLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 80/273 (29%), Positives = 133/273 (48%), Gaps = 35/273 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
E KLG+G FG V+ G VA+K L + E F E ++ KL H LV+L+
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 229 CIEQGEKILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
E+ I + EYM SL DF + + D A++ IA G
Sbjct: 70 VSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ--------------IASG 114
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR+ +E + +
Sbjct: 115 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWT 170
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407
+PE AL+G F+IKSDV+SFG+LL E L++K + + + +L +R +++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQV------ERGYRMP 223
Query: 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440
P E+L+ ++ C ++ +RPT
Sbjct: 224 CPPECPESLHDLM-------CQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 71/210 (33%), Positives = 118/210 (56%), Gaps = 24/210 (11%)
Query: 172 LGEGGFGPVYKGKLL-NGEEV----AVKRLSNKSGQGVE-EFKNEMILIAKLHHRNLVRL 225
LG G FG VYKG + GE V A+K L+ +G EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G C+ + L+ + MP+ L ++ ++K + G S+ +L+W + IA
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIG--------SQLLLNWCVQ------IA 119
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+G++YL + R++HRDL A NVL+ + KI+DFG+AR+ GDE + N +
Sbjct: 120 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+ E + F+ +SDV+S+GV + E ++
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 85/302 (28%), Positives = 146/302 (48%), Gaps = 35/302 (11%)
Query: 171 KLGEGGFGPVYKGKLLNGEE-----------------VAVKRL-SNKSGQGVEEFKNEMI 212
KLGEG FG V+ +++N ++ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL----FDYKYSSGFDMVTDPAS 268
++++L N++RL G C+++ +I EYM N L+ FL D K +G D V
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 269 KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-M 327
+ +++ + + IA G+ YL S L +HRDL N L+ ++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387
+ GD + R V +M+ E L G F+ SDV++FGV L E L K + +
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 388 LTLLGHAWNLWKDD-RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
++ +A ++D R L P + LY ++ L C + +RP+ S++ +
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSFSDIHA 300
Query: 447 MI 448
+
Sbjct: 301 FL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 68/225 (30%), Positives = 115/225 (51%), Gaps = 19/225 (8%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLN--GEE----VAVKRLSNKSGQGVEEFKNEMILIAKL 217
HN + +LGEG FG V+ + N E+ VAVK L + S ++F E L+ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H ++V+ +G C+E I+++EYM + L+ FL + + + ++ L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQM 122
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
+ I + IA G++YL + +HRDL N L+ ++ KI DFG++R D ++
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDY 175
Query: 338 NRIVG----TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
R+ G +M PE ++ F+ +SDV+S GV+L E + K
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 41/302 (13%)
Query: 165 NFSEENKLGEGGFGPVY------------KGKLLNGEE-----VAVKRL-SNKSGQGVEE 206
NF E KLGEG FG V+ K N VAVK L + S E+
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 207 FKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDP 266
F E+ ++++L N+ RL G C +I EYM N L+ FL +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL----QKHVAETSGLA 121
Query: 267 ASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
+ L ++T + + IA G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 327 -MFGGD--ELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
++ D +Q R +M+ E L G F+ KSDV++FGV L E L+ + +
Sbjct: 179 NLYSSDYYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 384 NIDSLTLLGHAWNLWKDDRAWKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMS 442
++ ++ +A + ++DD L P + +Y ++ C + + DRPT
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE-------CWRRDEEDRPTFR 288
Query: 443 EV 444
E+
Sbjct: 289 EI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG+G FG V + + ++ A+K L K + VE E ++++++H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD-WTTRVRIIEGIA 285
+ EK+ L+ EY P L L + +G R E I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---------------SKEGRFSEERARFYAAE-IV 103
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
L YLH L +I+RDLK N+LLD D + K++DFG+A+ + S N GT
Sbjct: 104 LALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y++PE L + D +S GVLL E L+
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 170 NKLGEGGFGPVYKGKL--LNGE----EVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
LG G FG VY+G +G+ +VAVK L + S Q +F E ++++K +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL G E+ + ++ E M L FL + + P+S + D +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENR-----PRPERPSSLTMKDL---LFCAR 123
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DMNPKISDFGIARMFGGDELQSNMNR 339
+A+G YL + IHRD+ A N LL KI+DFG+AR R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +M PE L G+F+ K+DV+SFGVLL E S
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRNLVRL 225
+LG G G V K G+ +AVK + + K E+ ++ K + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+G G+ + EYM SLD K G + K I +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKI---LKEVQG-RIPERILGK----------IAVAVL 110
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GL YLH + ++IHRD+K SN+L++ K+ DFG++ G + S VGT
Sbjct: 111 KGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSS 164
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLE 372
YM+PE +S+KSD++S G+ L+E
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 78/216 (36%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 172 LGEGGFGPV--YKGKLLN---GEEVAVKRLSNKSGQGVEE-FKNEMILIAKLHHRNLVRL 225
LGEG FG V Y N GE VAVK L + GQ +K E+ ++ L+H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 226 FGCCIEQGEKI--LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
GCC EQG K LI EY+P SL +L +K + ++ +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL----------------FAQQ 115
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL----QSNMNR 339
I +G+ YLH IHRDL A NVLLD D KI DFG+A+ + + +
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
V Y + E FS SDV+SFGV L E L+
Sbjct: 173 PVFWY---AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 54/291 (18%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
K+G+G FG VYKG L EVAVK S +F E ++ + H N+V+L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+++ ++ E +P SL FL K L +++ A G+
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--------------RKKKNRLTVKKLLQMSLDAAAGME 107
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD--ELQSNMNRIVGTYGYM 347
YL + IHRDL A N L+ + KISDFG++R G + + +I +
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWT 162
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLS---------SKKNTRFYNIDSLTLLGHAWNLW 398
+PE +G ++ +SDV+S+G+LL ET S S + TR
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------E 206
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
+ + +++ P L E +Y ++ L C + +RP+ SE+ + ++
Sbjct: 207 RIESGYRMPAPQLCPEEIY-------RLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 68/225 (30%), Positives = 114/225 (50%), Gaps = 18/225 (8%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ +LGEG FG V+ + N VAVK L + + ++F+ E L+ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDP-ASKGILDWTTRVRII 281
V+ +G C + I+++EYM + L+ FL + + + P +KG L + + I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
IA G++YL + +HRDL N L+ ++ KI DFG++R D ++ R+
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 342 G----TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRF 382
G +M PE ++ F+ +SDV+SFGV+L E + K F
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 76/219 (34%), Positives = 113/219 (51%), Gaps = 15/219 (6%)
Query: 166 FSEENKLGEGGFGPVYKGKL-LNGEE----VAVKRLSN-KSGQGVEEFKNEMILIAKLHH 219
F EE LGE FG +YKG L L G + VA+K L + + Q EF+ E L+A+LHH
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS--GFDMVTDPASKGILDWTTR 277
N+V L G ++ +++EY+ L FL S G D K LD
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQSN 336
+ I IA G+ YL + +H+DL A N+L+ ++ KISD G++R ++ D +
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
++ +M PE ++G FS SD++SFGV+L E S
Sbjct: 184 PKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 8e-24
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 165 NFSEENKLGEGGFGPVYKG-KLLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHRN 221
+F NK+G+G FG V+K + + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++R + +++G+ ++ EY N L L K G + D W R
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPED------QVW----RFF 107
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM-NRI 340
I GL +LH +++HRD+K+ N+ LD N KI D G+A++ +N N I
Sbjct: 108 IQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFANTI 161
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT Y+SPE ++ KSDV++ GV+L E
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 80/294 (27%), Positives = 128/294 (43%), Gaps = 45/294 (15%)
Query: 172 LGEGGFGPVYKGKLLN------GEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVR 224
LG+G FG VY+G VA+K ++ N S + EF NE ++ + + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG-ILDWTTRVRIIEG 283
L G +++ E M L +L + + + P + +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
IA G+ YL + +HRDL A N ++ D+ KI DFG+ R D +++ R G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 344 ----YGYMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNL 397
+M+PE G+F+ KSDV+SFGV+L E TL+ + N + L +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----- 235
Query: 398 WKDDRAWKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
LD P + L +++ C Q N RPT E+VS +K+
Sbjct: 236 -----DGGHLDLPENCPDKLLELMRM-------CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-23
Identities = 88/285 (30%), Positives = 144/285 (50%), Gaps = 39/285 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGV-EEFKNEMILIAKLHHRNLVRLFG 227
+ KLG+G FG V+ G +VA+K L K G + E F E ++ KL H LV L+
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLF--DYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
E+ I + E+M SL FL D KY + D A++ IA
Sbjct: 69 VVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLK-LPQLVDMAAQ--------------IA 112
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
G+ Y+ R+ IHRDL+A+N+L+ ++ KI+DFG+AR+ +E +
Sbjct: 113 DGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIK 168
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405
+ +PE AL+G F+IKSDV+SFG+LL E L +K + + + +L +R ++
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTE-LVTKGRVPYPGMVNREVLEQV------ERGYR 221
Query: 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ P E+L+ ++K LC +++ +RPT + S +++
Sbjct: 222 MPCPQGCPESLHELMK-------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 62/241 (25%), Positives = 96/241 (39%), Gaps = 49/241 (20%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLS-------NKSGQGVEEFKNEMILIA 215
+F +GEG F V K +E A+K L K V+ K E ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK----VKYVKIEKEVLT 56
Query: 216 KL-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
+L H +++L+ ++ + EY PN L ++ + D
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKC---------- 103
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL- 333
TR E I L YLH +IHRDLK N+LLD DM+ KI+DFG A++ +
Sbjct: 104 -TRFYAAE-ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
Query: 334 -----------------QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS 376
+ VGT Y+SPE SD+++ G ++ + L+
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
Query: 377 K 377
K
Sbjct: 219 K 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQG--VEEFKNEMILIAKLHHRNLVR 224
LG G F Y+ + + G +AVK+++ S Q VE + E+ L+A+L+H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ G E L E+M S+ L Y + ++ + E +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKY----------GAFKEAVI-----INYTEQL 112
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIA-----RMFGGDELQSNMN 338
+GL YLH+ ++IHRD+K +N+L+D +I+DFG A + G E Q +
Sbjct: 113 LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL- 168
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
+GT +M+PE + DV+S G +++E ++K +N + + H ++
Sbjct: 169 --LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHS--NHLALIF 221
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
K A E L P ++ V L C++ DRP E++
Sbjct: 222 KIASA---TTAPSIPEHLSPGLR---DVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 48/300 (16%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
F++ ++G G FG VY + + E VA+K++S Q E++++ E+ + +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ GC + + L+ EY S D++ + K L I
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC-------------LGSASDIL-EVHKKP-LQEVEIAAIC 121
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH + R IHRD+KA N+LL K++DFG A L S N V
Sbjct: 122 HGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFV 172
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
GT +M+PE L G + K DV+S G+ +E L+ +K F N+++++ L H +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNAMSALYH---IA 227
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSP 458
++D PTL + + ++ C+Q+ DRP+ E ++K+ V P
Sbjct: 228 QND------SPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEE---LLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFG 227
KLG G FG V+ G +VAVK L K G E F E ++ KL H LV+L+
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
E+ I + EYM SL FL D L V + +A G
Sbjct: 69 VVSEEPIYI-VTEYMSKGSLLDFLKD-------------GEGRALKLPNLVDMAAQVAAG 114
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ Y+ R+ IHRDL+++N+L+ + KI+DFG+AR+ +E + +
Sbjct: 115 MAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWT 170
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLS 375
+PE AL+G F+IKSDV+SFG+LL E ++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 73/205 (35%), Positives = 110/205 (53%), Gaps = 25/205 (12%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
+GEG FG V +G+ G++VAVK + K + F E ++ KLHH+NLVRL G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
G I++ E M +L FL + G +V+ +L ++ V A+G+ Y
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFL----RTRGRALVSVIQ---LLQFSLDV------AEGMEY 115
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
L +++HRDL A N+L+ D K+SDFG+AR+ G + ++ + T +PE
Sbjct: 116 LESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVKWT----APE 167
Query: 351 YALHGLFSIKSDVFSFGVLLLETLS 375
H FS KSDV+S+GVLL E S
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 172 LGEGGFGPVYKGKLLN-GEEVAVKR-----LSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG VY ++ G E+AVK+ S ++ + V + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 226 FGCCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+GC + E + I+ EYMP S+ L Y + + VT ++ IL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALT--ETVTRKYTRQIL------------ 114
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ-SNMNRIVGT 343
+G+ YLH ++HRD+K +N+L D N K+ DFG ++ + M + GT
Sbjct: 115 -EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+MSPE + K+DV+S G ++E L+ K
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 39/285 (13%)
Query: 172 LGEGGFGPVYKGKLLNGE----EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLF 226
+G+G FG VY G L++ + AVK L+ + + VE+F E I++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 227 GCCI-EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G C+ +G +++ YM + L F+ + +P K ++ + +V A
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETH--------NPTVKDLIGFGLQV------A 108
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY- 344
+G+ YL + +HRDL A N +LD K++DFG+AR E S N
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 345 -GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
+M+ E F+ KSDV+SFGVLL E L ++ + ++DS + R
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWE-LMTRGAPPYPDVDSFDIT----VYLLQGR- 219
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+LL P + LY +V L C RPT SE+VS I
Sbjct: 220 -RLLQPEYCPDPLY-------EVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 73/218 (33%), Positives = 112/218 (51%), Gaps = 36/218 (16%)
Query: 172 LGEGGFGPV----YKGKLLN-GEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLVRL 225
LGEG FG V Y + N GE+VAVK L +SG + + K E+ ++ L+H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 226 FGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
G C E G LI E++P+ SL +L P +K ++ +++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--------------PRNKNKINLKQQLKYAVQ 117
Query: 284 IAQGLLYL--HQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE----LQSNM 337
I +G+ YL QY +HRDL A NVL++ + KI DFG+ + D+ ++ ++
Sbjct: 118 ICKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ V Y +PE + F I SDV+SFGV L E L+
Sbjct: 173 DSPVFWY---APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-22
Identities = 30/67 (44%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMW 63
C G F++ +M++PD +++ S+ LKECE CL NC+C AY ++ I GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYAD-IRGGSGCLIW 59
Query: 64 FGDMIDM 70
G+++DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 32/220 (14%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVKR--LSNKSGQG-------VEEFKNEMILIAKLHHRN 221
+G G FG VY G +GE +AVK+ L + S ++ E+ L+ +L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V+ G ++ + EY+P S+ L +Y G + T +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY---------------GAFEETLVRNFV 112
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR-- 339
I +GL YLH +R +IHRD+K +N+L+D KISDFGI++ + L + N
Sbjct: 113 RQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 340 --IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ G+ +M+PE ++ K+D++S G L++E L+ K
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 47/291 (16%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
F++ ++G G FG VY + + E VA+K++S Q E++++ E+ + ++ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ GC + + L+ EY + D K L I
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---------------EVHKKPLQEVEIAAIT 131
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH ++ +IHRD+KA N+LL K++DFG A + S N V
Sbjct: 132 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFV 182
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH-AWNL 397
GT +M+PE L G + K DV+S G+ +E +++ +N+++++ L H A N
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN- 239
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
PTLQ+ + ++ C+Q+ DRPT E++ +
Sbjct: 240 ---------ESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 42/218 (19%)
Query: 166 FSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
F KLGEG +G VYK G+ VA+K + + ++E E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+G + + ++ EY G V+D I+ T + E I
Sbjct: 63 YYGSYFKNTDLWIVMEY----------------CGAGSVSD-----IMKITNKTLTEEEI 101
Query: 285 A-------QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
A +GL YLH + IHRD+KA N+LL+ + K++DFG++ +L M
Sbjct: 102 AAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS-----GQLTDTM 153
Query: 338 ---NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
N ++GT +M+PE ++ K+D++S G+ +E
Sbjct: 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 82/281 (29%), Positives = 137/281 (48%), Gaps = 46/281 (16%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVKRLS----NKSGQG-VEEFKNEMILIAKLHHRNLVRL 225
LG G FG VY+G L +G+ AVK +S ++GQ V++ + E+ L++KL H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 226 FGCCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G E + + I+ E +P SL L KY S + V ++ IL
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILL----------- 113
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
GL YLH R +HRD+K +N+L+D + K++DFG+A+ S G+
Sbjct: 114 --GLEYLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSP 165
Query: 345 GYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKN-TRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE G + + +D++S G +LE + K ++ + ++ +G + L
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL----- 220
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
+ L +EA K +I L C+Q + + RPT +E
Sbjct: 221 --PPIPDHLSDEA-----KDFI---LKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 26/211 (12%)
Query: 172 LGEGGFGPVYKGKLL-NGEE----VAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRL 225
LG G FG V+KG + G+ VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 226 FGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G C G + L+ + P SL + ++ S DP + +L+W + I
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDS------LDP--QRLLNWCVQ------I 118
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A+G+ YL ++ R++HR+L A N+LL D +I+DFG+A + D+ + +
Sbjct: 119 AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+ E L G ++ +SDV+S+GV + E +S
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 74/300 (24%), Positives = 133/300 (44%), Gaps = 56/300 (18%)
Query: 172 LGEGGFGPVYKGKLLNGE----EVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LGEG FG V +G+L + +VAVK +L + +EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 226 FGCCIEQGEK------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
G C E ++I +M + L FL + + + T ++
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP---------LQTLLK 117
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDEL-QSNM 337
+ IA G+ YL S IHRDL A N +L DM ++DFG+++ ++ GD Q +
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-------NTRFYNIDSLTL 390
++ +++ E +++ KSDV++FGV + E + + N Y+
Sbjct: 175 AKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD---YLR 229
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
G+ +L P + LY ++ C + + DRPT +++ +++N
Sbjct: 230 HGN-----------RLKQPEDCLDELYDLMYS-------CWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 81/301 (26%), Positives = 142/301 (47%), Gaps = 37/301 (12%)
Query: 172 LGEGGFGPVYKG-----KLLNG-EEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVR 224
LGEG FG V K K G VAVK L N S + + +E L+ +++H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE-- 282
L+G C + G +LI EY SL FL + + + +D R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 283 -------GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE--L 333
I++G+ YL + ++++HRDL A NVL+ KISDFG++R ++ +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
+ + RI +M+ E +++ +SDV+SFGVLL E ++ N + I L
Sbjct: 185 KRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPGIAPERL--- 238
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453
+NL K +++ P +E +Y ++ C ++ RPT +++ ++ +V
Sbjct: 239 -FNLLKT--GYRMERPENCSEEMYNLMLT-------CWKQEPDKRPTFADISKELEKMMV 288
Query: 454 N 454
Sbjct: 289 K 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQGVE-EFKNEMILIAKLHHRNL 222
E ++LGEG G V K +L N + A+K ++ ++ + E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 223 VRLFGCCIE--QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV-- 278
V+ +G ++ + EY SLD K + R+
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----------------KKVKKRGGRIGE 104
Query: 279 ----RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
+I E + +GL YLH ++IHRD+K SN+LL K+ DFG++ G+ +
Sbjct: 105 KVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVN 157
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
S GT YM+PE +SI SDV+S G+ LLE
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 170 NKLGEGGFGPVYKGKLLN-GEEVAVKRLS--NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
+G+G FG V K + + G+ + K + N + + ++ +E+ ++ +L H N+VR +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 227 GCCI-EQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
I + + I EY L + K + + I +
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEF------------IWRIL 111
Query: 285 AQGLLYLH-----QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
Q LL L+ V+HRDLK +N+ LD + N K+ DFG+A++ G D S
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKT 169
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT YMSPE H + KSD++S G L+ E
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-21
Identities = 83/303 (27%), Positives = 143/303 (47%), Gaps = 63/303 (20%)
Query: 169 ENKLGEGGFGPVYKGKL-LNGEE---VAVKRLSNKSG---QGVEEFKNEMILIAKLHHRN 221
E +G G FG V G+L L G+ VA+K L K+G + +F +E ++ + H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ L G + +++ EYM N SLD FL K+ F ++ V ++
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQ------------LVGML 112
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
GIA G+ YL S + +HRDL A N+L++ ++ K+SDFG++R+ L+ +
Sbjct: 113 RGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAY 164
Query: 342 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395
T G + +PE + F+ SDV+S+G+++ E +S + R Y W
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE--RPY-----------W 211
Query: 396 NLWKDD------RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
+ D ++L P AL+ ++ L C Q++ +RP ++VS++
Sbjct: 212 EMSNQDVIKAIEEGYRLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSILD 264
Query: 450 NEI 452
I
Sbjct: 265 KLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 77/296 (26%), Positives = 145/296 (48%), Gaps = 53/296 (17%)
Query: 167 SEENKLGEGGFGPVYKG--KLLNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRN 221
+++ +G G FG V++G K+ +EVAV + K G + ++F +E ++ + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++RL G + ++I EYM N +LD +L D+ G V ++
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--------------GEFSSYQLVGML 113
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
GIA G+ YL S + +HRDL A N+L++ ++ K+SDFG++R+ D
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--------E 162
Query: 342 GTYG---------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
GTY + +PE + F+ SDV+SFG+++ E +S + ++++ + ++
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-YWDMSNHEVMK 221
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+ ++L P A+Y ++ L C Q++ A RP ++V+++
Sbjct: 222 AI------NDGFRLPAPMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 27/234 (11%)
Query: 217 LHHRN---LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+H +V +G + + + E+M SLD P IL
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD----------RIYKKGGPIPVEILG 106
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+I + +GL YL Y+ R++HRD+K SN+L++ K+ DFG++ G+ +
Sbjct: 107 -----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELI 155
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
S + VGT YMSPE G +++KSDV+S G+ ++E K F NID
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
L + + P L + ++ ++ C+ ++ +RPT ++ +M
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 32/292 (10%)
Query: 171 KLGEGGFGPVYKGKLLNGEE---------------VAVKRL-SNKSGQGVEEFKNEMILI 214
KLGEG FG V+ + E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
++L + N++RL G C+ +I EYM N L+ FL + S F + S I +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDEL 333
+ + IA G+ YL + L +HRDL N L+ KI+DFG++R ++ GD
Sbjct: 132 ---LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
+ R V +M+ E L G F+ SDV++FGV L E + K + + ++ +
Sbjct: 186 RIQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
Query: 394 AWNLWKDD-RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+++ R L L ++ ++ R C + DRPT +++
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 48/293 (16%)
Query: 172 LGEGGFGPVYKGKL-----LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG+G FG V + GE VAVK+L + + + + +F+ E+ ++ L H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 227 GCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G C G + L+ EY+P SL +L ++ LD + I
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--------------LDHRKLLLYASQI 117
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG-- 342
+G+ YL R +HRDL N+L++ + KI DFG+ ++ D+ + R G
Sbjct: 118 CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGES 173
Query: 343 -TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKN----TRFY-----NIDSLTLL 391
+ Y +PE FS+ SDV+SFGV+L E + S K+ F + ++
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
H L K++ +L P +Y ++K C + + RP+ SE+
Sbjct: 233 YHLIELLKNN--GRLPAPPGCPAEIYAIMK-------ECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--EMILIAKLHHRNLVRLFG 227
K+GEG +G VYK + L GE VA+K++ + E+ L+ +L+H N+++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+G+ L++E+M + L + D + + + K L + QG
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRG-----LPESLIKSYL---------YQLLQG 110
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L + H + ++HRDLK N+L++ + K++DFG+AR FG V T Y
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYR 165
Query: 348 SPEYALH-GLFSIKSDVFSFGVLLLETLS 375
+PE L +S D++S G + E LS
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 37/284 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
E KLG G FG V+ +VAVK + S VE F E ++ L H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
++ I I E+M SL D+ S P ++D++ + IA+G+
Sbjct: 70 VTKEPIYI-ITEFMAKGSL----LDFLKSDEGSKQPLPK---LIDFSAQ------IAEGM 115
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
++ Q + IHRDL+A+N+L+ + KI+DFG+AR+ +E + + +
Sbjct: 116 AFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTA 171
Query: 349 PEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR--FYNIDSLTLLGHAWNLWKDDRAWKL 406
PE G F+IKSDV+SFG+LL+E ++ + N + + L + + + +
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC--- 228
Query: 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
E LY + + C + +RPT + S++ +
Sbjct: 229 ------PEELY-------NIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 68/216 (31%), Positives = 117/216 (54%), Gaps = 24/216 (11%)
Query: 166 FSEENKLGEGGFGPVYKGKLL-NGEE----VAVKRLSN-KSGQGVEEFKNEMILIAKLHH 219
F + LG G FG VYKG + GE+ VA+K L S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
++ RL G C+ + LI + MP L ++ ++K + G S+ +L+W +
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG--------SQYLLNWCVQ-- 117
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
IA+G+ YL + R++HRDL A NVL+ + KI+DFG+A++ G DE + +
Sbjct: 118 ----IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+ E LH +++ +SDV+S+GV + E ++
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 79/283 (27%), Positives = 129/283 (45%), Gaps = 47/283 (16%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
FS+ ++G G FG VY + + N E VA+K++S Q E++++ E+ + KL H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ GC + + L+ EY + D K L +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---------------EVHKKPLQEVEIAAVT 121
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH ++ +IHRD+KA N+LL K+ DFG A + + N V
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFV 172
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH-AWNL 397
GT +M+PE L G + K DV+S G+ +E +++ +N+++++ L H A N
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN- 229
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440
P LQ+ + ++ C+Q+ DRPT
Sbjct: 230 ---------ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 166 FSEENKLGEGGFGPVY-KGKLLNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
F +++G G FG VY E VAVK++S Q E++++ E+ + +L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ GC +++ L+ EY + D K L I
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---------------EVHKKPLQEVEIAAIT 127
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH ++ IHRD+KA N+LL K++DFG A S N V
Sbjct: 128 HGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFV 178
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
GT +M+PE L G + K DV+S G+ +E L+ +K F N+++++ L H +
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-NMNAMSALYH---IA 233
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
++D PTLQ+ + ++ C+Q+ +RP +E++
Sbjct: 234 QND------SPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 71/207 (34%), Positives = 110/207 (53%), Gaps = 25/207 (12%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFK-NEMILIAKLHHRNLVRLF 226
K+GEG +G VYK + L GE VA+K RL + +GV E+ L+ +L+H N+VRL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+ + L++E+ LD L Y SS + P K L ++++GIA
Sbjct: 65 DVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYL-----YQLLQGIA- 113
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
Y H + RV+HRDLK N+L+D + K++DFG+AR F G +++ + +V T Y
Sbjct: 114 ---YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWY 165
Query: 347 MSPEYALHG-LFSIKSDVFSFGVLLLE 372
+PE L +S D++S G + E
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 164 HNFSEENK---LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH 219
+ + E + LG+G +G VY + L +A+K + + + V+ E+ L + L H
Sbjct: 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
RN+V+ G E G + E +P SL L S + + D T +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALL-----RSKWGPLKDNEQ-------TIIF 112
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDMNPKISDFGIARMFGGDELQSN 336
+ I +GL YLH +++HRD+K NVL++ G + KISDFG ++ G +
Sbjct: 113 YTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVV--KISDFGTSKRLAG--INPC 165
Query: 337 MNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSK 377
GT YM+PE G + +D++S G ++E + K
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 166 FSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLV 223
F+ +G+G FG VYK + VA+K + ++ +E+ + E+ +++ +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G ++ + +I EY S D G LD T I+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----------------CLDLLKPGKLDETYIAFILRE 106
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR---I 340
+ GL YLH+ IHRD+KA+N+LL + + K++DFG++ +L S M++
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTF 158
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT +M+PE + K+D++S G+ +E
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 169 ENKLGEGGFGPVYKGKLLNG---EEVAVKRLSNKSGQG-VEEFKNEMILIAKL-HHRNLV 223
++ +GEG FG V K ++ + A+KR+ + + +F E+ ++ KL HH N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA------SKGILDWTTR 277
L G C +G L EY P+ +L FL + + TDPA + L
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-----LETDPAFAIANSTASTLSSQQL 126
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE--LQS 335
+ +A+G+ YL Q + IHRDL A N+L+ + KI+DFG++R G E ++
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
M R+ +M+ E + +++ SDV+S+GVLL E +S
Sbjct: 181 TMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 24/218 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFK-NEMILIAKLHHR 220
++++ K+GEG +G VYKG+ G+ VA+K RL ++ +GV E+ L+ +L H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHP 59
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V L +++ LI+E++ S+D KY + + P + +D
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFL---SMDL----KKY-----LDSLPKGQ-YMDAELVKSY 106
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ I QG+L+ H RV+HRDLK N+L+D K++DFG+AR F G ++ + +
Sbjct: 107 LYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEV 162
Query: 341 VGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377
V T Y +PE L +S D++S G + E + K
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 172 LGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+GGFG V GK+ +++ KRL + G+ + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-I 284
+ + L+ M L + +++ GF R I
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPE-------------ARAIFYAAQI 104
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
GL +LHQ R+++RDLK NVLLD N +ISD G+A G + GT
Sbjct: 105 ICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTP 158
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GYM+PE ++ D F+ G L E ++ +
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 172 LGEGGFGPVYKGKLL------NGEEVAVKRL-SNKSGQGVEEFKNE---MILIAKLHHRN 221
LGEG FG V K + + VAVK L + + + + + +E M +I K H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDP--ASKGILDW 274
++ L G C ++G ++ EY + +L FL S + K ++ +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
+V A+G+ +L + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 138 AYQV------ARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH- 393
+M+PE +++ +SDV+SFGVLL E TL G
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI--------------FTLGGSP 234
Query: 394 -----AWNLWKDDRAWKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
L+K + ++ P + LY +++ C E + RPT ++V
Sbjct: 235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 172 LGEGGFGPVYKGKLL-NGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG G FG VYKG + +GE VA+K L N S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G C+ + L+ + MP L ++ + K G S+ +L+W + IA
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIG--------SQDLLNWCVQ------IA 119
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+G+ YL + +R++HRDL A NVL+ + KI+DFG+AR+ DE + + +
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+ E LH F+ +SDV+S+GV + E ++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 58/292 (19%)
Query: 170 NKLGEGGFGPVYKG-KLLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
NK+G G FG VY L GE +AVK R+ + + ++E +EM ++ L H NLV+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 227 GCCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G + + EK+ I+ EY +L+ L ILD +
Sbjct: 66 GVEVHR-EKVYIFMEYCSGGTLEELL---------------EHGRILDEHVIRVYTLQLL 109
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIVGT 343
+GL YLH + ++HRD+K +N+ LD + K+ DFG A + + + GT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 344 YGYMSPEYALHGLFSIK---SDVFSFGVLLLETLSSKK-----NTRF---YNIDSLTLLG 392
YM+PE G +D++S G ++LE + K+ + F +++ + G
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----G 222
Query: 393 HAWNLWKDDRAWKLLDPTL-QNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
H P + + L P K ++ C++ + RPT SE
Sbjct: 223 HK--------------PPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 43/226 (19%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVK----------RLSNKSGQGVEEFKNEMILIAKLHHR 220
+G+G +G VY + GE +AVK R ++ V+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 221 NLVRLFGCCIEQGEKIL-IY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
N+V+ G E E+ L I+ EY+P S+ L Y G +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTY---------------GRFEEQLVR 111
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR----MFGGDELQ 334
E + +GL YLH ++HRDLKA N+L+D D KISDFGI++ ++ D+
Sbjct: 112 FFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-- 166
Query: 335 SNMNRIVGTYGYMSPE--YALHGLFSIKSDVFSFGVLLLETLSSKK 378
NM+ + G+ +M+PE ++ +S K D++S G ++LE + ++
Sbjct: 167 -NMS-MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 169 ENKLGEGGFGPVYKG---KLLNGEEVAVKRLSN-KSGQGVEEFKNEMILIAKL-HHRNLV 223
E+ +GEG FG V + K A+K L S +F E+ ++ KL HH N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA------SKGILDWTTR 277
L G C +G + EY P +L FL + + TDPA + L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV-----LETDPAFAKEHGTASTLTSQQL 121
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE--LQS 335
++ +A G+ YL S + IHRDL A NVL+ ++ KI+DFG++R G+E ++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
M R+ +M+ E + +++ KSDV+SFGVLL E +S
Sbjct: 176 TMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 81/300 (27%), Positives = 138/300 (46%), Gaps = 55/300 (18%)
Query: 169 ENKLGEGGFGPVYKGKL-LNGEE---VAVKRLSNKSG---QGVEEFKNEMILIAKLHHRN 221
E +G G FG V +G+L L G+ VA+K L KSG + +F +E ++ + H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ L G + ++I E+M N +LD FL + G V ++
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL--------------RQNDGQFTVIQLVGML 112
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
GIA G+ YL S + +HRDL A N+L++ ++ K+SDFG++R D +
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 342 G---TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
G + +PE + F+ SDV+S+G+++ E +S + R Y W++
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE--RPY-----------WDMS 216
Query: 399 KDD------RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
D + ++L P AL+ ++ L C Q++ RP ++VS + I
Sbjct: 217 NQDVINAIEQDYRLPPPMDCPTALHQLM-------LDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231
+G+G FG V G G +VAVK + N + + F E ++ +L H NLV+L G +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 232 Q-GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
+ G ++ EYM SL DY S G + +L ++ + + + Y
Sbjct: 71 EKGGLYIVTEYMAKGSL----VDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEY 117
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
L + +HRDL A NVL+ D K+SDFG+ + E S + + +PE
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE 169
Query: 351 YALHGLFSIKSDVFSFGVLLLETLS 375
FS KSDV+SFG+LL E S
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 33/215 (15%)
Query: 169 ENKLGEGGFGPVY---KGKLLNGEEVAV-KRLS------NKSGQGVEEFKNEMILIAKLH 218
+ +LG+G FG VY K + E + V K + N++ Q +E + L++KL
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLD 60
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
H +V+ +E+ +I EY + LD L + K++ +++
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG--KTLSEN------------ 106
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD-ELQSNM 337
++ E Q LL +H + R++HRDLKA N+ L ++ KI DFG++R+ G +L +
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTF 165
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
GT YMSPE H + KSD++S G +L E
Sbjct: 166 T---GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 64/218 (29%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFK-NEMILIAKLHHR 220
NF + K+GEG +G VYK + L GE VA+K RL ++ +GV E+ L+ +L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V+L + + L++E++ ++ L F+ D + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-------------DASPLSGIPLPLIKSY 105
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ + QGL + H + RV+HRDLK N+L++ + K++DFG+AR F G +++ + +
Sbjct: 106 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 161
Query: 341 VGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377
V T Y +PE L +S D++S G + E ++ +
Sbjct: 162 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKR-----LSNKSGQGVEEFKNEMILIAK 216
NF E K+G+G F VYK LL+G VA+K+ + + + ++ E+ L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR--QDCLKEIDLLKQ 58
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
L H N+++ IE E ++ E L + +K K ++ T
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFK-----------KQKRLIPERT 107
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
+ + L ++H R++HRD+K +NV + K+ D G+ R F +
Sbjct: 108 IWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA- 163
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ +VGT YMSPE ++ KSD++S G LL E
Sbjct: 164 -HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 5e-19
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 39/176 (22%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFK----NEMILIAKLHHR 220
+ + KLGEG +G VYK + GE VA+K++ + E E+ L+ +L H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 221 NLVRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDY--KYSSGFDMVTDPASKGILDWTTR 277
N+V+L I K+ L++EY D L Y K
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLSP--------------- 97
Query: 278 VRIIEGIA----QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
+I+ I +GL Y H + R++HRDLK N+L++ D K++DFG+AR FG
Sbjct: 98 -NLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVE-EFKNEMILIAKLHHRNLVRLFGCCI 230
LG+G FG V+KG L + VAVK Q ++ +F +E ++ + H N+V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
++ ++ E +P DF F K K L V+ A G+ Y
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRK------------KKDELKTKQLVKFALDAAAGMAY 108
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF-GGDELQSNMNRIVGTYGYMSP 349
L + IHRDL A N L+ + KISDFG++R G S + +I + +P
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAP 163
Query: 350 EYALHGLFSIKSDVFSFGVLLLETLS 375
E +G +S +SDV+S+G+LL ET S
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 40/283 (14%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
F++ ++G+G FG VYKG +EV A+K + + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
R +G ++ + +I EY+ S D++ G L+ T I+
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGG------------GSALDLL----KPGPLEETYIATILRE 109
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I +GL YLH R IHRD+KA+NVLL + K++DFG+A + Q N VGT
Sbjct: 110 ILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE + K+D++S G+ +E + N+ + + L L+
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP---------- 214
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
K PTL+ + P K +++ C+ ++ RPT E++
Sbjct: 215 --KNSPPTLEGQYSKPF-KEFVEA---CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 36/230 (15%)
Query: 166 FSEENKLGEGGFGPVYKGKLLN---GEEVAVKRL--SNKSGQGVEEFK-NEMILIAKLHH 219
+ E +G G +G VYK K N G+E A+K+ + G+ + E+ L+ +L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 220 RNLVRLFGCCIEQGEKI--LIYEYMPNKSLDFF-LFDYKYSSGFDMVTDPASKGILDWTT 276
N+V L +E +K L+++Y + D + + + + + K +L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLL-WQ- 116
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP----KISDFGIARMFGGDE 332
I G+ YLH V+HRDLK +N+L+ G+ KI D G+AR+F
Sbjct: 117 -------ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAP 165
Query: 333 LQS--NMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSK 377
L+ +++ +V T Y +PE L H +I D+++ G + E L+ +
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 48/223 (21%)
Query: 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCC 229
+GEG +G VYK + G+ VA+K + EE K E ++ K +H N+ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 230 IEQGEKI------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR---- 279
I++ L+ E S VTD KG+ R++
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGS----------------VTDLV-KGLRKKGKRLKEEWI 115
Query: 280 --IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
I+ +GL YLH+ +VIHRD+K N+LL + K+ DFG++ +L S +
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-----QLDSTL 167
Query: 338 ---NRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVLLLE 372
N +GT +M+PE + +SDV+S G+ +E
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 9e-19
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 172 LGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG VY G+ L ++V S ++ + V + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 226 FGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+GC ++ EK L EYMP S+ L Y G L + +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---------------GALTESVTRKYTRQ 114
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ-SNMNRIVG 342
I +G+ YLH ++HRD+K +N+L D N K+ DFG ++ + + + + G
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
T +MSPE + K+DV+S G ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 49/299 (16%)
Query: 87 PASQLGKKKTLWIVV---LIALPVVILPAF-FIFYGRKRKLK----EKGNMTRAKEFCEG 138
P ++ K + W + L A V+ L AF F+F + L+ E + T +F +
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 139 DSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSN 198
SK S I +I+ + EEN + G G YKGK + V + N
Sbjct: 677 -------SKVSKSI-----TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN 724
Query: 199 KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS 258
+M KL H N+V+L G C + LI+EY+ K+L L +
Sbjct: 725 DVNSIPSSEIADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776
Query: 259 GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
L W R +I GIA+ L +LH V+ +L +++DG P
Sbjct: 777 -------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823
Query: 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ + + D + + Y++PE + KSD++ FG++L+E L+ K
Sbjct: 824 LR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 78/292 (26%), Positives = 141/292 (48%), Gaps = 41/292 (14%)
Query: 172 LGEGGFGPVYKGKLLNGE---EVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LGEG FG V +G+L + +VAVK +++ + +E+F +E + + + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 227 GCCIEQGEK------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
G C++ E ++I +M + L FL YS D L V+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGD------CPQYLPTQMLVKF 117
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNR 339
+ IA G+ YL S IHRDL A N +L+ +MN ++DFG++ +++ GD + R
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ--GR 172
Query: 340 IVGT-YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
I +++ E +++ KSDV+SFGV + E ++++ T + +++ + + L
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE-IATRGQTPYPGVENSEIYDY---LR 228
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ +R L P + LY ++ C N DRP+ + ++
Sbjct: 229 QGNR---LKQPPDCLDGLYSLMSS-------CWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 172 LGEGGFGPVYKGKLLNG---EEVAVKRLSNKSGQG-VEEFKNEMILIAKL-HHRNLVRLF 226
+GEG FG V K ++ + A+KR+ + + +F E+ ++ KL HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA------SKGILDWTTRVRI 280
G C +G L EY P+ +L FL + + TDPA + L +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRV-----LETDPAFAIANSTASTLSSQQLLHF 117
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE--LQSNMN 338
+A+G+ YL S+ + IHRDL A N+L+ + KI+DFG++R G E ++ M
Sbjct: 118 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
R+ +M+ E + +++ SDV+S+GVLL E +S
Sbjct: 172 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN-----------EMI 212
+ + KLGEG + VYK + G VA+K++ K G E K E+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKI--KLG----ERKEAKDGINFTALREIK 54
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMP--------NKSLDFFLFDYKYSSGFDMVT 264
L+ +L H N++ L + L++E+M +KS+ D K
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK--------- 105
Query: 265 DPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324
+ +GL YLH ++HRDLK +N+L+ D K++DFG+
Sbjct: 106 --------------SYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148
Query: 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKS-----DVFSFGVLLLETL 374
AR FG M V T Y +PE LF + D++S G + E L
Sbjct: 149 ARSFGSPN--RKMTHQVVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 21/216 (9%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFK-NEMILIAKLHHRNL 222
NF + KLGEG + VYKG+ GE VA+K + + +G E+ L+ +L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL + + +L++EYM +K L KY D G LD T
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLK------KY---MDTHGVR---GALDPNTVKSFTY 107
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+ +G+ + H+ RV+HRDLK N+L++ K++DFG+AR F G + + N +V
Sbjct: 108 QLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV- 162
Query: 343 TYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377
T Y +P+ L +S D++S G ++ E ++ +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 35/217 (16%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ ++G G +G VYK + + GE VA+K + + G E + E+ ++ + H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFD-YKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
FG + + + ++ EY SL D Y+ + G P S+ + + R +
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQ----DIYQVTRG------PLSELQIAYVCRETL--- 111
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLL--DGDMNPKISDFGIARMFGGDELQSNMNR-- 339
+GL YLH+ IHRD+K +N+LL DGD+ K++DFG++ +L + + +
Sbjct: 112 --KGLAYLHE---TGKIHRDIKGANILLTEDGDV--KLADFGVSA-----QLTATIAKRK 159
Query: 340 -IVGTYGYMSPEYA---LHGLFSIKSDVFSFGVLLLE 372
+GT +M+PE A G + K D+++ G+ +E
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 42/217 (19%)
Query: 160 STATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRL---SNKSGQGVEEFKNEMILIA 215
+ ++ KLGEG FG VYK ++ G VA+K++ + K G + + E+ ++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPASKGILDW 274
KL H N+V L +E+ +K K ++ Y M D + G+L+
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSK------RKRGSVYMVTPY-------MDHDLS--GLLE- 106
Query: 275 TTRVR--------IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
V+ + + +G+ YLH+ ++HRD+KA+N+L+D KI+DFG+AR
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 327 MF---------GGDELQSNMNRIVGTYGYMSPEYALH 354
+ GG +V T Y PE L
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 170 NKLGEGGFGPVYKGKLLNGEEVAVKRL----SNK--SGQGVEEFKNEMILIAKLHHRNLV 223
LG+G +G VY G G+ +AVK++ SN + + E+ + E+ L+ L H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ G C++ + E++P S+ L ++ + V +K ILD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILD---------- 113
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR---MFGGDELQSNMNRI 340
G+ YLH V+HRD+K +NV+L + K+ DFG AR G SNM +
Sbjct: 114 ---GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 341 V-GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ GT +M+PE + KSD++S G + E + K
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-18
Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 56/289 (19%)
Query: 172 LGEGGFGP--VYK----GKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG +Y+ L+ +EV + RLS K + NE+++++ L H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPASKGILDWTTRVRIIE 282
+ +M + +L L + +Y++G +D + + + + +
Sbjct: 65 YN------------HFMDDNTL---LIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLF 108
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
I + Y+H+ ++HRD+K N+ L K+ DFGI+++ G + + +VG
Sbjct: 109 QIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVG 163
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
T YMSPE ++ KSD+++ G +L E L+ K+ D+ L + + +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR-----TFDATNPLNLVVKIVQGNY 218
Query: 403 AWKLLDPTLQNEALYPMVKRY----IKVALLCVQENAADRPTMSEVVSM 447
P+V Y I + +Q++ RPT EV+
Sbjct: 219 T--------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEE---FKNEMILIAKLHHRNLVRLFGC 228
+G G FG V+ + +++ + + +E +NE ++ L H N++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+E +++ EY P +L ++ + +S D IL + ++ L
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLD------EDTILHFFVQI---------L 111
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDG-DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L LH ++HRDLK N+LLD M KI DFGI+++ +S +VGT Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYI 168
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
SPE ++ KSD+++ G +L E S K+ N+ +L L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 172 LGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
LG+G FG VYK + G A K + +S + +E+F E+ ++++ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
+ + ++ E+ +LD + +G+ + R + + + L +
Sbjct: 73 YENKLWILIEFCDGGALD-------------SIMLELERGLTEPQIRY-VCRQMLEALNF 118
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
LH + +VIHRDLKA N+LL D + K++DFG++ LQ + +GT +M+PE
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR-DTFIGTPYWMAPE 173
Query: 351 YALHGLFS-----IKSDVFSFGVLLLE 372
F K+D++S G+ L+E
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 171 KLGEGGFGPVYKGKLLN--GEEVAVKRL---SNKSGQGVEEFKNEMIL--IAKLHHRNLV 223
++GEG +G V+K + L G VA+KR+ + + G + + +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 224 RLFGCCI-----EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
RLF C + + L++E++ D ++ D V +P G+ T +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEP---GVPTETIKD 114
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
+ + + +GL +LH + RV+HRDLK N+L+ K++DFG+AR++ Q +
Sbjct: 115 MMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALT 167
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+V T Y +PE L ++ D++S G + E K
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+LG+G FG VYK K G A K + KS + +E++ E+ ++A +H +V+L G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
G+ ++ E+ P ++D + + +G+ + +V I + + L
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLEL-------------DRGLTEPQIQV-ICRQMLEALQ 124
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
YLH +++IHRDLKA NVLL D + K++DFG++ LQ + +GT +M+P
Sbjct: 125 YLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRR-DSFIGTPYWMAP 179
Query: 350 EYAL-----HGLFSIKSDVFSFGVLLLE 372
E + + K+D++S G+ L+E
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 172 LGEGGFGPVYKGKLLNGEE--------VAVKRLS-NKSGQGVEEFKNEMILIAKL-HHRN 221
LGEG FG V + + ++ VAVK L N + + + + +EM L+ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTD--PASKGILDWTTRVR 279
++ L G C ++G +I EY +L FL + G D D + L + V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+A+G+ YL SR R IHRDL A NVL+ D KI+DFG+AR + +
Sbjct: 139 CAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+PE +++ +SDV+SFG+L+ E +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 172 LGEGGFGPVYKGKLLN-GEEVAVKRL-----SNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG VY + G E+AVK++ S ++ + V + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 226 FGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+GC + E+ L E+MP S+ L Y G L +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---------------GALTENVTRKYTRQ 114
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ-SNMNRIVG 342
I +G+ YLH ++HRD+K +N+L D N K+ DFG ++ L + M + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
T +MSPE + K+D++S G ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 65/288 (22%), Positives = 127/288 (44%), Gaps = 53/288 (18%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHH---RNLVRLF 226
+G G +G VY+GK + G VA+K ++ + V + + E+ L+++L N+ + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
G ++ +I EY S+ + + + V II +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV----------------IIREVLV 112
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR---IVGT 343
L Y+H+ VIHRD+KA+N+L+ N K+ DFG+A L N ++ VGT
Sbjct: 113 ALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGT 164
Query: 344 YGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL---TLLGHAWNLWK 399
+M+PE G + K+D++S G+ + E + N + ++D+ L+ +
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEM--ATGNPPYSDVDAFRAMMLIPKS----- 217
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
P L++ +++ ++ C+ E +R + E++
Sbjct: 218 -------KPPRLEDNGYSKLLREFVA---ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 22/183 (12%)
Query: 171 KLGEGGFGPVYKGKLL-NGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
++GEG G V+K K GE VA+K+ L G + E+ + H +V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+L+ EYMP+ L L D + + + K + +++G+A
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEE-----RPLPEAQVKSYM-----RMLLKGVA-- 113
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
Y+H ++HRDLK +N+L+ D KI+DFG+AR+F +E + + V T Y
Sbjct: 114 --YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYR 167
Query: 348 SPE 350
+PE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHRN 221
+F KLG+G +G VYK K L + + A+K L + S + E+ NE+ ++A ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ ++ + ++ EY P L K S + + W ++++
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEI-WRIFIQLL 113
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI- 340
G L LH+ +++HRDLK++N+LL + KI D GI+++ L+ NM +
Sbjct: 114 RG----LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQ 161
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+GT YM+PE +S KSD++S G LL E
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHR 220
F + N++GEG +G VY+ + +GE VA+K++ + + G + + E+ L+ L H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLD--FFLFDY---KYSSGFDMVTDPASKGILDWT 275
N+V L E + K LD F + +Y +S D + P S
Sbjct: 67 NIVEL-------------KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS------E 107
Query: 276 TRVR-IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
++V+ ++ + +GL YLH+ +IHRDLK SN+LL KI+DFG+AR +G
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPA 162
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
M V T Y +PE L + D+++ G +L E L+ K
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 63/302 (20%)
Query: 172 LGEGGFGPVYK------GKLLNGEEVAVKRLSNKSGQGVEE-FKNEMILIAKL-HHRNLV 223
LG G FG V + K +VAVK L + E +E+ +++ L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L G C G ++I EY L FL + F + D +L ++ +V
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLED-----LLSFSYQV----- 150
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG- 342
A+G+ +L + IHRDL A NVLL KI DFG+AR ++ ++ N +V
Sbjct: 151 -AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKG 201
Query: 343 ----TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK--------NTRFYNIDSLTL 390
+M+PE + +++ +SDV+S+G+LL E S +++FY
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY------- 254
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
L K+ +++ P +Y ++K C + RPT ++V +I
Sbjct: 255 -----KLIKE--GYRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLIGK 300
Query: 451 EI 452
++
Sbjct: 301 QL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 80/307 (26%), Positives = 140/307 (45%), Gaps = 45/307 (14%)
Query: 171 KLGEGGFGPVYKG---KLLNGE---EVAVKRLSNKSGQGVE--EFKNEMILIAKLHHRNL 222
+LG+G FG VY+G ++ GE VAVK + N+S E EF NE ++ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASVMKGFTCHHV 71
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL G + +++ E M + L +L + + + + +++
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA-----ENNPGRPPPTLQEMIQMAA 126
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA G+ YL+ + +HRDL A N ++ D KI DFG+ R D +++ R G
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGG 179
Query: 343 T----YGYMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWN 396
+M+PE G+F+ SD++SFGV+L E +L+ + N L +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456
L + D + + ++ +C Q N RPT E+V+++K+++ P
Sbjct: 240 LDQPDNCPERVTDLMR----------------MCWQFNPKMRPTFLEIVNLLKDDL--HP 281
Query: 457 SPQQPAF 463
S + +F
Sbjct: 282 SFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 171 KLGEGGFGPVYKG--KLLNGEE----VAVKRLSNKSGQGVE--EFKNEMILIAKLHHRNL 222
+LG+G FG VY+G K + +E VA+K + N++ E EF NE ++ + + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL G + ++I E M L +L + + V P S +++
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS-----LKKMIQMAG 126
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA G+ YL+ + +HRDL A N ++ D KI DFG+ R + + +
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNLWKD 400
+MSPE G+F+ SDV+SFGV+L E TL+ + N L + L K
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243
Query: 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
D +L ++ +C Q N RP+ E++S IK
Sbjct: 244 DNCPDML----------------FELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 72/283 (25%), Positives = 134/283 (47%), Gaps = 40/283 (14%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
F++ K+G+G FG V+KG ++V A+K + + + +E+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G ++ + +I EY+ S D++ G LD T I+
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGG------------GSALDLL----EPGPLDETQIATILRE 109
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I +GL YLH + IHRD+KA+NVLL K++DFG+A + Q N VGT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 164
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE + K+D++S G+ +E + ++ + + L L+
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP---------- 214
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
K PTL+ P+ K +++ C+ + + RPT E++
Sbjct: 215 --KNNPPTLEGNYSKPL-KEFVEA---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-17
Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 2 SDCKSGSQ---FIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGS 58
+C F+K D+++PD + +++L+EC CL NC+C AY +N G
Sbjct: 3 LNCGGDGSTDGFLKLPDVKLPDNASAIT--AISLEECREACLSNCSCTAYAYNN---GSG 57
Query: 59 GCLMWFGDMIDMKRTLGNLTGQSIYLR 85
GCL+W G + +++ + G ++YLR
Sbjct: 58 GCLLWNGLLNNLR--SLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 171 KLGEGGFGPVYKGKLLN-GEEVAVKRLS-NKSGQGVEEFK-NEMILIAKLHHRNLVRLFG 227
K+GEG +G V+K K E VA+KR+ + +GV E+ L+ +L H+N+VRL+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ L++EY ++ L KY FD + G +D + + +G
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLK------KY---FD-----SCNGDIDPEIVKSFMFQLLKG 111
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L + H + V+HRDLK N+L++ + K++DFG+AR F G ++ +V T Y
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYR 166
Query: 348 SPEYALHG-LFSIKSDVFSFGVLLLE 372
P+ L+S D++S G + E
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--EMILIAKL-HHRNLVRLF 226
+LG+G FG VY + GE VA+K++ K EE N E+ + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR-IIEGIA 285
E E ++EYM +L + ++ D KG + +R II I
Sbjct: 65 EVFRENDELYFVFEYM-EGNL------------YQLMKD--RKGKPFSESVIRSIIYQIL 109
Query: 286 QGLLYLHQ--YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN--MNRIV 341
QGL ++H+ + HRDLK N+L+ G KI+DFG+AR E++S V
Sbjct: 110 QGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYV 159
Query: 342 GTYGYMSPEYALH-GLFSIKSDVFSFGVLLLE 372
T Y +PE L +S D+++ G ++ E
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 172 LGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+GGFG V GKL +++ KRL K +G E E ++AK+H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDY-KYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ + L+ M L + +++ + + GF +P + +T + I
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRA---CFYTAQ------I 106
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
GL +LHQ R+I+RDLK NVLLD D N +ISD G+A + QS GT
Sbjct: 107 ISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTP 161
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
G+M+PE + D F+ GV L E ++++
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 34/291 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSN---KSGQGVEEFKNEMILIAKLHHR 220
NF E K+G G F VY+ LL+G VA+K++ + + E+ L+ +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+++ + IE E ++ E L + +K ++ + W V++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPEKTV-----WKYFVQL 115
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ H +SR RV+HRD+K +NV + K+ D G+ R F + + +
Sbjct: 116 CSALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSL 166
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400
VGT YMSPE ++ KSD++S G LL E + + + FY G NL+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSL 216
Query: 401 DRAWKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ + D P L ++ +++ + +C+ + RP ++ V + K
Sbjct: 217 CKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 62/241 (25%), Positives = 92/241 (38%), Gaps = 50/241 (20%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK----SGQGVEEFKNEMILIAKLHHR 220
+F +G+G FG V + + +++ + NK V NE ++ +L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW------ 274
LV L+ Y + + Y +V D G L +
Sbjct: 61 FLVNLW------------YSFQDE--------ENMY-----LVVDLLLGGDLRYHLSQKV 95
Query: 275 -----TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
+ I E I L YLH +IHRD+K N+LLD + I+DF IA
Sbjct: 96 KFSEEQVKFWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151
Query: 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389
D GT GYM+PE +S+ D +S GV E L + R Y S T
Sbjct: 152 PDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL---RGKRPYRGHSRT 205
Query: 390 L 390
+
Sbjct: 206 I 206
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
++ S+ ++ K+G+G G VY + G+EVA+K+++ + E NE+++
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ + H N+V + E ++ EY+ SL TD ++ +D
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL----------------TDVVTETCMD 113
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG +
Sbjct: 114 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
QS + +VGT +M+PE + K D++S G++ +E
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 86/357 (24%), Positives = 140/357 (39%), Gaps = 105/357 (29%)
Query: 172 LGEGGFGPVYK------GKLLNGEEVAVKRL-SNKSGQGVEEFKNEMILIAKL-HHRNLV 223
LG G FG V + GK N VAVK L ++ E +E+ +++ L H+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFL---------------------FDYK------- 255
L G C G ++I EY L FL DYK
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165
Query: 256 -------------------------YSSGFDMVTDPASKGI--LDWTTRVRIIEGIAQGL 288
S D + ++ LD +R +AQG+
Sbjct: 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG--- 345
+L + IHRD+ A NVLL KI DFG+AR ++ ++ N +V
Sbjct: 226 DFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLP 277
Query: 346 --YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK--------NTRFYNIDSLTLLGHAW 395
+M+PE +++++SDV+S+G+LL E S K N++FY +
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK-------- 329
Query: 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
R +++ P +Y ++K +C +RPT S++ +I+ ++
Sbjct: 330 ------RGYQMSRPDFAPPEIYSIMK-------MCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 75/310 (24%), Positives = 140/310 (45%), Gaps = 48/310 (15%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
++ SI ++ K+G+G G V+ + G+EVA+K+++ + E NE+++
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ +L + N+V + E ++ EY+ SL TD ++ +D
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL----------------TDVVTETCMD 113
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ Q L +LH +VIHRD+K+ NVLL D + K++DFG +
Sbjct: 114 EAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-- 168
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
QS + +VGT +M+PE + K D++S G++ +E + + + N + L
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPL----- 221
Query: 394 AWNLWKDDRAWKLL----DPTLQN-EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
RA L+ P LQN E L P+ + ++ C++ + R + E ++
Sbjct: 222 --------RALYLIATNGTPELQNPEKLSPIFRDFLN---RCLEMDVEKRGSAKE---LL 267
Query: 449 KNEIVNLPSP 458
++ + L P
Sbjct: 268 QHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 83/313 (26%), Positives = 137/313 (43%), Gaps = 55/313 (17%)
Query: 172 LGEGGFGPVYKGKLLNGEE--------VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHRN 221
LGEG FG V + + ++ VAVK L S+ + + + + +EM ++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFL-------FDYKYSSGFDMVTDPASKGILDW 274
++ L G C + G +I EY +L +L +Y Y+ + K ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
+V A+G+ YL + + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 146 AYQV------ARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394
+M+PE +++ +SDV+SFGVLL E TL G
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------------FTLGGSP 242
Query: 395 WNLWKDDRAWKLLD-------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
+ + +KLL P+ LY M++ C + RPT ++V
Sbjct: 243 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVED 295
Query: 448 IKNEIVNLPSPQQ 460
+ + I+ L S Q+
Sbjct: 296 L-DRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 165 NFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
K+GEG G V G +VAVK++ + Q E NE++++ H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
++ + E ++ E++ +L TD + ++ +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGAL----------------TDIVTHTRMNEEQIATVCLA 123
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR---I 340
+ + L +LH VIHRD+K+ ++LL D K+SDFG F ++ + R +
Sbjct: 124 VLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKSL 175
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT +M+PE + + D++S G++++E
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 37/227 (16%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRL-----SNKSGQGVEEFKNEMILIAKLH 218
N+ LG G FG VY + G E+AVK++ S ++ + V + E+ L+ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 219 HRNLVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
H +V+ +GC + EK L EYMP S+ L Y G L
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY---------------GALTENV 107
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR------MFGG 330
R I QG+ YLH ++HRD+K +N+L D N K+ DFG ++ M G
Sbjct: 108 TRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG- 163
Query: 331 DELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ + + GT +MSPE + K+DV+S ++E L+ K
Sbjct: 164 ----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 70/228 (30%), Positives = 105/228 (46%), Gaps = 40/228 (17%)
Query: 158 SISTATHNFSE---ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVE-EFKNEMI 212
S +A + SE N++G G G VYK G A+K + V + E+
Sbjct: 65 SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE 124
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL 272
++ ++H N+V+ GE ++ E+M SL+ T A + L
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--------------THIADEQFL 170
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
R +I+ GIA YLH R ++HRD+K SN+L++ N KI+DFG++R+
Sbjct: 171 ADVAR-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI----- 217
Query: 333 LQSNM---NRIVGTYGYMSPEYA----LHGLFS-IKSDVFSFGVLLLE 372
L M N VGT YMSPE HG + D++S GV +LE
Sbjct: 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 57/224 (25%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
S+ S+ ++ K+G+G G VY + G+EVA+K+++ + E NE+++
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ + + N+V + E ++ EY+ SL TD ++ +D
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL----------------TDVVTETCMD 113
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG +
Sbjct: 114 EGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
QS + +VGT +M+PE + K D++S G++ +E + +
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 165 NFSEENKLGEGGFGPVY--KGKLLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHR 220
+ K+GEG FG +Y K K + E +K L+ + E K E+IL+AK+ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V F E G ++ EY L + G D IL W +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSEDQ----ILSWFVQ--- 109
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQSNMN- 338
I+ GL ++H +++HRD+K+ N+ L + M K+ DFGIAR +L +M
Sbjct: 110 ---ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-----QLNDSMEL 158
Query: 339 --RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
VGT Y+SPE + ++ K+D++S G +L E + K N+ L L
Sbjct: 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFK-NEMILIAKLHHRNL 222
+ + K+GEG +G VYK + + E +A+K++ + +GV E+ L+ ++ H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL + L++EY+ D D D A L T +I+
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSNMNRIV 341
GIA Y H + RV+HRDLK N+L+D N K++DFG+AR F G +++ + +V
Sbjct: 114 GIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV 165
Query: 342 GTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
T Y +PE L +S D++S G + E ++ K
Sbjct: 166 -TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCI 230
+G G +G VYKG+ + ++A ++ + +G EE K E+ ++ K HHRN+ +G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTD--PASKG-ILDWTTRVRIIEGIAQG 287
++ +D L+ G VTD +KG L I I +G
Sbjct: 74 KKNP----------PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L +LHQ+ +VIHRD+K NVLL + K+ DFG++ D N +GT +M
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWM 178
Query: 348 SPEYAL-----HGLFSIKSDVFSFGVLLLE 372
+PE + KSD++S G+ +E
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 171 KLGEGGFGPVYKG--KLLNGEE--VAVKRLSNKSGQGV-EEFKNEMILIAKLHHRNLVRL 225
+GEG FG VY+G E+ VAVK N + V E+F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G E I + E P L +L KYS LD + + ++
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYLQVNKYS--------------LDLASLILYSYQLS 117
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL-QSNMNRIVGTY 344
L YL R +HRD+ A NVL+ K+ DFG++R + +++ ++
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PI 172
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+PE F+ SDV+ FGV + E L
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
S+ S+ ++ K+G+G G VY + G+EVA+++++ + E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ + + N+V + E ++ EY+ SL TD ++ +D
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL----------------TDVVTETCMD 114
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG +
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
QS + +VGT +M+PE + K D++S G++ +E + +
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 175 GGFGPVYKG-KLLNGEEVAVKRLSNKSGQG---VEEFKNEMILIAKLHHRNLVRLFGCCI 230
G +G V+ K G+ A+K + V++ E ++++ +V+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 231 EQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
QG+K L+ EY+P L +S + V G LD I I L
Sbjct: 63 -QGKKNLYLVMEYLPGGDL---------ASLLENV------GSLDEDVARIYIAEIVLAL 106
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN-------RIV 341
YLH +IHRDLK N+L+D + + K++DFG+++ G Q N+N RIV
Sbjct: 107 EYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIV 162
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
GT Y++PE L S D +S G +L E L
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
K+GEG G V + +G +VAVK + + Q E NE++++ H+N+V ++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ E ++ E++ +L TD S+ L+ + E + Q L
Sbjct: 88 LVGEELWVLMEFLQGGAL----------------TDIVSQTRLNEEQIATVCESVLQALC 131
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
YLH VIHRD+K+ ++LL D K+SDFG D +VGT +M+P
Sbjct: 132 YLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAP 186
Query: 350 EYALHGLFSIKSDVFSFGVLLLE 372
E + + D++S G++++E
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEE--------VAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRN 221
LGEG FG V + + ++ VAVK L + + + + + +EM ++ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFL-------FDYKYSSGFDMVTDPASKGILDW 274
++ L G C + G ++ EY +L +L DY FD P + L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS----FDTCKLPEEQ--LTF 133
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDEL 333
V +A+G+ YL + + IHRDL A NVL+ D KI+DFG+AR + D
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ N + +M+PE +++ +SDV+SFGVLL E +
Sbjct: 191 KKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKLHHR 220
NF E K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+++ IE E ++ E L + +K ++ + W V++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLIPERTV-----WKYFVQL 115
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ H +SR RV+HRD+K +NV + K+ D G+ R F + + +
Sbjct: 116 CSAVE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSL 166
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT YMSPE ++ KSD++S G LL E
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 72/216 (33%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 171 KLGEGGFGPVYKG--KLLNGEE-VAVKRLSNKSGQGVEEFKNEMILIAK----LHHRNLV 223
+LG G FG V KG K+ E+ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
R+ G C E +L+ E L+ FL K+ VT+ K I + ++
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFLQKNKH------VTE---KNITE------LVHQ 103
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
++ G+ YL + + +HRDL A NVLL KISDFG+++ G DE N +
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTH 157
Query: 344 ----YGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE + FS KSDV+SFGVL+ E S
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 172 LGEGGFGPVYKGKLLNGEE--------VAVKRLS-NKSGQGVEEFKNEMILIAKL-HHRN 221
LGEG FG V + L ++ VAVK L + + + + + +EM ++ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFL-----FDYKYSSGFDMVTDPASKGILDWTT 276
++ L G C + G +I EY +L +L +YS V D + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ----MTFKD 138
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
V +A+G+ YL + + IHRDL A NVL+ + KI+DFG+AR +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+PE +++ +SDV+SFGVL+ E +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 25/218 (11%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVK--RLSN-KSG---QGVEEFKNEMILIAKLHHRNL 222
++GEG +G VYK + GE VA+K RL N K G + E K ++ +L+HRN+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLNHRNI 68
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR--VRI 280
V L + K ++ +K + +F+Y D++ S G++ ++
Sbjct: 69 VNLKEIVTD---KQDALDFKKDKGAFYLVFEYM---DHDLMGLLES-GLVHFSEDHIKSF 121
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
++ + +GL Y H+ + L HRD+K SN+LL+ K++DFG+AR++ +E + N++
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 341 VGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
+ T Y PE L + DV+S G +L E + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 74/290 (25%), Positives = 125/290 (43%), Gaps = 51/290 (17%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRL-SNKSGQGVEEFKNEM-ILIAKLHHRNLVRLFGC 228
LG G +G V K + + + AVKR+ + + Q + ++ I + + V +G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+G+ + E M + SLD F + Y G + D K I I + L
Sbjct: 69 LFREGDVWICMEVM-DTSLDKF-YKKVYDKGLTIPEDILGK----------IAVSIVKAL 116
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV--GTYGY 346
YLH S+L VIHRD+K SNVL++ + K+ DFGI+ L ++ + + G Y
Sbjct: 117 EYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPY 169
Query: 347 MSPEYALHGL----FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD-- 400
M+PE L + +KSDV+S G+ ++E L ++ WK
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIE---------------LATGRFPYDSWKTPF 214
Query: 401 ---DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
+ + P L E P + ++ C+++N +RP E++
Sbjct: 215 QQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFK-NEMILIAKL---HH 219
+ E ++GEG +G VYK + L G VA+K++ S +G+ E+ L+ +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 220 RNLVRLFGCC-IEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
N+VRL C + ++ L++E++ ++ L +L G T I D
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPET------IKD- 111
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
++ + +G+ +LH + R++HRDLK N+L+ D KI+DFG+AR++ +
Sbjct: 112 -----LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FE 160
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ +V T Y +PE L ++ D++S G + E
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 69/283 (24%), Positives = 132/283 (46%), Gaps = 40/283 (14%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
F++ ++G+G FG V+KG ++V A+K + + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G ++ + +I EY+ S D++ G D +++
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGG------------GSALDLL----RAGPFDEFQIATMLKE 109
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I +GL YLH + IHRD+KA+NVLL + K++DFG+A + Q N VGT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHAWNLWKDDR 402
+M+PE + K+D++S G+ +E + N+ + + L L+
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP---------- 214
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
K PTL E K + + C+ ++ + RPT E++
Sbjct: 215 --KNNPPTLTGE----FSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 171 KLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVE-EFKNEMILIAKLHHRNLVRLFGC 228
++G G FG V+ G+L + VAVK ++ +F E ++ + H N+VRL G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGI-LDWTTRVRIIEGIAQG 287
C ++ ++ E + G D +T ++G L ++++E A G
Sbjct: 62 CTQKQPIYIVMELV---------------QGGDFLTFLRTEGPRLKVKELIQMVENAAAG 106
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIVGTYG 345
+ YL IHRDL A N L+ KISDFG++R G M +I
Sbjct: 107 MEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVK 161
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE +G +S +SDV+SFG+LL E S
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 171 KLGEGGFGPVYKG--KLLNGE-EVAVKRLSNKSGQGV-EEFKNEMILIAKLHHRNLVRLF 226
+LG G FG V KG K+ + +VA+K L N++ + V +E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
G C E +L+ E L+ FL S D +T + V ++ ++
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITV---------SNVVELMHQVSM 106
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY-- 344
G+ YL + +HRDL A NVLL KISDFG+++ G D+ R G +
Sbjct: 107 GMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPL 162
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE FS +SDV+S+G+ + E S
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
+F ++G G +G VYK + +N GE A+K + + G+ + E+I++ H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 224 RLFGCCIEQGEKILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
FG + + + + E+ SL D + VT P S+ + + +R +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY-----------HVTGPLSESQIAYVSRETL-- 116
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
QGL YLH + +HRD+K +N+LL + + K++DFG++ + +G
Sbjct: 117 ---QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIG 168
Query: 343 TYGYMSPEYAL---HGLFSIKSDVFSFGVLLLE 372
T +M+PE A G ++ D+++ G+ +E
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 164 HNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
H++ ++G G +G VYK L GE AVK + + G + E+ ++ + H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
V FG + + + + EY SL D + VT P S+ + + R +
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIY-----------HVTGPLSELQIAYVCRETL- 116
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
QGL YLH ++ HRD+K +N+LL + + K++DFG+A + +
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFI 167
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLE 372
GT +M+PE A +G ++ D+++ G+ +E
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 171 KLGEGGFGPVYKGKLLNGEE---VAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+LG+G FG VYK + N E A K + KS + +E++ E+ ++A H N+V+L
Sbjct: 12 ELGDGAFGKVYKAQ--NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ ++ E+ ++D + + + +T+P + + T +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERP-----LTEPQIRVVCKQTL---------EA 115
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L YLH+ ++IHRDLKA N+L D + K++DFG++ + +GT +M
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWM 170
Query: 348 SPEYAL-----HGLFSIKSDVFSFGVLLLE 372
+PE + + K+DV+S G+ L+E
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 172 LGEGGFGPVYKGKLL----NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG V + +L + ++VAVK L S +EEF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 226 FGCCIEQGEK------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
G + K ++I +M + L FL + G + T P T VR
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI--GEEPFTLPLQ-------TLVR 117
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDEL-QSNM 337
+ IA G+ YL S IHRDL A N +L+ +M ++DFG+++ ++ GD Q
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+++ +++ E +++ SDV++FGV + E ++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCI 230
+G G +G VYKG+ + ++A ++ + + EE K E+ ++ K HHRN+ +G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 231 EQG------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTRVRIIEG 283
++ + L+ E+ S+ D+V + + DW I
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVT------------DLVKNTKGNALKEDWIAY--ICRE 129
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I +GL +LH + +VIHRD+K NVLL + K+ DFG++ D N +GT
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184
Query: 344 YGYMSPEYAL-----HGLFSIKSDVFSFGVLLLE 372
+M+PE + +SD++S G+ +E
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 171 KLGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
K+GEG FG GK +E+ + ++S K EE + E+ +++ + H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER---EESRKEVAVLSNMKHPNIVQ 63
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
E G ++ +Y L YK + V P + ILDW + I
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL------YKKINAQRGVLFPEDQ-ILDWFVQ------I 110
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN---RIV 341
L ++H +++HRD+K+ N+ L D K+ DFGIAR+ L S + +
Sbjct: 111 CLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTVELARTCI 162
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
GT Y+SPE + ++ KSD+++ G +L E + K N+ +L L
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 169 ENKLGEGGFGPVYKG--KLLNGEE--VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
E LG G FG + +G KL + E VA+ L + S + F E + + + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL G +++ EYM N +LD FL + +G L + ++ G
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH--------------EGQLVAGQLMGMLPG 115
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN-MNRIVG 342
+A G+ YL S + +H+ L A VL++ D+ KIS F LQ + I
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYT 164
Query: 343 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
T + +PE + FS SDV+SFG+++ E +S
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 92/338 (27%), Positives = 135/338 (39%), Gaps = 79/338 (23%)
Query: 172 LGEGGFGPVYK------GKLLNGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRN 221
LG G FG V + K + VAVK L K G E+K M ILI HH N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 222 LVRLFGCCIEQGEKIL-IYE---------YMPNKSLDFFLFDYKYSSGFDMVTDPASKGI 271
+V L G C + G ++ I E Y+ +K F + K + +M K
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 272 LDWTT--------------RVRIIEGIAQG-------------LLYLHQYSR-------L 297
LD + + +E +G + Y Q +R
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 298 RVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIVGTYGYMSPEYALHG 355
+ IHRDL A N+LL + KI DFG+AR D ++ R+ +M+PE
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 356 LFSIKSDVFSFGVLLLETLSSKKNTRFY---NIDSLTLLGHAWNLWKDDRAWKLLDPTLQ 412
+++ +SDV+SFGVLL E S + Y ID ++ +L + T
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASP--YPGVQID-------------EEFCRRLKEGTRM 295
Query: 413 NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
Y + Y + L C N DRPT SE+V ++ +
Sbjct: 296 RAPEYATPEIY-SIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-14
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 32/203 (15%)
Query: 188 GEEVAVKRLSNKSGQGVEE---FKNEMILIAKLHHRNLVRLF--GCCIEQGEKILIYEYM 242
G EVA+K L + + + F+ E L A+L+H N+V L G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHR 302
P ++L L A+ G L R++ + L H ++HR
Sbjct: 62 PGRTLREVL---------------AADGALPAGETGRLMLQVLDALACAH---NQGIVHR 103
Query: 303 DLKASNVLL---DGDMNPKISDFGIARMFGG--DELQSNMNR---IVGTYGYMSPEYALH 354
DLK N+++ + K+ DFGI + G D + + R ++GT Y +PE
Sbjct: 104 DLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG 163
Query: 355 GLFSIKSDVFSFGVLLLETLSSK 377
+ SD++++G++ LE L+ +
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 57/297 (19%)
Query: 172 LGEGGFGPVYK-------GKLLNGEEVAVKRLS-----NKSGQGVEEFKNEMILIAK-LH 218
LG G FG VYK LL +E+ V + + + + + +E+ +I + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
H N+VR + +E ++ + + L + K R+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLG------------EHFNSLKEKKQRFTEERI 115
Query: 279 -RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
I + L YLH+ R ++HRDL +N++L D I+DFG+A+ + S +
Sbjct: 116 WNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKL 170
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397
+VGT Y PE + + K+DV++FG +L + FY+ + L+L
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSL------- 221
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYI---KVALL---CVQENAADRPTMSEVVSMI 448
A K++ EA+Y + + V + C+ +A RP + +V +MI
Sbjct: 222 -----ATKIV------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 22/190 (11%)
Query: 189 EEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE---YMPNK 245
E + KR+ S + + +NE++ + +L+H N++++ E+IL E YM +
Sbjct: 193 ERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQ 243
Query: 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305
DF L+ + Y FD P L TR I++ + + Y+H ++IHRD+K
Sbjct: 244 KYDFDLYSFMYDEAFDWKDRP-----LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIK 294
Query: 306 ASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFS 365
N+ L+ D + DFG A F + + VGT SPE + +D++S
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWS 353
Query: 366 FGVLLLETLS 375
G++LL+ LS
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHR 220
+ + N++ EG +G VY+ + GE VA+K+L K G + + IL+ KL H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL-KLQHP 64
Query: 221 NLVRL----FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
N+V + G +++ IY M ++ D K S + + P + +
Sbjct: 65 NIVTVKEVVVGSNLDK-----IYMVM-----EYVEHDLK--SLMETMKQPFLQSEVK-CL 111
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
++++ G+A +LH ++HRDLK SN+LL+ KI DFG+AR +G
Sbjct: 112 MLQLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKP 162
Query: 337 MNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
++V T Y +PE L +S D++S G + E L+ K
Sbjct: 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 34/286 (11%)
Query: 170 NKLGEGGFGPVYKGKLLNGEEVA---VKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRL 225
+++G G FG V G+ G A VK L + F E+ +L+H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G CIE +L+ E+ P L +L S MV A K +L R+ +A
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL-----RSNRGMVAQMAQKDVL-----QRMACEVA 110
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
GLL+LHQ IH DL N L D++ KI D+G+A ++ +
Sbjct: 111 SGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 346 YMSPEYA-------LHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
+++PE L + KS+++S GV + E L + + + ++ +L
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQVVR-- 224
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
++ KL P L R+ +V C + RPT EV
Sbjct: 225 --EQDIKLPKPQLD----LKYSDRWYEVMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG GGFG V K+ + A+K + + E +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
Y +K + L +Y G ++ T +G+ D T I +
Sbjct: 59 -----------YRTFKDKKYIYMLMEY--CLGGELWTILRDRGLFDEYTARFYIACVVLA 105
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQSNMNRIVGTYGY 346
YLH +I+RDLK N+LLD + K+ DFG A+ + G + + GT Y
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEY 158
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETL 374
++PE L+ + D +S G+LL E L
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 26/185 (14%)
Query: 171 KLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKN----EMILIAKLHHRNLVRL 225
+GEG +G V K + GE VA+K+ K + E+ K E+ ++ +L H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+G L++EY+ L+ AS G L I +
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---------------EASPGGLPPDAVRSYIWQLL 110
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
Q + Y H +IHRD+K N+L+ K+ DFG AR S + V T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-ASPLTDYVATRW 166
Query: 346 YMSPE 350
Y +PE
Sbjct: 167 YRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 171 KLGEGGFGPV-YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
K+GEG G V + G++VAVK++ + Q E NE++++ HH N+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ E ++ E++ +L TD + ++ + + + L
Sbjct: 89 LVGDELWVVMEFLEGGAL----------------TDIVTHTRMNEEQIATVCLSVLRALS 132
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
YLH VIHRD+K+ ++LL D K+SDFG + +VGT +M+P
Sbjct: 133 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAP 187
Query: 350 EYALHGLFSIKSDVFSFGVLLLETLSSK 377
E + + D++S G++++E + +
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 66/277 (23%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 171 KLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
K+GEG G V + +G+ VAVK++ + Q E NE++++ H N+V ++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ E ++ E++ +L TD + ++ + + + L
Sbjct: 87 LVGDELWVVMEFLEGGAL----------------TDIVTHTRMNEEQIAAVCLAVLKALS 130
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
LH VIHRD+K+ ++LL D K+SDFG E+ +VGT +M+P
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRR-KSLVGTPYWMAP 185
Query: 350 EYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDP 409
E + + D++S G++++E + + ++N L A + +D+ L P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP--YFNEPPLK----AMKMIRDN-----LPP 234
Query: 410 TLQN-EALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
L+N + P +K ++ L+ + A R T +E++
Sbjct: 235 KLKNLHKVSPSLKGFLDRLLV---RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 33/94 (35%), Positives = 57/94 (60%), Gaps = 6/94 (6%)
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
+I + +GL YL + + +++HRD+K SN+L++ K+ DFG++ G + S N
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 156
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT YMSPE ++++SD++S G+ L+E
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLH---HRNLV 223
++G G +G VYK + +G VA+K + +N+ G + + E+ L+ +L H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 224 RLFGCC----IEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
RL C ++ K+ L++E++ D + D V P L T
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPG----LPAETIK 111
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
++ +GL +LH ++HRDLK N+L+ K++DFG+AR++ Q +
Sbjct: 112 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALT 165
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+V T Y +PE L ++ D++S G + E K
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 51/207 (24%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
K+G+G FG V+K + + VA+K++ + K G + + E+ ++ L H N+V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 226 FGCCIEQGEK--------ILIYEY--------MPNKSLDFFLFDYKYSSGFDMVTDPASK 269
C + L++E+ + NK++ F L + K
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK-------------- 122
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
++++ + GL Y+H R +++HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 123 ---------KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 330 ---GDELQSNMNRIVGTYGYMSPEYAL 353
+ NR+V T Y PE L
Sbjct: 171 LSKNSKPNRYTNRVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 156 LASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGV--EEFKNEMI 212
++ T+ + + +G G FG V + L G+ VA+K++ V + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL 272
L+ L H N++ L I E I + L L + P K +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL-----------TSRPLEKQFI 110
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
+ + I +GL Y+H V+HRDLK SN+L++ + + KI DFG+AR+
Sbjct: 111 QY-----FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----- 157
Query: 333 LQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSK 377
M V T Y +PE L + ++ D++S G + E L K
Sbjct: 158 QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
LG+G FG V +L GE AVK L K +++LI +V +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLAL 51
Query: 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290
L + Y ++ + F ++ +G D++ KG D I GL +
Sbjct: 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQF 111
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTYGYMS 348
LH +I+RDLK NV+LD D + KI+DFG+ + +FG + + GT Y++
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIA 164
Query: 349 PEYALHGLFSIKSDVFSFGVLLLETL 374
PE ++ D +SFGVLL E L
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEM-ILIAKLHHRNLVRLF 226
LG+G FG V +L +E+ AVK L VE E +L H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
C + +++ FF+ +Y +G D++ G D I
Sbjct: 63 -SCFQTKDRL------------FFVMEY--VNGGDLMFHIQRSGRFDEPRARFYAAEIVL 107
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTY 344
GL +LH+ +I+RDLK NVLLD + + KI+DFG+ + + GG + GT
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTP 160
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y++PE + + D ++ GVLL E L
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 171 KLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFK---NEMILIAKLHHRNLVRLF 226
++G+GG+G V+ K + GE VA+KR+ + E + E ++ LV+L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTRVRIIEGIA 285
+ L EY+P G D T + G+L + R + E
Sbjct: 68 YAFQDDEYLYLAMEYVP---------------GGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+ LH L IHRDLK N L+D + K++DFG+++ + + N +VG+
Sbjct: 113 -AVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPD 163
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
YM+PE + D +S G +L E L
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLN---GEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHH- 219
+ + ++G G FG V K +L+ G +AVKR+ S + + ++ ++ +
Sbjct: 5 DLKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
+V+ +G +G+ + E M + SLD F YKY P IL +
Sbjct: 63 PYIVKFYGALFREGDCWICMELM-DISLDKF---YKYVYEVLKSVIPEE--ILG-----K 111
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM-- 337
I + L YL + L++IHRD+K SN+LLD + N K+ DFGI+ +L ++
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164
Query: 338 NRIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLE 372
R G YM+PE A G + ++SDV+S G+ L E
Sbjct: 165 TRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 53/217 (24%)
Query: 170 NKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKN---------EMILIAKL-H 218
KLG+G +G V+K E VA+K++ + F+N E++ + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPAS---KGILDW 274
H N+V+L + + +K D +L F+Y M TD + IL+
Sbjct: 66 HPNIVKLLN----------VIKAENDK--DIYLVFEY-------METDLHAVIRANILED 106
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF---GGD 331
+ I+ + + L Y+H S VIHRDLK SN+LL+ D K++DFG+AR +
Sbjct: 107 VHKRYIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 332 ELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 368
+ V T Y +PE L S ++ GV
Sbjct: 164 PENPVLTDYVATRWYRAPEILL------GSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 57/239 (23%), Positives = 93/239 (38%), Gaps = 53/239 (22%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLSN--------KSGQGVEEFK------NEMILI 214
LGEG +G V K L G+ VA+K++ K Q V E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFD---MVTDPASKGI 271
++ H N++ L +E L+ + M D +T+ K I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD 331
L I GL LH++ +HRDL +N+ ++ KI+DFG+AR +G
Sbjct: 125 L---------LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 332 ------------ELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377
+ + M V T Y +PE + + D++S G + E L+ K
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
IA GL +LH +I+RDLK NV+LD + + KI+DFG+ + +FGG ++
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----FC 162
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
GT Y++PE + + D ++FGVLL E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 164 HNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRN 221
+ + LG G G VYK LL +AVK + + + + ++ +E+ ++ K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ +G + + E+M SLD + ++ G RI
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-------------------RIA 101
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+ +GL YL L+++HRD+K SN+L++ K+ DFG++ + S V
Sbjct: 102 VAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYV 154
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
GT YM+PE + I SDV+S G+ +E
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 166 FSEENKLGEGGFGPV------YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH 219
F + LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
R +V L + L+ M L F ++ + +GF+ + + V
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE---EGRA---------VF 106
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
I GL LHQ R+++RDLK N+LLD + +ISD G+A E Q+ R
Sbjct: 107 YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGR 161
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
VGT GYM+PE + ++ D ++ G LL E ++ +
Sbjct: 162 -VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 54/201 (26%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMILIAKLHHRN 221
+G G +G V G +VA+K++SN F + E+ L+ L H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDF----FLFDYKYSSGFDMVTDPA----SKGILD 273
++ L IL P DF + + M TD S L
Sbjct: 61 IIGLL--------DILR----PPSPEDFNDVYIVTEL-------METDLHKVIKSPQPLT 101
Query: 274 WTTRVRIIEGIAQ---GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330
++ + Q GL YLH VIHRDLK SN+L++ + + KI DFG+AR
Sbjct: 102 -DDHIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 331 DEL-QSNMNRIVGTYGYMSPE 350
DE + + V T Y +PE
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 76/267 (28%), Positives = 107/267 (40%), Gaps = 68/267 (25%)
Query: 172 LGEGGFGPVYKG------KLLNGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRN 221
LG G FG V + K VAVK L K G E + M ILI HH N
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 72
Query: 222 LVRLFGCCIEQGEKILIY----------EYMPNKSLDFFLF---DYKYSSGFDMVTD--- 265
+V L G C + G +++ Y+ +K +F + D ++ G D
Sbjct: 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 266 --------------PASKGIL----------------DWTTRVRIIEG-------IAQGL 288
AS G + D +V +E +A+G+
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
+L SR + IHRDL A N+LL + KI DFG+AR D +M+
Sbjct: 193 EFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249
Query: 349 PEYALHGLFSIKSDVFSFGVLLLETLS 375
PE +++I+SDV+SFGVLL E S
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMIL-IAKLHHRN-- 221
+F ++LG G G V K + + ++L + + +N++I + LH N
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSP 63
Query: 222 -LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V +G GE + E+M SLD V A + + +V I
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLD-------------QVLKEAKRIPEEILGKVSI 110
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ +GL YL + + +++HRD+K SN+L++ K+ DFG++ G + S N
Sbjct: 111 --AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 162
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT YMSPE +S++SD++S G+ L+E
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 166 FSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRN 221
+ + +G G +G V G +VA+K+LS + Q K E+ L+ + H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR-- 279
++ L + P SL+ F +VT L+ + +
Sbjct: 76 VIGLLDV------------FTPASSLEDF-------QDVYLVT-HLMGADLNNIVKCQKL 115
Query: 280 -------IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
++ I +GL Y+H +IHRDLK SN+ ++ D KI DFG+AR
Sbjct: 116 SDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH----- 167
Query: 333 LQSNMNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
M V T Y +PE L+ + ++ D++S G ++ E L+ K
Sbjct: 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMIL-IAKLHHRN-- 221
+F + ++LG G G V+K + ++L + + +N++I + LH N
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSP 63
Query: 222 -LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V +G GE + E+M SLD V A + +V I
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLD-------------QVLKKAGRIPEQILGKVSI 110
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ +GL YL + + +++HRD+K SN+L++ K+ DFG++ G + S N
Sbjct: 111 --AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 162
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT YMSPE +S++SD++S G+ L+E
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 172 LGEGGFGPV------YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+GGFG V GK+ +++ KRL KSG+ + + E ++ K++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ L+ M L + +++ G +M + ++ ++ + I
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEM------ERVIHYSAQ------IT 105
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGTY 344
G+L+LH + +++RD+K NVLLD N ++SD G+A + G + GT
Sbjct: 106 CGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR----AGTN 158
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GYM+PE +S D F+ G + E ++ +
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 171 KLGEGGFGPVYKGKL---LNGEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
++G G FG V G++ +V VK L + S Q +F E L H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
G C E +L+ E+ P L +L + + M DP TT R+ IA
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE--LMTPDP--------TTLQRMACEIAL 111
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GLL+LH+ + IH DL N LL D+ KI D+G++ ++ +++ +
Sbjct: 112 GLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 347 MSPEYA--LHGLF-----SIKSDVFSFGVLLLE 372
++PE +HG + +S+V+S GV + E
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFK-NEMILIAKLHHRNLVRLF 226
E K+G G +G VYK K +G++ L G G+ E+ L+ +L H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVT-DPASKGILDWTTRVRIIEGIA 285
+ ++ + + LFDY + ++ ASK V++ G+
Sbjct: 65 KVFLSHADRKV-----------WLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMV 110
Query: 286 QGLLY-----LHQYSRLRVIHRDLKASNVLLDGDMNP-----KISDFGIARMFGGD-ELQ 334
+ LLY +H V+HRDLK +N+L+ G+ P KI+D G AR+F +
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPL 169
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
++++ +V T+ Y +PE L K+ D+++ G + E L+S+
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 172 LGEGGFG-PVYKGKLLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+GEG FG + + + ++ A+K + KS VE+ + E +L+AK+ H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
G ++ EY L + K G D IL W + + G+
Sbjct: 68 EADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDT----ILQWFVQ------MCLGVQ 114
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
++H+ RV+HRD+K+ N+ L + K+ DFG AR+ + VGT Y+ P
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPP 169
Query: 350 EYALHGLFSIKSDVFSFGVLLLE 372
E + ++ KSD++S G +L E
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG G FG V + + A+K LS K Q VE NE ++ + H LV L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD-WTTRVRIIEGIA 285
G + + +L + + +Y G ++ + G R + +
Sbjct: 68 GS------------FQDDSNL-YLVMEY--VPGGELFSHLRKSGRFPEPVARFYAAQ-VV 111
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
L YLH L +++RDLK N+LLD D KI+DFG A+ ++ + GT
Sbjct: 112 LALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPE 163
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y++PE L + D ++ G+L+ E L
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 166 FSEENKLGEGGFGPV------YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH 219
F + LG+GGFG V GK+ + + KR+ + G+ + NE ++ K++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
+ +V L + L+ M L F +++ + GF+ + L +
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFE------EERALFYAAE-- 110
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMN 338
I GL LH+ + ++RDLK N+LLD + +ISD G+A ++ G+ ++
Sbjct: 111 ----ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-- 161
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381
VGT GYM+PE + +++ D + G L+ E + + R
Sbjct: 162 --VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 44/220 (20%)
Query: 170 NKLGEGGFGPVYK------GKLLNGEEVAVKRLSNKSGQGVEEFKNEMIL--IAKLHHRN 221
++LG+G +G VYK G + +E+ RL ++E K I+ + LH
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 222 ---LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
+V +G +G + EYM SLD Y+ G + +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKL-----YAGG-------VATEGIPEDVLR 105
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
RI + +GL +L + +IHRD+K +NVL++G+ K+ DFG++ G+ + S
Sbjct: 106 RITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAK 159
Query: 339 RIVGTYGYMSPEY------ALHGLFSIKSDVFSFGVLLLE 372
+G YM+PE + ++++SDV+S G+ +LE
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 171 KLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFK--NEMILIAKLHHRNLVRLFG 227
KLGEG + VYKG +NG+ VA+K +S K+ +GV F E L+ L H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV---- 66
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSS-GFDMVTDPASKGILDWTTRVRIIEGIAQ 286
L+++ + K F+F+Y ++ M+ P G+ + R+ + + + +
Sbjct: 67 ---------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLR 114
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GL Y+H ++HRDLK N+L+ K++DFG+AR Q+ + +V T Y
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWY 169
Query: 347 MSPEYALHGL-FSIKSDVFSFGVLLLETL 374
P+ L +S D++ G + +E L
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 6/122 (4%)
Query: 256 YSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315
Y +G ++ T + + VR+ IA+ +L L +L +I+RD+K N+LLD +
Sbjct: 86 YVNGGELFTHLYQREHFT-ESEVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEG 142
Query: 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLET 373
+ ++DFG+++ F +E + GT YM+PE G D +S GVL E
Sbjct: 143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 374 LS 375
L+
Sbjct: 202 LT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 87/337 (25%), Positives = 133/337 (39%), Gaps = 76/337 (22%)
Query: 172 LGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRN 221
LG G FG V + + VAVK L K G E K M ILI +H N
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72
Query: 222 LVRLFGCCIE-QGEKILIYEYMPNKSL--------DFFL--------------------- 251
+V L G C + G ++I E+ +L +FF
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 252 FDYKYSSGFDMV------------TDPASKGILDWTTRVRIIE------GIAQGLLYLHQ 293
D + +G V T+P + W + + + + +A+G+ +L
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA- 191
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
SR + IHRDL A N+LL + KI DFG+AR D +M+PE
Sbjct: 192 -SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249
Query: 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413
+++ +SDV+SFGVLL E I SL + ++ +L D T
Sbjct: 250 DKVYTTQSDVWSFGVLLWE------------IFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ Y ++ L C Q + +RPT S +V ++ +
Sbjct: 298 APENATPEIY-RIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 34/93 (36%), Positives = 52/93 (55%)
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
Q LL +H +IHRD+K++N+LL + K+ DFG ++M+ GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
Y++PE +S K+D+FS GVLL E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 49/236 (20%)
Query: 171 KLGEGGFGPVYKG-KLLNGEEVAVKRL-SNKSGQGV--EEFKNEMILIAKLHHRNLVRLF 226
+G+GG G VY + VA+K++ + S + + F E + A L H +V ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVT--------DPASKGILDWT--- 275
C G+ +Y MP Y G+ + + + SK + + T
Sbjct: 69 SIC-SDGD--PVYYTMP------------YIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE--- 332
+ I I + Y+H S+ V+HRDLK N+LL I D+G A +E
Sbjct: 114 AFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 333 ----------LQSNMN---RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
S+M +IVGT YM+PE L S +D+++ GV+L + L+
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 172 LGEGGFGPV------YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ L+ M L F +++ + GFD R I A
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFD---------------EQRAIFYAA 109
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+ L R R+++RDLK N+LLD + +ISD G+A E ++ R VGT G
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGR-VGTVG 166
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
YM+PE + ++ D + G L+ E + + R
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 72/299 (24%), Positives = 139/299 (46%), Gaps = 49/299 (16%)
Query: 171 KLGEGGFGPVYKGKLLN-GEEVAVKR-LSNKSGQGVEEFK-NEMILIAKLHHRNLVRLFG 227
+GEG +G V K K G+ VA+K+ L ++ + V++ E+ ++ +L H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ L++E++ + LD KY +G LD + + + I +G
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNG------------LDESRVRKYLFQILRG 112
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF-GGDELQSNMNRIVGTYGY 346
+ + H ++ +IHRD+K N+L+ K+ DFG AR E+ ++ V T Y
Sbjct: 113 IEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY---VATRWY 166
Query: 347 MSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRF---YNIDSL--------TLLGHA 394
+PE + + D+++ G L+ E L+ F +ID L L+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG--EPLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 395 WNLWKDDRAWKLLD-PTLQNEALYPMVKRYIKVALL-------CVQENAADRPTMSEVV 445
+++ + + + P ++ + P+ KR+ K++ L C++ + DRP+ S+++
Sbjct: 225 QEIFQKNPLFAGMRLPEVKE--IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEV----AVKRLSNKSGQGVEE---FKNEMILIAKLHHRNLVR 224
LG+G FG V+ + + G + A+K L K+ V + K E ++A+++H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IEG 283
L +G+ LI LDF G D+ T SK ++ V+ +
Sbjct: 63 LHYAFQTEGKLYLI--------LDFL-------RGGDLFTR-LSKEVMFTEEDVKFYLAE 106
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+A L +LH L +I+RDLK N+LLD + + K++DFG+++ E GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 161
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
YM+PE + +D +SFGVL+ E L+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
+KLGEG + VYKG+ L VA+K RL ++ G + E+ L+ L H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+ L++EY+ +K L +L D ++ + + +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDD--------------CGNSINMHNVKLFLFQLLR 115
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GL Y H R +V+HRDLK N+L++ K++DFG+AR ++ N +V T Y
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWY 170
Query: 347 MSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
P+ L +S + D++ G + E + +
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKR-LSNKSGQGVEEFK-NEMILIAKLHHRN 221
+ + K+GEG +G VYK + G+ VA+K+ +G+ E+ L+ L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 222 -LVRLFGCCIEQGE----KILIY---EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+VRL +E E K +Y EY+ + L F+ G +
Sbjct: 62 YIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPL----------P 108
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDE 332
T + + +G+ + H++ V+HRDLK N+L+D KI+D G+ R F
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIP 164
Query: 333 LQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETL 374
++S + IV T Y +PE L +S D++S G + E
Sbjct: 165 VKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 42/182 (23%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+A+G+ +L + IHRDL A N+LL KI DFG+AR +++++ N +V
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 344 YG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK--------NTRFYNIDSLTL 390
+M+PE + +++ +SDV+S+G+LL E S +++FY
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY------- 327
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ K+ +++L P +Y ++K C + RPT ++V +I+
Sbjct: 328 -----KMIKE--GYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIEQ 373
Query: 451 EI 452
++
Sbjct: 374 QL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLE--TLSSKK------NTRFYNIDSLTLLGHAW 395
+M+PE + L++ SDV+SFG+LL E TL N +FYN
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN----------- 353
Query: 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453
R +++ P ++ +Y ++++ C +E RP S++V ++ + +
Sbjct: 354 ---AIKRGYRMAKPAHASDEIYEIMQK-------CWEEKFEIRPDFSQLVHLVGDLLT 401
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-IAQGLLYLHQYSRLRVIHRDLKA 306
+ F +Y +G D++ S G D R R I GL +LH+ +I+RDLK
Sbjct: 69 EHLFFVMEYLNGGDLMFHIQSSGRFD-EARARFYAAEIICGLQFLHKKG---IIYRDLKL 124
Query: 307 SNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVF 364
NVLLD D + KI+DFG+ + M G + + GT Y++PE ++ D +
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKGQKYNESVDWW 180
Query: 365 SFGVLLLETL 374
SFGVLL E L
Sbjct: 181 SFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 71/244 (29%)
Query: 164 HNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMIL 213
+ + +GEG +G V G +VA+K+ + F++ E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56
Query: 214 IAKLHHRNLVRLFGC----CIEQGEKI-LIYEYMP-------------NKSLDFFLFDYK 255
+ + H N++ + E + ++ E M N + +FL+
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ-- 114
Query: 256 YSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315
I +GL Y+H + V+HRDLK SN+LL+ +
Sbjct: 115 ----------------------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNC 143
Query: 316 NPKISDFGIARMFGGDELQSN-MNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLET 373
+ KI DFG+AR+ + + + V T Y +PE L+ K+ D++S G +L E
Sbjct: 144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
Query: 374 LSSK 377
LS++
Sbjct: 204 LSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFK-NEMILIAKLHHRNLVRLF 226
E K+G G +G VYK K +G++ L G G+ E+ L+ +L H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVT-DPASKG-----ILDWTTRVRI 280
+ ++ + + LFDY + ++ ASK L + +
Sbjct: 65 KVFLSHSDRKV-----------WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-----KISDFGIARMFGGD-ELQ 334
+ I G+ YLH V+HRDLK +N+L+ G+ P KI+D G AR+F +
Sbjct: 114 LYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPL 169
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
++++ +V T+ Y +PE L K+ D+++ G + E L+S+
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--GVEEFKNEMILIAKLHHRNLVRLFGCC 229
LG+G FG V+ +L + Q ++ K +++L+ +V
Sbjct: 3 LGKGSFGKVFLAEL------------KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 50
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ L + Y ++ + F +Y +G D++ S D I GL
Sbjct: 51 LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQ 110
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTYGYM 347
+LH +++RDLK N+LLD D + KI+DFG+ + M G + GT Y+
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYI 163
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
+PE L ++ D +SFGVLL E L + + F+ D L
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN-RIVG 342
I + L YL + + VIHRD+K SN+LLD N K+ DFGI+ G + S R G
Sbjct: 123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAG 176
Query: 343 TYGYMSPEY----ALHGLFSIKSDVFSFGVLLLE 372
YM+PE + + I++DV+S G+ L+E
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 33/172 (19%)
Query: 210 EMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
E +L+ ++H +++R+ + ++ +P+ S D + + K S +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI----DQA 159
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--- 326
I I + I +GL YLH R+IHRD+K N+ ++ I D G A+
Sbjct: 160 LI--------IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 327 ---MFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
F G + GT +PE ++ K+D++S G++L E L+
Sbjct: 209 VAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 38/229 (16%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS--NKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+G+G +G V + +G++ +K+L+ N S + + + E L+++L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTD-PASKG-------ILDWTTRVRI 280
+GE L+Y M + G D+ KG +++W +
Sbjct: 68 W--EGEDGLLYIVM------------GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ--- 110
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM-NR 339
IA L YLH+ ++HRDLK NV L K+ D GIAR+ E Q +M +
Sbjct: 111 ---IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMAST 161
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388
++GT YMSPE + ++ KSDV++ G + E + K +++SL
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 24/160 (15%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
KLGEG + VYKG+ L G+ VA+K RL ++ G + E L+ L H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IEGIAQ 286
+ L++EY+ + L ++ D G M VR+ + + +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDC--GGGLSM-------------HNVRLFLFQLLR 114
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
GL Y HQ RV+HRDLK N+L+ K++DFG+AR
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVA---VKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
++G G FG V ++ VA VK L +N S + EF + L H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLF--DYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G C+E +L++EY L +L + + ++ R+ I
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-------------RMACEI 108
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGT 343
A G+ ++H+++ L H DL N L D+ K+ D+GI + D +++ ++ V
Sbjct: 109 AAGVTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-P 164
Query: 344 YGYMSPEY--ALHG-LFSIK----SDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
+++PE HG L + + S+V++ GV L E + + ++ +L H
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNHVIK 223
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
D+ KL P L+ P +R+ +V C + R T EV
Sbjct: 224 ----DQQVKLFKPQLE----LPYSERWYEVLQFC-WLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 42/236 (17%)
Query: 172 LGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
+G GGFG VY GK+ + + KR+ K G+ + NE I+++ LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLS------LVST 53
Query: 226 FGC----CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
C C + Y + L F L +G D+ + G+
Sbjct: 54 GDCPFIVC-------MTYAFHTPDKLCFIL---DLMNGGDLHYHLSQHGVFSEKEMRFYA 103
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I GL ++H +R V++RDLK +N+LLD + +ISD G+A F + ++ V
Sbjct: 104 TEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 156
Query: 342 GTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETL------SSKKNTRFYNIDSLTL 390
GT+GYM+PE G + +D FS G +L + L K + ID +TL
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRNLVRLFG 227
+G G +G V G VAVK+LS + Q + K E+ L+ + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 228 CCIEQGEKILIYEYMPNKSLDFF--LFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ P +SL+ F ++ + G D+ + + D + I + I
Sbjct: 84 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-IL 130
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GL Y+H +IHRDLK SN+ ++ D KI DFG+AR M V T
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182
Query: 346 YMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
Y +PE L+ + ++ D++S G ++ E L+ +
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 172 LGEGGFGPV------YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ L+ M L F +++ + GFD R + A
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFD---------------EERAVFYAA 109
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGTY 344
+ L R R+++RDLK N+LLD + +ISD G+A + G+ ++ VGT
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTV 165
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GYM+PE + ++ D + G L+ E + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLVRLF 226
+G G FG V+ + + +V A+K L K Q + + E ++A +V+L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67
Query: 227 GCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
Q E+ L + EYMP G D++ K + T R I
Sbjct: 68 --YSFQDEEHLYLVMEYMP---------------GGDLMNLLIRKDVFPEET-ARFY--I 107
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA--------RMFGGDELQSN 336
A+ +L L +L IHRD+K N+L+D D + K++DFG+ R + ++ +
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 337 MNR-------------------IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
+ R VGT Y++PE + ++ D +S GV+L E L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
+ +GL Y+H + VIHRDLK SN+L++ D +I DFG+AR E + M V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 342 GTYGYMSPE--YALHGLFSIKSDVFSFGVLLLETL 374
T Y +PE +L ++ D++S G + E L
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 172 LGEGGFGPVY------KGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
+G GGFG VY GK+ + + KR+ K G+ + NE I+++ LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLS------LVST 53
Query: 226 FGC----CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
C C + Y + L F L +G D+ + G+
Sbjct: 54 GDCPFIVC-------MSYAFHTPDKLSFIL---DLMNGGDLHYHLSQHGVFSEAEMRFYA 103
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I GL ++H +R V++RDLK +N+LLD + +ISD G+A F + ++ V
Sbjct: 104 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 156
Query: 342 GTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETL 374
GT+GYM+PE G+ + +D FS G +L + L
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 170 NKLGEGGFGPVYKGKL-LNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
KLGEG + V+KG+ L VA+K RL ++ G + E+ L+ L H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
L++EY+ +K L ++ D I+ + I +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDD--------------CGNIMSMHNVKIFLYQILR 115
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
GL Y H R +V+HRDLK N+L++ K++DFG+AR ++ N +V T Y
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWY 170
Query: 347 MSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
P+ L +S + D++ G + E S +
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRN 221
++ + KLGEG + VYKGK +NG+ VA+K RL + G + E L+ L H N
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHAN 64
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V L + L++EY+ + D G+ ++ +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--------------DKHPGGLHPENVKLFLF 110
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
+ + +GL Y+HQ ++HRDLK N+L+ K++DFG+AR
Sbjct: 111 Q-LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304
+++D F +Y +G D++ G V I+ GL +LH R +I+RDL
Sbjct: 71 QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDL 127
Query: 305 KASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSD 362
K NV+LD + + KI+DFG+ + M G ++ GT Y++PE + + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT----FCGTPDYIAPEIIAYQPYGKSVD 183
Query: 363 VFSFGVLLLETLSSK 377
+++GVLL E L+ +
Sbjct: 184 WWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 172 LGEGGFGPVYK-GKLLNGEEVAVKRLSNKSGQGVEEFKNEM-ILIAKLHHRNLVRLFGCC 229
+G+G +G V+K NG + AVK L + EE + E IL A H N+V+ +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYG-- 82
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR------IIEG 283
+Y K+ D + +G VTD KG L R+ I+
Sbjct: 83 --------MYYKKDVKNGDQLWLVLELCNG-GSVTDLV-KGFLKRGERMEEPIIAYILHE 132
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
GL +LH + IHRD+K +N+LL + K+ DFG++ L+ N + VGT
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
Query: 344 YGYMSPEY-----ALHGLFSIKSDVFSFGVLLLE 372
+M+PE L + + DV+S G+ +E
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 175 GGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233
G FG VY K G+ A+K L + N K + + QG
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-----VKAERAIM-------MIQG 54
Query: 234 EKILIYE-YMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL--DWTTRVRIIEGIAQGLLY 290
E + + Y +S D+ +Y +G D + + G L DW + I E + G+
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA-KQYIAE-VVLGVED 112
Query: 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
LHQ +IHRD+K N+L+D + K++DFG++R G E + + VGT Y++PE
Sbjct: 113 LHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPE 163
Query: 351 YALHGLFSIK-SDVFSFGVLLLETL 374
+ G+ K SD +S G ++ E L
Sbjct: 164 -TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 38/196 (19%)
Query: 188 GEEVAVKRLSNKSGQGVEEFKN---EMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244
G+ VA+K+LS + Q V K E++L+ ++H+N++ L + P
Sbjct: 41 GQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 245 KSLDFF--------LFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSR 296
KSL+ F L D M LD ++ + G+ +LH
Sbjct: 88 KSLEEFQDVYLVMELMDANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAG- 138
Query: 297 LRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL 356
+IHRDLK SN+++ D KI DFG+AR G + M V T Y +PE L
Sbjct: 139 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMG 193
Query: 357 FSIKSDVFSFGVLLLE 372
+ D++S G ++ E
Sbjct: 194 YKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEE-VAVKRLSNKSGQGVEEFKN----EMILIAKLHHRNLVRLF 226
+GEG +G V K + +E VA+K+ K + EE K E+ ++ L N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+G+ L++EY+ L+ + G+ R I + I
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELL--------------EEMPNGVPPEKVRSYIYQLIKA 112
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
+H + ++HRD+K N+L+ + K+ DFG AR + +N V T Y
Sbjct: 113 ----IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWY 167
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLE 372
SPE L + D++S G +L E
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 15/196 (7%)
Query: 188 GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247
+ VAVK++ Q V+ E+ +I +L H N+V+++ G +
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD------LTEDVG 83
Query: 248 DFFLFDYKYSSGFDMVTDPA---SKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304
+ Y M TD A +G L + + +GL Y+H + V+HRDL
Sbjct: 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDL 140
Query: 305 KASNVLLDG-DMNPKISDFGIARMFGGD-ELQSNMNRIVGTYGYMSPEYALHGLFSIKS- 361
K +NV ++ D+ KI DFG+AR+ + ++ + T Y SP L K+
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 362 DVFSFGVLLLETLSSK 377
D+++ G + E L+ K
Sbjct: 201 DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304
+++D F +Y +G D++ G V IA GL +LH +I+RDL
Sbjct: 71 QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDL 127
Query: 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVF 364
K NV+LD + + KI+DFG+ + D + + GT Y++PE + + D +
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 365 SFGVLLLETLSSK 377
+FGVLL E L+ +
Sbjct: 186 AFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 72/267 (26%), Positives = 111/267 (41%), Gaps = 51/267 (19%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEM-ILIAKLHHRNLVRLF 226
LG+G FG V +L + AVK L VE E IL +H L +L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 227 GCCIEQGEKIL-IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-I 284
CC + +++ + E++ L +F + S FD R R I
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-------------EARARFYAAEI 105
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVG 342
L++LH +I+RDLK NVLLD + + K++DFG+ + +F G + G
Sbjct: 106 TSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCG 158
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
T Y++PE L+ D ++ GVLL E L GHA ++ +
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC----------------GHA--PFEAEN 200
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALL 429
L + L +E +YP V +L
Sbjct: 201 EDDLFEAILNDEVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 172 LGEGGFGPVYKGKLLNGEE-VAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+G G FG V+ + E A+K ++ + + NE ++ ++ H ++RLF
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+Q ++ EY+P L F Y +SG S G+ + V +E
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL----FSYLRNSG----RFSNSTGLFYASEIVCALE----- 115
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
YLH +++RDLK N+LLD + + K++DFG A+ +L+ + GT Y+
Sbjct: 116 --YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYL 165
Query: 348 SPEYALHGLFSIKS-------DVFSFGVLLLETLSSK 377
+PE I+S D ++ G+L+ E L
Sbjct: 166 APE-------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 172 LGEGGFGPV---YKGKLLNGEEVAVKRLSNKSGQGVEEFKN--EMILIAKLHHRNLVRLF 226
+G G +G V Y +L ++VAVK+LS + + E+ L+ + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS--GFDMVTDPASKGILDWTTRVRIIEGI 284
+ P S++ F Y ++ G D+ + + D + I + +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-L 127
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+GL Y+H +IHRDLK SNV ++ D +I DFG+AR + M V T
Sbjct: 128 LRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATR 179
Query: 345 GYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
Y +PE L+ + ++ D++S G ++ E L K
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 72/236 (30%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMILIAKLHHRN 221
+G G +G V K E+VA+K+++N F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 222 LVRLFGC----CIEQGEKI-LIYEYM---------PNKSL-----DFFLFDYKYSSGFDM 262
++ + E + ++YE M +++L +FL+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 263 VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322
+ +GL Y+H + V+HRDLK SN+LL+ + + KI DF
Sbjct: 117 ---------------------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF 152
Query: 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSK 377
G+AR E M V T Y +PE L+ ++ DV+S G + E L K
Sbjct: 153 GLART--TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 39/97 (40%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNMNRIV 341
I GL Y+H + V+HRDLK N+L++ D KI DFG+AR F E M V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 342 GTYGYMSPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
T Y +PE L K+ DV+S G +L E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 41/235 (17%)
Query: 156 LASISTATHNFSEENKLGEGGFGPVYK-GKLLNGEEVAVKRLSNKSGQGVEEFKNEMILI 214
L S+ T + +G+G +G VYK +G AVK L S EE + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 215 AKL-HHRNLVRLFGCCIEQ-----GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPAS 268
L +H N+V+ +G + G+ L+ E S+ +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----------------- 115
Query: 269 KGILDWTTRVR------IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322
KG+L R+ I+ G GL +LH R+IHRD+K +N+LL + K+ DF
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 323 GIARMFGGDELQSNMNRIVGTYGYMSPEY-----ALHGLFSIKSDVFSFGVLLLE 372
G++ L+ N + VGT +M+PE + + DV+S G+ +E
Sbjct: 173 GVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I +GL YLH ++HRD+K N+L++ + KI DFG+AR+ DE + +M + V T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVT 167
Query: 344 YGYMSPEY---ALHGLFSIKSDVFSFGVLLLETLSSK 377
Y +PE + H ++ D++S G + E L +
Sbjct: 168 QYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 153 FFSLA---SISTATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKRLSN--KSGQGVEE 206
F+S+ S T + + +G G G V + G VAVK+LS ++ +
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66
Query: 207 FKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDP 266
E++L+ ++H+N++ L + P KSL+ F Y D
Sbjct: 67 AYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQ 114
Query: 267 ASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
LD ++ + G+ +LH +IHRDLK SN+++ D KI DFG+AR
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171
Query: 327 MFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
+ + M V T Y +PE L + D++S G ++ E + K + F D
Sbjct: 172 TACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV--KGSVIFQGTD 226
Query: 387 SLTLLGHAWNLWKDDRAWKLLDPTLQ-NEALYPMVKRYI 424
+ WN + +L P+ + L P V+ Y+
Sbjct: 227 HID----QWNKVIE----QLGTPSAEFMNRLQPTVRNYV 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 20/189 (10%)
Query: 191 VAVKRLSN--KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248
VA+K+LS ++ + E++L+ ++H+N++ L + P KSL+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLE 92
Query: 249 FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308
F Y D + LD ++ + G+ +LH +IHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 368
+++ D KI DFG+AR G + M V T Y +PE L + D++S G
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 369 LLLETLSSK 377
++ E + K
Sbjct: 207 IMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
LG+G FG V +L +EV A+K L ++ M IL H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 227 GCCIEQGEKIL-IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-I 284
CC + +++ + EY+ L +F + S FD R R +
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-------------EPRSRFYAAEV 105
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVG 342
L++LH++ VI+RDLK N+LLD + + K++DFG+ + + G + G
Sbjct: 106 TLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT----FCG 158
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
T Y++PE + D ++ GVL+ E ++ +
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 166 FSEENKLGEGGFGPV-YKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ + ++G G +G V G +VA+K+L F++E L AK +R L R
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-------RPFQSE--LFAKRAYREL-R 66
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI---I 281
L + L+ + P+ SLD F D+ F M TD + + RI +
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRF-HDFYLVMPF-MGTDLGKLMKHEKLSEDRIQFLV 124
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+ +GL Y+H +IHRDLK N+ ++ D KI DFG+AR + S M V
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYV 176
Query: 342 GTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
T Y +PE L+ + ++ D++S G ++ E L+ K
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 45/194 (23%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMI---------LIAKLHHR 220
K+GEG +G V+K + G+ VA+K+ VE + +I ++ +L H
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHP 60
Query: 221 NLVRLFGCCIE---QGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
NLV L IE + K+ L++EY + L+ + +G+ +
Sbjct: 61 NLVNL----IEVFRRKRKLHLVFEYCDHTVLN--------------ELEKNPRGVPEHLI 102
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
+ +II Q + + H+++ IHRD+K N+L+ K+ DFG AR+ G +
Sbjct: 103 K-KIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DD 156
Query: 337 MNRIVGTYGYMSPE 350
V T Y +PE
Sbjct: 157 YTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVKRLSN--KSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+G G +G V GE+VA+K+LS +S + E+ L+ + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 229 CIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ ++ DF+L Y + ++ P S+ + + ++ + G
Sbjct: 81 ------DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCG 129
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
L Y+H +IHRDLK N+ ++ D KI DFG+AR + M V T Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYR 181
Query: 348 SPEYALHGLFSIKS-DVFSFGVLLLETLSSK 377
+PE L+ + ++ D++S G ++ E L+ K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 20/189 (10%)
Query: 191 VAVKRLSN--KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248
VA+K+LS ++ + E++L+ ++H+N++ L + P KSL+
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 249 FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308
F Y D + LD ++ + G+ +LH +IHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 368
+++ D KI DFG+AR G + M V T Y +PE L + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 369 LLLETLSSK 377
++ E +
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 170 NKLGEGGFGPVYKGKL-LNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
+KLGEG + V+KG+ L VA+K RL ++ G + E+ L+ L H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IEGIA 285
+ L++EY LD L Y + G M V+I + +
Sbjct: 70 DIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMH-----------NVKIFMFQLL 113
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+GL Y H + +++HRDLK N+L++ K++DFG+AR ++ N +V T
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLW 168
Query: 346 YMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
Y P+ L +S D++ G +L E + +
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 67/252 (26%), Positives = 97/252 (38%), Gaps = 51/252 (20%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPV-----------YKGKLLNGEEVAVKRLSNKSGQG 203
+ + +F +G G FG V Y KLL+ E+ +KR
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKR------SD 86
Query: 204 VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFD 261
F E ++A + +V+L Q +K L + EYMP L + +Y
Sbjct: 87 SAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--- 141
Query: 262 MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321
W R E + L +H IHRD+K N+LLD + K++D
Sbjct: 142 -----------KWA-RFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185
Query: 322 FGIA-RMFGGDELQSNMNRIVGTYGYMSPEYAL----HGLFSIKSDVFSFGVLLLETLSS 376
FG +M + VGT Y+SPE G + + D +S GV L E L
Sbjct: 186 FGTCMKM--DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
Query: 377 KKNTRFYNIDSL 388
+T FY DSL
Sbjct: 244 --DTPFYA-DSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--EMILIAKL-HHRNLVRL 225
K+GEG F V K + G+ A+K + K + +E+ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 226 FGCCIEQ--GEKILIYEYMPNKSLDFFLFDY----KYSSGFDMVTDPASKGILDWTTRVR 279
++ G L++E M D L++ K L
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRP--------------LPEKRVKS 104
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+ + + L ++H R + HRD+K N+L+ D K++DFG R G +
Sbjct: 105 YMYQLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTE 157
Query: 340 IVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLS 375
+ T Y +PE L G + K D+++ G + E LS
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 42/214 (19%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+ + K K VAVK+ L + S + ++ + E+I +L H N++
Sbjct: 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
I E ++ M S + L + + G I++ + L
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPE------------LAIAFILKDVLNALD 115
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQ-----------SNM 337
Y+H IHR +KAS++LL GD +S + M + Q N+
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 338 NRIVGTYGYMSPEY---ALHGLFSIKSDVFSFGV 368
++SPE L G ++ KSD++S G+
Sbjct: 173 P-------WLSPEVLQQNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 66/247 (26%), Positives = 97/247 (39%), Gaps = 66/247 (26%)
Query: 172 LGEGGFGPV-YKGKLLNGEEVAVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLVRLF 226
+G G FG V K G A+K+L + Q V + E ++A+ + +V+L+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 227 GCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTRVRIIEG 283
Q E LI EY+P G DM+T K + TR I E
Sbjct: 68 --YSFQDENYLYLIMEYLP---------------GGDMMTLLMKKDTFTEEETRFYIAET 110
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--------------- 328
I L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 111 I----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 329 ----GGDELQSNM-----------NRI------VGTYGYMSPEYALHGLFSIKSDVFSFG 367
D + M NR VGT Y++PE L ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 368 VLLLETL 374
V++ E L
Sbjct: 227 VIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-08
Identities = 23/83 (27%), Positives = 45/83 (54%), Gaps = 8/83 (9%)
Query: 5 KSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLK-NCTCRAYGNSNLIGGGSGCLMW 63
KS F++ + ++P ++++ +L+EC ++CL NC+CR++ +N G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 64 -FGDMIDMKRTLGNLTGQSIYLR 85
+ D + L G +Y +
Sbjct: 57 SESSLGDAR--LFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+A+G+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M+PE L++ SDV+S+G+LL E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+ +L L +L +I+RD+K N+LLD + + ++DFG+++ F DE++ + GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169
Query: 344 YGYMSPEYALHGL--FSIKSDVFSFGVLLLETLS 375
YM+P+ G D +S GVL+ E L+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 33/170 (19%)
Query: 172 LGEGGFGPVYKGKL--------LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
LG+G F ++KG L+ EV +K L E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+G C+ E I++ EY+ SLD +L +K +++ + ++ + +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--------------KKNKNLINISWKLEVAKQ 108
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLL--DGDM---NP---KISDFGIA 325
+A L +L + H ++ A NVLL + D NP K+SD GI+
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 278 VRIIEG-IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
VR G I L +LH +L +++RD+K N+LLD + + ++DFG+++ F +E +
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 337 MNRIVGTYGYMSPEY----ALHGLFSIKSDVFSFGVLLLE--------TLSSKKNTR 381
+ GT YM+PE HG D +S G+L+ E TL ++NT+
Sbjct: 164 YS-FCGTIEYMAPEIIRGKGGHGK---AVDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 4/101 (3%)
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
+R R A+ L L + VI+RDLK N+LLD + + DFG+ ++ D+ +
Sbjct: 92 LSRARFY--TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+N GT Y++PE L ++ D ++ GVLL E L+
Sbjct: 150 TNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG-IARMFGGDELQSNMNRIVG 342
+A+ +L + +L +HRD+K NVLLD + + +++DFG R+ +QSN+ VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 343 TYGYMSPEY--ALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
T Y+SPE A+ G + + D +S GV + E L + T FY
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L YLH V++RD+K N++LD D + KI+DFG+ + D + M GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 252 FDYKYSSGFDMVTDPASKGILDW---------TTRVRI-IEGIAQGLLYLHQYSRLRVIH 301
F ++ S +VTD S G L W R + I + L +LH+Y +++
Sbjct: 63 FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVY 119
Query: 302 RDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN--MNRIVGTYGYMSPEYALHGL-FS 358
RDLK N+LLD + + DFG+++ L N N GT Y++PE L ++
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKA----NLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 359 IKSDVFSFGVLLLE 372
D +S GVL+ E
Sbjct: 176 KHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L YLH S V++RDLK N++LD D + KI+DFG+ + G + + M GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
Y++PE + D + GV++ E + + FYN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG-IARMFGGDELQSNMNRIVG 342
IA+ +L +H +L +HRD+K NVLLD + + +++DFG +M +QS++ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165
Query: 343 TYGYMSPEY--ALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
T Y+SPE A+ G + + D +S GV + E L + T FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 20/184 (10%)
Query: 199 KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS 258
K+ G + E+ ++ + HR ++ L I+ Y ++ + YK
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKC-- 170
Query: 259 GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
D+ T G L + I + + L YLH +IHRD+K N+ LD N
Sbjct: 171 --DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAV 225
Query: 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
+ DFG A GT SPE + K+D++S G++L E +S K
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKN 284
Query: 379 NTRF 382
T F
Sbjct: 285 VTLF 288
|
Length = 392 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGTY 344
GL YLH+ ++++RDLK N+LLD + KI+DFG+ + M GD + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST----FCGTP 165
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
+++PE ++ D + GVL+ E L
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGE--EVAVKRLSNKS---GQGVEEFKNEMILIAKLHH 219
+F+ LG G FG V N + VA+KR + V+ +E ++ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
V L+G ++ L+ E++ +FF F + + F P G V
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-LRRNKRF-----PNDVGCFYAAQIVL 142
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
I E YL L +++RDLK N+LLD D K++DFG A++ + +
Sbjct: 143 IFE-------YLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYT 187
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
+ GT Y++PE L+ +D ++ G+ + E L
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 172 LGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
+G+G FG V K +G AVK L K+ +E + M +L+ L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
Y + + L +F+ DY + G + L+ R E +A
Sbjct: 63 ------------YSFQTAEKL-YFVLDY-VNGGELFFHLQRERCFLEPRARFYAAE-VAS 107
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
+ YLH L +I+RDLK N+LLD + ++DFG+ + G E + + GT Y
Sbjct: 108 AIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEY 162
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETL 374
++PE + D + G +L E L
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 44/249 (17%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIA-----KLHHRNLVRL 225
K+G G FG V+ K +E + S +G++E + ++I +L H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ + + L Y+ + D + M I+D T + +
Sbjct: 78 IDRFLNKANQKL---YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ------LL 128
Query: 286 QGLLYLHQY----SRLRVIHRDLKASNVL-----------------LDGDMNPKISDFGI 324
L Y H + RV+HRDLK N+ L+G KI DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSI--KSDVFSFGVLLLETLSSKKNTRF 382
++ G ++S + VGT Y SPE LH S KSD+++ G ++ E S K T F
Sbjct: 189 SKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPF 243
Query: 383 YNIDSLTLL 391
+ ++ + L
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 55/242 (22%)
Query: 172 LGEGGFGPVYKGKLLN---------GEEVAVKRLSNKSGQGV-EEFKNEMILIAKLHHRN 221
LG+G F +YKG L G+EV+V S F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
LV+L+G C+ E I++ EY+ LD FL K + V+ L W ++ +
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN-----VS-------LHW--KLDVA 107
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLL-----DGDMNP--KISDFGIARMFGG-DEL 333
+ +A L YL +++H ++ N+L+ + P K+SD GI +E
Sbjct: 108 KQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKS--DVFSFGVLLLE----------TLSSKKNTR 381
RI +++PE +G S+ D +SFG LLE TLSS + R
Sbjct: 165 VE---RI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217
Query: 382 FY 383
FY
Sbjct: 218 FY 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEE----VAVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLV 223
LG+GG+G V++ + + G + A+K L ++ + K E ++ + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L G+ LI EY+ SG ++ +GI T +
Sbjct: 64 DLIYAFQTGGKLYLILEYL---------------SGGELFMHLEREGIFMEDTACFYLSE 108
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I+ L +LHQ +I+RDLK N+LLD + K++DFG+ + + G + +
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
GT YM+PE + D +S G L+ + L+
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L YLH ++++RDLK N++LD D + KI+DFG+ + G + M GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGT 158
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 29/180 (16%)
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQSNMNRIVGTY 344
+ L Y+H + V HRDLK N+L + D KI DFG+AR F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 345 GYMSPEYALHGLFSIKS----DVFSFGVLLLETLSSK-----KNTRFYNIDSLT-LLG-- 392
Y +PE L G F K D++S G + E L+ K KN + +D +T LLG
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLLGTP 227
Query: 393 --HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKV---ALLCVQE----NAADRPTMSE 443
+ ++++A + L +++ + P +++ AL ++ + DRPT E
Sbjct: 228 SPETISRVRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
+G+G FG V K +G+ AVK L K+ +E K+ M +L+ + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
Y + L +F+ DY + G + + R E IA
Sbjct: 63 ------------YSFQTADKL-YFVLDY-VNGGELFFHLQRERSFPEPRARFYAAE-IAS 107
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
L YLH L +I+RDLK N+LLD + ++DFG+ + G E + GT Y
Sbjct: 108 ALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEY 162
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
++PE + D + G +L E L
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
YLH +I+RDLK N+LLD + K++DFG A+ ++ + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 350 EYALHGLFSIKSDVFSFGVLLLETL 374
E D ++ GVLL E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 70/237 (29%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 172 LGEGGFG-----------PVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR 220
+G G FG VY KLL+ E+ +KR + F E ++A +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAF------FWEERDIMAFANSP 103
Query: 221 NLVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
+V+LF C Q +K L + EYMP L + +Y D K +T V
Sbjct: 104 WVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEV 151
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
+L L + +IHRD+K N+LLD + K++DFG ++ M
Sbjct: 152 ---------VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD----ETGMV 198
Query: 339 RI---VGTYGYMSPEY----ALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388
R VGT Y+SPE G + + D +S GV L E L +T FY DSL
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 57/232 (24%), Positives = 106/232 (45%), Gaps = 65/232 (28%)
Query: 170 NKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKN-EMILIAKLHHRNLVRL-- 225
N +G G FG VY+ ++ E+VA+K++ ++KN E++++ L+H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 226 --FGCCIEQGEKIL----IYEYMP-------------NKSLDFFLFD-YKYSSGFDMVTD 265
+ C ++ EK + + E++P N +L FL Y Y
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178
Query: 266 PASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGI 324
+ + L Y+H S+ + HRDLK N+L+D + + K+ DFG
Sbjct: 179 ------------------LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGS 217
Query: 325 AR-MFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETL 374
A+ + G Q +++ I + Y +PE L ++ D++S G ++ E +
Sbjct: 218 AKNLLAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 28/90 (31%), Positives = 49/90 (54%)
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
Q +L L + +++HRDLK++N+ L K+ DFG ++ + + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y++PE +S K+D++S GV+L E L+
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I+ L YLH+ +I+RDLK NVLLD + + K++D+G+ + G + GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 159
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
Y++PE + D ++ GVL+ E ++ +
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L YLH V++RDLK N++LD D + KI+DFG+ + G + M GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
Y++PE + D + GV++ E + + FYN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 47/208 (22%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 180 VYKGKLLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK- 235
+YKG N +EV ++ ++ +NE+ + ++ N+++++G I+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 236 ---ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH 292
LI EY L L D D L + T++ + +GL L+
Sbjct: 95 PRLSLILEYCTRGYLREVL---------DKEKD------LSFKTKLDMAIDCCKGLYNLY 139
Query: 293 QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA 352
+Y+ +++L + + L+ + KI G+ ++ + N+N +V Y S +
Sbjct: 140 KYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKM- 191
Query: 353 LHGLFS---IKSDVFSFGVLLLETLSSK 377
L+ +FS IK D++S GV+L E + K
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I L +LH+ +I+RDLK NVLLD D + K++D+G+ + + GD +
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST----FC 157
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GT Y++PE + D ++ GVL+ E ++ +
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 172 LGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
+G+G FG V K L+G+ AVK L K +E K+ M +L+ + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
Y + + L +F+ D+ + G + + R E IA
Sbjct: 63 ------------YSFQTTEKL-YFVLDF-VNGGELFFHLQRERSFPEPRARFYAAE-IAS 107
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
L YLH + +++RDLK N+LLD + ++DFG+ + G GT Y
Sbjct: 108 ALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEY 162
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETL 374
++PE + D + G +L E L
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
+G+G FG V + E+ AVK L K+ +E K+ M +L+ + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+ + L +F+ DY + G + L+ R E IA
Sbjct: 63 ------------FSFQTADKL-YFVLDY-INGGELFYHLQRERCFLEPRARFYAAE-IAS 107
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
L YLH L +++RDLK N+LLD + ++DFG+ + E + GT Y
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEY 162
Query: 347 MSPEYALHGLFSIKSDVFSFGVLLLETL 374
++PE + D + G +L E L
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I+ L +LH+ +I+RDLK NVLLD + + K++D+G+ + + GD +
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST----FC 157
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GT Y++PE + D ++ GVL+ E ++ +
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 62/259 (23%), Positives = 101/259 (38%), Gaps = 69/259 (26%)
Query: 166 FSEENKLGEGGFGPV-YKGKLLNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRN 221
F + LG G FG V K+ A+K L K + V K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTRVRI 280
+V+L+ Y + +L +F+ DY G DM++ + + R I
Sbjct: 63 VVKLY------------YSFQDKDNL-YFVMDY--IPGGDMMSLLIRMEVFPEVLARFYI 107
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG----------- 329
A+ L + ++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 108 ----AELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163
Query: 330 ----------------------GDELQSNMNR------------IVGTYGYMSPEYALHG 355
GD L++ R +VGT Y++PE L
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223
Query: 356 LFSIKSDVFSFGVLLLETL 374
++ D +S GV+L E L
Sbjct: 224 GYTQLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 65/255 (25%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEV-AVKRLSNKS---GQGVEEFKNEMILIAKLHHRN 221
F + +G G FG V + ++ + A+K L K E ++A+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT-TRVRI 280
+V+L+ Y + +L +F+ DY G DM++ GI + R I
Sbjct: 63 VVKLY------------YSFQDKDNL-YFVMDY--IPGGDMMSLLIRLGIFEEDLARFYI 107
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF-----------G 329
E + + +H ++ IHRD+K N+L+D D + K++DFG+ F G
Sbjct: 108 AE-LTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 330 G----------DELQSNMNR--------------------IVGTYGYMSPEYALHGLFSI 359
+E +VGT Y++PE L ++
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223
Query: 360 KSDVFSFGVLLLETL 374
D +S GV+L E L
Sbjct: 224 LCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 45/232 (19%)
Query: 172 LGEGGFG-----------PVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR 220
+G G FG VY KLL+ E+ +KR + F E ++A +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEERDIMAFANSP 103
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V+LF + ++ EYMP L + +Y D K +T V
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEV-- 151
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+L L + IHRD+K N+LLD + K++DFG + + +
Sbjct: 152 -------VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTA 203
Query: 341 VGTYGYMSPEY----ALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388
VGT Y+SPE G + + D +S GV L E L +T FY DSL
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 28/175 (16%)
Query: 175 GGFGPVYKG-KLLNGEEVAVK-----RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
G FG VY G K N + AVK + NK+ V + + E +A +V L+
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNM--VHQVQAERDALALSKSPFIVHLYYS 72
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
L+ EY+ + L Y Y D V+ I +A L
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGY---------------FDEEMAVKYISEVALAL 117
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
YLH++ +IHRDLK N+L+ + + K++DFG++++ EL NM I+ T
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL--NMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 18/101 (17%)
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM---------- 337
L YLH Y ++HRDLK N+L+ + K++DFG++++ G L +N+
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169
Query: 338 ----NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
++ GT Y++PE L + D ++ G++L E L
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 63/258 (24%), Positives = 100/258 (38%), Gaps = 67/258 (25%)
Query: 166 FSEENKLGEGGFGPV-YKGKLLNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRN 221
F + LG G FG V K+ A+K L K V K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+VRL+ Y + +L +F+ DY G DM++ GI I
Sbjct: 63 VVRLY------------YSFQDKDNL-YFVMDY--IPGGDMMSLLIRMGIFPEDLARFYI 107
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF----------GGD 331
+ + +H ++ IHRD+K N+L+D D + K++DFG+ F GD
Sbjct: 108 AELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164
Query: 332 EL-QSNMN----------------------------------RIVGTYGYMSPEYALHGL 356
+ Q +M+ +VGT Y++PE L
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224
Query: 357 FSIKSDVFSFGVLLLETL 374
++ D +S GV+L E L
Sbjct: 225 YTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 39/161 (24%), Positives = 68/161 (42%), Gaps = 25/161 (15%)
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+ N ++L+ +LI +Y+ + L FD++ +G L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL------------FDLLK---KEGKLSEAEV 111
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSN 336
+II + + L LH++ +IH D+K NVL D + + D+G+ ++ G
Sbjct: 112 KKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD- 167
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
GT Y SPE + + D ++ GVL E L+ K
Sbjct: 168 -----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG-IARMFGGDELQSNMNRIVG 342
+A+ +L +H ++ +HRD+K NVL+D + K++DFG AR+ + S + VG
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VG 165
Query: 343 TYGYMSPEY--ALHG----LFSIKSDVFSFGVLLLETL 374
T Y++PE ++G + ++ D +S GV+ E +
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 34/163 (20%), Positives = 58/163 (35%), Gaps = 27/163 (16%)
Query: 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV--R 224
S L G VY E+ +K N S + + + E+ ++ L + L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGT-KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ G L+ E++ ++LD + + I E +
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE----------------------VSEEEKEDIAEQL 95
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327
A+ L LHQ L + H DL N+L+D I D+ A
Sbjct: 96 AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231
+G G FG V KL N ++V ++ NK EM L R C
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKW---------EM----------LKRAETACFR 49
Query: 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-------- 283
+ +L+ N+ + + ++ + +V D G D T + E
Sbjct: 50 EERDVLVNG--DNQWITTLHYAFQDENNLYLVMDYYVGG--DLLTLLSKFEDRLPEDMAR 105
Query: 284 --IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG-IARMFGGDELQSNMNRI 340
+A+ ++ + +L +HRD+K N+L+D + + +++DFG ++ +QS++
Sbjct: 106 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--A 163
Query: 341 VGTYGYMSPEY--ALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
VGT Y+SPE A+ G + + D +S GV + E L + T FY
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 45/136 (33%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-------------RMFGG 330
+A+ +L + +L IHRD+K N+L+D + K+SDFG++ ++ G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 331 DELQ------------------SNMNRI--------------VGTYGYMSPEYALHGLFS 358
+ S+ ++I VGT Y++PE L +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 359 IKSDVFSFGVLLLETL 374
+ D +S G ++ E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 45/137 (32%)
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF---------GIARMFGGDELQSNM 337
L YLH L +++RDLK N+LL + +SDF +
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 338 NRI------------------VGTYGYMSPEY---ALHGLFSIKSDVFSFGVLLLETL-- 374
+ VGT Y++PE HG ++ D ++ G+LL E L
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228
Query: 375 ------SSKKNTRFYNI 385
S++ T F NI
Sbjct: 229 TTPFKGSNRDET-FSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 55/247 (22%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG----QGVEEFKNEMILIAKLHHR 220
+F +G G FG V + + V ++ K+ + V + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V++F ++ LI E++P G DM+T K D T
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLP---------------GGDMMTLLMKK---DTLTEEET 103
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA--------------- 325
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 104 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 326 -RMFGGDELQSNMN-----------------RIVGTYGYMSPEYALHGLFSIKSDVFSFG 367
D NMN VGT Y++PE + ++ D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 368 VLLLETL 374
V++ E L
Sbjct: 224 VIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
I + + + YLH+ R+IHRD+KA N+ ++ + + DFG A F D +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRF 382
GT +PE + D++S G++L E +++ ++ F
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFE-MATCHDSLF 284
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 59/212 (27%)
Query: 187 NGEEVAVKRLSNKSGQGVEEFKNEMIL-------IAKL-HHRNLVRLFGCCIEQGEKILI 238
GE V V+R++ +E NEM+ ++KL +H N+V I E ++
Sbjct: 24 TGEYVTVRRIN------LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77
Query: 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLR 298
+M Y S D++ G+ + I++G+ + L Y+H +
Sbjct: 78 TSFM------------AYGSAKDLICTHFMDGMSELAI-AYILQGVLKALDYIHH---MG 121
Query: 299 VIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI----------------VG 342
+HR +KAS++L+ D G + G L+SN++ I V
Sbjct: 122 YVHRSVKASHILISVD--------GKVYLSG---LRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 343 TYGYMSPEYALHGL--FSIKSDVFSFGVLLLE 372
++SPE L + KSD++S G+ E
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 43/203 (21%)
Query: 188 GEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245
G V V+ L N + + ++ +NE++L H N++ + +I +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305
S + L Y + G S+ ++ I+ G +GL YLHQ IHR++K
Sbjct: 85 SANSLLKTY-FPEGM-------SEALIG-----NILFGALRGLNYLHQNG---YIHRNIK 128
Query: 306 ASNVLLDGDMNPKISDFGIARMFGGDELQSNMN-----RIVGTY--------GYMSPEYA 352
AS++L+ GD G+ + G L S + ++V + ++SPE
Sbjct: 129 ASHILISGD--------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 353 ---LHGLFSIKSDVFSFGVLLLE 372
L+G +++KSD++S G+ E
Sbjct: 181 RQDLYG-YNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 26/179 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKSGQGVEEFKNEMIL------ 213
+F KLGEG FG VYK L+N + +K+ + + G VE + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPNS 190
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA-SKGIL 272
A + L + ++ E L++ Y + L D S F +P +
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGEST----LADLMQSKEFPYNVEPYLLGKVQ 244
Query: 273 DW----TTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIA 325
D +II+ I + +L+ L ++HRD+K N++ G + KI D G A
Sbjct: 245 DLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 33/124 (26%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG-------------- 329
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 330 --GDELQSNMN-----------------RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
D NMN VGT Y++PE + ++ D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 371 LETL 374
E L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 281 IEGIAQGLL----YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
+ +A+ LL Y+H +IHRD+K NVL++G + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLET 373
I GT +PE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 55/196 (28%)
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL 272
++ ++ H+++V L+G C+ E I++ E++ LD F+ ++ S D++T P
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKS---DVLTTP------ 105
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-----DGDMNP--KISDFGI- 324
W + ++ + +A L YL ++H ++ N+LL DG+ P K+SD GI
Sbjct: 106 -W--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159
Query: 325 ----ARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLE------- 372
+R Q + RI +++PE SI +D +SFG L E
Sbjct: 160 ITVLSR-------QECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI 208
Query: 373 -----TLSSKKNTRFY 383
TL+ K+ RFY
Sbjct: 209 PLKDKTLAEKE--RFY 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.97 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.34 | |
| PLN02236 | 344 | choline kinase | 97.31 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.22 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.79 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.74 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.67 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.52 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.33 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.2 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.95 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-60 Score=466.50 Aligned_cols=288 Identities=44% Similarity=0.747 Sum_probs=253.3
Q ss_pred ceeeeCHHHHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeee
Q 040910 150 WFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229 (496)
Q Consensus 150 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 229 (496)
....|++.++..+|++|+..+.||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998765543145699999999999999999999999
Q ss_pred eecC-eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 230 IEQG-EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 230 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
.+.+ +.+||||||++|||.++|+.. ... .++|.+|++||.++|+||+|||+...++|+||||||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~------------~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGK------------KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCC------------CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 9999 599999999999999999741 111 78999999999999999999999998899999999999
Q ss_pred EEecCCCceEEeccccccccCCCccccccccc-cccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC-CC
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRI-VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN-ID 386 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~-~~ 386 (496)
||||+++++||+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++..... ..
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred eeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999765431 1112222 89999999999999999999999999999999999998877654 33
Q ss_pred cchhhHhhhhhhcccccccccCcccc-ccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQ-NEALY-PMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
...+..|++..+..++..+++||.+. ..... .++.++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 45588899999999999999999987 44444 68999999999999999999999999999997753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=395.01 Aligned_cols=259 Identities=32% Similarity=0.493 Sum_probs=210.6
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccC--HHHHHHHHHHHHHhcCCceeeeeeeeeecC-eeEEEEEecC
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQG--VEEFKNEMILIAKLHHRNLVRLFGCCIEQG-EKILIYEYMP 243 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~ 243 (496)
...+.||.|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999999444449999997653222 569999999999999999999999999988 7999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ceEEecc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NPKISDF 322 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DF 322 (496)
+|+|..+++. ..+..+++..+++++.|||+||.|||+.++ ||||||||+|||++.++ ++||+||
T Consensus 124 ~GsL~~~l~~-------------~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 124 GGSLSVLLHK-------------KRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCcHHHHHhh-------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence 9999999963 146789999999999999999999999874 99999999999999997 9999999
Q ss_pred ccccccCCCccccccccccccccccChhhhc--cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYAL--HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|+++...... ..++...||+.|||||++. ...|+.|+||||||++||||+||+.||..... ... +......
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~---~~~v~~~ 261 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQV---ASAVVVG 261 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHH---HHHHHhc
Confidence 9998765322 3344478999999999999 56999999999999999999999999875443 111 1111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
... +..+......+..++..||+.||+.||++.+++..|+.+.....
T Consensus 262 ~~R---------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 262 GLR---------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCC---------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 111 11122244677888889999999999999999999997655443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=409.38 Aligned_cols=271 Identities=28% Similarity=0.399 Sum_probs=223.1
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
..+....+.||+|+||.||+|+.. +...||||.|+..... ...+|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556789999999999999763 3468999999977655 678999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+|||..|+|.+||............... ...+|+..+.+.||.|||.||.||-+.. +|||||..+|+||.++.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~-~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQD-TPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999876544332222222 2567999999999999999999999887 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCC-CCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~~~~~~~~~~~~~~~~~ 394 (496)
.|||+||||+|.+...++.+......-+++|||||.++.+.||.+||||||||+|||+++-. .|+..... .+ +
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~E----V 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QE----V 714 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HH----H
Confidence 99999999999988888877665667789999999999999999999999999999999844 44432221 11 1
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
......+++ -..+...+.++..|+..||+.+|.+||+++||-..|+...
T Consensus 715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 222222332 1334445678899999999999999999999999998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=387.04 Aligned_cols=254 Identities=34% Similarity=0.517 Sum_probs=209.7
Q ss_pred CCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+...+.||+|-||.||.|.++....||||.++... ...+.|.+|+.+|++|+|+|||+++|+|..++..+||+|||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34567999999999999999777799999997653 44578999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|.+||.. ..+..++..+.+.++.|||.||+||++++ +|||||.++||||+++..+||+|||||
T Consensus 287 sLl~yLr~-------------~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 287 SLLDYLRT-------------REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred cHHHHhhh-------------cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 99999953 34567899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhhHhhhhhhcccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
+....+.+.. .....-++.|.|||.+..+.++.|||||||||+||||+|-.+ |++... ...++..+ ++..
T Consensus 351 r~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~l------e~Gy 421 (468)
T KOG0197|consen 351 RLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELL------ERGY 421 (468)
T ss_pred cccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHH------hccC
Confidence 9665544332 223345789999999999999999999999999999999554 333221 11111111 2333
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
++..|..+ +..+.+|+..||+.+|++|||++.+...|++..
T Consensus 422 Rlp~P~~C-------P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 422 RLPRPEGC-------PDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred cCCCCCCC-------CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 44444443 467788999999999999999999999998753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=362.97 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=206.7
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-eeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-EKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~ 241 (496)
+++..+.||+|..|+|||+++. +++.+|+|.+... +....+++.+|++++++.+||+||+++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445679999999999999885 6889999999543 3445678899999999999999999999999999 59999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|.+|||+.++.. .+.+++...-+++.+|++||.|||+ .. ||||||||+|||++..|++|||
T Consensus 160 MDgGSLd~~~k~---------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 160 MDGGSLDDILKR---------------VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred cCCCCHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEec
Confidence 999999999952 3569999999999999999999996 54 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||.++.+-+. ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...................
T Consensus 222 DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~- 296 (364)
T KOG0581|consen 222 DFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD- 296 (364)
T ss_pred cccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-
Confidence 99999977544 3456799999999999999999999999999999999999999987653322222211111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+. .|.+... ....++..++..||+.||.+||+++|++++
T Consensus 297 ~p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EP-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CC-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 1122111 245678889999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=375.14 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=211.4
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..|...+.||+|||+.||.++. .+|+.||+|++.+. .....+...+|+++-+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 78999999999753 3445678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|+|.+++|..++. .++.+++.++..++.||+.||.|||+.+ |+|||||..|+||+++.++||
T Consensus 98 ELC~~~sL~el~K---------------rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---------------RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred EecCCccHHHHHH---------------hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEe
Confidence 9999999999983 4678999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||||..+..+. ....+.+||+.|.|||++.....+..+||||+|||||.||.|++||+.....+. +...
T Consensus 160 gDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~I- 230 (592)
T KOG0575|consen 160 GDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKI- 230 (592)
T ss_pred cccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHH-
Confidence 9999999887543 334568999999999999999999999999999999999999999985432211 1111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+..+..-|. .......+|+.++|+.||.+|||+++|+.+
T Consensus 231 --k~~~Y~~P~-------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 --KLNEYSMPS-------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --HhcCccccc-------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111111 233556788899999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=359.49 Aligned_cols=202 Identities=31% Similarity=0.524 Sum_probs=181.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..+|...++||.|+||+||+|++. ++..||||.+... +....+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357788889999999999999885 5789999999765 5556778899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-----
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD----- 314 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~----- 314 (496)
|||.+|+|..|+. .++.+++.....++.|||.||++||+++ ||||||||.||||+.+
T Consensus 89 EyC~gGDLs~yi~---------------~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---------------RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred EeCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCC
Confidence 9999999999995 3457999999999999999999999998 9999999999999765
Q ss_pred -CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 315 -MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 315 -~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
-.+||+|||+|+.+..... ..+.+|++-|||||+++...|+.|+|+||+|+||||+++|+.||.....
T Consensus 151 ~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 4689999999999875432 3457999999999999999999999999999999999999999985443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.85 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=202.5
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCcc-------CHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQ-------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
..+.|.+.+.||+|+||.|-+|.- .+|+.||||.+++.... ......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345567789999999999999965 57999999999754211 1223569999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..|||+||+++|.|-+++-. .+.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---------------nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---------------NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSN 311 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---------------ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEecc
Confidence 99999999999999999853 445666677889999999999999999 999999999999976
Q ss_pred C---CceEEeccccccccCCCccccccccccccccccChhhhccCC---CCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 314 D---MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 314 ~---~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
+ ..+||+|||+|+..+.. ..+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.....+.
T Consensus 312 ~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred CCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 6 78999999999987643 4567789999999999998654 3457899999999999999999997543322
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. +..+. ..++. . ..+....+..++..+++.++|..||++|||+.|++++
T Consensus 389 s-l~eQI----~~G~y--~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 S-LKEQI----LKGRY--A----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred c-HHHHH----hcCcc--c----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1 11111 11110 0 0112233446778899999999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=342.98 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=210.5
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeee-eeeecCe-eEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFG-CCIEQGE-KILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 238 (496)
.+|.+.++||+|.||+|||+.. .+|..||.|.+.-. +.+..+....|+.+|++|+|||||++++ -+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4677889999999999999964 68999999998733 3445678899999999999999999999 4555555 8999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSR-LRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|||+..|+|...+..++ ..++.++++.+++++.|+++||..+|+.-+ ..|+||||||.||+|+.+|.+
T Consensus 99 mE~c~~GDLsqmIk~~K-----------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFK-----------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred HHhhcccCHHHHHHHHH-----------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 99999999999998755 456779999999999999999999998432 239999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++.+..... .....+||+.||+||.+.+.+|+.|+||||+||++|||..-++||...+... +. ..
T Consensus 168 KLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--L~----~K 239 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--LC----KK 239 (375)
T ss_pred eeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH--HH----HH
Confidence 9999999999875532 2345799999999999999999999999999999999999999998652111 11 11
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
...++.. +-...-....+.+++..|+..||+.||+...+++.+...
T Consensus 240 I~qgd~~--------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 240 IEQGDYP--------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred HHcCCCC--------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1111110 011134567788899999999999999976666666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=380.48 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=212.0
Q ss_pred CCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
...+.+.||.|.||.||+|+++- ...||||.|+... .....+|..|+.+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 44567899999999999998852 3589999998654 455679999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|||+||+|+.||.. +.+.+++.++.-++.+||.||.||-+.+ +|||||.++|||++.+..+||
T Consensus 710 EyMENGsLDsFLR~--------------~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ--------------NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred hhhhCCcHHHHHhh--------------cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEe
Confidence 99999999999974 3456999999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccc--cccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVG--TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||++|.+..+. ....+..-| +++|.|||.+....+|.++||||||+++||.++ |.+|+=. ...
T Consensus 773 sDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd--mSN--------- 840 (996)
T KOG0196|consen 773 SDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD--MSN--------- 840 (996)
T ss_pred ccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc--cch---------
Confidence 9999999876543 222222223 679999999999999999999999999999876 6666321 111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
.+..+.++....-..+.+.+..+.+|+++|||+|..+||.+.+|+.+|++.+.+
T Consensus 841 ----QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 ----QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 111122223333344556678899999999999999999999999999986554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=342.85 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=202.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|++.+.||+|+||.||.++.. +++.+|+|.+++.. ....+..++|..+|.+++||+||+++-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999764 68899999997652 3356778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+.||.|-.+|. .++.+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|++
T Consensus 103 Vld~~~GGeLf~hL~---------------~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---------------REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI 164 (357)
T ss_pred EEeccCCccHHHHHH---------------hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence 999999999999984 5677999999999999999999999999 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
+|+|||+++..-.. ...+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.... ...
T Consensus 165 ~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----~~~- 236 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----YDK- 236 (357)
T ss_pred EEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----HHH-
Confidence 99999999954332 2344558999999999999999999999999999999999999999975442211 111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP 439 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 439 (496)
....+. ...+.-......+++...+..||++|.
T Consensus 237 I~~~k~---------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 ILKGKL---------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HhcCcC---------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111110 001111235667888899999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=388.10 Aligned_cols=266 Identities=31% Similarity=0.486 Sum_probs=215.9
Q ss_pred hcCCCccccccccCCeeEEEEEecC--CC----EEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN--GE----EVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
..+.+..+.||+|.||.||.|.+.+ |. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667899999999999998753 33 4999999865 345678999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++++|||++|+|..||.+.+... .....|+..+.+.++.|||+|+.||+++. +|||||.++|+||++..
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~--------~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAP--------FQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERR 839 (1025)
T ss_pred EEEehhcccCcHHHHHHhccccc--------CCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccC
Confidence 99999999999999998754322 23566999999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||||+.+...++........-+.+|||||.+.++.++.|+|||||||+|||++|... |++... .......
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~- 916 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLD- 916 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHH-
Confidence 999999999997666665554444456789999999999999999999999999999999554 443222 2221111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
....+ ++-.|.. .+..+.+|+..||+.+|++||++..+++.+..+...
T Consensus 917 --~~~gg---RL~~P~~-------CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 --VLEGG---RLDPPSY-------CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --HHhCC---ccCCCCC-------CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11222 3333333 346778999999999999999999999999876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=328.08 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=205.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
+.|+.+.++|+|+||.|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999875 599999999975432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++..-|++.-. .-..++...+.+++.|++.|+.|+|+++ +|||||||+|||++.++.+|||
T Consensus 82 ~~dhTvL~eLe~---------------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 82 YCDHTVLHELER---------------YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred ecchHHHHHHHh---------------ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEec
Confidence 998766655432 2234778899999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCC-cchhhHh-----
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLLGH----- 393 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~-~~~~~~~----- 393 (496)
|||+|+.+..+ ....+..+.|..|+|||.+.+ ..|...+||||+||++.||++|.+-|+....- .......
T Consensus 144 DFGFAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 144 DFGFARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred cchhhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 99999988632 234556788999999999987 78999999999999999999999988765432 2221111
Q ss_pred ---hhhhhc-ccccccccCccc-----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 394 ---AWNLWK-DDRAWKLLDPTL-----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 394 ---~~~~~~-~~~~~~~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
-...+. ......+.-|.. .....+....-+++++..|++.||.+|++-++++.
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 111111111221 11122333456889999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.95 Aligned_cols=275 Identities=26% Similarity=0.354 Sum_probs=207.6
Q ss_pred HhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|.+.++||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999964 2356899999975432 2345789999999999 8999999999887654
Q ss_pred -eeEEEEEecCCCChhHHHhhcccCCCc----------------------------------cc-------------ccC
Q 040910 234 -EKILIYEYMPNKSLDFFLFDYKYSSGF----------------------------------DM-------------VTD 265 (496)
Q Consensus 234 -~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------~~-------------~~~ 265 (496)
..++||||+++|+|.+++......... .. ...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 588999999999999999753211000 00 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcccccccccccccc
Q 040910 266 PASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345 (496)
Q Consensus 266 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 345 (496)
......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 011346889999999999999999999988 99999999999999999999999999986543322222233456788
Q ss_pred ccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHH
Q 040910 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYI 424 (496)
Q Consensus 346 y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 424 (496)
|+|||++.+..++.++|||||||++|||++ |..||........ ... ....+.... . .......+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~----~~~~~~~~~-----~----~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ----RLKDGTRMR-----A----PENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH----HHhcCCCCC-----C----CCCCCHHHH
Confidence 999999999999999999999999999997 8888865432211 111 111111100 0 112234678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 425 KVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 425 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
+++.+||+.||.+|||+.+|++.|++.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.33 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=206.2
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 236 (496)
..+.|+.+++||+|+||.||+|+. .+|+.||+|+++... .....-..+||.+|++|+||||++|.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345678889999999999999975 579999999998654 34456678999999999999999999998877 6899
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
||+|||+ -+|.-++. ...-.++..++..++.|++.||.|+|+.+ |.|||||.+|||||.+|.
T Consensus 195 lVFeYMd-hDL~GLl~--------------~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~ 256 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLS--------------SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGV 256 (560)
T ss_pred EEEeccc-chhhhhhc--------------CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCC
Confidence 9999995 46666653 23446999999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~ 394 (496)
+||+|||||+++.... ....+..+-|..|+|||++.|. .|+.++|+||.||||.||+.|++.++...+-+ +..+-..
T Consensus 257 LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 257 LKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred EEeccccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 9999999999876543 2346777889999999999875 69999999999999999999999988755422 1111000
Q ss_pred -----hhhhcccccc--cccCcccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 -----WNLWKDDRAW--KLLDPTLQ-----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 -----~~~~~~~~~~--~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...|...++. ..+.+... .+.........++|+..+|..||.+|.|+.++++.
T Consensus 336 cGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 336 CGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0112211111 11111110 00111223467888999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.30 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=204.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC--eeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG--EKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 239 (496)
..++...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|...... ..++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677889999999999999875 48999999987654344677899999999999999999999855544 689999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~k 318 (496)
||+++|||.+++..+ .. .|++..+..++.||++||+|||+++ |+||||||+|||++. ++.+|
T Consensus 96 Ey~~~GsL~~~~~~~-------------g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~K 158 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY-------------GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVK 158 (313)
T ss_pred eccCCCcHHHHHHHc-------------CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEE
Confidence 999999999999642 12 6999999999999999999999998 999999999999999 79999
Q ss_pred EeccccccccCC-CccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGG-DELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||+++.... ...........||+.|||||++.++ ....++|||||||++.||+||++|+... . ........
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~---~~~~~~~~ 234 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F---EEAEALLL 234 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c---chHHHHHH
Confidence 999999987764 1222334457899999999999963 3345999999999999999999998753 1 11111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
....... | ..+........+++..|++.+|+.|||+.+++++.--.
T Consensus 235 ig~~~~~-----P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 235 IGREDSL-----P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HhccCCC-----C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1111111 1 12222345667788899999999999999999887553
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=356.69 Aligned_cols=262 Identities=31% Similarity=0.424 Sum_probs=205.9
Q ss_pred hcCCCccccccccCCeeEEEEEecC--C--CE-EEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN--G--EE-VAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.++....++||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455556899999999999998753 2 23 899998742 34567899999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|||+++||+|++||.. ....++..++..++.+.|.||+|||+.+ ++||||.++|+|++.+
T Consensus 236 l~ivmEl~~gGsL~~~L~k--------------~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKK--------------NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKK 298 (474)
T ss_pred cEEEEEecCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCC
Confidence 9999999999999999963 2236999999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
..+||+|||+++.-. .+........-+.+|+|||.+..+.|+.++|||||||++||+++ |..|++..... ....+
T Consensus 299 ~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~k 374 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAK 374 (474)
T ss_pred CeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHH
Confidence 999999999988643 11111112245789999999999999999999999999999998 66665532211 11111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCC
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPS 457 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 457 (496)
+ ...+. +. ..+...+..+..++..||..+|++||+|.++.+.|+.+......
T Consensus 375 I---~~~~~--r~-------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 I---VKNGY--RM-------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred H---HhcCc--cC-------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1 01010 11 11112245566677799999999999999999999987655443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=350.58 Aligned_cols=266 Identities=28% Similarity=0.474 Sum_probs=213.9
Q ss_pred HHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
....+.+.+.+.||+|.||+||+|++.. .||||.+... ..+..+.|++|+..+++-+|.||+-+.|||..+.. .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3344556678899999999999999843 4999999754 34567899999999999999999999999999887 99
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|.-+|++-+|..+|+. .+..|...+...|+.|||+||.|||.++ |||||||+.||||.+++.|
T Consensus 465 iTqwCeGsSLY~hlHv--------------~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHV--------------QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred eehhccCchhhhhccc--------------hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence 9999999999999963 3456888899999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
||+|||++..-..-.-........|...|||||++.. .+|+..+||||||+|+|||++|..|+.....+..
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------ 601 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------ 601 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe------
Confidence 9999999975433222233445678889999999974 5799999999999999999999999873332221
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
+|..++.+-..|.... .......+.+|+..||..++++||.+.+|+..|+..+..+|
T Consensus 602 --ifmVGrG~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 602 --IFMVGRGYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred --EEEecccccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 1222333223333222 22334677788899999999999999999999998765443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=336.51 Aligned_cols=269 Identities=26% Similarity=0.350 Sum_probs=202.9
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh--cCCceeeeeeeeeecC----eeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL--HHRNLVRLFGCCIEQG----EKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~l 237 (496)
......+.||+|.||.||||++ +++.||||++... ..+.|.+|-.+.... +|+||++++++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445567999999999999999 6699999999753 446778887777664 8999999999876665 8999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc------CCCCeeecCCCCCCEEe
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY------SRLRVIHRDLKASNVLL 311 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivH~Dlk~~NIll 311 (496)
|+||.++|||.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||
T Consensus 286 Vt~fh~kGsL~dyL~----------------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----------------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred EeeeccCCcHHHHHH----------------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 999999999999995 34699999999999999999999963 35789999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCC-CC-----ccccchhhhHHHHHHHhCCCCCCCC--
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FS-----IKSDVFSFGVLLLETLSSKKNTRFY-- 383 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~S~Gvvl~elltg~~~~~~~-- 383 (496)
.+|+++.|+|||+|..+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||++....+...
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 999999999999999887655444444589999999999997643 22 3689999999999999987654311
Q ss_pred CCCcchhhHhhhhhhcccccccccCccccccCC------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEAL------YPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.+....+...+.....-++.++++-........ ...+..+.+.+..||..||+.|.|+.=|.+.+.+..
T Consensus 430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 111111111111111111111111111111111 133567889999999999999999999999998853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.46 Aligned_cols=278 Identities=26% Similarity=0.429 Sum_probs=207.4
Q ss_pred cCCCccccccccCCeeEEEEEecC-----------------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-----------------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRL 225 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 225 (496)
++|.+.++||+|+||.||++.+.+ +..||||.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999997532 3369999987543 2335679999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcc----cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 040910 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFD----MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIH 301 (496)
Q Consensus 226 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 301 (496)
++++.+.+..++||||+++|+|.+++.......... ..........++|..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986532111000 0001123356899999999999999999999988 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++..+.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644333222334456789999999998999999999999999999998654443
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
+...................... .. ..........+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQ--VY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccc--cc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 33322222222221111111100 00 00111223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.03 Aligned_cols=266 Identities=27% Similarity=0.445 Sum_probs=215.9
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+...+.++||+|-||+|.++....+..||||.++..... ...+|..|+++|.+++|||||+|+|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 455667899999999999999978899999999876544 4589999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|..|+..+.. ..+.-....+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+||
T Consensus 618 EnGDLnqFl~ahea-------------pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL-------------PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred hcCcHHHHHHhccC-------------cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 99999999975321 11344566789999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+++.+...++.......+-+++|||||.+..+.++.++|||+||+.+||+++-.+.-++....................
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 99998877777777777788999999999999999999999999999999876544333333333333333333322222
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.... ...+......+.++++.||..+.++||+++++...|.+.
T Consensus 762 ~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 112233446788999999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=342.05 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=208.2
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
...++|...+.||+|+|++|++|+. ..++.+|||++.+. .....+-...|-.+|.+| .||.|++|+..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457888899999999999999975 46899999998653 223345567788899999 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
|+|+||+++|+|.+++.. .+.|++.....++.+|+.||+|||+.| ||||||||+|||||+|+
T Consensus 150 YFvLe~A~nGdll~~i~K---------------~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---------------YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDG 211 (604)
T ss_pred EEEEEecCCCcHHHHHHH---------------hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCC
Confidence 999999999999999953 466889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccccCCCccc---------ccc--ccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 316 NPKISDFGIARMFGGDELQ---------SNM--NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
++||+|||.|+.+...... ... ...+||..|.+||++.+...+..+|+|+|||+||+|+.|++||...+
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999987643211 112 45799999999999999999999999999999999999999998655
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
+.-.. +.+.. ++- .......+...+|+.+.|..||.+|++.++|-++.
T Consensus 292 eyliF--qkI~~----------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 292 EYLIF--QKIQA----------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHH--HHHHH----------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 42111 11100 011 11112225567888899999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=343.02 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=209.2
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
..|....+||+|+.|.||.+.- .+++.||||++........+-..+|+.+|+..+|+|||+++..+...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999964 468899999998776666677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+.+. ...+++.++..|+.++++||+|||..+ |+|||||.+|||++.+|.+||+||
T Consensus 353 ~ggsLTDvVt----------------~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 353 EGGSLTDVVT----------------KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred CCCchhhhhh----------------cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeee
Confidence 9999988884 334889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++..+..... .-.+.+||+.|||||++....|+.|.||||||++++||+-|.+|+-...+ ++..+ +.....
T Consensus 414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAly-LIa~ng 485 (550)
T KOG0578|consen 414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALY-LIATNG 485 (550)
T ss_pred eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHH-HHhhcC
Confidence 99998865543 34567999999999999999999999999999999999999998753221 11111 112222
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..++-.+ ......+.+++.+||+.|+++||++.|+|++
T Consensus 486 ~P~lk~~-------~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKLKNP-------EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCcCCc-------cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2222222 2234567788889999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.52 Aligned_cols=245 Identities=19% Similarity=0.299 Sum_probs=197.9
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccC---HHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeEEEEEe
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQG---VEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKILIYEY 241 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 241 (496)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 78999999997654333 4678899999999999999999999877 3468999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+++|+|.+++.. .+.++|....+++.|++.||+|||+. + ++||||||+|||+++++.+||+
T Consensus 104 ~~~g~L~~~l~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 104 CTRGYLREVLDK---------------EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred CCCCcHHHHHhh---------------CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEc
Confidence 999999999942 34688999999999999999999985 5 7899999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...... .
T Consensus 166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i---~ 235 (283)
T PHA02988 166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLI---I 235 (283)
T ss_pred ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---H
Confidence 999998654321 23467899999999976 68999999999999999999999998743321 111111 0
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..... +.. +......+.+++.+||+.||++|||++++++.|+..
T Consensus 236 ~~~~~-----~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 236 NKNNS-----LKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred hcCCC-----CCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00100 111 112245678899999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=328.35 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=209.6
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..+.|++.+.||.|..++||+|+. +.++.||||++... .....+.+.+|+..++.++||||++.+..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 557889999999999999999976 56899999999743 3344789999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
.||.+||+.+.+..+. ...+++..+..|+.++++||.|||.+| .||||||+.||||+++|.+||
T Consensus 104 pfMa~GS~ldIik~~~-------------~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-------------PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred hhhcCCcHHHHHHHHc-------------cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence 9999999999997543 223889999999999999999999999 999999999999999999999
Q ss_pred eccccccccCCCc-cccc-cccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 320 SDFGIARMFGGDE-LQSN-MNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 320 ~DFgla~~~~~~~-~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+|||.+..+.... .... ..+.+||+.|||||+++. ..|+.|+||||||+...||.+|..||..+.+-...+..
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--- 244 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--- 244 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH---
Confidence 9999876543222 1111 156799999999999653 57999999999999999999999999865432221110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+....+.-..+..+........+.+++..|++.||.+|||++++++.
T Consensus 245 ---Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 245 ---LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0111111111111122222334578889999999999999999999854
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=348.95 Aligned_cols=272 Identities=28% Similarity=0.390 Sum_probs=206.1
Q ss_pred hcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 234 (496)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999964 245689999997432 23456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCc---------------------------c-----------ccc------------
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGF---------------------------D-----------MVT------------ 264 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------~-----------~~~------------ 264 (496)
.++||||+++|+|.+++......... + ...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999999753311000 0 000
Q ss_pred ----------CCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccc
Q 040910 265 ----------DPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334 (496)
Q Consensus 265 ----------~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~ 334 (496)
.......++|..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0011236899999999999999999999988 999999999999999999999999999876433222
Q ss_pred cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCccccc
Q 040910 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413 (496)
Q Consensus 335 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 413 (496)
.......++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .... ....+. ....+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~----~~~~~~--~~~~~~--- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYK----MIKEGY--RMLSPE--- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHH----HHHhCc--cCCCCC---
Confidence 22223345678999999999999999999999999999998 777765432211 1111 111110 011111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 414 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.....+.+++.+||+.||++||++.+|+++|++.
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1134678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=307.40 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=205.7
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCcc-C-HHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQ-G-VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.+|...++||+|.||.||+|+. .+|+.||||+++..+.. + .....+|++.|+.++|+||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999975 57999999999754322 2 2457889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|| ..+|...+.+ +...++-.++..++.++++||+|||.+. |+||||||.|+|++++|.+||+
T Consensus 82 fm-~tdLe~vIkd--------------~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD--------------KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred ec-cccHHHHhcc--------------cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEee
Confidence 99 4688888753 4567888999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+|+.+...... .+..+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|+....-+ -.........
T Consensus 144 DFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LG 219 (318)
T KOG0659|consen 144 DFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALG 219 (318)
T ss_pred cccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcC
Confidence 99999998765432 3334789999999999875 69999999999999999999998776543211 1111111111
Q ss_pred ccccc------cc--------cCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 400 DDRAW------KL--------LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 400 ~~~~~------~~--------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..... .+ +.+..............++++..++..||.+|++++|.+++=
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11110 11 111111113334456678999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.79 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=207.5
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHH--HHHHHHHHHhc-CCceeeeeeeeeecC-eeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEF--KNEMILIAKLH-HRNLVRLFGCCIEQG-EKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~ 236 (496)
..++|...++||.|+||.||+|+- .+|..||||+++..-. .+++. .+|++.|++|+ |||||+|..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456888899999999999999975 4689999999976532 23433 57999999998 999999999999988 999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||| ..+|.+.+.+ ..+.+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..
T Consensus 87 fVfE~M-d~NLYqLmK~--------------R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~ 148 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKD--------------RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDV 148 (538)
T ss_pred eeHHhh-hhhHHHHHhh--------------cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccce
Confidence 999999 5688777753 3678999999999999999999999999 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~ 394 (496)
+||+|||+||.+... ...+..+.|..|+|||++. .+.|+.+.|||++|||++|+.+-++-|++..+-+ ....-.+
T Consensus 149 iKiaDFGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 149 IKIADFGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred eEecccccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 999999999987644 2344567899999999875 6789999999999999999999999888755432 1111111
Q ss_pred -----hhhhccc-ccccccC---cccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 395 -----WNLWKDD-RAWKLLD---PTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 395 -----~~~~~~~-~~~~~~d---~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
+..|.++ .+...+. |... ....+....++++++..|++.||.+|||+++.+++-
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111110 0001111 1111 112223567889999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.10 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=202.2
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
.++=||.|+.|-||+|++ .++.||||+++... ..+++-|++|+||||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 356799999999999999 67899999987433 3468889999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
...|. .+..++-...+.+..+||.||.|||.+. |||||||+-||||+.+..+||+|||-++.
T Consensus 200 ~~VLk---------------a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 200 YEVLK---------------AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred HHHHh---------------ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 99994 4567888899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc-cccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD-DRAWKL 406 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 406 (496)
.... .+...++||..|||||++.+.+.++|+|||||||||||||||.-|+...+... ..|.- .+...+
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIwGVGsNsL~L 330 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIWGVGSNSLHL 330 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------eEEeccCCcccc
Confidence 6432 33455799999999999999999999999999999999999998865322111 11111 111122
Q ss_pred cCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 407 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
. .+...+.-+.-|+..||+..|.+||++++++.+|+-+-.++-
T Consensus 331 p-------vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 331 P-------VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred c-------CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 2 223334566778889999999999999999999987654443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=347.20 Aligned_cols=273 Identities=28% Similarity=0.399 Sum_probs=207.0
Q ss_pred HhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.+++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 445788899999999999999874 234589999997543 23345788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCc-----------------------------------------------------
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGF----------------------------------------------------- 260 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------- 260 (496)
..++||||+++|+|.+++.........
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999999653210000
Q ss_pred --ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccc
Q 040910 261 --DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338 (496)
Q Consensus 261 --~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 338 (496)
...........+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 00000112345899999999999999999999988 9999999999999999999999999998654332211222
Q ss_pred cccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCH
Q 040910 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALY 417 (496)
Q Consensus 339 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 417 (496)
...++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. ...... .....+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~~--~~~~~~~------- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKRG--YQMSRPD------- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHcc--cCccCCC-------
Confidence 3345678999999999999999999999999999997 9988864332211 11 111100 0111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 418 PMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 418 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.....+.+++.+||+.||.+||++.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1135678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=378.77 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=213.0
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
...|...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999987 47899999998654322 23468899999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++. .++|..+.+++.||++||+|||..+.++|+||||||+||+++.++.+++.
T Consensus 765 ~~~g~L~~~l~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~- 825 (968)
T PLN00113 765 IEGKNLSEVLR------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825 (968)
T ss_pred CCCCcHHHHHh------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-
Confidence 99999999983 27899999999999999999997656679999999999999999988876
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||.+..... .....+|..|+|||++.+..++.++|||||||++|||++|+.|+............|+.......
T Consensus 826 ~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 826 LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899 (968)
T ss_pred ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence 666543321 12236789999999999999999999999999999999999998543333344455554444444
Q ss_pred ccccccCccccc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 402 RAWKLLDPTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 402 ~~~~~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.....+|+.+.. ....+++.++.+++.+||+.+|++||+|+||++.|+.+..
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 445566666533 2345667788999999999999999999999999998644
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.17 Aligned_cols=250 Identities=34% Similarity=0.528 Sum_probs=193.4
Q ss_pred ccccccccCCeeEEEEEec-----CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 168 EENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999886 256899999965432 3468999999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.++|... ....+++..+..|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|
T Consensus 83 ~~~g~L~~~L~~~-------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-------------NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp -TTEBHHHHHHHT-------------CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccc-------------cccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 9999999999742 3456899999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++....................|+|||.+.+..++.++||||||+++|||++ |+.|+... ......... ..
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~----~~ 220 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKL----KQ 220 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHH----HT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc----cc
Confidence 999987743332333334567789999999999999999999999999999999 56665433 111111111 11
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
... .. ........+.+++..||+.+|++||++.++++.|
T Consensus 221 ~~~--~~-------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQR--LP-------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEE--TT-------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc--ce-------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 11 1111235677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.91 Aligned_cols=269 Identities=29% Similarity=0.462 Sum_probs=209.0
Q ss_pred cCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999997643 2579999986443 233467899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccc-cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMV-TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|||+++|+|.+++............ ........+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999754321111000 00112256899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~--- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VI--- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 999999999986644333333344566889999999999999999999999999999998 888876432211 11
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
..+..... .......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 237 -~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -EMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 11122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.55 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=202.5
Q ss_pred hcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999763 356899999875432 334578999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ....++|..++.++.||+.||+|||+.+ ++||||||+|||++.++.+
T Consensus 84 v~e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 84 VTEYMSNGALDSFLRK--------------HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred EEEeCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcE
Confidence 9999999999999852 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
|++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..|+...... ......
T Consensus 147 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~-- 221 (266)
T cd05064 147 KISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAV-- 221 (266)
T ss_pred EECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH--
Confidence 9999998765432211 11112345678999999999999999999999999999775 88887643221 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.... ... ........+.+++..||+.+|.+||++.+|++.|++.
T Consensus 222 --~~~~--~~~-------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 --EDGF--RLP-------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --HCCC--CCC-------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1110 011 1112345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=302.86 Aligned_cols=267 Identities=23% Similarity=0.263 Sum_probs=215.1
Q ss_pred HHhcCCCccccccccCCeeEEEEE-ecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----e
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----E 234 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 234 (496)
.+.++|.+.+.||+|||+-||.++ +.+++.+|+|++.....++.+..++|++.-++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 356789999999999999999997 4578999999998777788889999999999999999999999876443 5
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.|++++|...|||.+.+...+ ..+..+++.++++|+.+|.+||.+||+.. ++++||||||.|||+.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k-----------~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~ 165 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK-----------IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDS 165 (302)
T ss_pred EEEEeehhccccHHHHHHHHh-----------hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCC
Confidence 899999999999999997533 34557999999999999999999999976 479999999999999999
Q ss_pred CceEEeccccccccCCC-----ccc--cccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 315 MNPKISDFGIARMFGGD-----ELQ--SNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~-----~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
+.++|.|||.+....-. +.. ........|..|+|||.+. +...++++|||||||+||+|+.|..||+..-
T Consensus 166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 99999999998754311 000 1112346789999999885 5678999999999999999999999987432
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.....+ ...+..+.+.-.......+.+.+++.+|++.||.+||++.+++..+++.
T Consensus 246 ~~GgSl------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 246 QQGGSL------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hcCCeE------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 211110 1112222222222333678899999999999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=328.06 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=200.2
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.|+..+.||+|+||.||++.. .+|+.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999976 478999999986432 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|..++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 81 ~~~~g~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 81 IMNGGDLKFHIYN-------------MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred ecCCCcHHHHHHh-------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 9999999888753 12335889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 219 (285)
T cd05631 145 DLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRVKE 219 (285)
T ss_pred eCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHHhhc
Confidence 999998754322 123457899999999999999999999999999999999999998754332110 001000000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
. . ..........+.+++.+||+.||.+||+ +++++++
T Consensus 220 ~--------~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 D--------Q--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred c--------c--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 0 0111122356778999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=326.22 Aligned_cols=268 Identities=26% Similarity=0.439 Sum_probs=209.0
Q ss_pred cCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.+|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999997633 478999999765433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++++|.+++.......... .........+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFL-KSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhh-cccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999997543211110 011234456899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... ......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-
Confidence 99999999986543332222233456788999999999999999999999999999998 88887543221 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
..+... .........+.+++..||+.+|++||++.||++.|++
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ---TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111110 0111223567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=332.89 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=203.6
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC----Cc-cCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK----SG-QGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 234 (496)
...+|...+.||+|+||.|+.|.. .+++.||||.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456888899999999999999966 46899999976543 11 23456678999999998 9999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+.+|+|.+++. ..+.+.+.....++.|+++|++|+|+.+ |+||||||+|||+|.+
T Consensus 95 ~~ivmEy~~gGdL~~~i~---------------~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~ 156 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---------------NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGN 156 (370)
T ss_pred EEEEEEecCCccHHHHHH---------------HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCC
Confidence 999999999999999995 3567888999999999999999999998 9999999999999999
Q ss_pred -CceEEeccccccccCCCccccccccccccccccChhhhccCC-CC-ccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 315 -MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FS-IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 315 -~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||....... +.
T Consensus 157 ~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--l~ 232 (370)
T KOG0583|consen 157 EGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--LY 232 (370)
T ss_pred CCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--HH
Confidence 999999999999773 1123455689999999999999977 75 78999999999999999999998632211 11
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.. ...+ +..-|.. .. ...+..++.+|++.+|..|+++.+|+
T Consensus 233 ~k----i~~~---~~~~p~~----~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RK----IRKG---EFKIPSY----LL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HH----HhcC---CccCCCC----cC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 0101 1111111 10 46778899999999999999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=340.29 Aligned_cols=274 Identities=25% Similarity=0.341 Sum_probs=208.4
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhc-CCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 233 (496)
..++|.+.+.||+|+||.||+|+.. .+..||||++..... ...+.|.+|+.++.++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4567888899999999999999752 234799999975432 33467999999999995 999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcc-------------------------------------cc-------------
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFD-------------------------------------MV------------- 263 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~-------------------------------------~~------------- 263 (496)
..++||||+++|+|.+++.......... ..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999997542110000 00
Q ss_pred -------------------------------cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 264 -------------------------------TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 264 -------------------------------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
........+++..+.+++.||+.||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 00001235889999999999999999999988 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~ 391 (496)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+... .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-Y 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-H
Confidence 999999999999986643322222233456788999999999999999999999999999997 88887643221111 0
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
....... .. .........+.+++.+||+.+|++||++.+|.++|+..+
T Consensus 351 ----~~~~~~~--~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ----NKIKSGY--RM-------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHhcCC--CC-------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0011110 00 011123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=332.63 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=201.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
..+|+..+.||+|+||.||+|++. +++ .||||.++... ....++|.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999864 333 48999987543 23456899999999999999999999999765 577
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 ~v~e~~~~g~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~ 147 (316)
T cd05108 85 LITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQH 147 (316)
T ss_pred eeeecCCCCCHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCc
Confidence 99999999999999853 2345889999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~---- 221 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS---- 221 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH----
Confidence 99999999997654332222222344678999999999999999999999999999998 888875322111 11
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
....... ....+ ......+.+++.+||+.+|.+||++.+++..|....
T Consensus 222 ~~~~~~~--~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 222 SILEKGE--RLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHhCCC--CCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111110 11111 112245788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=337.12 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=216.0
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
..-++|...+.||+|.||.|+++.+. +++.+|||.+++. ....++..+.|.+++... +||.|++|+.+|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999885 5789999999876 356678889999998888 599999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||..+|++..+. ....+++.+..-++..|+.||.|||+++ |||||||.+|||||.+|
T Consensus 445 ~fvmey~~Ggdm~~~~----------------~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----------------HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEG 505 (694)
T ss_pred EEEEEecCCCcEEEEE----------------ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccC
Confidence 9999999999953332 4467999999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
++||+|||+++.-.. ....+.+.+||+.|||||++.+..|+..+|.|||||+|||||.|+.||+..++++.
T Consensus 506 h~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------- 576 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------- 576 (694)
T ss_pred cEEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------
Confidence 999999999996432 23456779999999999999999999999999999999999999999986554332
Q ss_pred hhhcccccccccCccccc--cCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH----------HHhccccCCCCC
Q 040910 396 NLWKDDRAWKLLDPTLQN--EALYPMVKRYIKVALLCVQENAADRPTM-----SEVVS----------MIKNEIVNLPSP 458 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~----------~L~~~~~~~~~p 458 (496)
+|..+.. .++.-...+.+.++.+.+..+|++|.-+ .+|.+ .|+. ..+++|
T Consensus 577 -----------FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~--r~i~PP 643 (694)
T KOG0694|consen 577 -----------FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN--RRIKPP 643 (694)
T ss_pred -----------HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh--ccCCCC
Confidence 1111111 1233345677889999999999999966 33332 2322 456777
Q ss_pred CCCcchh
Q 040910 459 QQPAFSY 465 (496)
Q Consensus 459 ~~~~~~~ 465 (496)
-+|..-.
T Consensus 644 f~P~i~~ 650 (694)
T KOG0694|consen 644 FVPTIKG 650 (694)
T ss_pred CCcccCC
Confidence 7777643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=326.73 Aligned_cols=271 Identities=27% Similarity=0.430 Sum_probs=211.1
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888899999999999999752 34568999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++++|.+++......... .........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVL--MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCcccc--ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999754321111 111123345999999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....... ....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~-- 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC-- 234 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--
Confidence 99999999986644332222333456788999999999999999999999999999998 887765332211 1111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
...+.... ... .....+.+++.+||+.+|.+|||+.+|++.|+++..
T Consensus 235 --i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 --ITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111100 001 123467899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.13 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=209.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
...+|+..++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578888999999999999999888999999999876655677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d 147 (261)
T cd05148 84 MEKGSLLAFLRS-------------PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVAD 147 (261)
T ss_pred cccCCHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEcc
Confidence 999999999953 23356899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++......... .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+..... ........ .
T Consensus 148 ~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~----~ 219 (261)
T cd05148 148 FGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT----A 219 (261)
T ss_pred ccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH----h
Confidence 9999876433211 123346778999999998899999999999999999998 7887754321 11111111 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. .. .........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 220 ~~--~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 GY--RM-------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CC--cC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00 00 1112223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=332.12 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=203.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|+..+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468889999999999999999875 57889999987542 2334679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 84 HMDGGSLDQVLKE---------------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred cCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence 9999999999842 335889999999999999999999853 39999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh-c
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW-K 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~-~ 399 (496)
|||++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ........ .
T Consensus 147 Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~ 220 (331)
T cd06649 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVD 220 (331)
T ss_pred cCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccc
Confidence 99999865322 12335789999999999999999999999999999999999999864332111 00000000 0
Q ss_pred c-ccc----------------------------ccccC----ccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 D-DRA----------------------------WKLLD----PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~-~~~----------------------------~~~~d----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. ... .+..+ ..............+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000 00000 00000000123456889999999999999999999987
Q ss_pred HH
Q 040910 447 MI 448 (496)
Q Consensus 447 ~L 448 (496)
+-
T Consensus 301 h~ 302 (331)
T cd06649 301 HT 302 (331)
T ss_pred Ch
Confidence 64
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=326.95 Aligned_cols=273 Identities=25% Similarity=0.398 Sum_probs=211.6
Q ss_pred cCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677889999999999999752 345799999876555555789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCccc-ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDM-VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
||||+++++|.+++........... .........++|..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975432111000 001123346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~---- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI---- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----
Confidence 99999999986544332222334556789999999999999999999999999999999 888865432211 11
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
.......... .....+..+.+++.+||+.+|++||++.+|+++|+.+...
T Consensus 236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111 1111235678999999999999999999999999997553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=333.86 Aligned_cols=274 Identities=28% Similarity=0.377 Sum_probs=206.1
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeec-C
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ-G 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 233 (496)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999642 357899999874332 2345678899999999 899999999988654 5
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccc----------------------------------------------cCCC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMV----------------------------------------------TDPA 267 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----------------------------------------------~~~~ 267 (496)
..++++||+++++|..++............ ....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998643211000000 0000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcccccccccccccccc
Q 040910 268 SKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347 (496)
Q Consensus 268 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~ 347 (496)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1246899999999999999999999988 9999999999999999999999999998764332222233445677899
Q ss_pred ChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHH
Q 040910 348 SPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKV 426 (496)
Q Consensus 348 aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 426 (496)
|||++.+..++.++|||||||++|||++ |..|+........ +.. ....... .. ........+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~--~~-------~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR----RLKEGTR--MR-------APEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH----HHhccCC--CC-------CCccCCHHHHHH
Confidence 9999999999999999999999999998 8888764322211 110 0011100 00 011223567899
Q ss_pred HHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 427 ALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 427 ~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
+.+||+.+|++||++.+|+++|++++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=321.35 Aligned_cols=255 Identities=31% Similarity=0.461 Sum_probs=205.8
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888899999986432 34678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 84 ~~~~L~~~l~~-------------~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 84 AKGSLLDFLKS-------------DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred CCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCC
Confidence 99999999853 22345889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ....... ..
T Consensus 148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~----~~ 220 (261)
T cd05072 148 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQ----RG 220 (261)
T ss_pred ccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHH----cC
Confidence 999876533211 1222345778999999998899999999999999999998 88887542211 1111111 00
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. .. +. .......+.+++.+||+.+|++||+++++.+.|++
T Consensus 221 ~--~~--~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 221 Y--RM--PR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C--CC--CC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00 00 11123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=319.71 Aligned_cols=252 Identities=30% Similarity=0.446 Sum_probs=202.2
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|+..+.||+|+||.||++.+.++..+|+|.+... ....+.|.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788899999999999999888889999988643 3345688999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|.+++.. ....++|..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 83 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 83 NGCLLNYLRQ--------------RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred CCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCC
Confidence 9999998852 1235889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ......... .
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~----~- 217 (256)
T cd05114 146 MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISR----G- 217 (256)
T ss_pred CccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC----C-
Confidence 99865432221 1222345678999999998899999999999999999999 7877754321 111111111 0
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.....+.. ....+.+++.+||+.+|.+||++.++++.|.
T Consensus 218 -~~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 218 -FRLYRPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCC-------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01111111 1246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.53 Aligned_cols=263 Identities=26% Similarity=0.385 Sum_probs=213.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. ....+.+.+|++++++++|||||.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999764 67899999987543 3446678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+.+ +|..+|. ..+.++++.+..++.+++.||.|||+.. |.|||+||.|||++.++.+|++
T Consensus 82 ~a~g-~L~~il~---------------~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 82 YAVG-DLFTILE---------------QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred hhhh-hHHHHHH---------------hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeec
Confidence 9976 9999994 3456999999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+..... ....+...||+.|||||.+.+.+|+..+|.||+|||+||+++|++||..... ..-+.....
T Consensus 143 dFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----~~Lv~~I~~- 214 (808)
T KOG0597|consen 143 DFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----TQLVKSILK- 214 (808)
T ss_pred hhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----HHHHHHHhc-
Confidence 99999976543 2334567899999999999999999999999999999999999999863221 111111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhccccCCCCCCCCcc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPSPQQPAF 463 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~~~~p~~~~~ 463 (496)
||.. .+......+..++.-.++.||..|.+-.+++.+ .++.+.-...|.+|++
T Consensus 215 -------d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 215 -------DPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred -------CCCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 1111 122445677888889999999999999999864 3443333344444444
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.94 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=205.2
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|++.+.||+|++|.||+|...+++.||||.++... ...++|.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 84 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 147 (261)
T cd05068 84 KYGSLLEYLQG-------------GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADF 147 (261)
T ss_pred cCCcHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCc
Confidence 99999999852 22346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++........ .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... ...
T Consensus 148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~ 220 (261)
T cd05068 148 GLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQV----DQG 220 (261)
T ss_pred ceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----HcC
Confidence 999876532211 1111233468999999999999999999999999999999 8877753221 1111111 100
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
... .........+.+++.+||+.+|.+||++.++++.|++
T Consensus 221 --~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 --YRM-------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCC-------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000 0111234568889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.87 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=204.1
Q ss_pred hcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|+..+.||+|+||.||+|.+.. ...||||.+.... .....+|.+|+.++.+++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998742 3589999987543 2334678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+
T Consensus 83 v~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 83 ITEYMENGSLDKFLRE--------------NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145 (266)
T ss_pred EEEcCCCCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCE
Confidence 9999999999999852 2236899999999999999999999987 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+..... .......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~-- 221 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAV-- 221 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHH--
Confidence 9999999997752221111222345678999999999999999999999999999998 8877643221 1111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.... .. + ........+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 222 --~~~~--~~--~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 --EDGY--RL--P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --HcCC--CC--C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 00 0 0112235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=306.38 Aligned_cols=236 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||.|+||.|.+++.+ +|..+|+|.+.+.. ..+.+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888899999999999999875 58899999997653 234567788999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||.++|-|-.+|+ ..+.++.+....++.||+.||+|||+.+ |++|||||+|||+|.+|.+||
T Consensus 124 eyv~GGElFS~Lr---------------k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---------------KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred eccCCccHHHHHH---------------hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEE
Confidence 9999999999995 4567999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+.+.. .+.+.+||+.|+|||++...+++.++|.|||||++|||+.|.+||..... .... ....
T Consensus 186 tDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY----~KI~ 254 (355)
T KOG0616|consen 186 TDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIY----EKIL 254 (355)
T ss_pred EeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHH----HHHH
Confidence 99999997653 35678999999999999999999999999999999999999999875443 1111 1111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCC
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR 438 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 438 (496)
..+ +.-|. -....+.+|+...++.|-.+|
T Consensus 255 ~~~---v~fP~-------~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGK---VKFPS-------YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCc---ccCCc-------ccCHHHHHHHHHHHhhhhHhh
Confidence 111 11121 122455677778888888888
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=323.53 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=205.4
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.+++|+..+.||+|+||.||+|... .+..||||.+.... .....+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24679999986432 2334578899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|+||+++|+|.+++........ .......+++..+..++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEME-----NNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCcccc-----ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 9999999999999999864321100 0112345788999999999999999999987 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
+.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~ 233 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF 233 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999986654333222233456788999999999999999999999999999999 67776543211 11111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
........ . .......+.+++.+||+.+|++|||+.|++++|++
T Consensus 234 ----~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 ----VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111100 0 11123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.84 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=200.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.+|...+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777889999999999999864 344 478888754332 234577888889999999999999998754 45789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
++||+++|+|.+++.. ....++|..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 86 i~e~~~~gsL~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--------------HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIV 148 (279)
T ss_pred EEEeCCCCcHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcE
Confidence 9999999999999953 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+....... .. .
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~----~ 222 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VP----D 222 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----H
Confidence 9999999987643332222334567789999999999999999999999999999998 888875432211 11 1
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
....+. ....+.. ....+.+++.+||+.+|++|||+.|+++.|.....
T Consensus 223 ~~~~~~--~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 223 LLEKGE--RLAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHCCC--cCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111111 1111111 12456778899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=333.65 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 58899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 e~~~g~~L~~~l~---------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 81 EYVPGGDFRTLLN---------------NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred eCCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEE
Confidence 9999999999984 2345889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .... ..+.
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~ 214 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENL-KYWK 214 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHH-Hhcc
Confidence 99999986543 23345789999999999999999999999999999999999999865332211 1100 0000
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. +..+.. ..........+.+++.+||+.+|.+||++.+++++
T Consensus 215 --~~--~~~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 --ET--LQRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --cc--ccCCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 000110 00011234567789999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.91 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=204.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.+|...+.||+|+||.||+|... +++.||+|.+... ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999875 5889999998643 344678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~L~~~~~~-------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 85 TYGNLLDYLRE-------------CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred CCCcHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCC
Confidence 99999999843 23346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. +......
T Consensus 149 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~ 221 (263)
T cd05052 149 GLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV----YELLEKG 221 (263)
T ss_pred ccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCC
Confidence 999876543221 1122234668999999999999999999999999999998 88887643221 11 1111110
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..+ .........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 222 -----~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -----YRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 001 11112235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.76 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=201.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999885 57899999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++++++..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 81 YVEKNMLELLEE---------------MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred cCCCCHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 999887765542 2245889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh-hHhh-----
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL-LGHA----- 394 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~-~~~~----- 394 (496)
|||++....... ........||..|+|||++.+..++.++|||||||++|||++|+.||.......... ....
T Consensus 143 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 143 DFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred eccCcccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 999998764322 112234578999999999999899999999999999999999999987533211100 0000
Q ss_pred ---hh-hhcccccccccCcccccc------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 ---WN-LWKDDRAWKLLDPTLQNE------ALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ---~~-~~~~~~~~~~~d~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
+. ............+..... ........+.+++.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000000001111111000 01112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.68 Aligned_cols=276 Identities=26% Similarity=0.413 Sum_probs=204.8
Q ss_pred hcCCCccccccccCCeeEEEEEecC---------------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN---------------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLF 226 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~ 226 (496)
.++|.+.+.||+|+||.||++.... ...||||.++... ......|.+|++++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999986532 2358999987542 23346799999999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040910 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 306 (496)
Q Consensus 227 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 306 (496)
+++...+..++||||+++++|.+++......... ........++|..++.++.|++.||+|||+.+ ++|+||||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTF---THANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccc---cccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 9999999999999999999999999643211111 11122345789999999999999999999988 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+||++++++.+||+|||++................++..|+|||.+.+..++.++||||||++++||+++..+.++....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999998654333222233345577999999999999999999999999999999854433332222
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
...........+..... ... ..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQVIENTGEFFRNQGR-QIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHHHHHHHHhhhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 22222111111111000 000 00111123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.52 Aligned_cols=267 Identities=31% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEE
Q 040910 166 FSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKIL 237 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 237 (496)
|...+.||+|+||.||++.. .+++.||+|.+..... .....|.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3578999999875432 3456889999999999999999999988764 35789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 86 v~e~~~~~~l~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----------------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred EecCCCCCCHHHHHHH----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcE
Confidence 9999999999999842 24899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCcccc-ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQS-NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+................
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 999999998765332111 1122345677999999998899999999999999999999998875433211111111100
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
........+.++..............+.+++..||+.+|++|||+++|++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0001111111111111111222345788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.77 Aligned_cols=269 Identities=28% Similarity=0.414 Sum_probs=205.4
Q ss_pred cCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......|.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999974 246789999997433 2334678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCC--cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSG--FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
||||+++++|.+++........ ............+++..+..++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321110 000011122456899999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999987644332222333456778999999998899999999999999999998 7777653221 1111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
...... .........+.+++.+||+.+|.+||++.+|.++|+.
T Consensus 240 ----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 101100 0111123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=327.98 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=198.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 68899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 81 EYVPGGELFSYLRN---------------SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred eCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEE
Confidence 99999999999842 345889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 143 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i----~ 211 (291)
T cd05612 143 TDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKI----L 211 (291)
T ss_pred EecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----H
Confidence 999999865422 22357899999999999999999999999999999999999998643221 111110 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
... . . ........+.+++.+||+.||.+||+ +++++++
T Consensus 212 ~~~---~---~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 212 AGK---L---E----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred hCC---c---C----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 010 0 0 01111345778999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.82 Aligned_cols=273 Identities=26% Similarity=0.409 Sum_probs=210.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|+..+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888899999999999999763 23689999987532 23445788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCccc-ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDM-VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
..++||||+++|+|..++........... .........+++..+++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 99999999999999999975432111110 001123457999999999999999999999987 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~ 391 (496)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence 999999999999987654433222333445678999999999999999999999999999997 887765322111 11
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
........ ..........+.+++.+||+.+|++|||+.++++.|++++
T Consensus 245 ----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 ----KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111110 0111122356788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=325.33 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=207.2
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...|+..+.||+|.||.||||... .++.||+|++.-. .....++..+|+.++..++++||.+++|.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345667789999999999999764 6889999999754 34557788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+.+|++.+.+. ....+.+..+.-++.++..||.|||.++ .+|||||+.|||+..+|.+|++
T Consensus 92 y~~gGsv~~lL~---------------~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---------------SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred HhcCcchhhhhc---------------cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEE
Confidence 999999998883 3444577778889999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||.+-.+....... .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+-...+ .
T Consensus 154 DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------l--- 222 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------L--- 222 (467)
T ss_pred ecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------e---
Confidence 999999876544332 66899999999999999999999999999999999999999986544311000 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+.+-..|.+.. .....+.+++..|+..||+.||++.+++++
T Consensus 223 --Ipk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 223 --IPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 01112233322 334568889999999999999999999864
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=321.09 Aligned_cols=273 Identities=28% Similarity=0.408 Sum_probs=207.9
Q ss_pred hcCCCccccccccCCeeEEEEEecC-----------------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-----------------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVR 224 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 224 (496)
..+|.+.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987642 2468999987543 234568899999999999999999
Q ss_pred eeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 225 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
+++++..++..++|+||+++++|..++.......... ......+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL----ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc----cccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999999999999999999999999997543211111 123346899999999999999999999988 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhC--CCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS--KKNTRF 382 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg--~~~~~~ 382 (496)
||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||+++ ..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999999866443333333445667899999999988999999999999999999984 444432
Q ss_pred CCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 383 YNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.............+......... .........+.+++.+||+.+|.+|||+.+|++.|++
T Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 --LTDQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --cChHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22222222222111111111111 0111223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=318.37 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=202.0
Q ss_pred CCccccccccCCeeEEEEEecC----CCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe-----
Q 040910 166 FSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE----- 234 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 234 (496)
|.+.+.||+|+||.||+|.... +..||||+++... ....+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999998742 3679999987532 2335688999999999999999999999876554
Q ss_pred -eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 235 -KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 235 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
.++|+||+++|+|..++...... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~---------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~ 148 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG---------GLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLRE 148 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc---------CCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECC
Confidence 79999999999999998653211 12346899999999999999999999988 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .....
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05035 149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD 226 (273)
T ss_pred CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence 99999999999987654332222223345678999999998999999999999999999999 7777653221 11111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... .+... .........+.+++.+||+.||.+||++.+|++.|++.
T Consensus 227 ~~~----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLR----HGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHH----cCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11100 01112345788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=322.55 Aligned_cols=270 Identities=26% Similarity=0.417 Sum_probs=206.4
Q ss_pred CCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
+|.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999753 235789998865432 334678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCccc---------ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDM---------VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
|+||+++|+|.+++........... .........+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999875432110000 011122356899999999999999999999988 9999999999
Q ss_pred EEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDS 387 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~ 387 (496)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222233455778999999999999999999999999999998 88887533211
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
. .+....... .. .........+.+++.+||+.+|++||++.++++.|++++
T Consensus 237 -~----~~~~~~~~~--~~-------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 -R----LFNLLKTGY--RM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -H----HHHHHhCCC--CC-------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1 111111110 01 111122356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.79 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=203.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|..+..||+|+||.||+++-. +|..+|+|+|++.. ...++..+.|-.+|...++|.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999764 69999999998653 3456778899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||++||++..+|. ....|++.....++.+.+.|+.-||+.| +|||||||+|+|||..|++
T Consensus 219 iMEylPGGD~mTLL~---------------~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---------------RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred EEEecCCccHHHHHH---------------hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCE
Confidence 999999999999995 5678999999999999999999999999 9999999999999999999
Q ss_pred EEeccccccccCC----------------------Ccccc-----cc------------------ccccccccccChhhh
Q 040910 318 KISDFGIARMFGG----------------------DELQS-----NM------------------NRIVGTYGYMSPEYA 352 (496)
Q Consensus 318 kl~DFgla~~~~~----------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~ 352 (496)
||+||||+.-+.. .+... .. ...+||+.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999853321 00010 00 114799999999999
Q ss_pred ccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcc
Q 040910 353 LHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQ 432 (496)
Q Consensus 353 ~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~ 432 (496)
.+..|+..+|.||||||+||||.|-+||....+.....-...|.. . +..|.- .....+..++|.+|+.
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----~--l~fP~~-----~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----T--LKFPEE-----VDLSDEAKDLITRLLC 428 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----h--ccCCCc-----CcccHHHHHHHHHHhc
Confidence 999999999999999999999999999986554432111111110 0 111111 1112566788889888
Q ss_pred cCCCCCCC---HHHHHH
Q 040910 433 ENAADRPT---MSEVVS 446 (496)
Q Consensus 433 ~~p~~RPs---~~evl~ 446 (496)
||++|.- ++||-+
T Consensus 429 -d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKK 444 (550)
T ss_pred -CHHHhcCcccHHHHhc
Confidence 9999985 555543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.93 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=210.8
Q ss_pred HHhcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
....+....++||-|-||.||.|.|+. .-.||||.|+... -..++|..|+.+|+.++|||+|+|+|+|......|||.
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 344456667899999999999999864 5689999997654 45789999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|||.+|+|.+||.+. .+..++--..+.++.||+.||.||..++ +|||||.++|+|+.++-.+||
T Consensus 343 EfM~yGNLLdYLRec-------------nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLREC-------------NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred ecccCccHHHHHHHh-------------chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence 999999999999753 3455677788999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhC-CCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS-KKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg-~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||++++...+.+... ...--++.|.|||.+....++.|+|||+|||+||||.|- ..|++..+. .+++
T Consensus 407 ADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY--- 476 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVY--- 476 (1157)
T ss_pred eccchhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHH---
Confidence 99999998876644332 222347799999999999999999999999999999874 445443221 1222
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.+++.....+.+..++..+.+|+..||+.+|.+||++.|+-+.++.
T Consensus 477 ------~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 477 ------GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ------HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2223333333444456788999999999999999999999988875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=319.42 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=206.2
Q ss_pred HHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHH--hcCCceeeeeeeeeecC---
Q 040910 159 ISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAK--LHHRNLVRLFGCCIEQG--- 233 (496)
Q Consensus 159 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~--- 233 (496)
-.+...+..+.+.||+|.||+||+|++ .|+.||||++...++ ..+.+|.++.+. |+|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345667888899999999999999999 789999999976543 466777777766 49999999999866543
Q ss_pred -eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-----cCCCCeeecCCCCC
Q 040910 234 -EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-----YSRLRVIHRDLKAS 307 (496)
Q Consensus 234 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH~Dlk~~ 307 (496)
+++||.+|.++|||.+||. ...++....++++..+|.||++||. +++|.|.|||||+.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~----------------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLN----------------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred EEEEEeeecccCCcHHHHHh----------------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7899999999999999994 3568899999999999999999994 67899999999999
Q ss_pred CEEecCCCceEEeccccccccCCC--ccccccccccccccccChhhhccCC------CCccccchhhhHHHHHHHhCC--
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGD--ELQSNMNRIVGTYGYMSPEYALHGL------FSIKSDVFSFGVLLLETLSSK-- 377 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~elltg~-- 377 (496)
|||+..++.+.|+|+|||-....+ ......+..+||.+|||||++...- --..+||||||.|+||+.-..
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999877544 3344456789999999999986532 124589999999999987532
Q ss_pred --------CCCCCCCCCcchhhHhhhhhhcccccccccCcccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 378 --------KNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQ-NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 378 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.||...-+.+... ..+...+-.++ +.|.+. .-...+.+..+.+++..||..+|.-|-|+--|-+.|
T Consensus 426 ggi~eey~~Pyyd~Vp~DPs~-eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPSDPSF-EEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCEehhhcCCcccCCCCCCCH-HHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 2322211111111 11111111111 112221 123456778899999999999999999999999999
Q ss_pred hccc
Q 040910 449 KNEI 452 (496)
Q Consensus 449 ~~~~ 452 (496)
.+..
T Consensus 501 ~~l~ 504 (513)
T KOG2052|consen 501 AKLS 504 (513)
T ss_pred HHHh
Confidence 8753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=330.70 Aligned_cols=242 Identities=22% Similarity=0.256 Sum_probs=195.0
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+++.. +|+.||||.+.... ......+.+|+.++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68899999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 81 ELFFHLS---------------RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred cHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 9988884 2346889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (496)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ....
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~----~~~~--- 211 (323)
T cd05571 143 KEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI----LMEE--- 211 (323)
T ss_pred cccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHH----HcCC---
Confidence 753221 122334579999999999999999999999999999999999999986432111 11110 0000
Q ss_pred ccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 406 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.. ........+.+++.+||+.||++|| ++.+++++
T Consensus 212 ---~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 ---IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CC----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 00 1112235677899999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.87 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=201.5
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|...+.||+|+||.||+|+..++..+|||.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4567788999999999999988777789999986433 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 83 ~~~l~~~i~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g 145 (256)
T cd05113 83 NGCLLNYLRE--------------HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFG 145 (256)
T ss_pred CCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCc
Confidence 9999999852 1235899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ...... ....
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~----~~~~ 218 (256)
T cd05113 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKV----SQGL 218 (256)
T ss_pred cceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH----hcCC
Confidence 99865433221 1122345678999999998899999999999999999998 88887543321 111111 0010
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
. ...+ ......+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 ~--~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 R--LYRP-------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C--CCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 0001 112357788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.41 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=206.4
Q ss_pred cCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|...++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999642 356899999876665666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+++++|.+++....................+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975432111000011122346899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~-- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIECI-- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHHHH--
Confidence 9999999986543332222233345788999999999999999999999999999998 7877643221 1111100
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.... ....+ ......+.+++.+||+.||.+||++.+|++.|+
T Consensus 238 --~~~~--~~~~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --TQGR--ELERP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HcCc--cCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 00001 112345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.33 Aligned_cols=268 Identities=29% Similarity=0.435 Sum_probs=204.6
Q ss_pred CCCccccccccCCeeEEEEEecC------CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
+|.+.+.||+|+||.||+|...+ ++.||||+++..... ..+.|.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999997632 478999999754322 24678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCc-ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGF-DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
++||+++++|..++......... ...........+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998643221111 11111223456899999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... .....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~--- 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIE--- 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH---
Confidence 99999999986643332222334456789999999998899999999999999999998 6666653221 11111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
........ .........+.+++..||+.+|.+||++.+|++.|+.
T Consensus 238 -~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 -MIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111110 0111233557789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.07 Aligned_cols=245 Identities=23% Similarity=0.280 Sum_probs=199.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888899999999999999875 58899999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 98 e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 98 EFVVGGELFTHLRK---------------AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred cCCCCChHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEE
Confidence 99999999999852 345788899999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ....
T Consensus 160 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~----~~i~ 228 (329)
T PTZ00263 160 TDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIY----EKIL 228 (329)
T ss_pred eeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHH----HHHh
Confidence 999999866432 2235789999999999999999999999999999999999999864221 1111 1111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
.... .-|. .....+.+++.+||+.||.+||+ +++++.+
T Consensus 229 ~~~~---~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 AGRL---KFPN-------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCc---CCCC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1110 0011 11245678999999999999996 6777754
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.75 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=203.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.+++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 5688999886443 2334578999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++++|.+++...... ......++|..+.+++.||+.||+|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~--------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~ 152 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPR--------PERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK 152 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEecc
Confidence 99999999999999999653311 112346899999999999999999999988 9999999999999876
Q ss_pred C---ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 315 M---NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 315 ~---~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
+ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~ 230 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--V 230 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 5 589999999987643332222223344678999999999999999999999999999997 888776432211 1
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.. ....... ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~----~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ME----FVTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HH----HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1110100 0111122356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=321.71 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=194.3
Q ss_pred cCCCccccccccCCeeEEEEEec--CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh---cCCceeeeeeeeee-----
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL--NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL---HHRNLVRLFGCCIE----- 231 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 231 (496)
++|.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999763 46889999986432 22334667788877776 69999999999853
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
....++|+||++ ++|..++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~ 143 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK-------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 143 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEE
Confidence 346899999996 689888843 22345889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+.++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|++||....... ..
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~ 218 (290)
T cd07862 144 TSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QL 218 (290)
T ss_pred cCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HH
Confidence 99999999999999865432 22334578999999999999999999999999999999999999987543211 11
Q ss_pred Hhhhhhhc---ccccc-------cccCccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 392 GHAWNLWK---DDRAW-------KLLDPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 392 ~~~~~~~~---~~~~~-------~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
........ ..... ....+.. ...........+.+++.+||+.||++|||+.++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 219 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11110000 00000 0000000 00001112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=317.70 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=198.9
Q ss_pred CCccccccccCCeeEEEEEecCC-C--EEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------Ce
Q 040910 166 FSEENKLGEGGFGPVYKGKLLNG-E--EVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------GE 234 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 234 (496)
|.+.+.||+|+||.||+|...++ . .||+|.++.. .....+.|.+|+.++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34568999999999999987543 2 6899988643 233456789999999999999999999987532 25
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|+||+++|+|..++..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRL---------GDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN 148 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcc---------cCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC
Confidence 6899999999999998853211 112345899999999999999999999987 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
+.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~-- 224 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIY-- 224 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH--
Confidence 9999999999987654332222233356778999999999999999999999999999999 7777754221 1111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.....+.... ........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 225 --~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 --DYLRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111100 0111234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.47 Aligned_cols=272 Identities=25% Similarity=0.385 Sum_probs=201.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-----CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
.++|.+.+.||+|+||.||++... +++.||||.+........+.|.+|++++.+++||||+++.+++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 356788899999999999999752 5789999999766555567899999999999999999999987543 468
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++|+|.+++.. ....++|..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~ 145 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK--------------HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESEN 145 (284)
T ss_pred EEEEEecCCCCHHHHHHh--------------cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCC
Confidence 899999999999999852 2345899999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|..++..............
T Consensus 146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05081 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND 225 (284)
T ss_pred eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc
Confidence 9999999999876433211 111122344569999999998999999999999999999998765432211100000000
Q ss_pred hh-hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 395 WN-LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 395 ~~-~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.. ........+.+...............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0000000000000000011112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=314.14 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=195.0
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
+.||+|+||.||+|... +++.||+|.+.... ......|.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 68899999876433 23356799999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 81 LTFLRT--------------EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred HHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcc
Confidence 999842 2345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKL 406 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (496)
...............+..|+|||.+.+..++.++||||||+++||+++ |..|+...... .... .....
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~----~~~~~----- 212 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTRE----AIEQG----- 212 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHH----HHHcC-----
Confidence 543221111112233567999999999999999999999999999998 77766432211 1100 00000
Q ss_pred cCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 407 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
... .........+.+++.+||+.+|++||++.+|+++|+
T Consensus 213 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 VRL----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000 111122356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.27 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=208.0
Q ss_pred hcCCCccccccccCCeeEEEEEecC--CCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN--GEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998643 368999998643 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 109 v~Ey~~~g~L~~~i~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---------------NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred EEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCE
Confidence 9999999999999842 345889999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... .......
T Consensus 171 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~i--- 240 (340)
T PTZ00426 171 KMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQKI--- 240 (340)
T ss_pred EEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHHHH---
Confidence 99999999865422 2345789999999999999999999999999999999999999864322 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--Hhc------cccCCCCCCCCcch
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM--IKN------EIVNLPSPQQPAFS 464 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~--L~~------~~~~~~~p~~~~~~ 464 (496)
..... .+ +......+.+++.+|++.+|++|+ ++++++++ +.+ ....++.|..|.+.
T Consensus 241 -~~~~~--~~--------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 241 -LEGII--YF--------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred -hcCCC--CC--------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 11100 00 111124567899999999999995 89988875 221 11245666677664
Q ss_pred h
Q 040910 465 Y 465 (496)
Q Consensus 465 ~ 465 (496)
.
T Consensus 310 ~ 310 (340)
T PTZ00426 310 N 310 (340)
T ss_pred C
Confidence 3
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.36 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=202.1
Q ss_pred CCCccccccccCCeeEEEEEec-C-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-N-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999753 3 5788999876544444567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 148 ~gg~L~~~l~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 148 SGGDLNKQIKQRL-----------KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred CCCCHHHHHHHHH-----------hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence 9999999886421 23446889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. +.
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~---~~-~~ 287 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQV---LY-GK 287 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hh-CC
Confidence 9998765432222234467999999999999999999999999999999999999998643211 111110 00 11
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. .+ ........+.+++..||+.+|++||++.+++.
T Consensus 288 ~----~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 Y----DP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C----CC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 00 01112346788999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.99 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=198.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|...++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 68899999987443 23345778999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ |+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 85 LD-SDLKQYLDN--------------CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred CC-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECc
Confidence 97 589888742 2235788999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh----
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN---- 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~---- 396 (496)
||+++...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 147 fG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 222 (288)
T cd07871 147 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGT 222 (288)
T ss_pred CcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 99998653221 12234578999999999875 5689999999999999999999999865432211 000000
Q ss_pred ----hhcc----cccccccCccccccC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 ----LWKD----DRAWKLLDPTLQNEA----LYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ----~~~~----~~~~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.|.. ........+...... .......+.+++.+|++.||.+|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000111111110000 01123457789999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.65 Aligned_cols=273 Identities=27% Similarity=0.423 Sum_probs=204.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-----------------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-----------------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVR 224 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 224 (496)
.++|++.++||+|+||.||++... ++..||+|.+.... ......|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 23468999987543 234568999999999999999999
Q ss_pred eeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 225 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
+++++...+..++||||+++|+|.+++......... .......+++..+..++.|++.||+|||+.+ ++|+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA----EKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc----ccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 999999999999999999999999999753321110 1223346889999999999999999999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh--CCCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS--SKKNTRF 382 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~~~~~ 382 (496)
||+|||++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986643322222223345678999999988899999999999999999998 4455542
Q ss_pred CCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 383 YNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. ................. ....+ ........+.+++.+||+.||++||++.+|++.|++
T Consensus 237 ~~--~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LS--DEQVIENTGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cC--hHHHHHHHHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 22 11111111111111100 00001 011123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=321.49 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=197.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.++||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999875 688999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ ++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 84 YVH-TDLCQYMDK--------------HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred CCC-cCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEC
Confidence 995 677777742 2345788899999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|||++|..||.........+. .......
T Consensus 146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 222 (303)
T cd07869 146 DFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLG 222 (303)
T ss_pred CCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhC
Confidence 999997543221 22234568899999999875 4588999999999999999999999875432111111 0100000
Q ss_pred ccc--------cccccCcc-c---cccCCH------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 DDR--------AWKLLDPT-L---QNEALY------PMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~~~--------~~~~~d~~-~---~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... .....++. . ...... .....+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00000000 0 000000 01245678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.03 Aligned_cols=284 Identities=24% Similarity=0.298 Sum_probs=211.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cC-HHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QG-VEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 237 (496)
.++|..+++|++|+||.||+|+.. +++.||+|+++.... .+ .-.-.+|+.+|.+.+|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888899999999999999864 688999999985432 22 22457899999999999999998877543 47999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||++ .+|...+.. -.+++...++.-++.|+++|++|||+.. |+|||||++|+|++..|.+
T Consensus 155 VMe~~E-hDLksl~d~--------------m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMET--------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred eHHHHH-hhHHHHHHh--------------ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcE
Confidence 999995 578888853 2367888999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhH---
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLG--- 392 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~--- 392 (496)
||+|||+||.++.. ...++..+-|..|+|||.+.+. .|+...|+||+|||+.|++++++-|+....-+ .+..-
T Consensus 217 KiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 217 KIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred EecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 99999999988754 3456778899999999999875 69999999999999999999999887654321 11110
Q ss_pred -----hhhhhhccccccc-c-----cCccccccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCC
Q 040910 393 -----HAWNLWKDDRAWK-L-----LDPTLQNEALY-PMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460 (496)
Q Consensus 393 -----~~~~~~~~~~~~~-~-----~d~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~ 460 (496)
..|.-...-.... + .-..+...+.. ...+.-.+++...+..||.+|.|+.|-+++ +-..+.|-|..
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~ 372 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPID 372 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCC
Confidence 0010000000000 0 00000000000 023456778888999999999999998874 33456677777
Q ss_pred Ccchhhhh
Q 040910 461 PAFSYVRI 468 (496)
Q Consensus 461 ~~~~~~~~ 468 (496)
|.+..-+.
T Consensus 373 P~~~Pt~P 380 (419)
T KOG0663|consen 373 PSMFPTWP 380 (419)
T ss_pred hhhcCCCc
Confidence 77665444
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=332.93 Aligned_cols=274 Identities=26% Similarity=0.355 Sum_probs=207.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhc-CCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 233 (496)
..++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+.+|+.++.++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999853 346899999975432 23457899999999997 999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCc-------c---------------------------------------------
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGF-------D--------------------------------------------- 261 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~--------------------------------------------- 261 (496)
..++|+||+++|+|.+++......... .
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 999999999999999999754321000 0
Q ss_pred -------------------------------cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 262 -------------------------------MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 262 -------------------------------~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
..........++|..+..++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 0000012245889999999999999999999987 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~ 389 (496)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543221112223456789999999999899999999999999999998 7877754322111
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.. .....+. .... .......+.+++..||+.+|.+||++++|++.|++.+
T Consensus 351 ~~----~~~~~~~--~~~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FY----NAIKRGY--RMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH----HHHHcCC--CCCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 0000010 0111 1112356788999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=313.78 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=200.4
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.+|++.+.||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++||||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999988777789999986433 344678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 83 ~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 83 NGCLLNYLRE--------------RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred CCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcc
Confidence 9999999852 2236899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..|+...... ...... ...
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~----~~~- 217 (256)
T cd05059 146 LARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESV----SAG- 217 (256)
T ss_pred cceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHH----HcC-
Confidence 99865432211 1112234568999999999999999999999999999999 77777543221 111111 000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..... .......+.+++.+||+.+|++|||+.++++.|
T Consensus 218 -~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 -YRLYR-------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CcCCC-------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111 111345688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=324.85 Aligned_cols=200 Identities=27% Similarity=0.380 Sum_probs=173.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999875 57889999886542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+
T Consensus 84 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 84 HMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred cCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEe
Confidence 9999999999842 335788999999999999999999742 39999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
|||++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.|+...
T Consensus 147 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred eCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999765322 122346899999999999989999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=325.41 Aligned_cols=239 Identities=22% Similarity=0.287 Sum_probs=191.3
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 5789999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 81 FHHLQR---------------EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 999842 345889999999999999999999988 99999999999999999999999999985
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... ..
T Consensus 143 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~---~~~~~-~~----- 209 (312)
T cd05585 143 NMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMY---RKILQ-EP----- 209 (312)
T ss_pred CccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHH---HHHHc-CC-----
Confidence 43221 2233457899999999999999999999999999999999999998643211 111 11111 00
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTM---SEVVS 446 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~---~evl~ 446 (496)
. .........+.+++.+||+.||.+||++ .+++.
T Consensus 210 -~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 -L----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -C----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0 0111123457788999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=312.21 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=207.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999864 68999999876432 233457889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.... .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|
T Consensus 82 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 82 ELADAGDLSQMIKYFK-----------KQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EecCCCcHHHHHHHhh-----------hccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEE
Confidence 9999999999885321 22345788999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||++....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.............. .
T Consensus 148 ~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~ 221 (267)
T cd08228 148 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----E 221 (267)
T ss_pred Cccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----h
Confidence 9999998764332 112234688899999999988899999999999999999999999754322211111110 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
. ...+.. ........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 222 ~-----~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 222 Q-----CDYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred c-----CCCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 001111 1122346688999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=327.48 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=192.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.+|...++||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999864 689999999865432 3346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.... ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 154 ~~~~~L~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 154 MDGGSLEGTH-------------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred CCCCcccccc-------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcc
Confidence 9999984322 2456778899999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+++.+.... .......||..|+|||.+.. ...+.++|||||||++|||++|+.||........... ...
T Consensus 212 fG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~ 287 (353)
T PLN00034 212 FGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCA 287 (353)
T ss_pred cccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHH
Confidence 99998764321 12234578999999998743 2345689999999999999999999873322211111 000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .. . ..........+.+++.+||+.||++||++.|++++
T Consensus 288 ~~~-~~-----~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICM-SQ-----P----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred Hhc-cC-----C----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 0 01111223567889999999999999999999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.55 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=195.0
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6899999999753 2234567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 81 ELFFHLS---------------RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCC
Confidence 9988884 2346899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (496)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 143 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~~---~~-~~--- 211 (328)
T cd05593 143 KEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LM-ED--- 211 (328)
T ss_pred ccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHHh---cc-CC---
Confidence 753221 122334578999999999999999999999999999999999999986432211 11100 00 00
Q ss_pred ccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 406 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
..+ +......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ---~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 ---IKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---ccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 001 111234677889999999999997 88998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=318.56 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=201.9
Q ss_pred cCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
+.|.+.+.||+|+||.||++++ .++..||+|.++... ......+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567889999999999999974 357899999987543 33456899999999999999999999998875 568
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++++|.+++.. ....++|..+..++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 84 ~lv~e~~~g~~L~~~l~~--------------~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 146 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--------------NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEH 146 (284)
T ss_pred EEEEEccCCCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCC
Confidence 999999999999999842 1235899999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC--------
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-------- 386 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~-------- 386 (496)
.++|+|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.......
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05079 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226 (284)
T ss_pred CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence 9999999999876433211 1122345677899999999889999999999999999999987654221100
Q ss_pred --cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 387 --SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 387 --~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
........ ....... ...........+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 227 ~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 227 HGQMTVTRLV-RVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccHHHHH-HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 0000000 0011112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=318.19 Aligned_cols=267 Identities=25% Similarity=0.386 Sum_probs=208.5
Q ss_pred HhcCCCccccccccCCeeEEEEEecC-----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeee-cCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-QGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 234 (496)
..++|.+.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678888999999999999998765 6889999987442 2335678899999999999999999998876 467
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++++||+++|+|..++....... ......+++..+..++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~ 153 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGE-------ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEE 153 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccc-------cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCC
Confidence 899999999999999986532110 112356999999999999999999999987 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
+.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... .....+
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~ 231 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAY 231 (280)
T ss_pred CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHH
Confidence 9999999999986644332222233456778999999999999999999999999999999 8888754221 111111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
. ..+. .... .......+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 232 ~----~~~~--~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 L----KDGY--RLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred H----HcCC--CCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1110 1111 11123467889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.99 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=195.4
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||+|+||+||++... +++.||||.+.... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999764 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
..++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~~~-----------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 81 RYHIYNVD-----------EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred HHHHHhcc-----------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 98885311 23456899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
+.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ...
T Consensus 147 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~--------~~~ 214 (280)
T cd05608 147 LKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQ--------RIL 214 (280)
T ss_pred cCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHH--------hhc
Confidence 64332 12233578999999999999999999999999999999999999987533221110 0000 000
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.... .........+.+++..||+.||++|| ++++++++
T Consensus 215 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0000 11122345678899999999999999 66777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.12 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=203.8
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG---- 233 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 233 (496)
...++|.+.+.||+|+||.||+++. .+|+.||||.+.... ......+.+|+..+..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 468999999986542 334567889999999999999999988765432
Q ss_pred ----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 234 ----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 234 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~-----------~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NI 174 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRA-----------KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANI 174 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence 3689999999999999986421 23356889999999999999999999988 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
|++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~ 252 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--E 252 (496)
T ss_pred EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--H
Confidence 99999999999999998765432223334567999999999999999999999999999999999999998643211 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .. .... .++ ........+.+++.+||+.+|.+||++.+++++
T Consensus 253 ~~~---~~-~~~~----~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMH---KT-LAGR----YDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH---HH-hcCC----CCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 00 0010 000 111223567889999999999999999999864
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=318.56 Aligned_cols=270 Identities=24% Similarity=0.379 Sum_probs=206.6
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....+|.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 46789999987543 23346799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccc-------cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMV-------TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~-------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
++|+||+++|+|.+++............ ........+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 9999999999999999754321111100 01122346899999999999999999999988 9999999999
Q ss_pred EEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDS 387 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~ 387 (496)
|++++++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986543322222223345678999999999999999999999999999997 7667643221
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
..... .....+... ........+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 239 ~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIY----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 111111100 011223568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=326.51 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=194.1
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+++.. +|+.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999999753 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~L~~~l~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 81 ELFFHLS---------------RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred cHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHh
Confidence 9988884 2346889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (496)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 143 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~~---~~-~~--- 211 (323)
T cd05595 143 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI---LM-EE--- 211 (323)
T ss_pred ccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH---hc-CC---
Confidence 7532221 12234578999999999999999999999999999999999999986433211 11100 00 00
Q ss_pred ccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 406 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
..+ +......+.+++.+||+.||.+|| ++.+++++
T Consensus 212 ---~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 ---IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CCC----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 000 111234567889999999999998 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=321.02 Aligned_cols=273 Identities=25% Similarity=0.381 Sum_probs=207.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
...+|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3457778899999999999999741 24579999986432 34456789999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcc-cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFD-MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
....++||||+++|+|.+++.......... ..-.......++|..+..++.||+.||+|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997543211000 0000112356899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~ 389 (496)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+...... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--H
Confidence 99999999999999987654332222333456778999999999999999999999999999998 66666432211 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
. . ........ . .........+.+++.+||+.+|.+||++.+|++.|++++
T Consensus 248 ~---~-~~~~~~~~--~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 L---F-KLLKEGHR--M-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred H---H-HHHHcCCc--C-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1 1 11111110 0 011122356778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=327.97 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----eeE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----EKI 236 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 236 (496)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 6899999998643 2233457889999999999999999999886432 579
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 lv~e~~~-~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 141 (338)
T cd07859 81 VVFELME-SDLHQVIK---------------ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCK 141 (338)
T ss_pred EEEecCC-CCHHHHHH---------------hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCc
Confidence 9999995 78888874 2345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccc-cccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-hhhH
Q 040910 317 PKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLG 392 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~~~~ 392 (496)
+||+|||+++........ .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 142 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~ 221 (338)
T cd07859 142 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221 (338)
T ss_pred EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 999999999865322211 11234578999999999876 6789999999999999999999999865332110 0000
Q ss_pred --------hhhhhhccccccccc---Cccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 --------HAWNLWKDDRAWKLL---DPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 --------~~~~~~~~~~~~~~~---d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.....+......+.+ .+.. .....+.....+.+++.+||+.+|++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 222 DLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 0000 000001112456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=321.50 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=204.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|...+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999742 34579999987543 23346789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++|+||+++|+|.+++.. .....+++.++..++.|++.||+|||+.+ ++|+||||+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~ 176 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRR-------------KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTH 176 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcC
Confidence 99999999999999999853 12234899999999999999999999988 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~ 392 (496)
++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ...
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~ 255 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYK 255 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHH
Confidence 99999999999986643321111223355778999999999999999999999999999998 8888754322111 111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
. ..... .. .........+.+++.+||+.+|++||++.++++.|+..
T Consensus 256 ~----~~~~~--~~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 L----IKEGY--RM-------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred H----HHcCC--cC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 01000 00 01111235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.08 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=209.2
Q ss_pred CCccccccccCCeeEEEEEecC---CC--EEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLLN---GE--EVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
....+.||+|-||.||+|.+.+ |+ .||||..+.. .....+.|..|+.+|++++|||||+|+|+|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 3445789999999999998743 32 6899999864 455678999999999999999999999999765 678999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|.++-|-|..||.. .+..|+......++.||..||+|||+.. +|||||..+|||+...-.+||
T Consensus 470 EL~~~GELr~yLq~--------------nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 470 ELAPLGELREYLQQ--------------NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred ecccchhHHHHHHh--------------ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeee
Confidence 99999999999963 4556888999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+++.+..+.+.... ...-++.|||||.+.-..++.++|||-|||.+||+++ |.+||.+-...+.- .
T Consensus 533 aDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--~------ 603 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--G------ 603 (974)
T ss_pred cccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--E------
Confidence 999999998876655543 4456889999999999999999999999999999876 78888754332210 0
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.-++..++. .++..+..+..++.+||..+|.+||++.++...|++++.
T Consensus 604 ~iEnGeRlP-------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLP-------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCC-------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011222232 333445678889999999999999999999999877544
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.17 Aligned_cols=268 Identities=25% Similarity=0.393 Sum_probs=206.6
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578899999999999999999653 24589999886433 2234568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++........ .......+++..+..++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAE-----NNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 9999999999999999975322110 1122355678889999999999999999988 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ......
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~~ 233 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKF 233 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9999999999986644333222333455778999999999999999999999999999998 6667653221 111110
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
........ ........+.+++.+||+.+|.+|||+.++++.|++.+
T Consensus 234 ----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 ----VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00011000 01112357889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=316.26 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=207.1
Q ss_pred hcCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999997642 3689999986443 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|..++........ .......++|..+..++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAE-----NNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchh-----hccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 999999999999999965321110 0012345889999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+...... .....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~- 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKF- 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHH-
Confidence 999999999987654433333334456889999999998899999999999999999998 88777543221 11111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
......... .......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 234 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 ---VIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 11124577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=311.40 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=201.4
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4678889999999999999998888899999987543 34568999999999999999999999875 456899999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 84 ~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 84 KGSLLDFLKD-------------GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred CCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCce
Confidence 9999999853 22345899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....... ....
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~~ 220 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQV----ERGY 220 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----HcCC
Confidence 99866432211 1122345678999999998899999999999999999999 7777753221 1111111 0000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
...........+.+++.+||+.+|.+|||+.++.+.|++
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 ---------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001111223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.78 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=202.2
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
..+|.+.++||+|+||.||+|+..++..||+|.+.... ...+.|.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688899999999999999988777789999987533 345689999999999999999999998754 5679999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 83 SKGSLLDFLKG-------------EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred CCCcHHHHHhh-------------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccC
Confidence 99999999953 12345789999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|.++.+...... ......++..|+|||...+..++.++||||||+++|||++ |..|+...... ..... ....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~ 219 (262)
T cd05071 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQ----VERG 219 (262)
T ss_pred Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHHH----HhcC
Confidence 999866433221 1122346778999999998999999999999999999999 66666532211 11110 0000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
. . ..........+.+++.+|++.+|.+||++.++++.|++.
T Consensus 220 ~-----~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 Y-----R----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C-----C----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0 011123346688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.36 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=202.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-c-CHHHHHHHHHHHHHhcCCc-eeeeeeeeeecC-----
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-Q-GVEEFKNEMILIAKLHHRN-LVRLFGCCIEQG----- 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~----- 233 (496)
...|...++||+|+||+||+|+.. +|+.||+|+++.... + ......+|+.++++++|+| ||+|.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666789999999999999764 789999999985543 2 3345688999999999999 999999999887
Q ss_pred -eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 234 -EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 234 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
..++|+||+ .-+|..|+..... ....++-..+..++.||++||+|||+++ |+||||||.|||++
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~-----------~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~ 154 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPK-----------KPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLIS 154 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEEC
Confidence 789999999 6799999964221 1134555789999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
++|.+||+|||+|+.+.-+ ....+..++|..|+|||++.+. .|+...||||+|||+.||+++++-|+..... ...
T Consensus 155 ~~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql 230 (323)
T KOG0594|consen 155 SSGVLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQL 230 (323)
T ss_pred CCCcEeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHH
Confidence 9999999999999976533 2335667899999999999986 7999999999999999999988877654431 111
Q ss_pred Hhhhhhhcccc-----------cccccCcccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDR-----------AWKLLDPTLQ-----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~-----------~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........... .++..-+... ....+.......+++.+|++.+|.+|.|++..+.+
T Consensus 231 ~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 231 FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111111110 0010001111 00011111367889999999999999999999887
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=309.08 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=208.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999886 7899999988632 2233568899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 82 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 82 ELADAGDLSRMIKHFK-----------KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred ecCCCCCHHHHHHHhc-----------ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEE
Confidence 9999999999986421 23456889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+............. ..
T Consensus 148 ~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~ 221 (267)
T cd08224 148 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IE 221 (267)
T ss_pred eccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----hh
Confidence 9999988654322 11223468889999999999899999999999999999999999875433211111110 00
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... ..+ .........+.+++.+||+.+|.+||++.+|+++|+++
T Consensus 222 ~~~----~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 222 KCD----YPP----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cCC----CCC----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 000 000 01113345678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=321.24 Aligned_cols=273 Identities=25% Similarity=0.376 Sum_probs=206.9
Q ss_pred hcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 232 (496)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999999752 23579999997542 23456788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCccc-ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDM-VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+..++|+||+++|+|.+++........... .........++|..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975332110000 000123346999999999999999999999987 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HH
Confidence 9999999999999986643322222222334578999999999999999999999999999998 77776532211 11
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. ....... ..........+.+++..||+.+|.+||++.+|++.|+.++.
T Consensus 252 ~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 FK----LLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HH----HHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 1111100 01111223567789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=327.45 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
-|...+-||.|+-|.|-+|++ .+|+.+|||.+.+.. ........+|+.+|+.+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 456678999999999999986 579999999997652 2234457789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|-|-+++. .++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||...++||+
T Consensus 93 yv~gGELFdylv---------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 93 YVPGGELFDYLV---------------RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred ecCCchhHHHHH---------------hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeee
Confidence 999999999984 5778999999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+|..-..+ ....+-+|.+.|.|||+++|.+| +.++||||.|||||.||+|+.||...+... ++.. +.
T Consensus 155 DFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LLlK----V~ 225 (786)
T KOG0588|consen 155 DFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LLLK----VQ 225 (786)
T ss_pred ccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HHHH----HH
Confidence 99999865443 33455799999999999999988 578999999999999999999998433221 1111 11
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.+.. +.+.....++.+|+.+|+..||+.|.|++||+++-
T Consensus 226 ~G~f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVF----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcc----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1111 11223345677888999999999999999999874
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.91 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=202.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CC---CEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NG---EEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++.+++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357788899999999999999875 23 379999986542 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++++|..++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 84 v~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 84 ITEYMENGALDKYLRD--------------HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLEC 146 (268)
T ss_pred EEEcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcE
Confidence 9999999999999852 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccc-cccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 318 KISDFGIARMFGGDELQSN-MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
||+|||++........... ......+..|+|||.+.+..++.++||||||+++||+++ |..|+...... .....
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~-- 222 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKA-- 222 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHH--
Confidence 9999999986643221111 111223567999999998899999999999999999997 89887543211 11111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..... .. .........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 223 --i~~~~--~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 --INDGF--RL-------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HhcCC--CC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11000 00 01112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=311.42 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=193.9
Q ss_pred cccccCCeeEEEEEec---CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 171 KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+||+|+||.||+|.+. ++..+|+|+++.... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999653 578999999864432 33568899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~L~~~l~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 81 PLNKFLQK---------------NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccc
Confidence 99999842 335889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 326 RMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 326 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+........ .......++..|+|||.+....++.++||||||+++|||++ |..||...... ...... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i----~~~~~ 216 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI----ESGER 216 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----HCCCC
Confidence 876433211 11122334678999999988889999999999999999998 88887643221 111111 11111
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. . .+......+.+++.+||+.||.+||++.+|.+.|++
T Consensus 217 ~-----~----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 M-----E----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C-----C----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0 0 111223567789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.75 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=202.5
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999875 68999999997432 244567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 e~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 81 EYMPGGDLMNLLIR---------------KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred cCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEe
Confidence 99999999999853 246889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCc---------------------------cccccccccccccccChhhhccCCCCccccchhhhHHHHH
Q 040910 320 SDFGIARMFGGDE---------------------------LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372 (496)
Q Consensus 320 ~DFgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~e 372 (496)
+|||++....... .........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998664332 0012234578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 040910 373 TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-MSEVVSM 447 (496)
Q Consensus 373 lltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~ 447 (496)
|++|+.||....... .. ......... ...|. .......+.+++..|++ +|.+||+ +.+++++
T Consensus 223 ll~g~~Pf~~~~~~~--~~---~~i~~~~~~--~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 223 MLYGFPPFYSDTLQE--TY---NKIINWKES--LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hccCCCCCCCCCHHH--HH---HHHhccCCc--ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999999987543211 00 000000000 00000 00123567788889997 9999999 9999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.30 Aligned_cols=259 Identities=25% Similarity=0.313 Sum_probs=211.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecCC-CEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeee-eeec------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNG-EEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGC-CIEQ------ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~~------ 232 (496)
...+.++.+.|.+|||+.||.|....+ ..+|+|++-..+....+..++|+.+|++|+ |+|||.+++. ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456778889999999999999998766 999999998778888899999999999995 9999999993 3221
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
-+.+|.||||.+|+|-+|+... ....|++.++++|+.|+++|+++||... ++|||||||-+||||+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~R-------------lq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTR-------------LQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLS 180 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHH-------------HhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEc
Confidence 3789999999999999999642 2334999999999999999999999874 7799999999999999
Q ss_pred CCCceEEeccccccccCCCccccc-c------ccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCC
Q 040910 313 GDMNPKISDFGIARMFGGDELQSN-M------NRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRF 382 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~-~------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~ 382 (496)
.+++.||||||.|...-....... . -...-|+.|+|||++. +.++++|+|||+|||+||-|+....||+.
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 999999999999874322110000 0 0124589999999874 78899999999999999999999999985
Q ss_pred CCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 383 YNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
...- .+++....-...+.+...+..||..||+.||++||++-+|+..+-.+.
T Consensus 261 sg~l------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 261 SGKL------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred Ccce------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 4221 233333333334567889999999999999999999999999997753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.54 Aligned_cols=267 Identities=25% Similarity=0.337 Sum_probs=205.2
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEec--cCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee-----cC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLS--NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-----QG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 233 (496)
....|...+.||+|+||.|+.+.. .+|+.||||++. -.+....++..+|+++++.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 445666678999999999999976 478999999997 3445566788999999999999999999998865 34
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..|+|+|+| ..+|...+. .++.|+......++.||++||.|+|+.+ |+||||||+|+|++.
T Consensus 100 DvYiV~elM-etDL~~iik---------------~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~ 160 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---------------SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNA 160 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---------------cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeecc
Confidence 789999999 678888884 4455889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCC-cchhh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID-SLTLL 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~-~~~~~ 391 (496)
+..+||+|||+|+..........++..+.|..|+|||++. ...|+...||||.|||+.||++|++-|++.+.- +..+.
T Consensus 161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 9999999999999876543334456678899999999876 468999999999999999999999988875542 11111
Q ss_pred Hhh--------hhhhcccccccccC--cccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHA--------WNLWKDDRAWKLLD--PTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~--------~~~~~~~~~~~~~d--~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ......++....+. |... ....+......++++.+||..||.+|+|++|.+++
T Consensus 241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111 01111111111111 0000 00111223456788999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.77 Aligned_cols=271 Identities=27% Similarity=0.392 Sum_probs=204.1
Q ss_pred cCCCccccccccCCeeEEEEEec-----CCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeee--cCee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEK 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 235 (496)
..|...+.||+|+||.||++.+. +++.||||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999863 3679999999755432 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++
T Consensus 84 ~lv~e~~~~~~l~~~l~~--------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~ 146 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--------------HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESED 146 (284)
T ss_pred EEEEecCCCCCHHHHHHh--------------CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCC
Confidence 999999999999999953 2235899999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.++|+|||++........ ........++..|+|||.+.+..++.++||||||++++||++|..|+..............
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 226 (284)
T cd05038 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226 (284)
T ss_pred CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence 999999999987653221 1111223456679999999988999999999999999999999988754322111100000
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..........+.+...............+.+++.+||+.+|.+||++.+|+++|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000000000001111100111112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.58 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=211.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe-eEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE-KILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 239 (496)
++|...+++|+|+||.++..+.+ +++.+|+|.+.-. .........+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999998764 5779999998743 33444577899999999999999999999999998 99999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
+|++||+|.+.+.. .....++++.+..++.|++.|+.|||+.. |.|||||+.|||++.+..+||
T Consensus 84 ~Y~eGg~l~~~i~~-------------~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE-------------QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred eecCCCCHHHHHHH-------------HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceee
Confidence 99999999999964 33567899999999999999999999877 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+...... ......+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+......-
T Consensus 148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k-------- 217 (426)
T KOG0589|consen 148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK-------- 217 (426)
T ss_pred cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH--------
Confidence 9999999987654 234457999999999999999999999999999999999999999886554332110
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+. +......+..+...+..++..|++.+|+.||++.+++.+
T Consensus 218 ------i~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 ------IN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------Hh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 00 111122334455678889999999999999999999876
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.06 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=200.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|...++||+|+||.||+|++. +|+ .||+|.+.... .....++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457788899999999999999753 444 48999987543 23356788999999999999999999999754 578
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 l~~~~~~~g~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--------------NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNH 147 (279)
T ss_pred EEEEcCCCCCHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 99999999999999853 2346899999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~-- 223 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL-- 223 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH--
Confidence 99999999987653322111222345678999999999999999999999999999998 7887653221 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
....... .........+.+++.+||+.||++||++.++++.|+..
T Consensus 224 --~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 224 --LEKGERL---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --HHCCCcC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111100 00112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.18 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=195.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999764 67899999997532 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 82 YIPGGDMMSLLIR---------------MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred cCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEe
Confidence 9999999999852 345788899999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccc---------------------------------------------cccccccccccccChhhhccC
Q 040910 321 DFGIARMFGGDELQ---------------------------------------------SNMNRIVGTYGYMSPEYALHG 355 (496)
Q Consensus 321 DFgla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~ 355 (496)
|||+++.+...... .......||..|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 99998643210000 001234799999999999999
Q ss_pred CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHH--hccc
Q 040910 356 LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALL--CVQE 433 (496)
Q Consensus 356 ~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~ 433 (496)
.++.++|||||||++|||++|..||.......... .. ......... +. .......+.+++.+ |+..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~--~i---~~~~~~~~~--~~-----~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL--KV---INWENTLHI--PP-----QVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHH--HH---HccccccCC--CC-----CCCCCHHHHHHHHHHccCcc
Confidence 99999999999999999999999987543221110 00 000000000 00 00112345556655 6667
Q ss_pred CCCCCCCHHHHHHH
Q 040910 434 NAADRPTMSEVVSM 447 (496)
Q Consensus 434 ~p~~RPs~~evl~~ 447 (496)
+|..||++.+++.+
T Consensus 292 ~~~~R~~~~~~l~h 305 (381)
T cd05626 292 ERLGRNGADDIKAH 305 (381)
T ss_pred cccCCCCHHHHhcC
Confidence 77789999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=327.41 Aligned_cols=259 Identities=18% Similarity=0.193 Sum_probs=195.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+|.+.+.||+|+||.||++... +++.||+|.... ..+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999764 688999997532 3568899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+. ++|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 165 ~~-~~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 165 YK-TDLYCYLA---------------AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred CC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEe
Confidence 94 78888774 2345889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-----chhhHhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-----LTLLGHAWN 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-----~~~~~~~~~ 396 (496)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .........
T Consensus 226 FG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 226 FGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 99997543211 112234579999999999999999999999999999999999998764321100 000000000
Q ss_pred hhcc----------ccccc---------ccCccccc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKD----------DRAWK---------LLDPTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~----------~~~~~---------~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ..... ...+.... .........+.+++.+||+.||++|||++|++++
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 00000 00000000 0111234568889999999999999999999853
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.65 Aligned_cols=272 Identities=25% Similarity=0.356 Sum_probs=205.2
Q ss_pred cCCCccccccccCCeeEEEEEecC-CC--EEEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-GE--EVAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998753 33 5789888743 233456789999999999 799999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCccc-ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDM-VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
+||+++|+|.+++........... .........+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965332111100 001122346899999999999999999999987 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~---- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYE---- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----
Confidence 99999998743211 11111233567999999998899999999999999999997 888875432211 111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
....+ ..+ .........+.+++.+||+.+|.+||++.++++.|++++....
T Consensus 230 ~~~~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLPQG-----YRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHhcC-----CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 01000 000 0111123567889999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.01 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=193.2
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999753 223345678899888877 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 81 GDLMFHMQ---------------RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99988874 2345889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc---chhhHhhhhhhccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS---LTLLGHAWNLWKDD 401 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~---~~~~~~~~~~~~~~ 401 (496)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+........
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 220 (329)
T cd05618 143 CKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220 (329)
T ss_pred cccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC
Confidence 97532211 12234578999999999999999999999999999999999999986422211 11111111111111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT------MSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~evl~~ 447 (496)
.. ..+......+.+++.+||+.||.+||+ +.+++++
T Consensus 221 ~~----------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 QI----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CC----------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 10 011122356778999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.77 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=197.0
Q ss_pred CCCccccccccCCeeEEEEEe----cCCCEEEEEEeccC----CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 165 NFSEENKLGEGGFGPVYKGKL----LNGEEVAVKRLSNK----SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
+|++.+.||+|+||.||+++. .+++.||+|.+... .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35789999998642 123345688899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 81 ~lv~e~~~~g~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---------------RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEG 142 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCC
Confidence 999999999999999842 345889999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++.+..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......... ...
T Consensus 143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~ 219 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEV 219 (332)
T ss_pred CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHH
Confidence 999999999986543221 122345789999999999875 4789999999999999999999998643322111 001
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
..... -.++.+. ......+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~------~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 220 SRRIL------KCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHh------cCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00000 0111111 11234567889999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=314.35 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=202.6
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--------------ccCHHHHHHHHHHHHHhcCCceeee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--------------GQGVEEFKNEMILIAKLHHRNLVRL 225 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l 225 (496)
..-++|++.+.||+|.||.|-+|... +++.||||.+.+.. ....+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999764 68999999986431 0124678999999999999999999
Q ss_pred eeeeeec--CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040910 226 FGCCIEQ--GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRD 303 (496)
Q Consensus 226 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 303 (496)
+.+..+. +..|||+||+..|.+... +..+..++..+.++++.++..||.|||.++ |||||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---------------p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRD 235 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---------------PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRD 235 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---------------CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccc
Confidence 9998765 479999999998887322 122333999999999999999999999999 99999
Q ss_pred CCCCCEEecCCCceEEeccccccccCCC---ccccccccccccccccChhhhccCC----CCccccchhhhHHHHHHHhC
Q 040910 304 LKASNVLLDGDMNPKISDFGIARMFGGD---ELQSNMNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLETLSS 376 (496)
Q Consensus 304 lk~~NIll~~~~~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg 376 (496)
|||+|+||+++|++||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+||.||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999999866322 1222334478999999999988732 35678999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 377 KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
+.||-.... ..+. .+++...+.....+++-+.+.+|++++|+.||+.|.+..+|..+.-
T Consensus 316 ~~PF~~~~~--~~l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 316 QLPFFDDFE--LELF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred cCCcccchH--HHHH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 999863221 1111 1233333333333455677889999999999999999999877663
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=311.03 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=201.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999986 46889999999765555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 88 CGGGSLQDIYHV---------------TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred CCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECc
Confidence 999999998842 345789999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
||++..+.... .......++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ..
T Consensus 150 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~ 221 (267)
T cd06646 150 FGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM 221 (267)
T ss_pred Cccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee
Confidence 99998664221 1122346888999999884 4457889999999999999999999875322111000 00
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
... ....+... ........+.+++.+||+.+|++||++++++++|
T Consensus 222 ~~~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 SKS---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ecC---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 00111110 0112345778999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=310.21 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=209.2
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
...+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +.++.-.+++|+++|..|+||||+.++.+|.+.+..++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788889999999999999964 67999999999754 34455578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||..+|.|.+|+. ..+.|++....+++.||.+|+.|+|.+. ++|||||.+|||||.|+++
T Consensus 131 vMEYaS~GeLYDYiS---------------er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~Ni 192 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---------------ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNI 192 (668)
T ss_pred EEEecCCccHHHHHH---------------HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCe
Confidence 999999999999994 4667999999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||++-.+.... ...+++|++-|.+||++.|.+| .+.+|.|||||+||.|+.|..||...+.. .++.+.
T Consensus 193 KIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--~lvrQI-- 265 (668)
T KOG0611|consen 193 KIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--RLVRQI-- 265 (668)
T ss_pred eeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH--HHHHHh--
Confidence 999999998876543 3456899999999999999988 47899999999999999999999864421 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
......+|. .+....-|+.|||..+|++|-|+.+|..+.
T Consensus 266 -----s~GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 -----SRGAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----hcccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111111221 123456788999999999999999999876
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=310.10 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=207.0
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+|++.+.||+|+||.||++.. .+++.+|||.+.... .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677888999999999999986 478999999886432 223467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.... .....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|
T Consensus 82 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 82 ELADAGDLSRMIKHFK-----------KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EecCCCCHHHHHHHhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999885321 23456899999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||++....... .......++..|+|||.+.+..++.++|+||||+++|||++|..|+..............
T Consensus 148 ~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 220 (267)
T cd08229 148 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----- 220 (267)
T ss_pred CcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh-----
Confidence 9999988664322 112234688899999999999999999999999999999999998754322211111100
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.....+... .......+.+++.+||+.+|.+||||.+|++++++.
T Consensus 221 ----~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 221 ----EQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----hcCCCCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011111111 112345678899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=313.79 Aligned_cols=252 Identities=26% Similarity=0.316 Sum_probs=200.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
+|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999864 68899999986432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|..++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 81 ~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 81 LMNGGDLKFHIYN-------------MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred ccCCCcHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEe
Confidence 9999999988853 22345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... ......|+..|+|||++.+..++.++||||||+++||+++|+.||........ .........
T Consensus 145 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~- 218 (285)
T cd05605 145 DLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVK- 218 (285)
T ss_pred eCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhh-
Confidence 999998654322 12234789999999999999999999999999999999999999875332110 000100000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
. ............+.+++..||+.||.+|| ++++++++
T Consensus 219 --------~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 219 --------E-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --------h-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 00111122345678899999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=316.71 Aligned_cols=241 Identities=28% Similarity=0.359 Sum_probs=189.4
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 5789999998743 223345566677777655 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 81 GDLMFHIQS---------------SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred CcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcC
Confidence 999988842 345888999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i----~~~--- 211 (316)
T cd05592 143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSI----LND--- 211 (316)
T ss_pred CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HcC---
Confidence 98643222 2233457899999999999999999999999999999999999998643321 111110 000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS-EVVS 446 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 446 (496)
.+.+ +......+.+++.+||+.+|.+||++. ++++
T Consensus 212 ---~~~~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 ---RPHF----PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0111 111234567888999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.57 Aligned_cols=242 Identities=22% Similarity=0.262 Sum_probs=193.5
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||++... +|+.||+|.+... .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6889999999753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 81 ELFFHLS---------------RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred cHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCC
Confidence 9988884 23468999999999999999999997 56 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i---~~-~~-- 212 (325)
T cd05594 143 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LM-EE-- 212 (325)
T ss_pred CeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHH---hc-CC--
Confidence 87543221 12234579999999999999999999999999999999999999986433211 11100 00 00
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
..+ +......+.+++.+||+.||.+|| ++.+++++
T Consensus 213 ----~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 ----IRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 000 111234577889999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=309.05 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=203.2
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|.+.++||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++++++||||+++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45788889999999999999998889999999987543 34578999999999999999999999864 45789999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 83 ENGSLVDFLKT-------------PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred CCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccC
Confidence 99999998853 22346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++......... ......++..|+|||.+.+..++.++||||||++++|+++ |+.|+..... ....... ...
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~ 219 (260)
T cd05067 147 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL----ERG 219 (260)
T ss_pred cceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH----HcC
Confidence 999876532221 1122345778999999998899999999999999999999 8888763321 1111111 111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. .. . ........+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ~--~~---~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 Y--RM---P----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C--CC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 00 0 011123568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=318.90 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=193.6
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||++... +++.||||.++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999999753 233456678899999888 799999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~L~~~~~~---------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 81 GDLMFHIQR---------------SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred CCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCC
Confidence 999888842 345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....
T Consensus 143 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i----~~~~-- 212 (318)
T cd05570 143 CKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSI----LEDE-- 212 (318)
T ss_pred CeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHH----HcCC--
Confidence 87532211 122335689999999999999999999999999999999999999864321 1111110 0000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM-----SEVVSM 447 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~~ 447 (496)
.. ........+.+++.+||+.||.+||++ .+++++
T Consensus 213 -~~-------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 -VR-------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CC-------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 00 011123567889999999999999999 887654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.37 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=193.0
Q ss_pred ccccccCCeeEEEEEe----cCCCEEEEEEeccC----CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKL----LNGEEVAVKRLSNK----SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+.||+|+||.||+++. .+++.||||.+... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35789999998743 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|..++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 82 LSGGELFMHLER---------------EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred CCCchHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEee
Confidence 999999988842 345778888999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... .
T Consensus 144 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~---~~~~-~ 215 (323)
T cd05584 144 FGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTID---KILK-G 215 (323)
T ss_pred CcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHH---HHHc-C
Confidence 99987543221 1123357899999999999989999999999999999999999998643221 1111 1100 1
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.. . .+......+.+++.+||+.+|++|| ++.+++++
T Consensus 216 ~~------~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 KL------N----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CC------C----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00 0 0111234677899999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=317.19 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=190.8
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|... +++.||||.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999987531 23345667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~l~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 81 GDLMFHIQS---------------CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred CcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCc
Confidence 999998842 345889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i----~~~--- 211 (316)
T cd05619 143 CKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSI----RMD--- 211 (316)
T ss_pred ceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HhC---
Confidence 87532211 1223457899999999999999999999999999999999999998643321 111111 000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS-EVVS 446 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 446 (496)
.+.. +......+.+++.+||+.+|.+||++. ++.+
T Consensus 212 ---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ---NPCY----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCC----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0111 111234567889999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=308.28 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=193.7
Q ss_pred cccccCCeeEEEEEec---CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 171 KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.||+|+||.||+|.+. ++..||||.+..... ...+.|.+|+.++++++||||+++++++. .+..++|+||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999875432 33467999999999999999999999885 457899999999999
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
|.+++.. ....+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 81 L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 81 LNKFLSG--------------KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred HHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence 9999852 2346899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 327 MFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 327 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
........ .......++..|+|||.+.+..++.++||||||+++||+++ |..|+...... ... ........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~- 216 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM----SFIEQGKR- 216 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH----HHHHCCCC-
Confidence 65433211 11122234678999999998889999999999999999996 88887643211 111 11111110
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
...+......+.+++..||+.+|++||++.+|.+.|+..
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011112235677899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=311.68 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=192.8
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||+|+||.||+++.. +|+.||+|.+.... ......+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986422 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
..++.. .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 81 KYHIYN-------------VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred HHHHHh-------------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 988853 22345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... ......|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .......... .. +
T Consensus 145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~----~ 215 (277)
T cd05607 145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-DE----V 215 (277)
T ss_pred cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-cc----c
Confidence 64321 12335689999999999998999999999999999999999999864332111 0011111000 00 0
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
. .. .......+.+++.+||+.||++||++.|+++.+
T Consensus 216 ~--~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 216 K--FE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred c--cc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0 00 011234578899999999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=308.73 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=203.7
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|...+.||+|+||.||+|.. .|+.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45778889999999999999987 589999999975543 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~ 146 (256)
T cd05039 83 AKGSLVDYLRS-------------RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDF 146 (256)
T ss_pred CCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccc
Confidence 99999999853 22346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++...... .....+..|+|||.+.+..++.++||||||+++||+++ |..|+...... .+.... ...
T Consensus 147 g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~----~~~ 215 (256)
T cd05039 147 GLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHV----EKG 215 (256)
T ss_pred cccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH----hcC
Confidence 9998763221 12345678999999998899999999999999999997 88877533211 111111 111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. . .........+.+++.+||+.+|.+||++.+++++|+.
T Consensus 216 ~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YR--M-------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CC--C-------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 0 0111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.24 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=193.6
Q ss_pred ccccccCCeeEEEEEecC---CCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLLN---GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+|...+ +..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 45799999875432 23357889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|.+++..... .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 ~L~~~l~~~~~----------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 81 DLKGYLRSCRK----------AELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred cHHHHHHHhhh----------cccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccc
Confidence 99999964221 11234678888899999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhhhccC-------CCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhh
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHG-------LFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
+...............++..|+|||++.+. .++.++||||||+++|||++ |..|+........ ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~--- 222 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT--- 222 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---
Confidence 765433322222334578889999998642 35789999999999999996 9888864332211 1110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
. ........++.+... ....+.+++..|| .+|++|||+++|+..|+
T Consensus 223 ~-~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 V-REQQLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred h-hcccCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 111112222222211 1234667888898 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=291.51 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=207.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
-++|.+.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467899999999999999999875 56789999986542 33456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||.++|+|...|.+ .....++......++.|+|.||.|+|..+ |+||||||+|+|++.++..|
T Consensus 101 lEya~~gel~k~L~~-------------~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-------------GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred EEecCCchHHHHHHh-------------cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 999999999999953 34556888888999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||-+..-. ...-.+.+||..|.+||...+..++..+|+|++|++.||++.|.+||.....++. ...
T Consensus 165 iAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et--Ykr----- 233 (281)
T KOG0580|consen 165 IADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET--YKR----- 233 (281)
T ss_pred ccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--HHH-----
Confidence 99999987543 2233457999999999999999999999999999999999999999985542221 111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
-...++.+|. .......+++..|+..+|.+|.+..|++.+
T Consensus 234 --I~k~~~~~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 234 --IRKVDLKFPS-------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --HHHccccCCc-------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111233332 223567789999999999999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=326.08 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=197.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999875 68899999997432 234456889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~~g~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 81 EYLPGGDMMTLLMK---------------KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred CCCCCcHHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEE
Confidence 99999999999852 345899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCcccc------------------------------------ccccccccccccChhhhccCCCCccccc
Q 040910 320 SDFGIARMFGGDELQS------------------------------------NMNRIVGTYGYMSPEYALHGLFSIKSDV 363 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 363 (496)
+|||++..+....... ......||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987543211000 0112468999999999999999999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC---
Q 040910 364 FSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT--- 440 (496)
Q Consensus 364 ~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs--- 440 (496)
|||||++|||++|..||....... ..... ...... +..+. .......+.+++..|+. +|.+||+
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~~~--~~~~i---~~~~~~--~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNPQE--TYRKI---INWKET--LQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCHHH--HHHHH---HcCCCc--cCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 999999999999999986433211 11111 000000 00010 00112456677788886 9999998
Q ss_pred HHHHHHH
Q 040910 441 MSEVVSM 447 (496)
Q Consensus 441 ~~evl~~ 447 (496)
+.+++++
T Consensus 290 ~~~ll~h 296 (364)
T cd05599 290 VNEIKSH 296 (364)
T ss_pred HHHHhcC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=312.02 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=199.9
Q ss_pred CCCccccccccCCeeEEEEEecC-C---CEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN-G---EEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.|.+.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++++++.++...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 3 36999998754 2334568999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 85 e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl 147 (269)
T cd05065 85 EFMENGALDSFLRQ--------------NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKV 147 (269)
T ss_pred ecCCCCcHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEE
Confidence 99999999999852 2345899999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcccccccccc---ccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIV---GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+|||++................ .+..|+|||.+.+..++.++||||||+++||+++ |..|+...... ......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i- 224 (269)
T cd05065 148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI- 224 (269)
T ss_pred CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH-
Confidence 9999988654322111111111 2457999999999999999999999999999886 88887532211 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... ... ....+.+..+.+++..||+.+|.+||++.+|+..|+..
T Consensus 225 ---~~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ---EQD--YRL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---HcC--CcC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 000 01112234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.56 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=197.1
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChh
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 248 (496)
+.||+|+||.||+|...+++.+|+|.+..... .....|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875432 22347889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 249 FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 249 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 143 (250)
T cd05085 81 SFLRK--------------KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQE 143 (250)
T ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceec
Confidence 98842 2345789999999999999999999988 999999999999999999999999999764
Q ss_pred CCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 329 GGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... .......++..|+|||++.+..++.++||||||+++||+++ |..|+....... ..... .... ..
T Consensus 144 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~----~~~~--~~- 213 (250)
T cd05085 144 DDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQV----EKGY--RM- 213 (250)
T ss_pred ccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHH----HcCC--CC-
Confidence 43221 11122344678999999998899999999999999999998 888876432211 11101 0010 00
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.........+.+++.+||+.+|++||++.++++.|.
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 ------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 011122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=307.75 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999874 6889999998643 234567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 81 ~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 81 AENGDLHKLLKM-------------QRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred CCCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcc
Confidence 999999999863 12356889999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||+++....... ......++..|+|||+..+..++.++|+||||+++|||++|+.|+..... ....... ...
T Consensus 145 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~----~~~ 216 (256)
T cd08529 145 LGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKI----IRG 216 (256)
T ss_pred cccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HcC
Confidence 999987653321 12334678899999999999999999999999999999999999864331 1111110 001
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. + .........+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~-----~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VF-----P----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC-----C----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 0 1111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=319.83 Aligned_cols=248 Identities=19% Similarity=0.287 Sum_probs=194.2
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+++.. +++.||||.++.. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 6889999999753 223345688899999998 799999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~~~---------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 81 GDLMFHMQ---------------RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcc
Confidence 99988874 2346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc---chhhHhhhhhhccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS---LTLLGHAWNLWKDD 401 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~---~~~~~~~~~~~~~~ 401 (496)
++..... ........||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+........
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (329)
T cd05588 143 CKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220 (329)
T ss_pred ccccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC
Confidence 8743211 122234578999999999999999999999999999999999999986432211 11111111111111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT------MSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~evl~~ 447 (496)
.. . .+......+.+++.+||+.||.+||+ +.+++++
T Consensus 221 ~~------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 QI------R----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC------C----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 10 0 01112345778999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.81 Aligned_cols=274 Identities=27% Similarity=0.389 Sum_probs=203.6
Q ss_pred hcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeec-C
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ-G 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 233 (496)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999963 3578999999975432 2345788999999999 789999999988654 4
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCc----------------ccc----------------------------------
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGF----------------DMV---------------------------------- 263 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------~~~---------------------------------- 263 (496)
..++|+||+++|+|.+++......... ...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999999653210000 000
Q ss_pred --cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcccccccccc
Q 040910 264 --TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341 (496)
Q Consensus 264 --~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~ 341 (496)
........++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 00001235889999999999999999999988 9999999999999999999999999998654322212222334
Q ss_pred ccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHH
Q 040910 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMV 420 (496)
Q Consensus 342 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 420 (496)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .... ....... ...+. ...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~----~~~~~~~--~~~~~-------~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR----RLKEGTR--MRAPD-------YTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHH----HHhccCC--CCCCC-------CCC
Confidence 5678999999999999999999999999999997 877775432211 1111 0111110 00011 112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 421 KRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 421 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..+.+++..||+.+|.+||++.+|+++|+..+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=319.48 Aligned_cols=272 Identities=25% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
.+|.+.+.||+|+||.||++... .+..||+|.+.... ....+++.+|+.++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999642 12368999887432 33456899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
..++++||+++|+|.+++........ ............++|..+..++.|++.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999975321110 000001123456899999999999999999999988 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~ 391 (496)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~ 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELF 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHH
Confidence 999999999999987644322222222344678999999999999999999999999999998 77776532211 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
. ........ .........+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 247 ~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 K----LLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H----HHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 11111000 1111223567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=317.04 Aligned_cols=273 Identities=25% Similarity=0.384 Sum_probs=206.3
Q ss_pred hcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 232 (496)
..+|.+.++||+|+||.||+++.. ....+|+|.++... ......+.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357778899999999999999742 24579999987542 23456788999999999 699999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcc-cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFD-MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+..++|+||+++|+|.+++.......... ..........++|..+.+++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997643211000 0001123356999999999999999999999988 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987643322222222344568999999999999999999999999999999 77776532211 11
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
... ....... .........+.+++.+||+.+|++||++.++++.|+....
T Consensus 246 ~~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKL----LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH----HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 1111100 0111223467789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.42 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=199.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||++... +|+.||||.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 68899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 81 e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 81 EYQPGGDLLSLLNR--------------YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred CCCCCCCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEe
Confidence 99999999999853 2246889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc------cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+|||++..+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~--- 217 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--T--- 217 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--H---
Confidence 999999876533221 223357899999999986 4567899999999999999999999986432211 1
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.............. ........+.+++..|++ +|.+||++.+++++
T Consensus 218 ~~~i~~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 218 YNNIMNFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111111110100 011123456778888998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.86 Aligned_cols=270 Identities=25% Similarity=0.373 Sum_probs=203.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCC--EEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGE--EVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 237 (496)
.++|++.+.||+|+||.||+|... ++. .+|+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999864 444 46888776432 23456788999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCccc-ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDM-VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
|+||+++|+|.+++........... .........+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975432111000 000122346899999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~- 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL- 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHH-
Confidence 999999998643211 11112234678999999988889999999999999999998 888875332211 11110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... .. .........+.+++.+||+.+|.+||++.++++.|++++.
T Consensus 237 ---~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 237 ---PQGY-----RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---hcCC-----cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 00 0011123457889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=307.60 Aligned_cols=256 Identities=31% Similarity=0.466 Sum_probs=205.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.+.||+|+||.||+|...+++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998788899999987533 4467899999999999999999999999998999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 83 ~~~~~L~~~i~~-------------~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 83 MSKGSLLDFLKS-------------GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred cCCCCHHHHHhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECc
Confidence 999999999953 22346899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++..+....... ......+..|+|||.+.+..++.++||||||++++|+++ |+.|+..... .........
T Consensus 147 ~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~---- 219 (261)
T cd05034 147 FGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVER---- 219 (261)
T ss_pred cccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc----
Confidence 99998765322111 112234568999999999999999999999999999998 8888753221 111111100
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. ..... .......+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 220 ~--~~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 G--YRMPR-------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C--CCCCC-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 00000 11113567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=307.00 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=198.0
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeee-ecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI-EQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~ 242 (496)
++|.+.+.||+|+||.||++.. .|..||+|.++.. ...+.|.+|+.++++++|+|++++++++. +++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 5888999998643 33567999999999999999999999765 456789999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 83 AKGSLVDYLRS-------------RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred CCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCC
Confidence 99999999853 22345889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ...... ..+
T Consensus 147 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~----~~~ 215 (256)
T cd05082 147 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV----EKG 215 (256)
T ss_pred ccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----hcC
Confidence 9988543221 22344678999999999899999999999999999997 88776532211 111111 000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. .+ .........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 216 ~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 Y-----KM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C-----CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0 00 1111223567789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=308.30 Aligned_cols=240 Identities=22% Similarity=0.369 Sum_probs=188.2
Q ss_pred ccccccCCeeEEEEEecC-------------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 170 NKLGEGGFGPVYKGKLLN-------------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
+.||+|+||.||+|++.+ ...||+|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997532 2258999887655555568899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|+.++.. ....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--------------KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGI 143 (262)
T ss_pred EEEecccCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCc
Confidence 99999999999988742 2345899999999999999999999988 999999999999987664
Q ss_pred -------eEEeccccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040910 317 -------PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDS 387 (496)
Q Consensus 317 -------~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~ 387 (496)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||++ |..|+.......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred cCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 899999998754321 2345788999999887 4678999999999999999984 666654322111
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.. .... .. .... ......+.+++.+||+.||.+||++.+|++.|+
T Consensus 218 ~~------~~~~-~~-~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 KE------RFYE-GQ-CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HH------HHHh-cC-ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 0000 00 0010 111346788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=319.46 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=193.4
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +++.||||.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5789999998753 233456678899988876 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 81 GDLMFQIQR---------------SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred CcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccc
Confidence 999888842 345889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. ..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i---~~-~~-- 212 (321)
T cd05591 143 CKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESI---LH-DD-- 212 (321)
T ss_pred ceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHH---Hc-CC--
Confidence 87543221 1223457899999999999999999999999999999999999998743321 111111 00 00
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-------TMSEVVSM 447 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~evl~~ 447 (496)
...|. .....+.+++..||+.||++|| ++.+++++
T Consensus 213 -~~~p~-------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -VLYPV-------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCC-------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11111 1124677899999999999999 77888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=306.76 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=200.3
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.+|.+.++||+|++|.||++...++..+|+|.+.... ...+.|.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999988777789999886433 34567899999999999999999999875 456889999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. .....++|..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 84 ~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 84 KGSLLDFLKE-------------GDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CCCHHHHHhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCc
Confidence 9999999953 12345889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .....+. ...
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~- 219 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV----ERG- 219 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcC-
Confidence 99866433211 1122345778999999998999999999999999999999 7777753221 1111111 000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
... .........+.+++.+||+.+|++||++++|++.|++
T Consensus 220 -~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YRM-------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCC-------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1111234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=319.69 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=192.4
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHH---HHhcCCceeeeeeeeeecCeeEEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILI---AKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
|.+.+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68899999997432 23345667776665 456799999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 ~E~~~~~~L~~~~~----------------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 81 MEYAAGGDLMMHIH----------------TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EcCCCCCcHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEE
Confidence 99999999987773 235899999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++..... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .....
T Consensus 142 L~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~~~i---- 213 (324)
T cd05589 142 IADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VFDSI---- 213 (324)
T ss_pred eCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH----
Confidence 9999998753221 122334678999999999999999999999999999999999999986432211 11100
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.... . . .+......+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~~~~---~---~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 214 VNDE---V---R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HhCC---C---C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0000 0 0 0111235567899999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=305.13 Aligned_cols=248 Identities=29% Similarity=0.422 Sum_probs=197.8
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChh
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 248 (496)
++||+|+||.||++...+++.||+|.+...... ....|.+|+.++++++||||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998754333 4568999999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 249 FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 249 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
+++.. ....+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~l~~--------------~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 81 TFLRK--------------KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 99852 2235789999999999999999999988 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 329 GGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..............+..|+|||.+.+..++.++|+||||++++||++ |..|+....... ..... ... ....
T Consensus 144 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~----~~~--~~~~ 215 (251)
T cd05041 144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERI----ESG--YRMP 215 (251)
T ss_pred cCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHH----hcC--CCCC
Confidence 43222222122334677999999998899999999999999999999 676665332211 11110 000 0011
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 216 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11122356888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=323.91 Aligned_cols=202 Identities=25% Similarity=0.332 Sum_probs=174.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999764 58899999997532 233457888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 81 EFLPGGDMMTLLM---------------KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred cCCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEE
Confidence 9999999999984 2346899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccc---------------------------------cccccccccccccChhhhccCCCCccccchhh
Q 040910 320 SDFGIARMFGGDELQ---------------------------------SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSF 366 (496)
Q Consensus 320 ~DFgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 366 (496)
+|||+++.+...... ......+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999999765321100 00123579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCC
Q 040910 367 GVLLLETLSSKKNTRFY 383 (496)
Q Consensus 367 Gvvl~elltg~~~~~~~ 383 (496)
||++|||++|+.||...
T Consensus 223 Gvil~ell~G~~Pf~~~ 239 (363)
T cd05628 223 GVIMYEMLIGYPPFCSE 239 (363)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.63 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=199.5
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|.+.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568889999999999999999875 5889999998642 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 121 v~Ey~~gg~L~~~l~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----------------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred EEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCE
Confidence 9999999999998842 23677888899999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccC----CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...
T Consensus 182 kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~- 257 (370)
T cd05596 182 KLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TYS- 257 (370)
T ss_pred EEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--HHH-
Confidence 9999999987643221 112345799999999998753 47899999999999999999999987433211 111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAAD--RPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 447 (496)
........... + ........+.+++..|++.+|.+ ||++.+++++
T Consensus 258 --~i~~~~~~~~~--~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 --KIMDHKNSLTF--P-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --HHHcCCCcCCC--C-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11110000000 1 11112356778899999999987 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.49 Aligned_cols=240 Identities=28% Similarity=0.362 Sum_probs=190.2
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +|+.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 58899999997532 23445677788888765 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~i~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 81 GDLMFHIQD---------------KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCC
Confidence 999988842 345888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++..... ........||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~----~~~--- 211 (316)
T cd05620 143 CKENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESI----RVD--- 211 (316)
T ss_pred CeecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH----HhC---
Confidence 8743211 12233467899999999999999999999999999999999999998643221 111111 000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS-EVV 445 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 445 (496)
.+.... .....+.+++.+||+.||++||++. +++
T Consensus 212 ---~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ---TPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011111 1234567899999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=325.22 Aligned_cols=253 Identities=22% Similarity=0.263 Sum_probs=195.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999764 6889999998643 2233567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 81 EFLPGGDLMTMLIK---------------YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEE
Confidence 99999999999842 345788899999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccc------------c---------------------------------ccccccccccccChhhhcc
Q 040910 320 SDFGIARMFGGDELQ------------S---------------------------------NMNRIVGTYGYMSPEYALH 354 (496)
Q Consensus 320 ~DFgla~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~ 354 (496)
+|||+++.+...... . ......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 0 0012468999999999999
Q ss_pred CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccC
Q 040910 355 GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQEN 434 (496)
Q Consensus 355 ~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~ 434 (496)
..++.++|||||||++|||++|..||....... ..... ......... |. .......+.+++.+|++ +
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i---~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHE--TYRKI---INWRETLYF--PD-----DIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCCCCHHH--HHHHH---HccCCccCC--CC-----CCCCCHHHHHHHHHHhc-C
Confidence 999999999999999999999999986433211 11111 000000001 10 00122456778888987 6
Q ss_pred CCCC---CCHHHHHHH
Q 040910 435 AADR---PTMSEVVSM 447 (496)
Q Consensus 435 p~~R---Ps~~evl~~ 447 (496)
|.+| |++.+++++
T Consensus 290 ~~~r~~r~~~~~~l~h 305 (377)
T cd05629 290 AENRLGRGGAHEIKSH 305 (377)
T ss_pred HhhcCCCCCHHHHhcC
Confidence 6665 599998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.74 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=197.8
Q ss_pred ccccccCCeeEEEEEecC-CC--EEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN-GE--EVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|...+ +. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998753 43 57889887432 33456789999999999 899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcc-cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 245 KSLDFFLFDYKYSSGFD-MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
|+|.+++.......... ..........+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997543211100 0011123346899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||...... ...... ....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~----~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL----PQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHH----hCCC
Confidence 98632211 11112234667999999998899999999999999999997 88887532211 111111 0000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
. ..........+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 229 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0011112346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.89 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=207.9
Q ss_pred CccccccccCCeeEEEEEe-cCC----CEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 167 SEENKLGEGGFGPVYKGKL-LNG----EEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...++||+|+||+||+|.+ +.| -+||+|.+.... .+...++.+|+.+|.+++||||++|+|+|..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999976 333 479999987553 445689999999999999999999999999887 889999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
||+.|+|.+|++. .+..+.-+..+.|..|||+||.|||++. ++||||.++||||..-.++||.
T Consensus 778 ~mP~G~LlDyvr~--------------hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--------------HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred hcccchHHHHHHH--------------hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEE
Confidence 9999999999975 4556888899999999999999999887 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++....+..........-.+.|||-|.+....|+.++|||||||.+||++| |.+|......++. -.+++
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------~dlle 914 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------PDLLE 914 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------hHHHh
Confidence 9999999877655544444455789999999999999999999999999999987 6677654332221 11111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
.++ ++- .++.....+..++.+||..|+..||+++++...+.+...+
T Consensus 915 ~ge--RLs-------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGE--RLS-------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccc--cCC-------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 111 232 3334456788899999999999999999999988875444
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=318.91 Aligned_cols=236 Identities=26% Similarity=0.359 Sum_probs=189.5
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +++.||||.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999998743 234456778888888877 799999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~i~~---------------~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 81 GDLMFHIQK---------------SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred chHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 999988842 345889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .....
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~----i~~~~-- 212 (320)
T cd05590 143 CKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEA----ILNDE-- 212 (320)
T ss_pred CeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHH----HhcCC--
Confidence 87542211 12334578999999999999999999999999999999999999986433211 1111 11111
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
...+ ......+.+++.+||+.||.+||++
T Consensus 213 -~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VVYP-------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCC-------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111 1123467789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=305.98 Aligned_cols=248 Identities=32% Similarity=0.434 Sum_probs=195.1
Q ss_pred ccccccCCeeEEEEEecC----CCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 24567899999999999999999999875 4568999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 80 ~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 80 GPLLKYLKK---------------RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred CcHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccc
Confidence 999999952 236889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 325 ARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 325 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++........ .......++..|+|||.+.+..++.++||||||+++||+++ |..|+..... ........ ...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~----~~~ 215 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE----SGE 215 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH----cCC
Confidence 9876433211 11122234568999999999999999999999999999998 8888754322 11111111 111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... ........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 216 --~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 --RLP-------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --cCC-------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 000 1111235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.34 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----eeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----EKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv 238 (496)
.|...+.+|.|+||.||+|.+. +++.||||+.-....- --+|+++|++++|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999875 4689999998644321 145899999999999999999887543 34589
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-Cce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~ 317 (496)
+|||| .+|..++..+. ..+..++.-.+.-++.||.+||+|||+.+ |+||||||.|+|+|.+ |.+
T Consensus 101 leymP-~tL~~~~r~~~-----------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYT-----------RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred HHhch-HHHHHHHHHHh-----------hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeE
Confidence 99996 57888886532 23455777788889999999999999988 9999999999999976 899
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~~ 395 (496)
||||||.|+.+...+.. .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|+...... ....-.+.
T Consensus 166 KicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred EeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 99999999987654322 234568899999999874 69999999999999999999999888643321 11111110
Q ss_pred hhhccccc-------ccccCcccccc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRA-------WKLLDPTLQNE-----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~-------~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.....++. .+.-.|.+... .......+.++++.++++.+|.+|.++.|++.+
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00000000 01111111111 122334578899999999999999999998854
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.46 Aligned_cols=256 Identities=34% Similarity=0.479 Sum_probs=203.2
Q ss_pred ccccccCCeeEEEEEecC----CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|.... +..||||.+...... ..+.+.+|++.+..++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 789999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|.+++....... .......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.
T Consensus 81 ~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 81 GDLLDYLRKSRPVF------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred CcHHHHHhhccccc------cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 99999996421100 0012467999999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+................++..|+|||.+.+..++.++||||||++++||++ |..|+..... ...... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----~~~~~- 224 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEY----LRKGY- 224 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCC-
Confidence 987754432222344567889999999998899999999999999999999 5877764421 111111 11110
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
... ........+.+++.+||+.+|.+|||+.++++.|+
T Consensus 225 -~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -RLP-------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCC-------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 11122457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.04 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=192.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcC-CceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHH-RNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 239 (496)
+|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+..|+.++..++| ++|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999875 5789999998743 23445678889999999976 46888999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~~g~L~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 81 EYVNGGDLMYHIQQ---------------VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred cCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEE
Confidence 99999999988842 345889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---- 214 (324)
T cd05587 143 ADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIM---- 214 (324)
T ss_pred eecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH----
Confidence 9999987532211 1233457899999999999999999999999999999999999998643221 1111110
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
... .. .+......+.+++.+||+.+|.+||+.
T Consensus 215 ~~~------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 EHN------VS----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred cCC------CC----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 00 011123467789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.47 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=195.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 239 (496)
+|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 57899999987532 23345567788888877 6899999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~~g~L~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 81 EYVNGGDLMYQIQQ---------------VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred cCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEE
Confidence 99999999988842 345889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 143 ~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i----~ 214 (323)
T cd05616 143 ADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSI----M 214 (323)
T ss_pred ccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHH----H
Confidence 9999997543221 1223457899999999999999999999999999999999999998643321 111111 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM-----SEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 446 (496)
... . ..+......+.+++.+|++.+|.+|++. .++.+
T Consensus 215 ~~~---~-------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 215 EHN---V-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred hCC---C-------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 010 0 0111223567889999999999999984 56553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.02 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=203.2
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999975 46889999999866555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 99 ~~~~~L~~~~~~----------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~d 159 (296)
T cd06654 99 LAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 159 (296)
T ss_pred cCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECc
Confidence 999999998842 24788999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......... . .... .
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~----~~~~-~ 231 (296)
T cd06654 160 FGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-Y----LIAT-N 231 (296)
T ss_pred cccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-H----HHhc-C
Confidence 99988654322 1122346888999999999988999999999999999999999998643321110 0 0000 0
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....+. ........+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQ-------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCC-------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000000 111223557789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.09 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=195.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999864 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~~g~L~~~i~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 81 DYIPGGDMMSLLIR---------------LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred eCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence 99999999999842 345788888999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCcc-----------------------------------------ccccccccccccccChhhhccCCCC
Q 040910 320 SDFGIARMFGGDEL-----------------------------------------QSNMNRIVGTYGYMSPEYALHGLFS 358 (496)
Q Consensus 320 ~DFgla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 358 (496)
+|||++..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999853321000 0001134699999999999999999
Q ss_pred ccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCC
Q 040910 359 IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR 438 (496)
Q Consensus 359 ~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 438 (496)
.++|||||||++|||++|+.||.......... .. ..+. ..... +. .......+.+++.+|+ .+|.+|
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~i-~~~~--~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQL--KV-INWE--TTLHI--PS-----QAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHHH--HH-hccC--ccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999999999999987543221110 00 0010 00000 00 0111234556666665 499999
Q ss_pred C---CHHHHHHH
Q 040910 439 P---TMSEVVSM 447 (496)
Q Consensus 439 P---s~~evl~~ 447 (496)
| ++.+++++
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 88888866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.92 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=201.7
Q ss_pred cCCCccccccccCCeeEEEEEec-C---CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-N---GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.+|.+.+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++.+++||||+++.+++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999763 2 3379999986432 23356889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++
T Consensus 84 ~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 84 TEYMENGSLDAFLRK--------------HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred EEcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEE
Confidence 999999999999852 2245899999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCcccc-ccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGGDELQS-NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++||+++ |..|+....... .....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~-- 222 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI-- 222 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH--
Confidence 99999998765332111 1112233568999999999899999999999999999886 888875432211 11111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... ... + .....+..+.+++.+||+.+|.+||+|.++++.|+.+
T Consensus 223 --~~~--~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 --EEG--YRL--P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --hCC--CcC--C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 100 000 0 0111235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=327.50 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=171.7
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
+|...++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999864 67899999987532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 82 YIPGGDMMSLLIR---------------MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred CCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999998842 245788889999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCcc---------------------------------------------ccccccccccccccChhhhccC
Q 040910 321 DFGIARMFGGDEL---------------------------------------------QSNMNRIVGTYGYMSPEYALHG 355 (496)
Q Consensus 321 DFgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 355 (496)
|||++..+..... ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999864321000 0001234689999999999999
Q ss_pred CCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 356 LFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 356 ~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
.++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.29 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=197.3
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|...+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999976 46889999998654 233346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|
T Consensus 81 ~~~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 81 MDGGSLDVYR-------------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred CCCCChHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEee
Confidence 9999996543 3678888999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh-hHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL-LGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~-~~~~~~~~~~ 400 (496)
||++...... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ..........
T Consensus 139 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 139 FGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred CCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 9999865432 1233578999999999999999999999999999999999999986433221110 0000000000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .+.+. .......+.+++.+||+.+|++||++++++++
T Consensus 215 ~~-----~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 ED-----PPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cC-----CCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 11110 11123467889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.17 Aligned_cols=238 Identities=24% Similarity=0.280 Sum_probs=190.8
Q ss_pred ccccccCCeeEEEEEe----cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 170 NKLGEGGFGPVYKGKL----LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|++++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 82 GGDLFTRLSK---------------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred CCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeecc
Confidence 9999988842 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .. ...
T Consensus 144 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i---~~-~~~ 215 (318)
T cd05582 144 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMI---LK-AKL 215 (318)
T ss_pred CCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHH---Hc-CCC
Confidence 998654321 122345789999999999998999999999999999999999999864321 1111111 00 000
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 443 (496)
..+......+.+++.+||+.||++||++.+
T Consensus 216 ----------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112345678899999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.18 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=201.6
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.+|+..+.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677788999999999999988778899999986432 345689999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 83 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 83 HGCLSDYLRA--------------QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred CCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCc
Confidence 9999999852 2345889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++......... ......++.+|+|||.+.+..++.++||||||+++|||++ |..|+...... ...... . .
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~----~--~ 216 (256)
T cd05112 146 MTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETI----N--A 216 (256)
T ss_pred ceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHH----h--C
Confidence 99865433211 1122335678999999998899999999999999999998 88877532211 111110 0 0
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
......+.. ....+.+++.+||+.+|++||++.++++.|
T Consensus 217 ~~~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 GFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111122222 135688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=309.79 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=198.5
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec------
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ------ 232 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 232 (496)
.++..|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999874 57899999986543 4456788999999999 799999999998753
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
...++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ |+|+||||+||+++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~-------------~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~ 145 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN-------------TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT 145 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEEC
Confidence 468999999999999999853 22346889999999999999999999988 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
+++.++|+|||++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+.......
T Consensus 146 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~ 223 (272)
T cd06637 146 ENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223 (272)
T ss_pred CCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99999999999998654221 2233457899999999986 3468889999999999999999999885322111
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. ...... .. .+... .......+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~-----~~~~~~-~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 A-----LFLIPR-NP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-----HHHHhc-CC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000000 00 01111 1112346788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.39 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=166.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
...|.+.+.||+|+||.||++... .++.||||... ...+.+|+.++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346889999999999999999875 47889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+ .++|..++.. ....++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 242 ~-~~~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 242 Y-RSDLYTYLGA--------------RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred c-CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence 9 5788888742 2236999999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCC
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
||+++...............||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99998764332222223457999999999999999999999999999999999988654
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=304.48 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=189.4
Q ss_pred ccccccCCeeEEEEEecC---CCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLLN---GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+..++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 34788888764332 23457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|.+++..... ......++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~L~~~l~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 81 DLKNYLRSNRG----------MVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred cHHHHHHhccc----------cccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccc
Confidence 99999964321 11234568888999999999999999988 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhhhcc-------CCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhh
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
+...............++..|+|||++.. ..++.++|||||||++|||++ |..|+..... .......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~--- 222 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQV--- 222 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHH---
Confidence 75433222222233456778999998743 457889999999999999999 6666653221 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.. .....+..+.... .....+.+++..|| .||++|||+++|++.|.
T Consensus 223 ~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 223 VR-EQDIKLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred hh-ccCccCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1111222222221 22345566777888 49999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.21 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=199.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-----cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-----QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|...+.||+|++|.||++... +++.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999764 689999999864321 224578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 82 v~e~~~~~~l~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---------------YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143 (263)
T ss_pred EEEECCCCcHHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 9999999999998852 245788899999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccc-cccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSN-MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .... ..
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~---~~ 218 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAI---FK 218 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHH---HH
Confidence 9999999986543211111 1234678899999999999999999999999999999999998753221 1111 00
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....... +. ........+.+++..||+.+|.+|||+.+++++
T Consensus 219 ~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPTN-----PQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCCC-----CC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000000 11 111223457789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.49 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=203.3
Q ss_pred hcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|+..+.||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++||||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578889999999999999998864 78999999875432 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 80 CGAGSVSDIMKI--------------TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred CCCCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcc
Confidence 999999999852 2356899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ....
T Consensus 143 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~ 214 (256)
T cd06612 143 FGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNK 214 (256)
T ss_pred cccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccC
Confidence 999987653321 12334578899999999999999999999999999999999999864332111000 0000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. .+.. .........+.+++.+||+.+|++|||+.+|++
T Consensus 215 ~-----~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 215 P-----PPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C-----CCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 0000 011122356788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.03 Aligned_cols=249 Identities=31% Similarity=0.416 Sum_probs=198.0
Q ss_pred ccccccCCeeEEEEEecC--CC--EEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN--GE--EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~--~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|++|.||+|.+.+ ++ .||||.+..... ...+.|.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999998743 33 699999986654 556789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|.+++... ....++|..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 80 ~~L~~~l~~~-------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 80 GSLLDRLRKD-------------ALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred CcHHHHHHhc-------------ccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccc
Confidence 9999998531 1146899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCc-cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 325 ARMFGGDE-LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 325 a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++.+.... .........++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ....... ...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~---~~~- 217 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKID---KEG- 217 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---hcC-
Confidence 98765422 1112223457789999999999999999999999999999998 99887532211 1111110 000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
..... ....+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 218 -~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 -ERLER-------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CcCCC-------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00100 1122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.30 Aligned_cols=255 Identities=31% Similarity=0.475 Sum_probs=198.7
Q ss_pred ccccccCCeeEEEEEecC-------CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLN-------GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+.||+|+||.||+|+..+ ++.+|||.+.... ......|.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2579999886543 23466899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-----c
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-----N 316 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-----~ 316 (496)
+++++|.+++...... ......++|..+..++.|++.||+|||+.+ ++|+||||+||+++.+. .
T Consensus 81 ~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 81 MEGGDLLSYLRDARVE--------RFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred cCCCcHHHHHHHhhhc--------ccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcc
Confidence 9999999999642211 012345889999999999999999999987 99999999999999887 8
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... .......
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~- 226 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV- 226 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH-
Confidence 99999999986644332222233455788999999999999999999999999999998 8888753221 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.... .. .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 227 ---~~~~--~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ---TAGG--RL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---hcCC--cc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000 00 1111224567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.18 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=191.7
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 239 (496)
+|...+.||+|+||.||++... +|+.||||.+... .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4667789999999999999864 6889999998743 2234566788999988885 577888999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 Ey~~~g~L~~~i~---------------~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 81 EYVNGGDLMYHIQ---------------QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred cCCCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEE
Confidence 9999999998884 2345899999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 143 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---- 214 (323)
T cd05615 143 ADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIM---- 214 (323)
T ss_pred eccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH----
Confidence 9999998543221 1123356899999999999999999999999999999999999998643321 1111110
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
... . ..+......+.+++.+||+.+|.+|++.
T Consensus 215 ~~~---~-------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 215 EHN---V-------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred hCC---C-------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 000 0 0111123467789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.82 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=197.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999875 5789999998642 22334568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 121 v~Ey~~gg~L~~~l~~----------------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----------------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred EEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCE
Confidence 9999999999998842 23778889999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccC----CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--~--- 255 (370)
T cd05621 182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--T--- 255 (370)
T ss_pred EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--H---
Confidence 9999999987643221 122346799999999999754 37899999999999999999999986433211 1
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAA--DRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~evl~~ 447 (496)
............. .........+.+++..|++.++. .||++.+++++
T Consensus 256 ~~~i~~~~~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 YSKIMDHKNSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHhCCcccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111110000000 01112234566778888875554 38899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.75 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=201.7
Q ss_pred cCCCccccccccCCeeEEEEEecC-CC----EEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-GE----EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.+|...+.||+|+||.||+|...+ |+ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999998643 33 589998865432 345678999999999999999999999987 78899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+
T Consensus 86 v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--------------HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred EEecCCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeE
Confidence 9999999999999853 2335899999999999999999999987 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++...............++..|+|||.+.+..++.++|+||||+++||+++ |+.|+...... ......
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~-- 224 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLL-- 224 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHH--
Confidence 9999999987653321111112234668999999988899999999999999999998 99887643221 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... ....+ ......+.+++.+||..+|.+||++.++++.|++...
T Consensus 225 --~~~~--~~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 225 --EKGE--RLPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --hCCC--CCCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1010 01111 1122457788999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.32 Aligned_cols=262 Identities=19% Similarity=0.264 Sum_probs=192.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-------- 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 232 (496)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999874 68899999985432 2345799999999999999999886432
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
...++||||++ ++|..++..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~-----------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~ 204 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYA-----------RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLID 204 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEc
Confidence 14678999997 56777664321 23456899999999999999999999998 99999999999999
Q ss_pred CCC-ceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 313 GDM-NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 313 ~~~-~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
.++ .+||+|||+|+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .
T Consensus 205 ~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~ 279 (440)
T PTZ00036 205 PNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--Q 279 (440)
T ss_pred CCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--H
Confidence 665 69999999998764322 12235679999999998764 68999999999999999999999986533211 1
Q ss_pred hHhhhhhhccc----------ccccccCccc-----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 391 LGHAWNLWKDD----------RAWKLLDPTL-----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 391 ~~~~~~~~~~~----------~~~~~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........... ....+.-+.. ....+......+.+++.+||+.||.+|||+.|++++
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 11110000000 0000000110 000111123568899999999999999999999854
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.49 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=202.5
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
..+|.+.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999988778889999886432 345688999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 83 AKGSLLDFLKS-------------DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred CCCcHHHHHHh-------------CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCC
Confidence 99999999853 22345889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++..+...... ......++..|+|||.+.+..++.++|+||||++++++++ |..|+..... ....... ...
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~----~~~ 219 (260)
T cd05073 147 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL----ERG 219 (260)
T ss_pred cceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hCC
Confidence 999866432211 1122345678999999998899999999999999999999 7877753221 1111111 111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. . .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 220 ~~--~-------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YR--M-------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC--C-------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 0 0111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.41 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=193.6
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 57899999997532 23445688899999888 699999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~~~---------------~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 81 GDLMFHMQ---------------RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccc
Confidence 99988874 2345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhhhhhhccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHAWNLWKDDRA 403 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 403 (496)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (327)
T cd05617 143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220 (327)
T ss_pred ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC
Confidence 87532211 12234578999999999999999999999999999999999999986433221 1111111111111100
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM------SEVVSM 447 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~~ 447 (496)
. .+......+.+++.+||+.||.+||++ .+++++
T Consensus 221 ------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 ------R----IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ------C----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 0 011123456789999999999999984 466543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=339.52 Aligned_cols=270 Identities=22% Similarity=0.276 Sum_probs=206.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.++||+|+||.||+|... +|+.||||++..... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999864 589999999975322 23457999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++......... .......+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l----~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESL----SKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EcCCCCCHHHHHHHhhhcccc----chhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEE
Confidence 999999999998643221100 1112345678889999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCcc----------------ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 320 SDFGIARMFGGDEL----------------QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 320 ~DFgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999986621110 00112346999999999999999999999999999999999999998642
Q ss_pred CCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcccc
Q 040910 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEVVSMIKNEIV 453 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~ 453 (496)
........ ....++.... .....+..+.+++.+|++.||++|| +++++++.|+..+.
T Consensus 235 ~~~ki~~~------------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 235 KGRKISYR------------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred chhhhhhh------------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 22111000 0011111000 0112234577899999999999996 77888888877544
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.96 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=199.5
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 45666766789999999999999864 57789999987666566678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCc
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL--DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMN 316 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~ 316 (496)
||+++++|..++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.
T Consensus 85 e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 85 EQVPGGSLSALLRSK--------------WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred ecCCCCCHHHHHHHh--------------cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCe
Confidence 999999999998631 1223 78888999999999999999988 999999999999976 679
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCC--CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
++|+|||++....... .......++..|+|||++.+.. ++.++||||||+++|+|++|+.|+........... .
T Consensus 148 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--~ 223 (268)
T cd06624 148 VKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--K 223 (268)
T ss_pred EEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--h
Confidence 9999999997654322 1122345788999999987643 78999999999999999999998754322111100 0
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. . ... ..+. ........+.+++.+||+.+|.+|||+.+++++
T Consensus 224 ~-----~-~~~-~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 V-----G-MFK-IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred h-----h-hhc-cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 0 000 0011 111223567788999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=323.13 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=196.7
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----eeE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----EKI 236 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 236 (496)
+|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998643 2234467889999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 lv~e~~~-~~l~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~ 141 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---------------SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCV 141 (372)
T ss_pred EEeeccc-cCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCC
Confidence 9999996 67777763 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ......
T Consensus 142 ~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~ 218 (372)
T cd07853 142 LKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLIT 218 (372)
T ss_pred EEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHH
Confidence 9999999998654322 1223334678999999999874 57999999999999999999999986543211 000000
Q ss_pred hhhccccc----------cc-c----cCc-ccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRA----------WK-L----LDP-TLQ--NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~----------~~-~----~d~-~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ .. + ..+ ... ..........+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00 0 000 000 00011123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.41 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=198.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|...+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346777889999999999999763 444 578998865432 2234788999999999999999999998754 467
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.
T Consensus 85 ~v~e~~~~g~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--------------HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNH 147 (303)
T ss_pred eeehhcCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCc
Confidence 99999999999999852 2335889999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... .....
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~--- 222 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD--- 222 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---
Confidence 99999999987653322222223445778999999999999999999999999999997 8887753221 11111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
...... ....+ ......+.+++..||..+|++||++.++++.|+.+
T Consensus 223 -~~~~~~--~~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 223 -LLEKGE--RLPQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -HHHCCC--CCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 01111 11234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.25 Aligned_cols=240 Identities=21% Similarity=0.272 Sum_probs=187.6
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHH-HHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMI-LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+++.. +|+.||||.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 68999999986432 223345555655 46678999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 81 GELFFHLQ---------------RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCC
Confidence 99988874 2346889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++..... ........||..|+|||++.+..++.++|||||||++|||++|..||....... .... . .....
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~---~-~~~~~- 213 (325)
T cd05604 143 CKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDN---I-LHKPL- 213 (325)
T ss_pred cccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HHHH---H-HcCCc-
Confidence 8753221 122334578999999999999999999999999999999999999986432211 1111 0 10100
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.+. . .....+.+++.+|++.+|.+||++.+.+
T Consensus 214 -~~~----~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 -VLR----P----GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -cCC----C----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 011 1 1234567889999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.39 Aligned_cols=239 Identities=22% Similarity=0.342 Sum_probs=186.3
Q ss_pred cccccCCeeEEEEEecC-------------------------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeee
Q 040910 171 KLGEGGFGPVYKGKLLN-------------------------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 225 (496)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999875544445678899999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040910 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305 (496)
Q Consensus 226 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 305 (496)
++++.+....++||||+++|+|+.++.. ....+++..+..++.||++||+|||+.+ |+|||||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlk 144 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--------------EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVC 144 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCC
Confidence 9999999999999999999999998852 2346889999999999999999999987 9999999
Q ss_pred CCCEEecCCC-------ceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHH-hC
Q 040910 306 ASNVLLDGDM-------NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETL-SS 376 (496)
Q Consensus 306 ~~NIll~~~~-------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~ell-tg 376 (496)
|+|||++.++ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997654 3799999998654221 12356788999998875 56899999999999999985 68
Q ss_pred CCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 377 KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
..|+........ ... ... ..... . .....+.+++..||+.+|++||++.+|++.|+
T Consensus 219 ~~p~~~~~~~~~--~~~----~~~--~~~~~-----~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 219 EVPLKERTPSEK--ERF----YEK--KHRLP-----E----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CCCccccChHHH--HHH----HHh--ccCCC-----C----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 877754322111 100 000 00000 0 11235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=303.07 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=189.8
Q ss_pred ccccccCCeeEEEEEecCCC---EEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 170 NKLGEGGFGPVYKGKLLNGE---EVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999764433 46677765433 234568999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|..++.... .....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 81 DLKSYLSQEQ-----------WHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cHHHHHHhhh-----------cccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccc
Confidence 9999996421 12234677788899999999999999987 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhhhcc-------CCCCccccchhhhHHHHHHHhC-CCCCCCCCCCcchhhHhhhhh
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLETLSS-KKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~elltg-~~~~~~~~~~~~~~~~~~~~~ 397 (496)
................++..|+|||++.. ..++.++||||||+++|||+++ ..|+.... ........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~--- 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHV--- 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---
Confidence 64322222222234567889999998753 3457899999999999999975 44543221 11111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
+ .+....+.++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 222 ~-~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 I-KDQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred H-hhcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 122223344444322 2345667888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.55 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=199.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|++.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999864 57889999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+++++|.+++.. ...+++..+..++.||+.||.|||+. + ++|+||||+|||++.++.+||+
T Consensus 81 ~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~ 142 (308)
T cd06615 81 MDGGSLDQVLKK---------------AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLC 142 (308)
T ss_pred cCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEc
Confidence 999999999852 24588999999999999999999974 5 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..........
T Consensus 143 dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~ 216 (308)
T cd06615 143 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSE 216 (308)
T ss_pred cCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH--HHhhcCcccc
Confidence 99998755322 12335788999999999888899999999999999999999999864332111 0000000000
Q ss_pred cc--------------------ccccc-------CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DR--------------------AWKLL-------DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~--------------------~~~~~-------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..+.. .+.+.. ......+.+++.+||+.+|++||++.+|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 000000 0123457899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.60 Aligned_cols=251 Identities=31% Similarity=0.451 Sum_probs=191.8
Q ss_pred ccccccCCeeEEEEEecC----CCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeee-cCeeEEEEEecC
Q 040910 170 NKLGEGGFGPVYKGKLLN----GEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-QGEKILIYEYMP 243 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 243 (496)
+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998632 357999998543 23345688899999999999999999998764 456889999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg 143 (262)
T cd05058 81 HGDLRNFIRS--------------ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFG 143 (262)
T ss_pred CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcc
Confidence 9999999853 1234677888999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhhHhhhhhhcc
Q 040910 324 IARMFGGDELQ--SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 324 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
+++........ .......++..|+|||.+.+..++.++||||||+++|||++|+. |+... ......... ...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~---~~~ 218 (262)
T cd05058 144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYL---LQG 218 (262)
T ss_pred ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHH---hcC
Confidence 99865432211 11123355778999999998899999999999999999999654 44321 111111111 110
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.. ...+ ...+..+.+++..||+.+|++||++.+|++.|+++.
T Consensus 219 ~~---~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RR---LLQP-------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC---CCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 0001 111346788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.54 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=192.8
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHh---cCCceeeeeeeeeec-----C
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKL---HHRNLVRLFGCCIEQ-----G 233 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 233 (496)
+|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999775 688999999875322 2234566777777766 699999999988643 4
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++|+||++ ++|..++.. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~ 143 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK-------------VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 143 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 5799999997 588888742 22345899999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
++.+||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|++||....... ....
T Consensus 144 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~ 218 (288)
T cd07863 144 GGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK 218 (288)
T ss_pred CCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHH
Confidence 9999999999998664321 2233567899999999999999999999999999999999999886432211 1111
Q ss_pred hhhhhcc---ccc-------ccccCccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKD---DRA-------WKLLDPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~---~~~-------~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....... ... .....+.. ...........+.+++.+|++.||++|||+.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1000000 000 00000000 001111223567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.89 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 57889999987443 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 86 LDK-DLKQYMDD--------------CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred CCC-CHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence 974 78777742 2345788999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-hhhH-------
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLG------- 392 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~~~~------- 392 (496)
||+++...... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....
T Consensus 148 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 225 (309)
T cd07872 148 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225 (309)
T ss_pred cccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99998653322 11233467899999998865 4689999999999999999999999875433211 0000
Q ss_pred -hhhhhhccccc-ccccCccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 393 -HAWNLWKDDRA-WKLLDPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 393 -~~~~~~~~~~~-~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
..|..+..... ...-.+.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00100000000 0000000000 001112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.94 Aligned_cols=261 Identities=20% Similarity=0.236 Sum_probs=198.4
Q ss_pred hcCCCccccccccCCeeEEEEEec---CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..+|.+.+.||+|+||.||++... .++.||||.+... ..+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988643 23568999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|++. ++|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 166 e~~~-~~l~~~l~---------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 166 PKYK-CDLFTYVD---------------RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred hhcC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEE
Confidence 9995 68878773 2356899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~~~~~ 398 (496)
+|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99999987654433333344679999999999999999999999999999999999999986543321 00000000000
Q ss_pred ccccc--c-----------cccCccccccCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRA--W-----------KLLDPTLQNEAL-------YPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~--~-----------~~~d~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... . ............ ......+.+++.+||+.||.+|||+.+++.+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0 000000000000 0112456788999999999999999999876
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.40 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=198.5
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999875 4778899998765555667899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 87 ~~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 87 GAVDAVMLE--------------LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred CcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccc
Confidence 999888742 2346899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+....... .......++..|+|||++. +..++.++|||||||++|||++|+.|+....... ..... ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~---~~ 222 (282)
T cd06643 150 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKI---AK 222 (282)
T ss_pred cccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHH---hh
Confidence 87653221 1223456889999999984 4567889999999999999999999876432111 11000 00
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
........ .......+.+++.+||+.+|.+||++.+++++-
T Consensus 223 -~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 223 -SEPPTLAQ-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -cCCCCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000111 111235678899999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.54 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=203.7
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346888899999999999999986 4789999999976655556788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+
T Consensus 97 ~~~~~~L~~~~~~----------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~ 157 (297)
T cd06656 97 YLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 157 (297)
T ss_pred ccCCCCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEC
Confidence 9999999998842 34788899999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|..||........... ...
T Consensus 158 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~- 229 (297)
T cd06656 158 DFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IAT- 229 (297)
T ss_pred cCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----ecc-
Confidence 9999986543321 12234678899999999999999999999999999999999999864332111000 000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....... ........+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 NGTPELQ-------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 111223456788999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=309.13 Aligned_cols=204 Identities=25% Similarity=0.392 Sum_probs=163.2
Q ss_pred cccccccCCeeEEEEEec---CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEEEEEecC
Q 040910 169 ENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKILIYEYMP 243 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 243 (496)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 23567889999999999999999998854 456889999985
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe----cCCCceEE
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKI 319 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl 319 (496)
++|..++....... .......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 84 -~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 84 -HDLWHIIKFHRASK------ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred -CCHHHHHHhccccc------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 57877775322111 1112345889999999999999999999998 9999999999999 46678999
Q ss_pred eccccccccCCCcc-ccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 320 SDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 320 ~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
+|||+++.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99999987653321 1223446789999999999874 58999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.26 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=197.2
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.|+..+.||+|+||.||++... +++.||||.+..... .....+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999764 688999999865322 223467889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 81 ~~~g~~L~~~l~~-------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 81 LMNGGDLKFHIYH-------------MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred ecCCCcHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 9999999998853 12235889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .........
T Consensus 145 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~ 219 (285)
T cd05630 145 DLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE 219 (285)
T ss_pred eccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhh
Confidence 999987653221 122347899999999999999999999999999999999999998743221100 000000000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVS 446 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 446 (496)
. ... ........+.+++..||+.||++||| +.|+++
T Consensus 220 ~------~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 V------QEE----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h------hhh----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 000 11112345678899999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=304.08 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=200.2
Q ss_pred CCCccccccccCCeeEEEEEecC--CCEEEEEEeccCC----------ccCHHHHHHHHHHHHH-hcCCceeeeeeeeee
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN--GEEVAVKRLSNKS----------GQGVEEFKNEMILIAK-LHHRNLVRLFGCCIE 231 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 231 (496)
+|++.+.||+|+||.||+|.... ++.+|||.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999998754 6789999875321 1234567788888876 699999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIl 310 (496)
.+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil 146 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-----------EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIM 146 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-----------hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEE
Confidence 999999999999999999885321 233468899999999999999999996 45 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~ 221 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SL 221 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HH
Confidence 9999999999999998754332 233457889999999999988999999999999999999999987532211 11
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. .. ..... .+.. .......+.+++.+||+.||++||++.||..++++
T Consensus 222 ~~---~~-~~~~~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 222 AT---KI-VEAVY----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HH---HH-hhccC----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 10 00 00100 0100 01123567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=301.89 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=200.3
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++||||+++.+++...+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999864 6889999998643 2344577889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 81 ~~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 81 DGGDLMQKIKL-------------QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred CCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEccc
Confidence 99999998843 22345788999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++........ ......++..|+|||++.+..++.++|+||||+++|+|++|..||...... ... .... .+.
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~---~~~~-~~~ 216 (255)
T cd08219 145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NLI---LKVC-QGS 216 (255)
T ss_pred Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HHH---HHHh-cCC
Confidence 99986643221 122356888999999999989999999999999999999999998642211 111 1111 111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .+ .......+.+++.+||+.+|++||++.+++..
T Consensus 217 ~~-~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YK-PL--------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-CC--------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 10 00 11123457789999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.47 Aligned_cols=237 Identities=22% Similarity=0.272 Sum_probs=186.5
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHH-HHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMI-LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +|+.||||.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999875 68999999986432 222344555554 45778999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 81 GELFFHLQ---------------RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCC
Confidence 99998884 2345888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 143 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i---~~-~~-- 212 (323)
T cd05575 143 CKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDNI---LN-KP-- 212 (323)
T ss_pred CcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HHHHH---Hc-CC--
Confidence 8753221 122334578999999999999999999999999999999999999986432211 11100 00 00
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS 442 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 442 (496)
..+. ......+.+++.+||+.||.+||++.
T Consensus 213 ----~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 ----LRLK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCCC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0011 11235678899999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=305.32 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=197.1
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++.+++..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999774 68899999986432 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 82 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 82 MNGGDLKFHIYN-------------MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred ccCccHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEec
Confidence 999999988853 12335899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ ...........
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~ 220 (285)
T cd05632 146 LGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLET 220 (285)
T ss_pred CCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcc
Confidence 99997653221 12335789999999999999999999999999999999999999864322111 01111000000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
. .. ........+.+++..||+.+|++||+ +.+++.+
T Consensus 221 ~------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 E------EV----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c------cc----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 00 11112345678999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.36 Aligned_cols=193 Identities=22% Similarity=0.311 Sum_probs=165.2
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
....+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999875 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+ .++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 137 e~~-~~~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl 198 (357)
T PHA03209 137 PHY-SSDLYTYLTK--------------RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCI 198 (357)
T ss_pred Ecc-CCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 999 5688888742 2346899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCC
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
+|||+++..... .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 199 ~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 199 GDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999753221 1223456899999999999999999999999999999999876654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.47 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=200.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357788889999999999999764 6889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 88 ~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 88 CGGGSLQDIYHV---------------TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred cCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence 999999998842 345889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
||++....... .......|+..|+|||++. ...++.++|||||||++|||++|..|+........ ... ..
T Consensus 150 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~----~~ 222 (267)
T cd06645 150 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL----MT 222 (267)
T ss_pred ceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHh----hh
Confidence 99987654221 1223457899999999874 45688999999999999999999988753322111 000 00
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. .. ...+.... .......+.+++.+||+.+|++||++++|+++
T Consensus 223 ~-~~---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 K-SN---FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c-cC---CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 00 00111100 01123457789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=304.43 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=198.9
Q ss_pred CCccccccccCCeeEEEEEec----CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 166 FSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999763 36789999986542 234567899999999999999999999886542
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++++||+++|+|..++..... ......+++.....++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~---------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~ 148 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRI---------GEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNE 148 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcc---------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcC
Confidence 24788999999999988753211 012235788999999999999999999988 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++...............++..|++||.+.+..++.++||||||+++|||++ |+.|+..... .....
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05074 149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYN 226 (273)
T ss_pred CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHH
Confidence 99999999999987643332222233445678999999999999999999999999999999 7777653221 11111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
... .... . . ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ~~~----~~~~--~---~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLI----KGNR--L---K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHH----cCCc--C---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 0000 0 0 0112235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=317.74 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=199.2
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
++....++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999875 5789999998642 2233456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~ 177 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDK 177 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECC
Confidence 99999999999999998842 23778888999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccC----CCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 178 ~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~ 254 (371)
T cd05622 178 SGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G 254 (371)
T ss_pred CCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--H
Confidence 99999999999987643221 122346799999999998754 3789999999999999999999998743321 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAAD--RPTMSEVVSMI 448 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 448 (496)
. ..............+ .......+.+++.+|++..+.+ ||++.+++++.
T Consensus 255 ~---~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 T---YSKIMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred H---HHHHHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1 111111111111111 1122345677888899844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=300.92 Aligned_cols=238 Identities=25% Similarity=0.423 Sum_probs=187.7
Q ss_pred ccccccCCeeEEEEEecCCC-----------EEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 170 NKLGEGGFGPVYKGKLLNGE-----------EVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999885432 5788887654333 6789999999999999999999999988 778999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC---
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM--- 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~--- 315 (496)
+||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 79 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 79 EEYVKFGPLDVFLHR--------------EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred EEcCCCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCcccc
Confidence 999999999999853 1226889999999999999999999988 99999999999999888
Q ss_pred ----ceEEeccccccccCCCccccccccccccccccChhhhccC--CCCccccchhhhHHHHHHHhC-CCCCCCCCCCcc
Q 040910 316 ----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETLSS-KKNTRFYNIDSL 388 (496)
Q Consensus 316 ----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg-~~~~~~~~~~~~ 388 (496)
.+||+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~- 214 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE- 214 (259)
T ss_pred CCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-
Confidence 799999999986543 1223566789999999876 789999999999999999995 55554332111
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.... +.... .... .....+.+++.+||..+|.+||++.+|++.|+
T Consensus 215 -~~~~----~~~~~--~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 -KERF----YQDQH--RLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HHHH----HhcCC--CCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00000 0000 00157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=302.47 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=197.1
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|++.+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 7889999998643 2346789999999999999999999998664 5799999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 82 ~~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 82 KGNLVNFLRT-------------RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred CCCHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCc
Confidence 9999999853 22345889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++...... ......+..|+|||.+.+..++.++|+||||+++|||++ |+.|+....... ..... ...
T Consensus 146 ~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~- 213 (254)
T cd05083 146 LARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECV----EKG- 213 (254)
T ss_pred cceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH----hCC-
Confidence 98754321 112334568999999998899999999999999999998 888775432211 11110 101
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
... + ........+.+++.+||+.+|.+||+++++++.|++
T Consensus 214 -~~~-~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 -YRM-E------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCC-C------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000 0 111223567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.79 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=202.6
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999975 478999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|..++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 99 ~~~~L~~~~~----------------~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 99 AGGSLTDVVT----------------ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred CCCcHHHHHH----------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence 9999999884 234889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++........ ......++..|+|||.+.+..++.++|||||||++|++++|+.||......... ... .. ..
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~~---~~-~~ 231 (296)
T cd06655 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI---AT-NG 231 (296)
T ss_pred ccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH---Hh-cC
Confidence 99886543321 122346888999999999989999999999999999999999998643321110 000 00 00
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...+.. .......+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 TPELQN-------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCC-------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000101 11123457788999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=304.40 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=200.5
Q ss_pred cCCCccccccccCCeeEEEEEecCC----CEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNG----EEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+.||+|+||.||+|...+. ..||||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999986432 478999886544 3445689999999999999999999998875 457899
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 85 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 85 MELAPLGELRSYLQV--------------NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred EEcCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeE
Confidence 999999999999853 2235899999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||...... ......
T Consensus 148 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~--- 221 (270)
T cd05056 148 LGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI--- 221 (270)
T ss_pred EccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH---
Confidence 99999998765432211 122344568999999988889999999999999999986 99887643321 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.... .... .......+.+++.+|+..+|.+|||+.++++.|++..
T Consensus 222 -~~~~--~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 222 -ENGE--RLPM-------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -HcCC--cCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0010 0111 1112346788999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.06 Aligned_cols=252 Identities=30% Similarity=0.457 Sum_probs=197.9
Q ss_pred CCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCH--HHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 166 FSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGV--EEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
|+..+.||+|+||+||+++... ++.+|+|.+........ ....+|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998864 56899999986643322 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++. ....+++..+..++.|+++||++||+.+ ++|+||||+||++++++.++|+||
T Consensus 81 ~~~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 81 PGGSLQDYLQ---------------KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp TTEBHHHHHH---------------HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSG
T ss_pred cccccccccc---------------cccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 9999999995 2456899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhhhhhhcc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHAWNLWKD 400 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~~~~~~~ 400 (496)
|.+.... ..........++..|+|||++. +..++.++||||+|+++|+|++|..|+....... ........ .
T Consensus 143 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~- 216 (260)
T PF00069_consen 143 GSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---K- 216 (260)
T ss_dssp TTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---H-
T ss_pred ccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---c-
Confidence 9998641 1123344567899999999998 8899999999999999999999999887541111 00000000 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ... .... ........+.+++..||+.||++||++.+++++
T Consensus 217 ~---~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 217 R---PLP-SSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp T---HHH-HHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c---ccc-cccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 0000 000012678899999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=306.36 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=198.4
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999764 57899999987443 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 85 ~~~~L~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 85 GGGSALDLLK----------------PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred CCCcHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccc
Confidence 9999998873 235789999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++..+.... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .. . ....
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~---~-~~~~- 216 (277)
T cd06642 146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF---L-IPKN- 216 (277)
T ss_pred cccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh---h-hhcC-
Confidence 9998664322 112234678899999999999999999999999999999999998753222111 00 0 0000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.+ .......+.+++.+||+.+|++||++.+|+++
T Consensus 217 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 ----SPPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CCCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01111 11234567889999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=305.32 Aligned_cols=264 Identities=26% Similarity=0.363 Sum_probs=196.7
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|++|.||+|... +++.||||.++... ....+.+.+|+.++.+++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 68899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ ++|.+++.. ......+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~-~~l~~~~~~------------~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 81 LS-MDLKKYLDS------------LPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred CC-CCHHHHHhc------------CCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECc
Confidence 97 688888742 122356899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh-----
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW----- 395 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~----- 395 (496)
||++....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ......
T Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~ 221 (285)
T cd07861 145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTP 221 (285)
T ss_pred ccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 99998654321 112334678899999988754 578999999999999999999998864322110 000000
Q ss_pred --hhhcccc---cccccCcccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 --NLWKDDR---AWKLLDPTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 --~~~~~~~---~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..|.... ..+..-+... .........++.+++.+||+.||.+|||+.+|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000000000 00011123566789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=300.46 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=204.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999874 57899999998666566788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|..++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 83 ~~~~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 83 GGGSLQDIYQV--------------TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred CCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECcc
Confidence 99999998852 2245889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC---CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG---LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|++....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... ...
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~ 218 (262)
T cd06613 146 GVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISK 218 (262)
T ss_pred ccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHh
Confidence 9998654321 112335678899999999876 889999999999999999999998864332111100 000
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. ....+.+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 219 -~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 -S---NFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -c---cCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0001111 112234467889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.78 Aligned_cols=242 Identities=20% Similarity=0.242 Sum_probs=187.1
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHH-HHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMI-LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+++.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57789999986432 122234444444 56778999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 81 GELFYHLQR---------------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred CcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCC
Confidence 999998842 345778888899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...... ...... .. ...
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i---~~-~~~- 213 (325)
T cd05602 143 CKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNI---LN-KPL- 213 (325)
T ss_pred CcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHH---Hh-CCc-
Confidence 97543211 2233457999999999999999999999999999999999999998643221 111111 00 000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ........+.+++.+|++.+|.+||++.+.+..
T Consensus 214 -----~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 -----Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -----C----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 0 111223457788999999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=306.64 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=188.4
Q ss_pred ccccccCCeeEEEEEecC--------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLN--------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997632 235889988655545567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc-----
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN----- 316 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~----- 316 (496)
+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 81 ~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 81 VKFGSLDTYLKK--------------NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred CCCCcHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCC
Confidence 999999999852 2236889999999999999999999988 999999999999987765
Q ss_pred ---eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhh
Q 040910 317 ---PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLL 391 (496)
Q Consensus 317 ---~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~ 391 (496)
++++|||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|.. |+..... ....
T Consensus 144 ~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~ 215 (258)
T cd05078 144 PPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL 215 (258)
T ss_pred CceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHH
Confidence 599999998754321 23467889999999986 457999999999999999999964 4332111 1100
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.. .. . ... .+......+.+++.+||+.+|++|||++++++.|+
T Consensus 216 ~~----~~-~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QF----YE-D-RHQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HH----HH-c-ccc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0 000 11112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=299.76 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=202.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998753 5889999998643 234556789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 81 ANGGTLYDKIVR-------------QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred cCCCcHHHHHHh-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECc
Confidence 999999999853 22346889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... . ..... ..
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~---~~~~~-~~ 216 (256)
T cd08221 145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN--L---VVKIV-QG 216 (256)
T ss_pred CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH--H---HHHHH-cC
Confidence 999987643321 2234568999999999998889999999999999999999999876432111 1 11111 11
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
... .........+.+++.+||+.+|.+||++.++++++
T Consensus 217 ~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 NYT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 110 01122235678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=301.87 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=199.0
Q ss_pred CCCccccccccCCeeEEEEEecCCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
+|...+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888899999998864321 1235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 81 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 81 MEFVPGGSISSILNR---------------FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred EecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEE
Confidence 999999999999842 235789999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCc----cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 319 ISDFGIARMFGGDE----LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 319 l~DFgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
|+|||++....... .........++..|+|||.+.+..++.++||||||+++|||++|..||........ ....
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~ 220 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFYI 220 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHHh
Confidence 99999998653211 11122335688999999999998999999999999999999999999864321110 0000
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. .....+.+. ......+.+++.+||+.+|.+||++.++++
T Consensus 221 ---~~----~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 ---GA----HRGLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---hh----ccCCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000111111 122356788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=303.49 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=201.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999875 68899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~L~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 81 CGGGSCLDLLKP----------------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred eCCCcHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 999999999842 26899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||+++...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ...
T Consensus 142 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~----~~~ 213 (274)
T cd06609 142 FGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLI----PKN 213 (274)
T ss_pred cccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHh----hhc
Confidence 99998765432 12234567889999999999889999999999999999999999986433211 11000 001
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.+... .....+.+++.+||+.+|++||++++++++
T Consensus 214 -----~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 214 -----NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01111111 023457789999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.86 Aligned_cols=263 Identities=24% Similarity=0.249 Sum_probs=196.6
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ----- 232 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 232 (496)
...++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999764 58899999987532 23346788899999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 -GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
...++||||+++ +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill 152 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEE
Confidence 357999999964 5655552 23788899999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh-
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL- 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~- 390 (496)
+.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (355)
T cd07874 153 KSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_pred CCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998654321 2234578999999999999999999999999999999999999986533211000
Q ss_pred -hH---------------hhhhhhc-ccccccccCcccc--------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 391 -LG---------------HAWNLWK-DDRAWKLLDPTLQ--------NEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 391 -~~---------------~~~~~~~-~~~~~~~~d~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.. ....... .........+... ..........+.+++.+|++.||++|||+.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 00 0000000 0000000001000 001111234678999999999999999999999
Q ss_pred HH
Q 040910 446 SM 447 (496)
Q Consensus 446 ~~ 447 (496)
++
T Consensus 310 ~h 311 (355)
T cd07874 310 QH 311 (355)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=304.15 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=202.2
Q ss_pred HHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeee----
Q 040910 157 ASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCI---- 230 (496)
Q Consensus 157 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~---- 230 (496)
..+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 445567889999999999999999999774 57899999886432 2346788899999999 6999999999884
Q ss_pred -ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 231 -EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 231 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
.++..++||||+++++|..++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni 155 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFL-----------KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNI 155 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhh-----------ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhE
Confidence 3457899999999999999885321 23356889999999999999999999987 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
+++.++.+||+|||+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.|+....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999986643221 123346899999999875 3457899999999999999999999876432
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.... ... ..........++. .....+.+++.+||+.+|++|||+.++++++
T Consensus 234 ~~~~-----~~~-~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 234 PMRA-----LFK-IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhHH-----Hhh-ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2110 000 0000000111111 1124578899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=306.19 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=200.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|++.++||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356888899999999999999875 4889999999876656677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 91 ~~~~~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 91 CPGGAVDAIMLE--------------LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred CCCCcHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEcc
Confidence 999999888742 2345899999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||++....... .......++..|+|||++. ...++.++|||||||++|||++|..|+....... . ...
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~---~~~ 226 (292)
T cd06644 154 FGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V---LLK 226 (292)
T ss_pred Cccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--H---HHH
Confidence 99987543221 1123356788999999885 3457889999999999999999999876432211 0 000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. .... .+.. .........+.+++.+||+.+|++||++.+++++
T Consensus 227 ~-~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 227 I-AKSE-----PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred H-hcCC-----CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 0110 0111223467889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.03 Aligned_cols=262 Identities=29% Similarity=0.379 Sum_probs=202.8
Q ss_pred cCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
++|+....||+|+||.||+|+.. +.+.||+|.+...... ..+++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999863 3467999988654433 4568999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++....... .......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~------~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKD------EKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQRE 155 (275)
T ss_pred EEEEecCCCcHHHHHHhccccc------ccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCc
Confidence 9999999999999996422110 0011236899999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
++++|||++........ .......++..|+|||.+.+..++.++||||||+++++|++ |..|+..... .......
T Consensus 156 ~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~- 231 (275)
T cd05046 156 VKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRL- 231 (275)
T ss_pred EEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHH-
Confidence 99999999875433221 12233456788999999998889999999999999999999 6666643221 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
...... ... .......+.+++.+||+.+|.+||++.++++.|.
T Consensus 232 ---~~~~~~-~~~-------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ---QAGKLE-LPV-------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---HcCCcC-CCC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111110 000 1112356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.63 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=198.1
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc---------CHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ---------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999764 5789999988654322 12568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~ 142 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---------------YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNK 142 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---------------ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCC
Confidence 9999999999999999942 245788899999999999999999988 9999999999999999
Q ss_pred CceEEeccccccccCCCcccc----ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 315 MNPKISDFGIARMFGGDELQS----NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+.++|+|||+++......... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~ 220 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QA 220 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HH
Confidence 999999999998765321111 112345788999999999989999999999999999999999998643211 10
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
..... ....+.+ .......+.+++.+||+.+|.+||++.+|++
T Consensus 221 ---~~~~~------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 ---IFKIG------ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHHHh------ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 10000 0111111 1223456778999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=311.05 Aligned_cols=237 Identities=22% Similarity=0.277 Sum_probs=185.3
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHH-HHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMI-LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 58899999986432 122344555554 57788999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 81 GELFFHLQ---------------RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCC
Confidence 99988874 2345788889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|..||...+.. ..... ... ..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~---i~~-~~-- 212 (321)
T cd05603 143 CKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDN---ILH-KP-- 212 (321)
T ss_pred CccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHH---Hhc-CC--
Confidence 87532211 2233457899999999999999999999999999999999999998643211 11111 100 00
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS 442 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 442 (496)
. .........+.+++.+||+.+|.+||+..
T Consensus 213 ------~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ------L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01111234678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=311.37 Aligned_cols=264 Identities=19% Similarity=0.226 Sum_probs=192.3
Q ss_pred cccccccc--CCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 168 EENKLGEG--GFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 168 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+.++||+| +|++||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7899999976 468999999997542 223456778999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||
T Consensus 82 ~~~~l~~~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 82 AYGSAKDLICTH-------------FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred CCCcHHHHHHhh-------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEccc
Confidence 999999998531 2234889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccc-----cccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 323 GIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 323 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+.+......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 225 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC
Confidence 875543211100 01122356778999999976 46899999999999999999999998643211100000000
Q ss_pred h---hhc------------------cccccc--c---cCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 396 N---LWK------------------DDRAWK--L---LDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 396 ~---~~~------------------~~~~~~--~---~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
. ... ...... . ..+.. ...........+.+++.+||+.||++|||+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 0 000 000000 0 00000 0001112235678999999999999999999998
Q ss_pred HH
Q 040910 446 SM 447 (496)
Q Consensus 446 ~~ 447 (496)
++
T Consensus 306 ~~ 307 (327)
T cd08227 306 NH 307 (327)
T ss_pred cC
Confidence 63
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=317.85 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=195.7
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG---- 233 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 233 (496)
...++|...+.||+|+||.||++... +|+.||||.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999764 5889999998643 2234567889999999999999999999986543
Q ss_pred --eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 234 --EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 234 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~ 156 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-----------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 57999999965 5555542 13778889999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc---
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL--- 388 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~--- 388 (496)
+.++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+....
T Consensus 157 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~ 233 (359)
T cd07876 157 KSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK 233 (359)
T ss_pred CCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999864322 122345789999999999999999999999999999999999999875432110
Q ss_pred ----------hhhH----hhhhhhccccc------ccccCcccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 389 ----------TLLG----HAWNLWKDDRA------WKLLDPTLQ---NEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 389 ----------~~~~----~~~~~~~~~~~------~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.... ........... .+....-.. ..........+.+++.+||+.||++|||+.|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 00000000000 000000000 000111234578899999999999999999998
Q ss_pred HH
Q 040910 446 SM 447 (496)
Q Consensus 446 ~~ 447 (496)
++
T Consensus 314 ~h 315 (359)
T cd07876 314 RH 315 (359)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=303.47 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=199.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999875 58999999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 81 YCDHTVLNELEK---------------NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred ccCccHHHHHHh---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEEC
Confidence 999998887763 2335899999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh-Hhh----
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL-GHA---- 394 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~-~~~---- 394 (496)
|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ...
T Consensus 143 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 143 DFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred ccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987654321 1223457889999999876 5688999999999999999999998864432211000 000
Q ss_pred ----hhhhccccc-ccccCccccccC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 ----WNLWKDDRA-WKLLDPTLQNEA-----LYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ----~~~~~~~~~-~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...+..... .....+...... .......+.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000 000001100000 01123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.42 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=194.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||+|+||.||++... +++.||||.+... .......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 5889999999643 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 E~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 81 EFLPGGDMMTLLM---------------KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred eCCCCccHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEE
Confidence 9999999999984 2345889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccc---------------------------------cccccccccccccChhhhccCCCCccccchhh
Q 040910 320 SDFGIARMFGGDELQ---------------------------------SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSF 366 (496)
Q Consensus 320 ~DFgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 366 (496)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 00113479999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 040910 367 GVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT---MSE 443 (496)
Q Consensus 367 Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~e 443 (496)
||++|||++|+.||....... ..... ..... .+.-|. . ......+.+++.+++. +|.+|++ +.+
T Consensus 223 Gvilyel~tG~~Pf~~~~~~~--~~~~i---~~~~~--~~~~p~---~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~e 289 (360)
T cd05627 223 GVIMYEMLIGYPPFCSETPQE--TYRKV---MNWKE--TLVFPP---E--VPISEKAKDLILRFCT-DSENRIGSNGVEE 289 (360)
T ss_pred cceeeecccCCCCCCCCCHHH--HHHHH---HcCCC--ceecCC---C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence 999999999999986433211 11111 00000 000010 0 0112345666666654 9999985 566
Q ss_pred HHHH
Q 040910 444 VVSM 447 (496)
Q Consensus 444 vl~~ 447 (496)
++++
T Consensus 290 i~~h 293 (360)
T cd05627 290 IKSH 293 (360)
T ss_pred HhcC
Confidence 6654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=306.99 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=198.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999875 588999999864322 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..+.. ....++|..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 81 FVDHTVLDDLEK---------------YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred cCCccHHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEE
Confidence 999999987763 2234899999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh---
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN--- 396 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~--- 396 (496)
|||++....... .......++..|+|||++.+ ..++.++||||||+++|||++|++++...... ........
T Consensus 143 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~ 218 (286)
T cd07846 143 DFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLG 218 (286)
T ss_pred eeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhC
Confidence 999998764332 22233467889999999875 45788999999999999999999887533211 10000000
Q ss_pred -hh-------ccccc-ccccCccccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 -LW-------KDDRA-WKLLDPTLQN-----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 -~~-------~~~~~-~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..... .....+.... .........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000 0000000000 0011234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.68 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=201.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778899999999999999864 58899999886543 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+++++|..++.. .+.+++..+..++.+++.||.|||+. + ++|+||||+||++++++.++|+
T Consensus 85 ~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~ 146 (284)
T cd06620 85 MDCGSLDRIYKK---------------GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLC 146 (284)
T ss_pred CCCCCHHHHHHh---------------ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEc
Confidence 999999988842 34589999999999999999999974 5 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc------hhhHhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL------TLLGHA 394 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~------~~~~~~ 394 (496)
|||++...... ......|+..|+|||.+.+..++.++|+|||||++||+++|+.||........ ......
T Consensus 147 d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd06620 147 DFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222 (284)
T ss_pred cCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence 99998754322 12235789999999999888999999999999999999999999875432210 001111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
...... . .+.+. .......+.+++.+||+.||.+|||+.|++++.
T Consensus 223 ~~~~~~-~-----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 223 QQIVQE-P-----PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHhhc-c-----CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 110000 0 01111 111335678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.28 Aligned_cols=260 Identities=22% Similarity=0.257 Sum_probs=195.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 232 (496)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999764 5889999998743 233456788999999999999999999987543
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
...++||||+++ +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 160 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----------------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEEC
Confidence 357999999964 6666652 13778899999999999999999988 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
.++.+||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 161 ~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~ 235 (364)
T cd07875 161 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWN 235 (364)
T ss_pred CCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 99999999999998654321 2234578999999999999999999999999999999999999986533211 000
Q ss_pred hhhhh-------------------hcc-ccc-----ccccCccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040910 393 HAWNL-------------------WKD-DRA-----WKLLDPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444 (496)
Q Consensus 393 ~~~~~-------------------~~~-~~~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 444 (496)
..... ... ... .+...... ...........+.+++.+|++.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 00000 000 000 00000000 000011123467899999999999999999999
Q ss_pred HHH
Q 040910 445 VSM 447 (496)
Q Consensus 445 l~~ 447 (496)
+++
T Consensus 316 L~h 318 (364)
T cd07875 316 LQH 318 (364)
T ss_pred hcC
Confidence 885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=304.42 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=202.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|.+.+.||+|+||.||++... ++..||+|.+........+.|.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457888999999999999999874 5889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 84 ~~~~~L~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 84 CDGGALDSIMLE--------------LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred cCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEcc
Confidence 999999999853 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||++....... .......++..|+|||.+. +..++.++||||||+++|||++|+.|+....... ....
T Consensus 147 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~--- 219 (280)
T cd06611 147 FGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK--- 219 (280)
T ss_pred Cccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH---
Confidence 99987653221 1123356889999999985 3457889999999999999999999886432211 1100
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+.... .+.+. ........+.+++..||+.+|.+||++.++++.
T Consensus 220 -~~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 220 -ILKSE-----PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -HhcCC-----CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 01110 011223467788999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.87 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=162.5
Q ss_pred cccccccCCeeEEEEEec---CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEEEEEecC
Q 040910 169 ENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKILIYEYMP 243 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 243 (496)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999864 35789999986532 23567889999999999999999998854 457899999986
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe----cCCCceEE
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKI 319 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl 319 (496)
++|..++....... .......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 84 -~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 84 -HDLWHIIKFHRASK------ANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred -CcHHHHHHhhhccc------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 47777764322110 1112345889999999999999999999988 9999999999999 56779999
Q ss_pred eccccccccCCCcc-ccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 320 SDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 320 ~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99999987654321 122334578999999999876 458999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=300.90 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=201.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999874 58899999987443 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 84 ~~~~~L~~~i~----------------~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 84 LGGGSALDLLR----------------AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred CCCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcc
Confidence 99999999883 134788899999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++........ ......++..|+|||++.+..++.++|+||||+++|||++|..|+......... .
T Consensus 145 fg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~--------- 211 (277)
T cd06640 145 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--F--------- 211 (277)
T ss_pred cccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--h---------
Confidence 999987643321 122346788999999999889999999999999999999999987643221100 0
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+...............+.+++.+||+.+|.+||++.+++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 ----LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000112223445678899999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.11 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=192.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-----ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-----GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
.+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999764 58899999986432 12345688999999999999999999988753 577
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++
T Consensus 82 ~l~~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~ 143 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---------------YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAG 143 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCC
Confidence 899999999999999842 234788999999999999999999987 99999999999999999
Q ss_pred ceEEeccccccccCCCc-cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDE-LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~---~ 218 (266)
T cd06651 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--A---I 218 (266)
T ss_pred CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--H---H
Confidence 99999999998654221 1111223467889999999999899999999999999999999999986432111 0 1
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
..... ....+.+ .......+.+++ .||..+|++||+++||++
T Consensus 219 ~~~~~-----~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKIAT-----QPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHhc-----CCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000 0001111 111223344444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=298.86 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=199.2
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-CeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-GEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 240 (496)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++.+.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999864 57899999986432 23456789999999999999999999987644 46789999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++.. .....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 81 ~~~~~~l~~~l~~-------------~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~ 144 (257)
T cd08223 81 FCEGGDLYHKLKE-------------QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVG 144 (257)
T ss_pred ccCCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEe
Confidence 9999999999853 22345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... .......++..|+|||++.+..++.++||||||++++|+++|+.|+....... ...... .
T Consensus 145 df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~-~ 216 (257)
T cd08223 145 DLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYRII-E 216 (257)
T ss_pred cccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH-h
Confidence 999998664322 12234568899999999999999999999999999999999999876432111 111111 1
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+.. + .........+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 GKL-----P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCC-----C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 0 1112234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.40 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=204.8
Q ss_pred cccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChhH
Q 040910 171 KLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDF 249 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 249 (496)
.||+|.||+||.|+..+ ...+|||-+...+.+..+.+.+|+.+-++|+|.|||+++|.+.+++..-+.||-.+||||..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998754 55899999988888888889999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCcccccCCCCCCCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCCceEEecccccc
Q 040910 250 FLFDYKYSSGFDMVTDPASKGIL--DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIAR 326 (496)
Q Consensus 250 ~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFgla~ 326 (496)
.|. ...+++ ++.++-.+.+||++||.|||+.. |||||||-+|||++ -.|.+||+|||-++
T Consensus 662 LLr--------------skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsK 724 (1226)
T KOG4279|consen 662 LLR--------------SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSK 724 (1226)
T ss_pred HHH--------------hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccch
Confidence 996 345666 78888999999999999999988 99999999999995 57899999999999
Q ss_pred ccCCCccccccccccccccccChhhhccC--CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 327 MFGGDELQSNMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 327 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
.+.. ....+.+..||..|||||++..+ .|..++|||||||.+.||.||++||.............. .
T Consensus 725 RLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--------m- 793 (1226)
T KOG4279|consen 725 RLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--------M- 793 (1226)
T ss_pred hhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--------c-
Confidence 7753 23456678999999999999865 589999999999999999999999875443221111100 0
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
-..-+..+.+...+...++++|+.++|.+||++.++++
T Consensus 794 ----yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 ----YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 01123345566778889999999999999999999975
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.09 Aligned_cols=251 Identities=35% Similarity=0.501 Sum_probs=199.0
Q ss_pred CCccccccccCCeeEEEEEecC-----CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
|++.+.||.|+||.||+++..+ +..||+|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999998753 388999999755433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 81 e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 81 EYMEGGDLLDYLRKN-------------RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eccCCCCHHHHHHhh-------------hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEE
Confidence 999999999998531 1112899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||++............ ...++..|+|||.+.+..++.++||||+|++++||++ |..|+..... .......
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~---- 217 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYL---- 217 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----
Confidence 999999876544222211 2346789999999988889999999999999999998 6666553211 1111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..... .. ........+.+++.+|+..+|++|||+.++++.|
T Consensus 218 ~~~~~--~~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 KKGYR--LP-------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hcCCC--CC-------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 10110 00 0111345688899999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=311.68 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=193.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+++.. +++.||||.+... .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999875 5889999998642 2234566889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 e~~~g~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred ecCCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEE
Confidence 99999999999853 2345888999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+|||++..+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . .
T Consensus 144 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--~---~ 217 (331)
T cd05597 144 ADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--T---Y 217 (331)
T ss_pred EECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--H---H
Confidence 999999765432211 1223468999999999873 457889999999999999999999986432111 1 1
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQ--ENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~RPs~~evl~~ 447 (496)
...........+. + ........+.+++.+|+. .++..||++.+++++
T Consensus 218 ~~i~~~~~~~~~~-~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 218 GKIMNHKEHFQFP-P-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHcCCCcccCC-C-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111111111110 0 001123445566666554 444458899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.05 Aligned_cols=254 Identities=23% Similarity=0.288 Sum_probs=200.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999875 489999999975432 24567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|
T Consensus 81 e~~~~~~L~~~~~~-------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 81 DYCPGGELFRLLQR-------------QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EecCCCCHHHHHHh-------------CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEE
Confidence 99999999998842 22356899999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccc---------------------------cccccccccccccChhhhccCCCCccccchhhhHHHHH
Q 040910 320 SDFGIARMFGGDELQ---------------------------SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372 (496)
Q Consensus 320 ~DFgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~e 372 (496)
+|||++......... .......||..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998755322100 01123467889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 040910 373 TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT----MSEVVSM 447 (496)
Q Consensus 373 lltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~evl~~ 447 (496)
|++|..|+........ .. . +.+..............+.+++.+||+.+|++||+ +.+++.+
T Consensus 225 l~~g~~pf~~~~~~~~--~~---~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 225 MLYGTTPFKGSNRDET--FS---N---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HhhCCCCCCCCchHHH--HH---H---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999999864332111 00 0 00101000111113467889999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=306.45 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=197.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 57899999987443 33345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ ++|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|
T Consensus 86 ~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 86 LD-KDLKQYLDD--------------CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred cc-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECc
Confidence 96 688888752 2345789999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh-h--------
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL-L-------- 391 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~-~-------- 391 (496)
||++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .
T Consensus 148 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 225 (301)
T cd07873 148 FGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225 (301)
T ss_pred CcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99997653221 11223467889999998875 457889999999999999999999987543211100 0
Q ss_pred Hhhhhhhccc-ccccccCccccccC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 392 GHAWNLWKDD-RAWKLLDPTLQNEA----LYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 392 ~~~~~~~~~~-~~~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...|..+... .......+...... .......+.+++.+|++.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001000000 00000001110000 0112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=298.74 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=198.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-----ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-----GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
+|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999876 78999999986533 22456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 81 ~e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 81 LELVPGGSLAKLLKK---------------YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred EEecCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 999999999999842 235889999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+..... .. .....
T Consensus 143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~---~~~~~ 214 (258)
T cd06632 143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VA---AVFKI 214 (258)
T ss_pred EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HH---HHHHH
Confidence 99999988654332 223456888999999998776 89999999999999999999999864331 11 11110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...... +. ........+.+++.+||+.+|.+||++.+++.
T Consensus 215 ~~~~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 GRSKEL-----PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhcccC-----CC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000011 00 11112356678899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=306.43 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=197.5
Q ss_pred CccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 167 SEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33457999999999999864 58899999987655555677899999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 105 ~L~~~~~----------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 105 ALTDIVT----------------HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred cHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcch
Confidence 9998873 234789999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (496)
....... .......++..|+|||.+.+..++.++||||||+++||+++|+.|+...... ...... ..
T Consensus 166 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~---------~~ 232 (292)
T cd06658 166 AQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRI---------RD 232 (292)
T ss_pred hhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---------Hh
Confidence 7654321 1223356889999999999889999999999999999999999987632211 111100 00
Q ss_pred ccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 406 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.+.... .......+.+++..||+.+|.+|||+++++++
T Consensus 233 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 11123456778889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=319.03 Aligned_cols=252 Identities=29% Similarity=0.403 Sum_probs=203.7
Q ss_pred CCCccccccccCCeeEEEEEec--CCC--EEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL--NGE--EVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.....++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|||+++|+|+..+ ....||+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445679999999999999874 354 6899999865433 67899999999999999999999999988 7788999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|.++.|||.+-|++ ..+..|-......++.|||.||.||.++. +|||||..+|+||-..-.+||
T Consensus 190 ELaplGSLldrLrk-------------a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI 253 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-------------AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKI 253 (1039)
T ss_pred hhcccchHHHHHhh-------------ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeee
Confidence 99999999999953 46677888999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCc-cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCC-CCCCCCCCCcchhhHhhhhh
Q 040910 320 SDFGIARMFGGDE-LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 320 ~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~~~~~~~~~~~~~~~~~~~~ 397 (496)
+||||.+.++..+ .+......--++.|.|||.+....++.++|||+|||.+|||+|+. .|+.... ...
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~q-------- 323 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQ-------- 323 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHH--------
Confidence 9999999886543 333333344577899999999999999999999999999999865 4443211 111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
+.+.+|..-.-.......+++.++++.||..+|.+|||+..|.+.+
T Consensus 324 -----IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 -----ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -----HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1112222222233445568899999999999999999999997443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=313.84 Aligned_cols=260 Identities=24% Similarity=0.311 Sum_probs=194.7
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ----- 232 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 232 (496)
...++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999976 467899999986432 22345678899999999999999999987643
Q ss_pred -CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 -GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~ 151 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----------------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAV 151 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEE
Confidence 3578999988 788987763 235889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
++++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~ 224 (343)
T cd07878 152 NEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--Q 224 (343)
T ss_pred CCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--H
Confidence 99999999999999865432 233578999999999877 578999999999999999999999886432211 0
Q ss_pred hHhhhhhh-----------cccccccccC--cccccc----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 391 LGHAWNLW-----------KDDRAWKLLD--PTLQNE----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 391 ~~~~~~~~-----------~~~~~~~~~d--~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ ........+. +..... ........+.+++.+|++.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000000 000000 000012346789999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.16 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=198.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999875 6899999988643 2233567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEec
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++++|..++... .....+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|
T Consensus 82 ~~~~l~~~~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 82 DAGSLDKLYAGG------------VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred CCCCHHHHHHhc------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEee
Confidence 999999988521 1234689999999999999999999974 5 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccC------CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
||++..+... ......++..|+|||.+.+. .++.++|+|||||++|||++|+.||....... ......
T Consensus 147 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~ 220 (286)
T cd06622 147 FGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLS 220 (286)
T ss_pred cCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHH
Confidence 9999765322 12234678899999998544 35889999999999999999999986432211 111000
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ..... .+ .........+.+++.+||+.+|.+||++.+++..
T Consensus 221 ~-~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 A-IVDGD-----PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred H-HhhcC-----CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 00000 01 1122344667889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.89 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=197.5
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc----------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG----------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
+|...+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999754 688999998853211 11346888999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~ 143 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---------------YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDA 143 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---------------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcC
Confidence 99999999999999999842 246889999999999999999999987 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCC--CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
++.++|+|||+++...............++..|+|||.+.... ++.++|+||||+++||+++|..|+..... ..
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~-- 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IA-- 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HH--
Confidence 9999999999998654322122223456889999999987654 89999999999999999999998753211 10
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....... ......+.. .........+.+++..||+.+|.+||++.+|+++
T Consensus 220 -~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 -AMFKLGN-KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -HHHHhhc-cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111100 000011111 1112234677889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=311.12 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=195.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999875 5789999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 Ey~~gg~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred eCCCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEE
Confidence 99999999999953 1345888899999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~-- 218 (331)
T cd05624 144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG-- 218 (331)
T ss_pred EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--HHH--
Confidence 999999876433211 1223568999999999875 567899999999999999999999986432211 111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAAD--RPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 447 (496)
.......... + + .........+.+++.+|+...+.+ |+++++++++
T Consensus 219 -~i~~~~~~~~-~-p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 -KIMNHEERFQ-F-P----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -HHHcCCCccc-C-C----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111110000 0 1 111112355677888888765433 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.41 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=203.7
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC----cc----CHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS----GQ----GVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~----~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
.-++|...+.||.|..++|-+... .+|+..|+|++.... .. -.+.-..|+.+|+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677788999999999988865 468899999885321 11 134556799999999 79999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+.-.++|+|.|+.|.|-++| .+.-.++++...+|+.|+..|+.|||..+ |+||||||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyL---------------ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILl 156 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL---------------TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILL 156 (411)
T ss_pred cchhhhhhhhcccchHHHHh---------------hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheee
Confidence 99999999999999999999 35667999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhc------cCCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
|++.++||+|||+|+.+... ......+||++|+|||.+. ...|+..+|+|+.|||+|.|+.|.+||-...
T Consensus 157 ddn~~i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk- 232 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK- 232 (411)
T ss_pred ccccceEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-
Confidence 99999999999999988654 3456689999999999985 3468999999999999999999999975321
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
++. +.+...+++. +. .+..-.+......+++.+|++.||.+|.|.+|.+++
T Consensus 233 -Qml----MLR~ImeGky-qF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 233 -QML----MLRMIMEGKY-QF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHH----HHHHHHhccc-cc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111 1111111211 11 122233445567889999999999999999999864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.67 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=197.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc-----CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ-----GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
+|...+.||+|+||.||+|... +++.||||.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999864 6899999999754322 234677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+ +|+|..++.. ....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++
T Consensus 81 ~e~~-~~~L~~~i~~--------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 81 FEFM-ETDLEKVIKD--------------KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred Eccc-CCCHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEE
Confidence 9999 9999999842 1136899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||+++...... .......++..|+|||.+.+ ..++.++|||||||+++||++|.+++..... ..........
T Consensus 143 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~ 218 (298)
T cd07841 143 LADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEA 218 (298)
T ss_pred EccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHH
Confidence 99999998765432 12233456788999998865 4678999999999999999999776653322 1111111000
Q ss_pred hccc---------ccccccCccccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDD---------RAWKLLDPTLQN-----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~---------~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ............ .........+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 000000000000 0111224578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.56 Aligned_cols=246 Identities=31% Similarity=0.457 Sum_probs=200.8
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..|+.++.||.|+||-||.|+. .+.+.||||++.-. +...+.++..|+.+|++++|||++.+.|+|......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4567778999999999999976 46789999999743 3344678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||| -||-.+++. ..++++.+-.+..|+.+.+.||+|||+.+ .||||||+.||||++.|.|||
T Consensus 106 EYC-lGSAsDlle--------------VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 106 EYC-LGSASDLLE--------------VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HHH-hccHHHHHH--------------HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeee
Confidence 999 678888885 34667888999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||.|..... .+.++||+.|||||++. .+.|+-|+||||||+...||.-.++|.-.. ..+..+ +
T Consensus 168 aDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMSAL---Y- 235 (948)
T KOG0577|consen 168 ADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSAL---Y- 235 (948)
T ss_pred ccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--hHHHHH---H-
Confidence 99999976532 35679999999999985 578999999999999999999888774321 111111 1
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....+ -.|.+. ..++...+.+++..||+.-|.+|||.++++.+
T Consensus 236 HIAQN-----esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 236 HIAQN-----ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHhc-----CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11111 112332 34566778889999999999999999988754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.12 Aligned_cols=255 Identities=18% Similarity=0.232 Sum_probs=193.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.++||+|+||.||+++.. +++.+|+|.+.+. .......|.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999875 4778999998642 2223456888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 81 ey~~~g~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred eccCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence 99999999999953 2345889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+|||++..+..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...
T Consensus 144 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~--- 217 (332)
T cd05623 144 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY--- 217 (332)
T ss_pred eecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHH---
Confidence 99999976533221 1123357899999999986 346889999999999999999999998643211 111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQE--NAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~ 447 (496)
........... -+. ........+.+++.+|+.. ++..||++.+++++
T Consensus 218 ~~i~~~~~~~~--~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 218 GKIMNHKERFQ--FPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHhCCCcccc--CCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111110000 011 0111234556677777654 44447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.35 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|+||.||++... +|+.||+|.+... .....+++.+|+.++++++||||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999764 6889999998643 233456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 81 CEGGDLYKKINA-------------QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred CCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEee
Confidence 999999998853 22335788999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++....... .......|+..|+|||++.+..++.++|+||||++++++++|+.|+...... . ....... +
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~---~~~~~~~-~ 216 (256)
T cd08218 145 FGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--N---LVLKIIR-G 216 (256)
T ss_pred ccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--H---HHHHHhc-C
Confidence 99998664322 1122346788999999999999999999999999999999999987532211 1 1111100 0
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. + .........+.+++.+||+.+|.+||++.+|+++
T Consensus 217 ~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 SY-----P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CC-----C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 0 0111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=300.63 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=203.5
Q ss_pred eCHHHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 154 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
+.+.++..++++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334555667889999999999999999999874 68899999986432 2346778899999999 89999999999875
Q ss_pred c-----CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040910 232 Q-----GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 306 (496)
Q Consensus 232 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 306 (496)
. +..++|+||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++|+||||
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp 156 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL-----------ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKG 156 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCH
Confidence 4 35899999999999999885321 23346899999999999999999999987 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccC-----CCCccccchhhhHHHHHHHhCCCCCC
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-----LFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
+||+++.++.+||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+.
T Consensus 157 ~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 157 NNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred HHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999865432211 2234678899999988643 36899999999999999999999876
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... ... . +.......+.+ .......+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~-~~~----~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 235 DMHPVK-TLF----K-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcHHH-HHH----H-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 432111 111 0 00011111111 11223468889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=298.11 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=200.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 239 (496)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999874 578999999875432 3456789999999999999999999998654 4689999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.... .....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|
T Consensus 81 e~~~~~~L~~~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l 146 (287)
T cd06621 81 EYCEGGSLDSIYKKVK-----------KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKL 146 (287)
T ss_pred EecCCCCHHHHHHHHH-----------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEE
Confidence 9999999999875321 23445888999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC---cchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID---SLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~---~~~~~~~~~~ 396 (496)
+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......+..
T Consensus 147 ~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 221 (287)
T cd06621 147 CDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV- 221 (287)
T ss_pred eeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-
Confidence 9999987553221 12345788999999999999999999999999999999999998754321 111111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
......+.+. ..........+.+++.+||+.+|++|||+.|+++
T Consensus 222 ---~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 222 ---NMPNPELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---cCCchhhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0011011000 0101123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=296.23 Aligned_cols=274 Identities=20% Similarity=0.230 Sum_probs=215.5
Q ss_pred hcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
-+.|+.++.||.|.-|+||++++.+ +..+|+|++.+.. .....+...|-+||+.++||.++.|++.+..++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3466778899999999999999864 5899999997653 33445677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
||||+||+|...++ .+..+.++...+..++..|+-||+|||..| ||+|||||+||||.++|++-
T Consensus 156 meyCpGGdL~~Lrq-------------kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQ-------------KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIM 219 (459)
T ss_pred EecCCCccHHHHHh-------------hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEE
Confidence 99999999998884 366778999999999999999999999999 99999999999999999999
Q ss_pred EeccccccccCCC----------------------------c---c-c----------------------cccccccccc
Q 040910 319 ISDFGIARMFGGD----------------------------E---L-Q----------------------SNMNRIVGTY 344 (496)
Q Consensus 319 l~DFgla~~~~~~----------------------------~---~-~----------------------~~~~~~~gt~ 344 (496)
|+||.|+...... . . . ......+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 9999987543210 0 0 0 0112357999
Q ss_pred cccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHH
Q 040910 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYI 424 (496)
Q Consensus 345 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 424 (496)
.|+|||++.|...+.++|.|+|||++|||+.|.-||...+..... ..++-..+.-...+.....+.
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--------------~NIv~~~l~Fp~~~~vs~~ak 365 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--------------RNIVGQPLKFPEEPEVSSAAK 365 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH--------------HHHhcCCCcCCCCCcchhHHH
Confidence 999999999999999999999999999999999999876543321 111212221112224456788
Q ss_pred HHHHHhcccCCCCCCC----HHHHHHH--Hhc----cccCCCCCCCCcchhh
Q 040910 425 KVALLCVQENAADRPT----MSEVVSM--IKN----EIVNLPSPQQPAFSYV 466 (496)
Q Consensus 425 ~l~~~cl~~~p~~RPs----~~evl~~--L~~----~~~~~~~p~~~~~~~~ 466 (496)
+||...|..||.+|.. +.||-++ +++ .+....+|..|.....
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 9999999999999998 7776543 222 2334456666666544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=297.64 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=199.5
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999975 4688999999864321 124678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-c
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-N 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~ 316 (496)
|+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++ .
T Consensus 81 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---------------YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred EEeccCCCcHHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 9999999999999852 235889999999999999999999998 99999999999998776 5
Q ss_pred eEEeccccccccCCCcccc--ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDELQS--NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+||+|||++.......... ......++..|+|||.+.+..++.++||||+|+++++|++|..|+........ ....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~ 220 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALI 220 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHH
Confidence 9999999998765331111 11234678899999999988999999999999999999999998764322111 1111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... ................+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~~---------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKI---------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHH---------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 0000011122234467888999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.58 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=200.8
Q ss_pred CHHHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee-
Q 040910 155 SLASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE- 231 (496)
Q Consensus 155 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~- 231 (496)
++.++..+...|+..+.||.|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455567788999999999999999999874 57899999986443 3346788899999999 79999999999863
Q ss_pred -----cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040910 232 -----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 306 (496)
Q Consensus 232 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 306 (496)
....+++|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~ 149 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-------------KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 45789999999999999998531 2335778889999999999999999988 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
+||++++++.++|+|||++....... .......|+..|+|||.+. +..++.++|||||||++|||++|..||.
T Consensus 150 ~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 150 QNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 99999999999999999988653221 1223356889999999876 3568889999999999999999999885
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
......... .. .....+... .......+.+++.+||+.||.+||++.|+++
T Consensus 228 ~~~~~~~~~-----~~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPMRALF-----LI------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHhhhh-----hH------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 432111000 00 000011111 1122356888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=297.21 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=195.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-----ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-----GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999864 58899999885321 12245788899999999999999999998764 467
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++
T Consensus 82 ~~v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~ 143 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---------------YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143 (265)
T ss_pred EEEEEecCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCC
Confidence 899999999999999842 234788889999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...
T Consensus 144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~--- 218 (265)
T cd06652 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAI--- 218 (265)
T ss_pred CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHH---
Confidence 9999999999865432111 1223356888999999999888999999999999999999999997632111 000
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... .. ....+......+.+++.+|+. +|++||++++|+++
T Consensus 219 ~~~~~~-----~~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQ-----PT----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcC-----CC----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000000 00 111222334567778888885 89999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.66 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=202.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 58899999987553 24456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+
T Consensus 81 ~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 81 MDGGSLDKILKE--------------VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred cCCCcHHHHHHH--------------ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 999999999853 12568889999999999999999999 77 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||.+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...................
T Consensus 144 d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 218 (265)
T cd06605 144 DFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN- 218 (265)
T ss_pred ecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-
Confidence 999987653221 112568889999999999999999999999999999999999986543221111111111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ..+.+... .....+.+++..||..+|++|||+.+++.+
T Consensus 219 ~-----~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 E-----PPPRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C-----CCCCCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 00111111 134567889999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=295.09 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 67899999986433 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..++... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~l~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 81 LSGGSLLDIMKSS------------YPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred cCCCcHHHHHHHh------------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 9999999998531 11346899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccc--cccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 322 FGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 322 Fgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
||++......... .......++..|+|||.+... .++.++|+||||+++|||++|+.|+........ . ....
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~---~~~~ 220 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L---MLTL 220 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H---HHHh
Confidence 9999866543221 112334688999999998877 789999999999999999999999864322110 0 0000
Q ss_pred cccccccccCccccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEA-LYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..+...... .......+.+++..||+.||++||++.+++++
T Consensus 221 ~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 221 QN------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cC------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 10 011111110 11234567889999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=301.13 Aligned_cols=262 Identities=25% Similarity=0.329 Sum_probs=195.3
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999874 68899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ ++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 81 ~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 81 CD-QDLKKYFDS--------------CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred CC-CCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECc
Confidence 96 578777642 2345899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ ...........
T Consensus 143 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~ 219 (284)
T cd07839 143 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGT 219 (284)
T ss_pred cchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCC
Confidence 99998654321 122334678899999998764 478999999999999999999988543221111 11000000000
Q ss_pred cc------cccccCc----ccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DR------AWKLLDP----TLQ-----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~------~~~~~d~----~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .....+. ... ..........+.+++.+||+.||.+|||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 220 PTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000000 000 00111234567789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=303.21 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=197.3
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999764 6889999999765555567889999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
..++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 106 ~~~~~----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 106 TDIVS----------------QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred HHHHh----------------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 88773 234789999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
+.... .......++..|+|||++.+..++.++||||||+++|||++|+.|+...... ...... .....
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~----~~~~~---- 234 (297)
T cd06659 167 ISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL----RDSPP---- 234 (297)
T ss_pred ccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----hccCC----
Confidence 54322 1123356889999999999989999999999999999999999988643211 111110 00000
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+.. .........+.+++..||+.+|.+||++.+++++
T Consensus 235 -~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 235 -PKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0011123457788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.71 Aligned_cols=240 Identities=23% Similarity=0.295 Sum_probs=184.8
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh---cCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL---HHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
||+|+||.||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58999999986432 12234455677777665 699999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 g~L~~~l~---------------~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 81 GELFWHLQ---------------KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred ChHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCc
Confidence 99998884 2345889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
++...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... .. ........
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~----~~i~~~~~ 214 (330)
T cd05586 143 SKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MY----RNIAFGKV 214 (330)
T ss_pred CcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HH----HHHHcCCC
Confidence 97543221 223345799999999998764 48999999999999999999999986432211 11 11111110
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT----MSEVVS 446 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~evl~ 446 (496)
.+. .. .....+.+++.+||+.+|.+||+ +.++++
T Consensus 215 -~~~-----~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -RFP-----KN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCC-----Cc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 010 00 12345678899999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.42 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=192.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHH-HHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMIL-IAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|++.+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++..++..++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 68999999987543 2233456667665 455689999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|++ |+|..++.... .....+++..+..++.||+.||+|||+. + ++||||||+||+++.++.+||
T Consensus 81 ~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 81 VMD-TSLDKFYKKVY-----------DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred hhc-ccHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 996 78888875421 2235689999999999999999999986 5 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc----CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.......... .
T Consensus 146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~ 218 (283)
T cd06617 146 CDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----K 218 (283)
T ss_pred eeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----H
Confidence 9999998654221 1223467889999998865 456889999999999999999999875322111111 0
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... . ..+.+.. ......+.+++.+||+.+|.+||++.++++
T Consensus 219 ~~~~-~-----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVVE-E-----PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHh-c-----CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 0111111 112356788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=305.27 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=204.5
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEecc--CCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSN--KSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+| .|.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467889999999999999999987888999998753 3556678899999999999 599999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||- .-+|..+|.. .......| .+..+..|++.++.++|.++ |||.||||.|+|+- .|.+|
T Consensus 439 mE~G-d~DL~kiL~k-------------~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 439 MECG-DIDLNKILKK-------------KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eecc-cccHHHHHHh-------------ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEE
Confidence 9986 6799999954 22233445 78889999999999999998 99999999999994 57899
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccC-----------CCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-----------LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
|+|||+|..+..+.........+||+.||+||.+... ..+.++||||+|||||+|+.|+.||.....
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-- 577 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-- 577 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--
Confidence 9999999999887766666778999999999998642 256889999999999999999999873221
Q ss_pred chhhHhhhhhhcccccccccCccccccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALY-PMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+ .++..+.||.-.-+++. ..-..+++++..||+.||++||+..+++++
T Consensus 578 ----~~-------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ----QI-------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HH-------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11 12334555532111110 111228899999999999999999999875
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.39 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=200.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 239 (496)
+|++.+.||.|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999764 67899999986432 2335678899999999999999999998764 34679999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEecCCCce
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||+++++|.+++.... .....+++..++.++.||+.||+|||..+ ..+++|+||+|+||++++++.+
T Consensus 81 e~~~~~~L~~~l~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-----------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149 (265)
T ss_pred hhccCCCHHHHHHHHh-----------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE
Confidence 9999999999996421 23456899999999999999999999332 2349999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||++........ ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+..... .......
T Consensus 150 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~--- 222 (265)
T cd08217 150 KLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKI--- 222 (265)
T ss_pred EEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHH---
Confidence 9999999987654321 12234688999999999998899999999999999999999999875431 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ..........+.+++.+|++.+|++||++.+|+++
T Consensus 223 -~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 -KEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -hcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11110 11122334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.42 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=210.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCcc---CHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQ---GVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 236 (496)
....|.+.+.||+|.||.||+++... |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44577888999999999999998764 999999999765433 4568999999999998 999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC--
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-- 314 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-- 314 (496)
+|||++.+|.|.+.+.. . .+++.....++.||+.+++|||+.+ |+||||||+|+|+...
T Consensus 113 lvmEL~~GGeLfd~i~~-------------~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVK-------------K---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEEecCCchHHHHHHH-------------c---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccC
Confidence 99999999999988853 1 2889999999999999999999988 9999999999999543
Q ss_pred --CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 315 --MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 315 --~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
+.+|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........
T Consensus 174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~- 249 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA- 249 (382)
T ss_pred CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-
Confidence 5799999999998765 3456678999999999999999999999999999999999999999976554332220
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....+ ..............+.+++..++..||..|+|+.+++++
T Consensus 250 -----i~~~~------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 -----ILRGD------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----HHcCC------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 00011 122223334445677789999999999999999999996
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=300.49 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=195.5
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 688999999875432 2234677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ ++|..++.. ....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 85 ~~-~~L~~~~~~--------------~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 85 LD-TDLKQYMDD--------------CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred CC-CCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECc
Confidence 97 589888852 2236889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+.....
T Consensus 147 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~ 223 (291)
T cd07844 147 FGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGT 223 (291)
T ss_pred cccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCC
Confidence 99987543221 11122356889999999875 458999999999999999999999886433111 111111110000
Q ss_pred c--ccc--------------cccCccccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 401 D--RAW--------------KLLDPTLQNEA--LYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 401 ~--~~~--------------~~~d~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. ..+ ....+...... .......+.+++.+|++.+|++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000 00000000000 0011256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=295.53 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=205.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|...+.||+|++|.||+++.. +++.||||++..... .....+.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46788899999999999999876 489999999876543 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 81 MDGGSLADLLKK---------------VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred cCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEc
Confidence 999999999952 2568899999999999999999999 87 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCC-CcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI-DSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~-~~~~~~~~~~~~~~ 399 (496)
|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ..........
T Consensus 143 df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---- 216 (264)
T cd06623 143 DFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---- 216 (264)
T ss_pred cCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----
Confidence 99999876533221 1234678899999999999999999999999999999999999865432 1111111111
Q ss_pred ccccccccCccccccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYP-MVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..+.. ... ....+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~-----~~~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DG-----PPPSL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cC-----CCCCC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 01111 111 34678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.64 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=196.4
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999874 68899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+. ++|..++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~-~~l~~~~~~-------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 81 LH-QDLKKFMDA-------------SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred cc-cCHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEee
Confidence 95 689888842 23456899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++....... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .........-..
T Consensus 144 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~ 220 (284)
T cd07860 144 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP 220 (284)
T ss_pred ccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99998654321 1223345688999999887644 6889999999999999999999886433211 010000000000
Q ss_pred -c--------------ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 -D--------------RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 -~--------------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ........... .........+.+++.+||+.||.+||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 221 DEVVWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ChhhhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00000000000 0011122456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.93 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=200.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|+..+.||+|+||.||+|... +++.||||.++.. .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999875 5789999998643 23345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++++++..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 81 YVERTLLELLEA---------------SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred cCCCCHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEE
Confidence 999877766552 2344889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh----
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW---- 395 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~---- 395 (496)
|||++........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+....... ......
T Consensus 143 d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~ 219 (288)
T cd07833 143 DFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLG 219 (288)
T ss_pred eeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 9999987654322 122335678899999999888 88999999999999999999998876432211 000000
Q ss_pred -------hhhcccc------cccccCcccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 -------NLWKDDR------AWKLLDPTLQ-NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 -------~~~~~~~------~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.... .....++... ..........+.+++.+||+.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 0000000000 00111125678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.06 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=193.3
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC------ceeeeeeeee
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR------NLVRLFGCCI 230 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~ 230 (496)
++...+++|.+.++||+|+||.||+|... +++.||||+++... ....++..|+.++.+++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445788999999999999999999764 57899999996432 2334567788888887654 5888998887
Q ss_pred ec-CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCC
Q 040910 231 EQ-GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASN 308 (496)
Q Consensus 231 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~N 308 (496)
.. .+.++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+. + |+||||||+|
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~N 262 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---------------HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPEN 262 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 65 4788999988 7788888742 34689999999999999999999974 6 9999999999
Q ss_pred EEecCCC----------------ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHH
Q 040910 309 VLLDGDM----------------NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372 (496)
Q Consensus 309 Ill~~~~----------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~e 372 (496)
||++.++ .+||+|||.+..... ......||..|+|||++.+..++.++|||||||++||
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 9998765 499999998864321 2234679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCcc-hhhHhh-------hh-hhcccccccc----------cCccc----cc-c--CCHHHHHHHHHH
Q 040910 373 TLSSKKNTRFYNIDSL-TLLGHA-------WN-LWKDDRAWKL----------LDPTL----QN-E--ALYPMVKRYIKV 426 (496)
Q Consensus 373 lltg~~~~~~~~~~~~-~~~~~~-------~~-~~~~~~~~~~----------~d~~~----~~-~--~~~~~~~~l~~l 426 (496)
|++|+.||........ ...... |. .+.......+ .++.. .. . ........+.+|
T Consensus 338 lltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 417 (467)
T PTZ00284 338 LYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL 417 (467)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence 9999999875432110 000000 00 0000000000 00000 00 0 000112457799
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 040910 427 ALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 427 ~~~cl~~~p~~RPs~~evl~~ 447 (496)
+..||+.||++|||++|++++
T Consensus 418 i~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 418 IYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHhCCcChhhCCCHHHHhcC
Confidence 999999999999999999873
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=300.46 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=202.8
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788889999999999999975 36789999998755555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 98 ~~~~~L~~~~~~----------------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 98 LAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred CCCCcHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEcc
Confidence 999999999842 34788999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++........ ......++..|+|||.+.+..++.++||||||+++|++++|+.||.......... ......
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~ 231 (293)
T cd06647 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG 231 (293)
T ss_pred Ccceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCC
Confidence 999876543321 1233468889999999998889999999999999999999999986433211100 000000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. +.. .........+.+++..||+.+|.+||++.+++.+
T Consensus 232 ~------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 T------PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0111223457789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.66 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=199.1
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|+||.||++... +++.+|||.+... .......+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999764 6789999998654 233456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-CceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~ 320 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++++ ..+||+
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 81 APGGTLAEYIQK-------------RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred CCCCCHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999953 22345889999999999999999999988 9999999999999865 468999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+....... ..... ..
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~---~~- 215 (256)
T cd08220 145 DFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKI---MS- 215 (256)
T ss_pred cCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHH---Hh-
Confidence 999998764332 1223567889999999998889999999999999999999999876433211 11111 00
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ........+.+++..||+.+|.+|||+.+++++
T Consensus 216 ~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 GTFAP---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCCCC---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00000 011123567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.61 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=197.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 236 (496)
..++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......|..|+.++.+++|||||++++++.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4568999999999999999999875 56789999886432 23356789999999999999999999988653 5689
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCCEEec
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSR----LRVIHRDLKASNVLLD 312 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlk~~NIll~ 312 (496)
|||||+++|+|..+|.... .....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+
T Consensus 91 IVMEY~~gGSL~~lL~k~~-----------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCY-----------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHh-----------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 9999999999999996421 223569999999999999999999998542 3499999999999996
Q ss_pred C-----------------CCceEEeccccccccCCCccccccccccccccccChhhhcc--CCCCccccchhhhHHHHHH
Q 040910 313 G-----------------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLET 373 (496)
Q Consensus 313 ~-----------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el 373 (496)
. ...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 3348999999998664322 1234578999999999864 4589999999999999999
Q ss_pred HhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 374 LSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 374 ltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
++|..||....... .+. ...... +.+. .......+.+|+..||+.+|.+||++.+++.
T Consensus 237 LTGk~PF~~~~~~~-qli----~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 237 CSGKTPFHKANNFS-QLI----SELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHCCCCCCcCCcHH-HHH----HHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999986432111 111 111100 0000 0112356788999999999999999999984
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=294.08 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=200.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc--CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ--GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 6889999998765443 567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~L~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 81 CSGGTLEELLE---------------HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred CCCCcHHHHHh---------------hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 99999999984 2345788999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccc--cccccccccccChhhhccCC---CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 322 FGIARMFGGDELQSN--MNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 322 Fgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||++........... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||......... ...
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~----~~~ 218 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI----MFH 218 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH----HHH
Confidence 999987654322111 12346788999999998766 899999999999999999999998643211110 000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... .. .+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 219 ~~~-~~-----~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGA-GH-----KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred Hhc-CC-----CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00 111100 1111345678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=296.12 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=198.4
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 239 (496)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 46889999998654 3344567889999999996 999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 82 e~~~~~~L~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 82 EYAEGGSVRTLMKA----------------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred ecCCCCcHHHHHHc----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEE
Confidence 99999999988841 25889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||++....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..|+....... ... ..
T Consensus 143 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~ 214 (277)
T cd06917 143 CDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LI 214 (277)
T ss_pred ccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-cc
Confidence 9999998765432 22233568899999999875 457899999999999999999999986432111 000 00
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ..+.+... .....+.+++.+||+.+|++||++.+++.+
T Consensus 215 ~~~-----~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 PKS-----KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccC-----CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000 11111111 123567789999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.10 Aligned_cols=256 Identities=19% Similarity=0.271 Sum_probs=200.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999875 57899999987543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 81 e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 81 EYVEGGDCATLLKN---------------IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred ecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEE
Confidence 99999999999842 345889999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccc-------------cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 320 SDFGIARMFGGDELQ-------------SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 320 ~DFgla~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+|||+++........ .......++..|+|||.+.+..++.++|+||||+++||+++|..|+......
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998742111000 0111235788999999999889999999999999999999999988632211
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
...... ... ....+... ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 --~~~~~~----~~~---~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 --ELFGQV----ISD---DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHHHHH----Hhc---ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 000 01111111 1123457889999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=296.82 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=198.3
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
-|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3567789999999999999764 67899999886432 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|..++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~l~~~i~----------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 85 GGGSALDLLE----------------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred CCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeec
Confidence 9999998883 235789999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++..+..... ......++..|+|||.+.+..++.++|+|||||++|+|++|..|+...... .... . .....
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~---~-~~~~~ 217 (277)
T cd06641 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLF---L-IPKNN 217 (277)
T ss_pred ccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHH---H-HhcCC
Confidence 99986643221 122346788999999999888999999999999999999999887532211 1000 0 00000
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.+ .......+.+++.+||+.+|.+||++.+++++
T Consensus 218 -----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 -----PPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----CCCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111 11223567789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.14 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=204.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKILIY 239 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 239 (496)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 688999999875442 4567899999999999999999999999988 8999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 81 e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l 142 (260)
T cd06606 81 EYVSGGSLSSLLKK---------------FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKL 142 (260)
T ss_pred EecCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEE
Confidence 99999999999852 227899999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||.+................++..|+|||.+.+...+.++||||||+++++|++|..|+..... .....+....
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~ 218 (260)
T cd06606 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGS 218 (260)
T ss_pred cccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccc
Confidence 999999877654321112345688899999999988899999999999999999999999875441 1111111111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ..........+.+++.+|++.+|.+||++.+++++
T Consensus 219 ~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0011 11112224678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=297.32 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=200.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999874 68999999987543 33356899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 81 ~-~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 81 M-PSDLSEVLRD--------------EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred c-CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEee
Confidence 9 9999998853 2256899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++........ .......++..|+|||.+.+. .++.++||||+|++++||++|.+++..... .............
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~ 219 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGT 219 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCC
Confidence 999987654321 122345788999999988654 468999999999999999999776653221 1111111100000
Q ss_pred c------------ccccccCcccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 D------------RAWKLLDPTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~------------~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ....+..+... .....+....+.+++.+|++.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 00111223678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.32 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=195.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578889999999999999999764 688999999875432 23346788999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+. ++|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 83 e~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 83 EYMH-TDLAQYMIQ--------------HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred eccc-CCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEE
Confidence 9995 677766642 2235778889999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+++...... .......++..|+|||++.+. .++.++||||||+++|||++|..||........ .....+...
T Consensus 145 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~ 221 (291)
T cd07870 145 ADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVL 221 (291)
T ss_pred eccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHc
Confidence 9999997643221 112334578899999998764 578899999999999999999999864332111 111111100
Q ss_pred ccc------------ccccccCccccccC------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 399 KDD------------RAWKLLDPTLQNEA------LYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 399 ~~~------------~~~~~~d~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... .......+...... .......+.+++.+|++.||++|||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000000000000 0011345678899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.52 Aligned_cols=198 Identities=26% Similarity=0.354 Sum_probs=171.6
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-C-----CceeeeeeeeeecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-H-----RNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 237 (496)
+|.+.+.||+|+||.|.++.. .+++.||||+++... .-..+-..|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 889999999999999999965 469999999997543 33456678999999996 4 389999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC--
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-- 315 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-- 315 (496)
|+|.+ .-+|.+|+.. .+...++...+..|+.||+.||.+||+.+ |||+||||+||||.+-.
T Consensus 266 VfELL-~~NLYellK~-------------n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 266 VFELL-STNLYELLKN-------------NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eehhh-hhhHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcC
Confidence 99999 6799999964 45566999999999999999999999988 99999999999996543
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
.+||+|||.|+..... ......+..|+|||++.|.+|+.+.||||||||+.||++|.+-|+..++
T Consensus 329 ~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 6999999999976432 2245678899999999999999999999999999999999887766544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=300.23 Aligned_cols=248 Identities=30% Similarity=0.445 Sum_probs=195.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.+.|...+.||+|+||.||+|... +++.||+|.+..... ...+++.+|+++++.++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999874 688999999864332 2335788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 94 ~e~~~-g~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 94 MEYCL-GSASDILEV--------------HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred HHhhC-CCHHHHHHH--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEE
Confidence 99996 677666632 2345899999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
|+|||++...... ....++..|+|||.+. ...++.++||||||+++|||++|..|+....... .. .
T Consensus 156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~---~ 224 (307)
T cd06607 156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL---Y 224 (307)
T ss_pred EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HH---H
Confidence 9999998754322 2346788999999874 4568899999999999999999999875322111 00 0
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.... ... +.+ ........+.+++.+||+.+|++||++.+|+.+.
T Consensus 225 ~~~~-~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 225 HIAQ-NDS-----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHhc-CCC-----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 000 111 1112345688999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=300.96 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=197.2
Q ss_pred CCCccccccccCCeeEEEEEec---CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKI 236 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 236 (496)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999874 47899999997632 33456778899999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--- 313 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--- 313 (496)
+||||+++ +|..++..... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~ 146 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQ----------AKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGP 146 (316)
T ss_pred EEEeCCCc-CHHHHHHhhcc----------CCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCC
Confidence 99999975 66666643211 12246889999999999999999999998 999999999999999
Q ss_pred -CCceEEeccccccccCCCcc-ccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcch-
Q 040910 314 -DMNPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT- 389 (496)
Q Consensus 314 -~~~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~- 389 (496)
++.+||+|||++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.........
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 147 ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 99999999999987643321 1122345678899999988764 5899999999999999999999998754432200
Q ss_pred ------hhHhhhhhhcc------------ccccc---ccCccccc-cCCH-------HHHHHHHHHHHHhcccCCCCCCC
Q 040910 390 ------LLGHAWNLWKD------------DRAWK---LLDPTLQN-EALY-------PMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 390 ------~~~~~~~~~~~------------~~~~~---~~d~~~~~-~~~~-------~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
........+.. ..... ........ .... .....+.+++.+|++.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 00000000000 00000 00000000 0001 12346889999999999999999
Q ss_pred HHHHHHH
Q 040910 441 MSEVVSM 447 (496)
Q Consensus 441 ~~evl~~ 447 (496)
+.|++++
T Consensus 307 ~~eil~~ 313 (316)
T cd07842 307 AEEALEH 313 (316)
T ss_pred HHHHhcC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.66 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=200.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------ 233 (496)
++++|++.+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999875 57899999987543 3456799999999999 7999999999997654
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~ 148 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLR-----------KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTK 148 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHh-----------hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEcc
Confidence 4899999999999999885321 12356899999999999999999999988 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~ 388 (496)
++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||++++++++|..|+......
T Consensus 149 ~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-- 224 (275)
T cd06608 149 NAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-- 224 (275)
T ss_pred CCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--
Confidence 9999999999987654321 22234568899999998753 34778999999999999999999998632211
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...... .... .+.+ .........+.+++.+||..||++|||+.++++
T Consensus 225 ~~~~~~----~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 RALFKI----PRNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHh----hccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111100 0000 0111 111223457889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.69 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=197.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999875 58999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.+||
T Consensus 81 e~~~~~~L~~~~~~---------------~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 81 EYVPGGELFSHLRK---------------SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred ecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEE
Confidence 99999999999842 356889999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+..... ...... ..
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~ 211 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEK----IL 211 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----Hh
Confidence 999999876433 2334688999999999988899999999999999999999998764331 111110 00
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 446 (496)
... ..+ +......+.+++.+||+.+|.+|| +++|+++
T Consensus 212 ~~~------~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 212 EGK------VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCC------ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 010 001 111235677899999999999999 5566553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=296.86 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=195.8
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
|+..+.||+|++|.||+|... +|+.||||++.... ......+.+|+.++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 78999999987443 223467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
+ ++|..++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 81 D-LDLKKYMDS-------------SPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred C-cCHHHHHhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeec
Confidence 4 789988842 12246899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh-----
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN----- 396 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~----- 396 (496)
|+++...... .......++..|+|||++.+. .++.++||||||+++|||++|+.||........ .......
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 220 (283)
T cd07835 144 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPD 220 (283)
T ss_pred ccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence 9997654221 112234568899999988764 578999999999999999999998864322110 0000000
Q ss_pred -----hhccc-c----cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 -----LWKDD-R----AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 -----~~~~~-~----~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... . ......+.. ..........+.+++.+||+.+|.+||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 221 EDVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hHHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0 000000000 01111223567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=293.10 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=198.0
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 6889999998755545566789999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 101 ~~L~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 101 GALTDIVTH----------------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred CCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEccccc
Confidence 999998841 35889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
+....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... .. ....
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~---~~-~~~~-- 231 (285)
T cd06648 162 CAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMK---RI-RDNL-- 231 (285)
T ss_pred chhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHH---HH-HhcC--
Confidence 87654321 112234688999999999988999999999999999999999998754221 11111 10 0010
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.+... ........+.+++.+||+.+|++||++.++++
T Consensus 232 ---~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 232 ---PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01110 01112356888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.81 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=203.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++.+++++|+|++++.+++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999875 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 81 ~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 81 GGSLKDLLKS--------------TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred CCcHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecc
Confidence 9999999852 1256899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
.+........ .....++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ... .....
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~~~ 214 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL--FKI----ATNGP 214 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHH----HhcCC
Confidence 9987654321 23456888999999999888999999999999999999999987643211110 000 00001
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .......+.+++..||+.+|.+|||+.+++++
T Consensus 215 ~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 215 PGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 11113567889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.65 Aligned_cols=247 Identities=24% Similarity=0.276 Sum_probs=200.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
+|...+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 58999999997542 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 81 LLLGGDLRYHLSQ---------------KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred CCCCCCHHHHHHh---------------cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEe
Confidence 9999999999842 246889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+......... ........
T Consensus 143 d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~ 216 (258)
T cd05578 143 DFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQET 216 (258)
T ss_pred ecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHhcc
Confidence 999998764332 223356788999999999888999999999999999999999998754432111 11100000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM--SEVV 445 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl 445 (496)
. . ...+......+.+++.+||+.+|.+||++ +|++
T Consensus 217 --~-~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --A-D-------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --c-c-------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 0 01111223678889999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=292.40 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=199.2
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999875 57899999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~ 320 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 81 CDGGDLMKRINR-------------QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred CCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEec
Confidence 999999999853 22335789999999999999999999988 99999999999999886 46999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||.+....... .......|+..|+|||++.+..++.++||||||+++||+++|..|+...... ........
T Consensus 145 d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~- 216 (257)
T cd08225 145 DFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ- 216 (257)
T ss_pred ccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-
Confidence 999998764322 1122346888999999999889999999999999999999999987543211 11111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... . .........+.+++.+||+.+|++|||+.+++++
T Consensus 217 ~~~----~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 GYF----A-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ccC----C-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 110 0 0111223467889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.09 Aligned_cols=275 Identities=28% Similarity=0.401 Sum_probs=209.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec----C----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL----N----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
..++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 4455566679999999999999753 1 4579999998553 34567899999999999 79999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccc-cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMV-TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.+..++|.||+..|+|..||...+.....+.. ........++..+.+.++.|||.|++||++.. ++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 99999999999999999999876611111110 00111135999999999999999999999987 999999999999
Q ss_pred ecCCCceEEeccccccccCCCcccc-ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcc
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQS-NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSL 388 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~ 388 (496)
++++..+||+|||+|+......... ......-+..|||||.+....|+.++|||||||+||||+|... |++. -....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPPTE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCcHH
Confidence 9999999999999999766554443 2122124678999999999999999999999999999999654 3332 11011
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.+ +....++. ++- .+.....++.+++..||+.+|++||++.++++.|+..+.
T Consensus 530 ~l----~~~l~~G~--r~~-------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 530 EL----LEFLKEGN--RME-------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH----HHHHhcCC--CCC-------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 11222222 122 222224677899999999999999999999999998544
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.31 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=197.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 238 (496)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++.+++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999875 58899999997433 22234677899999999999999999999877 899999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||++ ++|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 85 ~e~~~-~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~ 146 (293)
T cd07843 85 MEYVE-HDLKSLMET--------------MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILK 146 (293)
T ss_pred ehhcC-cCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEE
Confidence 99997 589888742 2236899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh---
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA--- 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~--- 394 (496)
|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|||++|..|+....... .....
T Consensus 147 l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~ 222 (293)
T cd07843 147 ICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKL 222 (293)
T ss_pred EeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHH
Confidence 99999998765432 122334578899999998764 46899999999999999999999886433211 11000
Q ss_pred --------hhhhcc------cccccccCccccccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 --------WNLWKD------DRAWKLLDPTLQNEALYP-MVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 --------~~~~~~------~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
|..+.. ..........+....... ....+.+++..||+.+|++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 000000000111111111 24567789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.55 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=203.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.+++|+..+.||+|++|.||+|... +++.||+|.+..... ..+.+.+|++.+++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 5567888899999999999999886 688999999975543 56788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 96 ~~~~~~L~~~l~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 96 YMDGGSLTDIITQN--------------FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred ccCCCcHHHHHHHh--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEEC
Confidence 99999999999531 136899999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+....... ..... ..
T Consensus 159 d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~----~~ 230 (286)
T cd06614 159 DFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLI----TT 230 (286)
T ss_pred ccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----Hh
Confidence 999987654321 11223457889999999998889999999999999999999999875322111 00000 00
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....... ........+.+++.+||+.+|.+||++.+|+++
T Consensus 231 ~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 231 KGIPPLK-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cCCCCCc-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000000 111123567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=292.92 Aligned_cols=262 Identities=27% Similarity=0.383 Sum_probs=197.8
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+|+..++||+|++|.||+|+.. +|+.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999875 588999999875432 23467788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
+ ++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 81 ~-~~l~~~~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 81 D-KDLKKYMDTH------------GVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred C-ccHHHHHHhc------------CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeec
Confidence 7 4888887531 22346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh----
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL---- 397 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~---- 397 (496)
|++....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ........
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~ 220 (284)
T cd07836 145 GLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTP 220 (284)
T ss_pred chhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCC
Confidence 9998654321 112334678899999988664 57899999999999999999999886543221 11110000
Q ss_pred -------hcccccccccCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 398 -------WKDDRAWKLLDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 398 -------~~~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
+..........+.. ...........+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 221 TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 00011122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=291.10 Aligned_cols=242 Identities=26% Similarity=0.315 Sum_probs=186.1
Q ss_pred cccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHh---cCCceeeeeeeeeecCeeEEEEEecC
Q 040910 171 KLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKL---HHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.||+|+||.||++... +++.+|||.+..... .....+.+|..++..+ +||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 588999998864321 1223344555444433 79999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||
T Consensus 81 ~~~L~~~i~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 81 GGDLHYHLSQ---------------HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred CCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCC
Confidence 9999988842 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++....... .....|+..|+|||.+. +..++.++|||||||+++||++|..||............... .
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~--- 212 (279)
T cd05633 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L--- 212 (279)
T ss_pred cceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h---
Confidence 997654221 12346899999999986 456899999999999999999999998644322211111000 0
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.....+ .......+.+++..||+.||.+|| ++++++++
T Consensus 213 ---~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 ---TVNVEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cCCcCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001111 112335677889999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=297.51 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=194.4
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556679999999999999864 58899999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
+. ++|..+.... .......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+
T Consensus 85 ~~-~~l~~l~~~~----------~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 85 MD-ISLDKFYKYV----------YEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred cc-CCHHHHHHHH----------HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEe
Confidence 85 4555443210 011235689999999999999999999975 5 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccC---CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG---LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||+++...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ........
T Consensus 151 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~ 223 (288)
T cd06616 151 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQV 223 (288)
T ss_pred ecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhh
Confidence 999998654322 11234678899999999876 689999999999999999999999864321 11111110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ...+.+...........+.+++.+||+.+|++|||+.+|+++
T Consensus 224 ~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VK------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cC------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011112122212344578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.96 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=208.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+-|.++++||+|+||.||++.++ .|+.+|||.+.-. .+.++...|+.++++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34677889999999999999764 6999999998643 45688999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
.-||..+.+. ...++|++..+..++...+.||+|||... =+|||||+.||||+.+|.+||+||
T Consensus 111 GAGSiSDI~R--------------~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 111 GAGSISDIMR--------------ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred CCCcHHHHHH--------------HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence 9999999996 35678999999999999999999999876 799999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|.|..+... -...+++.||+.|||||++..-.|+.++||||+|+...||.-|++|+....+-..
T Consensus 174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------------- 237 (502)
T KOG0574|consen 174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------------- 237 (502)
T ss_pred cccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------
Confidence 999876532 2334568999999999999999999999999999999999999998764332110
Q ss_pred cccccC--ccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLD--PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.-++. |.-....+..+...+.+++..||-..|++|-|+.+++++
T Consensus 238 -IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 -IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 00111 111112244566789999999999999999999998875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=296.34 Aligned_cols=249 Identities=30% Similarity=0.425 Sum_probs=195.7
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.|...+.||+|+||.||+++.. ++..||+|.+..... .....+.+|+.++++++|||++++++++.++...++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999864 688999999864322 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ |+|.+++.. ....++|..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+
T Consensus 106 ~~~-g~l~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 106 YCL-GSASDLLEV--------------HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred CCC-CCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEe
Confidence 996 577776642 2345899999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||++..... .....++..|+|||++. ...++.++|||||||++|||++|+.|+...... .....
T Consensus 168 dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~---- 235 (317)
T cd06635 168 DFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH---- 235 (317)
T ss_pred cCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----
Confidence 9999875432 22346788999999974 456899999999999999999999987532211 10100
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
+..... +. .........+.+++.+||+.+|.+||++.+|++++--.
T Consensus 236 ~~~~~~-----~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 236 IAQNES-----PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHhccC-----CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 000000 00 01112334578899999999999999999999877553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=279.29 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=199.1
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEecc--CCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSN--KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.+++|++-+.||+|.|+.||+... ++|+.+|+|.+.- -...+.+++.+|+.+-+.|+|||||+|.....+.+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346778888999999999999854 5788899887752 2345778899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---CC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DM 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~ 315 (496)
+|+|.+++|-.-+-. +-..++...-..+.||+.+|.|+|..+ |||||+||+|+||.. ..
T Consensus 89 Fe~m~G~dl~~eIV~---------------R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---------------REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred EecccchHHHHHHHH---------------HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCC
Confidence 999999999655432 234677788899999999999999998 999999999999943 34
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
-+||+|||+|..++.. ......+||++|||||++...+|+..+|||+-|||||-|+.|..||.... ...+.+...
T Consensus 151 ~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~ 225 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIK 225 (355)
T ss_pred ceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHh
Confidence 5899999999988732 33445789999999999999999999999999999999999999986422 222222111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.+. .+ + .+.+.....+...+|+.+||..||.+|.|+.|.++
T Consensus 226 ----~g~-yd-~----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 ----AGA-YD-Y----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----ccc-cC-C----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 000 00 1 11122223456678889999999999999988774
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=291.64 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=192.2
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhc-CCceeeeeeeeeec--CeeEEEEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQ--GEKILIYE 240 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 240 (496)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999864 68899999987542 222234457888999885 99999999999987 88999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ |+|.+++.. ....++|..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+
T Consensus 81 ~~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~ 141 (282)
T cd07831 81 LMD-MNLYELIKG--------------RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLA 141 (282)
T ss_pred cCC-ccHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEE
Confidence 996 578777742 2346899999999999999999999988 999999999999999 999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh---
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN--- 396 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~--- 396 (496)
|||+++....... .....++..|+|||.+. +..++.++|||||||++|||++|..||......+ .......
T Consensus 142 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~ 216 (282)
T cd07831 142 DFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG 216 (282)
T ss_pred ecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence 9999987643321 12245788999999765 4567899999999999999999999886543211 1111100
Q ss_pred --------hhcccccccccCccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 --------LWKDDRAWKLLDPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 --------~~~~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.....+......+.... .........+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000111111000 0011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=288.43 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=193.2
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||.|++|.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 48899999986432 23346799999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~l~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 81 WTILRD---------------RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred HHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 999842 234889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+........ .....
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~----- 211 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI---LKGNG----- 211 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH---hccCC-----
Confidence 65432 12234678899999999888899999999999999999999999875443221111110 00000
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVS 446 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 446 (496)
....+......+.+++.+||+.+|.+||+ ++|+++
T Consensus 212 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 ----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 00111112457889999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=288.73 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=202.9
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999764 67899999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|..++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 81 APFGDLSKAISKRK-----------KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred cCCCCHHHHHHHHH-----------hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEee
Confidence 99999999986421 22356899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||+++..... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... .... ....
T Consensus 147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~ 216 (256)
T cd08530 147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYK----VQRG 216 (256)
T ss_pred ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HhcC
Confidence 9999876543 1223467889999999999999999999999999999999999986433211 1110 0111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..........+.+++.+|++.+|++||++.+++++
T Consensus 217 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KY---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11 11122344668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=294.18 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=194.5
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|+..+.||+|++|.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 68899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl 319 (496)
|++ ++|..++.. .....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||
T Consensus 82 ~~~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 82 YLD-LDLKKHMDS-------------SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred ccc-ccHHHHHHh-------------CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEE
Confidence 995 578777732 12234678888999999999999999987 999999999999985 567999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .........
T Consensus 145 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~ 220 (294)
T PLN00009 145 ADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRIL 220 (294)
T ss_pred cccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 9999998654321 11233467889999998876 457899999999999999999999886432211 110000000
Q ss_pred ccc--ccc---------cccCccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDD--RAW---------KLLDPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~--~~~---------~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ..+ ....+.... ...+.....+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 000000000 0011223457889999999999999999999863
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=294.58 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=195.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 237 (496)
.++|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999874 589999999864322 2234567899999999999999999998765 46899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+. ++|..++.. ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+
T Consensus 86 v~e~~~-~~l~~~l~~--------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 147 (309)
T cd07845 86 VMEYCE-QDLASLLDN--------------MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCL 147 (309)
T ss_pred EEecCC-CCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999996 588888752 1256899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 148 kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~ 223 (309)
T cd07845 148 KIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQ 223 (309)
T ss_pred EECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 999999998765322 12223345788999999875 56899999999999999999999988643321 11111111
Q ss_pred hhcc--cccc---------ccc--C-cccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKD--DRAW---------KLL--D-PTLQ--NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~--~~~~---------~~~--d-~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ...+ ... . .... ..........+.+++.+|++.||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000 000 0 0000 00001124556789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.35 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=198.6
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Cee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 235 (496)
+++|.+.+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999976 468999999986432 23456788899999999999999999987654 357
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+. ++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 84 ~lv~e~~~-~~l~~~~~----------------~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~ 143 (336)
T cd07849 84 YIVQELME-TDLYKLIK----------------TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNC 143 (336)
T ss_pred EEEehhcc-cCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCC
Confidence 99999996 57766662 235899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
.+||+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~ 221 (336)
T cd07849 144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNL 221 (336)
T ss_pred CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 9999999999865432211 11233568899999998764 568999999999999999999999886432111 0000
Q ss_pred hhhhhcc---cccccccCcc---------cccc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcccc
Q 040910 394 AWNLWKD---DRAWKLLDPT---------LQNE-----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIV 453 (496)
Q Consensus 394 ~~~~~~~---~~~~~~~d~~---------~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~ 453 (496)
....... +....+.+.. .... ..+.....+.+++.+||+.+|++|||+.+++++ ++....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000 0000000000 0000 001123567899999999999999999999987 665433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=292.56 Aligned_cols=260 Identities=17% Similarity=0.215 Sum_probs=181.9
Q ss_pred hcCCCccccccccCCeeEEEEEecCC----CEEEEEEeccCCccCHH-----------HHHHHHHHHHHhcCCceeeeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNG----EEVAVKRLSNKSGQGVE-----------EFKNEMILIAKLHHRNLVRLFG 227 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~H~niv~l~~ 227 (496)
.++|.+.+.||+|+||.||+|...++ ..+|+|........... ....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46788999999999999999987543 45666654322211111 1122233445568999999999
Q ss_pred eeeecC----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040910 228 CCIEQG----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRD 303 (496)
Q Consensus 228 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 303 (496)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+.+ |+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrD 151 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---------------IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGD 151 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---------------hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 776554 3466777663 355555421 223567888999999999999999988 99999
Q ss_pred CCCCCEEecCCCceEEeccccccccCCCcc-----ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC
Q 040910 304 LKASNVLLDGDMNPKISDFGIARMFGGDEL-----QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378 (496)
Q Consensus 304 lk~~NIll~~~~~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~ 378 (496)
|||+|||++.++.++|+|||+|+.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999987642211 111233479999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 379 NTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
||........ ....... +-..++..+..... .....+.+++..|++.+|++||++.++.+.|+
T Consensus 232 P~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 232 PWKGFGHNGN-LIHAAKC----DFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCccccchH-HHHHhHH----HHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9875432211 1110000 00011111111111 12356778999999999999999999998763
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=293.55 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=195.1
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe-----
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE----- 234 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~----- 234 (496)
++|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 68899999886432 22346788899999999 56999999999987665
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
.++||||+++ +|..++.... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~ 146 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNG----------RGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQ 146 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhc----------ccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecC
Confidence 8999999975 8888885321 012346899999999999999999999988 999999999999998
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ..
T Consensus 147 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~ 222 (295)
T cd07837 147 KGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL 222 (295)
T ss_pred CCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH
Confidence 8999999999998653321 11223356788999998865 4579999999999999999999988864322111 00
Q ss_pred hhhhhhcccc--cc----cccC----cccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNLWKDDR--AW----KLLD----PTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~~~~~~--~~----~~~d----~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.......... .+ ...+ +... ..........+.+++..||+.+|.+||++.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 00 0000 0000 00011234567889999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=292.63 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=196.8
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEEEEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKILIYE 240 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 240 (496)
|.+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999875 47899999997653 33456788999999999999999999999988 89999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ ++|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~-~~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~ 142 (287)
T cd07840 81 YMD-HDLTGLLDS--------------PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLA 142 (287)
T ss_pred ccc-ccHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEc
Confidence 997 488888742 1246899999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ..........
T Consensus 143 d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~ 219 (287)
T cd07840 143 DFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCG 219 (287)
T ss_pred cccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhC
Confidence 9999987654321 12233456888999998765 467899999999999999999999886433211 1111111000
Q ss_pred cc---cc--------cc------ccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DD---RA--------WK------LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~---~~--------~~------~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .. .. .....+.......+...+.+++..||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 220 SPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00 00 000000000001124678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.44 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=207.6
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.-|.+.+-||+|.|+.|-+|++ -+|..||||++.+.. ......+..|++-|+.++|||||+|+.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4566778999999999999975 389999999997543 3344577889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe-cCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-DGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl 319 (496)
.-.+|+|.+|+.. ....+++....+++.||+.|+.|+|... +|||||||+||.+ ..-|-+||
T Consensus 98 LGD~GDl~DyImK--------------He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--------------HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred ecCCchHHHHHHh--------------hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEe
Confidence 9999999999975 3455888999999999999999999998 9999999999877 45678999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCC-ccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
.|||++-.+... ...++.+|...|-|||++.|..|+ +++||||||||||.|++|+.||+..+..+..
T Consensus 161 TDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------- 228 (864)
T KOG4717|consen 161 TDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------- 228 (864)
T ss_pred eeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------
Confidence 999999877654 446678999999999999998886 5679999999999999999999865543221
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.-++|-.. ..+.....++.+|+..||+.||.+|.+.++|+..
T Consensus 229 -----TmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 -----TMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -----hhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 12333222 2344556789999999999999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=284.12 Aligned_cols=271 Identities=24% Similarity=0.317 Sum_probs=217.5
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGC 228 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~ 228 (496)
..++.....+++..-.+-+|.||.||+|.+. +.+.|-||.++... .-+...|..|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455555667877788999999999999653 34578889887543 3456788999999999999999999999
Q ss_pred eeecC-eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 229 CIEQG-EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 229 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
+.+.. ..+++|.++.-|+|..||...+.. ++...+.++..+...++.|++.|++|||+.+ +||.||.++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~-------~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaR 425 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGD-------DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAAR 425 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccC-------CCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhh
Confidence 98764 678999999999999999865522 3345567888899999999999999999998 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNID 386 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~ 386 (496)
|+++|+..++||+|=.++|.+-..++..-....-.+..||+||.+.+..|+..+|||||||+||||+| |+.|....++.
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 99999999999999999998877776666666667889999999999999999999999999999988 55554432222
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
++ .. ..+ +..++..|. ..+.++..++.-||...|++||+++|++.-|.+.
T Consensus 506 Em--~~----ylk--dGyRlaQP~-------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 EM--EH----YLK--DGYRLAQPF-------NCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HH--HH----HHh--ccceecCCC-------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 21 11 112 222333333 3346788899999999999999999999988764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.68 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Ce
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 234 (496)
.++|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999764 6899999998643 233455778899999999999999999988654 35
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|+||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~lv~e~~~-~~L~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~ 144 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---------------SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNAN 144 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC
Confidence 799999995 78888773 2346899999999999999999999988 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....
T Consensus 145 ~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~ 220 (337)
T cd07858 145 CDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKL 220 (337)
T ss_pred CCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHH
Confidence 999999999998664332 12233467889999998865 568999999999999999999999986432111 0000
Q ss_pred hhh-----------hhcccccccc-------cCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 040910 394 AWN-----------LWKDDRAWKL-------LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKN 450 (496)
Q Consensus 394 ~~~-----------~~~~~~~~~~-------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~ 450 (496)
... ........+. .++... .........+.+++.+||+.+|++|||+++++++ ++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000 0000000000 000000 0011234567899999999999999999999987 655
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=300.76 Aligned_cols=264 Identities=27% Similarity=0.347 Sum_probs=197.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec--Cee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 235 (496)
..++|+..+.||+|+||.||+|... +++.+|||++... .......+..|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999875 5789999988542 233445678899999999 999999999998654 368
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||++ ++|..++.. ..++|..+..++.||+.||+|||+.+ |+|+||||+||+++.++
T Consensus 85 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~ 144 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----------------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDC 144 (337)
T ss_pred EEEecccc-cCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCC
Confidence 99999996 688888731 26789999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccc---cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 316 NPKISDFGIARMFGGDELQ---SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.+||+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..
T Consensus 145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~ 222 (337)
T cd07852 145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QL 222 (337)
T ss_pred cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 9999999999866433221 12234568899999998765 567899999999999999999999886432211 00
Q ss_pred Hhhhh-----------hhcccccccccCccc------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWN-----------LWKDDRAWKLLDPTL------QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~-----------~~~~~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .+.......+++... ...........+.+++.+||+.+|.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 000000000110000 000011124568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.76 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=191.5
Q ss_pred HHHHHHhcCCCccccc--cccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec
Q 040910 157 ASISTATHNFSEENKL--GEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ 232 (496)
Q Consensus 157 ~~~~~~~~~f~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 232 (496)
.+.....++|.+.+.+ |+|+||.||++... +++.+|+|.+........ |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444555677777777 99999999999764 678899999865322211 22222222 799999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
+..++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~ 143 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK---------------EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYD 143 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEe
Confidence 999999999999999999842 237899999999999999999999998 99999999999999
Q ss_pred CCC-ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 313 GDM-NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~-~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.++ .++|+|||++...... ....++..|+|||++.+..++.++||||||++++||++|+.|+...........
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred CCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 998 9999999998865422 123578899999999999999999999999999999999999874332222111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-MSEVVS 446 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 446 (496)
...... ... . .........+.+++.+||+.+|.+||+ ++++++
T Consensus 218 ~~~~~~---~~~--~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQ---QKK--L-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhh---ccc--C-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111110 000 0 011123456788999999999999995 688874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=298.58 Aligned_cols=261 Identities=22% Similarity=0.264 Sum_probs=197.1
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ----- 232 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 232 (496)
...++|+..+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999864 6899999998643 223345778899999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 -GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
...++|+||+. ++|..++.. .+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~ 151 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 151 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 35799999995 578777631 2788899999999999999999988 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+.++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ..
T Consensus 152 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~ 226 (353)
T cd07850 152 KSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QW 226 (353)
T ss_pred CCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HH
Confidence 999999999999998764322 1233467889999999999999999999999999999999999886443210 00
Q ss_pred Hhhhh------------------hhccc-------ccccccCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040910 392 GHAWN------------------LWKDD-------RAWKLLDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMS 442 (496)
Q Consensus 392 ~~~~~------------------~~~~~-------~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 442 (496)
..... ..... ...++..... ...........+.+++.+||+.||.+|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 00000 00000 0000111000 0011112345678999999999999999999
Q ss_pred HHHHH
Q 040910 443 EVVSM 447 (496)
Q Consensus 443 evl~~ 447 (496)
|++++
T Consensus 307 eiL~~ 311 (353)
T cd07850 307 DALQH 311 (353)
T ss_pred HHhcC
Confidence 99865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=296.09 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=191.4
Q ss_pred cccccc--CCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEG--GFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
..||+| +||+||+++.. +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 99999999874 78999999986432 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.
T Consensus 84 ~~l~~~l~~~-------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 84 GSANSLLKTY-------------FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred CCHHHHHHhh-------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHH
Confidence 9999998642 1234888999999999999999999988 99999999999999999999999986
Q ss_pred ccccCCCcccc-----ccccccccccccChhhhccC--CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh-
Q 040910 325 ARMFGGDELQS-----NMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN- 396 (496)
Q Consensus 325 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~- 396 (496)
+.......... ......++..|+|||++.+. .++.++|||||||++|||++|..|+................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence 54332111000 01112345679999999763 57899999999999999999999986433211100000000
Q ss_pred --------------hhc----------------ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 --------------LWK----------------DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 --------------~~~----------------~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.+. ........+..+...........+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00000011111111122334567899999999999999999999985
Q ss_pred H
Q 040910 447 M 447 (496)
Q Consensus 447 ~ 447 (496)
+
T Consensus 308 ~ 308 (328)
T cd08226 308 H 308 (328)
T ss_pred C
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=288.76 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=195.9
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||.|+||.||++... +|+.+|+|.+..... ...+.+.+|+.++.+++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999886 489999999865432 3456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~l~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 81 ASLLEN---------------VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred HHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 999852 236899999999999999999999988 99999999999999999999999999886
Q ss_pred cCCCcc------ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 328 FGGDEL------QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 328 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
...... ........++..|+|||...+...+.++||||||++++|+++|..|+....... .... . ...
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~---~-~~~ 216 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQN---I-LNG 216 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---H-hcC
Confidence 533211 112234567889999999998889999999999999999999999876433211 1110 0 000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
.. ..+. .......+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 217 ~~---~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 217 KI---EWPE-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred Cc---CCCc-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 0000 00124567889999999999999999777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.44 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=193.5
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHh---cCCceeeeeeeeeecCe-----
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKL---HHRNLVRLFGCCIEQGE----- 234 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 234 (496)
|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999986 489999999974322 2234567788877776 59999999999988776
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.+++|||+. ++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~-------------~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~ 143 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSK-------------CPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSD 143 (287)
T ss_pred eEEEehhcc-cCHHHHHHH-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccC
Confidence 999999996 588888743 12235899999999999999999999988 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+.+||+|||++....... ......++..|+|||.+.+..++.++|+||||+++|||++|..|+....... .....
T Consensus 144 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~ 218 (287)
T cd07838 144 GQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKI 218 (287)
T ss_pred CCEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHH
Confidence 999999999998764332 1223457889999999999999999999999999999999988876433211 11111
Q ss_pred hhhhcc--------ccc--ccccCccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKD--------DRA--WKLLDPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~--------~~~--~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...... ... ........ ...........+.+++.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 000 00000000 01111233466788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=284.29 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=203.6
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|...+.||.|+||.||++... +++.+|+|++..... .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999875 588999999875432 4567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.... .....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 81 ADGGDLSQKIKKQK-----------KEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred cCCCcHHHHHHHhh-----------ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECC
Confidence 99999999986421 12467999999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++....... .......++..|+|||...+..++.++||||+|+++++|++|..|+....... ... .. ...
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~---~~-~~~ 218 (258)
T cd08215 147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL---KI-LKG 218 (258)
T ss_pred ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH---HH-hcC
Confidence 99998765432 12233468889999999999899999999999999999999999876433111 111 11 111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .+ .......+.+++.+||..+|.+||++.+++++
T Consensus 219 ~~~-----~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 QYP-----PI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 11 11223567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.78 Aligned_cols=241 Identities=25% Similarity=0.327 Sum_probs=188.7
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++||||+++.+++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~l~~-------------~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 81 KYHIYN-------------VGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred HHHHHH-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999853 12246899999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
.... .......++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ........ .
T Consensus 145 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~------~ 213 (277)
T cd05577 145 LKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLE------M 213 (277)
T ss_pred hccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcccc------c
Confidence 5432 12223467889999999998889999999999999999999999986543311100 00000000 0
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 443 (496)
. ..........+.+++.+||+.+|.+||+..+
T Consensus 214 ~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 214 A----VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred c----ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0 0111122456778999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=290.60 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=194.9
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChh
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 248 (496)
.+||+|+||.||++... +++.||||.+..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 68899999986554445667899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 249 FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 249 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 106 ~~~~----------------~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 106 DIVT----------------HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred HHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceec
Confidence 8773 124789999999999999999999988 999999999999999999999999998765
Q ss_pred CCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccC
Q 040910 329 GGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLD 408 (496)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 408 (496)
.... .......++..|+|||.+.+..++.++|+||||+++|||++|..|+...... ...... .. ...
T Consensus 167 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~----~~-----~~~ 233 (292)
T cd06657 167 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMI----RD-----NLP 233 (292)
T ss_pred cccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----Hh-----hCC
Confidence 4322 1123356789999999998888999999999999999999999987642211 111100 00 000
Q ss_pred ccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 409 PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 409 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+.+. ........+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1110 011123456788899999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.36 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=192.4
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34555666666666655 7899999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+.
T Consensus 86 l~~~l~~~-------------~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 86 CEDLLKTH-------------FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred HHHHHHHh-------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccce
Confidence 99998632 2234788899999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCcc-----ccccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh---
Q 040910 327 MFGGDEL-----QSNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN--- 396 (496)
Q Consensus 327 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~--- 396 (496)
....... ........++..|+|||++.+ ..++.++|||||||++|||++|..||......... ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~ 228 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML-LEKVRGTVP 228 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCc
Confidence 5532211 111233457788999999876 45889999999999999999999998643321111 100000
Q ss_pred -hhc-------cccccc----ccCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 -LWK-------DDRAWK----LLDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 -~~~-------~~~~~~----~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ...... ..++.. ...........+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 000000 011122334578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=293.38 Aligned_cols=268 Identities=21% Similarity=0.317 Sum_probs=193.6
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG----- 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 233 (496)
..++|+..++||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457888999999999999999874 68899999986432 222345678999999999999999999987654
Q ss_pred ---eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 234 ---EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 234 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
..++|+||+. ++|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil 151 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN--------------KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANIL 151 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 4599999996 578777742 2235899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccc--cccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
++.++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred ECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999866432211 122334678899999988764 47889999999999999999998876433211
Q ss_pred c-hhhHhhhhhh-----cccccccccC----ccccccCC------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 388 L-TLLGHAWNLW-----KDDRAWKLLD----PTLQNEAL------YPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 388 ~-~~~~~~~~~~-----~~~~~~~~~d----~~~~~~~~------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. .......... .........+ +....... ......+.+++.+||+.||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 0000000000 0000000000 00000000 0012356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=288.93 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=198.3
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
|...+.||+|++|.||++... +++.+|+|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999874 688999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 81 ~~-~l~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 81 DT-DLYKLIKD--------------RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred CC-CHHHHHHh--------------hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeee
Confidence 74 88887742 2246899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc-
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD- 400 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~- 400 (496)
|.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ...........
T Consensus 143 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~ 218 (283)
T cd05118 143 GLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTP 218 (283)
T ss_pred eeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCC
Confidence 9998765432 112234578899999998876 78999999999999999999998876433211 11000000000
Q ss_pred --cccccccC---------cccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 --DRAWKLLD---------PTLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 --~~~~~~~d---------~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.......+ +... ..........+.+++..||+.||.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 0000 01112335678899999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.32 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=195.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-----CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-----SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
.+|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999864 6889999987532 123345788999999999999999999998764 468
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~---------------~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---------------YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAG 143 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCC
Confidence 899999999999999842 234788899999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.++|+|||+++....... ........++..|+|||.+.+..++.++|+||||++++|+++|+.||..... ......
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~- 220 (264)
T cd06653 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIFK- 220 (264)
T ss_pred CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHHH-
Confidence 999999999986542211 1112235688999999999988899999999999999999999999863211 111100
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .. ...+......+.+++..||+ +|..||+..+++.+
T Consensus 221 --~~~~~-----~~----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 --IATQP-----TK----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --HHcCC-----CC----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00000 00 11122233567788899999 57999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=303.06 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=190.1
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEec----cCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe--eEEEEEe
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE--KILIYEY 241 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~ 241 (496)
...||+|+|-+||||... +|..||=-.++ .++....++|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 458999999999999763 46677632222 1234556899999999999999999999999987664 7899999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~ 320 (496)
+..|+|..|+..+ +.++.+.+.+|+.||++||.|||++. |||||||||-+||+|+. -|.|||+
T Consensus 125 ~TSGtLr~Y~kk~---------------~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---------------RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred ccCCcHHHHHHHh---------------ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeec
Confidence 9999999999643 45777899999999999999999975 78999999999999975 5799999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|+|||....... .....||+.|||||+.. ..|++.+||||||++++||+|+..|+..- .-...++..+..
T Consensus 189 DLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~S 258 (632)
T KOG0584|consen 189 DLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTS 258 (632)
T ss_pred chhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHc
Confidence 999999775432 33479999999999776 89999999999999999999999887531 112222222222
Q ss_pred c----ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 D----RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~----~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+ .+.++-| ..+.++|.+|+.. .++|||+.|+++.
T Consensus 259 GiKP~sl~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 259 GIKPAALSKVKD------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCCHHHhhccCC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2 2222222 2456788899999 8999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.10 Aligned_cols=266 Identities=25% Similarity=0.327 Sum_probs=196.8
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG---- 233 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 233 (496)
...++|++.+.||+|+||.||+|... +|+.||||.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 46678999999999999999999875 58899999997542 233456788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 234 ------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 234 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~ 145 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--------------GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCS 145 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 78999999975 66666631 2346899999999999999999999988 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
||++++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......
T Consensus 146 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 146 NILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999987643321 11222356778999998865 45789999999999999999999888643221
Q ss_pred cchhhHhhhhhhcccc-----------cccccCcccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDR-----------AWKLLDPTLQ-----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~-----------~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.............. .....++... ..........+.+++..||+.+|.+||++.+++.+
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 --AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred --HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111100000 0000000000 00000123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=291.43 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=199.6
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..+.|+.-+.||+||||.||-.+.. +|+.+|.|++.+. ...+..-..+|-.++.+++.+.||.+--.+.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999998764 6999999988643 23455667889999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+..|++|+|..+|.+. ....+++++...++.+|+.||.+||... ||+|||||+|||||+.|++
T Consensus 263 VLtlMNGGDLkfHiyn~-------------g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Ghv 326 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH-------------GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHV 326 (591)
T ss_pred EEEeecCCceeEEeecc-------------CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCe
Confidence 99999999999998642 2356999999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
+|+|.|+|..+.... .....+||.+|||||++.++.|+...|.||+||+||||+.|+.||.........
T Consensus 327 RISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------- 395 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------- 395 (591)
T ss_pred EeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------
Confidence 999999999876543 334459999999999999999999999999999999999999999754322110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
.+-+..-+-++.. +.....++...+....|+.||++|.-
T Consensus 396 -eEvdrr~~~~~~e---y~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 396 -EEVDRRTLEDPEE---YSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -HHHHHHHhcchhh---cccccCHHHHHHHHHHHccCHHHhcc
Confidence 0000000111211 22233445566667788999999974
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=297.48 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=198.3
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 235 (496)
..+|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++.+++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999764 68999999987542 2345678889999999999999999998763 3468
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++
T Consensus 84 ~lv~e~~~-~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~ 144 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---------------SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDC 144 (334)
T ss_pred EEEEehhh-hhHHHHhc---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCC
Confidence 99999995 68888873 2345899999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccc--cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch-hh
Q 040910 316 NPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT-LL 391 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~-~~ 391 (496)
.+||+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (334)
T cd07855 145 ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224 (334)
T ss_pred cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHH
Confidence 9999999999865432211 11233578899999999865 46899999999999999999999998643321100 00
Q ss_pred --------HhhhhhhcccccccccCc-ccccc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 392 --------GHAWNLWKDDRAWKLLDP-TLQNE-----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 392 --------~~~~~~~~~~~~~~~~d~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.........+...+..+. ..... ........+.+++..||+.+|.+||++.+++.+-
T Consensus 225 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000000001000000 00000 0112346788999999999999999999988753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.22 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=200.4
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|+..+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++.+++|||++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999765 578999999976543 3557899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~L~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 81 AENGSLRQIIKK---------------FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred CCCCcHHHHHHh---------------ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEec
Confidence 999999999842 256899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||++......... .....++..|+|||...+..++.++||||+|+++++|++|+.|+..... .. ..+.... .
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~---~~~~~~~-~ 214 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MA---ALFRIVQ-D 214 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HH---HHHHHhc-c
Confidence 9999876543221 2335678899999999888899999999999999999999998764321 11 0111100 1
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. +.. .......+.+++.+||+.+|++||++.+++.
T Consensus 215 ~~-----~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DH-----PPL----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC-----CCC----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 10 111 1112356778999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.69 Aligned_cols=244 Identities=23% Similarity=0.253 Sum_probs=187.5
Q ss_pred ccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHH-HhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIA-KLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.||+|+||.||+|... +++.||||.+..... .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999764 588999999865321 12233445554443 44899999999999999999999999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 82 ~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 82 GDCASLIKT---------------LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred CCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccc
Confidence 999999842 235889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... . +.........
T Consensus 144 ~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~ 211 (260)
T cd05611 144 SRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--V----FDNILSRRIN 211 (260)
T ss_pred ceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHhcccC
Confidence 875432 223467889999999998889999999999999999999999986432211 1 1111000000
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
..+ .........+.+++.+||+.+|++||++.++.+.|+
T Consensus 212 --~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 212 --WPE----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --CCC----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 000 011122356788999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.85 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=192.2
Q ss_pred cCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|...+.||+|+||.||+|...+ ++.||||.++.... ....++..|+.++.+. .||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999864 88999999975432 2345667788777777 49999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|++ ++|..++.. ....+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||
T Consensus 95 ~~~-~~l~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 95 LMS-TCLDKLLKR--------------IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred ccC-cCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEE
Confidence 984 577666642 123689999999999999999999974 5 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCC----CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+|||++..+..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... .....
T Consensus 157 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~-- 230 (296)
T cd06618 157 CDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTK-- 230 (296)
T ss_pred CccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHH--
Confidence 99999986543221 12235778999999987553 8899999999999999999999986422111 11111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ........ .......+.+++.+||+.+|.+||++.+++++
T Consensus 231 -~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 231 -ILQ-EEPPSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -Hhc-CCCCCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 11100000 00123567889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=288.09 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=194.8
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEec
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
|.+.+.||+|++|+||+|... +++.||||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999875 478999999875432 22234567899999998 999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
+|+|.+++.. .....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 81 -~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 81 -EGNLYQLMKD-------------RKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred -CCCHHHHHHh-------------cccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeec
Confidence 8899888853 12346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh----------
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL---------- 391 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~---------- 391 (496)
|++....... ......++..|+|||.+. +..++.++|+||||++++||++|+.|+...........
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07830 144 GLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220 (283)
T ss_pred ccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence 9998654322 122346788999999875 45679999999999999999999988865432111000
Q ss_pred -HhhhhhhcccccccccCccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 -GHAWNLWKDDRAWKLLDPTL---QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 -~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.............+.... ...........+.+++.+||+.+|++||++.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000000000000 000011113568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.67 Aligned_cols=270 Identities=20% Similarity=0.282 Sum_probs=187.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecC--CCEEEEE------------------EeccCCccCHHHHHHHHHHHHHhcCCc
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN--GEEVAVK------------------RLSNKSGQGVEEFKNEMILIAKLHHRN 221 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 221 (496)
...+|.+.++||+|+||.||++.... +..+++| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999986532 2222222 111 11223456889999999999999
Q ss_pred eeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 040910 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIH 301 (496)
Q Consensus 222 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 301 (496)
|+++++++...+..++|+|++. ++|..++..... .............++.||+.||+|||+.+ |+|
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----------~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiH 290 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF----------DWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIH 290 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc----------cccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999984 567677643211 11122345667789999999999999988 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
|||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999999987653321 11223578999999999999999999999999999999999885432
Q ss_pred CCCC-CcchhhHhhhhhhc--cc-------ccccccCccc---cccCCHH------HHHHHHHHHHHhcccCCCCCCCHH
Q 040910 382 FYNI-DSLTLLGHAWNLWK--DD-------RAWKLLDPTL---QNEALYP------MVKRYIKVALLCVQENAADRPTMS 442 (496)
Q Consensus 382 ~~~~-~~~~~~~~~~~~~~--~~-------~~~~~~d~~~---~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~ 442 (496)
.... .............. .. +..+.++... ....... ....+.+++.+||+.||.+|||+.
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~ 449 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA 449 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence 2211 11111100000000 00 0000100000 0000000 123466778899999999999999
Q ss_pred HHHHH
Q 040910 443 EVVSM 447 (496)
Q Consensus 443 evl~~ 447 (496)
|++++
T Consensus 450 elL~h 454 (501)
T PHA03210 450 ELLAL 454 (501)
T ss_pred HHhhC
Confidence 99874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=286.89 Aligned_cols=255 Identities=23% Similarity=0.282 Sum_probs=197.8
Q ss_pred CCCccccccccCCeeEEEEEe----cCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 165 NFSEENKLGEGGFGPVYKGKL----LNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
+|+..+.||+|++|.||+++. .+++.||||.++... ....+.+.+|+.++.++ +||||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999975 357889999986432 23345788999999999 699999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|..++. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++
T Consensus 81 ~lv~e~~~~~~L~~~~~---------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 81 HLILDYVNGGELFTHLY---------------QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEG 142 (288)
T ss_pred EEEEecCCCCcHHHHHh---------------hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCC
Confidence 99999999999999884 2345889999999999999999999987 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCC--CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
.++|+|||+++.+...... ......++..|+|||.+.+.. .+.++||||||+++|||++|..|+........ ....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~ 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEI 220 (288)
T ss_pred CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHH
Confidence 9999999999865433211 112346788999999987765 78899999999999999999999864322111 0000
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
....... .+. ........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 221 ~~~~~~~-------~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SRRILKS-------KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHcc-------CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0010000 011 111123456788999999999999999998887755
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.32 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=193.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478988999999999999999864 68999999986432 223456889999999999999999999987543
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++|+||+. .+|..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~ 152 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----------------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNE 152 (342)
T ss_pred eEEEEecccc-cCHHHHH-----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 5689999996 4665544 124889999999999999999999988 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 153 ~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~ 225 (342)
T cd07879 153 DCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLT 225 (342)
T ss_pred CCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999864321 223467889999999876 468999999999999999999999987533211 111
Q ss_pred hhhhh-----------hcccccccccC--ccccccC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 040910 393 HAWNL-----------WKDDRAWKLLD--PTLQNEA----LYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNE 451 (496)
Q Consensus 393 ~~~~~-----------~~~~~~~~~~d--~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 451 (496)
..... ........... +...... .+.....+.+++..||+.||++||++++++.+ ++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 00000000000 0000000 01123457899999999999999999999965 6664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=290.38 Aligned_cols=250 Identities=32% Similarity=0.432 Sum_probs=194.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666789999999999999864 5789999998642 2223457888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+. |+|..++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|
T Consensus 95 e~~~-~~l~~~~~~--------------~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 95 EYCL-GSASDLLEV--------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred EccC-CCHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEE
Confidence 9996 688777642 2345789999999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||++...... ....++..|+|||.+. ...++.++|||||||++|||++|..|+....... .....
T Consensus 157 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~-- 226 (308)
T cd06634 157 GDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI-- 226 (308)
T ss_pred CCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHH--
Confidence 999998765322 2346788999999975 3567889999999999999999998875322111 00000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..... +... .......+.+++.+||+.+|++||++.+++.+.-..
T Consensus 227 --~~~~~-----~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 227 --AQNES-----PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred --hhcCC-----CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00000 1111 112335577899999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=274.39 Aligned_cols=207 Identities=28% Similarity=0.432 Sum_probs=169.9
Q ss_pred hcCCCccccccccCCeeEEEEEecC-----CCEEEEEEeccCC-ccC-HHHHHHHHHHHHHhcCCceeeeeeeeee-cCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKS-GQG-VEEFKNEMILIAKLHHRNLVRLFGCCIE-QGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 234 (496)
-..|+....||+|.||.||+|.-.+ .+.+|||+++... ..+ .....+|+.+++.++||||+.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3567888899999999999995432 3379999997542 222 2456889999999999999999999987 778
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++++||.+. +|...+..++. ...+.++-..+.+|+.||+.|++|||++. |+||||||.|||+..+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~----------~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRA----------SKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGD 168 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhcc----------chhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEecc
Confidence 9999999965 56666654331 23357899999999999999999999987 9999999999999887
Q ss_pred ----CceEEeccccccccCCCc-cccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 315 ----MNPKISDFGIARMFGGDE-LQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 315 ----~~~kl~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
|.+||+|||+++.+.+.- .......++-|+.|+|||.+.|. .||.+.|||+.|||+.||++-.+-|...
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 899999999999886542 22234567889999999999885 5899999999999999999988777543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=287.53 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=200.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 238 (496)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999875 6899999998643 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++
T Consensus 81 ~e~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 81 LEYAPNGELLQYIRK---------------YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred EcCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 999999999999842 236999999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccc------------------cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCC
Q 040910 319 ISDFGIARMFGGDELQ------------------SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 319 l~DFgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
|+|||++......... .......++..|+|||...+..++.++||||||++++++++|+.|+
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999876543211 1122346788999999999888999999999999999999999988
Q ss_pred CCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 040910 381 RFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM----SEVVS 446 (496)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~evl~ 446 (496)
...... ....... .. ...........+.+++..||+.+|.+||++ +++++
T Consensus 223 ~~~~~~--~~~~~~~------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 223 RGSNEY--LTFQKIL------KL--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCccHH--HHHHHHH------hc--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 744311 1111100 00 001111224567899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=283.25 Aligned_cols=242 Identities=26% Similarity=0.316 Sum_probs=186.1
Q ss_pred cccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHH---HHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 171 KLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILI---AKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.||+|+||.||++... +++.||+|.+..... .....+..|..++ +...||||+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 588999999865421 1222344454443 33479999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|..++. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 g~~L~~~l~---------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 81 GGDLHYHLS---------------QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred CCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCc
Confidence 999998884 2346999999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++..+.... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.............. .
T Consensus 143 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~---- 211 (278)
T cd05606 143 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T---- 211 (278)
T ss_pred CccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---h----
Confidence 997654321 2234689999999998754 689999999999999999999999865422211111000 0
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
....+.+ .......+.+++.+|++.+|.+|| ++.+++++
T Consensus 212 --~~~~~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 --LTMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --hccCCCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011111 111245678899999999999999 89998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=290.33 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=193.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
.++|++.++||+|+||.||+|... +++.+|||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 588999999864432 22346788999999999999999999875443
Q ss_pred --eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 234 --EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 234 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
..++|+||+.. +|..++.. ....+++..+..++.|+++||+|||+.+ ++|+||||+||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--------------~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~ 148 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--------------PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILI 148 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 46999999964 66666632 2346899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccc---------cccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQ---------SNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
++++.++|+|||+++........ .......++..|+|||.+.+. .++.++||||||+++|||++|++|+.
T Consensus 149 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 149 DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999865432211 111234568889999988654 58999999999999999999999886
Q ss_pred CCCCCcchhhHhhhhhhccc---------cccc----ccCcccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 382 FYNIDSLTLLGHAWNLWKDD---------RAWK----LLDPTLQ---NEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~---------~~~~----~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
...... .....+...... .... ....... ..........+.+++.+|++.+|.+|||+.+++
T Consensus 229 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 229 GKSDID--QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred CCCHHH--HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 433211 111111100000 0000 0000000 000111225678999999999999999999987
Q ss_pred H
Q 040910 446 S 446 (496)
Q Consensus 446 ~ 446 (496)
.
T Consensus 307 ~ 307 (311)
T cd07866 307 E 307 (311)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=284.93 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=193.4
Q ss_pred CCCccccccccCCeeEEEEEe----cCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 165 NFSEENKLGEGGFGPVYKGKL----LNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999976 368899999987432 22346788999999999 699999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++
T Consensus 81 ~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---------------RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNG 142 (290)
T ss_pred EEEEecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCC
Confidence 999999999999999842 345788999999999999999999988 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccC--CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
.+||+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAEI 220 (290)
T ss_pred CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHHH
Confidence 999999999986543221 122235688899999998753 478899999999999999999999864322111 1111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVS 446 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 446 (496)
....... .+. ........+.+++.+||+.+|++|| +..+++.
T Consensus 221 ~~~~~~~-------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKS-------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhcc-------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111000 000 1111234677899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.74 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=203.9
Q ss_pred CCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
-|.+...||.|+||.||+|...+ +-..|-|.+........++|+-|+++|+..+||+||+|++.|...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45567789999999999997654 34557888877777888999999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
||-.+..+.. -...|+..++.-++.|++.||.|||+.. |||||||+.|||++-+|.++|+|||
T Consensus 113 GGAVDaimlE--------------L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 113 GGAVDAIMLE--------------LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred CchHhHHHHH--------------hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccc
Confidence 9999988863 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
.+..... ....-..+.||+.|||||+.+ +.+|+.++||||||+.|.||.-+.+|....++ +.++ ...
T Consensus 176 VSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVl----lKi 247 (1187)
T KOG0579|consen 176 VSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL----LKI 247 (1187)
T ss_pred ccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHH----HHH
Confidence 9864321 122334578999999999986 56899999999999999999999988653221 1111 111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. +.-.|.+. .+..+...+.+++..||..||..||++.+++++
T Consensus 248 a-----KSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 A-----KSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred h-----hcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 11122221 234566778899999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.81 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=197.6
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
..++...+++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456677889999999999999999999975 468899999986432 22346788899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040910 233 ------GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 306 (496)
Q Consensus 233 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 306 (496)
...+++++++ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp 148 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKP 148 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 3467788776 789987773 234889999999999999999999988 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....
T Consensus 149 ~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 149 SNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred HHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998864321 223467889999999876 5688999999999999999999998864332
Q ss_pred CcchhhHhhhhh--hccccccccc----------------CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 386 DSLTLLGHAWNL--WKDDRAWKLL----------------DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 386 ~~~~~~~~~~~~--~~~~~~~~~~----------------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ........ .........+ ..... .........+.+++..|++.+|.+||++.+++.+
T Consensus 224 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 224 ID--QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HH--HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11 10000000 0000000000 00000 0000123457899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.01 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=201.4
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----eeE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----EKI 236 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 236 (496)
+|.+.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 48899999987543 344568899999999999999999999998775 789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||++ ++|..++. ....+++..+..++.||+.||+|||+.+ |+|+||||.|||++.++.
T Consensus 81 lv~e~~~-~~l~~~l~---------------~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~ 141 (330)
T cd07834 81 IVTELME-TDLHKVIK---------------SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCD 141 (330)
T ss_pred EEecchh-hhHHHHHh---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 9999997 57888773 2337899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCcc-ccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... .....
T Consensus 142 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i 219 (330)
T cd07834 142 LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLI 219 (330)
T ss_pred EEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHH
Confidence 99999999987654321 0123345678899999999887 89999999999999999999999986543211 00000
Q ss_pred hhhh-----------cccccccccCc---c---ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 040910 395 WNLW-----------KDDRAWKLLDP---T---LQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKN 450 (496)
Q Consensus 395 ~~~~-----------~~~~~~~~~d~---~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~ 450 (496)
.... ......+.+.. . -...........+.+++..||+.+|.+||++.+++++ +++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000 00000000000 0 0000011134567889999999999999999999985 554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=288.35 Aligned_cols=244 Identities=31% Similarity=0.446 Sum_probs=190.6
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
|...++||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|||++++.+++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455678999999999999864 688999999864322 2335688899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+. |+|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 103 ~~-~~l~~~l~~--------------~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 103 CL-GSASDLLEV--------------HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred CC-CCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEee
Confidence 95 677777642 2345899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
||++.... ......|+..|+|||++. ...++.++||||||+++|||++|..|+..... ....... .
T Consensus 165 fg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~---~ 233 (313)
T cd06633 165 FGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHI---A 233 (313)
T ss_pred cCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH---H
Confidence 99986432 122356888999999984 45688999999999999999999998754321 1111110 0
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ... +... .......+.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~-~~~-----~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 Q-NDS-----PTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred h-cCC-----CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 1111 11122457789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.99 Aligned_cols=203 Identities=30% Similarity=0.466 Sum_probs=174.5
Q ss_pred CCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------CeeEE
Q 040910 166 FSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------GEKIL 237 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 237 (496)
+...+.||+|+||.||+|+. .+|+.||||.++.. .....+...+|++++++++|+|||++++.=.+. ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999985 57999999999754 345678889999999999999999999875543 36789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe--cCCC
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL--DGDM 315 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~ 315 (496)
|||||.+|||...+. .+.+...|++...+.++.+++.||.|||+++ |+||||||.||++ .++|
T Consensus 95 vmEyC~gGsL~~~L~------------~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedg 159 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLN------------SPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDG 159 (732)
T ss_pred EEeecCCCcHHHHhc------------CcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCC
Confidence 999999999999996 3445566999999999999999999999988 9999999999999 3444
Q ss_pred c--eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 316 N--PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 316 ~--~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+ .||+|||.|+.++.+. .....+||..|.+||.... +.|+..+|.|||||++|+.+||..||......
T Consensus 160 q~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 160 QSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 4 6999999999876543 5667899999999999984 88999999999999999999999999765433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=269.17 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=193.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++...+..||.|+.|.||+.+.. +|..+|||.+.... .+..++....+.++.+- ++|.||+.+|||..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 33445668999999999999875 58999999997543 34445666667666655 48999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
.| ..-+++++. ..++++++..+=++...++.||.||.++. .|+|||+||+|||+|+.|++|++
T Consensus 172 lM-s~C~ekLlk--------------rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 172 LM-STCAEKLLK--------------RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred HH-HHHHHHHHH--------------HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 98 445555554 34566888888899999999999998765 59999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||++..+-.+ ...+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+..-..+-..+. .+.
T Consensus 235 DFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kvl-- 308 (391)
T KOG0983|consen 235 DFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KVL-- 308 (391)
T ss_pred cccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HHH--
Confidence 99999765432 23445688999999999864 4689999999999999999999999876444322221 111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.++. |.+.... .....+.++...||+.|+.+||...+++++
T Consensus 309 --n~eP-----P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 309 --NEEP-----PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --hcCC-----CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111 2221111 134678888999999999999999998865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=291.89 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=194.4
Q ss_pred cCCCc-cccccccCCeeEEEEEec-CCCEEEEEEeccCCccC--------------HHHHHHHHHHHHHhcCCceeeeee
Q 040910 164 HNFSE-ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQG--------------VEEFKNEMILIAKLHHRNLVRLFG 227 (496)
Q Consensus 164 ~~f~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 227 (496)
++|.. .+.||+|+||.||+|... +++.||||.++...... ...+.+|++++.+++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999864 68999999986432211 125778999999999999999999
Q ss_pred eeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 228 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
++...+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+.+ ++|+||+|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---------------~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~ 148 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---------------RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPA 148 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH
Confidence 9999999999999996 68888884 2345889999999999999999999988 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCcc------------ccccccccccccccChhhhccC-CCCccccchhhhHHHHHHH
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDEL------------QSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETL 374 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~ell 374 (496)
||+++.++.++|+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999986652111 1112223567889999998764 4689999999999999999
Q ss_pred hCCCCCCCCCCCcchhhHhhhhhhcccccc-----------cccC---ccccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 375 SSKKNTRFYNIDSLTLLGHAWNLWKDDRAW-----------KLLD---PTLQNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 375 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
+|..|+....... ............... .... +.............+.+++..||+.+|++||+
T Consensus 229 tg~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 306 (335)
T PTZ00024 229 TGKPLFPGENEID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306 (335)
T ss_pred hCCCCCCCCCHHH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC
Confidence 9999886443211 111111111000000 0000 00000011122456789999999999999999
Q ss_pred HHHHHHH
Q 040910 441 MSEVVSM 447 (496)
Q Consensus 441 ~~evl~~ 447 (496)
+++++.+
T Consensus 307 ~~~~l~~ 313 (335)
T PTZ00024 307 AKEALKH 313 (335)
T ss_pred HHHHhcC
Confidence 9999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=282.56 Aligned_cols=260 Identities=28% Similarity=0.360 Sum_probs=197.7
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+||+++.+++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999875 48999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
+ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+||
T Consensus 81 ~-~~l~~~i~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 81 D-MDLKKYLDK--------------RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred C-cCHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecC
Confidence 7 689999853 1146899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh-------
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA------- 394 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~------- 394 (496)
|+++....... ......++..|+|||.+.+. .++.++||||||+++||+++|+.|+....... .....
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~ 218 (282)
T cd07829 143 GLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTP 218 (282)
T ss_pred CcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCC
Confidence 99987643321 22234567789999998776 88999999999999999999988875433211 11000
Q ss_pred ----hhhhcccccccccCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 ----WNLWKDDRAWKLLDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ----~~~~~~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
|..+......+..-+.. .....+.....+.+++..||+.+|++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 10000000000000000 001111124568999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=292.48 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=194.5
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC---
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG--- 233 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 233 (496)
....++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999754 68999999985432 223456889999999999999999999987553
Q ss_pred ---eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 234 ---EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 234 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
..++|+||+ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nil 150 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----------------HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLA 150 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 458999998 778887773 235889999999999999999999988 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||++++++++|..||.........
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999865322 223467889999999876 45889999999999999999999998643221100
Q ss_pred hh---------HhhhhhhcccccccccC--ccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 390 LL---------GHAWNLWKDDRAWKLLD--PTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 390 ~~---------~~~~~~~~~~~~~~~~d--~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. ......+.......... +.... .........+.+++.+|++.||.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000000000 00000 000112345789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.71 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=181.8
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG---- 233 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 233 (496)
+.-.++|++++.||+||||.|||++.+ ||+.+|||++.... ........+|+..+++|+|||||+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 556788999999999999999999764 89999999997543 333456788999999999999999987554311
Q ss_pred --------------------------------------------------------------------------------
Q 040910 234 -------------------------------------------------------------------------------- 233 (496)
Q Consensus 234 -------------------------------------------------------------------------------- 233 (496)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCC-ChhhH
Q 040910 234 -----------------------------------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTR 277 (496)
Q Consensus 234 -----------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l-~~~~~ 277 (496)
.+|+-||||+..+|..++.... .. .-...
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---------------~~~~~d~~ 699 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---------------FNSQRDEA 699 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---------------cchhhHHH
Confidence 1233444444444444442210 01 24567
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccC----C------------Ccccccccccc
Q 040910 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG----G------------DELQSNMNRIV 341 (496)
Q Consensus 278 ~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~----~------------~~~~~~~~~~~ 341 (496)
++++.+|+.||+|+|+.+ ||||||||.||+||++..+||+|||+|.... . .......+..+
T Consensus 700 wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V 776 (1351)
T KOG1035|consen 700 WRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV 776 (1351)
T ss_pred HHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence 899999999999999998 9999999999999999999999999998721 0 00111345678
Q ss_pred ccccccChhhhccC---CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHH
Q 040910 342 GTYGYMSPEYALHG---LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYP 418 (496)
Q Consensus 342 gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 418 (496)
||.-|+|||++.+. .|+.|+|+||+||||+||+. ||.... +-.... ...+.+.. ..+ .+...+
T Consensus 777 GTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----ERa~iL-~~LR~g~i---P~~---~~f~~~ 842 (1351)
T KOG1035|consen 777 GTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----ERASIL-TNLRKGSI---PEP---ADFFDP 842 (1351)
T ss_pred ceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH----HHHHHH-HhcccCCC---CCC---cccccc
Confidence 99999999999765 49999999999999999974 333211 111110 11111111 111 122333
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 419 MVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 419 ~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
....-.+++.|+++.||++|||+.|++.
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3444568899999999999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=280.43 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=194.0
Q ss_pred CCCccccccccCCeeEEEEEecC-CCEEEEEEeccC-----CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNK-----SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
+|.+.++||+|+||.||+++... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999997643 445666665431 122344677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||+++++|..++.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.++
T Consensus 81 ~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-----------HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred EEeCCCCCHHHHHHHHh-----------hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEe
Confidence 99999999999886422 23456899999999999999999999988 999999999999975 5699
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+..... .......
T Consensus 146 l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~- 217 (260)
T cd08222 146 IGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRI- 217 (260)
T ss_pred ecccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH-
Confidence 99999998664322 112234678899999999888899999999999999999999998753221 1111000
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ..+. ........+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 VEG-----PTPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HcC-----CCCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 001 0111 122334577889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.37 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=196.5
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeee-cCee
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-QGEK 235 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 235 (496)
...+++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999764 7899999988643 22345678899999999999999999999865 5578
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+ +++|..++. ...+++.....++.|++.||+|||+.+ |+|+||+|+||++++++
T Consensus 86 ~lv~e~~-~~~L~~~~~----------------~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----------------SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENC 145 (328)
T ss_pred EEEeehh-ccCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCC
Confidence 9999998 568887773 234778888999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh---
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL--- 391 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~--- 391 (496)
.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........
T Consensus 146 ~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 146 DLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred CEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999754321 223456889999998766 5789999999999999999999998865432110000
Q ss_pred ------HhhhhhhcccccccccCc-cccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 ------GHAWNLWKDDRAWKLLDP-TLQNEAL-----YPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ------~~~~~~~~~~~~~~~~d~-~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
......+...+..+.+.. ....... ......+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000011000 0000001 1123578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.33 Aligned_cols=263 Identities=23% Similarity=0.280 Sum_probs=193.0
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec---------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--------- 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 232 (496)
..+|...+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367888999999999999999764 6889999998766656677889999999999999999999876544
Q ss_pred -----CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 233 -----GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 233 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
...++|+||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~ 143 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----------------QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 35789999996 58877773 234889999999999999999999988 999999999
Q ss_pred CEEec-CCCceEEeccccccccCCCccc-cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 308 NVLLD-GDMNPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 308 NIll~-~~~~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
||+++ +++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99997 5567899999999865432111 11123457889999998754 568899999999999999999999986433
Q ss_pred CCcchhhHhhhhhh--cc---cccccccCc-----cccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 385 IDSLTLLGHAWNLW--KD---DRAWKLLDP-----TLQN-----EALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 385 ~~~~~~~~~~~~~~--~~---~~~~~~~d~-----~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...... ....... .. ......... .... .........+.+++.+||+.||.+|||+.+++.
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 224 ELEQMQ-LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHH-HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 211000 0000000 00 000000000 0000 001112356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.61 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=204.3
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..+-++.....||.|.||.||-|.. .+|...|+|-++... ........+|+.++..++|||+|+.+|+=.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3455677788999999999999965 568999999876443 3455678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
.||||++|+|.+.+. ..+..++.....+..|++.|++|||+++ ||||||||.||||+.+|.+
T Consensus 1312 FMEyC~~GsLa~ll~---------------~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---------------HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHhccCcHHHHHH---------------hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcE
Confidence 999999999999984 3344666677778999999999999999 9999999999999999999
Q ss_pred EEeccccccccCCCc--cccccccccccccccChhhhccC---CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 318 KISDFGIARMFGGDE--LQSNMNRIVGTYGYMSPEYALHG---LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 318 kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
|++|||.|..+.+.. .........||+-|||||++.+. ....++||||+|||++||+||++|+...+....-..
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy- 1452 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY- 1452 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-
Confidence 999999999886542 12223456899999999999764 467889999999999999999999875544322111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.+..+.. +..+......-.+++..|++.||++|.++.|++++=
T Consensus 1453 ----~V~~gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1453 ----HVAAGHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ----HHhccCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1111111 122222445567888899999999999988877664
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.69 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=190.1
Q ss_pred CCCccccccccCCeeEEEEEec-C--CCEEEEEEeccCC--ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec----Ce
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-N--GEEVAVKRLSNKS--GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ----GE 234 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 234 (496)
+|.+.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999874 3 6799999986432 22346788899999999 599999999875433 35
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~ 141 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---------------SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNAD 141 (332)
T ss_pred EEEEEeccc-CCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCC
Confidence 678888885 68888873 2346889999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccc--cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 315 MNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+.+||+|||+++.+...... .......|+..|+|||.+.+ ..++.++|+||||+++|++++|..||....... ..
T Consensus 142 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~ 219 (332)
T cd07857 142 CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QL 219 (332)
T ss_pred CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HH
Confidence 99999999999866432211 11233578999999998765 568999999999999999999998886533211 00
Q ss_pred Hh-----------hhhhhcccccccccC-----ccc-cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 392 GH-----------AWNLWKDDRAWKLLD-----PTL-QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 392 ~~-----------~~~~~~~~~~~~~~d-----~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. .+..+.......... +.. ...........+.+++.+|++.+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 220 NQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000000000000000 000 00000111346788999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=290.02 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=203.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
-...|.+...||+|.|+.|.+|+.. ++..||||.+.+.. ......+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4467888899999999999999874 68999999987543 23345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||..+|.+.+|+.. .+.........++.|+.+|++|||+++ |+|||||++||||+.+.++|
T Consensus 134 ~eya~~ge~~~yl~~---------------~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK---------------HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIK 195 (596)
T ss_pred EEeccCchhHHHHHh---------------cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhccccccccee
Confidence 999999999999964 233445778889999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||++..+... ....+.+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+........
T Consensus 196 IaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------- 264 (596)
T KOG0586|consen 196 IADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------- 264 (596)
T ss_pred eeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------
Confidence 9999999987643 33455799999999999998776 68899999999999999999999854432211
Q ss_pred hcccccccccCccccc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
++.+.. ..+.-....+-+++++++-.+|.+|++++++.+.
T Consensus 265 ----------~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 ----------PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----------chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1122224567788999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=290.82 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=195.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe----
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE---- 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 234 (496)
..++|...+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 5789999998643 22334567889999999999999999998876654
Q ss_pred --eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 235 --KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 235 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----------------~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~ 152 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----------------CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVN 152 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC
Confidence 89999998 679988873 235899999999999999999999988 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||....... ..
T Consensus 153 ~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~ 225 (343)
T cd07851 153 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QL 225 (343)
T ss_pred CCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 9999999999999865422 233467889999999865 467899999999999999999999886432211 01
Q ss_pred Hhhhh-----------hhcccccccccCc---cccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWN-----------LWKDDRAWKLLDP---TLQN---EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~-----------~~~~~~~~~~~d~---~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .+........+.. .... .........+.+++.+||+.+|.+|||+.+|+++
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 0000 0001124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=271.52 Aligned_cols=236 Identities=28% Similarity=0.342 Sum_probs=191.0
Q ss_pred ccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999875432 2456889999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 81 FSHLSK---------------EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence 999842 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... .......++..|+|||.+.+...+.++|+||||+++||+++|..|+..... ....... ... ..
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~----~~~---~~- 210 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI----LKD---PL- 210 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH----hcC---CC-
Confidence 64332 123345678899999999988899999999999999999999999864332 1111111 000 00
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 443 (496)
.........+.+++.+||..||++||++.+
T Consensus 211 ------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 ------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011111356788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=269.23 Aligned_cols=242 Identities=23% Similarity=0.255 Sum_probs=195.4
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|..++.||+|.||.|-+++-+ +++.+|+|++++.- ...+..-..|-++|+.-+||.+..|.-.++..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478899999999999999999754 78999999998653 2334445668889999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||..+|.|-.+| .....+++.+...+-..|+.||.|||+.+ ||+||||.+|.|||.+|++
T Consensus 246 VMeyanGGeLf~HL---------------srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---------------SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred EEEEccCceEeeeh---------------hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCce
Confidence 99999999997777 34567888888889999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++.-- .+...+.+.+||+.|+|||++.+..|...+|.|.+||++|||++|+.||...+.+...-+..+
T Consensus 308 KitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--- 382 (516)
T KOG0690|consen 308 KITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--- 382 (516)
T ss_pred Eeeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---
Confidence 999999998421 234567788999999999999999999999999999999999999999875444322111100
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP 439 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 439 (496)
.++--|+ ....+...|+.-.|..||.+|.
T Consensus 383 ------ed~kFPr-------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 ------EDLKFPR-------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------hhccCCc-------cCCHHHHHHHHHHhhcChHhhc
Confidence 1111111 1123344566678899999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=269.81 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=197.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+.+.+..||.|+||+|+|-.++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3344568999999999998764 699999999986544 5567888888877666 799999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
| .-||+.+...- ....+..+++..+-+|+.-.+.||.||-..- .|||||+||+|||||..|.+||||
T Consensus 145 M-d~SlDklYk~v----------y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 145 M-DISLDKLYKRV----------YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred H-hhhHHHHHHHH----------HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeec
Confidence 9 67887776421 1124556888888899999999999998754 599999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhc--cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL--HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
||++..+..+ -..+..+|-..|||||.+. +..|+.++||||||+.|+|+.||+.|....+. ...+......
T Consensus 212 FGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~ 284 (361)
T KOG1006|consen 212 FGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVI 284 (361)
T ss_pred ccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHc
Confidence 9999876432 2234457888999999986 34699999999999999999999988764332 2222222111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+....+..+ .........+..++-.|+..|.++||.+.++.++
T Consensus 285 -gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 -GDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -CCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111111 1112344567888888999999999999987653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=305.29 Aligned_cols=145 Identities=28% Similarity=0.429 Sum_probs=129.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999875 68899999997532 222467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|..++.. ...+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||
T Consensus 84 Ey~~g~~L~~li~~---------------~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 84 EYLIGGDVKSLLHI---------------YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred eCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEE
Confidence 99999999999842 235788899999999999999999987 999999999999999999999
Q ss_pred ecccccc
Q 040910 320 SDFGIAR 326 (496)
Q Consensus 320 ~DFgla~ 326 (496)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=265.04 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=196.4
Q ss_pred ccccccCCeeEEEEE-ecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
+.||+|+|+.|--++ +.+|..+|||++.+.......+..+|++++..- .|+||++|+.+|.++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998875 468999999999888777788899999999998 699999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc---eEEecccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN---PKISDFGI 324 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFgl 324 (496)
..++. ....+++.+..+++.+|+.||.|||.++ |.||||||+|||...... +||+||.+
T Consensus 164 LshI~---------------~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 164 LSHIQ---------------KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred HHHHH---------------HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 99995 3556899999999999999999999999 999999999999965543 79999998
Q ss_pred ccccCCC-----ccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 325 ARMFGGD-----ELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 325 a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
..-+... .......+.+|+..|||||++. ...|+.+.|.||||||||-||+|.+||......+..
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----- 300 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----- 300 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC-----
Confidence 7643211 1122234578999999999874 346899999999999999999999999865443221
Q ss_pred hhhhcccccc--------cccCccccccCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAW--------KLLDPTLQNEAL----YPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~--------~~~d~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
|..++.. +.|.... -+++ ........+++...+..++.+|.++.+++.
T Consensus 301 ---WdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 ---WDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---ccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111 1111000 0111 122345567777888899999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.09 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=193.1
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
.+.||.|-||+||-|+.+ +|+.||||.+.+. ...+...+++|+.+|++++||.||.|...|.+.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999874 7999999998653 3345578999999999999999999999999999999999999 55
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC---CceEEecc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD---MNPKISDF 322 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DF 322 (496)
+..+.+.. ..++.|+...-..++.||+.||.|||.++ |+|+||||+||||... -++||+||
T Consensus 648 DMLEMILS-------------sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 648 DMLEMILS-------------SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hHHHHHHH-------------hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccc
Confidence 55555532 45677999888999999999999999998 9999999999999643 47999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+|+.++...+. ..++||+.|+|||++.+..|+..-|+||.|||+|--++|..||.....-. +-.+.+..
T Consensus 712 GfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-dQIQNAaF------ 781 (888)
T KOG4236|consen 712 GFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-DQIQNAAF------ 781 (888)
T ss_pred cceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-HHhhcccc------
Confidence 999999866544 34799999999999999999999999999999999999998886422111 11111100
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
+. ......+.....++++...||..-.+|-|...-+
T Consensus 782 ---My----Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 782 ---MY----PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---cc----CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 00 0111223334567788888888888888876654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=267.36 Aligned_cols=220 Identities=18% Similarity=0.120 Sum_probs=174.5
Q ss_pred cCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhh
Q 040910 175 GGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFD 253 (496)
Q Consensus 175 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 253 (496)
|.+|.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999764 68899999987543 234455555666899999999999999999999999999999999853
Q ss_pred cccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcc
Q 040910 254 YKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333 (496)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~ 333 (496)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+......
T Consensus 79 ---------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-- 138 (237)
T cd05576 79 ---------------FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-- 138 (237)
T ss_pred ---------------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence 234899999999999999999999988 999999999999999999999999988765432
Q ss_pred ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccc
Q 040910 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413 (496)
Q Consensus 334 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 413 (496)
.....++..|+|||.+.+..++.++||||+|+++|||++|..++....... .... .+ .
T Consensus 139 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~--~~---~--- 196 (237)
T cd05576 139 ---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHT--TL---N--- 196 (237)
T ss_pred ---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cccc--cc---C---
Confidence 222345678999999988889999999999999999999997754211100 0000 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040910 414 EALYPMVKRYIKVALLCVQENAADRPTMS 442 (496)
Q Consensus 414 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 442 (496)
.+......+.+++.+|++.||.+||++.
T Consensus 197 -~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 197 -IPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -CcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0111234677899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.59 Aligned_cols=278 Identities=21% Similarity=0.236 Sum_probs=214.5
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 231 (496)
..++.....+|.+.+.||+|+||.|..++.. +++.+|.|++++. ......-|.+|-.+|..-+.+=|+++.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455667789999999999999999999875 5889999999873 34456779999999998899999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
..++|+|||||+||+|-..+.. ...++......++..|+-||.-||+.| +|||||||+||||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---------------~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---------------FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLL 208 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---------------cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEe
Confidence 9999999999999999999843 236899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhc----c-CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL----H-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
|.+|++||+|||.+-.+..+.. ......+|||.|.+||++. + +.|+..+|.||+||++|||+.|.-||....
T Consensus 209 d~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-- 285 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-- 285 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--
Confidence 9999999999999987764432 2344579999999999995 3 579999999999999999999999987322
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH--hc----cccCCCC
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT---MSEVVSMI--KN----EIVNLPS 457 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~L--~~----~~~~~~~ 457 (496)
+...........+...+.+ ..+......+||...+. +|+.|.. ++++-.+- ++ -+.+..+
T Consensus 286 ---lveTY~KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~p 354 (1317)
T KOG0612|consen 286 ---LVETYGKIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVP 354 (1317)
T ss_pred ---HHHHHHHHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCC
Confidence 2222222222222211211 11223445556665544 7788887 88887653 11 2355567
Q ss_pred CCCCcchh
Q 040910 458 PQQPAFSY 465 (496)
Q Consensus 458 p~~~~~~~ 465 (496)
|-.|..+.
T Consensus 355 P~vPevss 362 (1317)
T KOG0612|consen 355 PVVPEVSS 362 (1317)
T ss_pred CCCCcCCC
Confidence 77776643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=238.75 Aligned_cols=200 Identities=28% Similarity=0.429 Sum_probs=169.0
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+|...++||+|.||+||+|+.. +++.||+|+++..+ ........+|+-+++.++|+|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999764 57899999987442 22345778999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+ ..+|.+|.. .-.+.++.+....++.|+++||.++|+++ +.||||||.|.|++.+|++|++|
T Consensus 83 c-dqdlkkyfd--------------slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 83 C-DQDLKKYFD--------------SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred h-hHHHHHHHH--------------hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecc
Confidence 9 668888874 23456888899999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCC-CCCCC
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKN-TRFYN 384 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~-~~~~~ 384 (496)
||+++-++-+- ......+-|..|++|.++.+. .|+...|+||-|||+.|+....+| |+..+
T Consensus 145 fglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 145 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred cchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 99999876432 233445779999999999885 589999999999999999876655 44433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=261.61 Aligned_cols=238 Identities=29% Similarity=0.391 Sum_probs=191.9
Q ss_pred CCeeEEEEEec-CCCEEEEEEeccCCccC-HHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhh
Q 040910 176 GFGPVYKGKLL-NGEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFD 253 (496)
Q Consensus 176 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 253 (496)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999886 48999999998665544 68999999999999999999999999999999999999999999999852
Q ss_pred cccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcc
Q 040910 254 YKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333 (496)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~ 333 (496)
...+++..+..++.+++.+++|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 81 ---------------RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 122889999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccc
Q 040910 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413 (496)
Q Consensus 334 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 413 (496)
......++..|+|||.+.+..++.++||||||++++++++|..|+...... ...... ...... .. .
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~----~~~~~~-~~------~ 207 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKK----IGKPKP-PF------P 207 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH----HhccCC-CC------c
Confidence 233456788999999999888999999999999999999999887642111 111110 000000 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 414 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.........+.+++.+|+..+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000003357888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=270.29 Aligned_cols=240 Identities=26% Similarity=0.335 Sum_probs=193.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
.+|..+..||+|+||.|-+|..+ +.+.+|||+|++. ...+.+--+.|-++|+.. +-|.++++..++++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46777889999999999999764 4678999999864 233444456677777666 678999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+.+|+|-.++.+ -+.+.+.....+|..||-||-+||+++ |++||||..|||||.+|++|
T Consensus 429 MEyvnGGDLMyhiQQ---------------~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiK 490 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---------------VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIK 490 (683)
T ss_pred EEEecCchhhhHHHH---------------hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceE
Confidence 999999999888853 345777888999999999999999999 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++.---+ ..++.+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.. +.
T Consensus 491 i~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--~a----- 561 (683)
T KOG0696|consen 491 IADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--QA----- 561 (683)
T ss_pred eeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-----
Confidence 9999999842211 23456789999999999999999999999999999999999999999865543322 11
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP 439 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 439 (496)
+.+... .++.....+.+.+....+...|.+|.
T Consensus 562 -------I~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 -------IMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------HHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111111 23334456667778888899999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.71 Aligned_cols=274 Identities=20% Similarity=0.231 Sum_probs=184.4
Q ss_pred HhcCCCccccccccCCeeEEEEEe-----------------cCCCEEEEEEeccCCccCHHH--------------HHHH
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-----------------LNGEEVAVKRLSNKSGQGVEE--------------FKNE 210 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 210 (496)
..++|.+.++||+|+||.||+|.+ .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986543322233 3446
Q ss_pred HHHHHHhcCCce-----eeeeeeeee--------cCeeEEEEEecCCCChhHHHhhcccCCC---------cccccCCCC
Q 040910 211 MILIAKLHHRNL-----VRLFGCCIE--------QGEKILIYEYMPNKSLDFFLFDYKYSSG---------FDMVTDPAS 268 (496)
Q Consensus 211 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~~ 268 (496)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....... .........
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888753 3568999999999999999975321110 001111122
Q ss_pred CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccC
Q 040910 269 KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348 (496)
Q Consensus 269 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 348 (496)
...++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 345788999999999999999999988 99999999999999999999999999976543211 11122345789999
Q ss_pred hhhhccCC----------------------CCccccchhhhHHHHHHHhCCC-CCCCCCCCcchh-----hHhhhhhhcc
Q 040910 349 PEYALHGL----------------------FSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTL-----LGHAWNLWKD 400 (496)
Q Consensus 349 PE~~~~~~----------------------~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~-----~~~~~~~~~~ 400 (496)
||.+.... ...+.||||+||+++||++|.. |+.....-.... ....|..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875422 1234799999999999999875 443211100000 0011111111
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENA---ADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~evl~~ 447 (496)
... +-. ..........+++.+++..+| .+|+|++|++++
T Consensus 459 ~~~----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 110 111 111123456778888888765 789999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=269.63 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=191.7
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-Cc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeec-Ce
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-GE 234 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~ 234 (496)
++|-.++.||+|||+.||+|.. ...+.||||+-... ++ ...+...+|..+-+.|+||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566788999999999999964 46789999975421 11 1234467899999999999999999998754 57
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec--
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-- 312 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-- 312 (496)
.+-|.||+++.+|+.||.. .+.++++....|+.||+.||.||.+. +++|||-||||.||||-
T Consensus 543 FCTVLEYceGNDLDFYLKQ---------------hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---------------HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred ceeeeeecCCCchhHHHHh---------------hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence 8899999999999999954 44588999999999999999999987 46799999999999994
Q ss_pred -CCCceEEeccccccccCCCccccc-----cccccccccccChhhhcc----CCCCccccchhhhHHHHHHHhCCCCCCC
Q 040910 313 -GDMNPKISDFGIARMFGGDELQSN-----MNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLETLSSKKNTRF 382 (496)
Q Consensus 313 -~~~~~kl~DFgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~elltg~~~~~~ 382 (496)
..|.+||+|||+++....+.+... +....||..|++||.+.- ..++.|+||||.|||+|+.+.|++||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 457899999999998876544322 244689999999998752 3589999999999999999999999974
Q ss_pred CCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 383 YNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
..... ..+... ...... ++--| ..+........++.+||+..-++|....++.
T Consensus 687 nqsQQ-dILqeN-TIlkAt---EVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQ-DILQEN-TILKAT---EVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHH-HHHhhh-chhcce---eccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 32211 111100 001111 11111 1111223456788899999999998766653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.86 Aligned_cols=240 Identities=22% Similarity=0.248 Sum_probs=191.0
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
+..|.....+|.|+|+.|-++.. .+++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56777888899999999999876 4688999999976522 224566666665 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe-cCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-DGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl 319 (496)
.+.++-|.+-+. ..+... ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|
T Consensus 397 ~l~g~ell~ri~---------------~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 397 LLDGGELLRRIR---------------SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred hccccHHHHHHH---------------hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEE
Confidence 999888766663 222233 677889999999999999998 9999999999999 69999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||.++..... ..+.+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ ..... ...
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~----~i~ 527 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT----RIQ 527 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH----hhc
Confidence 999999976543 33457788999999999999999999999999999999999998754433 11111 111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+. ..........+|+.+||+.||.+||+|.++..+
T Consensus 528 ~~~------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MPK------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CCc------------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 111 112223556788889999999999999998754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.13 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=209.7
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee--
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE-- 231 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 231 (496)
+..+...+..|.+.+.||.|.+|.||+++. .+++.+|||++.... ...++...|.++++.+ .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334445677888899999999999999975 478899999986543 3446778889999988 79999999999874
Q ss_pred ---cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 232 ---QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 232 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
+++++||||||.+||..+.+.+. ....+.|..+..|+..+++||++||... ++|||||-.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~-------------~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~N 153 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNT-------------KGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQN 153 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhh-------------cccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCce
Confidence 46899999999999999999652 2567999999999999999999999987 9999999999
Q ss_pred EEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
||++.++.+|+.|||.+..+... .....+.+||+.|||||++.. ..|+..+|+||||++..||--|.+|+...
T Consensus 154 iLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 154 VLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred EEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99999999999999999887543 233456789999999999963 45888999999999999999999887643
Q ss_pred CCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+-.. ++.. .-.|...-..+..+.+++.+++..|+..|.+.||++.+++++
T Consensus 232 HPmra--------LF~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 232 HPMRA--------LFLI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhh--------hccC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 32110 0100 111222223455678899999999999999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=285.91 Aligned_cols=275 Identities=19% Similarity=0.189 Sum_probs=170.5
Q ss_pred HhcCCCccccccccCCeeEEEEEec-C----CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeee------ee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-N----GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC------CI 230 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 230 (496)
..++|...+.||+|+||.||+|.+. + +..||||++..... .+.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999875 4 68999999864321 1222222 1222233333333222 24
Q ss_pred ecCeeEEEEEecCCCChhHHHhhcccCCC-ccc----ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040910 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSG-FDM----VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305 (496)
Q Consensus 231 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~----~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 305 (496)
.....++|+||+++++|.+++........ .+. ..............+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 55689999999999999999864221000 000 000001112234456789999999999999988 9999999
Q ss_pred CCCEEecC-CCceEEeccccccccCCCccccccccccccccccChhhhccC----------------------CCCcccc
Q 040910 306 ASNVLLDG-DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG----------------------LFSIKSD 362 (496)
Q Consensus 306 ~~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 362 (496)
|+|||+++ ++.+||+|||+|+.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 68999999999986543211 122345789999999966422 2345679
Q ss_pred chhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc-cccccccCcccccc------CCHHHHHHHHHHHHHhcccCC
Q 040910 363 VFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD-DRAWKLLDPTLQNE------ALYPMVKRYIKVALLCVQENA 435 (496)
Q Consensus 363 v~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~------~~~~~~~~l~~l~~~cl~~~p 435 (496)
||||||+||||+++..+.... ...+.......-.+ ......+.+....+ ..........+++.+|++.||
T Consensus 362 VwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999876543211 00000000000000 00000111110000 000011234579999999999
Q ss_pred CCCCCHHHHHHH
Q 040910 436 ADRPTMSEVVSM 447 (496)
Q Consensus 436 ~~RPs~~evl~~ 447 (496)
++|||+.+++++
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=262.24 Aligned_cols=262 Identities=22% Similarity=0.220 Sum_probs=200.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC--C----ceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH--R----NLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~~ 235 (496)
+++|.+...+|+|.||.|-..... .+..||||+++... ...+..+-|++++.++.+ | -+|++.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 789999999999999999998653 47899999997543 334566789999999932 3 388899999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-- 313 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-- 313 (496)
++|+|.+ +-|+.+|+. ..+..+++...+..|+.|++++++|||+.. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk-------------~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLK-------------ENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred EEEEecc-ChhHHHHhc-------------cCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 9999998 679999994 355677999999999999999999999998 999999999999932
Q ss_pred ------------------CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh
Q 040910 314 ------------------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375 (496)
Q Consensus 314 ------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt 375 (496)
+..++|+|||.|...... ....+.|..|+|||++.+.+++..+||||+||||.|+.+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 345899999999865432 245788999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCc-chh--------hHhhh------hhhccccc-----------ccccCcc----ccccCCHHHHHHHHH
Q 040910 376 SKKNTRFYNIDS-LTL--------LGHAW------NLWKDDRA-----------WKLLDPT----LQNEALYPMVKRYIK 425 (496)
Q Consensus 376 g~~~~~~~~~~~-~~~--------~~~~~------~~~~~~~~-----------~~~~d~~----~~~~~~~~~~~~l~~ 425 (496)
|..-|+..+..+ +.. +..+. .....+++ ....++. ........+..++++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 998776544211 000 00000 00000100 0000000 011223455678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 040910 426 VALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 426 l~~~cl~~~p~~RPs~~evl~~ 447 (496)
|+..+|..||.+|+|+.|++.+
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=240.18 Aligned_cols=213 Identities=26% Similarity=0.376 Sum_probs=175.2
Q ss_pred eCHHHHHHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeee
Q 040910 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCI 230 (496)
Q Consensus 154 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 230 (496)
.....+....++......||+|++|.|-+-++ .+|+..|||++... +.+..++..+|+.+..+- .+|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 33334555666667778999999999988876 47999999999754 344556777888877665 7999999999999
Q ss_pred ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 231 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.....++.||.| ..||+.|..+-. ...+.+++..+=+|+..|..||.|||++- .++|||+||+|||
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~-----------~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiL 181 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVL-----------KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNIL 181 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHH-----------hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEE
Confidence 999999999999 689998876422 35567899999999999999999999864 5999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhcc----CCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH----GLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
++.+|++|+||||++-.+.++ -..+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|++..
T Consensus 182 In~~GqVKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 182 INYDGQVKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred EccCCcEEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999999999999999876533 12233467789999998853 47999999999999999999999987643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=251.86 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=195.0
Q ss_pred HhcCCCcc-ccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec----Ce
Q 040910 162 ATHNFSEE-NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ----GE 234 (496)
Q Consensus 162 ~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 234 (496)
.+++|++. ++||-|-.|.|-....+ +++.+|+|.|... ...++|+++--+. .|||||.+++++.+. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566553 57999999999988654 7899999998643 3457788866555 699999999988643 46
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
+++|||.|++|.|..-+.+ ...+.+++.+...|+.||+.|+.|||+.+ |.||||||+|+|...
T Consensus 134 LLiVmE~meGGeLfsriq~-------------~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-------------RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTT 197 (400)
T ss_pred eEeeeecccchHHHHHHHH-------------cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecC
Confidence 7899999999999887743 34556999999999999999999999998 999999999999964
Q ss_pred --CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 314 --DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 314 --~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
|-.+||+|||+|+.-.. .....+.+-|+.|.|||++....|+...|+||+||++|-|++|-+||........ .
T Consensus 198 ~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--s 272 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--S 272 (400)
T ss_pred CCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--C
Confidence 55689999999996432 2345567889999999999999999999999999999999999999875433211 1
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.-+......+. ++.. ...-....+...+++...|..+|++|.|+.+++.+
T Consensus 273 pgMk~rI~~gq-y~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQ-YEFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccC-ccCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111110000 0111 11222345667789999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=251.31 Aligned_cols=267 Identities=21% Similarity=0.372 Sum_probs=194.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--------
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-------- 232 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 232 (496)
..|....+||+|.||+||+|+.. .|+.||+|+....+ ..-.....+|+.+|..|+|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555679999999999999865 57889998765322 12234557899999999999999999988643
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
...++||.+++. +|.-.|. .....++...+.+++.++..||.|+|... |+|||+|+.|+|++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--------------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--------------NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLIT 158 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--------------CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEc
Confidence 357999999964 6666663 23456889999999999999999999987 99999999999999
Q ss_pred CCCceEEeccccccccCCCc--cccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-c
Q 040910 313 GDMNPKISDFGIARMFGGDE--LQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-L 388 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~ 388 (496)
.++.+||+|||+++.+.... .....+..+-|..|++||.+.| ..|+++.|||.-|||+.||+++.+.++...... .
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99999999999998765332 2233455677999999999886 568999999999999999999998776543321 1
Q ss_pred hhhH--------hhhhhhcccccccccCcc-ccc---cCCHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 389 TLLG--------HAWNLWKDDRAWKLLDPT-LQN---EALYPMV------KRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 389 ~~~~--------~~~~~~~~~~~~~~~d~~-~~~---~~~~~~~------~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.+.. .+|.....-.+++.+... +.. ....+.. ...++++..++..||.+||.+.+++.+-
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1111 111111111222222111 100 0011111 2567888899999999999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=267.37 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=209.6
Q ss_pred CCCccccccccCCeeEEEEEecCCC-EEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGE-EVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++....-||-||||.|-+.+..+.. .+|+|.+++. +....+....|-.+|...+.|.||+|+-.|.+....|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567899999999999885433 3888888754 33445667889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
-|-+|.|...|. .++.++..+...++..+..|++|||.++ ||+|||||+|.+||.+|-+||.
T Consensus 501 aClGGElWTiLr---------------dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 501 ACLGGELWTILR---------------DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhcCchhhhhhh---------------hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEe
Confidence 999999999994 4566888888899999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+.+... ..+++.+||+.|.|||++.+...+.++|.||||++++||++|.+||...++-.. .... .+.
T Consensus 563 DFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt--Yn~I---LkG 634 (732)
T KOG0614|consen 563 DFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT--YNLI---LKG 634 (732)
T ss_pred ehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH--HHHH---Hhh
Confidence 99999988654 456789999999999999999999999999999999999999999986554221 1111 000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH-------hc-cccCCCCCCCCcchh
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSMI-------KN-EIVNLPSPQQPAFSY 465 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~L-------~~-~~~~~~~p~~~~~~~ 465 (496)
-+. + ..+........+++.+.+..+|.+|.. +.+|-++- ++ ....+|+|-.|....
T Consensus 635 id~--i-------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 635 IDK--I-------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred hhh--h-------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 010 0 112222345667888888899999986 55665542 11 123567777776643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=261.69 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=175.3
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
..-|..++.||-|+||+|.++.. ++...+|.|.|++.+ .......++|-.||+..+.+=||+|+-.|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35677788999999999999965 446689999998653 34456678899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|+|+++|++-.+|. ..+.+.+.....++..+..|+.+.|+.| +|||||||+|||||.+|++|
T Consensus 708 MdYIPGGDmMSLLI---------------rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---------------RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EeccCCccHHHHHH---------------HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCcee
Confidence 99999999999885 3456888888889999999999999998 99999999999999999999
Q ss_pred EeccccccccCC---------Ccccc--cc-----------------------------ccccccccccChhhhccCCCC
Q 040910 319 ISDFGIARMFGG---------DELQS--NM-----------------------------NRIVGTYGYMSPEYALHGLFS 358 (496)
Q Consensus 319 l~DFgla~~~~~---------~~~~~--~~-----------------------------~~~~gt~~y~aPE~~~~~~~~ 358 (496)
|+||||+.-+.. .+..+ .+ -..+||..|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999999854321 10000 00 014699999999999999999
Q ss_pred ccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 359 IKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 359 ~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
..+|.||.|||||||+.|+.||....+.+
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 99999999999999999999997655544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=244.17 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=192.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 237 (496)
-++|..++.||+|+|+.|..+++. +.+.+|+|++++. ..++.+=...|-.+.... +||.+|.|..++++...+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368999999999999999999875 5789999998753 233344445566666665 79999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|.||.++|+|--+. +.+..|+++....+...|.-||.|||+.+ |++||||..|||+|..|++
T Consensus 329 vieyv~ggdlmfhm---------------qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---------------QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred EEEEecCcceeeeh---------------hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCce
Confidence 99999999996665 34567899999999999999999999999 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC--cchhhHhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID--SLTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~--~~~~~~~~~ 395 (496)
||+|+|+++.--. ....+.+.+||+.|.|||++.+..|...+|.|++||+++||+.|+.||..-..+ +.+......
T Consensus 391 kltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 391 KLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 9999999985322 224456789999999999999999999999999999999999999999764433 122111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP 439 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 439 (496)
... ++..+ ..+.....+...++..-+..||.+|.
T Consensus 469 qvi--------lekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVI--------LEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHH--------hhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 111 11111 01122234556677778899998885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.21 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=186.3
Q ss_pred CCccccccccCCee-EEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecC
Q 040910 166 FSEENKLGEGGFGP-VYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 166 f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
|...+.+|.|+-|+ ||+|.+ .|+.||||++-.. ..+-..+|+..++.- +|||||++++.-.+.+..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456788998865 699988 8899999998642 234567899998887 7999999999988999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---C--CceE
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---D--MNPK 318 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~--~~~k 318 (496)
..+|++++.... . ......-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++
T Consensus 586 ~~sL~dlie~~~----~-------d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 586 ACSLQDLIESSG----L-------DVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred hhhHHHHHhccc----c-------chhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEE
Confidence 789999996420 0 0001111345778899999999999987 999999999999975 3 5689
Q ss_pred EeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhC-CCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS-KKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg-~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||+++.+..+.. ........||-+|+|||.+....-+.++||||+||++|+.++| .+||...-..+.+..
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl----- 726 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL----- 726 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-----
Confidence 999999998865532 2335567899999999999999889999999999999999998 678764322222111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
........+. ...+. ...+|+..|+..+|..||++.+|+.
T Consensus 727 --~~~~~L~~L~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 --TGNYTLVHLE------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --cCccceeeec------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111101111 11111 5678999999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=232.24 Aligned_cols=211 Identities=36% Similarity=0.614 Sum_probs=183.1
Q ss_pred ccccCCeeEEEEEecC-CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChhH
Q 040910 172 LGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDF 249 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 249 (496)
||+|.+|.||++...+ ++.++||.+...... ..+.+.+|+..++.++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 899999999765432 35689999999999999999999999999999999999999999999
Q ss_pred HHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCceEEecccccccc
Q 040910 250 FLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKISDFGIARMF 328 (496)
Q Consensus 250 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFgla~~~ 328 (496)
++... ...+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+...
T Consensus 81 ~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 81 LLKEN--------------EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred HHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 98531 145889999999999999999999998 999999999999999 899999999999876
Q ss_pred CCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccccc
Q 040910 329 GGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407 (496)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (496)
..... ......+...|++||..... ..+.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 43321 12335678899999999887 889999999999999998
Q ss_pred CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 408 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577888999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=243.16 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=191.1
Q ss_pred CCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-----eeEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-----EKIL 237 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 237 (496)
.+..+.||-|+||.||....+ +|+.||+|++... +-...+.+.+|++++.-++|.|++..++..+-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345679999999999999764 7999999998643 2234578889999999999999999988765443 5677
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|.|.| ..+|.+.+ .+-+.++-..+.-++.||++||.|||+.+ |.||||||.|.|++.|-.+
T Consensus 135 ~TELm-QSDLHKII---------------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvL 195 (449)
T KOG0664|consen 135 LTELM-QSDLHKII---------------VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCIL 195 (449)
T ss_pred HHHHH-Hhhhhhee---------------ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceE
Confidence 88888 55676666 34456777788889999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhH---
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLG--- 392 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~--- 392 (496)
||+|||+++....++ ...++..+-|..|+|||+++|. .|+.+.||||.|||+.|++..+--|....+-+ .++..
T Consensus 196 KICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 196 KICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred Eecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 999999999876443 4456777889999999999985 58999999999999999997776565443321 11110
Q ss_pred -----hhhhhhccccccccc-----Cccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 393 -----HAWNLWKDDRAWKLL-----DPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 393 -----~~~~~~~~~~~~~~~-----d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
...+.--++...-++ .|.+.. ......-...+.+...++..||..|.+..+.+..+.
T Consensus 275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000000000000 011100 000011123455667789999999999999887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=241.89 Aligned_cols=263 Identities=20% Similarity=0.237 Sum_probs=192.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-----C---Cceeeeeeeeeec-
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-----H---RNLVRLFGCCIEQ- 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~- 232 (496)
..+|.+.++||-|.|++||++.. .+.+.||+|+.+.. ....+....|+++|++++ | .+||+|+++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46788999999999999999965 46789999998643 344567789999999983 3 3699999999754
Q ss_pred ---CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 233 ---GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 233 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
.+.+||+|++ +.+|..++.. ...+-++...+.+|+.||+.||.|||..+ +|||.||||+||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~-------------s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY-------------SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH-------------hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 5899999999 7788888854 23445889999999999999999999987 699999999999
Q ss_pred EecCC---------------------------------------------------------------------------
Q 040910 310 LLDGD--------------------------------------------------------------------------- 314 (496)
Q Consensus 310 ll~~~--------------------------------------------------------------------------- 314 (496)
|+..+
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 99310
Q ss_pred --------------------------------------------------------------------------------
Q 040910 315 -------------------------------------------------------------------------------- 314 (496)
Q Consensus 315 -------------------------------------------------------------------------------- 314 (496)
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence
Q ss_pred -----------CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 315 -----------MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 315 -----------~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
..+||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|++|||+||..-|...
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 0035555555554321 122345788999999999999999999999999999999999877654
Q ss_pred CCCc----chhhHhhh--------hhhccccc-ccccCcc-----------------c--cccCCHHHHHHHHHHHHHhc
Q 040910 384 NIDS----LTLLGHAW--------NLWKDDRA-WKLLDPT-----------------L--QNEALYPMVKRYIKVALLCV 431 (496)
Q Consensus 384 ~~~~----~~~~~~~~--------~~~~~~~~-~~~~d~~-----------------~--~~~~~~~~~~~l~~l~~~cl 431 (496)
.... .+.+..+. .+...++. .+.++.+ + .-....++..++.+++.-||
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL 534 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML 534 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence 3221 11111111 11111111 1111110 0 12345567888999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 040910 432 QENAADRPTMSEVVSM 447 (496)
Q Consensus 432 ~~~p~~RPs~~evl~~ 447 (496)
+.+|++|||+.+.+++
T Consensus 535 ef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLKH 550 (590)
T ss_pred hcCccccccHHHHhcC
Confidence 9999999999998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=223.92 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=194.3
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecC--eeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQG--EKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~l 237 (496)
..++|++.+++|+|-+++||.|.. .+++.++||.++... .+...+|+.+|..|. ||||++|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457889999999999999999964 578899999997543 356789999999996 999999999987654 6789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-Cc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~ 316 (496)
|+||..+.+..... +.|+-.++...+.+++.||.|+|+.| |.|||+||.|+++|.. -.
T Consensus 113 iFE~v~n~Dfk~ly------------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred HhhhhccccHHHHh------------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 99999998887665 34777788999999999999999999 9999999999999865 46
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
++|+|+|+|........ .+..+.+..|..||.+.+ ..|+..-|+|||||+|..|+..+.||-........++.-+.
T Consensus 172 LrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred eeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 89999999998754421 223456778899999876 46889999999999999999999998654443322222111
Q ss_pred hhhcccccc-------cccCcccc----------------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAW-------KLLDPTLQ----------------NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~-------~~~d~~~~----------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+ ..+++. --+||... ++...-...+.++++.+.+..|-.+|||++|.+.+
T Consensus 249 VL-Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 249 VL-GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred Hh-ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 10 000000 00122111 01111112466788889999999999999997643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=228.51 Aligned_cols=198 Identities=34% Similarity=0.482 Sum_probs=171.7
Q ss_pred CCccccccccCCeeEEEEEecC-CCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 166 FSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998865 889999999865544 57789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCC-CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGI-LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
+++|.+++.. ... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+||
T Consensus 81 ~~~L~~~~~~---------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 81 GGDLFDYLRK---------------KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred CCCHHHHHHh---------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeC
Confidence 9999999853 112 789999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhh-ccCCCCccccchhhhHHHHHHHhCCCCCCC
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGVLLLETLSSKKNTRF 382 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~ 382 (496)
|.+....... ........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 143 g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9998765432 1122345678899999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=245.19 Aligned_cols=196 Identities=24% Similarity=0.366 Sum_probs=165.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--------ccCHHHHHHHHHHHHHhc---CCceeeeeeeeee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--------GQGVEEFKNEMILIAKLH---HRNLVRLFGCCIE 231 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 231 (496)
.+|+..+.+|+|+||.|+.+.++ +...|+||.+.+.. ....-..-.|+.+|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888899999999999999875 45688999876532 111123456999999997 9999999999999
Q ss_pred cCeeEEEEEecC-CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMP-NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
++..||++|-.. +-+|-+|+ ..++.+++.....|+.||+.|+++||+.+ |||||||-+||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---------------E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvi 702 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---------------EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVI 702 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---------------hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEE
Confidence 999999999764 44666666 34667999999999999999999999999 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCC-ccccchhhhHHHHHHHhCCCCCC
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
++.+|-+||+|||.|....+.. ....+||.+|.|||++.|..|- ..-|||++|++||.++....|+.
T Consensus 703 vd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 703 VDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999998765543 3457999999999999998885 55799999999999988777653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=230.80 Aligned_cols=262 Identities=23% Similarity=0.242 Sum_probs=193.6
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 232 (496)
...+|.-+..+|.|.- .|..+.. -.++.||+|++... +....++..+|...+..++|+|+++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777788999988 5655533 36899999998633 345567788999999999999999999998643
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
.+.|+||||| ..+|...+. ..++-.++..+..|+..|+.|||+.+ |+||||||+||++.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~-----------------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL-----------------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVN 152 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH-----------------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceec
Confidence 3679999999 678877763 23677889999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-----
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS----- 387 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~----- 387 (496)
.+..+||.|||+|+.-+.+ -.++..+.|..|.|||++.+..+.+.+||||.||++.||++|.--|+..+.-+
T Consensus 153 ~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 153 SDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred chhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 9999999999999865432 34566788999999999999889999999999999999999997666432110
Q ss_pred --------c----hhhHhhhhhhcccc------cccc-cCcccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 388 --------L----TLLGHAWNLWKDDR------AWKL-LDPTLQ--NEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 388 --------~----~~~~~~~~~~~~~~------~~~~-~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. .+...+........ ..+. .|.... .+...-......+++.+||-.+|++|.+++++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 01111111111000 0000 000000 0111112334567888999999999999999998
Q ss_pred HH
Q 040910 447 MI 448 (496)
Q Consensus 447 ~L 448 (496)
+=
T Consensus 310 HP 311 (369)
T KOG0665|consen 310 HP 311 (369)
T ss_pred CC
Confidence 63
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=240.77 Aligned_cols=268 Identities=20% Similarity=0.225 Sum_probs=202.6
Q ss_pred HHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc------CCceeeeeeeeee
Q 040910 159 ISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH------HRNLVRLFGCCIE 231 (496)
Q Consensus 159 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~ 231 (496)
......+|.+....|+|-|++|.+|... .|..||||+++... .-.+.=+.|+++|.+|+ --|.++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3446778888899999999999999764 47899999997542 22233467999999995 3589999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.++++||||-+ ..+|.+.|..+... -.|....+..++.|+.-||..|-..+ |+|.||||.|||+
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~n------------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRN------------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcc------------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 99999999988 78999999876432 33777889999999999999999988 9999999999999
Q ss_pred cCCCc-eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 312 DGDMN-PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~-~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
++.-+ +||||||.|......+ .+...-+..|.|||++.|.+|+...|+||.||.||||.||+-.|+......+..
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 98664 6999999998765443 223345668999999999999999999999999999999998887755433211
Q ss_pred hH-h--------hh------h---------------hhcccc---cccccCc------cc-----cccCCHHHHHHHHHH
Q 040910 391 LG-H--------AW------N---------------LWKDDR---AWKLLDP------TL-----QNEALYPMVKRYIKV 426 (496)
Q Consensus 391 ~~-~--------~~------~---------------~~~~~~---~~~~~d~------~~-----~~~~~~~~~~~l~~l 426 (496)
+. . +. . .+.+.. ....+.| .+ .++..+..+..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 10 0 00 0 000000 0001111 01 122334557788999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 040910 427 ALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 427 ~~~cl~~~p~~RPs~~evl~~ 447 (496)
+..|+..||++|.|..+.+++
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=227.55 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=197.6
Q ss_pred HHHHhcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 159 ISTATHNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 159 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
+....+.|...++||+|.|++||++.+. .++.||+|.+...+ ......+|++.|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455678889999999999999999764 36789999987543 346689999999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
...+|+||+++....+++.. ++...+..++..+..||+++|+.| ||||||||+|+|.+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNR 167 (418)
T ss_pred eeEEEecccCccCHHHHHhc------------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCcccccccc
Confidence 99999999999999999853 668889999999999999999999 999999999999975
Q ss_pred C-CceEEeccccccccCCCc----------------------------------ccc--------ccccccccccccChh
Q 040910 314 D-MNPKISDFGIARMFGGDE----------------------------------LQS--------NMNRIVGTYGYMSPE 350 (496)
Q Consensus 314 ~-~~~kl~DFgla~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aPE 350 (496)
. +.-.|.|||+|...+... +.. ......||+||+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 4 457899999997321100 000 001246999999999
Q ss_pred hhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh---------------h--hhccccc---------
Q 040910 351 YALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW---------------N--LWKDDRA--------- 403 (496)
Q Consensus 351 ~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~---------------~--~~~~~~~--------- 403 (496)
++.. ...++++||||-|||++-+++++.||-....+-..+.+-+- . +|...+.
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 9875 56789999999999999999999998654433211111000 0 1111110
Q ss_pred ccccC-ccccc-cC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 404 WKLLD-PTLQN-EA--------LYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 404 ~~~~d-~~~~~-~~--------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
++-++ ..+.. .. .......++++..+|+..||.+|.|+++.+++
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00110 00000 00 01112367899999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=244.38 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=200.8
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...+|....++|.|+||.|||++. ..++..|||.++........-...|+-+++.-+|||||.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788889999999999999976 4689999999987766677777889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+.+|+|.+..+ -.+++++.++..+.....+||+|||+.+ =+|||||-.|||+++.+.+|++
T Consensus 93 ycgggslQdiy~---------------~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---------------VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred ecCCCcccceee---------------ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeec
Confidence 999999988774 3567889999999999999999999998 7999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||.+-.+... -.......||+.|||||+.. .+.|..++|||+.|+...|+---++|.-...+ ..+..+
T Consensus 155 Dfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~L 226 (829)
T KOG0576|consen 155 DFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFL 226 (829)
T ss_pred ccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHH
Confidence 99998876432 22334578999999999874 57899999999999999998665554321111 111111
Q ss_pred hcccccccccCc-cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 398 WKDDRAWKLLDP-TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 398 ~~~~~~~~~~d~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... ..+| .+. ........+.++++.|+-.+|++||+++.+++
T Consensus 227 mTkS----~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 MTKS----GFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhcc----CCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1111 111 12234466778888999999999999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=267.18 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=139.5
Q ss_pred HhcC-Cceeeeeeee-------eecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHH
Q 040910 216 KLHH-RNLVRLFGCC-------IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287 (496)
Q Consensus 216 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~ 287 (496)
.++| +||++++++| .+....++++||+ +++|.+++.. ....+++..++.++.||++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~a 92 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--------------PDRSVDAFECFHVFRQIVEI 92 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--------------ccccccHHHHHHHHHHHHHH
Confidence 4456 6888888887 2334677888987 6799999942 23458999999999999999
Q ss_pred HHHhhhcCCCCeeecCCCCCCEEecC-------------------CCceEEeccccccccCCCcc--------------c
Q 040910 288 LLYLHQYSRLRVIHRDLKASNVLLDG-------------------DMNPKISDFGIARMFGGDEL--------------Q 334 (496)
Q Consensus 288 L~yLH~~~~~~ivH~Dlk~~NIll~~-------------------~~~~kl~DFgla~~~~~~~~--------------~ 334 (496)
|+|||+.+ |+||||||+||||+. ++.+|++|||+++....... .
T Consensus 93 l~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 169 (793)
T PLN00181 93 VNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFP 169 (793)
T ss_pred HHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCc
Confidence 99999988 999999999999954 44566777777654321000 0
Q ss_pred cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCcccccc
Q 040910 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE 414 (496)
Q Consensus 335 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 414 (496)
.......||+.|||||++.+..++.++|||||||+||||++|..|+..... ..... . .....+..
T Consensus 170 ~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~----~----~~~~~~~~--- 234 (793)
T PLN00181 170 MKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL----R----HRVLPPQI--- 234 (793)
T ss_pred ccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH----H----HhhcChhh---
Confidence 001123578899999999999999999999999999999998876432110 00000 0 00111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 415 ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 415 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.........++.+||+.+|.+||+|.|++++
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1112345678889999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=211.36 Aligned_cols=256 Identities=19% Similarity=0.341 Sum_probs=189.7
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeee-eeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGC-CIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lv 238 (496)
..+.|.+.+.||+|.||.+-++.++ +.+.+|+|-+... .....+|.+|...--.| .|.||+.-+++ |+..+-.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3456888899999999999999885 4678999988643 34567899998876666 59999998764 5667788899
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe-c-CCCc
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-D-GDMN 316 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll-~-~~~~ 316 (496)
+||++.|+|..-+.. ..+.+.-..+++.|+++||.|+|+++ +||||||.+|||+ + +...
T Consensus 101 qE~aP~gdL~snv~~----------------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----------------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYR 161 (378)
T ss_pred eccCccchhhhhcCc----------------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccE
Confidence 999999999776631 33667777899999999999999998 9999999999999 3 4457
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccC-----CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-----LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+||+|||+.+..+.. ....--+..|.|||..... ...+.+|+|.||++++.+++|+.|++.........
T Consensus 162 vKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y- 235 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY- 235 (378)
T ss_pred EEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-
Confidence 999999999865422 2223345679999977532 34678999999999999999999998443333322
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
|-|..|..+....+ |.. ......++..+..+-+..+|++|--..++.++...
T Consensus 236 -~~~~~w~~rk~~~~--P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 236 -WEWEQWLKRKNPAL--PKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -HHHHHHhcccCccC--chh----hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 33444544443322 111 12223456667778899999999777776666544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=206.14 Aligned_cols=167 Identities=19% Similarity=0.121 Sum_probs=124.8
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|||.+++.. .+..++|..++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||+
T Consensus 1 GsL~~~l~~--------------~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~ 55 (176)
T smart00750 1 VSLADILEV--------------RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGS 55 (176)
T ss_pred CcHHHHHHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccc
Confidence 688888852 2446999999999999999999999875 999999999999999 999
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
++..... ...||+.|||||++.+..++.++|||||||++|||++|+.|+.............. .....
T Consensus 56 ~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~---- 123 (176)
T smart00750 56 VAFKTPE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-NGMPA---- 123 (176)
T ss_pred eEeeccc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-HHhcc----
Confidence 9865432 12688999999999999999999999999999999999999754322111111111 00000
Q ss_pred cccCccccccCCHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 405 KLLDPTLQNEALYPMV--KRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~--~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.++.. ........ ..+.+++.+||+.+|.+||++.++++++...
T Consensus 124 --~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 124 --DDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --CCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00000 00111122 2588999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=215.54 Aligned_cols=175 Identities=19% Similarity=0.253 Sum_probs=133.9
Q ss_pred HHhcCCCccccccccCCeeEEEEEec--CCCEEEEEEeccCC-----ccCHHHHHHHHHHHHHhcCCceee-eeeeeeec
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL--NGEEVAVKRLSNKS-----GQGVEEFKNEMILIAKLHHRNLVR-LFGCCIEQ 232 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~ 232 (496)
....+|...+.||+|+||.||+|... +++.||||++.... ....+.|.+|++++.+++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35678999999999999999999764 57788999875331 123457999999999999999985 4432
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCEEe
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NIll 311 (496)
+..++||||+++++|.. +. ... ...++.|++++|+|||+.+ |+|||| ||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---------------~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv 145 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---------------PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLM 145 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---------------ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEE
Confidence 46799999999999952 10 000 1467889999999999988 999999 9999999
Q ss_pred cCCCceEEeccccccccCCCccccc------cccccccccccChhhhccC------CCCccccch
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSN------MNRIVGTYGYMSPEYALHG------LFSIKSDVF 364 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~ 364 (496)
+.++.+||+|||+|+.+........ .+...++..|+|||.+... ..+..+|-|
T Consensus 146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999999999997754321111 2356788899999988643 233446666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=203.86 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=185.9
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.-+|.+...|+.|+|++. |..+++|++.-. ......+|..|.-.++-+.||||+.++|.|....+..+|..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 347899999999999994 455666776533 33445689999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe--cccc
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS--DFGI 324 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~--DFgl 324 (496)
|...|++ ...-..+..+..+++.+||+|++|||+.. +.|.---|.+..|++|++.+++|+ |--+
T Consensus 274 lynvlhe-------------~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 274 LYNVLHE-------------QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred HHHHHhc-------------CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence 9999964 34445777889999999999999999986 234455789999999999998875 3222
Q ss_pred ccccCCCccccccccccccccccChhhhccCCCC---ccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS---IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 325 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
+.+ .....-.+.||+||.++..+-+ ..+|+|||++++||+.|..-||....+-+...
T Consensus 340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------- 399 (448)
T KOG0195|consen 340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------- 399 (448)
T ss_pred eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------
Confidence 211 1112346789999999876543 57899999999999999999987543322111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
++.-..+....++.....+.+++.-|+..||.+||.+..|+-.|+..
T Consensus 400 ---kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 400 ---KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ---hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 01111111222333446778889999999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=201.46 Aligned_cols=263 Identities=22% Similarity=0.254 Sum_probs=193.4
Q ss_pred CCCccccccccCCeeEEEEEecCC--CEEEEEEeccCCccCHHHHHHHHHHHHHhcC----Cceeeeeeee-eecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNG--EEVAVKRLSNKSGQGVEEFKNEMILIAKLHH----RNLVRLFGCC-IEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 237 (496)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 4788888765433333377889999999973 5888898888 47778899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC---
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD--- 314 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--- 314 (496)
||+.+ +.+|.++... ...+.++..+.++++.|++.+|.+||+.| ++||||||.|+++...
T Consensus 99 VM~l~-G~sL~dl~~~-------------~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKR-------------NPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred EEecc-CccHHHHHHh-------------CCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCc
Confidence 99988 8999887743 12467999999999999999999999999 9999999999999765
Q ss_pred --CceEEecccccc--ccCCCcc-----ccc-cccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 315 --MNPKISDFGIAR--MFGGDEL-----QSN-MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 315 --~~~kl~DFgla~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
-.+.|.|||+++ .+..... ... ....+||.+|.++....+...+.+.|+||++.++.|++.|..|+....
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 468999999999 3322211 111 223569999999999999999999999999999999999998875433
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
.... ...... ......... .....+ ..+.++...+-..+..++|....+...|++.....
T Consensus 242 ~~~~--~~~~~~----~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 242 MTDL--KSKFEK----DPRKLLTDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ccch--HHHHHH----Hhhhhcccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 2211 000000 000011111 111222 33444444455689999999999999988765443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-22 Score=193.39 Aligned_cols=260 Identities=31% Similarity=0.396 Sum_probs=196.5
Q ss_pred CCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc---CHHHHHHHHHHHHHhcCC-ceeeeeeeeeecCeeEEEEEe
Q 040910 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ---GVEEFKNEMILIAKLHHR-NLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 241 (496)
|...+.||.|+||.||++... ..+|+|.+...... ....|.+|+.++..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999875 88999999755332 367899999999999888 799999999777778999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~ 320 (496)
+.++++..++.... .. ..+.......++.|++.++.|+|..+ ++|||+||+||+++... .++++
T Consensus 80 ~~~~~l~~~~~~~~-----------~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~ 144 (384)
T COG0515 80 VDGGSLEDLLKKIG-----------RK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLI 144 (384)
T ss_pred CCCCcHHHHHHhcc-----------cc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEe
Confidence 99999996664211 00 36888899999999999999999998 99999999999999998 79999
Q ss_pred ccccccccCCCcccc----ccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCC--cchhh
Q 040910 321 DFGIARMFGGDELQS----NMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID--SLTLL 391 (496)
Q Consensus 321 DFgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~--~~~~~ 391 (496)
|||+++......... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224 (384)
T ss_pred ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence 999998665433221 2456789999999999988 57899999999999999999999996544321 11111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
......... .................+.+++..|+..+|..|.++.+....
T Consensus 225 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111100 000000000001223456788888999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=185.25 Aligned_cols=269 Identities=20% Similarity=0.262 Sum_probs=201.7
Q ss_pred hcCCCccccccccCCeeEEEEE-ecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.-+|.+.++||+|.||.++.|+ +-+++.||||.-...+. .-++..|.+..+.| ..+.|...+-|-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3478999999999999999996 45899999998654432 34677888888888 57999999999889989999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-----
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM----- 315 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----- 315 (496)
.+ +-||++++.- -...++.+++..+|.|++.-++|+|++. +|+|||||+|.||...+
T Consensus 105 LL-GPSLEDLFD~--------------CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--------------CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred hh-CcCHHHHHHH--------------hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCc
Confidence 98 8899888752 4567999999999999999999999998 99999999999996443
Q ss_pred ceEEeccccccccCCCccccc-----cccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 316 NPKISDFGIARMFGGDELQSN-----MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
.+.|+|||+|+.+....+... .....||.+||+--...+...+.+.|+=|+|-++...|-|..|+.....+...
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK- 245 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK- 245 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-
Confidence 478999999998765543322 23467999999999999999999999999999999999999999865443211
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCC
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~ 459 (496)
..+. +.++..+.......-...+++....+..+. ..+-.+-|..+-+...+.+.+..+....
T Consensus 246 --~kYe--KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 246 --EKYE--KIGETKRSTPIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred --HHHH--HhccccccCCHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 1111 112222222221111224444444444444 5567778888877777766555544433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=179.79 Aligned_cols=140 Identities=19% Similarity=0.184 Sum_probs=108.6
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCcc--C-------HHHH-----------------HHHHHHHHHhcCCce
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--G-------VEEF-----------------KNEMILIAKLHHRNL 222 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~ni 222 (496)
.+.||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 1122 349999999988776
Q ss_pred eeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeee
Q 040910 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYL-HQYSRLRVIH 301 (496)
Q Consensus 223 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH 301 (496)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|.|+ |+.+ |+|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiH 141 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---------------KDAPLSESKARELYLQVIQIMRILYQDCR---LVH 141 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 44333222 23389999999887754432 123578899999999999999999 6777 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
|||||+|||++ ++.++|+|||+|....
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 99999999998 4789999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=182.66 Aligned_cols=170 Identities=15% Similarity=0.159 Sum_probs=133.7
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHH---H------HHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVE---E------FKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
..++|...+.+|+|+||.||.... ++..+|||.+......... . |.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999765 6778999999755333222 2 68899999999999999999886643
Q ss_pred --------CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 233 --------GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 233 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
+..++||||+++.+|.++.. ++. ....+++.+|..+|..+ ++|||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------------~~~----~~~~~i~~~l~~lH~~g---i~H~Di 161 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------------ISE----DVKAKIKASIESLHQHG---MVSGDP 161 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------------ccH----HHHHHHHHHHHHHHHcC---CccCCC
Confidence 35789999999999977641 111 24569999999999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHH
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLET 373 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el 373 (496)
+|+||+++.++ ++|+|||.......+... ..++....+..++|+||||+.+..+
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 99999999998 999999988754321100 1134445567899999999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-23 Score=214.29 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=184.1
Q ss_pred CccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccC----HHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQG----VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
...+.+|.|++|.|+..... .....+.|..+.. .... ...+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977777543 3333444433210 1111 112455666677789999999888888777666669
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||++. +|-.++. ....++-.++..++.|+..|+.|+|+.+ |.|||||++|++++.++.+||
T Consensus 401 E~~~~-Dlf~~~~---------------~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---------------SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred hcccH-HHHHHHh---------------cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEE
Confidence 99999 9988884 2246778889999999999999999999 999999999999999999999
Q ss_pred eccccccccCCCccc--cccccccccccccChhhhccCCCCcc-ccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHGLFSIK-SDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||.+..+..+... ......+|...|+|||.+.+..|.+. .||||.|+++..|++|+.|+................
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~ 541 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS 541 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc
Confidence 999999877544322 33455789999999999999998765 699999999999999999887655443221110000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.+. .... -..........+...++..+++.+|.+|.|+++|++
T Consensus 542 ~~~-----~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQR-----NIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc-----cccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 0000 001112334456778889999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=173.80 Aligned_cols=141 Identities=19% Similarity=0.214 Sum_probs=111.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCcc---------------------C-----HHHHHHHHHHHHHhcCCce
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ---------------------G-----VEEFKNEMILIAKLHHRNL 222 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 222 (496)
.+.||+|+||.||+|...+|+.||||.++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998878999999998754211 0 1124578999999999987
Q ss_pred eeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeee
Q 040910 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIH 301 (496)
Q Consensus 223 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH 301 (496)
.....+... ..+|||||++++++..... ....++......++.|++.++.++|+ .+ |+|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivH 141 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---------------KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVH 141 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---------------hhccCCHHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 554444333 3489999999886543321 12346778889999999999999999 87 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccCC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFGG 330 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~~ 330 (496)
|||||+|||++ ++.++|+|||++.....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=169.51 Aligned_cols=276 Identities=18% Similarity=0.209 Sum_probs=202.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC-CceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH-RNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 240 (496)
..+|.+.++||.|+||.+|.|.. .+|..||||.-+..... .++.-|.++.+.|+| ..|..+..|..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46789999999999999999965 57999999987654332 456778899999964 678888888889999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC---Cce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD---MNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~ 317 (496)
.+ +-||.+.+.- -...++.++++-++-|++.-++|+|..+ ++||||||+|.|..-+ ..+
T Consensus 92 LL-GPsLEdLfnf--------------C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--------------CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred cc-CccHHHHHHH--------------HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceE
Confidence 98 8899888753 2345888999999999999999999998 9999999999999654 357
Q ss_pred EEeccccccccCCCcc-----ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 318 KISDFGIARMFGGDEL-----QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 318 kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
.++|||+|+.+..... ........||.+|.+--...+...+.+.|+=|+|.+|..+.-|..|++....... .
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~ 230 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---K 230 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---H
Confidence 8999999997754322 2223456899999999988888899999999999999999999999876443211 1
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchhhhh
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRI 468 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~~~~ 468 (496)
+.+....+.+.. ..-..++...+ .++.-.+.-|-..--++-|...-+-+.+.-....+.- ++.+.+.|.
T Consensus 231 QKyEkI~EkK~s-~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~--~~d~iyDW~ 299 (341)
T KOG1163|consen 231 QKYEKISEKKMS-TPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH--QYDYIYDWT 299 (341)
T ss_pred HHHHHHHHhhcC-CCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc--cCCeEeeHH
Confidence 111111222211 11112233332 3455566678888888889887776666554444443 334444444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=194.64 Aligned_cols=216 Identities=24% Similarity=0.358 Sum_probs=164.2
Q ss_pred HHhcCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc
Q 040910 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY 294 (496)
Q Consensus 215 ~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 294 (496)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++.+|+.||+|||+.
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--------------~~~~~d~~F~~s~~rdi~~Gl~ylh~s 67 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--------------EDIKLDYFFILSFIRDISKGLAYLHNS 67 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--------------cccCccHHHHHHHHHHHHHHHHHHhcC
Confidence 467899999999999999999999999999999999963 345699999999999999999999986
Q ss_pred CCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccC-------CCCccccchhhh
Q 040910 295 SRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-------LFSIKSDVFSFG 367 (496)
Q Consensus 295 ~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~G 367 (496)
. -..|+.|+++|+++|..+.+||+|||+.................-..-|.|||.+.+. ..+.+.||||||
T Consensus 68 ~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ 145 (484)
T KOG1023|consen 68 P--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG 145 (484)
T ss_pred c--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence 5 2399999999999999999999999998866421111111122345579999998763 246779999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcc--hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 368 VLLLETLSSKKNTRFYNIDSL--TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 368 vvl~elltg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
++++|+++...||........ .....+ .. .....+.|.+.... +....+..++..||..+|++||++++|-
T Consensus 146 ii~~ei~~r~~~~~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 146 IIMYEILFRSGPFDLRNLVEDPDEIILRV----KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHHHHHhccCccccccccCChHHHHHHH----Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999999999999886444322 122111 11 12223333332211 2333688899999999999999999999
Q ss_pred HHHhcccc
Q 040910 446 SMIKNEIV 453 (496)
Q Consensus 446 ~~L~~~~~ 453 (496)
..++....
T Consensus 219 ~~~~~~~~ 226 (484)
T KOG1023|consen 219 SKLLTINK 226 (484)
T ss_pred hhhhhhcc
Confidence 99887643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=163.63 Aligned_cols=137 Identities=20% Similarity=0.291 Sum_probs=106.6
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-----cCCceeeeeeeeeecC---e-eEE
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-----HHRNLVRLFGCCIEQG---E-KIL 237 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~l 237 (496)
...+.||+|+||.||. .+.....+||+.........+.+.+|+.+++.+ +||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 443333479988765445567899999999999 5799999999998874 3 337
Q ss_pred EEEe--cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 238 IYEY--MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL-LYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 238 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
|+|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+.+ |+||||||+|||++.
T Consensus 83 I~e~~G~~~~tL~~~l~~----------------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----------------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRI 141 (210)
T ss_pred EecCCCCcchhHHHHHHc----------------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEecc
Confidence 8999 558999999942 124444 35678888887 9999998 999999999999973
Q ss_pred ---CCceEEecccccc
Q 040910 314 ---DMNPKISDFGIAR 326 (496)
Q Consensus 314 ---~~~~kl~DFgla~ 326 (496)
+..++|+||+-+.
T Consensus 142 ~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 142 SESEVIPVVCDNIGES 157 (210)
T ss_pred CCCCCcEEEEECCCCc
Confidence 3479999954443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=160.22 Aligned_cols=184 Identities=17% Similarity=0.136 Sum_probs=138.2
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCcc----CHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEe
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ----GVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|.+|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999998765 7788888887654321 1225889999999994 5889999886 456999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCEEecCCCceEEe
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL-KASNVLLDGDMNPKIS 320 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~ 320 (496)
+.+.+|...+. . ....++.|++++|.++|..+ |+|||| ||+|||++.++.++|+
T Consensus 80 I~G~~L~~~~~----------------~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LI 134 (218)
T PRK12274 80 LAGAAMYQRPP----------------R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVI 134 (218)
T ss_pred ecCccHHhhhh----------------h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEE
Confidence 99988854321 0 11357789999999999998 999999 7999999999999999
Q ss_pred ccccccccCCCccc------ccc-----ccccccccccChhhhccC-CCC-ccccchhhhHHHHHHHhCCCCC
Q 040910 321 DFGIARMFGGDELQ------SNM-----NRIVGTYGYMSPEYALHG-LFS-IKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 321 DFgla~~~~~~~~~------~~~-----~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
|||+|......... ... -....++.|++|+...-. ..+ ...+.++-|.-+|.++|++-+.
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 99999865433210 000 012357788888855432 333 5668889999999999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=170.41 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=151.8
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhc----------CCceeeeeeeee
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLH----------HRNLVRLFGCCI 230 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~ 230 (496)
.+...+.||.|+++.||.++.. +|+.+|||.+.... ....+++++|.-.+..+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3345678999999999999885 58999999886332 234677777776555532 212222222111
Q ss_pred ---------ecC--------eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh
Q 040910 231 ---------EQG--------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293 (496)
Q Consensus 231 ---------~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 293 (496)
... ..+++|+-+ .++|..++...... ......+....++.+..|+++.+++||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~--------~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSR--------AQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHH--------TTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhc--------ccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 111 236677777 78888886432211 1113345666778889999999999999
Q ss_pred cCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc--------CCCCccccchh
Q 040910 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--------GLFSIKSDVFS 365 (496)
Q Consensus 294 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S 365 (496)
.+ ++|+||+|+|++++.+|.+.|+||+.....+... .....+..|.+||.... ..++.+.|.|+
T Consensus 164 ~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp TT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred cc---eEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 99 9999999999999999999999999887654221 11234578999997743 25788999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCC
Q 040910 366 FGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR 438 (496)
Q Consensus 366 ~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 438 (496)
+|+++|.|+++..|+........... .+ ..+. +.++.+..++..+|+.+|.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999875432211100 11 2233 566777889999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=189.42 Aligned_cols=253 Identities=18% Similarity=0.251 Sum_probs=183.2
Q ss_pred HHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCee
Q 040910 159 ISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 159 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~ 235 (496)
+......|.+.+.||+|+||.||+|...+|+.||+|.-+..+. -+|.--.+++.||+ -+-|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3345567888999999999999999988899999998765432 23444455566665 23344444455556778
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec---
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD--- 312 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~--- 312 (496)
+||+||.+.|+|.+++. ..+.++|...+.++.|+++-+..||..+ |||+||||+|.||.
T Consensus 770 ~lv~ey~~~Gtlld~~N---------------~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---------------TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREI 831 (974)
T ss_pred eeeeeccccccHHHhhc---------------cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeeccc
Confidence 99999999999999983 4567899999999999999999999998 99999999999993
Q ss_pred ----CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc
Q 040910 313 ----GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388 (496)
Q Consensus 313 ----~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~ 388 (496)
++..++|+|||.+.....-.........++|-.+--+|...|.+++..+|.|.|+.+++-||.|+..- .
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~------ 904 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V------ 904 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h------
Confidence 34468999999987543222223445678899999999999999999999999999999999998542 1
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..+..+ .++..+......+...++..+++ ..|-..=|...++...|++.+.
T Consensus 905 ----------~~g~~~-~~~~~~~Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 905 ----------KNGSSW-MVKTNFPRYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ----------cCCcce-eccccchhhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHHHHH
Confidence 111111 11111222222333444444444 3555566777777777776543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=191.50 Aligned_cols=251 Identities=19% Similarity=0.223 Sum_probs=175.2
Q ss_pred CCCccccccccCCeeEEEEEecCCCEEEEEEeccCC-ccCHHHHHHHHHHHHH--hcCCceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS-GQGVEEFKNEMILIAK--LHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++...+.||.+.|=.|.+|+.+.|. |+||++-+.. ....+.|.++++-++. ++|||.+++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999997777 9999987654 4456667666655553 4899999988776555556666666
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
.. .+|.+-| ..++.+...+...|+.|++.||.-+|..+ |+|||||.+|||++.=.-+.|+|
T Consensus 103 vk-hnLyDRl---------------STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtD 163 (1431)
T KOG1240|consen 103 VK-HNLYDRL---------------STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTD 163 (1431)
T ss_pred Hh-hhhhhhh---------------ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhc
Confidence 63 3444333 35566788888999999999999999998 99999999999999888899999
Q ss_pred cccccccC--CCc---cccccccccccccccChhhhccC----------C-CCccccchhhhHHHHHHHhC-CCCCCCCC
Q 040910 322 FGIARMFG--GDE---LQSNMNRIVGTYGYMSPEYALHG----------L-FSIKSDVFSFGVLLLETLSS-KKNTRFYN 384 (496)
Q Consensus 322 Fgla~~~~--~~~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~S~Gvvl~elltg-~~~~~~~~ 384 (496)
|..-+... .++ +.-...+...-..|.|||-+... . .+++-||||+||++.||++- +++|....
T Consensus 164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 98776432 221 11111222334579999987531 2 56778999999999999885 55554311
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
+. +++.........++. .+. -..+.++++.|++.||++|.++++.++.-.+
T Consensus 244 -----L~--aYr~~~~~~~e~~Le-~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 244 -----LL--AYRSGNADDPEQLLE-KIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----HH--hHhccCccCHHHHHH-hCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 10 010000000000000 000 0246678889999999999999999988655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-20 Score=183.63 Aligned_cols=250 Identities=24% Similarity=0.277 Sum_probs=185.2
Q ss_pred cccccCCeeEEEEEe----cCCCEEEEEEeccCCcc--CHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEecC
Q 040910 171 KLGEGGFGPVYKGKL----LNGEEVAVKRLSNKSGQ--GVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.+|+|.||.|++.+- +.|..+|.|.+++.... .......|..++...+ ||.+|++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997632 35778898888754321 1125566788888886 9999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|.|-..+ .....++..........++-++.++|+.+ ++|||+|++||+++.+|++++.|||
T Consensus 81 gg~lft~l---------------~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 81 GGDLFTRL---------------SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred cchhhhcc---------------ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCch
Confidence 99996666 34455777778888899999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+++..-... ..+||..|||||++. .....+|.||||++++||++|..||.. +.. .
T Consensus 143 lske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~---~-------- 197 (612)
T KOG0603|consen 143 LSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTM---K-------- 197 (612)
T ss_pred hhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHH---H--------
Confidence 998653221 128999999999998 678899999999999999999999874 110 0
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHHhc-----------cccCCCCCCCCcchhh
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM--SEVVSMIKN-----------EIVNLPSPQQPAFSYV 466 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl~~L~~-----------~~~~~~~p~~~~~~~~ 466 (496)
.+.. .....+.+.......+...+...+|.+|.-. ..+.++.+. .-...++|..|.....
T Consensus 198 -~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e 270 (612)
T KOG0603|consen 198 -RILK--AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITE 270 (612)
T ss_pred -HHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccch
Confidence 0110 0112233344455566667778888888754 344444432 1134566777766553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=157.55 Aligned_cols=134 Identities=19% Similarity=0.285 Sum_probs=114.1
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCcc--------CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
+.||+|++|.||+|.. +|..|+||........ ....+.+|+.++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986543221 124578899999999999998888888788889999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ..+ .+..++.+++.+|+++|+.+ ++|+|++|.|||++ ++.++|+|
T Consensus 81 ~~G~~L~~~~~~------------------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liD 137 (211)
T PRK14879 81 IEGEPLKDLINS------------------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLID 137 (211)
T ss_pred eCCcCHHHHHHh------------------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEE
Confidence 999999988842 112 77899999999999999998 99999999999999 78999999
Q ss_pred cccccc
Q 040910 322 FGIARM 327 (496)
Q Consensus 322 Fgla~~ 327 (496)
||.+..
T Consensus 138 f~~a~~ 143 (211)
T PRK14879 138 FGLAEF 143 (211)
T ss_pred CCcccC
Confidence 999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=160.98 Aligned_cols=144 Identities=16% Similarity=0.126 Sum_probs=111.1
Q ss_pred cCCCccccccccCCeeEEEEE--ecCCCEEEEEEeccCCcc------------------------CHHHHHHHHHHHHHh
Q 040910 164 HNFSEENKLGEGGFGPVYKGK--LLNGEEVAVKRLSNKSGQ------------------------GVEEFKNEMILIAKL 217 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 217 (496)
..|.+.+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347788999999999999998 568999999998743210 012356899999999
Q ss_pred cCC--ceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC
Q 040910 218 HHR--NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS 295 (496)
Q Consensus 218 ~H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 295 (496)
.+. .+.+++++ ...++||||+++++|..+.. ....+.......++.||+.+|++||+.+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---------------KDVEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---------------ccCCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 753 34444443 23589999999988865541 1223455567889999999999999876
Q ss_pred CCCeeecCCCCCCEEecCCCceEEeccccccccC
Q 040910 296 RLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 296 ~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
.++||||||+||+++ ++.++|+|||.+....
T Consensus 169 --~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 169 --ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred --CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 499999999999999 8899999999998654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-18 Score=154.68 Aligned_cols=145 Identities=18% Similarity=0.176 Sum_probs=112.9
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc----------------------CHHHHHHHHHHHH
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ----------------------GVEEFKNEMILIA 215 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~ 215 (496)
++......|...+.||+|+||.||++...+|+.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444457778999999999999998888999999987643210 1123677889999
Q ss_pred HhcCCc--eeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh
Q 040910 216 KLHHRN--LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293 (496)
Q Consensus 216 ~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 293 (496)
.+.|++ +.+.++. ...++||||+++++|..... ......++.+++.++.++|+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------------------~~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------------------LEDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------------------cccHHHHHHHHHHHHHHHHH
Confidence 998874 4444442 35589999999999865431 02446788999999999999
Q ss_pred cCCCCeeecCCCCCCEEecCCCceEEeccccccccCC
Q 040910 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330 (496)
Q Consensus 294 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~ 330 (496)
.+ ++|+||||+||++++++.++|+|||++..+..
T Consensus 144 ~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 144 HG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CC---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 87 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-19 Score=129.99 Aligned_cols=66 Identities=50% Similarity=1.184 Sum_probs=59.1
Q ss_pred CCCCCceEeccCCCCCCchhhhhhccCChHHHHHHhhccCceEEEeeecccCCCccccccccccchh
Q 040910 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMIDM 70 (496)
Q Consensus 4 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~ncsC~a~~~~~~~~~~~~C~~w~~~l~~~ 70 (496)
|+.+|+|+++++|++|++...+++.++++++|++.||+||||+||+|.+.. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 667899999999999999877766779999999999999999999997654 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=153.08 Aligned_cols=130 Identities=22% Similarity=0.348 Sum_probs=107.7
Q ss_pred cccccCCeeEEEEEecCCCEEEEEEeccCCcc--------CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.||+|+||.||+|.+ ++..|++|........ ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 7789999986543211 1256778999999999887766666666777789999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. .. ..++.+++.+|++||+.+ ++|+|++|.||+++ ++.++++||
T Consensus 80 ~g~~l~~~~~~---------------~~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDf 133 (199)
T TIGR03724 80 EGKPLKDVIEE---------------GN-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDF 133 (199)
T ss_pred CCccHHHHHhh---------------cH-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEEC
Confidence 99999888742 00 078999999999999998 99999999999999 889999999
Q ss_pred ccccc
Q 040910 323 GIARM 327 (496)
Q Consensus 323 gla~~ 327 (496)
|+++.
T Consensus 134 g~a~~ 138 (199)
T TIGR03724 134 GLGKY 138 (199)
T ss_pred CCCcC
Confidence 99875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=173.59 Aligned_cols=139 Identities=20% Similarity=0.317 Sum_probs=113.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC-c-------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS-G-------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
....|...+.||+|+||.||+|.+.. ..+++|+..... . ...+.+.+|++++.+++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34455667899999999999998744 444555432111 1 12356889999999999999998888888877
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ +
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~ 462 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-R 462 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-E
Confidence 8899999999999988872 34678999999999999988 9999999999999 6
Q ss_pred CCceEEecccccccc
Q 040910 314 DMNPKISDFGIARMF 328 (496)
Q Consensus 314 ~~~~kl~DFgla~~~ 328 (496)
++.++|+|||+++..
T Consensus 463 ~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCcEEEEeCcccccC
Confidence 789999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-18 Score=172.16 Aligned_cols=175 Identities=25% Similarity=0.316 Sum_probs=129.2
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++.|+++...+|.+|+.. .......+|.....++.|++.|+.| ++ .+|+|+||.||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~r------------r~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~ 391 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR------------RRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSD 391 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC------------CCcccccchhHHHHHHHhhccchhh---cc---chhhhcccccccccc
Confidence 57899999999999999963 2334557888999999999999999 55 999999999999999
Q ss_pred CCceEEeccccccccCCCc----cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCC-CCCCCCCCCcc
Q 040910 314 DMNPKISDFGIARMFGGDE----LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSL 388 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~~~~~~~~~~~ 388 (496)
+..+||.|||+........ .....+...||..||+||.+.+..|+.|+||||||++|+|++.-- -.+.
T Consensus 392 d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------- 464 (516)
T KOG1033|consen 392 DDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------- 464 (516)
T ss_pred chhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------
Confidence 9999999999988765443 233456678999999999999999999999999999999998621 1110
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 444 (496)
-. ....+.....++|....+++. =..++.+++...|.+||++.++
T Consensus 465 -r~-----~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 465 -RI-----ATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -HH-----HhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 00 000111112333333222221 2356678999999999944443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=153.58 Aligned_cols=198 Identities=21% Similarity=0.243 Sum_probs=135.3
Q ss_pred cCCceeeeeeeeee---------------------------cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCC
Q 040910 218 HHRNLVRLFGCCIE---------------------------QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG 270 (496)
Q Consensus 218 ~H~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 270 (496)
+|||||+++++|.+ +...|+||.-+ ..+|..|+-. .
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----------------~ 336 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----------------R 336 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----------------C
Confidence 59999999988763 23578888877 4688888842 2
Q ss_pred CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe--cCCC--ceEEeccccccccCCC----ccccccccccc
Q 040910 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL--DGDM--NPKISDFGIARMFGGD----ELQSNMNRIVG 342 (496)
Q Consensus 271 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~DFgla~~~~~~----~~~~~~~~~~g 342 (496)
..+.....-++.|++.|+.|||.++ |.|||+|++|||+ |+|+ .+.|+|||.+---... .+....-..-|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG 413 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG 413 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence 3445566778999999999999998 9999999999999 4444 4689999976432221 11111222346
Q ss_pred cccccChhhhccCC------CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCC
Q 040910 343 TYGYMSPEYALHGL------FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEAL 416 (496)
Q Consensus 343 t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 416 (496)
...-||||+....+ .-.|+|.|+.|.+.||++....||.....-..... ...+.--|.+..
T Consensus 414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----------~Yqe~qLPalp~--- 480 (598)
T KOG4158|consen 414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----------TYQESQLPALPS--- 480 (598)
T ss_pred cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----------hhhhhhCCCCcc---
Confidence 67889999876322 24689999999999999999999875332111110 000111122211
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 417 YPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 417 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.....+.+++...++.||++||+..-....|+
T Consensus 481 -~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 -RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 12234667888899999999999877666664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.3e-16 Score=140.39 Aligned_cols=137 Identities=20% Similarity=0.227 Sum_probs=99.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCcc--CHHH----------------------HHHHHHHHHHhcCC--ce
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--GVEE----------------------FKNEMILIAKLHHR--NL 222 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--ni 222 (496)
.+.||+|+||.||+|...+|+.||||++...... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653211 1111 13566666666443 34
Q ss_pred eeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeee
Q 040910 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIH 301 (496)
Q Consensus 223 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH 301 (496)
.+.+++ ...++||||++++++...... . .. .. .....++.+++.++.++|. .+ |+|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~-----------~-~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH 138 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK-----------D-VR---LL-EDPEELYDQILELMRKLYREAG---LVH 138 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhh-----------h-hh---hc-ccHHHHHHHHHHHHHHHhhccC---cCc
Confidence 444443 246899999998654322110 0 00 01 5678899999999999998 76 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
+||||+||+++ ++.++|+|||.+....
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999 9999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=132.48 Aligned_cols=135 Identities=22% Similarity=0.239 Sum_probs=114.4
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC--CceeeeeeeeeecCeeEEEEEecCCC
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH--RNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
+.+.||+|.++.||++... +..++||....... ...+..|+.++..++| +++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3568999999999999984 47899999865433 5678999999999976 58999999988888899999999887
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
++..+ +......++.+++.+|++||......++|+|++|+||++++.+.+++.|||.+
T Consensus 79 ~~~~~----------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 79 TLDEV----------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred ecccC----------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 76321 45567788999999999999865456999999999999999999999999998
Q ss_pred cc
Q 040910 326 RM 327 (496)
Q Consensus 326 ~~ 327 (496)
..
T Consensus 137 ~~ 138 (155)
T cd05120 137 GY 138 (155)
T ss_pred cC
Confidence 74
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-15 Score=142.06 Aligned_cols=135 Identities=22% Similarity=0.252 Sum_probs=105.1
Q ss_pred cccc-ccCCeeEEEEEecCCCEEEEEEeccCC-------------ccCHHHHHHHHHHHHHhcCCce--eeeeeeeeecC
Q 040910 170 NKLG-EGGFGPVYKGKLLNGEEVAVKRLSNKS-------------GQGVEEFKNEMILIAKLHHRNL--VRLFGCCIEQG 233 (496)
Q Consensus 170 ~~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~ 233 (496)
..|| .||.|+||+... ++..+|||++.... ......+.+|+.++.+|+|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 899999999987 57889999885321 1223567889999999998775 67777654432
Q ss_pred ----eeEEEEEecCC-CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 234 ----EKILIYEYMPN-KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 234 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
..++|+||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||.|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----------------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~N 172 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----------------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHN 172 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----------------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchh
Confidence 23599999997 689888732 123332 3678999999999998 9999999999
Q ss_pred EEecCCCceEEecccccccc
Q 040910 309 VLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~ 328 (496)
||++.++.++|+|||.+...
T Consensus 173 ILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 173 ILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EEEcCCCCEEEEECCCcccC
Confidence 99999999999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=166.61 Aligned_cols=211 Identities=21% Similarity=0.292 Sum_probs=138.9
Q ss_pred HhcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...+|..++.|..|++|.||..++.. .+.+|.| +++++- -.++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-----------------
Confidence 34688889999999999999998753 5677773 332220 0111 22222344433
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+-...+. .-+.++- +.+.+++|||+.+ |+|||+||+|.+|+.-|++|++
T Consensus 136 ----gDc~tllk---------------~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlT 185 (1205)
T KOG0606|consen 136 ----GDCATLLK---------------NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLT 185 (1205)
T ss_pred ----chhhhhcc---------------cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeeccccccc
Confidence 33333331 1122222 2278999999998 9999999999999999999999
Q ss_pred ccccccccCCCc-------------cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 321 DFGIARMFGGDE-------------LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 321 DFgla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
|||+++...... .+-....++||+.|.|||++....|...+|.|++|+|+||.+-|..||....+++
T Consensus 186 DfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 186 DFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred chhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 999987532110 0011233589999999999999999999999999999999999999987543322
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
+...+.. +... ..+.+.....+..+++...|+.+|..|--
T Consensus 266 --lfg~vis---d~i~--------wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 266 --LFGQVIS---DDIE--------WPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred --HHhhhhh---hhcc--------ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 2222111 0000 01111222345566777889999999973
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-16 Score=166.36 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=184.7
Q ss_pred hcCCCccccccccCCeeEEEEEec--CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL--NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 237 (496)
...|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345666778999999999887653 34467777665432 222333444666666675 9999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCCEEecCCC-
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNVLLDGDM- 315 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlk~~NIll~~~~- 315 (496)
+.+|..++++...+.. ......+-...-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+
T Consensus 99 ~~~~s~g~~~f~~i~~-------------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~ 162 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-------------PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGS 162 (601)
T ss_pred ccCccccccccccccc-------------CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCC
Confidence 9999999998665520 11113444566778999999999999 777 99999999999999999
Q ss_pred ceEEeccccccccCC-Cccccccccccc-cccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 316 NPKISDFGIARMFGG-DELQSNMNRIVG-TYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 316 ~~kl~DFgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
..+++|||+|..+.. ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|+............
T Consensus 163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~ 242 (601)
T KOG0590|consen 163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS 242 (601)
T ss_pred cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee
Confidence 999999999998776 444455556778 9999999999884 5577889999999999999999988765544322222
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
|. ..+.. . .............++..+++..+|+.|.+.+++.
T Consensus 243 ~~-----~~~~~--~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 243 WK-----SNKGR--F----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ec-----ccccc--c----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 21 11100 0 0000111123445666778888999999987764
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.3e-15 Score=112.82 Aligned_cols=71 Identities=18% Similarity=0.368 Sum_probs=61.1
Q ss_pred CCCCCceEeccCCCCCCchhhhhhccCChHHHHHHhhc---cCceEEEeeecccCCCcccccccccc-chhhhccccCCC
Q 040910 4 CKSGSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLK---NCTCRAYGNSNLIGGGSGCLMWFGDM-IDMKRTLGNLTG 79 (496)
Q Consensus 4 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~---ncsC~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~ 79 (496)
|.++++|+++.+|++|++.. ++++||++.|++ ||||+||+|.+. +.||++|++++ ++++... ..|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~--~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEF--SHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhcc--CCC
Confidence 45678999999999999775 589999999999 999999999643 46999999999 9998775 357
Q ss_pred cceeec
Q 040910 80 QSIYLR 85 (496)
Q Consensus 80 ~~~ylr 85 (496)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 899987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-14 Score=145.10 Aligned_cols=144 Identities=22% Similarity=0.257 Sum_probs=102.8
Q ss_pred CCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCH----------------------------------------
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGV---------------------------------------- 204 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------- 204 (496)
.|. .+.||.|++|.||+|++.+|+.||||+.+.......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 368999999999999999999999999865321100
Q ss_pred HHHHHHHHHHHHhc-----CCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHH
Q 040910 205 EEFKNEMILIAKLH-----HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279 (496)
Q Consensus 205 ~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 279 (496)
-+|.+|+..+.++. ++++.-..-+....+..+|||||+++++|.++..... ... .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--------------~~~---~~~~ 260 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--------------AGL---DRKA 260 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--------------cCC---CHHH
Confidence 13556666666662 3333222222233456799999999999988764210 011 2455
Q ss_pred HHHHHHH-HHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccC
Q 040910 280 IIEGIAQ-GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 280 i~~~ia~-~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
++..++. .+..+|..+ ++|+|++|.||++++++.++++|||++..+.
T Consensus 261 ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 261 LAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6766666 478889887 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-14 Score=135.78 Aligned_cols=207 Identities=20% Similarity=0.199 Sum_probs=141.0
Q ss_pred HHHHHhcCCceeeeeeeeeecC-----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHH
Q 040910 212 ILIAKLHHRNLVRLFGCCIEQG-----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286 (496)
Q Consensus 212 ~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~ 286 (496)
..|-.+.|-|||++..|+.+.. +..++.|||..|+|..||...+ .....+......+|+-||..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-----------~~~~a~~~~~wkkw~tqIls 187 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-----------KNQKALFQKAWKKWCTQILS 187 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-----------HhhhhhhHHHHHHHHHHHHh
Confidence 3455567999999999987543 5789999999999999998644 34456788888999999999
Q ss_pred HHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc--cccCCCccccccccccccccccChhhhccCCCCccccch
Q 040910 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA--RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVF 364 (496)
Q Consensus 287 ~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 364 (496)
||.|||+. .++|+|+++..+.|++..++-+||.----. ...-............+-++|.|||+=.....+..+|||
T Consensus 188 al~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy 266 (458)
T KOG1266|consen 188 ALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIY 266 (458)
T ss_pred hhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhh
Confidence 99999996 478999999999999999999987532111 100000011112234567899999987777788899999
Q ss_pred hhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040910 365 SFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444 (496)
Q Consensus 365 S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 444 (496)
+||+..+||.-+.-....... ...... ...+........++ ..++..|++.+|..||+|.++
T Consensus 267 ~fgmcAlemailEiq~tnseS--~~~~ee-----~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 267 KFGMCALEMAILEIQSTNSES--KVEVEE-----NIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred hhhHHHHHHHHheeccCCCcc--eeehhh-----hhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhh
Confidence 999999999776643111100 000000 00000011111111 234557999999999999998
Q ss_pred HHHH
Q 040910 445 VSMI 448 (496)
Q Consensus 445 l~~L 448 (496)
+.+.
T Consensus 329 lfHp 332 (458)
T KOG1266|consen 329 LFHP 332 (458)
T ss_pred hcCc
Confidence 7654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-12 Score=115.09 Aligned_cols=131 Identities=23% Similarity=0.169 Sum_probs=98.1
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCcee-eeeeeeeecCeeEEEEEecCCCCh
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV-RLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
.+.|+.|.++.||+++. .++.|++|....... ....+..|+.++..+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35789999999999987 578899998754332 234568899999999665554 444443 3345899999999887
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
...- .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+
T Consensus 79 ~~~~-----------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 79 LTED-----------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred cccc-----------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 4220 011345789999999999876 33469999999999999 668999999998
Q ss_pred cc
Q 040910 326 RM 327 (496)
Q Consensus 326 ~~ 327 (496)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 64
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-13 Score=135.60 Aligned_cols=250 Identities=21% Similarity=0.253 Sum_probs=176.7
Q ss_pred hcCCCccccccc--cCCeeEEEEEe---cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGE--GGFGPVYKGKL---LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 234 (496)
...|...+.+|. |.+|.||.+.. .++..+|+|+-+..- ......=.+|+..-.++ .|+|.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345666788999 99999999976 367899999844321 22222224566666666 59999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCCEE
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ----GLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.++-.|++ +.+|..+... ....++....+....+..+ ||.++|... ++|-|+||.||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~--------------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~ 254 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT--------------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIF 254 (524)
T ss_pred ceeeeccc-cchhHHhhhc--------------ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhhee
Confidence 99999988 5788777742 2233555666777777777 999999988 999999999999
Q ss_pred ecCC-CceEEeccccccccCCCcccccc---ccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 311 LDGD-MNPKISDFGIARMFGGDELQSNM---NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 311 l~~~-~~~kl~DFgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
...+ ...+++|||+...+......... ....|...|++||.+. +.++...|+|++|.+..+..++.......-..
T Consensus 255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 9999 88999999999988765533221 2236788999999655 57889999999999999998887654422111
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.|...+-.. +...... ....++..++..+++.+|..|++.+.+..
T Consensus 334 ----------~W~~~r~~~-ip~e~~~----~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 ----------SWSQLRQGY-IPLEFCE----GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----------Ccccccccc-Cchhhhc----CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111 1111111 11223344777899999999998777653
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=105.34 Aligned_cols=80 Identities=34% Similarity=0.829 Sum_probs=64.7
Q ss_pred CCCCCCC---CceEeccCCCCCCchhhhhhccCChHHHHHHhhccCceEEEeeecccCCCccccccccccchhhhccccC
Q 040910 1 MSDCKSG---SQFIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGDMIDMKRTLGNL 77 (496)
Q Consensus 1 ~~~c~~~---~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~ncsC~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~ 77 (496)
.++|+.+ ++|..++++++|+..... .++++++|++.||+||+|+||+|.+ ++++|.+|.+.+.+..... .
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~--~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLS--S 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeec--C
Confidence 3679654 699999999999987643 7789999999999999999999964 3578999999888865432 3
Q ss_pred CCcceeeccC
Q 040910 78 TGQSIYLRAP 87 (496)
Q Consensus 78 ~~~~~ylr~~ 87 (496)
.+..+|+|+|
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 3578899875
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.4e-12 Score=131.24 Aligned_cols=148 Identities=17% Similarity=0.178 Sum_probs=96.9
Q ss_pred hcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCcc--------------------------C----H-------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQ--------------------------G----V------- 204 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~--------------------------~----~------- 204 (496)
-..|+. +.||.|++|.||+|++.+ |+.||||++++.-.. . .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999987 999999999754110 0 0
Q ss_pred ---HHHHHHHHHHHHhc----CCceeeeeeeeee-cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhh
Q 040910 205 ---EEFKNEMILIAKLH----HRNLVRLFGCCIE-QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276 (496)
Q Consensus 205 ---~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~ 276 (496)
-+|.+|+..+.++. +.+.+.+-.++.+ .+..+|||||+.++.+.++-.-.. .......+....
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---------~g~d~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---------AGTDMKLLAERG 268 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---------cCCCHHHHHHHH
Confidence 12455555555552 3343443333332 456789999999999977531000 000111233333
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC----ceEEeccccccccCC
Q 040910 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM----NPKISDFGIARMFGG 330 (496)
Q Consensus 277 ~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFgla~~~~~ 330 (496)
...++.|+ ...+ ++|+|++|.||+++.++ .+++.|||++..++.
T Consensus 269 v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33334444 3355 99999999999999988 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.8e-11 Score=122.59 Aligned_cols=166 Identities=17% Similarity=0.204 Sum_probs=126.5
Q ss_pred ecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCccccc
Q 040910 185 LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVT 264 (496)
Q Consensus 185 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 264 (496)
..++.+|.|...+..+....+...+-++.++.++||||++++..+...+..|+|+|-+. .|..++..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----------- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----------- 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence 34788999998876665445567778889999999999999999999999999999873 56556632
Q ss_pred CCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccc
Q 040910 265 DPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344 (496)
Q Consensus 265 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~ 344 (496)
++-.....-+.||+.||.|||+.+ .++|++|....|++++.|+.||++|.++........ ......--.
T Consensus 101 -------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~ 169 (690)
T KOG1243|consen 101 -------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIE 169 (690)
T ss_pred -------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhh
Confidence 334566678899999999999766 499999999999999999999999998865432211 011112223
Q ss_pred cccChhhhccCCCCccccchhhhHHHHHHHhC
Q 040910 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSS 376 (496)
Q Consensus 345 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg 376 (496)
.|..|+.+.... -..|.|-||++++|++.|
T Consensus 170 s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 466666543222 456999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.8e-11 Score=109.10 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=105.2
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcC--CceeeeeeeeeecC---eeEEEEEecC
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHH--RNLVRLFGCCIEQG---EKILIYEYMP 243 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 243 (496)
+.|+.|..+.||++...+|+.+++|....... .....+..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886678999999764332 235678999999999965 45677787776543 5689999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-----------------------------
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY----------------------------- 294 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------- 294 (496)
+.++...+. ...++...+..++.+++++|+.||+.
T Consensus 84 G~~l~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 84 GRVLRDRLL----------------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred CEecCCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 988865431 02345555566666666666666632
Q ss_pred ------------------------CCCCeeecCCCCCCEEecC--CCceEEeccccccc
Q 040910 295 ------------------------SRLRVIHRDLKASNVLLDG--DMNPKISDFGIARM 327 (496)
Q Consensus 295 ------------------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DFgla~~ 327 (496)
....++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-10 Score=103.68 Aligned_cols=138 Identities=12% Similarity=0.089 Sum_probs=98.9
Q ss_pred ccccccCCeeEEEEEecC-------CCEEEEEEeccCC------------c----------cCHHHHH----HHHHHHHH
Q 040910 170 NKLGEGGFGPVYKGKLLN-------GEEVAVKRLSNKS------------G----------QGVEEFK----NEMILIAK 216 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~~----~E~~~l~~ 216 (496)
..||.|--+.||.|...+ +..+|||..+... . .....+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 4799999864210 0 0122333 79999999
Q ss_pred hc--CCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHh-hh
Q 040910 217 LH--HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYL-HQ 293 (496)
Q Consensus 217 l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~ 293 (496)
+. .-++.+++++ ..-+|||||+.++.+..... ....++......+..+++.+|..| |.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---------------kd~~~~~~~~~~i~~~i~~~l~~l~H~ 143 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---------------KDAKLNDEEMKNAYYQVLSMMKQLYKE 143 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---------------hccccCHHHHHHHHHHHHHHHHHHHHh
Confidence 94 3566777765 45689999997654421110 111234455677889999999999 77
Q ss_pred cCCCCeeecCCCCCCEEecCCCceEEeccccccccCC
Q 040910 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330 (496)
Q Consensus 294 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~ 330 (496)
.+ ++|+||++.|||++ ++.+.|+|||.+.....
T Consensus 144 ~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 144 CN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CC---eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 77 99999999999997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7e-10 Score=110.06 Aligned_cols=182 Identities=20% Similarity=0.251 Sum_probs=137.5
Q ss_pred CCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeEEEEEecC-CCChhH
Q 040910 176 GFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKILIYEYMP-NKSLDF 249 (496)
Q Consensus 176 ~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~-~gsL~~ 249 (496)
--.+.||+.. .||..|++||+.....+....-..-++.++++.|+|+|++..++.. +...++||+|.+ .++|-+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3456788865 4899999999954433333233445788999999999999998873 347899999998 578887
Q ss_pred HHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccC
Q 040910 250 FLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 250 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
+.+....................++..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+..++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776554433233333445566888999999999999999999998 8889999999999999999999999887765
Q ss_pred CCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCC
Q 040910 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379 (496)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~ 379 (496)
.+.... + .-..+-|.=.||.+++-|.+|...
T Consensus 445 ~d~~~~----------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP----------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc----------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 442100 0 112456888999999999999754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.6e-11 Score=121.61 Aligned_cols=248 Identities=19% Similarity=0.183 Sum_probs=173.1
Q ss_pred HHhcCCCccccccccCCeeEEEEEe--cCCCEEEEEEeccCCccCHHH--HHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL--LNGEEVAVKRLSNKSGQGVEE--FKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
....+|..+..||.|.|+.|++... .++..+++|.+.........+ -..|+.+...+ .|.++++....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3445788899999999999999864 367899999886553332222 23456666666 699999988888888888
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD- 314 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~- 314 (496)
++=-||++++++.... .....++...++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 342 ~ip~e~~~~~s~~l~~---------------~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---------------VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred cCchhhhcCcchhhhh---------------HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 8999999999987665 23345777788999999999999999887 9999999999999886
Q ss_pred CceEEeccccccccCCCcccccccccccccccc--ChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYM--SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
+..++.|||.+..+.-. ......+.+++ +|+......+..++|++|||.-+.|.+++..-..... +
T Consensus 404 ~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~ 471 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------Q 471 (524)
T ss_pred hhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------c
Confidence 78899999998643211 11122333444 5555567789999999999999999888875322110 0
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
| .....+.. +.. ......+..++..++..++..||.+.++..+.+-
T Consensus 472 ~--~~i~~~~~-----p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 S--LTIRSGDT-----PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c--eeeecccc-----cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 00000111 010 1111334445556788999999998887665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.6e-10 Score=95.82 Aligned_cols=131 Identities=21% Similarity=0.313 Sum_probs=101.1
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCcc--------CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..+++|+-+.+|.+.+ -|..+++|.=.++... ..+.-.+|+.++.++.--.|.-..-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3688999999999977 4445666643222111 124567899999999655555555566677888999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
.++..|.+++.. ....++..|-.-+.-||..+ |+|+||.++||++..+. +.++|
T Consensus 81 I~G~~lkd~l~~----------------------~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~ID 134 (204)
T COG3642 81 IEGELLKDALEE----------------------ARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFID 134 (204)
T ss_pred eCChhHHHHHHh----------------------cchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEE
Confidence 999999988842 12567888888999999998 99999999999998765 99999
Q ss_pred cccccc
Q 040910 322 FGIARM 327 (496)
Q Consensus 322 Fgla~~ 327 (496)
|||+..
T Consensus 135 fGLg~~ 140 (204)
T COG3642 135 FGLGEF 140 (204)
T ss_pred CCcccc
Confidence 999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.2e-09 Score=93.14 Aligned_cols=143 Identities=22% Similarity=0.281 Sum_probs=105.1
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEE-eccCC-------ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKR-LSNKS-------GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
....|-+|+-+.|+++.+ .|+...||. +.+.- .-...+.++|++++.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456889999999999988 777777774 32221 123456788999999986555555555666666778999
Q ss_pred EecCC-CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC---
Q 040910 240 EYMPN-KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM--- 315 (496)
Q Consensus 240 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~--- 315 (496)
||+++ .++.+|+...-. ....-+....++..|-+.+.-||..+ |+|+||..+||+|..++
T Consensus 90 E~~~g~~~vk~~i~~~~~-------------~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME-------------DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EeccchhHHHHHHHHHcc-------------CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcC
Confidence 99966 478888864221 11122233678899999999999998 99999999999996655
Q ss_pred ceEEeccccccc
Q 040910 316 NPKISDFGIARM 327 (496)
Q Consensus 316 ~~kl~DFgla~~ 327 (496)
.+.++|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 358999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.4e-09 Score=98.25 Aligned_cols=134 Identities=19% Similarity=0.150 Sum_probs=97.7
Q ss_pred CeeEEEEEecCCCEEEEEEeccCCc-----------cCHHHHHHHHHHHHHhc--CCceeeeeeeeee-----cCeeEEE
Q 040910 177 FGPVYKGKLLNGEEVAVKRLSNKSG-----------QGVEEFKNEMILIAKLH--HRNLVRLFGCCIE-----QGEKILI 238 (496)
Q Consensus 177 ~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~-----~~~~~lv 238 (496)
...|++..+ +|+.+.||+...... .....+.+|...+.++. .-...+++++... ....+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667766 788999998743321 11124788999999984 3344455556543 2357899
Q ss_pred EEecCCC-ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC----
Q 040910 239 YEYMPNK-SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---- 313 (496)
Q Consensus 239 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---- 313 (496)
+|++++- +|.+++.... ....+...+..++.+++..++-||..+ |+|+|++++|||++.
T Consensus 114 te~l~~~~sL~~~~~~~~-------------~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-------------TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred EeeCCCCccHHHHHHhhc-------------ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 9999876 8988874211 123445667789999999999999999 999999999999975
Q ss_pred ---CCceEEeccccccc
Q 040910 314 ---DMNPKISDFGIARM 327 (496)
Q Consensus 314 ---~~~~kl~DFgla~~ 327 (496)
++.+.++||+.++.
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 56899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=9e-09 Score=92.49 Aligned_cols=126 Identities=25% Similarity=0.286 Sum_probs=84.1
Q ss_pred eEEEEEecCCCEEEEEEeccCC-------------cc-------------CHHHHHHHHHHHHHhcCC--ceeeeeeeee
Q 040910 179 PVYKGKLLNGEEVAVKRLSNKS-------------GQ-------------GVEEFKNEMILIAKLHHR--NLVRLFGCCI 230 (496)
Q Consensus 179 ~Vy~~~~~~~~~vavK~l~~~~-------------~~-------------~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 230 (496)
.||.|...+|..+|||..+... .. ......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999875321 00 123467899999999654 566666552
Q ss_pred ecCeeEEEEEecC--CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCC
Q 040910 231 EQGEKILIYEYMP--NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY-LHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 231 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlk~~ 307 (496)
.-+|||||++ +..+..+.. ..++......++.+++..+.. +|..+ |+|+||.+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-----------------~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~ 136 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-----------------VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEY 136 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-----------------CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STT
T ss_pred ---CCEEEEEecCCCccchhhHHh-----------------ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChh
Confidence 4479999998 555544331 112244567788888886666 46777 999999999
Q ss_pred CEEecCCCceEEeccccccccC
Q 040910 308 NVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~ 329 (496)
|||++++ .+.|+|||.+....
T Consensus 137 NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 137 NILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp SEEEETT-CEEE--GTTEEETT
T ss_pred hEEeecc-eEEEEecCcceecC
Confidence 9999988 99999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.8e-10 Score=117.50 Aligned_cols=205 Identities=22% Similarity=0.238 Sum_probs=142.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
....|.+.+.+-.|.++.++.+.-. .|...+.|...... ....+....+-.++-...||-++....-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777778889999999887532 24334444332211 1112222222223323356777776666556678899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
+++|..+++|...|+.. +..+..-.......+.+++.|||... +.|+|++|.|.|...+++.
T Consensus 882 ~~~~~~~~~~~Skl~~~---------------~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---------------GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred hhHHhccCCchhhhhcC---------------CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCc
Confidence 99999999998887531 12333334456667888999999876 8999999999999999999
Q ss_pred EEeccccccccCC-------------------------Ccccc----ccccccccccccChhhhccCCCCccccchhhhH
Q 040910 318 KISDFGIARMFGG-------------------------DELQS----NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 368 (496)
Q Consensus 318 kl~DFgla~~~~~-------------------------~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv 368 (496)
+++|||.....+. ..... ......+|+.|.+||.+.+......+|.|++|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 9999984432210 00000 112346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 040910 369 LLLETLSSKKNTRFYN 384 (496)
Q Consensus 369 vl~elltg~~~~~~~~ 384 (496)
+++|.++|..||....
T Consensus 1024 ~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAET 1039 (1205)
T ss_pred hhhhhhcCCCCCCCcc
Confidence 9999999999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.4e-08 Score=88.79 Aligned_cols=137 Identities=20% Similarity=0.188 Sum_probs=98.0
Q ss_pred CCccccccccCCeeEEEEEecCCCEEEEEEeccCC----------------------ccCHHHHHHHHHHHHHhcCC--c
Q 040910 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS----------------------GQGVEEFKNEMILIAKLHHR--N 221 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 221 (496)
..+.++||-|--+.||.|..+.|.++|||.=+... ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567999999999999999999999999532110 01234567899999999544 6
Q ss_pred eeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 040910 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIH 301 (496)
Q Consensus 222 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 301 (496)
+.+.+++ +.-.+||||.++--|... .++-...-.++..|+.-+.-+-..| |+|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~--------------------r~~~en~~~il~~il~~~~~~~~~G---iVH 225 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL--------------------RLDVENPDEILDKILEEVRKAYRRG---IVH 225 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc--------------------cCcccCHHHHHHHHHHHHHHHHHcC---ccc
Confidence 7777665 455799999987655211 1123334445555555555555556 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
+|+++-||++++||.+.++||--+...+
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999999998776544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.2e-07 Score=84.06 Aligned_cols=138 Identities=16% Similarity=0.162 Sum_probs=104.3
Q ss_pred ccccCCeeEEEEEecCCCEEEEEEeccC---C---ccCHHHHHHHHHHHHHhc--CCceeeeeeeee-ec----CeeEEE
Q 040910 172 LGEGGFGPVYKGKLLNGEEVAVKRLSNK---S---GQGVEEFKNEMILIAKLH--HRNLVRLFGCCI-EQ----GEKILI 238 (496)
Q Consensus 172 lG~G~~g~Vy~~~~~~~~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~-~~----~~~~lv 238 (496)
-|+||.+.|++-.+ +|+.+-||+.... + +-+...|.+|...|.++. .-.+.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999877 5667999987522 1 346678999999999994 33455555 332 11 246899
Q ss_pred EEecC-CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc-
Q 040910 239 YEYMP-NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN- 316 (496)
Q Consensus 239 ~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~- 316 (496)
+|-++ --+|.+++.+ ....+.+...+..++.+|+..++-||+.+ +.|+|+.+.|||++.++.
T Consensus 104 Te~L~g~~~L~~~l~~-------------~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~ 167 (216)
T PRK09902 104 TEDMAGFISIADWYAQ-------------HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKA 167 (216)
T ss_pred EEeCCCCccHHHHHhc-------------CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCe
Confidence 99775 3688888842 22334566778899999999999999998 999999999999986666
Q ss_pred -eEEeccccccc
Q 040910 317 -PKISDFGIARM 327 (496)
Q Consensus 317 -~kl~DFgla~~ 327 (496)
++++||.-++.
T Consensus 168 ~v~lIDlEk~r~ 179 (216)
T PRK09902 168 EAGFLDLEKSRR 179 (216)
T ss_pred eEEEEEhhccch
Confidence 99999987764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=91.61 Aligned_cols=197 Identities=15% Similarity=0.144 Sum_probs=126.8
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeee------eecC-eeEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCC------IEQG-EKILI 238 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~------~~~~-~~~lv 238 (496)
...+.||+|+-+.+|-.-- -+. .+-|+..........+ -+..|.+. .||-+-.=+.+= -+.+ ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch-hhc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457899999999986421 122 3446665443322222 22233333 566443311110 1112 24456
Q ss_pred EEecCCC-ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNK-SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|..+++. -...++ ...+...+.....|.-.++.+..+|.+.+-||..| .+-+|+.++|+|+++++.+
T Consensus 89 mP~v~g~~pI~~~y---------~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 89 MPKVSGKEPIHMIY---------SPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred cccCCCccchhhhc---------CchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceE
Confidence 6666543 111111 11123345667899999999999999999999998 8999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhC-CCCCCCC
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSS-KKNTRFY 383 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg-~~~~~~~ 383 (496)
.|.|=..-....++ ....-.+|...|.+||.-. +..-+...|-|-+|+++++++.| ++|+...
T Consensus 157 ~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 157 VLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred EEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 99984433222211 1122357888999999654 45567889999999999999887 8888653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.1e-08 Score=98.70 Aligned_cols=146 Identities=18% Similarity=0.233 Sum_probs=96.9
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc--------------------------C----HH--------
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--------------------------G----VE-------- 205 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~----~~-------- 205 (496)
..|.. +.|+.++-|.||+|++.+|+.||||+.+..-.. . .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34543 689999999999999999999999997653111 0 01
Q ss_pred --HHHHHHHHHHHhc-----CCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHH
Q 040910 206 --EFKNEMILIAKLH-----HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278 (496)
Q Consensus 206 --~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 278 (496)
++..|+..+.+++ .+++.-.-=|+.-.+..+|+|||++|-.+.+...- ....++- .
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--------------~~~g~d~---k 267 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--------------KSAGIDR---K 267 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--------------HhcCCCH---H
Confidence 2445555555552 34433333333445678999999999998877521 1122332 2
Q ss_pred HHHHHHHHH-HHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCC
Q 040910 279 RIIEGIAQG-LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330 (496)
Q Consensus 279 ~i~~~ia~~-L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~ 330 (496)
.++..++++ +..+-..+ +.|.|..|.||+++.++.+.+.|||+...+..
T Consensus 268 ~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 268 ELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 333333332 22222234 99999999999999999999999999987754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.8e-07 Score=86.08 Aligned_cols=124 Identities=25% Similarity=0.250 Sum_probs=92.1
Q ss_pred CCCEEEEEEeccCC-------ccCHHHHHHHHHHHHHhc--CCceeeeeeeeeecC----eeEEEEEecCC-CChhHHHh
Q 040910 187 NGEEVAVKRLSNKS-------GQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQG----EKILIYEYMPN-KSLDFFLF 252 (496)
Q Consensus 187 ~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~ 252 (496)
.++.+.+|.+...- .-....+.+|...+.++. .-...+.+++..... ..++|+|++++ -+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543211 123346788998888884 445666777765532 45899999987 48999885
Q ss_pred hcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC---ceEEecccccccc
Q 040910 253 DYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM---NPKISDFGIARMF 328 (496)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFgla~~~ 328 (496)
.. ..++......++.+++..++-||..+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 111 ~~---------------~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QW---------------EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hh---------------cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 31 11455667889999999999999999 99999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.4e-08 Score=102.80 Aligned_cols=153 Identities=22% Similarity=0.320 Sum_probs=99.4
Q ss_pred HHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCC-ccccccc------cccccccccChhhhc
Q 040910 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD-ELQSNMN------RIVGTYGYMSPEYAL 353 (496)
Q Consensus 281 ~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~-~~~~~~~------~~~gt~~y~aPE~~~ 353 (496)
+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+....+. ++..... -......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999755 6999999999999999999999999988655431 1111111 112355899999999
Q ss_pred cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhccc
Q 040910 354 HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQE 433 (496)
Q Consensus 354 ~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 433 (496)
+...+.++|+||+|++++-+..|+++.-.......... .. .. ..+... ..+....+.++.+=+.+.+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~------~~---~~~~~~-~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FS------RN---LLNAGA-FGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hh------hc---cccccc-ccccccCcHHHHHHHHHHhcC
Confidence 98899999999999999999855554321111110000 00 00 000000 011122234455556678899
Q ss_pred CCCCCCCHHHHHH
Q 040910 434 NAADRPTMSEVVS 446 (496)
Q Consensus 434 ~p~~RPs~~evl~ 446 (496)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-07 Score=71.40 Aligned_cols=61 Identities=30% Similarity=0.850 Sum_probs=49.4
Q ss_pred CCceEeccCCCCCCchhhhhhccCChHHHHHHhhc-cCceEEEeeecccCCCccccccc-cccchhh
Q 040910 7 GSQFIKFDDMQVPDLLEVLLNESVNLKECEAECLK-NCTCRAYGNSNLIGGGSGCLMWF-GDMIDMK 71 (496)
Q Consensus 7 ~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~-ncsC~a~~~~~~~~~~~~C~~w~-~~l~~~~ 71 (496)
.+.|.+++++.+++..... ....++++|++.|+. +|+|.||.|.+ ++.+|.+|. +.+.+..
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR 65 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence 4679999999999765532 456799999999999 99999999964 456899999 6666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.8e-06 Score=79.27 Aligned_cols=152 Identities=17% Similarity=0.203 Sum_probs=86.8
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC--ceeeeeeeeeecCeeEEEEEecCCCC-
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR--NLVRLFGCCIEQGEKILIYEYMPNKS- 246 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lv~e~~~~gs- 246 (496)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..- .+.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47999999999984 35567888876432 345678899999998643 35677888777778889999998863
Q ss_pred hhHHHhhcc----------cCCCcccccCCCCCCCCC--hhhHHHHH-------HHHHH-HHHHhhh-cCCCCeeecCCC
Q 040910 247 LDFFLFDYK----------YSSGFDMVTDPASKGILD--WTTRVRII-------EGIAQ-GLLYLHQ-YSRLRVIHRDLK 305 (496)
Q Consensus 247 L~~~l~~~~----------~~~~~~~~~~~~~~~~l~--~~~~~~i~-------~~ia~-~L~yLH~-~~~~~ivH~Dlk 305 (496)
+...+.... ......+...+.....+. +......+ ..+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221111000 000000000000000010 00000000 00001 1222221 123457899999
Q ss_pred CCCEEecCCCceEEeccccccc
Q 040910 306 ASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 306 ~~NIll~~~~~~kl~DFgla~~ 327 (496)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.7e-06 Score=74.44 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=93.0
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHH---------HHHHHHHHHhc---CCceeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEF---------KNEMILIAKLH---HRNLVRLFGCC 229 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~~~~ 229 (496)
..++|...+.+-......|.+-.. +|+.+++|..+.......+.| .+.+..+.+++ -...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456787777887777777877766 778999998876543322222 23344444442 22333333332
Q ss_pred e-----ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 230 I-----EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 230 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
. -....++||||++|..|.++.. ++. .++..+++++.-||..| +.|+|.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~ 161 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------------IDE----DLAEKIVEAIKQLHKHG---FYHGDP 161 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------------------cCH----HHHHHHHHHHHHHHHcC---CccCCC
Confidence 2 2235678999999988855431 111 35567888899999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccc
Q 040910 305 KASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~ 327 (496)
.|.|+++++++ +++.||+..+.
T Consensus 162 hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 162 HPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred CcCcEEEECCc-EEEEECccccc
Confidence 99999998655 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.9e-06 Score=75.15 Aligned_cols=156 Identities=17% Similarity=0.190 Sum_probs=101.1
Q ss_pred eCHHHHHHHhcCCCccc---cccccCCeeEEEEEecCCCEEEEEEeccCCcc-------------------CHHH-----
Q 040910 154 FSLASISTATHNFSEEN---KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-------------------GVEE----- 206 (496)
Q Consensus 154 ~~~~~~~~~~~~f~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~----- 206 (496)
.++..+....++..+.. .|..|--+.||+|.-.++..+|||+++..... +...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555555444 45567778899998778999999998643211 1111
Q ss_pred HHHHHHHHHHh--cCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHH
Q 040910 207 FKNEMILIAKL--HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284 (496)
Q Consensus 207 ~~~E~~~l~~l--~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 284 (496)
...|...|.++ .+-.+.+.+++. .-.|||||+....+.. ..-..-.+.......+..++
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pA---------------P~LkDv~~e~~e~~~~~~~~ 175 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPA---------------PRLKDVPLELEEAEGLYEDV 175 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCC---------------CCcccCCcCchhHHHHHHHH
Confidence 23466667666 355555665553 4479999996442100 00111122233566777888
Q ss_pred HHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCC
Q 040910 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD 331 (496)
Q Consensus 285 a~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~ 331 (496)
++.+.-|-... .+||+||+.-|||+. ++.+.|+|||-|.....+
T Consensus 176 v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 176 VEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred HHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 88888887633 399999999999999 889999999998766543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.8e-06 Score=85.86 Aligned_cols=146 Identities=18% Similarity=0.214 Sum_probs=92.5
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc-------------------------------------CHHH
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-------------------------------------GVEE 206 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------------------------------------~~~~ 206 (496)
..|+ .+.||.-+.|.||+|++++|+.||||+.++.-.. ..-+
T Consensus 162 ~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 162 SEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred HhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 3444 3689999999999999999999999987643111 0112
Q ss_pred HHHHHHHHHHh----cCCc---eeeeeeee-eecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHH
Q 040910 207 FKNEMILIAKL----HHRN---LVRLFGCC-IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278 (496)
Q Consensus 207 ~~~E~~~l~~l----~H~n---iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 278 (496)
|..|++...+. .|-+ -|.+=.++ .-...++|+||||+|..+.+.-.- .+..++-..+.
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--------------~~~gi~~~~i~ 306 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--------------DKRGISPHDIL 306 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--------------HHcCCCHHHHH
Confidence 55566555444 4555 11222222 234578999999999888666421 11223333333
Q ss_pred HHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec----CCCceEEeccccccccC
Q 040910 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD----GDMNPKISDFGIARMFG 329 (496)
Q Consensus 279 ~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~----~~~~~kl~DFgla~~~~ 329 (496)
.-+.+...-+-+- .| ++|+|=.|.||+++ .++.+.+.|||+...+.
T Consensus 307 ~~l~~~~~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 307 NKLVEAYLEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHHHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3333322222222 23 99999999999998 36789999999988664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.3e-05 Score=75.80 Aligned_cols=76 Identities=14% Similarity=0.158 Sum_probs=55.4
Q ss_pred cccccCC-eeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecCCCChh
Q 040910 171 KLGEGGF-GPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLD 248 (496)
Q Consensus 171 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 248 (496)
.|-.|.. ..||+... ++..++||+..... .....+|++++..+ .+.-+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 78899976 34788888875432 34567899999888 3455667788777666789999999998886
Q ss_pred HH
Q 040910 249 FF 250 (496)
Q Consensus 249 ~~ 250 (496)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 54
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.7e-06 Score=75.91 Aligned_cols=105 Identities=20% Similarity=0.187 Sum_probs=83.1
Q ss_pred HHHHHHHHHhcC-CceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHH
Q 040910 208 KNEMILIAKLHH-RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286 (496)
Q Consensus 208 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~ 286 (496)
.+|..+++.+++ +++.+++|+| ..++|.||...+++..... ........+|..|.+||.++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~------------~l~~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYR------------PLSQFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccc------------ccccccccCHHHHHHHHHHHHH
Confidence 357888888876 6999999999 3478999998776632100 0012234789999999999999
Q ss_pred HHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 287 ~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
.+.+|++.....+...|++++|+-+++++.+|+.|...+...
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999866556999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.1e-07 Score=92.92 Aligned_cols=185 Identities=16% Similarity=0.076 Sum_probs=131.9
Q ss_pred CCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc-eeeeeeeeeecCeeEEEEEecCC
Q 040910 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN-LVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+...+.+++|+++.++|.+-.-.+...++.+... ....-++++|.+.+||| .+..++-+..+....++++++..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3334668899999999986533344445555322 44466889999999999 77777777777788899999876
Q ss_pred C-ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 245 K-SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 245 g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+ +-..- .....-.+..-+...+...-+++++|||+.. =+|+| ||+..+ ...+..||+
T Consensus 319 ~rs~~~~--------------~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 319 GRSSALE--------------MTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred Ccccccc--------------CChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence 6 11000 0012222334445566667778999999864 48898 777766 678999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCC
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
....+.... ..+...+|+.++|||+.....+..+.|+|+.|+-..++--|-+|.
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 988765432 344567899999999999999999999999998777766666554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-05 Score=73.50 Aligned_cols=78 Identities=21% Similarity=0.297 Sum_probs=57.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC--ceeeeeeeeeec---CeeEEEEEecC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR--NLVRLFGCCIEQ---GEKILIYEYMP 243 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~~ 243 (496)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999998866 69999997543 3456778899999888433 355666644332 35689999999
Q ss_pred CCChhH
Q 040910 244 NKSLDF 249 (496)
Q Consensus 244 ~gsL~~ 249 (496)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 998877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.2e-05 Score=84.39 Aligned_cols=79 Identities=18% Similarity=0.406 Sum_probs=58.7
Q ss_pred cccccccCCeeEEEEEecCC---CEEEEEEeccCC-ccCHHHHHHHHHHHHHhc-CCce--eeeeeeeeec---CeeEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLNG---EEVAVKRLSNKS-GQGVEEFKNEMILIAKLH-HRNL--VRLFGCCIEQ---GEKILI 238 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv 238 (496)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |+++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467888764332 123457889999999995 6664 7788888764 467899
Q ss_pred EEecCCCCh
Q 040910 239 YEYMPNKSL 247 (496)
Q Consensus 239 ~e~~~~gsL 247 (496)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00016 Score=65.58 Aligned_cols=132 Identities=17% Similarity=0.262 Sum_probs=91.7
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEEeccCC----------------ccCHHHHHHHHHHHHHhc------CCceeee
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS----------------GQGVEEFKNEMILIAKLH------HRNLVRL 225 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 225 (496)
....||+|+.-.||. ++++....||+..... .....++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345899999999996 4566677889887554 223566777877776666 8899999
Q ss_pred eeeeeecCeeEEEEEecCC--C----ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCe
Q 040910 226 FGCCIEQGEKILIYEYMPN--K----SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRV 299 (496)
Q Consensus 226 ~~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 299 (496)
+|+..++...-+|+|.+.+ | +|.+++. ...++. ...+.+.+ -..||-... |
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----------------~~~~~~-~~~~~L~~---f~~~l~~~~---I 139 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----------------EGGLTE-ELRQALDE---FKRYLLDHH---I 139 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----------------cCCccH-HHHHHHHH---HHHHHHHcC---C
Confidence 9999999999999998753 3 4555553 122433 33333333 345555555 9
Q ss_pred eecCCCCCCEEecCCC----ceEEec-ccc
Q 040910 300 IHRDLKASNVLLDGDM----NPKISD-FGI 324 (496)
Q Consensus 300 vH~Dlk~~NIll~~~~----~~kl~D-Fgl 324 (496)
+.+|++|.||++..+. .+.|+| ||-
T Consensus 140 v~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 140 VIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred eecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 9999999999995332 477777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=9e-05 Score=66.74 Aligned_cols=125 Identities=23% Similarity=0.397 Sum_probs=91.9
Q ss_pred cCCCccccccccCC-eeEEEEEecCCCEEEEEEeccC---C---------c---------cCHHHHHHHHHHHHHhc---
Q 040910 164 HNFSEENKLGEGGF-GPVYKGKLLNGEEVAVKRLSNK---S---------G---------QGVEEFKNEMILIAKLH--- 218 (496)
Q Consensus 164 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~---~---------~---------~~~~~~~~E~~~l~~l~--- 218 (496)
.+++..+.||.|.- |.||+++. +|+.+|+|.++.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 8889999994321 0 0 12346889999999984
Q ss_pred CCce--eeeeeeeeec------------------CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHH
Q 040910 219 HRNL--VRLFGCCIEQ------------------GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278 (496)
Q Consensus 219 H~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 278 (496)
+.++ |+.+||..-. ....||.||.+... ....
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------------------~~~~ 167 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------------------PLQI 167 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------------ccch
Confidence 4456 8999987422 12356777664322 1123
Q ss_pred HHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccc
Q 040910 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325 (496)
Q Consensus 279 ~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla 325 (496)
+-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 45677888889999998 999999999985 4589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6e-05 Score=65.69 Aligned_cols=129 Identities=23% Similarity=0.328 Sum_probs=87.9
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceee-eeeeeeecCeeEEEEEecCCC
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR-LFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~g 245 (496)
...+.||+|++|.||+|.+ .|..+|+|.-+..+ ....+..|++++..++--++.+ ++.| +.-++.|||..+-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence 3456899999999999998 56689999876543 4567899999999997666554 3333 2334559999888
Q ss_pred ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC--CCEEecCCCceEEeccc
Q 040910 246 SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA--SNVLLDGDMNPKISDFG 323 (496)
Q Consensus 246 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~--~NIll~~~~~~kl~DFg 323 (496)
.|.+.-.. .+ .+....++..---|...+ |-|+.|.- .||++.+ ..+.|+||.
T Consensus 98 ~L~~~~~~------------------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd 151 (201)
T COG2112 98 PLGKLEIG------------------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFD 151 (201)
T ss_pred chhhhhhc------------------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEcc
Confidence 88666521 01 223334444433344445 88888874 4555544 499999999
Q ss_pred ccccc
Q 040910 324 IARMF 328 (496)
Q Consensus 324 la~~~ 328 (496)
-|..-
T Consensus 152 ~At~k 156 (201)
T COG2112 152 SATFK 156 (201)
T ss_pred chhhc
Confidence 98743
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.3e-06 Score=55.82 Aligned_cols=43 Identities=33% Similarity=0.461 Sum_probs=33.7
Q ss_pred cCCCCCCCCcchhhhhhhhccccccccc--cCCCCCceeeeccccC
Q 040910 453 VNLPSPQQPAFSYVRIVEKSVLLENSEA--EASSGNCLTLSMVDAR 496 (496)
Q Consensus 453 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 496 (496)
..+|.|++|+|...+.......+++ .. ..+|+|+||+|+|+||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss-~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSS-KQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcc-cccCCCCCeeeEEEEeEecC
Confidence 5799999999999988543333332 23 6789999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00013 Score=68.71 Aligned_cols=73 Identities=12% Similarity=0.232 Sum_probs=46.8
Q ss_pred ccccccCCe-eEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC---ceeeeeeeeeecC---eeEEEEEec
Q 040910 170 NKLGEGGFG-PVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR---NLVRLFGCCIEQG---EKILIYEYM 242 (496)
Q Consensus 170 ~~lG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~---~~~lv~e~~ 242 (496)
+.|+.|+.. .||+. +..+++|..+. ......+.+|++++..+... .+.+.++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 48875 23567776543 22345789999999888532 3444444433322 348899999
Q ss_pred CCCChh
Q 040910 243 PNKSLD 248 (496)
Q Consensus 243 ~~gsL~ 248 (496)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00016 Score=67.96 Aligned_cols=74 Identities=20% Similarity=0.289 Sum_probs=49.3
Q ss_pred ccccccCCeeEEEEEecC--CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc-eeeeeeeeeecCeeEEEEEecCCCC
Q 040910 170 NKLGEGGFGPVYKGKLLN--GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN-LVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
+.|..|-...+|+....+ ++.|++|......... ..-.+|+.++..+.... ..++++... -.+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999997654 6789999775432221 23356888888885333 344444332 248999999877
Q ss_pred hh
Q 040910 247 LD 248 (496)
Q Consensus 247 L~ 248 (496)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=69.27 Aligned_cols=150 Identities=14% Similarity=0.084 Sum_probs=80.2
Q ss_pred cccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCce-eeeeeeeeecCeeEEEEEecCCCChhH
Q 040910 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL-VRLFGCCIEQGEKILIYEYMPNKSLDF 249 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 249 (496)
.+..|-.+.+|+... +++.+++|........-.-...+|..+++.+....+ .++++... -.+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456688889998874 677888987654322211235779999999854333 33444332 368999999877643
Q ss_pred H-------HhhcccCCCcccccCCCCCCCCChhhH-HHHHHH---------HHHHHHHhhhc-----CCCCeeecCCCCC
Q 040910 250 F-------LFDYKYSSGFDMVTDPASKGILDWTTR-VRIIEG---------IAQGLLYLHQY-----SRLRVIHRDLKAS 307 (496)
Q Consensus 250 ~-------l~~~~~~~~~~~~~~~~~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlk~~ 307 (496)
- +.... .....+.........++.... .....+ +.+.+..+-.. .+..++|+|+.|.
T Consensus 78 ~~~~~~~~~~~la-~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 78 DQFVALDLLLELA-ALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccccCchhHHHHH-HHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 00000 000000000001111111111 111111 11112222111 1345899999999
Q ss_pred CEEecCCCceEEeccccccc
Q 040910 308 NVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~ 327 (496)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00037 Score=67.93 Aligned_cols=78 Identities=13% Similarity=0.136 Sum_probs=58.4
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-C--Cceeeeeeeeeec---CeeEEEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-H--RNLVRLFGCCIEQ---GEKILIYE 240 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~---~~~~lv~e 240 (496)
...+.||.|..+.||+....++ .+++|..+. ......|..|++.++.|. + ..+.++++++... +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456899999999999876555 466777433 113357899999999994 2 4688888887543 56899999
Q ss_pred ecCCCCh
Q 040910 241 YMPNKSL 247 (496)
Q Consensus 241 ~~~~gsL 247 (496)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00041 Score=69.83 Aligned_cols=80 Identities=15% Similarity=0.204 Sum_probs=57.2
Q ss_pred ccccccCCeeEEEEEecCC-CEEEEEEeccC------C-ccCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCeeEEE
Q 040910 170 NKLGEGGFGPVYKGKLLNG-EEVAVKRLSNK------S-GQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 238 (496)
+.||.|.+..||+....+| +.|+||.-... . ....+.+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 48999984321 1 234567788888888872 2456777776 34567899
Q ss_pred EEecCCCC-hhHHH
Q 040910 239 YEYMPNKS-LDFFL 251 (496)
Q Consensus 239 ~e~~~~gs-L~~~l 251 (496)
|||+++.. +...|
T Consensus 110 ME~L~~~~~lr~~L 123 (401)
T PRK09550 110 MEDLSDHKILRKGL 123 (401)
T ss_pred EecCCCccHHHHHH
Confidence 99998644 43443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0016 Score=63.41 Aligned_cols=153 Identities=20% Similarity=0.174 Sum_probs=89.1
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC--ceeeeeee------eeecCeeEEEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR--NLVRLFGC------CIEQGEKILIYE 240 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lv~e 240 (496)
.+.|..|....+|+... ++..+++|+... ...+....|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45778888889999876 445788898764 2345667788888888433 34555442 123345689999
Q ss_pred ecCCCChhH----HHhhc--------ccCCCcccccCCCCCCCCChhhHH----------HHHHHHHHHHHHhhh----c
Q 040910 241 YMPNKSLDF----FLFDY--------KYSSGFDMVTDPASKGILDWTTRV----------RIIEGIAQGLLYLHQ----Y 294 (496)
Q Consensus 241 ~~~~gsL~~----~l~~~--------~~~~~~~~~~~~~~~~~l~~~~~~----------~i~~~ia~~L~yLH~----~ 294 (496)
|++|..+.. ..... ........ .........|.... .....+...+.++.. .
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPG--ERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCc--cCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 999877643 11100 00000000 00011112232211 111223344455443 1
Q ss_pred CCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 295 SRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 295 ~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
.+..++|+|+.|.||+++++..+.|.||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 234599999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00017 Score=79.07 Aligned_cols=198 Identities=22% Similarity=0.221 Sum_probs=132.3
Q ss_pred HHHHHHHHHHhcCCceeeeeeeeeecCeeE----EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHH
Q 040910 207 FKNEMILIAKLHHRNLVRLFGCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282 (496)
Q Consensus 207 ~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 282 (496)
..-|...+.++.|+|++.+++|-.+....- +..|++..-++...+ .....++....+.+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---------------q~v~~i~~~~~r~~~~ 293 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---------------QSVGSIPLETLRILHQ 293 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---------------hhccccCHHHHHHHHH
Confidence 344667778889999999999876654322 234555555555555 3456688888999999
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCC---CEEecCCCceEEe--ccccccccCCCccccccccccccccccChhhhccCCC
Q 040910 283 GIAQGLLYLHQYSRLRVIHRDLKAS---NVLLDGDMNPKIS--DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF 357 (496)
Q Consensus 283 ~ia~~L~yLH~~~~~~ivH~Dlk~~---NIll~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 357 (496)
++..||+|+|+.. ..|.-|..+ +...+..+.+.++ ||+.++........ .....+..+.|||.......
T Consensus 294 ~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~ 367 (1351)
T KOG1035|consen 294 KLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTA 367 (1351)
T ss_pred HHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccc
Confidence 9999999999975 555555554 5555677777777 99988866543221 12234556788887776555
Q ss_pred Cc--cccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCC
Q 040910 358 SI--KSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENA 435 (496)
Q Consensus 358 ~~--~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p 435 (496)
.. ..|+|.+|..+..+..|..+........ .+.+ .... ..+.+....|+..++
T Consensus 368 ~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-----------------~~l~----~~~~----~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 368 KKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-----------------SLLD----VLST----SELLDALPKCLDEDS 422 (1351)
T ss_pred hhhhhhHHHHHHHHHhhhhhcCcccccccchh-----------------hhhc----cccc----hhhhhhhhhhcchhh
Confidence 44 4799999999999988876533211100 0110 0011 034455567999999
Q ss_pred CCCCCHHHHHHHHhc
Q 040910 436 ADRPTMSEVVSMIKN 450 (496)
Q Consensus 436 ~~RPs~~evl~~L~~ 450 (496)
++|++..+++.+.-.
T Consensus 423 ~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 423 EERLSALELLTHPFL 437 (1351)
T ss_pred hhccchhhhhhchhc
Confidence 999999999887643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0035 Score=61.81 Aligned_cols=153 Identities=20% Similarity=0.191 Sum_probs=81.1
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC--ceeeeeee------eeecCeeEEEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR--NLVRLFGC------CIEQGEKILIYE 240 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lv~e 240 (496)
.+.|+.|....+|+....+| .+++|+... ...+....|+.++..|... .+.+.+.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677787789999876555 688898752 2234444566667666322 23343321 123456789999
Q ss_pred ecCCCChhH-----H------Hhh-cccCCCcccccCCCCCCCCCh-hhHHH------------HH-HHHHHHHHHhhhc
Q 040910 241 YMPNKSLDF-----F------LFD-YKYSSGFDMVTDPASKGILDW-TTRVR------------II-EGIAQGLLYLHQY 294 (496)
Q Consensus 241 ~~~~gsL~~-----~------l~~-~~~~~~~~~~~~~~~~~~l~~-~~~~~------------i~-~~ia~~L~yLH~~ 294 (496)
|+++..+.. . +-. +.....+.. .......+.| ..... .. ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPL--ERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCc--cCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 998875421 1 100 000111110 0001111222 21111 11 1111222333211
Q ss_pred ----CCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 295 ----SRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 295 ----~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
-+..++|+|+.+.||+++++...-|+||+.+..
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776668999998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0043 Score=60.87 Aligned_cols=154 Identities=20% Similarity=0.166 Sum_probs=85.4
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC--Cceeeeeeee------eecCeeEEEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH--RNLVRLFGCC------IEQGEKILIYE 240 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~------~~~~~~~lv~e 240 (496)
.+.++.|....+|+....+| .+++|+..... ..+....|++++..|.. -.+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 57788765422 23455667788878742 2244544422 12356789999
Q ss_pred ecCCCChhHH----Hhh--------cccCCCcccccCCCCCCCCChhhHH------------HHHHHHHHHHHHhhh---
Q 040910 241 YMPNKSLDFF----LFD--------YKYSSGFDMVTDPASKGILDWTTRV------------RIIEGIAQGLLYLHQ--- 293 (496)
Q Consensus 241 ~~~~gsL~~~----l~~--------~~~~~~~~~~~~~~~~~~l~~~~~~------------~i~~~ia~~L~yLH~--- 293 (496)
|++|..+... ... +....++..... .....-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~-~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRK-NSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCC-CCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9988654211 110 000111110000 000111222110 111223344555542
Q ss_pred -cCCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 294 -YSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 294 -~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
..+..++|+|+.+.||++++++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0015 Score=63.10 Aligned_cols=75 Identities=16% Similarity=0.231 Sum_probs=49.7
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCeeEEEEEecC
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|++-|+.|. --.+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678989999999987 5788999998762 23357888999888883 4467788888877777899999998
Q ss_pred CC
Q 040910 244 NK 245 (496)
Q Consensus 244 ~g 245 (496)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.003 Score=62.95 Aligned_cols=149 Identities=19% Similarity=0.250 Sum_probs=83.6
Q ss_pred ccccccCCeeEEEEEecC-----CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCcee-eeeeeeeecCeeEEEEEecC
Q 040910 170 NKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV-RLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~ 243 (496)
..|-.|-...+|+....+ ++.|++|..........++ .+|..++..+..-++. ++++++..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355557778888887532 3678999876554333333 6789999888544443 455655332 5899998
Q ss_pred CCChhHHHh-h----------cc-cCCCcccccCCCCCCCCChhhHHHHHHHH-----------------HHHHHHh---
Q 040910 244 NKSLDFFLF-D----------YK-YSSGFDMVTDPASKGILDWTTRVRIIEGI-----------------AQGLLYL--- 291 (496)
Q Consensus 244 ~gsL~~~l~-~----------~~-~~~~~~~~~~~~~~~~l~~~~~~~i~~~i-----------------a~~L~yL--- 291 (496)
+.+|..--. + .. .+.. + .+.......|.++.++..++ ...+..|
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~-~---~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSL-D---MPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCC-C---CCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 777752210 0 00 0000 0 00011112233333332211 1112222
Q ss_pred -hh-cCCCCeeecCCCCCCEEecC-CCceEEeccccccc
Q 040910 292 -HQ-YSRLRVIHRDLKASNVLLDG-DMNPKISDFGIARM 327 (496)
Q Consensus 292 -H~-~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFgla~~ 327 (496)
.. ..+..++|+|+++.||++++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22 22346899999999999986 47899999988863
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0049 Score=60.29 Aligned_cols=75 Identities=25% Similarity=0.410 Sum_probs=49.9
Q ss_pred ccccccCCeeEEEEEecC-------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCce-eeeeeeeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLN-------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL-VRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~ 241 (496)
+.|..|-...+|+....+ ++.+++|...... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667778899987654 5789999876543 222345778888888853333 345555432 358999
Q ss_pred cCCCChhH
Q 040910 242 MPNKSLDF 249 (496)
Q Consensus 242 ~~~gsL~~ 249 (496)
++|..+..
T Consensus 79 i~G~~l~~ 86 (302)
T cd05156 79 IPSRTLTT 86 (302)
T ss_pred eCCCcCCH
Confidence 99887754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00033 Score=52.63 Aligned_cols=53 Identities=13% Similarity=0.272 Sum_probs=40.2
Q ss_pred eEeccCCCCCCchhhhhhccCChHHHHHHhhccCceEEEeeecccCCCccccccccc
Q 040910 10 FIKFDDMQVPDLLEVLLNESVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFGD 66 (496)
Q Consensus 10 f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~ncsC~a~~~~~~~~~~~~C~~w~~~ 66 (496)
|..++++.+++.+.... ...+.++|+..|+.+++|.||+|.. +...|+++.+.
T Consensus 6 ~~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 45557888887665433 3558999999999999999999963 34689987764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.012 Score=57.18 Aligned_cols=156 Identities=15% Similarity=0.210 Sum_probs=84.8
Q ss_pred cccccCCeeEEEEEecCCCEEEEEEecc--CCccCHHHHHHHHHHHHHhc--CCceeeeeeeeeecC--eeEEEEEecCC
Q 040910 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSN--KSGQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQG--EKILIYEYMPN 244 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~--~~~lv~e~~~~ 244 (496)
.+-.|..-.+|+... +++.++|+ ... ..........+|..+|+.+. -.-+.+.++.|.++. ..+.||+|.++
T Consensus 32 ~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 32 EISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 333333333444433 37778888 331 22234456677888888873 334556677777766 77999999988
Q ss_pred CChhHHHh------------------hcccCCCcccccCC-----CCCCCCChhhHHHHH--------HHHHHHHHHhhh
Q 040910 245 KSLDFFLF------------------DYKYSSGFDMVTDP-----ASKGILDWTTRVRII--------EGIAQGLLYLHQ 293 (496)
Q Consensus 245 gsL~~~l~------------------~~~~~~~~~~~~~~-----~~~~~l~~~~~~~i~--------~~ia~~L~yLH~ 293 (496)
..+...+. ....-......... ...+.-.|...+..+ -....-..+|+.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 33322211 10000000000000 111122233222111 112223445543
Q ss_pred c-----CCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 294 Y-----SRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 294 ~-----~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
. +.+.++|+|+.+.|++++.+.-+-|.||+++..-
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 3356999999999999999988999999999754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.01 Score=57.08 Aligned_cols=31 Identities=26% Similarity=0.507 Sum_probs=26.2
Q ss_pred CCeeecCCCCCCEEecCCCc-eEEeccccccc
Q 040910 297 LRVIHRDLKASNVLLDGDMN-PKISDFGIARM 327 (496)
Q Consensus 297 ~~ivH~Dlk~~NIll~~~~~-~kl~DFgla~~ 327 (496)
+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45999999999999997555 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.041 Score=53.89 Aligned_cols=65 Identities=17% Similarity=0.265 Sum_probs=40.7
Q ss_pred eEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC--ceeeeeee------eeecCeeEEEEEecCCCChh
Q 040910 179 PVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR--NLVRLFGC------CIEQGEKILIYEYMPNKSLD 248 (496)
Q Consensus 179 ~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lv~e~~~~gsL~ 248 (496)
.||+....+| .+++|+... ..+....|+..+..|... .+++++.. ...++..++++||++|.++.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 3888876444 688998752 224456677777777322 34444432 22355789999999986653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0089 Score=55.09 Aligned_cols=31 Identities=35% Similarity=0.519 Sum_probs=21.9
Q ss_pred CCeeecCCCCCCEEe-cCCCceEEeccccccc
Q 040910 297 LRVIHRDLKASNVLL-DGDMNPKISDFGIARM 327 (496)
Q Consensus 297 ~~ivH~Dlk~~NIll-~~~~~~kl~DFgla~~ 327 (496)
..++|+||.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348899999999999 8999999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.043 Score=54.01 Aligned_cols=151 Identities=23% Similarity=0.302 Sum_probs=85.3
Q ss_pred cccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc------eeeeee----eeeecCeeEEEEE
Q 040910 171 KLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN------LVRLFG----CCIEQGEKILIYE 240 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~----~~~~~~~~~lv~e 240 (496)
.|.+ .-..+|+....+|+. ++|..... ....+...|+..+..|.-.. |..+=| ....+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789988867766 88887654 34566777888888883211 122112 1112237788999
Q ss_pred ecCCCChhH-----HHhhc--------ccCCCcccccCCCCCCCCChh-------------hHHHHHHHHHHHHHHhhh-
Q 040910 241 YMPNKSLDF-----FLFDY--------KYSSGFDMVTDPASKGILDWT-------------TRVRIIEGIAQGLLYLHQ- 293 (496)
Q Consensus 241 ~~~~gsL~~-----~l~~~--------~~~~~~~~~~~~~~~~~l~~~-------------~~~~i~~~ia~~L~yLH~- 293 (496)
|++|..+.. .++.. ....++.. ..+.......|. .-.....++...+..+.+
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~-~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPF-ERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCc-cCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 999988873 11100 00011110 011122223332 112233344444444443
Q ss_pred ---cCC---CCeeecCCCCCCEEecCCCc-eEEecccccc
Q 040910 294 ---YSR---LRVIHRDLKASNVLLDGDMN-PKISDFGIAR 326 (496)
Q Consensus 294 ---~~~---~~ivH~Dlk~~NIll~~~~~-~kl~DFgla~ 326 (496)
.-+ ..+||+|+.|.||+++++.. ..+.||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 222 22999999999999999885 8999999876
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0041 Score=59.65 Aligned_cols=147 Identities=15% Similarity=0.138 Sum_probs=95.1
Q ss_pred eCHHHHHHHhc---CCCccccccccCCeeEEEEEecCCCEEEEEEeccC-----------------C---cc--CHHHHH
Q 040910 154 FSLASISTATH---NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK-----------------S---GQ--GVEEFK 208 (496)
Q Consensus 154 ~~~~~~~~~~~---~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-----------------~---~~--~~~~~~ 208 (496)
+.+..+.+..+ -++..++||-|--+-||.+...+|++.++|.-+.. . +. +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 34444444443 35778999999999999999888999998842110 0 00 122345
Q ss_pred HHHHHHHHhc-CC-ceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHH
Q 040910 209 NEMILIAKLH-HR-NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286 (496)
Q Consensus 209 ~E~~~l~~l~-H~-niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~ 286 (496)
.|...|..|. |. -+.+.+++ +.-++|||++.+-.|...- ...+-.++. ..+..
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------------------~v~d~~~ly---~~lm~ 213 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------------------HVEDPPTLY---DDLMG 213 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------------------ecCChHHHH---HHHHH
Confidence 6888888883 33 34455554 3557889988776663221 112222333 33333
Q ss_pred HHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 287 ~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
-+--|...| +||+|..--||+++++..++++||--....
T Consensus 214 ~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 214 LIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred HHHHHHHcC---ceecccchheeEEecCCCEEEeechHhhcc
Confidence 344455566 999999999999999999999999865543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.092 Score=48.21 Aligned_cols=76 Identities=16% Similarity=0.268 Sum_probs=55.9
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh---cCCceeeeeeeeeecCeeEEEEEecCCC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL---HHRNLVRLFGCCIEQGEKILIYEYMPNK 245 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~g 245 (496)
.+++--|.--..|.... +..++.||+-. .+....|.+|+.-|..| +--++.+.+.+-...++.|+|+||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555565555666543 56788999743 34456788888877777 3466888888888999999999999988
Q ss_pred Chh
Q 040910 246 SLD 248 (496)
Q Consensus 246 sL~ 248 (496)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 776
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.035 Score=54.93 Aligned_cols=81 Identities=15% Similarity=0.181 Sum_probs=52.2
Q ss_pred cccccCCeeEEEEEecCC-CEEEEEEecc-------CCccCHHHHHHHHHHHHHhc--CCc-eeeeeeeeeecCeeEEEE
Q 040910 171 KLGEGGFGPVYKGKLLNG-EEVAVKRLSN-------KSGQGVEEFKNEMILIAKLH--HRN-LVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~n-iv~l~~~~~~~~~~~lv~ 239 (496)
.||.|....||++..++| +.|+||.-.. .-+-..++..-|.+.|.... -|. +.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999997654 6899996421 11334455566777776662 343 4444433 555667999
Q ss_pred EecCC-CChhHHHhh
Q 040910 240 EYMPN-KSLDFFLFD 253 (496)
Q Consensus 240 e~~~~-gsL~~~l~~ 253 (496)
|+++. ..|...|..
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 99964 345455543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.027 Score=55.78 Aligned_cols=74 Identities=16% Similarity=0.265 Sum_probs=47.2
Q ss_pred ccccccCCeeEEEEEecC----CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCcee-eeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV-RLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~ 244 (496)
+.|..|-...+|+....+ +..|++|.......... .-.+|..++..+..-++. ++++++.. + +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 455557777788886533 23788998765443322 336788899988655543 55665532 2 58999987
Q ss_pred CChh
Q 040910 245 KSLD 248 (496)
Q Consensus 245 gsL~ 248 (496)
..|.
T Consensus 95 ~~l~ 98 (330)
T PLN02421 95 RTLT 98 (330)
T ss_pred CCCC
Confidence 7663
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.062 Score=54.19 Aligned_cols=81 Identities=14% Similarity=0.091 Sum_probs=54.5
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCC---c----cCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCeeEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS---G----QGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~---~----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 238 (496)
.+.||.|....||+... ++..++||+-.... . -...+-..|+..|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999876 45679999754211 1 13334445677776663 357888888877 446789
Q ss_pred EEecCC--CChhHHHh
Q 040910 239 YEYMPN--KSLDFFLF 252 (496)
Q Consensus 239 ~e~~~~--gsL~~~l~ 252 (496)
|||+++ ..+.+-+.
T Consensus 114 ME~L~~~~~ilr~~Ll 129 (418)
T PLN02756 114 MRYLEPPHIILRKGLI 129 (418)
T ss_pred EeecCCcceehhhhhc
Confidence 999976 34555553
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.048 Score=53.48 Aligned_cols=141 Identities=18% Similarity=0.204 Sum_probs=92.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccC-------Cc--cC-------------HHH----HHHHHHHHHHhcCCce
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK-------SG--QG-------------VEE----FKNEMILIAKLHHRNL 222 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~-------~~--~~-------------~~~----~~~E~~~l~~l~H~ni 222 (496)
...|..|--+.||.+.-.+|..+|||+++.. .. .+ .+. ...|++.|.+|+.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4567788899999999889999999986421 00 00 000 2346777777754333
Q ss_pred eeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeec
Q 040910 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHR 302 (496)
Q Consensus 223 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 302 (496)
...--... ..-+|||+|+...... ...-....++...+..+-.|++.-|.-|...+ ++||.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~---------------aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHA 289 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWA---------------APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHA 289 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCc---------------CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceecc
Confidence 22111111 1246899998532221 11123345666677888888888888888877 59999
Q ss_pred CCCCCCEEecCCCceEEeccccccccC
Q 040910 303 DLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 303 Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
||+--|+|+ .+|.+.|+|-+-+....
T Consensus 290 DLSEfN~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 290 DLSEFNLLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred chhhhhheE-ECCEEEEEEccccccCC
Confidence 999999998 45689999988776544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.0024 Score=72.18 Aligned_cols=160 Identities=12% Similarity=-0.059 Sum_probs=110.5
Q ss_pred HHHHHHHHhcCCceeeeeeeee--ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHH
Q 040910 209 NEMILIAKLHHRNLVRLFGCCI--EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286 (496)
Q Consensus 209 ~E~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~ 286 (496)
.|....+...|++++....-.. +..+.+..++|+..|.+...+.... ...+.++..-+.....+...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~-----------ee~~~ld~~~v~~~~kvsvl 1346 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL-----------EESPDLDRSPVHLRHKVSVL 1346 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc-----------ccCCcchhchHHHHHHHHHh
Confidence 3444455568988877654433 2346678899999999988886422 22233333333333333245
Q ss_pred HHHHhhhc--CCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccch
Q 040910 287 GLLYLHQY--SRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVF 364 (496)
Q Consensus 287 ~L~yLH~~--~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 364 (496)
+..-.|.. .....+|++||+-|.++..+.++|++++|+.+...+. ........+++.|++|++...-.++.++|+|
T Consensus 1347 ~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1347 NRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred ccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence 55554432 2345899999999999999999999999999833221 1223445778899999999888999999999
Q ss_pred hhhHHHHHHHhCCCCCC
Q 040910 365 SFGVLLLETLSSKKNTR 381 (496)
Q Consensus 365 S~Gvvl~elltg~~~~~ 381 (496)
..|+-+|+.--|..++.
T Consensus 1425 r~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHhcccHHHH
Confidence 99999999877776543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.036 Score=55.55 Aligned_cols=82 Identities=12% Similarity=0.135 Sum_probs=54.5
Q ss_pred cccccccCCeeEEEEEecC-CCEEEEEEecc------CCccCHHHHHHHHHHHHHhc--CCc-eeeeeeeeeecCeeEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLN-GEEVAVKRLSN------KSGQGVEEFKNEMILIAKLH--HRN-LVRLFGCCIEQGEKILI 238 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~------~~~~~~~~~~~E~~~l~~l~--H~n-iv~l~~~~~~~~~~~lv 238 (496)
.+.||.|.-.-||++...+ ++.|+||.-.. .-+-..++..-|.+.|+... -|. +.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4689999999999998743 57899996421 11334566677888887763 343 4445544 45566789
Q ss_pred EEecCC-CChhHHHh
Q 040910 239 YEYMPN-KSLDFFLF 252 (496)
Q Consensus 239 ~e~~~~-gsL~~~l~ 252 (496)
||+++. ..|...|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 999964 33555554
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.46 Score=46.97 Aligned_cols=72 Identities=15% Similarity=0.104 Sum_probs=46.5
Q ss_pred cCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC--Cceeeee---e--eeeecCeeEEEEEecCCCCh
Q 040910 175 GGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH--RNLVRLF---G--CCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 175 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~---~--~~~~~~~~~lv~e~~~~gsL 247 (496)
+.-..||+....++..+++|..+... ....+...|+..+..|.. -.++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 44567999888778889999875332 345667788888888732 2233322 1 12234567889999987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.031 Score=54.68 Aligned_cols=57 Identities=21% Similarity=0.207 Sum_probs=49.8
Q ss_pred CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccccc
Q 040910 269 KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328 (496)
Q Consensus 269 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~ 328 (496)
.+...|++...++.+-+.-++-+...- ++-|||+.-.||||+ +|++.|+||-++|.-
T Consensus 315 ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 315 IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 344678999999999999888887754 699999999999999 999999999999943
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 496 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-34 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 405 bits (1044), Expect = e-140
Identities = 123/305 (40%), Positives = 180/305 (59%), Gaps = 22/305 (7%)
Query: 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVE-EFKNEMI 212
FSL + A+ NFS +N LG GGFG VYKG+L +G VAVKRL + QG E +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL 272
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + P S+ L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-----------RPESQPPL 128
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
DW R RI G A+GL YLH + ++IHRD+KA+N+LLD + + DFG+A++ D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DY 186
Query: 333 LQSNMN-RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT---RFYNIDSL 388
+++ + GT G+++PEY G S K+DVF +GV+LLE ++ ++ R N D +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPM--VKRYIKVALLCVQENAADRPTMSEVVS 446
LL L K+ + L+D LQ Y V++ I+VALLC Q + +RP MSEVV
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGN--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 447 MIKNE 451
M++ +
Sbjct: 305 MLEGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-137
Identities = 101/309 (32%), Positives = 151/309 (48%), Gaps = 34/309 (11%)
Query: 154 FSLASISTATHNFSEE------NKLGEGGFGPVYKGKLLNGEEVAVKRLSN----KSGQG 203
FS + T+NF E NK+GEGGFG VYKG +N VAVK+L+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 204 VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMV 263
++F E+ ++AK H NLV L G + + L+Y YMPN SL L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS----------- 122
Query: 264 TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323
L W R +I +G A G+ +LH+ IHRD+K++N+LLD KISDFG
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
+AR +RIVGT YM+PE L G + KSD++SFGV+LLE ++
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE- 236
Query: 384 NIDSLTLLGHAWNLWKDDRAW-KLLDPTLQNEALYPM--VKRYIKVALLCVQENAADRPT 440
+ + LL + +++ +D + + V+ VA C+ E RP
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 441 MSEVVSMIK 449
+ +V +++
Sbjct: 294 IKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-121
Identities = 102/315 (32%), Positives = 170/315 (53%), Gaps = 21/315 (6%)
Query: 139 DSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSN 198
D+ + L + AT+NF + +G G FG VYKG L +G +VA+KR +
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 199 KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS 258
+S QG+EEF+ E+ ++ H +LV L G C E+ E ILIY+YM N +L L+
Sbjct: 74 ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG----- 128
Query: 259 GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
+ W R+ I G A+GL YLH + +IHRD+K+ N+LLD + PK
Sbjct: 129 ------SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 319 ISDFGIARMFGGDELQSNMN-RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
I+DFGI++ + Q++++ + GT GY+ PEY + G + KSDV+SFGV+L E L ++
Sbjct: 180 ITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 378 KNTRFYN-IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPM--VKRYIKVALLCVQEN 434
+ + L A + + +++DP L ++ ++++ A+ C+ +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK--IRPESLRKFGDTAVKCLALS 296
Query: 435 AADRPTMSEVVSMIK 449
+ DRP+M +V+ ++
Sbjct: 297 SEDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-91
Identities = 68/320 (21%), Positives = 121/320 (37%), Gaps = 41/320 (12%)
Query: 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
++ + G FG V+K +L E VAVK + Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 214 IAKLHHRNLVRLFGCCIE----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
+ + H N+++ G + LI + SL FL
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----------------KA 115
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQ-------YSRLRVIHRDLKASNVLLDGDMNPKISDF 322
++ W I E +A+GL YLH+ + + HRD+K+ NVLL ++ I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-----FSIKSDVFSFGVLLLETLSSK 377
G+A F + + + VGT YM+PE + ++ D+++ G++L E S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 378 KNTRF----YNIDSLTLLGHAWNL--WKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLC 430
Y + +G +L ++ K P L++ + + + C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 431 VQENAADRPTMSEVVSMIKN 450
+A R + V I
Sbjct: 296 WDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 8e-76
Identities = 72/346 (20%), Positives = 121/346 (34%), Gaps = 58/346 (16%)
Query: 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNE--M 211
+ + S N +G G +G VYKG L + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 212 ILIAKLHHRNLVRLFGCCIE-----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDP 266
+ + H N+ R + E +L+ EY PN SL +L +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------- 107
Query: 267 ASKGILDWTTRVRIIEGIAQGLLYLHQ------YSRLRVIHRDLKASNVLLDGDMNPKIS 320
DW + R+ + +GL YLH + + + HRDL + NVL+ D IS
Sbjct: 108 -----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162
Query: 321 DFGIARMFGG------DELQSNMNRIVGTYGYMSPEYALHGLFSI--------KSDVFSF 366
DFG++ G E + VGT YM+PE L G ++ + D+++
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYAL 221
Query: 367 GVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLD--------PTLQNE--AL 416
G++ E + + + + P
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 417 YPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPA 462
V+ + C ++A R T + ++ + +
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-64
Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 42/300 (14%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
E +G G FG V K K ++VA+K++ +S + F E+ +++++H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+G C+ L+ EY SL L + + +
Sbjct: 67 YGACLN--PVCLVMEYAEGGSLYNVLHGAE------------PLPYYTAAHAMSWCLQCS 112
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMN-PKISDFGIARMFGGDELQSNMNRIVGTY 344
QG+ YLH +IHRDLK N+LL KI DFG A ++Q++M G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404
+M+PE +S K DVFS+G++L E ++ +K ++ W + R
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-- 222
Query: 405 KLLDPTLQN---EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQP 461
P L + + ++ R C ++ + RP+M E+V ++ + + P +P
Sbjct: 223 ----PPLIKNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-63
Identities = 71/301 (23%), Positives = 134/301 (44%), Gaps = 35/301 (11%)
Query: 165 NFSE---ENKLGEGGFGPVYKGKLLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHH 219
+ + + K+G G FG V++ + +G +VAVK L + + V EF E+ ++ +L H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
N+V G + ++ EY+ SL + ++ ++ LD R+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSL------------YRLLHKSGAREQLDERRRLS 141
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+ +A+G+ YLH ++HR+LK+ N+L+D K+ DFG++R+ L
Sbjct: 142 MAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKS 198
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
GT +M+PE + KSDV+SFGV+L E + + + N++ ++
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV----- 251
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
+K + P V I+ C RP+ + ++ +++ I + P
Sbjct: 252 ---GFKCKRLEIPRNLN-PQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
Query: 460 Q 460
Sbjct: 305 N 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-61
Identities = 64/318 (20%), Positives = 110/318 (34%), Gaps = 65/318 (20%)
Query: 169 ENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG+G FG K GE + +K L + F E+ ++ L H N+++ G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ I EY+ +L + W+ RV + IA G
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--------------MDSQYPWSQRVSFAKDIASG 120
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN----------- 336
+ YLH + +IHRDL + N L+ + N ++DFG+AR+ ++ Q
Sbjct: 121 MAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 337 -MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395
+VG +M+PE + K DVFSFG++L E +
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV------------------ 219
Query: 396 NLWKDDRAWKLLDPT-----LQNEALYPMV------KRYIKVALLCVQENAADRPTMSEV 444
A P L + + + C + RP+ ++
Sbjct: 220 ------NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273
Query: 445 VSMIKNEIVNLPSPQQPA 462
++ ++L
Sbjct: 274 EHWLETLRMHLAGHLPLG 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-60
Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 50/301 (16%)
Query: 165 NFSE---ENKLGEGGFGPVYKGKLLNGEEVAVKRL----SNKSGQGVEEFKNEMILIAKL 217
+F+E E +G GGFG VY+ G+EVAVK Q +E + E L A L
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H N++ L G C+++ L+ E+ L+ L + +
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------------IPPDIL 107
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--------KISDFGIARMFG 329
V IA+G+ YLH + + +IHRDLK+SN+L+ + KI+DFG+AR
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-- 165
Query: 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389
++ G Y +M+PE +FS SDV+S+GVLL E L+ + F ID L
Sbjct: 166 --WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLA 221
Query: 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
+ L P+ E +++ C + RP+ + ++ +
Sbjct: 222 VAYGV--AMNKLA---LPIPSTCPEPFAKLMED-------CWNPDPHSRPSFTNILDQLT 269
Query: 450 N 450
Sbjct: 270 T 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-60
Identities = 69/300 (23%), Positives = 137/300 (45%), Gaps = 49/300 (16%)
Query: 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQG-------VEEFKNEMILIAKL 217
E ++G+GGFG V+KG+L+ + VA+K L +G +EF+ E+ +++ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+H N+V+L+G ++ E++P L L D + W+ +
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--------------KAHPIKWSVK 124
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-----GDMNPKISDFGIARMFGGDE 332
+R++ IA G+ Y+ ++HRDL++ N+ L + K++DFG+++ +
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----Q 178
Query: 333 LQSNMNRIVGTYGYMSPE--YALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
+++ ++G + +M+PE A ++ K+D +SF ++L L+ + F +
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKI 236
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ R PT+ E P ++ I+ LC + RP S +V +
Sbjct: 237 KFINMIREEGLR------PTI-PEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-57
Identities = 69/288 (23%), Positives = 130/288 (45%), Gaps = 37/288 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
++G G FG VYKGK +G+ VAVK L + + Q ++ FKNE+ ++ K H N++
Sbjct: 29 GQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
G I + ++ SL L S+ + + I A+
Sbjct: 87 GYSTAPQLAI-VTQWCEGSSLYHHLHA--------------SETKFEMKKLIDIARQTAR 131
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
G+ YLH +IHRDLK++N+ L D KI DFG+A ++ G+ +
Sbjct: 132 GMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 347 MSPE---YALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
M+PE +S +SDV++FG++L E ++ + + NI++ + + + +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI--IEMVGRGSLS 244
Query: 404 WKLLD-PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
L + + + ++ C+++ +RP+ +++ I+
Sbjct: 245 PDLSKVRSNCPKRMKRLMAE-------CLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 165 NFSE---ENKLGEGGFGPVYKGKLLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHH 219
+F + KL E G ++KG+ G ++ VK L + S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 220 RNLVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
N++ + G C I +MP SL L + ++D +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-------------NFVVDQSQA 113
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
V+ +A+G+ +LH L + L + +V++D DM +IS + F
Sbjct: 114 VKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QS 165
Query: 338 NRIVGTYGYMSPEYALHG----LFSIKSDVFSFGVLLLETLSSKKNTR---FYNIDSLTL 390
+ +++PE AL +D++SF VLL E + TR F ++ ++ +
Sbjct: 166 PGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELV-----TREVPFADLSNMEI 219
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
A + L PT+ + P V + +K +C+ E+ A RP +V +++
Sbjct: 220 GMKV--------ALEGLRPTIP-PGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-56
Identities = 65/314 (20%), Positives = 122/314 (38%), Gaps = 51/314 (16%)
Query: 165 NFSE---ENKLGEGGFGPVYKGKLLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHH 219
F + +G+G FG VY G+ +GE VA++ + + ++ FK E++ + H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
N+V G C+ +I ++L + D +K +LD +
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--------------AKIVLDVNKTRQ 134
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN--- 336
I + I +G+ YLH ++H+DLK+ NV D + I+DFG+ + G +
Sbjct: 135 IAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 337 MNRIVGTYGYMSPE---------YALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387
+ G +++PE FS SDVF+ G + E + + F +
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPA 248
Query: 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
+ W + + P L + + + C +RPT ++++ M
Sbjct: 249 EAI---IWQMGTGMK------PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDM 296
Query: 448 IKNEIVNLPSPQQP 461
++ P
Sbjct: 297 LEKLPKRNRRLSHP 310
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-52
Identities = 71/307 (23%), Positives = 118/307 (38%), Gaps = 45/307 (14%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNE--MILIAKLHHRNLVRLF 226
++G+G +G V+ GK GE+VAVK + E + + H N++
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 227 GCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
I+ LI +Y N SL +L LD + +++
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----------------KSTTLDAKSMLKLAY 141
Query: 283 GIAQGLLYLH-----QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQS 335
GL +LH + + HRDLK+ N+L+ + I+D G+A F +E+
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 336 NMNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLETLS---SKKNTRFYNID 386
N VGT YM PE H I +D++SFG++L E S Y +
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 387 SLTLLGH--AWNLWKDDRAWKLLDPTL-QNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
L+ ++ ++ K L P+ + +++ K+ C N A R T
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 444 VVSMIKN 450
V +
Sbjct: 322 VKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 66/315 (20%), Positives = 115/315 (36%), Gaps = 45/315 (14%)
Query: 161 TATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNE--MILIAKLH 218
T + + +G+G +G V++G GE VAVK S+ + + + E + L
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 219 HRNLVRLFGCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
H N++ + LI Y SL +L LD
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----------------QLTTLDT 104
Query: 275 TTRVRIIEGIAQGLLYLH-----QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF- 328
+ +RI+ IA GL +LH + + HRDLK+ N+L+ + I+D G+A M
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 329 -GGDELQSNMNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381
++L N VGT YM+PE + D+++FG++L E +
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 382 FYNI-----DSLTLLGHAWNLWKDDRAWKLLDPTL-QNEALYPMVKRYIKVALLCVQENA 435
+ ++ + P + P + K+ C +N
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 436 ADRPTMSEVVSMIKN 450
+ R T + +
Sbjct: 285 SARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-49
Identities = 65/307 (21%), Positives = 113/307 (36%), Gaps = 45/307 (14%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNE--MILIAKLHHRNLVRLF 226
+ +G+G FG V++GK GEEVAVK S+ + + E + L H N++
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 227 GCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
+ L+ +Y + SL +L Y + +++
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------------VTVEGMIKLAL 146
Query: 283 GIAQGLLYLHQ-----YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQS 335
A GL +LH + + HRDLK+ N+L+ + I+D G+A D +
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 336 NMNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLLLETLS---SKKNTRFYNI- 385
N VGT YM+PE H ++D+++ G++ E Y +
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 386 -DSLTLLGHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSE 443
L + + + L P + N ++ K+ C N A R T
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 444 VVSMIKN 450
+ +
Sbjct: 327 IKKTLSQ 333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 71/329 (21%), Positives = 123/329 (37%), Gaps = 75/329 (22%)
Query: 169 ENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
++LG+G FG V + G VAVK+L + +F+ E+ ++ LH +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 224 RLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ G G + L+ EY+P+ L FL + LD + +
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------------QRHRARLDASRLLLYS 133
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I +G+ YL R +HRDL A N+L++ + + KI+DFG+A++ D+
Sbjct: 134 SQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK--------- 181
Query: 342 GTYGY----------MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
Y +PE +FS +SDV+SFGV+L E +
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT---------------Y 226
Query: 392 GHA--WNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENA 435
+ R L +++ + ++ LC +
Sbjct: 227 CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-ELMKLCWAPSP 285
Query: 436 ADRPTMSEVVSMIKNEIVNLPSPQQPAFS 464
DRP+ S + + + AF+
Sbjct: 286 QDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 72/307 (23%), Positives = 126/307 (41%), Gaps = 58/307 (18%)
Query: 169 ENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
+LG+G FG V + GE VAVK+L + + + + +F+ E+ ++ L H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 224 RLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ G C G + LI EY+P SL +L K +D ++
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--------------QKHKERIDHIKLLQYT 120
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I +G+ YL R IHRDL N+L++ + KI DFG+ ++ D+
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--------- 168
Query: 342 GTYG----------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
+ + +PE FS+ SDV+SFGV+L E + + ++ + + ++
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 392 GHA-WNLWKDDRAWKLLD-------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
G+ +LL P + +Y + C N RP+ +
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-------MIMTECWNNNVNQRPSFRD 281
Query: 444 VVSMIKN 450
+ +
Sbjct: 282 LALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 58/307 (18%)
Query: 169 ENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
+LG+G FG V + GE VAVK+L + + + + +F+ E+ ++ L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 224 RLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ G C G + LI EY+P SL +L K +D ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--------------QKHKERIDHIKLLQYT 151
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I +G+ YL R IHRDL N+L++ + KI DFG+ ++ D+
Sbjct: 152 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--------- 199
Query: 342 GTYG----------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
Y + +PE FS+ SDV+SFGV+L E + + ++ + + ++
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 392 GHA-WNLWKDDRAWKLLD-------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
G+ +LL P + +Y + C N RP+ +
Sbjct: 260 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-------MIMTECWNNNVNQRPSFRD 312
Query: 444 VVSMIKN 450
+ +
Sbjct: 313 LALRVDQ 319
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-46
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ +LGEG FG V+ + N VAVK L S ++F+ E L+ L H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VR FG C E ++++EYM + L+ FL + + + + G L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+A G++YL + L +HRDL N L+ + KI DFG++R D ++ R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 343 TYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+M PE L+ F+ +SDV+SFGV+L E +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 45/290 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE-EVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
++G G FG V+ G+L VAVK +F E ++ + H N+VRL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
G C ++ ++ E + FL L T ++++ A
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRT--------------EGARLRVKTLLQMVGDAAA 224
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
G+ YL IHRDL A N L+ KISDFG++R G
Sbjct: 225 GMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQV 277
Query: 347 ----MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN--TRFYNIDSLTLLGHAWNLWKD 400
+PE +G +S +SDV+SFG+LL ET S + N + +
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV--------- 328
Query: 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
++ +L P L +A++ ++++ C RP+ S + +++
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 76/305 (24%), Positives = 124/305 (40%), Gaps = 58/305 (19%)
Query: 169 ENKLGEGGFGPVYKGKLL-----NGEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
LGEG FG V + GE+VAVK L G + + K E+ ++ L+H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 223 VRLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
V+ G C E G LI E++P+ SL +L P +K ++ +++
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--------------PKNKNKINLKQQLKY 131
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
I +G+ YL + +HRDL A NVL++ + KI DFG+ + D+
Sbjct: 132 AVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-------- 180
Query: 341 VGTYG----------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
Y + +PE + F I SDV+SFGV L E L+ + L +
Sbjct: 181 -EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 391 LGHAWNLWKDDRAWKLLD-----PTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSE 443
+G R L P N + +Y ++ C + ++R +
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-------QLMRKCWEFQPSNRTSFQN 292
Query: 444 VVSMI 448
++
Sbjct: 293 LIEGF 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-45
Identities = 85/322 (26%), Positives = 128/322 (39%), Gaps = 67/322 (20%)
Query: 169 ENKLGEGGFGPVYKGKLLN-----GEEVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
LGEG FG V GE VAVK L ++ Q +K E+ ++ L+H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 223 VRLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
++ GCC + G L+ EY+P SL +L + + +
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------------IGLAQLLLF 139
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ I +G+ YLH IHRDL A NVLLD D KI DFG+A+
Sbjct: 140 AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-------- 188
Query: 341 VGTYGY-------------MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387
Y +PE F SDV+SFGV L E L+ +++
Sbjct: 189 ----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 388 LTLLGHAWNLWKDDRAWKLLD-------PTLQNEALYPMVKRYIKVALLCVQENAADRPT 440
L L+G A R +LL+ P +Y ++K C + A+ RPT
Sbjct: 245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRPT 297
Query: 441 MSEVVSMIKNEIVNLPSPQQPA 462
++ ++K + Q P+
Sbjct: 298 FENLIPILK-TVHEKYQGQAPS 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ +LGEG FG V+ + N VAVK L + + ++F+ E L+ L H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYK-YSSGFDMVTDPASKGILDWTTRVRII 281
V+ +G C + I+++EYM + L+ FL + + +KG L + + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
IA G++YL + +HRDL N L+ ++ KI DFG++R D ++ R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191
Query: 342 GTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
G + +M PE ++ F+ +SDV+SFGV+L E +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFG 227
++G G FG V+ G LN ++VA+K + + G E+F E ++ KL H LV+L+G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
C+EQ L+ E+M + L +L +G+ T + + + +G
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL--------------RTQRGLFAAETLLGMCLDVCEG 116
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---Y 344
+ YL VIHRDL A N L+ + K+SDFG+ R D+ S+ GT
Sbjct: 117 MAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPV 169
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ SPE +S KSDV+SFGVL+ E S
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-44
Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRN 221
+LGE FG VYKG L VA+K L G EEF++E +L A+L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMV-TDPASKGILDWTTRVRI 280
+V L G + +I+ Y + L FL S D K L+ V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ IA G+ YL S V+H+DL NVL+ +N KISD G+ R E+ +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYK 185
Query: 341 VGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +M+PE ++G FSI SD++S+GV+L E S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-44
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+G+G FG V G G +VAVK + K+ + F E ++ +L H NLV+L G
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 229 CIEQGEKILI-YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+E+ + I EYM SL +L + +L ++ + +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS-------------RGRSVLGGDCLLKFSLDVCEA 129
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG-- 345
+ YL +HRDL A NVL+ D K+SDFG+ + + +
Sbjct: 130 MEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGK 175
Query: 346 ----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE FS KSDV+SFG+LL E S
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 37/283 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE-EVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
++KLG G +G VY+G VAVK L + VEEF E ++ ++ H NLV+L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
C + +I E+M +L +L + + + + + I+
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECN-------------RQEVSAVVLLYMATQISSA 330
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ YL + IHR+L A N L+ + K++DFG++R+ GD ++ +
Sbjct: 331 MEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWT 386
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKN--TRFYNIDSLTLLGHAWNLWKDDRAWK 405
+PE + FSIKSDV++FGVLL E + + LL ++ ++
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYR 437
Query: 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+ P E +Y +++ C Q N +DRP+ +E+
Sbjct: 438 MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAF 473
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+G+G FG V G G +VAVK + K+ + F E ++ +L H NLV+L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 229 CIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+E+ + ++ EYM SL +L + +L ++ + +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS-------------RGRSVLGGDCLLKFSLDVCEA 301
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG-- 345
+ YL +HRDL A NVL+ D K+SDFG+ +
Sbjct: 302 MEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGK 347
Query: 346 ----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE FS KSDV+SFG+LL E S
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+LG G FG V GK +VA+K + + +EF E ++ L H LV+L+G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
C +Q +I EYM N L +L + + + + + + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--------------REMRHRFQTQQLLEMCKDVCEAM 133
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YG 345
YL + +HRDL A N L++ K+SDFG++R DE VG+
Sbjct: 134 EYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVR 186
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ PE ++ FS KSD+++FGVL+ E S
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 78/296 (26%), Positives = 127/296 (42%), Gaps = 44/296 (14%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
E KLG G FG V+ +VAVK + VE F E ++ L H LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
++ I I E+M SL FL + S + IA+G+
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLKSDEGSK-------------QPLPKLIDFSAQIAEGM 297
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YG 345
++ + IHRDL+A+N+L+ + KI+DFG+AR+ +E G
Sbjct: 298 AFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIK 350
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN--TRFYNIDSLTLLGHAWNLWKDDRA 403
+ +PE G F+IKSDV+SFG+LL+E ++ + N + + L +R
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERG 401
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
+++ P E LY + + C + +RPT + S++ ++ Q
Sbjct: 402 YRMPRPENCPEELY-------NIMMRCWKNRPEERPTFEYIQSVL-DDFYTATESQ 449
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE-EVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
++KLG G +G VY+G VAVK L + VEEF E ++ ++ H NLV+L G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
C + +I E+M +L +L + + + + + I+
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECN-------------RQEVSAVVLLYMATQISSA 123
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN-----RIVG 342
+ YL + IHRDL A N L+ + K++DFG++R+ GD ++ +
Sbjct: 124 MEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 177
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE + FSIKSDV++FGVLL E +
Sbjct: 178 ---WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 37/296 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
E KLG+G FG V+ G VA+K L E F E ++ KL H LV+L+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
E+ I + EYM SL FL L V + IA G+
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGETGKY-------------LRLPQLVDMAAQIASGM 376
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR+ +E + + +
Sbjct: 377 AYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTA 432
Query: 349 PEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKL 406
PE AL+G F+IKSDV+SFG+LL E T N + L + +R +++
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRM 483
Query: 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPA 462
P E+L+ + C ++ +RPT + + +++ + QP
Sbjct: 484 PCPPECPESLH-------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-43
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 47/299 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+G G FG VY G LL+ + AVK L V +F E I++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 224 RLFGCCIEQGEKIL-IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
L G C+ L + YM + L F+ +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--------------RNETHNPTVKDLIGFGL 135
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+A+G+ YL + + +HRDL A N +LD K++DFG+AR D +
Sbjct: 136 QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHN 188
Query: 343 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
G +M+ E F+ KSDV+SFGVLL E ++ + ++++ + +
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-PPYPDVNTFDITVY--- 244
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455
L + R LL P + LY ++ + C A RP+ SE+VS I
Sbjct: 245 LLQGRR---LLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 37/296 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
E KLG+G FG V+ G VA+K L E F E ++ KL H LV+L+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
E+ I + EYM SL FL L V + IA G+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGETGKY-------------LRLPQLVDMAAQIASGM 293
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
Y+ R+ +HRDL+A+N+L+ ++ K++DFG+AR+ +E + + +
Sbjct: 294 AYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTA 349
Query: 349 PEYALHGLFSIKSDVFSFGVLLLE--TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKL 406
PE AL+G F+IKSDV+SFG+LL E T N + L + +R +++
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRM 400
Query: 407 LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPA 462
P E+L+ + C ++ +RPT + + +++ + QP
Sbjct: 401 PCPPECPESLH-------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-43
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 42/222 (18%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE-----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
LG G FG VYKG + E VA+K L S + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
RL G C+ ++ I + MP L ++ + K + +
Sbjct: 80 CRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCV 124
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E
Sbjct: 125 QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------K 172
Query: 343 TYGY---------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y M+ E LH +++ +SDV+S+GV + E ++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-43
Identities = 85/301 (28%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+LG G FG V+ G +VAVK L + + F E L+ +L H+ LVRL+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
++ I I EYM N SL FL L + + IA+G+
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLKTPSGIK-------------LTINKLLDMAAQIAEGM 122
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YG 345
++ IHRDL+A+N+L+ ++ KI+DFG+AR+ +E G
Sbjct: 123 AFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIK 175
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN--TRFYNIDSLTLLGHAWNLWKDDRA 403
+ +PE +G F+IKSDV+SFG+LL E ++ + N + + L +R
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERG 226
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ---Q 460
++++ P E LY ++ LC +E DRPT + S++ + Q Q
Sbjct: 227 YRMVRPDNCPEELY-------QLMRLCWKERPEDRPTFDYLRSVL-EDFFTATEGQYQPQ 278
Query: 461 P 461
P
Sbjct: 279 P 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-43
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+LG G FG V GK +VAVK + + +EF E + KL H LV+ +G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
C ++ ++ EY+ N L +L + L+ + + + + +G+
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--------------RSHGKGLEPSQLLEMCYDVCEGM 117
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YG 345
+L + IHRDL A N L+D D+ K+SDFG+ R D+ VGT
Sbjct: 118 AFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVK 170
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE + +S KSDV++FG+L+ E S
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 78/332 (23%), Positives = 136/332 (40%), Gaps = 74/332 (22%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE---VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHRNLV 223
++ +GEG FG V K ++ A+KR+ S +F E+ ++ KL HH N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-KYSSGFDMVTDPASKGILDWTTRVRIIE 282
L G C +G L EY P+ +L FL + ++ L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+A+G+ YL S+ + IHRDL A N+L+ + KI+DFG++R G +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK------K 198
Query: 343 TYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA-WN 396
T G +M+ E + +++ SDV+S+GVLL E +S LG +
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------------LGGTPY- 242
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADRPTMS 442
+ LY + + Y + C +E +RP+ +
Sbjct: 243 ------------CGMTCAELYEKLPQGYRLEKPLNCDDEVY-DLMRQCWREKPYERPSFA 289
Query: 443 EVVSMIKNEI------VNLPSPQQPAFSYVRI 468
+++ + + VN ++ F+Y I
Sbjct: 290 QILVSLNRMLEERKTYVNTTLYEK--FTYAGI 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
E +G G G V G+L + VA+K L + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL G +++ EYM N SLD FL G V ++ G
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT--------------HDGQFTIMQLVGMLRG 159
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+ G+ YL S L +HRDL A NVL+D ++ K+SDFG++R+ D
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP----------- 205
Query: 344 YGY------------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+PE FS SDV+SFGV++ E L+
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 79/309 (25%), Positives = 126/309 (40%), Gaps = 67/309 (21%)
Query: 170 NKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
+LG+G FG VY+G + VA+K + S + EF NE ++ + + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL G + ++I E M L +L + + + V P S + +++
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM-----IQMAG 145
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA G+ YL + + +HRDL A N ++ D KI DFG+ R ++ G
Sbjct: 146 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKG 197
Query: 343 TYGY-----MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397
G MSPE G+F+ SDV+SFGV+L E TL +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI--------------ATLAEQPY-- 241
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADRPTMSE 443
L NE + V + ++ +C Q N RP+ E
Sbjct: 242 -----------QGLSNEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLE 289
Query: 444 VVSMIKNEI 452
++S IK E+
Sbjct: 290 IISSIKEEM 298
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 57/308 (18%)
Query: 168 EENKLGEGGFGPVYKGKLLNGEE---VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+ +LG G FG V +G ++ VA+K L EE E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 224 RLFGCCIEQGEKILI-YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
RL G C Q E +++ E L FL + + + ++
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVG--------------KREEIPVSNVAELLH 117
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
++ G+ YL +HRDL A NVLL KISDFG+++ G D+ +
Sbjct: 118 QVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTA 169
Query: 343 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY----NIDSLTLLG 392
+ +PE FS +SDV+S+GV + E LS + Y + + +
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI- 226
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
++ ++ P LY + C DRP V ++
Sbjct: 227 --------EQGKRMECPPECPPELY-------ALMSDCWIYKWEDRPDFLTVEQRMRACY 271
Query: 453 VNLPSPQQ 460
+L S +
Sbjct: 272 YSLASKVE 279
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 49/305 (16%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNL 222
LGEG FG V +G L + VAVK + N S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 223 VRLFGCCIEQG-----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+RL G CIE + ++I +M L +L + + T
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR---------LETGPKHIPLQTL 149
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQSN 336
++ + IA G+ YL S +HRDL A N +L DM ++DFG+++ ++ GD +
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-- 204
Query: 337 MNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
G +++ E +++ KSDV++FGV + E + T + + + +
Sbjct: 205 ----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM-TPYPGVQNHEMY 259
Query: 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451
+ L R L P + LY ++ C + + DRPT S + ++
Sbjct: 260 DY---LLHGHR---LKQPEDCLDELYEIMYS-------CWRTDPLDRPTFSVLRLQLEKL 306
Query: 452 IVNLP 456
+ +LP
Sbjct: 307 LESLP 311
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-42
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE-----VAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNL 222
LG G FG V+KG + E V +K + +KSG Q + + M+ I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VRL G C ++ + +Y+P SL + ++ + + +L+W
Sbjct: 78 VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGV------ 122
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA+G+ YL ++HR+L A NVLL +++DFG+A + D+ Q +
Sbjct: 123 QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL-----LY 174
Query: 343 TYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +M+ E G ++ +SDV+S+GV + E ++
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 47/299 (15%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+G G FG VY G LL+ + AVK L V +F E I++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 224 RLFGCCIEQGEKIL-IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
L G C+ L + YM + L F+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--------------RNETHNPTVKDLIGFGL 199
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+A+G+ +L + + +HRDL A N +LD K++DFG+AR D + +
Sbjct: 200 QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHN 252
Query: 343 TYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
G +M+ E F+ KSDV+SFGVLL E ++ + ++++ + +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-PPYPDVNTFDITVY--- 308
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455
L + R LL P + LY ++ + C A RP+ SE+VS I
Sbjct: 309 LLQGRR---LLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 72/321 (22%), Positives = 131/321 (40%), Gaps = 66/321 (20%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE--------VAVKRL-SNKSGQGVEEFKNEMILIAKL-H 218
LGEG FG V + + ++ VAVK L + + + + + +EM ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H+N++ L G C + G +I EY +L ++ + + + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
V +A+G+ YL + + IHRDL A NVL+ + KI+DFG+AR ++ +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 211
Query: 338 NRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
T G +M+PE +++ +SDV+SFGVL+ E TL G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------------FTLGG 257
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADR 438
+ P + E L+ ++K Y + C + R
Sbjct: 258 SPY-------------PGIPVEELFKLLKEGHRMDKPANCTNELY-MMMRDCWHAVPSQR 303
Query: 439 PTMSEVVSMIKNEIVNLPSPQ 459
PT ++V + + + +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 76/322 (23%), Positives = 136/322 (42%), Gaps = 73/322 (22%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRN 221
LGEG FG V K + + VAVK L N S + + +E ++ +++H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFL---------FDYKYSSGFDMVTDPASKGIL 272
+++L+G C + G +LI EY SL FL + S D + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
+ I+QG+ YL + ++++HRDL A N+L+ KISDFG++R +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----D 199
Query: 333 LQSNMNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387
+ + + + G +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------ 247
Query: 388 LTLLGHA-WNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQ 432
LG + P + E L+ ++K Y ++ L C +
Sbjct: 248 ---LGGNPY-------------PGIPPERLFNLLKTGHRMERPDNCSEEMY-RLMLQCWK 290
Query: 433 ENAADRPTMSEVVSMIKNEIVN 454
+ RP +++ ++ +V
Sbjct: 291 QEPDKRPVFADISKDLEKMMVK 312
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 29/228 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRN 221
+GEG FG V++ + VAVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFL---------FDYKYSSGFDMVTDPASKGIL 272
+V+L G C L++EYM L+ FL L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----N 223
Query: 333 LQSNMNRIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ S M PE + ++ +SDV+++GV+L E S
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 74/312 (23%), Positives = 131/312 (41%), Gaps = 50/312 (16%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNL 222
LG+G FG V + +L + VAVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 223 VRLFGCCIEQGEKI------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
+L G + K +I +M + L FL + + L T
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR---------IGENPFNLPLQT 138
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-MFGGDELQS 335
VR + IA G+ YL S IHRDL A N +L DM ++DFG++R ++ GD +
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR- 194
Query: 336 NMNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390
G +++ E L+++ SDV++FGV + E ++ + T + I++ +
Sbjct: 195 -----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ-TPYAGIENAEI 248
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ L +R L P E +Y ++ + C + RP+ + + ++N
Sbjct: 249 YNY---LIGGNR---LKQPPECMEEVYDLMYQ-------CWSADPKQRPSFTCLRMELEN 295
Query: 451 EIVNLPSPQQPA 462
+ +L
Sbjct: 296 ILGHLSVLSTSQ 307
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 46/225 (20%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE-----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
+ +G G FG VYKG L VA+K L + + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
+RL G + ++I EYM N +LD FL + G V ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE--------------KDGEFSVLQLVGMLR 154
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
GIA G+ YL + + +HRDL A N+L++ ++ K+SDFG++R+ D
Sbjct: 155 GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---------- 201
Query: 343 TYGY------------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+PE + F+ SDV+SFG+++ E ++
Sbjct: 202 -EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 170 NKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHRN 221
LG G FG V + ++ VAVK L + +E+ ++ + HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 222 LVRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYK-YSSGFDMVTDPASKGILDWTTRVR 279
+V L G C + G + +I E+ +L +L + + + + K L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+A+G+ +L + + IHRDL A N+LL KI DFG+AR ++ + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204
Query: 340 IVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +M+PE +++I+SDV+SFGVLL E S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 168 EENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
+ +G+G FG VY G+ ++ + A+K L Q VE F E +L+ L+H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 223 VRLFGCCIEQGEKILI-YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ L G + + YM + L F+ + +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--------------PQRNPTVKDLISFG 130
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+A+G+ YL + + +HRDL A N +LD K++DFG+AR D L +
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQ 183
Query: 342 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ + E F+ KSDV+SFGVLL E L+
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 73/312 (23%), Positives = 129/312 (41%), Gaps = 66/312 (21%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE--------VAVKRL-SNKSGQGVEEFKNEMILIAKL-H 218
LGEG FG V + + ++ VAVK L + + + + + +EM ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYK-YSSGFDMVTDPASKGILDWTTR 277
H+N++ L G C + G +I EY +L +L + + + + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
V +A+G+ YL + + IHRDL A NVL+ + KI+DFG+AR ++ +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 257
Query: 338 NRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
T G +M+PE +++ +SDV+SFGVL+ E TL G
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------------FTLGG 303
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADR 438
+ P + E L+ ++K Y + C + R
Sbjct: 304 SPY-------------PGIPVEELFKLLKEGHRMDKPANCTNELY-MMMRDCWHAVPSQR 349
Query: 439 PTMSEVVSMIKN 450
PT ++V +
Sbjct: 350 PTFKQLVEDLDR 361
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 66/248 (26%), Positives = 96/248 (38%), Gaps = 39/248 (15%)
Query: 138 GDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGE----EVAV 193
G + + I + KLG+G FG V +G+ VAV
Sbjct: 1 GSAGEGPLQSLTCLI---------GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV 51
Query: 194 KRLSN---KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF 250
K L + +++F E+ + L HRNL+RL+G + K+ + E P SL
Sbjct: 52 KCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR 110
Query: 251 LFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310
L +G T R +A+G+ YL R IHRDL A N+L
Sbjct: 111 LRK--------------HQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLL 153
Query: 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGT---YGYMSPEYALHGLFSIKSDVFSFG 367
L KI DFG+ R ++ M + + +PE FS SD + FG
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 368 VLLLETLS 375
V L E +
Sbjct: 212 VTLWEMFT 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-41
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 42/222 (18%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE-----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNL 222
LG G FG VYKG + E VA+K L S + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
RL G C+ ++ I + MP L ++ + K + +
Sbjct: 80 CRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCV 124
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
IA+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E
Sbjct: 125 QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------K 172
Query: 343 TYGY---------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y M+ E LH +++ +SDV+S+GV + E ++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 84/333 (25%), Positives = 141/333 (42%), Gaps = 79/333 (23%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE--------EVAVKRL-SNKSGQGVEEFKNEMILIAKL-H 218
LGEG FG V + + + +VAVK L S+ + + + + +EM ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-------FDYKYSSGFDMVTDPASKGI 271
H+N++ L G C + G +I EY +L +L +Y Y+ + +SK +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD 331
+ + +A+G+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 194 VSCAYQ------VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----- 239
Query: 332 ELQSNMNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386
++ T G +M+PE +++ +SDV+SFGVLL E
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI------------- 286
Query: 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQ 432
TL G + P + E L+ ++K Y + C
Sbjct: 287 -FTLGGSPY-------------PGVPVEELFKLLKEGHRMDKPSNCTNELY-MMMRDCWH 331
Query: 433 ENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465
+ RPT ++V + IV L S Q+ + +
Sbjct: 332 AVPSQRPTFKQLVEDLDR-IVALTSNQEMGYYH 363
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-40
Identities = 67/308 (21%), Positives = 115/308 (37%), Gaps = 55/308 (17%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE---VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ +LG G FG V +G ++ VA+K L EE E ++ +L + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L G C + + + E L FL + + + ++ +
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQV 445
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+ G+ YL +HR+L A NVLL KISDFG+++ G D+ +
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARS 497
Query: 345 G------YMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY----NIDSLTLLGHA 394
+ +PE FS +SDV+S+GV + E LS + Y + + +
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI--- 552
Query: 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454
++ ++ P LY + C DRP V ++ +
Sbjct: 553 ------EQGKRMECPPECPPELY-------ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
Query: 455 LPSPQQPA 462
L S +
Sbjct: 600 LASKVEGG 607
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+ +G G FG V G+L + VA+K L + + +F E ++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL G + +++ EYM N SLD FL V ++ G
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK--------------HDAQFTVIQLVGMLRG 155
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
IA G+ YL S + +HRDL A N+L++ ++ K+SDFG+ R+ D
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP----------- 201
Query: 344 YGY------------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
SPE + F+ SDV+S+G++L E +S
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 51/305 (16%)
Query: 169 ENKLGEGGFGPVYKGKL--LNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHR 220
LG G FG V + L E+ VAVK L S E +E+ +++ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V L G C G ++I EY L FL D A+ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS-TASTRDLLHF 169
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+AQG+ +L + IHRD+ A NVLL KI DFG+AR ++ ++ N I
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYI 221
Query: 341 VGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS--------SKKNTRFYNIDS 387
V +M+PE +++++SDV+S+G+LL E S N++FY
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK--- 278
Query: 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447
L G+ ++ P + +Y +++ C RPT ++ S
Sbjct: 279 LVKDGY-----------QMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSF 320
Query: 448 IKNEI 452
++ +
Sbjct: 321 LQEQA 325
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 168 EENKLGEGGFGPVYKGKLLNGE---EVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNL 222
E+ +LG G FG V KG + VAVK L +E E ++ +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 223 VRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
VR+ G C + E L+ E L+ +L ++ + + ++
Sbjct: 81 VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH---------------VKDKNIIELV 123
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
++ G+ YL +HRDL A NVLL KISDFG+++ DE N
Sbjct: 124 HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYK 175
Query: 342 GTYG------YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ +PE + FS KSDV+SFGVL+ E S
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 169 ENKLGEGGFGPVYKGKL--LNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHR 220
LG G FG V + L + VAVK L + E +E+ +++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFL---FDYKYSSGFDMVTDPASKGILDWTTR 277
N+V L G C G ++I EY L FL D S + LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
+ +A+G+ +L + IHRDL A N+LL KI DFG+AR +++++
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDS 199
Query: 338 NRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
N +V +M+PE + +++ +SDV+S+G+ L E S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
+F E +G GGFG V+K K ++G+ +KR+ + E+ + E+ +AKL H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL-DWTTR----- 277
GC ++S LF + + KG L W +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLF---------IQMEFCDKGTLEQWIEKRRGEK 118
Query: 278 ------VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD 331
+ + E I +G+ Y+H ++I+RDLK SN+ L KI DFG+ D
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 332 ELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391
R GT YMSPE + + D+++ G++L E L +
Sbjct: 176 ---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETS----- 225
Query: 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ D R + + ++ ++++ + + DRP SE+
Sbjct: 226 ----KFFTDLRDGII--SDIFDKKEKTLLQK-------LLSKKPEDRPNTSEI 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 81/326 (24%), Positives = 126/326 (38%), Gaps = 78/326 (23%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE------EVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRN 221
LG G FG VY+G++ +VAVK L S Q +F E ++I+K +H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+VR G ++ + ++ E M L FL + + P+ L + +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR--------PRPSQPSSLAMLDLLHVA 146
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DMNPKISDFGIARMFGGDELQSNMN 338
IA G YL IHRD+ A N LL KI DFG+AR ++
Sbjct: 147 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASY 198
Query: 339 RIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
G M PE + G+F+ K+D +SFGVLL E S LG+
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGY 243
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADRP 439
+ P+ N+ + V Y ++ C Q DRP
Sbjct: 244 --------MPY----PSKSNQEVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRP 290
Query: 440 TMSEVVSMIKN-----EIVNLPSPQQ 460
+ ++ I+ +++N P +
Sbjct: 291 NFAIILERIEYCTQDPDVINTALPIE 316
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 50/229 (21%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE--------EVAVKRLSNKSGQGVEEFKNEMILIAKLHHR 220
LG+G F ++KG EV +K L E F +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+LV +G C+ E IL+ E++ SLD +L +K ++ ++ +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--------------NKNCINILWKLEV 118
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--------KISDFGIARMFGGDE 332
+ +A + +L +IH ++ A N+LL + + K+SD GI+ +
Sbjct: 119 AKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 333 LQSNMNRIVGTYGY-----MSPEYALHG-LFSIKSDVFSFGVLLLETLS 375
+ PE + ++ +D +SFG L E S
Sbjct: 176 -----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 48/224 (21%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+GEG FG V++G ++ E VA+K + S E+F E + + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+L G E I I E L FL K LD + +
Sbjct: 80 KLIGVITENPVWI-IMELCTLGELRSFLQV--------------RKYSLDLASLILYAYQ 124
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
++ L YL R +HRD+ A NVL+ + K+ DFG++R
Sbjct: 125 LSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----------- 170
Query: 344 YGY------------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y M+PE F+ SDV+ FGV + E L
Sbjct: 171 --YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 48/224 (21%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
LGEG FG VY+G N + VAVK + + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+L G E+ I I E P L +L +K L T V
Sbjct: 77 KLIGIIEEEPTWI-IMELYPYGELGHYLER--------------NKNSLKVLTLVLYSLQ 121
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I + + YL + +HRD+ N+L+ K+ DFG++R ++
Sbjct: 122 ICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----------- 167
Query: 344 YGY------------MSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y MSPE F+ SDV+ F V + E LS
Sbjct: 168 --YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-40
Identities = 81/326 (24%), Positives = 126/326 (38%), Gaps = 78/326 (23%)
Query: 169 ENKLGEGGFGPVYKGKLLNGE------EVAVKRL-SNKSGQGVEEFKNEMILIAKLHHRN 221
LG G FG VY+G++ +VAVK L S Q +F E ++I+K +H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+VR G ++ + ++ E M L FL + + P+ L + +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR--------PRPSQPSSLAMLDLLHVA 187
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DMNPKISDFGIARMFGGDELQSNMN 338
IA G YL IHRD+ A N LL KI DFG+AR ++
Sbjct: 188 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGY 239
Query: 339 RIVGTYGY-----MSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
G M PE + G+F+ K+D +SFGVLL E S LG+
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGY 284
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKR--------------YIKVALLCVQENAADRP 439
+ P+ N+ + V Y ++ C Q DRP
Sbjct: 285 --------MPY----PSKSNQEVLEFVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRP 331
Query: 440 TMSEVVSMIKN-----EIVNLPSPQQ 460
+ ++ I+ +++N P +
Sbjct: 332 NFAIILERIEYCTQDPDVINTALPIE 357
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE------VAVKRL-SNKSGQGVEEFKNEMILIAKL-HHR 220
LG G FG V + VAVK L E +E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N+V L G C G LI+EY L +L + D + K + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 281 IEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
+A+G+ +L +HRDL A NVL+ KI DFG+AR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221
Query: 333 LQSNMNRIVGTYG-----YMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
+ S+ N +V +M+PE G+++IKSDV+S+G+LL E S
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 75/326 (23%), Positives = 119/326 (36%), Gaps = 62/326 (19%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNL 222
+F LG GGFG V++ K ++ A+KR+ E+ E+ +AKL H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 223 VRLFGCCIE---------QGEKILIY---EYMPNKSLDFFLFDYKYSSGFDMVTDPASKG 270
VR F +E K+ +Y + ++L ++ + +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT------IEERERSV 119
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330
L IA+ + +LH ++HRDLK SN+ D K+ DFG+
Sbjct: 120 CLHIFL------QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 331 DE----------LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380
DE + VGT YMSPE +S K D+FS G++L E L
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----Y 225
Query: 381 RFYNIDSLTLLGHAWNLWKDDRAWKL-LDPTLQNEALYPMVKRYIKVALLCVQENAADRP 439
F D R K T + Y MV+ + + +RP
Sbjct: 226 PFSTQMERVR------TLTDVRNLKFPPLFTQKYPCEYVMVQD-------MLSPSPMERP 272
Query: 440 TMSEVVSMIKNEIV-NLPSPQQPAFS 464
+ I+N + +L P +
Sbjct: 273 EAINI---IENAVFEDLDFPGKTVLR 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN 221
+F E LG+G FG V K + L+ A+K++ + + + +E++L+A L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG--FDMVTDPASKGILDWTTRVR 279
+VR + +E+ + + KS F +Y +G +D++ R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEY-CENGTLYDLIHS--ENLNQQRDEYWR 120
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF----------- 328
+ I + L Y+H +IHRDLK N+ +D N KI DFG+A+
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 329 -GGDELQSNMNRIVGTYGYMSPE-YALHGLFSIKSDVFSFGVLLLE 372
N+ +GT Y++ E G ++ K D++S G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 68/304 (22%), Positives = 112/304 (36%), Gaps = 55/304 (18%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEE----VAVKRL-SNKSGQGVEEFKNEMILIAKLHHRNLV 223
+GEG FG V++G ++ E VA+K + S E+F E + + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+L G E I I E L FL K LD + +
Sbjct: 455 KLIGVITENPVWI-IMELCTLGELRSFL--------------QVRKFSLDLASLILYAYQ 499
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
++ L YL R +HRD+ A NVL+ + K+ DFG++R +
Sbjct: 500 LSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-P 555
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA-WNLWKDDR 402
+M+PE F+ SDV+ FGV + E L G + K++
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILM---------------HGVKPFQGVKNND 600
Query: 403 AWKLLD-----PTLQN--EALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455
++ P N LY + C + + RP +E+ + + +
Sbjct: 601 VIGRIENGERLPMPPNCPPTLY-------SLMTKCWAYDPSRRPRFTELKAQLSTILEE- 652
Query: 456 PSPQ 459
Q
Sbjct: 653 EKLQ 656
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 62/322 (19%)
Query: 164 HNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
++ KLGEGGF V + L +G A+KR+ Q EE + E + +H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 223 VRLFGCCIEQGEK----ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
+RL C+ + L+ + +L ++ + L +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNE-------IERLKDKGNFLTEDQIL 137
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR-----MFGGDEL 333
++ GI +GL +H HRDLK +N+LL + P + D G + G +
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 334 QSNMNRI--VGTYGYMSPE---YALHGLFSIKSDVFSFGVLL--LETLSSKKNTRFYNID 386
+ + T Y +PE H + ++DV+S G +L + + F D
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRY-------IKVALLCVQENAADRP 439
S+ L +QN+ P R+ + + + RP
Sbjct: 255 SVALA-------------------VQNQLSIPQSPRHSSALWQLLNS---MMTVDPHQRP 292
Query: 440 TMSEVVSMIKNEIVNLPSPQQP 461
+ ++S + E + P+P Q
Sbjct: 293 HIPLLLSQL--EALQPPAPGQH 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 67/305 (21%), Positives = 127/305 (41%), Gaps = 35/305 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHR 220
NF E K+G G F VY+ LL+G VA+K++ + + E+ L+ +L+H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVR 279
N+++ + IE E ++ E L + +K + + + +
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP------ERTVWKYFVQ-- 144
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+ L ++H RV+HRD+K +NV + K+ D G+ R F + +
Sbjct: 145 ----LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS 195
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
+VGT YMSPE ++ KSD++S G LL E + + + D + L + +
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ---SPFYGDKMNLYSLCKKIEQ 252
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459
D P L ++ +++ + +C+ + RP ++ V + K + +
Sbjct: 253 CDY------PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKR-MHACTASS 302
Query: 460 QPAFS 464
Sbjct: 303 LEHHH 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 35/235 (14%)
Query: 158 SISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKR--LSNKSGQGVEEFKNEMILIA 215
S+S +S ++G GG V++ + A+K L Q ++ ++NE+ +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 216 KLHHRNL--VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
KL + +RL+ I ++ E N L + K +D
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL------------NSWLK---KKKSID 125
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
R + + + + +HQ+ ++H DLK +N L+ D K+ DFGIA D
Sbjct: 126 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181
Query: 334 QSNMNRIVGTYGYMSPE-----------YALHGLFSIKSDVFSFGVLLLETLSSK 377
+ VGT YM PE S KSDV+S G +L K
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 70/363 (19%), Positives = 133/363 (36%), Gaps = 56/363 (15%)
Query: 137 EGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKR- 195
DS G + + IS +S ++G GG V++ + A+K
Sbjct: 29 HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88
Query: 196 -LSNKSGQGVEEFKNEMILIAKLHHRNL--VRLFGCCIEQGEKILIYEYMPNKSLDFFLF 252
L Q ++ ++NE+ + KL + +RL+ I ++ E N L
Sbjct: 89 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL----- 142
Query: 253 DYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312
+ K +D R + + + + +HQ+ ++H DLK +N L+
Sbjct: 143 -------NSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE-----------YALHGLFSIKS 361
D K+ DFGIA D + VG YM PE S KS
Sbjct: 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 362 DVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQ---NEALYP 418
DV+S G +L K T F I + + + ++DP + +
Sbjct: 249 DVWSLGCILYYMTYGK--TPFQQIIN-----------QISKLHAIIDPNHEIEFPDIPEK 295
Query: 419 MVKRYIKVALLCVQENAADRPTMSEVVS--MIKNEIVNLPSPQQPAFSYVRIVEKSVLLE 476
++ +K C++ + R ++ E+++ ++ + + + ++ V ++
Sbjct: 296 DLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 352
Query: 477 NSE 479
NS
Sbjct: 353 NSP 355
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRN 221
+ K+GEG FG K +G + +K +S S + EE + E+ ++A + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V+ E G ++ +Y L + K F ILDW +
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQ------EDQILDWFVQ---- 133
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I L ++H +++HRD+K+ N+ L D ++ DFGIAR+ +
Sbjct: 134 --ICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACI 186
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
GT Y+SPE + ++ KSD+++ G +L E
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYE 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 170 NKLGEGGFGPVYKGKLLNGEEVAVKR--LSNKSGQGVEEFKNEMILIAKL--HHRNLVRL 225
++G GG V++ + A+K L Q ++ ++NE+ + KL H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ I ++ E N L + K +D R + +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDL------------NSWL---KKKKSIDPWERKSYWKNML 118
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
+ + +HQ+ ++H DLK +N L+ D K+ DFGIA D + VGT
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 346 YMSPE-----------YALHGLFSIKSDVFSFGVLLLETLSSK 377
YM PE S KSDV+S G +L K
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 42/281 (14%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
++G G F VYKG EVA + + + FK E ++ L H N+VR +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 228 CCIEQGEK----ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +L+ E M + +L +L + ++
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF---------------KVMKIKVLRSWCRQ 137
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKISDFGIARMFGGDELQSNMNRIVG 342
I +GL +LH +IHRDLK N+ + G + KI D G+A + ++ ++G
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
T +M+PE + DV++FG+ +LE +S+ + + + R
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYR--------R 241
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
+ P ++ P VK I+ C+++N +R ++ +
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRN 221
++ +G G +G K + +G+ + K + + + +E+ L+ +L H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 222 LVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG-------IL 272
+VR + I++ L + EY L ++T + +L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDL------------ASVITKGTKERQYLDEEFVL 114
Query: 273 DWTTRVRIIEGIAQGLLYLHQ--YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330
T+ + L H+ V+HRDLK +NV LDG N K+ DFG+AR+
Sbjct: 115 RVMTQ------LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 331 DELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
D S VGT YMSPE ++ KSD++S G LL E
Sbjct: 169 D--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 51/223 (22%), Positives = 80/223 (35%), Gaps = 26/223 (11%)
Query: 160 STATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAK 216
S +F ++LG G +G V+K +G AVK + + E+ K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 217 L-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
+ H VRL E G L E SL + + + +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQ------VWGYL 163
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS 335
L +LH ++H D+K +N+ L K+ DFG+ G
Sbjct: 164 RD------TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-- 212
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
G YM+PE L G + +DVFS G+ +LE + +
Sbjct: 213 -GEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 36/237 (15%)
Query: 156 LASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKS-GQGVEEFKNEMIL 213
+ S ST+ H + + LG+G V++G+ G+ A+K +N S + V+ E +
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIY---EYMPNKSLDFFLFDYKYSSGFDMVTDPASKG 270
+ KL+H+N+V+LF E+ E+ P SL + ++ +P++
Sbjct: 61 LKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSL------------YTVLEEPSNAY 107
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGIAR 326
L + + ++ + G+ +L + ++HR++K N++ DG K++DFG AR
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
Query: 327 MFGGDELQSNMNRIVGTYGYMSPE--------YALHGLFSIKSDVFSFGVLLLETLS 375
DE + GT Y+ P+ + D++S GV +
Sbjct: 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 164 HNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRN 221
L EGGF VY+ + + +G E A+KRL + + E+ + KL H N
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLF-DYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V+ E+ +F L + + + S+G L T ++I
Sbjct: 88 IVQFCSAASIGKEE------SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF-----------G 329
+ + ++H + +IHRDLK N+LL K+ DFG A
Sbjct: 142 FYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 330 GDELQSNMNRIVGTYGYMSPE-YALHGLFSI--KSDVFSFGVLLLE 372
++ + R T Y +PE L+ F I K D+++ G +L
Sbjct: 201 RALVEEEITR-NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
LG+G +G VY G+ L N +A+K + + + + E+ L L H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 231 EQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
E I I+ E +P SL ++ + T + I +GL
Sbjct: 90 E-NGFIKIFMEQVPGGSL------------SALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDM-NPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
YLH +++HRD+K NVL++ KISDFG ++ G + GT YM+
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMA 191
Query: 349 PEYALHGL--FSIKSDVFSFGVLLLETLSSK 377
PE G + +D++S G ++E + K
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 36/212 (16%)
Query: 171 KLGEGGFGPVYKGK--LLNGEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLVRL-- 225
+ GG G +Y +NG V +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 226 FGCCIEQGEKILIY---EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
F ++ + Y EY+ +SL L + +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK------------RSKGQK-----LPVAEAIAYLL 189
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
I L YLH + +++ DLK N++L + K+ D G + G
Sbjct: 190 EILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN----SFGY--LYG 239
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
T G+ +PE G ++ +D+++ G L
Sbjct: 240 TPGFQAPEIVRTGP-TVATDIYTVGRTLAALT 270
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 55/296 (18%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEM-ILIAKLHHRNLV 223
+F ++ LG G G + + + +VAVKR+ + E+ +L H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
R F ++ + + E L +Y F + +++
Sbjct: 82 RYFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPIT----------LLQQ 126
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLL-----DGDMNPKISDFGIARMFGGDEL-QSNM 337
GL +LH L ++HRDLK N+L+ G + ISDFG+ + S
Sbjct: 127 TTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 338 NRIVGTYGYMSPEY---ALHGLFSIKSDVFSFGVLLLETLS------SKKNTRFYNIDSL 388
+ + GT G+++PE + D+FS G + +S K R NI
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--- 240
Query: 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
L A +L K D + ++++ + + RP+ V
Sbjct: 241 --LLGACSL-DCLHPEKHEDVIARE-----LIEK-------MIAMDPQKRPSAKHV 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 160 STATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL 217
ST+ H + + LG+G V++G+ G+ A+K +N S + V+ E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 218 HHRNLVRLFGCCIEQGEKILIY---EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
+H+N+V+LF E+ E+ P SL + ++ +P++ L
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSL------------YTVLEEPSNAYGLPE 111
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGIARMFGG 330
+ + ++ + G+ +L + ++HR++K N++ DG K++DFG AR
Sbjct: 112 SEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 331 DELQSNMNRIVGTYGYMSPE--------YALHGLFSIKSDVFSFGVLL 370
DE + GT Y+ P+ + D++S GV
Sbjct: 169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
KLG GG VY + + +VA+K + + + ++ F+ E+ ++L H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
E L+ EY+ +L ++ S G L T + I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---------------ESHGPLSVDTAINFTNQILD 122
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL-QSNMNRIVGTYG 345
G+ + H +R++HRD+K N+L+D + KI DFGIA+ L Q+N ++GT
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH--VLGTVQ 177
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y SPE A +D++S G++L E L
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRL-SNKSGQGVEEFKNEM-ILI 214
S+ + +LG G +G V K + + +G+ +AVKR+ + + Q + ++ I +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
+ V +G +G+ + E M + SLD F + IL
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ------TIPEDIL-- 111
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
+I I + L +LH S+L VIHRD+K SNVL++ K+ DFGI+ L
Sbjct: 112 ---GKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLV 161
Query: 335 SNM--NRIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLE 372
++ + G YM+PE +S+KSD++S G+ ++E
Sbjct: 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 71/337 (21%), Positives = 116/337 (34%), Gaps = 77/337 (22%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNL 222
+F +G GGFG V++ K ++ A+KR+ E+ E+ +AKL H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDP---------------- 266
VR F +E + E D S
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 267 ----------------ASKGIL-DWTTR------------VRIIEGIAQGLLYLHQYSRL 297
K L DW R + I IA+ + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---K 183
Query: 298 RVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS----------NMNRIVGTYGYM 347
++HRDLK SN+ D K+ DFG+ DE + VGT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407
SPE +S K D+FS G++L E L +T+ + +T + ++ +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFE-LLYSFSTQMERVRIITDV-------RNLK----F 291
Query: 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ YP ++ + + +RP +++
Sbjct: 292 PLLFTQK--YPQEHMMVQ---DMLSPSPTERPEATDI 323
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG+GGF ++ E A K + K Q E+ E+ + L H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 107
Query: 227 GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
G E + + ++ E +SL ++ K + + R + I
Sbjct: 108 GF-FEDNDFVFVVLELCRRRSL------------LELHK--RRKALTEPEAR-YYLRQIV 151
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR---IVG 342
G YLH+ RVIHRDLK N+ L+ D+ KI DFG+A D R + G
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCG 203
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLL 370
T Y++PE S + DV+S G ++
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 25/244 (10%)
Query: 132 AKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEE 190
K+ E + + + + F+ +F + ++LG G G V+K +G
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 191 VAVKRLSNKSGQGV-EEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDF 249
+A K + + + + E+ ++ + + +V +G GE + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 250 FLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309
K + + IL ++ + +GL YL + +++HRD+K SN+
Sbjct: 121 V---LKKAGRIP-------EQIL-----GKVSIAVIKGLTYLR--EKHKIMHRDVKPSNI 163
Query: 310 LLDGDMNPKISDFGIARMFGGDELQSNM-NRIVGTYGYMSPEYALHGLFSIKSDVFSFGV 368
L++ K+ DFG++ +L +M N VGT YMSPE +S++SD++S G+
Sbjct: 164 LVNSRGEIKLCDFGVSG-----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 369 LLLE 372
L+E
Sbjct: 219 SLVE 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 30/206 (14%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG+GGF ++ E A K + K Q E+ E+ + L H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 81
Query: 227 GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD-WTTRVRIIEGI 284
G E + + ++ E +SL ++ + L R + I
Sbjct: 82 GF-FEDNDFVFVVLELCRRRSL------------LELH---KRRKALTEPEAR-YYLRQI 124
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
G YLH R RVIHRDLK N+ L+ D+ KI DFG+A D + GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTP 179
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLL 370
Y++PE S + DV+S G ++
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFK-NEMILIAKLHHR 220
H + + ++G G FG V++ K G + AVK++ +E F+ E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110
Query: 221 NLVRLFGCCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
+V L+G E G + I+ E + SL ++ G L +
Sbjct: 111 RIVPLYGAVRE-GPWVNIFMELLEGGSLG------------QLIK---QMGCLPEDRALY 154
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSNMN 338
+ +GL YLH R++H D+KA NVLL D + + DFG A D L ++
Sbjct: 155 YLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 339 R---IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
I GT +M+PE + K D++S ++L L+
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRL-SNKSGQGVEEFKNEM-ILIAKLHHR 220
+ + ++G G +G V K +G+ +AVKR+ S + ++ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+V+ +G +G+ + E M + S D F Y + ++ D + IL +I
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKF-----YKYVYSVLDDVIPEEIL-----GKI 130
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM--N 338
+ L +L L++IHRD+K SN+LLD N K+ DFGI+ +L ++
Sbjct: 131 TLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-----QLVDSIAKT 183
Query: 339 RIVGTYGYMSPE----YALHGLFSIKSDVFSFGVLLLE 372
R G YM+PE A + ++SDV+S G+ L E
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 67/311 (21%), Positives = 106/311 (34%), Gaps = 66/311 (21%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEM-ILIAKLHHRNLVR 224
E LG G G V G VAVKR+ + E+ +L H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 225 LFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ C + + E L D S + + + ++
Sbjct: 74 YY-CSETTDRFLYIALELCNLN-----LQDLVESKNV----SDENLKLQKEYNPISLLRQ 123
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLD-------------GDMNPKISDFGIARMFGG 330
IA G+ +LH L++IHRDLK N+L+ ++ ISDFG+ +
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 331 DE--LQSNMNRIVGTYGYMSPEYALHGLFSI-------KSDVFSFGVLLLETLSSK---- 377
+ ++N+N GT G+ +PE D+FS G + LS
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 378 --KNTRFYNI--DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQE 433
K +R NI +L + L EA I ++
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRS----------LIAEA-----TDLIS-QMIDH-- 282
Query: 434 NAADRPTMSEV 444
+ RPT +V
Sbjct: 283 DPLKRPTAMKV 293
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 25/211 (11%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQG---VEEFKNEMILIAKLHHRNLVR 224
+G GG G VY+ + + VA+K +S + E +L ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ G+ + + L L +G L V I+ I
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML---------------RRQGPLAPPRAVAIVRQI 143
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL-QSNMNRIVGT 343
L H HRD+K N+L+ D + DFGIA ++L Q VGT
Sbjct: 144 GSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
YM+PE + ++D+++ +L E L
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK----RLSNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG GG V+ + L + +VAVK L+ F+ E A L+H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIVAV 77
Query: 226 FGCCIEQGEKILIY----EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ + + EY+ +L + ++G + + +I
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---------------HTEGPMTPKRAIEVI 122
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL---QSNMN 338
Q L + H + +IHRD+K +N+++ K+ DFGIAR Q+
Sbjct: 123 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA- 178
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
++GT Y+SPE A +SDV+S G +L E L
Sbjct: 179 -VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
++ K+G+G G VY + G+EVA+++++ + E NE++++ + + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ E ++ EY+ SL TD ++ +D +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSL----------------TDVVTETCMDEGQIAAVCREC 125
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
Q L +LH +VIHRD+K+ N+LL D + K++DFG QS + +VGT
Sbjct: 126 LQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTP 180
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+M+PE + K D++S G++ +E
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG+G F VY+ + + G EVA+K + K+G V+ +NE+ + +L H +++ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKHPSILELY 77
Query: 227 GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
E + L+ E N + Y + K + R + I
Sbjct: 78 NY-FEDSNYVYLVLEMCHNGEM----NRYLKNRV---------KPFSENEAR-HFMHQII 122
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA--RMFGGDELQSNMNRIVGT 343
G+LYLH + ++HRDL SN+LL +MN KI+DFG+A ++ + + GT
Sbjct: 123 TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCGT 175
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y+SPE A ++SDV+S G + L
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
K+GEG G V + +G +VAVK + + Q E NE++++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
++ + E ++ E++ +L TD S+ L+ + E +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------------TDIVSQVRLNEEQIATVCEAV 150
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
Q L YLH VIHRD+K+ ++LL D K+SDFG + +VGT
Sbjct: 151 LQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTP 205
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+M+PE L++ + D++S G++++E
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 32/242 (13%)
Query: 141 AAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRL-SN 198
++ K++ ++ ++ ++G G G V+K + G +AVK++ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 199 KSGQGVEEFKNEM-ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYS 257
+ + + ++ +++ +V+ FG I + + E M +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK------ 115
Query: 258 SGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317
+ P + IL ++ I + L YL + VIHRD+K SN+LLD
Sbjct: 116 ----RMQGPIPERIL-----GKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQI 164
Query: 318 KISDFGIARMFGGDELQSNM--NRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVLL 370
K+ DFGI+ L + +R G YM+PE + I++DV+S G+ L
Sbjct: 165 KLCDFGISG-----RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 371 LE 372
+E
Sbjct: 220 VE 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 24/239 (10%), Positives = 53/239 (22%), Gaps = 31/239 (12%)
Query: 159 ISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRL---SNKSGQGVEEFKNEMILI 214
+S L G V+ + + E+ A+K + S +E
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 215 AKLHHRNLVRLFGCC---------IEQGEKILIYEYMPNKSLD----FFLFDYKYSSGFD 261
A+L + Q + L
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 262 MVTD----PASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317
+ + +G + + + L ++H N+ + D
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRL 233
Query: 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETL 374
+ D G + Y E+ F+ + + G+ +
Sbjct: 234 MLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 40/302 (13%), Positives = 91/302 (30%), Gaps = 53/302 (17%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKL---------- 217
LG+ + GE V +++ K E++ + L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLD----FFLFDYKYSSGFD----MVTDPASK 269
H + F + +K +I + + + FFL+ S+ +++ ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
L R+++ + + L LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 330 GDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384
G S + R + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC--------- 312
Query: 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPM-VKRYIKVALLCVQENAADRPTMSE 443
DD A + ++ P V+ ++ L + DR +
Sbjct: 313 -------ADL--PNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL---RYPKEDRLLPLQ 360
Query: 444 VV 445
+
Sbjct: 361 AM 362
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 51/243 (20%), Positives = 90/243 (37%), Gaps = 46/243 (18%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKG-KLLNGEEVAVKR--LSNKSGQGVEEFKNEM 211
++ S T F E K+G G FG V+K K L+G A+KR + E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 212 ILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG 270
A L H ++VR F E ++ EY SL + + + +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY--FKEAE--- 116
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP------------- 317
+ D + + +GL Y+H + ++H D+K SN+ + P
Sbjct: 117 LKDLLLQ------VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167
Query: 318 ------KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS--IKSDVFSFGVL 369
KI D G S+ G +++ E L ++ K+D+F+ +
Sbjct: 168 SNKVMFKIGDLGHVTRI------SSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALT 220
Query: 370 LLE 372
++
Sbjct: 221 VVC 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEE-FKNEMILIAKLHHRNL 222
+ + +LG GGFG V + GE+VA+K+ + E + E+ ++ KL+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 223 VRLFGCCIEQGEKI-------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
V + +K+ L EY L + + L
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDL------------RKYLNQFENCCGLKEG 121
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDMNPKISDFGIARMFGGDE 332
++ I+ L YLH+ R+IHRDLK N++L + KI D G A+ E
Sbjct: 122 PIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 333 LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
L VGT Y++PE +++ D +SFG L
Sbjct: 179 L---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 171 KLGEGGFGPVYKGKLLNGEEVAVKRLS-----------------NKSGQGVEEFKNEMIL 213
L +G F + + + + A+K+ ++FKNE+ +
Sbjct: 38 TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 214 IAKLHHRNLVRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGIL 272
I + + + G I +++ +IYEYM N S+ + V D +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI----LKFDEYFF---VLDKNYTCFI 148
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
II+ + Y+H + + HRD+K SN+L+D + K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 333 LQSNMNRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVLLLETL 374
++ GTY +M PE + +G K D++S G+ L
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ +LG+G FG VYK K G A K + KS + +E++ E+ ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L G G+ ++ E+ P ++D ++ L + +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVD------------AIML--ELDRGLTEPQIQVVCRQM 126
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+ L +LH R+IHRDLKA NVL+ + + +++DFG++ + + +GT
Sbjct: 127 LEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTP 181
Query: 345 GYMSPEYALHGLFS-----IKSDVFSFGVLLLE 372
+M+PE + K+D++S G+ L+E
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 79/357 (22%), Positives = 123/357 (34%), Gaps = 102/357 (28%)
Query: 169 ENKLGEGGFGPVYKGKLLN------GEEVAVKRL-SNKSGQGVEEFKNEM-ILIAKLHHR 220
LG G FG V + VAVK L + +E+ ILI HH
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 221 NLVRLFGCCIEQGEKI-LIYEYMPNKSLDFFLF--------------------DYKYSSG 259
N+V L G C + G + +I E+ +L +L DY +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 260 FDM-------------------------------VTDPASKGILDWTTRVRIIEGIAQGL 288
D+ + K L + +A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG--- 345
+L + + IHRDL A N+LL KI DFG+AR ++ + + +
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLP 258
Query: 346 --YMSPEYALHGLFSIKSDVFSFGVLLLETLSS--------KKNTRFYNIDSLTLLGHAW 395
+M+PE +++I+SDV+SFGVLL E S K + F G
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---RLKEGT-- 313
Query: 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
++ P +Y + C + RPT SE+V + N +
Sbjct: 314 ---------RMRAPDYTTPEMYQTMLD-------CWHGEPSQRPTFSELVEHLGNLL 354
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
F KLGEG +G VYK G+ VA+K++ + ++E E+ ++ + ++V
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVV 87
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G + + ++ EY S+ D++ L I++
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVS------------DIIR--LRNKTLTEDEIATILQS 133
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+GL YLH +R IHRD+KA N+LL+ + + K++DFG+A + + N ++GT
Sbjct: 134 TLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGT 188
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+M+PE ++ +D++S G+ +E
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
F++ K+G+G FG V+KG + VA+K + + + +E+ + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ +G ++ + +I EY+ S D G LD T I+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGS----------------ALDLLEPGPLDETQIATILRE 127
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR---I 340
I +GL YLH + IHRD+KA+NVLL K++DFG+A +L +
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG-----QLTDTQIKRNTF 179
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
VGT +M+PE + K+D++S G+ +E
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVR 224
LG+G FG VY + + +A+K L K+G + + E+ + + L H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILR 73
Query: 225 LFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIE 282
L+G ++ LI EY P ++ + FD + T I
Sbjct: 74 LYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFD-----------EQRTA-TYIT 116
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+A L Y H RVIHRD+K N+LL KI+DFG + + G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCG 169
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
T Y+ PE + K D++S GVL E L
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHR 220
F + KLG G FG V+ + +G E +K ++ ++S +E+ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N++++F + ++ E L + +V+ A L +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLER-------IVSAQARGKALSEGYVAEL 129
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNM 337
++ + L Y H V+H+DLK N+L KI DFG+A +F DE
Sbjct: 130 MKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---S 183
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
GT YM+PE + K D++S GV++
Sbjct: 184 TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 35/253 (13%)
Query: 124 KEKGNMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKG 183
+ R + +GD ++ FI + + + KLG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDL----QATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLC 56
Query: 184 K-LLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240
+ + E A+K + S + E+ ++ L H N+++L+ ++ L+ E
Sbjct: 57 RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVI 300
L FD + + + II+ + G+ YLH+ ++
Sbjct: 117 CYKGGEL------------FDEII---HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIV 158
Query: 301 HRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF 357
HRDLK N+LL + D KI DFG++ +F + M +GT Y++PE L +
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKY 214
Query: 358 SIKSDVFSFGVLL 370
K DV+S GV+L
Sbjct: 215 DEKCDVWSIGVIL 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 138 GDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRL 196
G + F+ S A + + + LG+G FG V K + G+E AVK +
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59
Query: 197 SNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFD 253
S + E E+ L+ +L H N+++L+ ++G L+ E L
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL------ 113
Query: 254 YKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-- 311
FD + S+ RII + G+ Y+H+ +++HRDLK N+LL
Sbjct: 114 ------FDEII---SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLES 161
Query: 312 -DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
D N +I DFG++ F + M +GT Y++PE LHG + K DV+S GV+L
Sbjct: 162 KSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 33/232 (14%), Positives = 66/232 (28%), Gaps = 30/232 (12%)
Query: 163 THNFSEENKLGEGGFGPVYKGK------LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAK 216
+ + LGEG F VY+ N ++ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
++ + + Q +L+ E +L + YK + M +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR--- 180
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL-----------DGDMNPKISDFGIA 325
+ + +H +IH D+K N +L D + D G +
Sbjct: 181 -------MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ T G+ E + ++ + D F + L
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 57/332 (17%), Positives = 105/332 (31%), Gaps = 60/332 (18%)
Query: 155 SLASISTATHNFSEENKLGEG--GFGPVYKGK-LLNGEEVAVKR--LSNKSGQGVEEFKN 209
++S + +G+G V + GE V V+R L S + V +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 210 EMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
E+ + +H N+V I E ++ +M S D++
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA------------KDLIC-THFM 122
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
++ I++G+ + L Y+H + +HR +KAS++L+ D +S
Sbjct: 123 DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 330 GDELQSN-----MNRIVGTYGYMSPE---YALHGLFSIKSDVFSFGVLLLE--------- 372
+ V ++SPE L G + KSD++S G+ E
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFK 238
Query: 373 -----------------TLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEA 415
L + A + D P+ +
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 416 LYPMVKRYIKV----ALLCVQENAADRPTMSE 443
+P + + C+Q N RP+ S
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
LG+G FG V K K + +E AVK + ++ + E+ L+ KL H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
F + ++ E L FD + + RII+ +
Sbjct: 87 FEILEDSSSFYIVGELYTGGEL------------FDEII---KRKRFSEHDAARIIKQVF 131
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
G+ Y+H+ ++HRDLK N+LL + D + KI DFG++ F + M +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIG 185
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLL 370
T Y++PE L G + K DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+LG G FG V++ G A K + E + E+ ++ L H LV L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPASKGILDWTTRVRIIEGI 284
+ E ++IYE+M SG F+ V D + V + +
Sbjct: 222 AFEDDNEMVMIYEFM---------------SGGELFEKVAD--EHNKMSEDEAVEYMRQV 264
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLL--DGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+GL ++H+ +H DLK N++ K+ DFG+ + ++ G
Sbjct: 265 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTG 318
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLL 370
T + +PE A +D++S GVL
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG+G FG V K K + +E AVK ++ + E+ L+ KL H N+++LF
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
+ ++ E L FD + + RII+ + G
Sbjct: 89 ILEDSSSFYIVGELYTGGEL------------FDEII---KRKRFSEHDAARIIKQVFSG 133
Query: 288 LLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+ Y+H+ ++HRDLK N+LL + D + KI DFG++ F + M +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTA 187
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLL 370
Y++PE L G + K DV+S GV+L
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNL 222
++ + +G G V E+VA+KR++ + Q ++E E+ +++ HH N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V + + + E L+ + + S+ + + + G G+LD +T I+
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKG------EHKSGVLDESTIATILR 128
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI-ARMFGGDELQSNMNR-- 339
+ +GL YLH + IHRD+KA N+LL D + +I+DFG+ A + G ++ N R
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 340 IVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLE 372
VGT +M+PE + K+D++SFG+ +E
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/240 (24%), Positives = 109/240 (45%), Gaps = 34/240 (14%)
Query: 139 DSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS 197
D A + + ++ + + S+ LG G FG V+K + G ++A K +
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123
Query: 198 NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYS 257
+ + EE KNE+ ++ +L H NL++L+ + + +L+ EY+
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV--------------- 168
Query: 258 SG---FDMVTDPASKGILDWTTR--VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL- 311
G FD + D + + T + ++ I +G+ ++HQ + ++H DLK N+L
Sbjct: 169 DGGELFDRIID---ESY-NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCV 221
Query: 312 -DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
KI DFG+AR + E + GT +++PE + S +D++S GV+
Sbjct: 222 NRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+G G +G V A K++ + V+ FK E+ ++ L H N++RL+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ + L+ E L F+ V K + + RI++ + +
Sbjct: 76 EDNTDIYLVMELCTGGEL------------FERVV---HKRVFRESDAARIMKDVLSAVA 120
Query: 290 YLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
Y H+ L V HRDLK N L D K+ DFG+A F ++ M VGT Y
Sbjct: 121 YCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYY 174
Query: 347 MSPEYALHGLFSIKSDVFSFGVLL 370
+SP+ L GL+ + D +S GV++
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 52/263 (19%), Positives = 95/263 (36%), Gaps = 43/263 (16%)
Query: 118 GRKRKLKEKGNMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSE----ENKLG 173
G K + K G + D K + + + + +LG
Sbjct: 11 GSKVRGKYDGPKINDYDKFYEDIWKKYVPQ----------PVEVKQGSVYDYYDILEELG 60
Query: 174 EGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232
G FG V++ G K ++ KNE+ ++ +LHH L+ L ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 233 GEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
E +LI E++ SG FD + + + + +GL
Sbjct: 121 YEMVLILEFL---------------SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLK 163
Query: 290 YLHQYSRLRVIHRDLKASNVLL--DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
++H+ ++H D+K N++ + KI DFG+A DE + T +
Sbjct: 164 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFA 217
Query: 348 SPEYALHGLFSIKSDVFSFGVLL 370
+PE +D+++ GVL
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 56/261 (21%), Positives = 91/261 (34%), Gaps = 50/261 (19%)
Query: 152 IFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNKSGQGVE 205
++F S+ + + +G+G +G V A+K ++ + + VE
Sbjct: 14 LYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 206 EFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTD 265
K E+ L+ KLHH N+ RL+ ++ L+ E L D D
Sbjct: 74 RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGK 129
Query: 266 PASKGILDWTTRV-----------------------------RIIEGIAQGLLYLHQYSR 296
A + I+ I L YLH
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--- 186
Query: 297 LRVIHRDLKASNVLL--DGDMNPKISDFGIARMFGGDELQSN--MNRIVGTYGYMSPEYA 352
+ HRD+K N L + K+ DFG+++ F M GT +++PE
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-V 245
Query: 353 LHGL---FSIKSDVFSFGVLL 370
L+ + K D +S GVLL
Sbjct: 246 LNTTNESYGPKCDAWSAGVLL 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG+G FG VY + N +A+K L K G + + E+ + + L H N++R++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80
Query: 227 GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGI 284
++I L+ E+ P L + G FD + + +E +
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFD-----------EQRSA-TFMEEL 123
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
A L Y H +VIHRD+K N+L+ KI+DFG + ++ + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTL 176
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y+ PE K D++ GVL E L
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 43/255 (16%)
Query: 137 EGDSAAKGKSKESWFIFFSLAS--ISTATHNFSEE----NKLGEGGFGPVYKGK-LLNGE 189
A S+ F+FF L S +E LG G G V +
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCK 161
Query: 190 EVAVKRLS--------NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241
+VA++ +S + + E+ ++ KL+H ++++ + + ++ E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIH 301
M L FD + + + K + + YLH+ +IH
Sbjct: 221 MEGGEL----FDKVVGNKR--LKEATCK---------LYFYQMLLAVQYLHE---NGIIH 262
Query: 302 RDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE---YALHG 355
RDLK NVLL + D KI+DFG +++ G L M + GT Y++PE
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTA 319
Query: 356 LFSIKSDVFSFGVLL 370
++ D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 29/211 (13%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+G+G F V + G++ AVK + ++ G E+ K E + L H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV--RIIE 282
L G +++E+M L + A G + ++ V +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL------------CFEIVKRADAGFV-YSEAVASHYMR 137
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNR 339
I + L Y H +IHRD+K VLL + K+ FG+A G
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
VGT +M+PE + DV+ GV+L
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 42/243 (17%)
Query: 145 KSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS------ 197
++ I ++ + KLG G +G V K E A+K +
Sbjct: 20 AINPGMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76
Query: 198 -------NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF 250
+ EE NE+ L+ L H N+++LF ++ L+ E+ L
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--- 133
Query: 251 LFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310
F+ + ++ D I++ I G+ YLH+ ++HRD+K N+L
Sbjct: 134 ---------FEQII---NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 311 L---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFG 367
L + +N KI DFG++ F D + +GT Y++PE L ++ K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 368 VLL 370
V++
Sbjct: 235 VIM 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 34/208 (16%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
LG G FG V++ + + K + G K E+ ++ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPASKGILDWTTR--VRIIEGI 284
E ++I+E++ SG F+ + + R V + +
Sbjct: 71 ESMEELVMIFEFI---------------SGLDIFERINT---SAF-ELNEREIVSYVHQV 111
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--KISDFGIARMFGGDELQSNMNRIVG 342
+ L +LH + H D++ N++ + KI +FG AR + N +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFT 165
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLL 370
Y +PE H + S +D++S G L+
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 34/237 (14%), Positives = 77/237 (32%), Gaps = 42/237 (17%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKL---------- 217
LG+ + GE V +++ K E++ + L
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLD----FFLFDYKYSSGFD----MVTDPASK 269
H + F + +K +I + + + FFL+ S+ +++ ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
L R+++ + + L LH Y ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 330 GDELQSNMNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLETLS 375
+ G+ PE L + D ++ G+++
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 42/223 (18%)
Query: 164 HNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKS---------GQGVEEFKNEMIL 213
+S + LG G FG V+ +EV VK + K + + E+ +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFI-KKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
++++ H N++++ + N+ F L K+ SG D+ LD
Sbjct: 83 LSRVEHANIIKV-------------LDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLD 128
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
I + + YL +IHRD+K N+++ D K+ DFG A +L
Sbjct: 129 EPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKS------DVFSFGVLL 370
GT Y +PE + +++S GV L
Sbjct: 186 ---FYTFCGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS---NKSGQGVEEFKNEMILIAKLHHRN 221
FS+ ++G G FG VY + + N E VA+K++S +S + ++ E+ + KL H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ GC + + L+ EY + D K L +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---------------HKKPLQEVEIAAVT 160
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH +IHRD+KA N+LL K+ DFG A + + N V
Sbjct: 161 HGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFV 211
Query: 342 GTYGYMSPEYALH---GLFSIKSDVFSFGVLLLE 372
GT +M+PE L G + K DV+S G+ +E
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+G+G F V + +L G EVA+K + + + +++ E+ ++ L+H N+V+LF
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 229 CIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
IE + + LI EY + FDY + G + I
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYL-----------VAHGRMKEKEARSKFRQIVSA 126
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+ Y H + R++HRDLKA N+LLD DMN KI+DFG + F ++ G Y
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYA 180
Query: 348 SPEYALHGLFS------IKSDVFSFGVLL 370
+PE LF + DV+S GV+L
Sbjct: 181 APE-----LFQGKKYDGPEVDVWSLGVIL 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLV 223
F +G G +G VYKG+ + G+ A+K + + +G EE K E+ ++ K HHRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 224 RLFGCCIEQGEKI------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+G I++ L+ E+ S+ D++ L
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT------------DLI-KNTKGNTLKEEWI 131
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
I I +GL +LHQ +VIHRD+K NVLL + K+ DFG++ +L +
Sbjct: 132 AYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTV 183
Query: 338 NR---IVGTYGYMSPEYALHGLFS-----IKSDVFSFGVLLLE 372
R +GT +M+PE KSD++S G+ +E
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
LGEG +G V + E VAVK + ++ E K E+ + L+H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 230 IEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+G L EY L FD + R + G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRI-----------EPDIGMPEPDAQRFFHQLMAGV 118
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
+YLH + + HRD+K N+LLD N KISDFG+A +F + + +N++ GT Y++
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 349 PE------YALHGLFSIKSDVFSFGVLL 370
PE + H DV+S G++L
Sbjct: 176 PELLKRREF--HAE---PVDVWSCGIVL 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
LGEG +G V + E VAVK + ++ E K E+ + L+H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 230 IEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+G L EY L FD + R + G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRI-----------EPDIGMPEPDAQRFFHQLMAGV 118
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
+YLH + + HRD+K N+LLD N KISDFG+A +F + + +N++ GT Y++
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 349 PE------YALHGLFSIKSDVFSFGVLL 370
PE + H DV+S G++L
Sbjct: 176 PELLKRREF--HAE---PVDVWSCGIVL 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNK-SGQGVEEFKNEMILIAKLHHRNLV 223
+LG G F V K + G+E A K RLS+ G EE + E+ ++ ++ H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPASKGILDWTTRVRI 280
L + + +LI E + SG FD + + K L +
Sbjct: 72 TLHDIFENKTDVVLILELV---------------SGGELFDFLAE---KESLTEDEATQF 113
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGIARMFGGDELQSN 336
++ I G+ YLH R+ H DLK N++L + K+ DFGIA
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---E 167
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
I GT +++PE + +++D++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 163 THNFSEE----NKLGEGGFGPVYKG-KLLNGEEVAVKRLSNK--SGQGVEEFKNEMILIA 215
+ FS+ +LG+G F V + G E A K ++ K S + ++ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDPASKG 270
KL H N+VRL E+ L+++ + LF+ YS AS
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSE------ADASH- 109
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARM 327
I+ I + + Y H ++HR+LK N+LL K++DFG+A
Sbjct: 110 ---------CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
E + GT GY+SPE +S D+++ GV+L
Sbjct: 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 163 THNFSE----ENKLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNK-SGQGVEEFKNEM 211
N + +LG G F V K + G + A K R + G E+ + E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG---FDMVTDPAS 268
++ ++ H N++ L + + ILI E + +G FD + +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELV---------------AGGELFDFLAE--- 107
Query: 269 KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGI 324
K L ++ I G+ YLH L++ H DLK N++L KI DFG+
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
A I GT +++PE + +++D++S GV+
Sbjct: 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLF 226
+LG G F V + G+E A K + + E +E+ ++ ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
E ILI EY + F +MV++ +R+I+ I +
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDV---------IRLIKQILE 142
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
G+ YLHQ ++H DLK N+LL + KI DFG++R G + I+GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLL 370
Y++PE + + +D+++ G++
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 36/223 (16%)
Query: 163 THNFSE----ENKLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNK-SGQGVEEFKNEM 211
+ +LG G F V K + G E A K + G EE + E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGI 271
++ ++ H N++ L + + +LI E + L FD + K
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL------------FDFLAQ---KES 111
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGIARM 327
L I+ I G+ YLH ++ H DLK N++L + K+ DFG+A
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
I GT +++PE + +++D++S GV+
Sbjct: 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS----NKSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LGEG +G V + AVK L + G K E+ L+ +L H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 227 G-CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR---VRII 281
E+ +K+ ++ EY + + D K ++I
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDS-----------VPEKRFPVCQAHGYFCQLI 119
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+G+ YLH ++H+D+K N+LL KIS G+A
Sbjct: 120 DGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 342 GTYGYMSPEYAL-----HGLFSIKSDVFSFGVLL 370
G+ + PE A G K D++S GV L
Sbjct: 173 GSPAFQPPEIANGLDTFSGF---KVDIWSAGVTL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 36/223 (16%)
Query: 163 THNFSE----ENKLGEGGFGPVYKGK-LLNGEEVAVK-----RLSNK-SGQGVEEFKNEM 211
+ +LG G F V K + G E A K + G EE + E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGI 271
++ ++ H N++ L + + +LI E + L FD + K
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL------------FDFLAQ---KES 111
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGDMNPKISDFGIARM 327
L I+ I G+ YLH ++ H DLK N++L + K+ DFG+A
Sbjct: 112 LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
I GT +++PE + +++D++S GV+
Sbjct: 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 160 STATHNFSE----ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILI 214
S T N + LG G F V+ K L G+ A+K + +NE+ ++
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDPASK 269
K+ H N+V L L+ + + L FD Y+ D +
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTE-----KDAS-- 109
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIAR 326
+I+ + + YLH+ ++HRDLK N+L + + I+DFG+++
Sbjct: 110 ---------LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 327 MFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
M + + GT GY++PE +S D +S GV+
Sbjct: 158 MEQNGIMST----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 60/237 (25%), Positives = 92/237 (38%), Gaps = 52/237 (21%)
Query: 160 STATHNFSEE----NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGV---------E 205
S +TH F E LG G V + +E AVK + G E
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 206 EFKNEM-ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSG 259
E+ IL H N+++L L+++ M L FDY S
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE- 123
Query: 260 FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319
K I+ + + + LH+ L ++HRDLK N+LLD DMN K+
Sbjct: 124 -----KETRK----------IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165
Query: 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLL 370
+DFG + E + + GT Y++PE H + + D++S GV++
Sbjct: 166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 57/233 (24%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLS--------------------------NKSGQGV 204
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 205 EEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY---EYMPNKSLDFFLFDYKYSSGFD 261
E+ E+ ++ KL H N+V+L ++ + +Y E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV------------ME 127
Query: 262 MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321
+ + L + + +G+ YLH ++IHRD+K SN+L+ D + KI+D
Sbjct: 128 VP----TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 322 FGIARMF-GGDELQSNMNRIVGTYGYMSPE--YALHGLFS-IKSDVFSFGVLL 370
FG++ F G D L ++ VGT +M+PE +FS DV++ GV L
Sbjct: 181 FGVSNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 47/221 (21%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVK-------RLSNKSGQGVEE-FKNEM-ILIAKLHHR 220
+G G V + G E AVK RLS + + V E + E IL H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDPASKGILDWT 275
+++ L L+++ M L FDY S
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSE------KETRS------ 204
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS 335
I+ + + + +LH ++HRDLK N+LLD +M ++SDFG + E
Sbjct: 205 ----IMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-- 255
Query: 336 NMNRIVGTYGYMSPE------YALHGLFSIKSDVFSFGVLL 370
+ + GT GY++PE H + + D+++ GV+L
Sbjct: 256 -LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 159 ISTATHNFSEE----NKLGEGGFGPVYKG-KLLNGEEVAVKRLSNK--SGQGVEEFKNEM 211
+ A+ FS+ +LG+G F V + G E A K ++ K S + ++ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 212 ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDP 266
+ KL H N+VRL E+ L+++ + L F+ YS
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSE------AD 129
Query: 267 ASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFG 323
AS I+ I + + Y H ++HR+LK N+LL K++DFG
Sbjct: 130 AS----------HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
+A E + GT GY+SPE +S D+++ GV+L
Sbjct: 177 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLS--------NKSGQGVEEFKNEMILIAKLHHRN 221
LG G G V ++VA+K +S + + E+ ++ KL+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++++ + + ++ E M L FD + + + K
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR--LKEATCK---------LYF 120
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMN 338
+ + YLH +IHRDLK NVLL + D KI+DFG +++ G L M
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MR 174
Query: 339 RIVGTYGYMSPE---YALHGLFSIKSDVFSFGVLL 370
+ GT Y++PE ++ D +S GV+L
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 29/194 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSG---QGVEEFKNEMILIAKLH 218
F + KLG G + VYKG G VA+K +L ++ G + E L+ +L
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELK 61
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPN--KSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
H N+VRL+ + + L++E+M N K D T + L+
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKY------------MDSRTVGNTPRGLELNL 109
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
+ QGL + H+ +++HRDLK N+L++ K+ DFG+AR F G + +
Sbjct: 110 VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 337 MNRIVGTYGYMSPE 350
+ +V T Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVK---RLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG G FG V G+ L G +VAVK R +S V + K E+ + H ++++L+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
I ++ EY+ L FDY G ++ R+ + I
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYI-----------CKHGRVEEMEARRLFQQILS 122
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
+ Y H R V+HRDLK NVLLD MN KI+DFG++ M E + G+ Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNY 176
Query: 347 MSPE------YALHGLFSIKSDVFSFGVLL 370
+PE Y G + D++S GV+L
Sbjct: 177 AAPEVISGRLY--AGP---EVDIWSCGVIL 201
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 2e-23
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 34/195 (17%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--------EMILIA 215
NF + K+GEG +G VYK + L GE VA+K++ ++ E+ L+
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLK 57
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
+L+H N+V+L + + L++E++ D K D ++ +
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ--------DLK------KFMDASALTGIPLP 103
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS 335
+ + QGL + H + RV+HRDLK N+L++ + K++DFG+AR F G +++
Sbjct: 104 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRT 159
Query: 336 NMNRIVGTYGYMSPE 350
+ +V T Y +PE
Sbjct: 160 YTHEVV-TLWYRAPE 173
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 160 STATHNFSEE----NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK--SGQGVEEFKNEMI 212
+ F+EE +LG+G F V + +L G+E A ++ K S + ++ + E
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-----KYSSGFDMVTDPA 267
+ L H N+VRL E+G LI++ + L F+ YS A
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSE------ADA 112
Query: 268 SKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGI 324
S I+ I + +L+ HQ + V+HR+LK N+LL K++DFG+
Sbjct: 113 SH----------CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159
Query: 325 ARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
A G+ Q GT GY+SPE + D+++ GV+L
Sbjct: 160 AIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 50/202 (24%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKN--------EMILIAK 216
+ + K+GEG +G VYK K G VA+KR+ ++ E+ L+ +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKE 75
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
LHH N+V L + L++E+M D+ K +LD
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK----------------DL------KKVLD-EN 112
Query: 277 RVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328
+ + + + +G+ + HQ+ R++HRDLK N+L++ D K++DFG+AR F
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 329 GGDELQSNMNRIVGTYGYMSPE 350
G ++S + +V T Y +P+
Sbjct: 170 -GIPVRSYTHEVV-TLWYRAPD 189
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 36/213 (16%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEM-----ILIAKL-----HHR 220
LG+GGFG V+ G L + +VA+K + G + + + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 221 NLVRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
++RL E E L+ E P + D LFDY KG L
Sbjct: 99 GVIRLLDW-FETQEGFMLVLER-PLPAQD--LFDYI-----------TEKGPLGEGPSRC 143
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSNMN 338
+ + + H V+HRD+K N+L+D K+ DFG + +
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD--- 197
Query: 339 RIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLL 370
GT Y PE+ + + + V+S G+LL
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 34/211 (16%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN------EMILIAKLHHR--NL 222
LG GGFG VY G + + VA+K + E N E++L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 223 VRLFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+RL E+ + LI E P D LFD+ +G L
Sbjct: 111 IRLLDW-FERPDSFVLILER-PEPVQD--LFDFI-----------TERGALQEELARSFF 155
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQSNMNRI 340
+ + + + H V+HRD+K N+L+D + K+ DFG +
Sbjct: 156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 208
Query: 341 VGTYGYMSPEYALHGLFS-IKSDVFSFGVLL 370
GT Y PE+ + + + V+S G+LL
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSN---KSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG G FG V GK L G +VAVK L+ +S V + + E+ + H ++++L+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
I I ++ EY+ L FDY G LD R+ + I
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYI-----------CKNGRLDEKESRRLFQQILS 127
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
G+ Y H R V+HRDLK NVLLD MN KI+DFG++ M E + G+ Y
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNY 181
Query: 347 MSPE------YALHGLFSIKSDVFSFGVLL 370
+PE YA + D++S GV+L
Sbjct: 182 AAPEVISGRLYA-----GPEVDIWSSGVIL 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 28/193 (14%)
Query: 171 KLGEGGFGPVYKGK---LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
K+G G +G VYK K + ++ A+K++ +G + + E+ L+ +L H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 228 CCIEQGEKI--LIYEYMPN--KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ ++ L+++Y + + F K + + K +L
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL---------YQ 136
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP----KISDFGIARMFGGDELQ--SNM 337
I G+ YLH V+HRDLK +N+L+ G+ KI+D G AR+F L+ +++
Sbjct: 137 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADL 192
Query: 338 NRIVGTYGYMSPE 350
+ +V T+ Y +PE
Sbjct: 193 DPVVVTFWYRAPE 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 51/203 (25%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--------EMILIA 215
+ + K+GEG +G V+K K E VA+KR+ +++ E+ L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLK 56
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
+L H+N+VRL + L++E+ D+ K D +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----------------DL------KKYFD-S 93
Query: 276 TRVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327
+ + +GL + H V+HRDLK N+L++ + K+++FG+AR
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA 150
Query: 328 FGGDELQSNMNRIVGTYGYMSPE 350
F G ++ +V T Y P+
Sbjct: 151 F-GIPVRCYSAEVV-TLWYRPPD 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 52/205 (25%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKN--------EMIL 213
+ + + LGEG F VYK + + VA+K +L ++ E K+ E+ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-----SEAKDGINRTALREIKL 65
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ +L H N++ L + L++++M D+ + I+
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET----------------DL------EVIIK 103
Query: 274 WTTRVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325
+ + QGL YLHQ+ ++HRDLK +N+LLD + K++DFG+A
Sbjct: 104 -DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159
Query: 326 RMFGGDELQSNMNRIVGTYGYMSPE 350
+ F G ++ +++V T Y +PE
Sbjct: 160 KSF-GSPNRAYTHQVV-TRWYRAPE 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKN-EMILIAKLHHRNLVR 224
++ +G G FG V++ KL+ +EVA+K++ + FKN E+ ++ + H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 225 LFGCCIEQGEKI------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
L G+K L+ EY+P +++ Y+ K +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP-ETV------YRA-----SRHYAKLKQTMPMLLIK 144
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDELQSNM 337
+ + + L Y+H + + HRD+K N+LLD K+ DFG A++ + N+
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199
Query: 338 NRIVGTYGYMSPE 350
+ I Y Y +PE
Sbjct: 200 SYICSRY-YRAPE 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSN---KSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LGEG FG V ++VA+K +S K + E+ + L H ++++L+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
I I ++ EY + LFDY K + R + I
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYI-----------VEKKRMTEDEGRRFFQQIIC 119
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
+ Y H R +++HRDLK N+LLD ++N KI+DFG++ + + G+ Y
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNY 173
Query: 347 MSPEYALHGLFS-IKSDVFSFGVLL 370
+PE L++ + DV+S G++L
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 50/202 (24%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKN--------EMILIAK 216
+ K+GEG +G VYK + GE A+K++ +E+ E+ ++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKE 56
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
L H N+V+L+ + +L++E++ D+ K +LD
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ----------------DL------KKLLD-VC 93
Query: 277 RVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328
+ + G+ Y H RV+HRDLK N+L++ + KI+DFG+AR F
Sbjct: 94 EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150
Query: 329 GGDELQSNMNRIVGTYGYMSPE 350
G ++ + IV T Y +P+
Sbjct: 151 -GIPVRKYTHEIV-TLWYRAPD 170
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 41/178 (23%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMI---------LI 214
+ + K+GEG +G V+K + G+ VA+K+ +E + +I ++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRML 56
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPN---KSLDFFLFDYKYSSGFDMVTDPASKGI 271
+L H NLV L + L++EY + LD +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------------------RYQRG 98
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
+ I Q + + H++ IHRD+K N+L+ K+ DFG AR+
Sbjct: 99 VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 52/238 (21%), Positives = 89/238 (37%), Gaps = 46/238 (19%)
Query: 157 ASISTATHNFSE-----ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNE 210
S + + F + E+ LGEG V L+ +E AVK + + G E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 211 M-ILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGF----DMVTD 265
+ +L HRN++ L E+ L++E M S+ + + +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELE---- 112
Query: 266 PASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDF 322
AS +++ +A L +LH + HRDLK N+L + KI DF
Sbjct: 113 -AS----------VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 323 GIARMF-----GGDELQSNMNRIVGTYGYMSPE-----YALHGLFSIKSDVFSFGVLL 370
+ + G+ YM+PE ++ + D++S GV+L
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN----EMILIAKLHH 219
+ + K+G+G FG V+K + G++VA+K++ E F E+ ++ L H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLKH 75
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPASKGILDWTTRV 278
N+V L C + +L FD+ D G+L V
Sbjct: 76 ENVVNLIEICRTKASP------YNRCKGSIYLVFDF-------CEHD--LAGLLS-NVLV 119
Query: 279 RIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG- 329
+ + GL Y+H+ +++HRD+KA+NVL+ D K++DFG+AR F
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 330 -GDELQSNM-NRIVGTYGYMSPE 350
+ + NR+V T Y PE
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPE 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 43/179 (24%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMI---------LI 214
+ +GEG +G V K + G VA+K+ +E ++M+ L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLL 78
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPN---KSLDFFLFDYKYSSGFDMVTDPASKGI 271
+L H NLV L C ++ L++E++ + L+ + +G D
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQV------- 125
Query: 272 LDWTTRVR-IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
V+ + I G+ + H + +IHRD+K N+L+ K+ DFG AR
Sbjct: 126 ------VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 46/200 (23%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSG---QGVEEFKNEMILIAKLH 218
+ + +KLGEG + VYKGK L VA+K RL ++ G + E L+ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLK 58
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
H N+V L + L++EY+ D+ K LD
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK----------------DL------KQYLD-DCGN 95
Query: 279 RIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGG 330
I + +GL Y H+ +V+HRDLK N+L++ K++DFG+AR
Sbjct: 96 IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-S 151
Query: 331 DELQSNMNRIVGTYGYMSPE 350
++ N +V T Y P+
Sbjct: 152 IPTKTYDNEVV-TLWYRPPD 170
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 41/223 (18%)
Query: 163 THNFSE-----ENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNE-MILIA 215
+ ++ + LG G G V + G++ A+K L + + + E
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSG--FDMVTDPASKGIL 272
++V + +YE M + + + G F + + +G
Sbjct: 78 ASGGPHIVCILD----------VYENMHHGKRCLLIIMEC-MEGGELFSRIQE---RGDQ 123
Query: 273 DWTTR--VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARM 327
+T R I+ I + +LH + HRD+K N+L + D K++DFG A+
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 328 FGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
+ LQ+ T Y++PE + D++S GV++
Sbjct: 181 TTQNALQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+LG G VY+ K + A+K L + + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
E L+ E + L FD + + KG ++ I + +
Sbjct: 118 ETPTEISLVLELVTGGEL------------FDRIVE---KGYYSERDAADAVKQILEAVA 162
Query: 290 YLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGY 346
YLH+ ++HRDLK N+L D KI+DFG++++ L M + GT GY
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGY 216
Query: 347 MSPEYALHGLFSIKSDVFSFGVLL 370
+PE + + D++S G++
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/219 (21%), Positives = 80/219 (36%), Gaps = 36/219 (16%)
Query: 163 THNFSEE----NKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL 217
+ F++ +G G + + E AVK + EE IL+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYG 73
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H N++ L + ++ E M L D F ++ R
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKF-------------FSER 116
Query: 278 --VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNP-KISDFGIARMFGGD 331
++ I + + YLH V+HRDLK SN+L G+ +I DFG A+ +
Sbjct: 117 EASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 332 ELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
+ T +++PE + D++S GVLL
Sbjct: 174 --NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 54/203 (26%), Positives = 80/203 (39%), Gaps = 47/203 (23%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN--------EMILIA 215
+ KLGEG +G VYK + E VA+KR+ +E + E+ L+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLK 88
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPN---KSLDFFLFDYKYSSGFDMVTDPASKGIL 272
+L HRN++ L LI+EY N K +D +
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------------------KNPDV 129
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-----KISDFGIARM 327
+ + G+ + H R +HRDLK N+LL KI DFG+AR
Sbjct: 130 SMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 328 FGGDELQSNMNRIVGTYGYMSPE 350
F G ++ + I+ T Y PE
Sbjct: 187 F-GIPIRQFTHEII-TLWYRPPE 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKN-EMILIAKLHHR 220
++++ +G G FG VY+ KL +GE VA+K++ + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 221 NLVRLFGCCIEQGEKI------LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
N+VRL GEK L+ +Y+P + YS + K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVK----- 159
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMFGGDE 332
+ + + L Y+H + HRD+K N+LLD D K+ DFG A+ E
Sbjct: 160 ----LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 38/209 (18%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230
+G G FG + L E VAVK + + E + E+I L H N+VR I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV-I 85
Query: 231 EQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
+ +I EY L ++ + G + + G+
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERI-----------CNAGRFSEDEARFFFQQLLSGVS 130
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGD--MNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
Y H +++ HRDLK N LLDG KI DFG ++ VGT Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 184
Query: 348 SPE------YALHGLFSIKSDVFSFGVLL 370
+PE Y G +DV+S GV L
Sbjct: 185 APEVLLRQEYD--GK---IADVWSCGVTL 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 44/229 (19%), Positives = 87/229 (37%), Gaps = 40/229 (17%)
Query: 157 ASISTATHNFSEE-----NKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNE 210
+ + + ++ LG G G V + E+ A+K L + + + E
Sbjct: 50 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 104
Query: 211 -MILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSG--FDMVTDP 266
+ ++VR+ +YE + + + G F + D
Sbjct: 105 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMEC-LDGGELFSRIQD- 152
Query: 267 ASKGILDWTTR--VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISD 321
+G +T R I++ I + + YLH + + HRD+K N+L + K++D
Sbjct: 153 --RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTD 207
Query: 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
FG A+ ++ T Y++PE + D++S GV++
Sbjct: 208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 33/184 (17%)
Query: 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKR-LSNKSGQGVEEFKN----EMILIAK 216
F E G+G FG V GK G VA+K+ + + F+N M +A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 217 LHHRNLVRLFGCCIEQGEK-------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
LHH N+V+L GE+ ++ EY+P +L ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTL------HRC-----CRNYYRRQ 123
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-KISDFGIARMF 328
+ + + + LH S + V HRD+K NVL++ K+ DFG A+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 329 GGDE 332
E
Sbjct: 183 SPSE 186
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 36/211 (17%)
Query: 169 ENKLGEGGFGPVYKG-KLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLF 226
+ LGEG F K + + AVK +S + + E+ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGF----DMVTDPASKGILDWTTRVRIIE 282
+Q L+ E + L F+ + AS I+
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETE-----AS----------YIMR 113
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIARMFGGDELQSNMNR 339
+ + ++H + V+HRDLK N+L + ++ KI DFG AR+ D +
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKT 168
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370
T Y +PE + D++S GV+L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 39/183 (21%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS-NKSGQGVEEFKN----EMILIAKLH 218
+ ++G G +G VYK + +G VA+K + G G E+ L+ +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 219 ---HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPASKGILDW 274
H N+VRL C ++ + L F++ + D + LD
Sbjct: 70 AFEHPNVVRLMDVCATSR---------TDREIKVTLVFEH-------VDQD--LRTYLDK 111
Query: 275 TTRVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326
+ +GL +LH ++HRDLK N+L+ K++DFG+AR
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
Query: 327 MFG 329
++
Sbjct: 169 IYS 171
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG GGFG V+ ++ ++ A K+L+ K +G + E ++AK+H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDY-KYSSGFDMVTDPASKGILDWTTRVRI-IEGI 284
E + L+ M + + +++ + + GF R I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-------------PRAIFYTAQI 298
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
GL +LHQ +I+RDLK NVLLD D N +ISD G+A + + GT
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTP 353
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
G+M+PE L + D F+ GV L E +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 57/191 (29%)
Query: 165 NFSEENKLGEGGFGPVYKGK--LLNGEEVAVKRLSNKSGQGVEEFKN--------EMILI 214
+ ++GEG +G V+K + G VA+KR+ V+ + E+ ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVL 65
Query: 215 AKLH---HRNLVRLF----GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDP 266
L H N+VRLF ++ K+ L++E++ D+
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----------------DL---- 105
Query: 267 ASKGILDWTTRVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
LD + + +GL +LH + RV+HRDLK N+L+ K
Sbjct: 106 --TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160
Query: 319 ISDFGIARMFG 329
++DFG+AR++
Sbjct: 161 LADFGLARIYS 171
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-19
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
LG+GGFG V ++ ++ A K+L K +G NE ++ K++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IEGIA 285
E + + L+ M L F + +GF R I
Sbjct: 251 YAYETKDALCLVLTLMNGGDL-KFHIYHMGQAGFPE-------------ARAVFYAAEIC 296
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
GL LH R R+++RDLK N+LLD + +ISD G+A + VGT G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVG 350
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETL 374
YM+PE + ++ D ++ G LL E +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-19
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFG 227
LGEG F V + L E A+K L + V E ++++L H V+L+
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 228 CCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGI 284
Q ++ L Y N L Y G FD + TR E I
Sbjct: 98 TF--QDDEKLYFGLSYAKNGEL----LKYIRKIGSFD-----------ETCTRFYTAE-I 139
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
L YLH +IHRDLK N+LL+ DM+ +I+DFG A++ + Q+ N VGT
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375
Y+SPE SD+++ G ++ + ++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 22/209 (10%), Positives = 56/209 (26%), Gaps = 55/209 (26%)
Query: 171 KLGEGGFGPVYKGK--LLNGEEVAVKRL---SNKSGQGVEEFKNEMILIAKLHHRNLVRL 225
G ++ L +VA+ + ++E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIA 285
+ +++ E++ SL ++ +R ++ +A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQ------------EVADTS-----PSPVGAIRAMQSLA 139
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
H R V S V + D + ++
Sbjct: 140 AAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------- 174
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETL 374
M + + D+ G L L
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALL 196
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 7e-18
Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 172 LGEGGFGPVYKG-KLLNGEEVAVKRLSNK---SGQGVEEFKNE-MIL--IAKLHHRNLVR 224
+G GGFG VY K G+ A+K L K QG NE ++L ++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 225 LFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IE 282
+ +K+ I + M L + L F +R
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSE-------------ADMRFYAA 299
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
I GL ++H V++RDLK +N+LLD + +ISD G+A F + + VG
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 343 TYGYMSPEYALHGLFSIKS-DVFSFGVLLLETL 374
T+GYM+PE G+ S D FS G +L + L
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 48/247 (19%), Positives = 102/247 (41%), Gaps = 41/247 (16%)
Query: 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKN-EMILIAKLH 218
T++ +S LG G FG V + + +G+ A+K++ +KN E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKG-----ILD 273
H N+++L G++ P+ + ++ V S+ I++
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 274 W--TTRVRIIEG-------------------IAQGLLYLHQYSRLRVIHRDLKASNVLLD 312
+ T ++++ + + + ++H L + HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 313 GDMNP-KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLL 370
N K+ DFG A+ + ++ I + Y +PE L ++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 371 LETLSSK 377
E + K
Sbjct: 233 GELILGK 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 7e-15
Identities = 37/199 (18%), Positives = 61/199 (30%), Gaps = 34/199 (17%)
Query: 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRL--------SNKSGQGVEEFKNEMIL 213
T K+GEG FG V++ + VA+K + + + EE E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 214 IAKLH---------HRNLVRLFGCCIEQGE--KILIYEYM----PNKSLDFFLFDYKYSS 258
+L + L QG +L+ + S + +K
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 259 GF--------DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310
F + + + T I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 311 LDGDMNPKISDFGIARMFG 329
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 42/254 (16%), Positives = 89/254 (35%), Gaps = 75/254 (29%)
Query: 130 TRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNG 188
++ + S+ S + + + + +G G +G V + L
Sbjct: 25 QEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 189 EEVAVKRLSNKSGQGVEEFKN---------EMILIAKLHHRNLVRLFGCCI----EQGEK 235
VA+K++ F++ E+ ++ +L+H ++V++ I E+ ++
Sbjct: 79 RVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131
Query: 236 I-LIYEYMP---------NKSLD-----FFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+ ++ E L L++
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN--------------------------- 164
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ G+ Y+H S ++HRDLK +N L++ D + K+ DFG+AR E ++ I
Sbjct: 165 ---LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 341 VGTYGYMSPEYALH 354
M+ H
Sbjct: 219 SPREDDMNLVTFPH 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ +G G G V + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFD-MVTD--PASK 269
L+ ++H+N++ L + P K+L+ F Y + M + +
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLV---MELMDANLCQVIQ 158
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329
LD ++ + G+ +LH +IHRDLK SN+++ D KI DFG+AR G
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
Query: 330 GDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
+ M V T Y +PE L + D++S G ++ E + K
Sbjct: 216 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 32/165 (19%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNE-MILIAKLHHRNLVRLFGC 228
LG G G V + E+ A+K L + + + E + ++VR+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78
Query: 229 CIEQGEKILIYEYMPNKSLDFFL-FDYKYSSG--FDMVTDPASKGILDWTTR--VRIIEG 283
+YE + + + G F + +G +T R I++
Sbjct: 79 ---------VYENLYAGRKCLLIVMEC-LDGGELFSRIQ---DRGDQAFTEREASEIMKS 125
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNPKISDFGIA 325
I + + YLH + + HRD+K N+L + K++DFG A
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 52/237 (21%), Positives = 83/237 (35%), Gaps = 54/237 (22%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEE--FKN---------EMILI 214
++ + + G +G V G G VA+KR+ N G + E+ L+
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 215 AKLHHRNLVRLFGCCIEQGEKI-----LIYEYMPN------KSLDFFLFD--YKYSSGFD 261
HH N++ L + E L+ E M + +Y
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY----- 138
Query: 262 MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321
+ I GL LH+ V+HRDL N+LL + + I D
Sbjct: 139 ------------------FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177
Query: 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
F +AR D N V Y +PE + F+ D++S G ++ E + K
Sbjct: 178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 59/233 (25%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNE-MILIAKLHHRNL 222
++ KLG G + V++ + N E+V VK L + + K E IL N+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 93
Query: 223 VRLFGCCIEQGEK--ILIYEYMPNKSL-----DFFLFDYKYSSGFDMVTDPASKGILDWT 275
+ L + + L++E++ N +D ++
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF------------------- 134
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQ 334
+ I + L Y H S ++HRD+K NV++D + ++ D+G+A + +
Sbjct: 135 ----YMYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185
Query: 335 SNMNRIVGTYGYMSPE---------YALHGLFSIKSDVFSFGVLLLETLSSKK 378
N V + + PE Y+L D++S G +L + K+
Sbjct: 186 -EYNVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ +G G G V + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPA 267
L+ ++H+N++ L + P KSL+ F + + M +
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMEL-------MDANLC 117
Query: 268 S--KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA 325
+ LD ++ + G+ +LH +IHRDLK SN+++ D KI DFG+A
Sbjct: 118 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
R G + M V T Y +PE L + D++S G ++ E +
Sbjct: 175 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 36/232 (15%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ + LG GG G V+ + VA+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFL-FDYKYSSGFDMVTDPA---S 268
+I +L H N+V++F G ++ + ++ +Y M TD A
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-------METDLANVLE 113
Query: 269 KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIARM 327
+G L + + +GL Y+H + V+HRDLK +N+ ++ D+ KI DFG+AR+
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 328 FGGDELQSN-MNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
++ + T Y SP L ++ D+++ G + E L+ K
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/216 (22%), Positives = 85/216 (39%), Gaps = 33/216 (15%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+G G F V K+ +V A+K ++ V F+ E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+ + L+ EY L L K+ + R + E I
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL-LTLL-SKFGERIP----------AEMA-RFYLAE-IVM 173
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGTYG 345
+ +H+ L +HRD+K N+LLD + +++DFG ++ ++S + VGT
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPD 228
Query: 346 YMSPE-------YALHGLFSIKSDVFSFGVLLLETL 374
Y+SPE G + + D ++ GV E
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 64/239 (26%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ +G G +G V +GE+VA+K+LS F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPA 267
L+ + H N++ L + P SL F + + M TD
Sbjct: 76 LLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPF-------MQTD-- 114
Query: 268 SKGILDWTTRVRIIEG--------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319
L ++ E + +GL Y+H V+HRDLK N+ ++ D KI
Sbjct: 115 ----LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167
Query: 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
DFG+AR + M V T Y +PE L ++ D++S G ++ E L+ K
Sbjct: 168 LDFGLARHA-----DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 53/225 (23%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMILIAKLHHRN 221
+G G +G V G +VA+K+L F++ E+ L+ + H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHEN 85
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPA---SKGILD 273
++ L + P+++LD F + + M TD L
Sbjct: 86 VIGLLDV------------FTPDETLDDFTDFYLVMPF-------MGTDLGKLMKHEKLG 126
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
++ + +GL Y+H +IHRDLK N+ ++ D KI DFG+AR
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----- 178
Query: 334 QSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK 377
S M V T Y +PE L ++ D++S G ++ E ++ K
Sbjct: 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG---QGVEEFK-----NEMILIAKLH--H 219
KLG G F V+ K ++N VA+K + +E K N+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 220 RNLVRLFGCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
++++L +G +++E + ++L + Y++ G +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPL------------- 130
Query: 276 TRVR-IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD------GDMNPKISDFGIARMF 328
V+ I + + GL Y+H R +IH D+K NVL++ + KI+D G A +
Sbjct: 131 IYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CW 187
Query: 329 GGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ + + T Y SPE L + +D++S L+ E
Sbjct: 188 YDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+G G FG V KL N ++V A+K L+ F+ E ++ + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 228 CCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
+ + L+ +Y L L K+ + R + E +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLS-KFEDRLPE----------EMA-RFYLAE-MVI 186
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGTYG 345
+ +HQ L +HRD+K N+L+D + + +++DFG ++ +QS++ VGT
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPD 241
Query: 346 YMSPE-----YALHGLFSIKSDVFSFGVLLLETL 374
Y+SPE G + + D +S GV + E L
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 63/241 (26%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
++ + +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPA 267
++ + H N++ + + + +++ + D M TD
Sbjct: 78 ILLRFRHENIIGI-------------NDIIRAPTIEQMKDVYIVQDL-------METD-- 115
Query: 268 SKGILDWTTRVRIIEG---------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
L + + + I +GL Y+H S V+HRDLK SN+LL+ + K
Sbjct: 116 ----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLK 168
Query: 319 ISDFGIARMFGGDELQSN-MNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSS 376
I DFG+AR+ D + + V T Y +PE L ++ D++S G +L E LS+
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 377 K 377
+
Sbjct: 229 R 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 15/97 (15%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+ L YL R+IHRD+K N+LLD + I+DF IA M + + M GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM---AGT 177
Query: 344 YGYMSPE------YALHGLFSIKSDVFSFGVLLLETL 374
YM+PE A + F++ D +S GV E L
Sbjct: 178 KPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAYELL 211
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFG 227
+G G FG V + + +V A+K LS F E ++A + +V+LF
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
Q ++ L + + +Y G D+V ++ + + R E +
Sbjct: 137 AF--QDDRYL-----------YMVMEYM--PGGDLVNLMSNYDVPEKWARFYTAE-VVLA 180
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA-RMFGGDELQSNMNRIVGTYGY 346
L +H + IHRD+K N+LLD + K++DFG +M ++ + VGT Y
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDY 235
Query: 347 MSPE-------YALHGLFSIKS-DVFSFGVLLLETL 374
+SPE +G + D +S GV L E L
Sbjct: 236 ISPEVLKSQGGDGYYG----RECDWWSVGVFLYEML 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 58/245 (23%), Positives = 93/245 (37%), Gaps = 75/245 (30%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 213 LIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPA 267
L+ + H N++ L + P +SL+ F + M D
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHL-------MGAD-- 119
Query: 268 SKGILDWTTRVRIIEG--------------IAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313
L+ I++ I +GL Y+H +IHRDLK SN+ ++
Sbjct: 120 ----LN-----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLE 372
D KI DFG+AR M V T Y +PE L ++ D++S G ++ E
Sbjct: 168 DCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 373 TLSSK 377
L+ +
Sbjct: 223 LLTGR 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 50/266 (18%)
Query: 127 GNMTRAKEFCEGDS--AAKGKSKESWFIFFSLASISTAT-HNFSEENKLGEGGFGPVYKG 183
GN AK+ E +S K+KE + + S +TA F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 184 KL-LNGEEVAVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238
K +G A+K L K Q +E NE ++ ++ LV+L + L
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNL- 116
Query: 239 YEYMPNKSLDFF----LFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293
YM +++ +F + G F + R + I YLH
Sbjct: 117 --YM---VMEYVAGGEMFSHLRRIGRFS-----------EPHARFYAAQ-IVLTFEYLHS 159
Query: 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL 353
+I+RDLK N+L+D +++DFG A+ ++ + GT ++PE L
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIIL 211
Query: 354 ---HGLFSIKS-DVFSFGVLLLETLS 375
+ K+ D ++ GVL+ E +
Sbjct: 212 SKGYN----KAVDWWALGVLIYEMAA 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 40/246 (16%), Positives = 80/246 (32%), Gaps = 72/246 (29%)
Query: 139 DSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLS 197
+ +F + N+ ++ +G G +G VY + VA+K+++
Sbjct: 4 HHHHSSGRENLYFQGIKNVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 198 NKSGQGVEEFKN---------EMILIAKLHHRNLVRLFGCCIEQGEKI-----LIYEYMP 243
F++ E+ ++ +L ++RL+ I ++ E
Sbjct: 61 R-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 244 ---------NKSLD-----FFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
L L++ +L G
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYN-----------------LL-------------LGEN 143
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSP 349
++H +IHRDLK +N LL+ D + K+ DFG+AR ++ + +N +
Sbjct: 144 FIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 350 EYALHG 355
L
Sbjct: 201 NKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 55/250 (22%), Positives = 90/250 (36%), Gaps = 80/250 (32%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMILIA 215
F ++ LGEG +G V GE VA+K++ F E+ ++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64
Query: 216 KLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFF-----LFDYKYSSGFDMVTDPASKG 270
H N++ + + S + F + + M TD
Sbjct: 65 HFKHENIITI-------------FNIQRPDSFENFNEVYIIQEL-------MQTD----- 99
Query: 271 ILDWTTRVRIIEG--------------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316
L R+I + + LH + VIHRDLK SN+L++ + +
Sbjct: 100 -LH-----RVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCD 150
Query: 317 PKISDFGIARMFGGDELQSNMNRI--------VGTYGYMSPEYAL-HGLFSIKSDVFSFG 367
K+ DFG+AR+ ++ V T Y +PE L +S DV+S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 368 VLLLETLSSK 377
+L E +
Sbjct: 211 CILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I L YLH S V++RDLK N++LD D + KI+DFG+ + + G M
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFC 310
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
GT Y++PE + D + GV++ E +
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNE-MILIAKLHHRNLVRLF 226
LG+G FG V + +E+ AVK L VE E +L L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-IA 285
C + +++ +F+ +Y +G D++ G IA
Sbjct: 409 -SCFQTMDRL------------YFVMEY--VNGGDLMYHIQQVGRFK-EPHAVFYAAEIA 452
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGT 343
GL +L +I+RDLK NV+LD + + KI+DFG+ + ++ G GT
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGT 505
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y++PE + + D ++FGVLL E L
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 47/218 (21%)
Query: 172 LGEGGFGPVYKGKLL-NGEEVAVKRLSN----KSGQGVEEFKNEMILIAKLHHRNLVRLF 226
LG G FG V+ + NG A+K L + Q VE +E ++++ + H ++R++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRMW 72
Query: 227 GCCIEQGEKILIYEYMPNKSLDFF----LFDYKYSSG-FDMVTDPASKGILDWTTRVRII 281
G Q + + +M +D+ LF S F + +
Sbjct: 73 GTF--QDAQQI---FM---IMDYIEGGELFSLLRKSQRFP-----------NPVAKFYAA 113
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
E + L YLH +I+RDLK N+LLD + + KI+DFG A+ + +
Sbjct: 114 E-VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC 164
Query: 342 GTYGYMSPEYAL---HGLFSIKS-DVFSFGVLLLETLS 375
GT Y++PE + KS D +SFG+L+ E L+
Sbjct: 165 GTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLA 198
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I L YLH V++RD+K N++LD D + KI+DFG+ + + G M
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
GT Y++PE + D + GV++ E +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
+A L +LH L +I+RDLK N+LLD + + K++DFG+++ + + S
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FC 187
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
GT YM+PE + +D +SFGVL+ E L
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNE-MILIAKLHHRNLVRLF 226
LG+G FG V + +E+ AVK L VE E +L L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-IA 285
C + +++ +F+ +Y +G D++ G IA
Sbjct: 88 -SCFQTMDRL------------YFVMEYV--NGGDLMYHIQQVGRFK-EPHAVFYAAEIA 131
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGT 343
GL +L +I+RDLK NV+LD + + KI+DFG+ + ++ G GT
Sbjct: 132 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGT 184
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
Y++PE + + D ++FGVLL E L
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 1e-09
Identities = 58/376 (15%), Positives = 122/376 (32%), Gaps = 85/376 (22%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK----SGQGV---EEFKNEMILIAK 216
H+ + + GE + YK L E+ V K + + EE + I+++K
Sbjct: 3 HHHHMDFETGEHQYQ--YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDH--IIMSK 58
Query: 217 LHHRNLVRLFGCCIEQGEKILI----------YEYMPNK--------SLDFFLFDYKYSS 258
+RLF + + E+++ Y+++ + S+ ++ +
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 259 GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL---K---ASNVLLD 312
++ +K + +R++ + Q LL L + +I L K A +V L
Sbjct: 119 LYNDN-QVFAKYNV---SRLQPYLKLRQALLELRPAKNV-LIDGVLGSGKTWVALDVCLS 173
Query: 313 GDMNPKISDFGI-----ARMFGGDELQSNMNRIVGTYGYMSPEYA--LHGLFSIKSDVFS 365
+ K+ DF I + + + ++ + P + +IK + S
Sbjct: 174 YKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKL---LYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 366 FGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLD---PTLQNEALYPMVKR 422
L L SK L +L + N AW + L + R
Sbjct: 230 IQAELRRLLKSKPYEN-----CLLVLLNVQNAK----AWNAFNLSCKIL-------LTTR 273
Query: 423 YIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYVRIVEKSVLLENSE--A 480
+ +V +++ +E+ +L K + +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-------LL------KYLDCRPQDLPR 320
Query: 481 EASSGNCLTLSMVDAR 496
E + N LS++
Sbjct: 321 EVLTTNPRRLSIIAES 336
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 5e-05
Identities = 61/510 (11%), Positives = 145/510 (28%), Gaps = 146/510 (28%)
Query: 10 FIK-FDDMQVPDLL-EVLLNESVN--LKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFG 65
F+ FD V D+ +L E ++ + K+ L W
Sbjct: 29 FVDNFDCKDVQDMPKSILSKEEIDHIIMS------KDAVSGTL-----------RLFW-- 69
Query: 66 DMIDMKRTLGNLTGQSIYLRAPASQLGKKKTLWIVVLIAL----PVVILPAFFIFYGRKR 121
+ K + + + L + +++ I P ++ + R R
Sbjct: 70 -TLLSK-------QEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPSMMTRMYI--EQRDR 118
Query: 122 -----KLKEKGNMTRAKEFCEGDSAAKGKSKESWFIFFSLASISTATHNFSEENKLGEGG 176
++ K N++R + + + A + G G
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI----------D--------GVLG 160
Query: 177 FGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236
G K + A+ + Q +FK I L+ C +
Sbjct: 161 SG---KTWV------ALDVCLSYKVQCKMDFK-----IFWLN-------LKNCNSPETVL 199
Query: 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSR 296
+ + + + D ++S D ++ + I +R LL Y
Sbjct: 200 EMLQKL------LYQIDPNWTSRSDHSSNIKLR-IHSIQAELRR-------LLKSKPYEN 245
Query: 297 LRVIHRDLKASNVLLDGDMNPKI----SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA 352
++ +++ + +++ KI + + ++P+
Sbjct: 246 CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI--SLDHHSMTLTPDEV 303
Query: 353 LHGLFS---------IKSDVFSFGVLLL----ETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
L + +V + L E++ T W+ WK
Sbjct: 304 K-SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT--------------WDNWK 348
Query: 400 DDRAWKL---LDPTLQNEALYP--MVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454
KL ++ +L L P K + ++++ +A + ++S+I ++
Sbjct: 349 HVNCDKLTTIIESSL--NVLEPAEYRKMFDRLSVF--PPSA---HIPTILLSLIWFDV-- 399
Query: 455 LPSPQQPAFSYVRIVEKSVLLENSEAEASS 484
++ + S++ + + S
Sbjct: 400 --IKSDVMVVVNKLHKYSLVEKQPKESTIS 427
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I GL +LH +++RDLK N+LLD D + KI+DFG+ + M G + +
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT----FC 179
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
GT Y++PE L ++ D +SFGVLL E L
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 68/215 (31%)
Query: 163 THNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKN---------EMI 212
+ KLG+G +G V+K GE VAVK++ + F+N E++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 213 LIAKLH-HRNLVRLFGCCI-EQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
++ +L H N+V L + + L+++YM TD
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME--------------------TD---- 96
Query: 270 GILDWTTRVRIIEG--------------IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315
L +I + + + YLH S ++HRD+K SN+LL+ +
Sbjct: 97 --LH-----AVIRANILEPVHKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAEC 146
Query: 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPE 350
+ K++DFG++R F +N + + +
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 15/97 (15%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I+ L YLH+ +I+RDLK NVLLD + + K++D+G+ + + GD +
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FC 171
Query: 342 GTYGYMSPE---YALHGLFSIKSDVFSFGVLLLETLS 375
GT Y++PE +G FS+ D ++ GVL+ E ++
Sbjct: 172 GTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIV 341
I+ L +LHQ +I+RDLK N++L+ + K++DFG+ + + G +
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----FC 182
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
GT YM+PE + + D +S G L+ + L
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNK---SGQGVEEFKNE-MILIAKLHHRNLVRLF 226
+G G + V +L + + A++ + + + ++ + E + +H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 227 GCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG-IA 285
C + ++ FF+ +Y +G D++ + L R I+
Sbjct: 120 -SCFQTESRL------------FFVIEYV--NGGDLMFHMQRQRKLP-EEHARFYSAEIS 163
Query: 286 QGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVGT 343
L YLH+ +I+RDLK NVLLD + + K++D+G+ + + GD + GT
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FCGT 216
Query: 344 YGYMSPE---YALHGLFSIKSDVFSFGVLLLETLS 375
Y++PE +G FS+ D ++ GVL+ E ++
Sbjct: 217 PNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMA 248
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 17/97 (17%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIA--RMFGGDELQSNMNRIV 341
I L++LH +I+RDLK NVLLD + + K++DFG+ + G
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 342 GTYGYMSPE---YALHGLFSIKS-DVFSFGVLLLETL 374
GT Y++PE L+G + D ++ GVLL E L
Sbjct: 186 GTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEML 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 172 LGEGGFGPVYKGKLLNGEEV-AVKRLSNKSGQGVEEFKNEM----ILIAKLHHRNLVRLF 226
+G+G FG V + E AVK L K+ +E K+ M +L+ + H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 227 GCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI-IEGI 284
+ +K+ + +Y+ L + L + F R R I
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHL---QRERCFL-------------EPRARFYAAEI 148
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR--MFGGDELQSNMNRIVG 342
A L YLH L +++RDLK N+LLD + ++DFG+ + + + G
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCG 201
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETL 374
T Y++PE + D + G +L E L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 30/212 (14%)
Query: 170 NKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG---QGVEEFK--NEMILIAKLHHRNLV 223
+ +G+G FG V K + E VA+K + NK Q E + M +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII-E 282
L + + L++E + + +L L + + G + R +
Sbjct: 120 HLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR-GVSL-------------NLTRKFAQ 164
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--KISDFGIARMFGGDELQSNMNRI 340
+ LL+L L +IH DLK N+LL KI DFG + G +
Sbjct: 165 QMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ----Y 218
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ + Y SPE L + + D++S G +L+E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 33/166 (19%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFG 227
++GEG FG +++G LLN ++VA+K +S Q +E++ +L + ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYY 73
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
E +L+ + + SL+ L D T + +
Sbjct: 74 FGQEGLHNVLVIDLLG-PSLE-DLLDL-------------CGRKFSVKTVAMAAKQMLAR 118
Query: 288 LLYLHQYSRLRVIHRDLKASNVLLDGDMNPK-----ISDFGIARMF 328
+ +H+ S +++RD+K N L+ + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 25/170 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
NF K+G G FG + GK L E VA+K KS + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR-FYKQLGSGDGIP 68
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+++ ++ E + SL+ LFD + F + T + I
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRT-FSL------------KTVLMIAIQ 113
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK-----ISDFGIARMF 328
+ + Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 114 LISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 36/163 (22%), Positives = 66/163 (40%), Gaps = 25/163 (15%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV-RLFGC 228
K+G G FG +Y G + EEVA+K + K+ E + L + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+E +L+ + + SL+ LF++ L T + + + + +
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFC-------------SRKLSLKTVLMLADQMINRV 116
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPK---ISDFGIARMF 328
++H S +HRD+K N L+ I DFG+A+ +
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
I L +LH+ L +I+RD+K N+LLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 344 YGYMSPE---YALHGLFSIKSDVFSFGVLLLETL 374
YM+P+ G D +S GVL+ E L
Sbjct: 224 IEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELL 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 25/163 (15%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH-RNLVRLFGC 228
K+G G FG +Y G + GEEVA+K K+ E + + + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
E +++ E + SL+ LF++ T + + + + +
Sbjct: 74 GAEGDYNVMVMELL-GPSLE-DLFNFC-------------SRKFSLKTVLLLADQMISRI 118
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPK---ISDFGIARMF 328
Y+H + IHRD+K N L+ I DFG+A+ +
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 172 LGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHR------N 221
+G+G FG V K + VA+K + N+ Q EE + ++ L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDY-KYSS--GFDMVTDPASKGILDWTTRV 278
++ + + + +E L L++ K + GF + V
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSL-------------PLV 202
Query: 279 RII-EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--KISDFGIARMFGGDELQS 335
R I Q L LH + R+IH DLK N+LL K+ DFG + + + +
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYT 258
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ + Y +PE L + + D++S G +L E
Sbjct: 259 ----YIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 23/183 (12%), Positives = 59/183 (32%), Gaps = 41/183 (22%)
Query: 169 ENKLGEGGFGPVYKGK---------LLNGEEVAVKRLSNKSGQGVEEFK----------- 208
++ G +Y+ ++ ++K L K G+ E
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 209 NEMILIAKLHHRNLVRLFGCCIEQGE-KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA 267
N+ + + G + Q + + L+ + +SL D
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE----- 158
Query: 268 SKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI--SDFGIA 325
+ +++ + L +LH+ +H ++ A N+ +D + ++ + +G A
Sbjct: 159 -------RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 326 RMF 328
+
Sbjct: 209 FRY 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 39/207 (18%), Positives = 72/207 (34%), Gaps = 48/207 (23%)
Query: 171 KLGEGGFGPVYKGKLLNGE------EVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+G+GGFG +Y + + E VK + +G E K + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 225 L-------------FGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
G + G+ +I + L +++ +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEA-------------NA 146
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK---ISDFGIAR 326
T +++ I L Y+H++ +H D+KASN+LL NP + D+G+A
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL-NYKNPDQVYLVDYGLAY 202
Query: 327 MF----GGDELQSNMNR-IVGTYGYMS 348
+ ++ R GT + S
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTS 229
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 35/181 (19%), Positives = 67/181 (37%), Gaps = 44/181 (24%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVA---VKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL- 225
K+G GGFG +Y E+ A VK ++G E K + K + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 226 ------------FGCCIEQGEK--ILIYEYMPNKSL-DFFLFDYKYSSGFDMVTDPASKG 270
G +G ++ E + L + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK----------ST 152
Query: 271 ILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK---ISDFGIARM 327
+L +R+++ + Y+H+ +H D+KA+N+LL G NP ++D+G++
Sbjct: 153 VL--QLGIRMLDVLE----YIHENE---YVHGDIKAANLLL-GYKNPDQVYLADYGLSYR 202
Query: 328 F 328
+
Sbjct: 203 Y 203
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 50/234 (21%), Positives = 81/234 (34%), Gaps = 60/234 (25%)
Query: 171 KLGEGGFGPVYKG--KLLNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHR----- 220
LGEG FG V + +VA+K + N E +L K+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKIKEKDKENK 81
Query: 221 -NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
V + G + +E + K+ FL + + + + VR
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNF-QPYPL-------------PHVR 126
Query: 280 II-EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-------------------KI 319
+ + L +LH ++ H DLK N+L ++
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLE 372
+DFG A F + + IV T Y PE L L ++ DV+S G +L E
Sbjct: 184 ADFGSA-TFDHE----HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 64/238 (26%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKL-----HHRN 221
K+G+G FG V + + N + AVK + N E IL K+ ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDDINNNN 97
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR-I 280
+V+ G + LI+E + SL + Y+ GF + ++
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHI-------------EDIKLY 142
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP----------------------- 317
I + L YL ++ + H DLK N+LLD
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 318 --KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLE 372
K+ DFG A F D I+ T Y +PE L L + + SD++SFG +L E
Sbjct: 200 GIKLIDFGCA-TFKSD----YHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAE 251
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 33/171 (19%), Positives = 55/171 (32%), Gaps = 67/171 (39%)
Query: 262 MVTDPASKGILDWTTR----------VR-IIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310
MV + +L W + V+ II+ + QGL YLH ++ R+IH D+K N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENIL 179
Query: 311 L-------------------------------------------------DGDMNPKISD 321
L + KI+D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
G A + + T Y S E + ++ +D++S + E
Sbjct: 240 LGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFE 285
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 51/234 (21%), Positives = 85/234 (36%), Gaps = 60/234 (25%)
Query: 171 KLGEGGFGPVYKGK--LLNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHR----- 220
LGEG FG V + G VAVK + N E + +L L+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTTDPNST 76
Query: 221 -NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
V++ G +++E + S F+ + + F + +R
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF-LPFRL-------------DHIR 121
Query: 280 II-EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-------------------KI 319
+ I + + +LH ++ H DLK N+L K+
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLE 372
DFG A + + + + +V T Y +PE L L +S DV+S G +L+E
Sbjct: 179 VDFGSA-TYDDE----HHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.16 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 89.84 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.13 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.03 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.13 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.26 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.6 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=458.87 Aligned_cols=272 Identities=26% Similarity=0.404 Sum_probs=208.2
Q ss_pred cCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|.+.++||+|+||.||+|++. +++.||||+++..+....++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 478899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++....................++|.++++|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976443221111112233467999999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+|+.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||..... ......+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i-- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCI-- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHH--
Confidence 9999999997765544444556789999999999999999999999999999999999 8998864332 1111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..+. +...| ......+.+|+.+||+.||++||||+||+++|+.+..
T Consensus 274 --~~g~--~~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 --TQGR--ELERP-------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHTC--CCCCC-------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HcCC--CCCCc-------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 11111 1223567889999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=450.05 Aligned_cols=270 Identities=26% Similarity=0.418 Sum_probs=215.5
Q ss_pred cCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56777899999999999999863 467899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.++|........ ..........++|.++++++.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~--~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAV--LMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHH--HC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEcCCCCcHHHHHHhcCcccc--cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999975321000 0001123457999999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+|+.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||..... ......+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i-- 243 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECI-- 243 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH--
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH--
Confidence 9999999997765444444445679999999999999999999999999999999999 8999864332 1111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..+... ..+...+..+.+++.+||+.||++||||++|++.|+++..
T Consensus 244 --~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 --TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111110 1111223567889999999999999999999999998644
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=447.84 Aligned_cols=269 Identities=29% Similarity=0.428 Sum_probs=214.1
Q ss_pred CCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++...++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455789999999999999863 46789999997543 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcc-cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFD-MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
||||+++|+|.++|.......... ..........++|..+++|+.|||+||+|||+.+ |+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999997543322111 1111233467999999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||..... ......+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMI- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH-
Confidence 99999999997765544444556789999999999999999999999999999999998 8888864332 1222111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
..+... ..+...+..+.+++.+||+.||++||||+||++.|+..
T Consensus 261 ---~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 ---RNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 11122345678899999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=440.05 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=204.0
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.+++.+.++||+|+||+||+|++. ..||||.++... ....++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 357788899999999999999874 369999987432 3446789999999999999999999999865 56899999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.++|.. ....++|..+++|+.|||+||+|||+.+ |+||||||+||||++++++||+
T Consensus 112 y~~gGsL~~~l~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 112 WCEGSSLYKHLHV--------------QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp CCSSCBHHHHHHT--------------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEEC
T ss_pred cCCCCCHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEe
Confidence 9999999999963 3356999999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||+|+...............||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ .....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~--- 250 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMV--- 250 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH---
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHH---
Confidence 9999997654443344556789999999999964 4689999999999999999999999864332111 11111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
..+ ...|.+ .......+..+.+++.+||+.||++||||.||++.|+.+...+|
T Consensus 251 -~~~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 251 -GRG----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -HTT----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -hcC----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111 111111 01112234567889999999999999999999999987644443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=434.57 Aligned_cols=282 Identities=26% Similarity=0.371 Sum_probs=218.8
Q ss_pred CHHHHHHHhcCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcC-Cceeeee
Q 040910 155 SLASISTATHNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHH-RNLVRLF 226 (496)
Q Consensus 155 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~ 226 (496)
.....+...++|.+.+.||+|+||.||+|.+.. ++.||||++..... ...++|.+|+.++.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 333344456789999999999999999998643 35899999975433 335679999999999965 9999999
Q ss_pred eeeeec-CeeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 227 GCCIEQ-GEKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 227 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
|+|.+. +..++|||||++|+|.++|........ .........+..++|..++.++.|||+||+|||+.+ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999976432211 111112233567999999999999999999999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFY 383 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~ 383 (496)
||+|||+++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765544444556789999999999999999999999999999999998 89998754
Q ss_pred CCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..... +. .....+.. ...| ......+.+++.+||+.||++|||+.||+++|+++++
T Consensus 292 ~~~~~-~~----~~i~~g~~--~~~p-------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 292 KIDEE-FC----RRLKEGTR--MRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSHH-HH----HHHHHTCC--CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH-HH----HHHHcCCC--CCCC-------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 33221 11 11111111 1111 1123567889999999999999999999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=425.46 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=200.5
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----eeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG----EKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 239 (496)
++|.+.++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567788999999999999998 7899999999653221 122334555667789999999999998764 579999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCCEEecCC
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-----SRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlk~~NIll~~~ 314 (496)
||+++|+|.+++.. ..++|..+.+++.|+++||+|||+. ..++|+||||||+||||+.+
T Consensus 81 Ey~~~gsL~~~l~~----------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp ECCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred cCCCCCcHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 99999999999953 3489999999999999999999986 23459999999999999999
Q ss_pred CceEEeccccccccCCCcc--ccccccccccccccChhhhccC------CCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 315 MNPKISDFGIARMFGGDEL--QSNMNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+++||+|||+|+....... .......+||+.|||||++.+. .++.++|||||||+||||+||.+|+......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 9999999999987654322 1223346899999999999764 4678999999999999999998876543322
Q ss_pred cchhh---------HhhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 387 SLTLL---------GHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 387 ~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..... ........ .+..+|.+... ...+.+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchhcccccchHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11110 11111111 11122222111 22345677889999999999999999999999998854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=422.55 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=208.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
..|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999875 69999999998666666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 154 ~gg~L~~~l~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 154 EGGALTDIVTH----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp TTEEHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecC
Confidence 99999998842 34899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ....... ....
T Consensus 215 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i----~~~~ 286 (346)
T 4fih_A 215 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI----RDNL 286 (346)
T ss_dssp TTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH----HHSS
T ss_pred cCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH----HcCC
Confidence 9999775432 234457899999999999999999999999999999999999999864321 1111111 1110
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.+. ........+.+++.+||+.||++|||++|++++
T Consensus 287 -----~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 -----PPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -----CCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110 111223567789999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=427.29 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=201.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|.+.++||+|+||.||+|+.. +|+.||||++.... ....+.|.+|+.++++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 69999999997542 3345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 104 y~~gg~L~~~i~~-------------~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 104 YCEGGDLFKRINA-------------QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp CCTTCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEEC
T ss_pred CCCCCcHHHHHHH-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEc
Confidence 9999999999953 23345788999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ...... ..
T Consensus 168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i---~~- 239 (350)
T 4b9d_A 168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVLKI---IS- 239 (350)
T ss_dssp STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH---HH-
T ss_pred ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH---Hc-
Confidence 999999764321 2234568999999999999999999999999999999999999999753321 111111 11
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... +.. .......+.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~-----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 GSF-----PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC-----CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 011 11123567889999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=423.26 Aligned_cols=256 Identities=23% Similarity=0.270 Sum_probs=206.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+.|...++||+|+||.||+|+.. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999874 689999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ceEEec
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NPKISD 321 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~D 321 (496)
++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 133 ~gg~L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 133 EGGSLGQLIKQ---------------MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp TTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECC
T ss_pred CCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEee
Confidence 99999999953 346999999999999999999999998 99999999999999988 699999
Q ss_pred cccccccCCCcccc---ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 322 FGIARMFGGDELQS---NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 322 Fgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ....
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~i~--- 269 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--LKIA--- 269 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--HHHH---
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHH---
Confidence 99999875443222 223467999999999999999999999999999999999999999754433221 1111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
...... ..........+.+++.+||+.||++|||+.|++++|...+...
T Consensus 270 ~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 270 SEPPPI--------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp HSCCGG--------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCCCCc--------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 111000 0111222356778999999999999999999999998866543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=410.38 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=195.6
Q ss_pred CccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeEEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKILIY 239 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 239 (496)
...++||+|+||.||+|... +++.||||.+... .....+.|.+|+.++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44568999999999999874 5889999999644 23345679999999999999999999999875 34689999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~k 318 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+|
T Consensus 109 Ey~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp ECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEE
T ss_pred eCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEE
Confidence 99999999999953 346899999999999999999999875 3599999999999998 489999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+... .
T Consensus 173 l~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~----i 242 (290)
T 3fpq_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRR----V 242 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHH----H
T ss_pred EEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHH----H
Confidence 9999999864332 2345689999999998865 69999999999999999999999986432211 11111 1
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.. .+...... ...+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~----~~~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 243 TSGVK----PASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCC----CGGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCC----CCCCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 01111111 2357789999999999999999999763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-53 Score=423.28 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=208.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999874 68999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 231 ~gG~L~~~i~~----------------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 231 EGGALTDIVTH----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp TTEEHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCC
T ss_pred CCCcHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecC
Confidence 99999998842 34899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ....... ....
T Consensus 292 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i----~~~~ 363 (423)
T 4fie_A 292 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI----RDNL 363 (423)
T ss_dssp TTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH----HHSC
T ss_pred ccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH----HcCC
Confidence 9999775432 234557899999999999999999999999999999999999999864321 1111111 1110
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.+. ........+.+|+.+||+.||++|||+.|++++
T Consensus 364 -----~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 364 -----PPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----CCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110 111123567789999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=414.38 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=208.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+|+.. +|+.||||.+.+. .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999864 6899999999743 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 112 Ey~~gG~L~~~i~~---------------~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---------------IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp CCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred ecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEE
Confidence 99999999999953 346899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. ..+.....
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~---- 247 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKII---- 247 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH----
Confidence 999999987654444445667999999999999999999999999999999999999999974332 11111111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.... .+ +......+.+++.+||+.||++|||++|++
T Consensus 248 ~~~~------~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 248 KLEY------DF----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HTCC------CC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cCCC------CC----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1110 01 111234577899999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=398.11 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=189.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999864 68999999997542 334568999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||
T Consensus 93 Ey~-~g~L~~~l~~---------------~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl 153 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---------------RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 153 (275)
T ss_dssp ECC-CEEHHHHHHH---------------SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEE
T ss_pred eCC-CCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEE
Confidence 999 6899998853 346999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... ..+.....
T Consensus 154 ~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~--- 225 (275)
T 3hyh_A 154 ADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNIS--- 225 (275)
T ss_dssp CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH---
T ss_pred eecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH---
Confidence 9999998764332 2345689999999999998876 5799999999999999999999964321 11111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... .+ +......+.+++.+||+.||++|||++|++++
T Consensus 226 -~~~~------~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 226 -NGVY------TL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -HTCC------CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -cCCC------CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 01 01123467789999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=407.53 Aligned_cols=247 Identities=24% Similarity=0.298 Sum_probs=194.8
Q ss_pred cCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999762 46899999997532 2233468899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 104 vmEy~~gg~L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---------------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp EECCCTTCEEHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCE
T ss_pred EEEcCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCE
Confidence 9999999999999953 346899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .......
T Consensus 166 Kl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~-- 239 (304)
T 3ubd_A 166 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMIL-- 239 (304)
T ss_dssp EEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH--
T ss_pred EecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHH--
Confidence 999999998654322 2334578999999999999999999999999999999999999999753321 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM-----SEVVS 446 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 446 (496)
. .. ...| ......+.+++.+||+.||++|||+ +|+++
T Consensus 240 -~-~~---~~~p-------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 240 -K-AK---LGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -H-CC---CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -c-CC---CCCC-------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 11 0001 1123467789999999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=399.41 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=186.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC--------
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-------- 233 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 233 (496)
++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999864 689999999975433 33567999999999999999999999987654
Q ss_pred ----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 234 ----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 234 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
..++||||+++|+|.+++... ......++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NI 149 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR------------CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNI 149 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC------------CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc------------CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHe
Confidence 368999999999999999631 12234567778999999999999999998 99999999999
Q ss_pred EecCCCceEEeccccccccCCCcccc----------ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCC
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQS----------NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~ 379 (496)
|++.++.+||+|||+|+.+....... ..+..+||+.|||||++.+..|+.++|||||||++|||++ |
T Consensus 150 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---P 226 (299)
T 4g31_A 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226 (299)
T ss_dssp EECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---C
T ss_pred EECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---C
Confidence 99999999999999999875432211 1234579999999999999999999999999999999996 4
Q ss_pred CCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 380 TRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
|... ....... ....... .|.. .......+.+++.+||+.||++|||+.|++++
T Consensus 227 f~~~----~~~~~~~-~~~~~~~-----~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 227 FSTQ----MERVRTL-TDVRNLK-----FPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CSSH----HHHHHHH-HHHHTTC-----CCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCc----cHHHHHH-HHHhcCC-----CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4311 1111100 0001000 0111 11223345679999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=386.25 Aligned_cols=283 Identities=35% Similarity=0.590 Sum_probs=240.1
Q ss_pred HHHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 157 ASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 157 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++...+++|...+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455788999999999999999999998889999999988766666788999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|.+++... ......++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 112 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGS-----------DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177 (321)
T ss_dssp EEEECCTTCBTGGGSSSS-----------CCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCC
T ss_pred EEEEcCCCCcHHHHHhcc-----------CCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCC
Confidence 999999999999988531 122346999999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~~~~~ 395 (496)
+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .....+..
T Consensus 178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 99999999987543332233344578999999999999999999999999999999999999987654432 23333444
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.........+.+++.+...........+.+++.+||+.||++|||+.+|++.|+.++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4444555666777777667778888999999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=381.87 Aligned_cols=289 Identities=41% Similarity=0.668 Sum_probs=245.1
Q ss_pred eeeeCHHHHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeee
Q 040910 151 FIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCC 229 (496)
Q Consensus 151 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 229 (496)
+..+++.++....++|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456889999999999999999999999999999988899999999975432 2334789999999999999999999999
Q ss_pred eecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 230 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
.+.+..++||||+++|+|.+++... ......++|..+..++.|++.||+|||+...++|+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRER-----------PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCC-----------STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhc-----------cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 9999999999999999999999642 23445699999999999999999999998323399999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCC---CCC
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY---NID 386 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~---~~~ 386 (496)
|++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 999999999999999987653322 2233456999999999999999999999999999999999999998632 222
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
......+............+.+..+...........+.+++.+||+.||.+|||+.+|+++|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 33445555556666667777788877788888999999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=394.81 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=200.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee------cCe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE------QGE 234 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 234 (496)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999874 79999999997543 2334678899999999999999999998764 357
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.||||||++ |+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---------------~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~ 194 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---------------SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN 194 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---------------SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT
T ss_pred EEEEEeCCC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCC
Confidence 899999995 78988883 3457999999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCc--cccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 315 MNPKISDFGIARMFGGDE--LQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+.+||+|||+|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||....... ..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l 272 (398)
T 4b99_A 195 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QL 272 (398)
T ss_dssp CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HH
T ss_pred CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HH
Confidence 999999999999765332 22234567899999999998875 56999999999999999999999997543221 11
Q ss_pred Hhhhhhhccc--cccc------------ccCcccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDD--RAWK------------LLDPTLQ---NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~--~~~~------------~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.......... .... .+.+... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111000000 0000 0000000 00001113467889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=383.61 Aligned_cols=200 Identities=24% Similarity=0.347 Sum_probs=171.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 236 (496)
..+.|++.++||+|+||.||+|+.. +++.||||++.... ....+.+|++++..+ +|||||++++++.+.++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999753 46789999986543 346788999999999 6999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-C
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-M 315 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~ 315 (496)
+||||+++|+|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +
T Consensus 97 lvmE~~~g~~L~~~~~------------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp EEEECCCCCCHHHHHT------------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EEEeCCCcccHHHHHc------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCC
Confidence 9999999999998882 2889999999999999999999998 9999999999999877 7
Q ss_pred ceEEeccccccccCCCccc--------------------------cccccccccccccChhhhccC-CCCccccchhhhH
Q 040910 316 NPKISDFGIARMFGGDELQ--------------------------SNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGV 368 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gv 368 (496)
.+||+|||+|+........ ......+||+.|||||++.+. .++.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 9999999999865432110 112345799999999999876 5899999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 040910 369 LLLETLSSKKNTRFYN 384 (496)
Q Consensus 369 vl~elltg~~~~~~~~ 384 (496)
++|||++|+.||....
T Consensus 236 il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHHTCSSSSCCS
T ss_pred HHHHHHHCCCCCCCCC
Confidence 9999999999986433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=399.95 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=207.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++|.+.+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.+|+.++|||||++++++.+.+..+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999874 68999999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC--CceEEe
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD--MNPKIS 320 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~ 320 (496)
++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 237 ~gg~L~~~i~~--------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~ 299 (573)
T 3uto_A 237 SGGELFEKVAD--------------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 299 (573)
T ss_dssp CCCBHHHHHTC--------------TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred CCCcHHHHHHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEe
Confidence 99999998842 3356999999999999999999999998 9999999999999854 899999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+.+.... .....+||+.|||||++.+..|+.++|||||||++|||++|..||...... ........
T Consensus 300 DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~---- 370 (573)
T 3uto_A 300 DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS---- 370 (573)
T ss_dssp CCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT----
T ss_pred eccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHh----
Confidence 999999875432 234568999999999999999999999999999999999999998753321 11111110
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ... .+... ......+.+|+.+||+.||++|||+.|++++
T Consensus 371 ~~-~~~-~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 CD-WNM-DDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TC-CCC-CSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC-CCC-Ccccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 11111 1123457789999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=359.49 Aligned_cols=283 Identities=36% Similarity=0.541 Sum_probs=229.4
Q ss_pred ceeeeCHHHHHHHhcCCCcc------ccccccCCeeEEEEEecCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHhcC
Q 040910 150 WFIFFSLASISTATHNFSEE------NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKLHH 219 (496)
Q Consensus 150 ~~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H 219 (496)
.+..|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568999999999999887 8899999999999987 78999999986432 2335789999999999999
Q ss_pred CceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCe
Q 040910 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRV 299 (496)
Q Consensus 220 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 299 (496)
|||+++++++.+.+..++||||+++|+|.+++... .....++|..++.++.||+.||+|||+.+ |
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL------------DGTPPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG------------GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 99999999999999999999999999999998632 12346899999999999999999999998 9
Q ss_pred eecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCC
Q 040910 300 IHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379 (496)
Q Consensus 300 vH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~ 379 (496)
+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987654332223344578999999998865 588999999999999999999999
Q ss_pred CCCCCCCcchhhHhhhhhh-cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 380 TRFYNIDSLTLLGHAWNLW-KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
+.......... ....... ........+++.+ ..........+.+++..||+.+|.+|||+.+|+++|+++
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 234 VDEHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp BCTTBSSSBTT-HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccCcchHHHH-HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 87654332111 1111111 1112223333333 334566778899999999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=395.59 Aligned_cols=249 Identities=25% Similarity=0.304 Sum_probs=198.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHH---HHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNE---MILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
++|.+.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 6899999999643 12333444444 45556668999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
|||||+++|+|..+|.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.+|+
T Consensus 269 lVmEy~~GGdL~~~l~~---------------~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---------------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGH 330 (689)
T ss_dssp EEECCCCSCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSC
T ss_pred EEEecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCC
Confidence 99999999999999953 346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+|+.+.... ....+||+.|||||++.. ..|+.++|+|||||+||||++|..||........... ..
T Consensus 331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i--~~ 404 (689)
T 3v5w_A 331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DR 404 (689)
T ss_dssp EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH--HH
T ss_pred EEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HH
Confidence 9999999999765432 345689999999999974 5799999999999999999999999975433221111 00
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
.... .. . . .+......+.+++.+||+.||++|++ ++||+++
T Consensus 405 ~i~~-~~---~---~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 405 MTLT-MA---V---E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHH-CC---C---C----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hhcC-CC---C---C----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0000 00 0 0 11112356778999999999999998 6777653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=365.37 Aligned_cols=269 Identities=25% Similarity=0.411 Sum_probs=203.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
...+|.+.+.||+|+||.||+|+. +|+.||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456888899999999999999987 78999999997543 233467899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||
T Consensus 114 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 114 EYLSRGSLYRLLHKS------------GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp ECCTTCBHHHHHHST------------THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEE
T ss_pred ecCCCCcHHHHHhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEE
Confidence 999999999999531 12234899999999999999999999875 34999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .
T Consensus 181 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~--~ 254 (309)
T 3p86_A 181 CDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGF--K 254 (309)
T ss_dssp CCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHH--S
T ss_pred CCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh--c
Confidence 9999998654321 22334678999999999999999999999999999999999999986433211 1111100 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCC
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~ 460 (496)
... ... .......+.+++.+||+.||.+|||+.++++.|+..+....+|+.
T Consensus 255 -~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 255 -CKR-----LEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp -CCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred -CCC-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 000 011 111234678899999999999999999999999998766544443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.69 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=211.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|...+.||+|+||.||+|... +++.||+|.+........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888899999999999999874 5899999999766666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 89 IKGGTLRGIIKS--------------MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp CTTCBHHHHHHH--------------CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECC
T ss_pred cCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEee
Confidence 999999999963 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCcccc------------ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 322 FGIARMFGGDELQS------------NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 322 Fgla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
||+++......... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998765432211 111457999999999999999999999999999999999999887654332211
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
...... ...+... .......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 232 ~~~~~~---------~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 232 FGLNVR---------GFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp SSBCHH---------HHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhhhhh---------ccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 110000 0000000 111124577899999999999999999999999986443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=369.98 Aligned_cols=273 Identities=24% Similarity=0.376 Sum_probs=213.7
Q ss_pred hcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 232 (496)
.++|.+.+.||+|+||.||+|+.. ++..||||.++... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999763 34579999997543 23456899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCc-ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGF-DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+..++||||+++|+|.+++......... ...........+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999999764321100 00001112356899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+....... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999997765443334445567889999999999999999999999999999999 888886533221 1
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... ..... + .........+.+++.+||+.||.+||++.|+++.|+.++.
T Consensus 315 ~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 315 FKLL----KEGHR-----M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHH----HTTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----hcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11110 0 1111223567889999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.72 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=208.0
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999985 4689999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~ 158 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158 (297)
T ss_dssp CCTTCBHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred CCCCCCHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEe
Confidence 9999999999853 24889999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 159 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~- 230 (297)
T 3fxz_A 159 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIAT- 230 (297)
T ss_dssp CCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHH-
T ss_pred eCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-
Confidence 999998765432 223446799999999999999999999999999999999999999864322111 100000
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........+ ......+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 231 NGTPELQNP-------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HCSCCCSCG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCc-------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000011111 1123457789999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.67 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=208.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----eeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG----EKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l 237 (496)
..++|.+.+.||+|+||.||+|+. .++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 446889999999999999999987 58999999996543 23345667888999999999999999998754 4699
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc----------CCCCeeecCCCCC
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY----------SRLRVIHRDLKAS 307 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~ivH~Dlk~~ 307 (496)
||||+++|+|.+++.. ..++|..+..++.||+.||+|||+. + |+||||||+
T Consensus 100 v~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~ 160 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSK 160 (322)
T ss_dssp EEECCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGG
T ss_pred EEecCCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChH
Confidence 9999999999999953 2489999999999999999999988 6 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCC
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRF 382 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~ 382 (496)
|||++.++.+||+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987765443333445689999999999987 3566789999999999999999999875
Q ss_pred CCCCcchhhH----------hhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 383 YNIDSLTLLG----------HAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 383 ~~~~~~~~~~----------~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.......... ......... ...+.+... ........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4332211100 000000001 111111110 1223456789999999999999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.75 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=200.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|+..+.||+|+||.||+|+.. +++ .||+|.+... .....++|.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357888999999999999999864 344 4688888643 3355678999999999999999999999998764 78
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 93 ~v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EEEECCTTCBHHHHHHH--------------STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEEecCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCC
Confidence 99999999999999964 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||........ ....
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~- 232 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL- 232 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH-
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HHHH-
Confidence 99999999997765443333444567889999999999999999999999999999999 9998865432221 1111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.... .. .........+.+++.+||+.+|.+||++.+++++|+...
T Consensus 233 ---~~~~--~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 233 ---EKGE--RL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---HTTC--CC-------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---HcCC--CC-------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1010 00 111122356788999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=353.09 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=213.1
Q ss_pred eeCHHHHHHHhcC----------CCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc
Q 040910 153 FFSLASISTATHN----------FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN 221 (496)
Q Consensus 153 ~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n 221 (496)
.++..++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4667777777654 666789999999999999876 79999999998776677788999999999999999
Q ss_pred eeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 040910 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIH 301 (496)
Q Consensus 222 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 301 (496)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+|
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH 164 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----------------QVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 9999999999999999999999999999883 235899999999999999999999998 999
Q ss_pred cCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 302 RDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 302 ~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
|||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998765432 12334679999999999999999999999999999999999999986
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....... ... ..+.+.. .......+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~--~~~~~~~----~~~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 243 SDSP--VQAMKRL----RDS-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TSCH--HHHHHHH----HHS-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCH--HHHHHHH----hcC-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4321 1111111 000 1111100 11123457789999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=362.35 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=207.3
Q ss_pred hcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|... .+..||||.+... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356788899999999999999874 3446999999754 33345689999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 128 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--------------HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp EEECCTTCBHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EeeCCCCCcHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCE
Confidence 9999999999999952 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 318 KISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ......
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~- 267 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSV- 267 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH-
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH-
Confidence 9999999987654321 112233456788999999999999999999999999999999 99887543221 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
.... .. .........+.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus 268 ---~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 268 ---EEGY--RL-------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---HTTC--CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HcCC--CC-------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1010 00 01112235678899999999999999999999999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=373.72 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=209.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..++|.+.+.||+|+||.||+|+.. +++.||||.++.... ...+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999986 689999999875432 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 192 e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--------------EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp ECCTTCBHHHHHHH--------------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEE
Confidence 99999999999963 2235889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... ..
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~----~~ 328 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE----FV 328 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHH----HH
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HH
Confidence 99999987654332222233456788999999999999999999999999999998 88887643211 1111 11
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..+. ....+ ......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 329 ~~~~--~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 329 EKGG--RLPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HTTC--CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC--CCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111 11111 112356778999999999999999999999998863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=367.35 Aligned_cols=287 Identities=24% Similarity=0.354 Sum_probs=219.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ......+.+|++++.++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999862 23579999997543 23456789999999999 99999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.+..++||||+++|+|.+++........ ............+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976432111 000111123456999999999999999999999998 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~ 389 (496)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+...... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999997765443344455678899999999999999999999999999999999 88887643221 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchhh
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYV 466 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~~ 466 (496)
... ....... +.. .......+.+++.+||+.||++|||+.+|++.|+.++...+....+.+...
T Consensus 302 ~~~----~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 365 (382)
T 3tt0_A 302 LFK----LLKEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365 (382)
T ss_dssp HHH----HHHTTCC-----CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-------
T ss_pred HHH----HHHcCCC-----CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcc
Confidence 111 1111110 000 111235678899999999999999999999999998765555554444333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=360.74 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=206.4
Q ss_pred hcCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Cee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 235 (496)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.|.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788899999999999999984 36889999999876666667899999999999999999999998654 468
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 89 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~ 151 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK--------------HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENEN 151 (295)
T ss_dssp EEEEECCTTCBHHHHHHH--------------CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred EEEEEeCCCCCHHHHHHh--------------cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCC
Confidence 999999999999999964 2335899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-------
Q 040910 316 NPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS------- 387 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~------- 387 (496)
.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 999999999987654321 122333457888999999999999999999999999999999998875321110
Q ss_pred ---chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 388 ---LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 388 ---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
............... ...........+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CCTHHHHHHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhHHHHHHHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000000000000 01111223456888999999999999999999999999876554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=368.47 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=197.9
Q ss_pred hcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|+.. ++..||||.++... ....++|.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999875 46789999997542 3345689999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 124 v~e~~~~~sL~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--------------HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVC 186 (373)
T ss_dssp EEECCTTCBHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEeCCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCE
Confidence 9999999999999953 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 318 KISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++ |+.|+..... .......
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i- 263 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAV- 263 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHH-
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH-
Confidence 99999999876543211 11222345778999999999999999999999999999998 9988754321 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
... ............+.+++.+||+.||++||++.+|++.|+.++..
T Consensus 264 ---~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 ---DEG---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---HTT---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HcC---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 101 00111112345688899999999999999999999999986543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.33 Aligned_cols=266 Identities=28% Similarity=0.407 Sum_probs=210.7
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999853 4668999999654 234455789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPR--------PSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCC--------SSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSS
T ss_pred EEEEEeCCCCCHHHHHHhhccc--------cCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCC
Confidence 9999999999999999764321 123356899999999999999999999998 99999999999999555
Q ss_pred ---ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhh
Q 040910 316 ---NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ---~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~ 391 (496)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~ 296 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL 296 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 599999999986543333333444678999999999999999999999999999999998 88887643221 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
... ..... . .........+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 297 ~~i----~~~~~--~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFV----TSGGR--M-------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHH----HTTCC--C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH----HcCCC--C-------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 11110 0 01111234678899999999999999999999999876443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=348.18 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=210.4
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|...+.||+|+||.||+|...+++.||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35788889999999999999998888999999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 88 ~~~~L~~~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 88 EHGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp TTCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCT
T ss_pred CCCcHHHHHHh--------------cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccc
Confidence 99999999952 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ...
T Consensus 151 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~----~~~ 223 (269)
T 4hcu_A 151 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDI----STG 223 (269)
T ss_dssp TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH----HTT
T ss_pred ccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHH----hcC
Confidence 99987654321 22334566888999999999999999999999999999999 88887643221 111111 000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.....+. .....+.+++..||+.||++|||+.+++++|+++.
T Consensus 224 --~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 224 --FRLYKPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp --CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccCCCCC-------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0111111 11356788999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=348.20 Aligned_cols=261 Identities=26% Similarity=0.333 Sum_probs=202.3
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHH--hcCCceeeeeeeeeec----CeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAK--LHHRNLVRLFGCCIEQ----GEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~ 236 (496)
.++|.+.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56889999999999999999988 7899999998643 34567778888877 7999999999997653 4689
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCC
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH--------QYSRLRVIHRDLKASN 308 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlk~~N 308 (496)
+||||+++|+|.+++. ...+++..+++++.||+.||+||| +.+ |+||||||+|
T Consensus 83 lv~e~~~~g~L~~~l~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 143 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----------------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKN 143 (301)
T ss_dssp EEECCCTTCBHHHHHT----------------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGG
T ss_pred EehhhccCCCHHHHHh----------------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHh
Confidence 9999999999999993 235899999999999999999999 666 9999999999
Q ss_pred EEecCCCceEEeccccccccCCCccc--cccccccccccccChhhhccC------CCCccccchhhhHHHHHHHhC----
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLETLSS---- 376 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg---- 376 (496)
||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 144 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~ 223 (301)
T 3q4u_A 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223 (301)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCc
Confidence 99999999999999999866433221 112335799999999999876 556799999999999999999
Q ss_pred ------CCCCCCCCCCcchhhHhhhhhhcccccccccCcccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 377 ------KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQ-NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 377 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
+.||.............. ....... ..+... ..........+.+++.+||+.||++|||+.+|++.|+
T Consensus 224 ~~~~~~~~pf~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 224 GIVEDYKPPFYDVVPNDPSFEDMR-KVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCcchhhhh-HHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 666654332222111111 1111111 111111 1112345678899999999999999999999999998
Q ss_pred cc
Q 040910 450 NE 451 (496)
Q Consensus 450 ~~ 451 (496)
++
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 74
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=367.34 Aligned_cols=282 Identities=26% Similarity=0.354 Sum_probs=216.0
Q ss_pred eCHHHHHHHhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeee
Q 040910 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRL 225 (496)
Q Consensus 154 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 225 (496)
+.........++|.+.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455555678999999999999999999974 2457999999975432 3346799999999999 89999999
Q ss_pred eeeeeecC-eeEEEEEecCCCChhHHHhhcccCCCc--------------------------------------------
Q 040910 226 FGCCIEQG-EKILIYEYMPNKSLDFFLFDYKYSSGF-------------------------------------------- 260 (496)
Q Consensus 226 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------- 260 (496)
++++.+.+ ..++||||+++|+|.+++.........
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 489999999999999999764321000
Q ss_pred -------ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCcc
Q 040910 261 -------DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333 (496)
Q Consensus 261 -------~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~ 333 (496)
...........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 00000011334899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccccccCcccc
Q 040910 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQ 412 (496)
Q Consensus 334 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 412 (496)
........||..|+|||++.+..++.++||||||+++|||++ |..||......... .. ....... ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~----~~~~~~~--~~~---- 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CR----RLKEGTR--MRA---- 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-HH----HHHHTCC--CCC----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-HH----HHHcCCC--CCC----
Confidence 333445678999999999999999999999999999999998 99998654432211 11 1111110 000
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 413 NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 413 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.......+.+++..||+.||.+|||+.+|+++|+.++
T Consensus 318 ---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 ---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1112346788999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=353.38 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=204.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999875 789999999865432 334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 86 YCSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp CCTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCCCcHHHHHh---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEE
Confidence 999999988883 3445899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++.+.............||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+..
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---- 223 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---- 223 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----
Confidence 9999987654333333455689999999999988775 78999999999999999999999765443222221111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ...+ .......+.+++.+||+.||++|||+.|++++
T Consensus 224 -~~~--~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 -KKT--YLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TCT--TSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccc--cCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 0000 01123456789999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.22 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=204.6
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..+|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45789999999999999999987 57999999999754 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 94 e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl 155 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---------------HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155 (328)
T ss_dssp CCCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ECCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEE
Confidence 99999999999853 345889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCC-ccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+++...... ......||+.|+|||++.+..++ .++|||||||++|||++|+.||....... .....
T Consensus 156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i---- 226 (328)
T 3fe3_A 156 ADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRERV---- 226 (328)
T ss_dssp CSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----
T ss_pred eeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH----
Confidence 9999998765332 23456899999999999988775 79999999999999999999987533211 11111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.. . .+......+.+++.+||+.||.+|||++|++++
T Consensus 227 ~~~~~---~-------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 227 LRGKY---R-------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHCCC---C-------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HhCCC---C-------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00100 0 011123467789999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=351.75 Aligned_cols=265 Identities=19% Similarity=0.195 Sum_probs=211.3
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999986 4789999999875432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc----
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN---- 316 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---- 316 (496)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 86 LL-GPSLEDLFDL--------------CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTT
T ss_pred eC-CCCHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCc
Confidence 99 9999999963 1346999999999999999999999998 999999999999999887
Q ss_pred -eEEeccccccccCCCcccc-----ccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 317 -PKISDFGIARMFGGDELQS-----NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 317 -~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 9999999999765432211 1245689999999999999999999999999999999999999997654332211
Q ss_pred -hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCC
Q 040910 391 -LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPS 457 (496)
Q Consensus 391 -~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 457 (496)
...... ... ........... + .+.+++..||+.+|.+||++.+|++.|++.......
T Consensus 228 ~~~~i~~----~~~--~~~~~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 228 RYQKIGD----TKR--ATPIEVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHH----HHH--HSCHHHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHh----hhc--cCCHHHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 111100 000 00000000111 2 788899999999999999999999999986655443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=374.28 Aligned_cols=267 Identities=28% Similarity=0.433 Sum_probs=209.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788899999999999999999877889999997543 456789999999999999999999999876 678999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 260 ~~~gsL~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 260 MSKGSLLDFLKG-------------ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp CTTCBHHHHHSH-------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred hcCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECC
Confidence 999999999953 12345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... ..
T Consensus 324 fG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i----~~ 396 (452)
T 1fmk_A 324 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----ER 396 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HT
T ss_pred CccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hc
Confidence 999987653322 11223456789999999999999999999999999999999 8888764321 1111111 11
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPA 462 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~ 462 (496)
+ .+.. .+......+.+++.+||+.||++|||+++|++.|+......++..+|.
T Consensus 397 ~--~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 397 G--YRMP-------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449 (452)
T ss_dssp T--CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred C--CCCC-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence 1 0111 111223567889999999999999999999999999876665555543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=375.36 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=212.0
Q ss_pred HhcCCCccccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...+|.+.+.||+|+||.||+|.+.. +..||||.+.... ...++|.+|+.++++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568888999999999999999864 8899999997543 457889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 297 ~~~~g~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 360 (495)
T 1opk_A 297 FMTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVA 360 (495)
T ss_dssp CCTTCBHHHHHHH-------------SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEEC
T ss_pred ccCCCCHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEe
Confidence 9999999999964 22345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |..|+....... ..... .
T Consensus 361 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~----~ 433 (495)
T 1opk_A 361 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----E 433 (495)
T ss_dssp CTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHH----H
T ss_pred ecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----H
Confidence 9999997654322 22233456789999999999999999999999999999999 888876543221 11111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. .+. .........+.+++.+||+.||++|||+.+|++.|+..+.
T Consensus 434 ~~--~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 434 KD--YRM-------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TT--CCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred cC--CCC-------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11 011 1111223567889999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=374.48 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=211.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788899999999999999999888999999997543 45789999999999999999999999986 5678999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 264 ~~~g~L~~~l~~~-------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-------------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp CTTCBHHHHHHSH-------------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred cCCCcHHHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence 9999999999531 1235788999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++........ ......+|..|+|||++.+..++.++||||||+++|||++ |+.|+..... ........ .
T Consensus 328 FG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~----~ 400 (454)
T 1qcf_A 328 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALE----R 400 (454)
T ss_dssp TTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHH----H
T ss_pred CCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----c
Confidence 9999876543221 1223456789999999999999999999999999999999 9988864321 11111111 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
+ .....+ ......+.+++.+||+.||++|||+.+|++.|++.....
T Consensus 401 ~--~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 401 G--YRMPRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp T--CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred C--CCCCCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 111111 122356788999999999999999999999999975543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.64 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=210.1
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|.+.+.||+|+||.||+|+..++..||||.+.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788899999999999999999888899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 86 ~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 86 SNGCLLNYLRS--------------HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp TTCBHHHHHHH--------------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCT
T ss_pred CCCcHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccC
Confidence 99999999963 2335899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..... ...
T Consensus 149 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~----~~~ 221 (268)
T 3sxs_A 149 GMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKV----SQG 221 (268)
T ss_dssp TCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH----HTT
T ss_pred ccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHH----HcC
Confidence 999876544322 2233456778999999999999999999999999999999 888876433211 11110 000
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.....+.. ....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 222 --~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 222 --HRLYRPHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --CCCCCCTT-------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CCCCCCCc-------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01111111 1246788999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.11 Aligned_cols=267 Identities=24% Similarity=0.368 Sum_probs=196.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecCC----CEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNG----EEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
..++|.+.+.||+|+||.||+|..... ..||||.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456899999999999999999987543 27999999754 334467899999999999999999999999877655
Q ss_pred ------EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 236 ------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 236 ------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
++|+||+++|+|.+++...... .....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NI 168 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIG---------ENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC 168 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcc---------ccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceE
Confidence 9999999999999999653311 12235899999999999999999999998 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcc
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSL 388 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~ 388 (496)
|++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~- 247 (323)
T 3qup_A 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE- 247 (323)
T ss_dssp EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-
Confidence 999999999999999987755443333444567889999999999999999999999999999999 888876433221
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
..... ..... ..........+.+++.+||+.||.+|||+.++++.|++++..+
T Consensus 248 -~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 -IYNYL----IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHHH----HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHHH----hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 00100 0111122356788999999999999999999999999986654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.62 Aligned_cols=274 Identities=16% Similarity=0.220 Sum_probs=218.0
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999986 578999999986543 234688999999999 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc----
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN---- 316 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---- 316 (496)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 87 ~~-~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 87 LL-GPSLEDLLDL--------------CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred ec-CCCHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCC
Confidence 99 9999999963 2345899999999999999999999998 999999999999987776
Q ss_pred -eEEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-h
Q 040910 317 -PKISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-T 389 (496)
Q Consensus 317 -~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~ 389 (496)
+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 999999999876543221 123446799999999999999999999999999999999999999876443221 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchh
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~ 465 (496)
............. .+.+.. .....+.+++..||+.||++||++++|++.|++++..........+.|
T Consensus 229 ~~~~~~~~~~~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 229 KYERIGEKKQSTP-----LRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HHHHHHHHHHHSC-----HHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHHHHHhhccCcc-----HHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 1111100000000 001111 123567889999999999999999999999999887776665555555
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=361.31 Aligned_cols=276 Identities=25% Similarity=0.356 Sum_probs=210.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeee--ecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI--EQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 235 (496)
.++|.+.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46788899999999999999984 367899999998766566678999999999999999999999887 45578
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~ 164 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--------------RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred EEEEeecCCCCHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCC
Confidence 9999999999999999631 235899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+..............
T Consensus 165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 999999999987654322 1223345688899999999999999999999999999999999998753221100000000
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
..........+.+...............+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000000000111111111112233456889999999999999999999999999875543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=357.56 Aligned_cols=278 Identities=25% Similarity=0.377 Sum_probs=210.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578889999999999999999862 4568999999754 234457899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCc--------ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGF--------DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 305 (496)
..++||||+++|+|.+++......-.. ...........+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999753211000 00001112345899999999999999999999998 9999999
Q ss_pred CCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCC
Q 040910 306 ASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYN 384 (496)
Q Consensus 306 ~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~ 384 (496)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333233344567889999999999999999999999999999998 998886543
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
.... ..... .... .+ .........+.+++.+||+.||.+|||+.+++++|+..+...+
T Consensus 280 ~~~~-~~~~~----~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDAN-FYKLI----QNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHH-HHHHH----HTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHH-HHHHH----hcCC-----CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3221 11111 1110 00 0111123567889999999999999999999999998765443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.01 Aligned_cols=276 Identities=24% Similarity=0.370 Sum_probs=213.0
Q ss_pred HHhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
...++|.+.+.||+|+||.||+|+.. +++.||||.+..... ...+.|.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 35678999999999999999999874 347899999975432 33567999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccc---------cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMV---------TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
..++||||+++|+|.+++............ ........+++..++.++.||+.||+|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999764321110000 00112367999999999999999999999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFY 383 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~ 383 (496)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654433333445678999999999999999999999999999999999 88887643
Q ss_pred CCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
... .... ......... ........+.+++.+||+.||.+||++.+|++.|+++...
T Consensus 281 ~~~--~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 AHE--EVIY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CHH--HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ChH--HHHH----HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 211 1111 111111100 1112235678899999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.36 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|+.. +++.||||.+..... ...+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999864 688999999864432 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 90 ~e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---------------HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EECCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred EeCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 999999999999953 345899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 152 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHI 225 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHH
T ss_pred EEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHh
Confidence 999999987653321 223345799999999999999999999999999999999999999864332111 00101
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhccccC
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEVVSMIKNEIVN 454 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~ 454 (496)
.. .. +.............+.+++.+||+.||.+|| +++++.+.|+..+..
T Consensus 226 ~~-~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 226 QD-SV-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SS-CC-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hc-cC-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00 00 0111111122235678899999999999999 999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=347.03 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=208.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.+.||+|+||.||+++..++..||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 456788899999999999999999888899999997543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 101 MANGCLLNYLRE--------------MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp CTTCBHHHHHHC--------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECS
T ss_pred cCCCcHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcc
Confidence 999999999953 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... .
T Consensus 164 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~---~- 236 (283)
T 3gen_A 164 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIA---Q- 236 (283)
T ss_dssp TTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHH---T-
T ss_pred cccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHh---c-
Confidence 999987654322 22233456788999999999999999999999999999998 99888643321 1111110 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
. .....+. .....+.+++.+||+.+|.+|||+.++++.|++++.
T Consensus 237 ~--~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 237 G--LRLYRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp T--CCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c--cCCCCCC-------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0 0111111 112567889999999999999999999999988643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=344.89 Aligned_cols=274 Identities=21% Similarity=0.283 Sum_probs=213.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC--eeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG--EKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 238 (496)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999875 48999999997543 345678899999999999999999999998765 77999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe----cCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGD 314 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~ 314 (496)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.+
T Consensus 88 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEP------------SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (319)
T ss_dssp EECCTTCBHHHHHHSG------------GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSC
T ss_pred EeCCCCCCHHHHHHHh------------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCC
Confidence 9999999999999632 12234899999999999999999999998 9999999999999 888
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhc--------cCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL--------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+.+||+|||+++...... ......||..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 153 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 153 SVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp EEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred ceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 889999999998765432 223457999999999986 578899999999999999999999998654332
Q ss_pred cch--hhHhhhhhhcccccc---ccc--------CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 387 SLT--LLGHAWNLWKDDRAW---KLL--------DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 387 ~~~--~~~~~~~~~~~~~~~---~~~--------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
... ............... ... +..............+.+++.+||+.||++|||++|++++..+...
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111 111111000000000 000 0011123345667788899999999999999999999999998744
Q ss_pred C
Q 040910 454 N 454 (496)
Q Consensus 454 ~ 454 (496)
.
T Consensus 310 ~ 310 (319)
T 4euu_A 310 R 310 (319)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.37 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=202.0
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.++||+|+||.||+|+..+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467889999999999999999988899999999974422 234678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 100 ~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 100 FME-KDLKKVLDE--------------NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp CCS-EEHHHHHHT--------------CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCC-CCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEc
Confidence 997 578777752 2345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 162 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~ 237 (311)
T 3niz_A 162 DFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILG 237 (311)
T ss_dssp CCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHC
T ss_pred cCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHC
Confidence 999998764322 22344578999999999876 5689999999999999999999999875443321 111111000
Q ss_pred ccc----------------cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDR----------------AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~----------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .....+..............+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 000000000000011123467889999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.17 Aligned_cols=274 Identities=25% Similarity=0.378 Sum_probs=213.8
Q ss_pred HhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
..++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788899999999999999976 245789999997543 3345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcc---------cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFD---------MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~---------~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 305 (496)
.++||||+++|+|.+++.......... ..........+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 999999999999999997643211000 0000112345899999999999999999999998 9999999
Q ss_pred CCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCC
Q 040910 306 ASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYN 384 (496)
Q Consensus 306 ~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~ 384 (496)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987754433333344567889999999999999999999999999999999 998886443
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
... .... ...... + .........+.+++.+||+.||++||++.++++.|+.++.
T Consensus 258 ~~~--~~~~----~~~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PER--LFNL----LKTGHR-----M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGG--HHHH----HHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HHHH----hhcCCc-----C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 1111 111110 0 1111223567889999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=343.06 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=195.8
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|+..+.||+|+||.||+|.. .++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999987 58999999986542 23457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-----
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG----- 313 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~----- 313 (496)
|||+++++|.+++. ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~----------------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----------------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp EECCTTEEHHHHHT----------------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred EEcCCCCCHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccc
Confidence 99999999999883 245899999999999999999999987556899999999999986
Q ss_pred ---CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 314 ---DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 314 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
++.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 222 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-- 222 (271)
T ss_dssp CCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--
T ss_pred cccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 7789999999998654332 2235789999999999999999999999999999999999999864332111
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
. ........ .. .........+.+++.+||+.||.+|||+.|++++|+.
T Consensus 223 ~---~~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 A---YGVAMNKL-----AL----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp H---HHHHTSCC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred H---HhhhcCCC-----CC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 00000000 00 1111223567889999999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.70 Aligned_cols=276 Identities=26% Similarity=0.376 Sum_probs=214.1
Q ss_pred HhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788899999999999999975 3467999999975432 3457899999999999 9999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccc---cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMV---TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
..++||||+++|+|.+++............ ........+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 999999999999999999754321000000 00112346999999999999999999999998 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~ 389 (496)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987765433333344567889999999999999999999999999999999 8888865433221
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
..... ... .... ........+.+++.+||+.||.+|||+.+++++|++.+.+
T Consensus 257 ~~~~~----~~~--~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 FYKMI----KEG--FRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHH----HHT--CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHh----ccC--CCCC-------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111 000 0000 0111235678899999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=367.53 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=205.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-eeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG-EKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+|.+ .|+.||||.++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 346788889999999999999988 57899999997543 4578999999999999999999999987765 7899999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 268 ~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp CCTTCBHHHHHHHH-------------CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEEC
T ss_pred ecCCCcHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEe
Confidence 99999999999642 2234789999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++..... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..... .
T Consensus 332 DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i----~ 400 (450)
T 1k9a_A 332 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----E 400 (450)
T ss_dssp CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHH----H
T ss_pred eCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----H
Confidence 99999854322 122367889999999999999999999999999999998 998887543322 11111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.+. +.. .+......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 401 ~~~--~~~-------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 401 KGY--KMD-------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TTC--CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC--CCC-------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 111 11122356788999999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.71 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=204.7
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
..+.|.+.+.||+|+||.||++... +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467888999999999999999875 689999999975432 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~ 151 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---------------QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---------------TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCT
T ss_pred EEEEEEcCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCC
Confidence 999999999999999983 3456999999999999999999999998 9999999999999887
Q ss_pred C----ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 315 M----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 315 ~----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~ 226 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ET 226 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH
T ss_pred CCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 7 79999999998765432 234467999999999999999999999999999999999999998643221 11
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
..... ... ...++.... .....+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~i~----~~~--~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 LANIT----AVS--YDFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHH----TTC--CCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHH----hcC--CCCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 000 001111111 11245778999999999999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=354.59 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=203.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCE----EEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEE----VAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|...+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++.+++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888899999999999999864 4443 8888875433 334467788999999999999999999986 56789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--------------HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp EEEECCTTCBSHHHHHS--------------SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSC
T ss_pred EEEEeCCCCCHHHHHHH--------------ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCe
Confidence 99999999999999953 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||........ ....
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~- 230 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLL- 230 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHH-
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHH-
Confidence 99999999998765543344455678889999999999999999999999999999999 9999875433221 1111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... ....+.. ....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 231 ---~~~~--~~~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 231 ---EKGE--RLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---HTTC--BCCCCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---HcCC--CCCCCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1110 1111111 12346678899999999999999999999988643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.42 Aligned_cols=265 Identities=27% Similarity=0.461 Sum_probs=204.0
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|.+.+.||+|+||.||+|+. .++.||||.+... ...+.|.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 5678889999999999999987 5789999998643 345789999999999999999999999874 4799999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc-eEEecc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN-PKISDF 322 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DF 322 (496)
+|+|.+++... .....+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+||
T Consensus 83 ~~~L~~~l~~~------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 83 GGSLYNVLHGA------------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp TCBHHHHHHCS------------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCHHHHHhcc------------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 99999999631 22335788999999999999999999943234999999999999998886 799999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|++...... .....||..|+|||++.+..++.++||||||+++|||++|+.||........... +.... ..
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~~ 221 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHN-GT 221 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHT-TC
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhc-CC
Confidence 999865422 2334689999999999999999999999999999999999999875433221111 11111 10
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAF 463 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~ 463 (496)
.+.... .....+.+++.+||+.||.+|||+.++++.|+.+...++.+..|..
T Consensus 222 -----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 222 -----RPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp -----CCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred -----CCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 111111 1234677899999999999999999999999998776666555544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=358.24 Aligned_cols=283 Identities=16% Similarity=0.182 Sum_probs=212.4
Q ss_pred HhcCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCCccC-----------HHHHHHHHHHHHHhcCCceee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSGQG-----------VEEFKNEMILIAKLHHRNLVR 224 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 224 (496)
..++|.+.+.||+|+||.||+|.+.+ ++.||||.+....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999987543211 112233444555667999999
Q ss_pred eeeeeeec----CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCee
Q 040910 225 LFGCCIEQ----GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVI 300 (496)
Q Consensus 225 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 300 (496)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--------------NAKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 99999875 4589999999 9999999953 2356999999999999999999999998 99
Q ss_pred ecCCCCCCEEec--CCCceEEeccccccccCCCcccc-----ccccccccccccChhhhccCCCCccccchhhhHHHHHH
Q 040910 301 HRDLKASNVLLD--GDMNPKISDFGIARMFGGDELQS-----NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLET 373 (496)
Q Consensus 301 H~Dlk~~NIll~--~~~~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el 373 (496)
||||||+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 89999999999998765332111 11334599999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 374 LSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 374 ltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
++|+.||......... ....... .......++++.+.... ....+.+++..||+.+|.+||++.+|++.|++.+.
T Consensus 255 ~~g~~Pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 255 LTGHLPWEDNLKDPKY-VRDSKIR-YRENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHSCCTTGGGTTCHHH-HHHHHHH-HHHCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhCCCCccccccCHHH-HHHHHHH-hhhhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 9999999753332211 1111111 01122223322221111 13567788999999999999999999999999888
Q ss_pred CCCCCCCCcchhhh
Q 040910 454 NLPSPQQPAFSYVR 467 (496)
Q Consensus 454 ~~~~p~~~~~~~~~ 467 (496)
....+....+.|..
T Consensus 330 ~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 330 AIGSKDDGKLDLSV 343 (364)
T ss_dssp HTTCCCCCCCCC--
T ss_pred HcCCCcCCccceEe
Confidence 77777666666543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.97 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=206.2
Q ss_pred hcCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--Ce
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 234 (496)
.+.|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34578889999999999999984 36889999999744 334567899999999999999999999999877 56
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--------------NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 162 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--------------HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred EEEEEEeCCCCcHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCC
Confidence 8999999999999999953 2345899999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCC-------
Q 040910 315 MNPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID------- 386 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~------- 386 (496)
+.+||+|||++........ ........+|..|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 9999999999987754332 12234456888999999999999999999999999999999999875421100
Q ss_pred --cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 387 --SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 387 --~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
................ ...........+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000000000000 01111223356889999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=346.56 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=204.2
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||++... +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999875 589999999875432 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 90 ~lv~e~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---------------EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRN 151 (326)
T ss_dssp EEEEECCCSCBHHHHHT---------------TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSS
T ss_pred EEEEEcCCCCCHHHHHH---------------hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCC
Confidence 99999999999999984 2356899999999999999999999998 99999999999999887
Q ss_pred ----ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 316 ----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~ 226 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL 226 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH
T ss_pred CCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHH
Confidence 79999999998765332 233457999999999999999999999999999999999999998643211 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .. ....+.... .....+.+++.+||+.||++|||+.+++++
T Consensus 227 ~~~~~----~~--~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 227 ANVSA----VN--YEFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHH----TC--CCCCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHh----cC--CCcCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 00 000011101 112457789999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.42 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=204.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|...+.||+|+||.||+++.. +|+.||||.++.. .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999875 6899999999753 334567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 84 ~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---------------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EECCTTCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred EeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEE
Confidence 999999999999853 345889999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 146 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i---~ 218 (337)
T 1o6l_A 146 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELI---L 218 (337)
T ss_dssp ECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---H
T ss_pred EeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHH---H
Confidence 99999998643221 2234568999999999999999999999999999999999999998643211 111111 0
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
. .. . .. +......+.+++.+||+.||++|| +++|++++
T Consensus 219 ~-~~---~---~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 M-EE---I---RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp H-CC---C---CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred c-CC---C---CC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 00 0 00 111235677899999999999999 89999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=355.19 Aligned_cols=271 Identities=29% Similarity=0.370 Sum_probs=207.0
Q ss_pred CCccccccccCCeeEEEEEec-----CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEE
Q 040910 166 FSEENKLGEGGFGPVYKGKLL-----NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKIL 237 (496)
Q Consensus 166 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 237 (496)
|.+.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988652 678999999975432 3456799999999999999999999999874 57899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 113 v~e~~~~~~L~~~l~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----------------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp EECCCTTCBHHHHGGG----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEecccCCcHHHHHhh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCE
Confidence 9999999999999842 23899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+................
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 9999999997754322 122334567889999999999999999999999999999999999876422110000000000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
........+.+...............+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 00000011111111111112223457889999999999999999999999999865543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=355.66 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=197.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467889999999999999999875 57899999997542 23345678899999888 89999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 131 V~E~~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---------------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp EEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EEEcCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCE
Confidence 9999999999999853 345899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc---hhhHhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL---TLLGHA 394 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~---~~~~~~ 394 (496)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 193 kL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 193 KLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred EEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 99999999863322 1234456899999999999999999999999999999999999999964332111 000111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
........ . ..+......+.+++..||+.||.+||++
T Consensus 271 ~~~i~~~~---~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQVILEKQ---I-------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHCC---C-------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHhccc---c-------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11111110 0 0111123567789999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=353.34 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=199.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCE----EEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEE----VAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|.+.+.||+|+||.||+|... +++. ||+|.+... .....+.+.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467889999999999999999864 4443 588877543 3456788999999999999999999999998765 78
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 93 ~v~~~~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EEECCCSSCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEEecCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCC
Confidence 99999999999999964 2345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |..||........ ....
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~- 232 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL- 232 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH-
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHH-
Confidence 99999999987754433333344567889999999999999999999999999999999 9998865433221 1111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... .. .........+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 233 ---~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 ---EKGE--RL-------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---HTTC--CC-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---HcCC--CC-------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0010 00 0111123467889999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=351.27 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=197.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------- 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 233 (496)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999886 78999999997543 334578999999999999999999999986653
Q ss_pred --------------------------------------------------eeEEEEEecCCCChhHHHhhcccCCCcccc
Q 040910 234 --------------------------------------------------EKILIYEYMPNKSLDFFLFDYKYSSGFDMV 263 (496)
Q Consensus 234 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 263 (496)
..++||||+++|+|.+++...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------- 155 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--------- 155 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC---------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc---------
Confidence 279999999999999999632
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccc---------
Q 040910 264 TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ--------- 334 (496)
Q Consensus 264 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~--------- 334 (496)
......++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 156 ---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 156 ---CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp ---CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred ---cCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence 23344677789999999999999999998 999999999999999999999999999977543211
Q ss_pred -cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccc
Q 040910 335 -SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413 (496)
Q Consensus 335 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 413 (496)
.......||+.|+|||++.+..++.++||||||+++|||++|..|+.. ... ...... ....+
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~-~~~~~~-----~~~~~---- 292 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVR-IITDVR-----NLKFP---- 292 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHH-HHHHHH-----TTCCC----
T ss_pred cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHH-HHHHhh-----ccCCC----
Confidence 122345799999999999999999999999999999999998765321 000 000000 00001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 414 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.........+.+++.+||+.||++|||+.|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1112233456889999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=352.96 Aligned_cols=275 Identities=24% Similarity=0.366 Sum_probs=212.4
Q ss_pred HhcCCCccccccccCCeeEEEEEec--------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 231 (496)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578889999999999999999863 46789999997543 23456789999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcc-cccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFD-MVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.+..++||||+++|+|.+++.......... ..........+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 999999999999999999997543211000 0001112345899999999999999999999998 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcch
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLT 389 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~ 389 (496)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+...... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H
Confidence 99999999999999987765443333444567889999999999999999999999999999999 88887643211 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
..... ..... +. ........+.+++.+||+.+|.+|||+.++++.|+.++..
T Consensus 268 ~~~~~----~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 LFKLL----KEGHR-----MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHH----HHTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111 11110 00 1111235678899999999999999999999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.56 Aligned_cols=269 Identities=24% Similarity=0.378 Sum_probs=201.1
Q ss_pred HHhcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC-
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG- 233 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 233 (496)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35678889999999999999999764 24589999987542 234567999999999999999999999998765
Q ss_pred ----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 234 ----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 234 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
..++|+||+++|+|..++..... ......+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI 178 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRL---------ETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC 178 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTB---------TTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhh---------hcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence 34999999999999999864321 123456999999999999999999999998 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcc
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSL 388 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~ 388 (496)
|++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 257 (313)
T 3brb_A 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE- 257 (313)
T ss_dssp EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-
Confidence 999999999999999987654433333444567889999999999999999999999999999999 777776433221
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
...... .... +.. .......+.+++.+||+.||.+|||+.+++++|+.++..+|
T Consensus 258 -~~~~~~----~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 -MYDYLL----HGHR-----LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -HHHHHH----TTCC-----CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -HHHHHH----cCCC-----CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111110 0100 011 11123567889999999999999999999999999876665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.13 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=204.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|.+.+.||+|+||.||++... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999875 5789999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--CCceEE
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--DMNPKI 319 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl 319 (496)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 83 ~~g~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 83 ISGLDIFERINT--------------SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp CCCCBHHHHHTS--------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred CCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEE
Confidence 999999999842 2346899999999999999999999998 999999999999987 789999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|..||...... ........
T Consensus 146 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~--- 217 (321)
T 1tki_A 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMN--- 217 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH---
T ss_pred EECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHc---
Confidence 9999998775432 233467899999999999988999999999999999999999998643321 11111100
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ..++.... .....+.+++.+||+.||.+|||+.|++++
T Consensus 218 -~~~--~~~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 218 -AEY--TFDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -TCC--CCCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCC--CCChhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 00110001 123567889999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.50 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=209.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 346788899999999999999998888899999996543 456789999999999999999999999864 568999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 89 MENGSLVDFLKT-------------PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp CTTCBHHHHTTS-------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCCCCHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECC
Confidence 999999999842 11235899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ........ .
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~----~ 225 (279)
T 1qpc_A 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE----R 225 (279)
T ss_dssp CTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----T
T ss_pred CcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHHh----c
Confidence 9999876543221 2233456789999999999999999999999999999999 8888764321 11111110 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCC
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQ 459 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~ 459 (496)
. ..... .......+.+++..||+.||++|||+.++++.|++.........
T Consensus 226 ~--~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 226 G--YRMVR-------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp T--CCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred c--cCCCC-------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 0 00111 11123567889999999999999999999999998766544433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.00 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=193.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|+..++||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999886 789999999865322 2334556666666666 899999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+ +++|..++.. ....++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 136 ~e~~-~~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--------------WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp EECC-CCBHHHHHHH--------------HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEE
T ss_pred Eecc-CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 9999 7899988864 2345999999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... . +...
T Consensus 198 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~----~~~~ 264 (311)
T 3p1a_A 198 LGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G----WQQL 264 (311)
T ss_dssp ECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H----HHHH
T ss_pred EccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H----HHHH
Confidence 99999998765332 2334568999999998876 79999999999999999999977654211 0 1111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ...+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~----~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQG----YLPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTT----CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcc----CCCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 11111111 123567889999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=375.00 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=212.7
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
..++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 446788889999999999999999878889999997543 456789999999999999999999999876 678999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 343 ~~~gsL~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-------------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp CTTEEHHHHHSHH-------------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred hcCCcHHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcc
Confidence 9999999999531 2245889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++....... .......++..|+|||.+.+..++.++|||||||+||||++ |+.|+..... ....... ..
T Consensus 407 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i----~~ 479 (535)
T 2h8h_A 407 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----ER 479 (535)
T ss_dssp TTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHH----HT
T ss_pred cccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hc
Confidence 999987653321 11223456789999999999999999999999999999999 8888764321 1111111 11
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCC
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQ 460 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~ 460 (496)
+ .+.. ........+.+++.+||+.||++|||+.+|++.|+.......+..+
T Consensus 480 ~--~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 480 G--YRMP-------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp T--CCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred C--CCCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 1 0111 1112235678899999999999999999999999998665544433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.09 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=195.1
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..++|.+.++||+|+||.||+|+. ...||||.++... ....+.|.+|+.++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 356899999999999999999985 3469999997543 23456799999999999999999999965 456789999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 99 e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--------------SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp ECCCEEEHHHHHTT--------------C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEE
T ss_pred EecCCCcHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEE
Confidence 99999999999842 3456899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||+++...............||+.|+|||.+. +..++.++||||||+++|||++|+.||........ .....
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-- 238 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMV-- 238 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHH--
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHh--
Confidence 9999998665433233344567899999999987 66789999999999999999999999865332211 11111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..... .+.. ..........+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 239 --~~~~~----~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 --GRGSL----SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --HHTSC----CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --ccccc----Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11110 1110 01111223568889999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.79 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=196.1
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcC--CceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHH--RNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45788899999999999999998889999999987543 2345778999999999976 9999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+|
T Consensus 88 ~e-~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---------------KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp EC-CCSEEHHHHHHH---------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEE
T ss_pred Ee-CCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEE
Confidence 99 568999999953 346889999999999999999999998 99999999999997 67899
Q ss_pred EeccccccccCCCccccccccccccccccChhhhcc-----------CCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
|+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 999999987754433333445689999999999865 678999999999999999999999986422111
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
. ... ..+++.............+.+++.+||+.||.+|||+.|++++-
T Consensus 228 ~----~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 S----KLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp H----HHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred H----HHH---------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1 111 11111111111111124677899999999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=352.10 Aligned_cols=273 Identities=26% Similarity=0.382 Sum_probs=210.5
Q ss_pred HhcCCCccccccccCCeeEEEEEecC------CCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
..++|...+.||+|+||.||+|.... ...||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998642 24799999975432 3456799999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++|+|.+++........... ........+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDP-AFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 99999999999999999975321100000 00012346899999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........ ...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHH
Confidence 99999999999987644332223334567889999999999999999999999999999998 8888764432211 111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.. .... ....+. .....+.+++.+||+.||.+|||+.+|++.|++..
T Consensus 279 ~~----~~~~--~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 LV----KDGY--QMAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HH----HHTC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----hcCC--CCCCCC-------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11 1000 011111 11356788999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.63 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=199.0
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|.+.+.||+|+||.||+|+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999998789999999996443 23347788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 143 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--------------CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIAD 143 (288)
T ss_dssp CSE-EHHHHHHT--------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cCC-CHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeE
Confidence 974 89888852 2345889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............
T Consensus 144 fg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 219 (288)
T 1ob3_A 144 FGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGT 219 (288)
T ss_dssp TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred CccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCC
Confidence 99998764321 22334578999999999976 45899999999999999999999998653321 111111111000
Q ss_pred c--------ccccccCcccc-------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 D--------RAWKLLDPTLQ-------NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~--------~~~~~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ......++... ..........+.+++.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000111100 00111123567789999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=339.31 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=200.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999875 688999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~-~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp CCSE-EHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred cCCC-CHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 9975 55555532 2356899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++...... .......||..|+|||++.+.. ++.++|||||||++|||++|+.|+....... ...........
T Consensus 144 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~ 220 (292)
T 3o0g_A 144 NFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLG 220 (292)
T ss_dssp CCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHC
T ss_pred ecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhC
Confidence 999998764322 2234457899999999998766 8999999999999999999988854322211 11111111110
Q ss_pred cccc------ccccC---------ccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRA------WKLLD---------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~------~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....+ ..............+.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000 000001111234567789999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.69 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=203.0
Q ss_pred hcCCCccccccccCCeeEEEEEecC-C-------CEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-G-------EEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578888999999999999997643 3 4799999977666677889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--------------NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIRE 149 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--------------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEEC
T ss_pred CEEEEECCCCCCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecC
Confidence 9999999999999999963 2334889999999999999999999998 9999999999999988
Q ss_pred Cc--------eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 315 MN--------PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 315 ~~--------~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
+. +||+|||++...... ....+|..|+|||.+.+ ..++.++||||||+++|||++|..++.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 87 999999999765322 23457889999999987 7799999999999999999997655432211
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. ...... ..... +.+. ....+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 224 ~~-~~~~~~---~~~~~----~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 224 SQ-RKLQFY---EDRHQ----LPAP--------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HH-HHHHHH---HTTCC----CCCC--------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hH-HHHHHh---hccCC----CCCC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 111000 00000 0000 12346788999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.15 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=194.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--------------------------cCHHHHHHHHHHHH
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--------------------------QGVEEFKNEMILIA 215 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 215 (496)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367889999999999999999864 688999999865421 12356899999999
Q ss_pred HhcCCceeeeeeeeee--cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh
Q 040910 216 KLHHRNLVRLFGCCIE--QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ 293 (496)
Q Consensus 216 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 293 (496)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----------------~~~~~~~~~~~~~~~qi~~~l~~lH~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----------------TLKPLSEDQARFYFQDLIKGIEYLHY 155 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----------------CSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----------------hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999987 56899999999999997654 23468999999999999999999999
Q ss_pred cCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCC---CCccccchhhhHHH
Q 040910 294 YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLL 370 (496)
Q Consensus 294 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl 370 (496)
.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++||||||+++
T Consensus 156 ~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 156 QK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp TT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred CC---eeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 98 9999999999999999999999999998765432 1233457999999999998765 47889999999999
Q ss_pred HHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 371 LETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 371 ~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
|||++|+.||..... ....... ..... .. +. .......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~l~~g~~pf~~~~~--~~~~~~~----~~~~~-~~--~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 231 YCFVFGQCPFMDERI--MCLHSKI----KSQAL-EF--PD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHH----HHCCC-CC--CS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHCCCCCCCccH--HHHHHHH----hcccC-CC--CC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999864321 1111110 00000 00 00 0112356788999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.82 Aligned_cols=254 Identities=26% Similarity=0.522 Sum_probs=203.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccC-------HHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQG-------VEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999874 78999999986543221 267899999999999999999999987665
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.+
T Consensus 97 -~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--------------KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--------------TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCC
T ss_pred -eEEEEecCCCCHHHHHhc--------------ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEecc
Confidence 699999999999888852 3446999999999999999999999875 349999999999999887
Q ss_pred Cc-----eEEeccccccccCCCccccccccccccccccChhhhc--cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 315 MN-----PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL--HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 315 ~~-----~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
+. +||+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred CCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 76 99999999985432 233467899999999984 5567899999999999999999999987554433
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
......... . ...+.. .......+.+++.+||+.||.+|||+.++++.|++
T Consensus 236 ~~~~~~~~~----~----~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 236 IKFINMIRE----E----GLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHH----S----CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHhc----c----CCCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 222211111 0 011111 11223567889999999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=349.53 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
..++|.+.+.||+|+||.||++... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999874 68999999997543 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC---
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM--- 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~--- 315 (496)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 107 ~e~~~gg~L~~~l~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---------------AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp ECCCCSCBHHHHHT---------------TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTC
T ss_pred EecCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCC
Confidence 99999999999884 2356899999999999999999999998 99999999999998654
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .......
T Consensus 169 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i- 242 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQI- 242 (362)
T ss_dssp CEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH-
T ss_pred CEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH-
Confidence 59999999998765332 23346799999999999999999999999999999999999999864321 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ....+. .......+.+++.+||+.||++||++.+++++
T Consensus 243 ---~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 ---KAGAY-DYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---HHTCC-CCCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---HhCCC-CCCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00100 000010 01123467789999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.00 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=209.4
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|...+.||+|+||.||++...+++.||||.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35788889999999999999998888899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 86 ~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 86 EHGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp TTCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCT
T ss_pred CCCcHHHHHhh--------------CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccc
Confidence 99999999963 2345889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... ...
T Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i----~~~ 221 (267)
T 3t9t_A 149 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDI----STG 221 (267)
T ss_dssp TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTT
T ss_pred ccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHH----hcC
Confidence 99987653321 22233467889999999999999999999999999999999 8888764321 1111111 101
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.....+. .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 222 --~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 222 --FRLYKPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --CCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CcCCCCc-------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111111 12356788999999999999999999999998864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=352.30 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=199.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 236 (496)
..++|.+.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999875 5899999999753 234567788999999998 7999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 101 lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---------------SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence 99999999999999853 345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 163 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i-- 236 (353)
T 3txo_A 163 CKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAI-- 236 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH--
T ss_pred EEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHH--
Confidence 9999999998643221 2334568999999999999999999999999999999999999998753321 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM------SEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~ 446 (496)
.... ..-| ......+.+++.+||+.||.+||++ .++++
T Consensus 237 --~~~~---~~~p-------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 237 --LNDE---VVYP-------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --HHCC---CCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --HcCC---CCCC-------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0010 1111 1123457789999999999999998 67764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.40 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=211.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888999999999999999885 4789999999753 3446789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~L~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 90 FMTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp CCTTEEHHHHHHH-------------CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cCCCCcHHHHHHh-------------cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 9999999999964 23456899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|+........ .... .
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~----~ 226 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL----E 226 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH----H
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----h
Confidence 9999987654322 22334567889999999999999999999999999999999 8888765432211 1111 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. ... .........+.+++.+||+.||.+|||+.++++.|+....
T Consensus 227 ~~-----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 227 KD-----YRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-----CCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 00 000 1111223567889999999999999999999999988643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=351.18 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=203.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++.+++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367888999999999999999875 5889999998643 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~e~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---------------QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp ECCCTTEEHHHHHH---------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EecCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEE
Confidence 99999999999985 2346899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 156 L~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~- 231 (384)
T 4fr4_A 156 ITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT- 231 (384)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-
T ss_pred EeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-
Confidence 9999999876533 23345689999999999974 4689999999999999999999999875443322111100
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-MSEVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 446 (496)
..... . ..+......+.+++.+||+.||.+||+ +++|.+
T Consensus 232 --~~~~~---~-------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 --FETTV---V-------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --HHHCC---C-------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --Hhhcc---c-------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00000 0 011122356788999999999999998 777764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=348.03 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=204.2
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-----CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-----SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.+.|.+.+.||+|+||.||+|... +|+.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457888999999999999999874 6899999998632 2235678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|..++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA-----------DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH-----------HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSST
T ss_pred EEEeCCCCCCHHHHHHHhc-----------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCC
Confidence 9999999999988886422 12345889999999999999999999998 999999999999987655
Q ss_pred ---eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 317 ---PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 317 ---~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ......
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~ 243 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEG 243 (351)
T ss_dssp TCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHH
T ss_pred CCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHH
Confidence 9999999998765432 12334579999999999999999999999999999999999999986421 111111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ..... ...+.... .....+.+++.+||+.||++|||+.+++++
T Consensus 244 i----~~~~~--~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 I----IKGKY--KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp H----HHTCC--CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H----HcCCC--CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000 01111111 113567889999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.78 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=194.3
Q ss_pred hcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|.... +..||||.+.... ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998743 4579999987543 234567999999999999999999999984 567899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 93 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--------------RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp EEECCTTEEHHHHHHH--------------TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred EEecCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCE
Confidence 9999999999999953 2345899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 156 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i-- 230 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI-- 230 (281)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH--
T ss_pred EECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHH--
Confidence 99999999876543221 2233456789999999999999999999999999999997 888886433221 11111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..... +. ........+.+++.+||+.||++|||+.++++.|+.++
T Consensus 231 --~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 231 --ENGER-----LP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --HTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HcCCC-----CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00100 00 11122356778999999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.10 Aligned_cols=281 Identities=26% Similarity=0.357 Sum_probs=214.5
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFG 227 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~ 227 (496)
........++|.+.+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445668899999999999999999974 3467999999975432 3346789999999999 7999999999
Q ss_pred eeeecC-eeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 040910 228 CCIEQG-EKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLK 305 (496)
Q Consensus 228 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 305 (496)
++...+ ..++||||+++|+|.+++........ ............+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988765 58999999999999999975321100 000001112344899999999999999999999998 9999999
Q ss_pred CCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCC
Q 040910 306 ASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYN 384 (496)
Q Consensus 306 ~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~ 384 (496)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433333344567899999999999999999999999999999998 998886543
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..... .... ..... ... .......+.+++.+||+.||.+|||+.+|+++|+.++.
T Consensus 256 ~~~~~-~~~~----~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 256 IDEEF-CRRL----KEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CSHHH-HHHH----HHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHH-HHHh----ccCcc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 32211 1111 11110 000 11123467889999999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=349.61 Aligned_cols=254 Identities=23% Similarity=0.258 Sum_probs=194.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468899999999999999999875 68999999997543 334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc--eE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN--PK 318 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~k 318 (496)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 97 ~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 97 YASGGELYERICN---------------AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp CCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEE
T ss_pred eCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEE
Confidence 9999999999853 345899999999999999999999998 999999999999987776 99
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCcc-ccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIK-SDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... .......
T Consensus 159 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~ 234 (361)
T 3uc3_A 159 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRI 234 (361)
T ss_dssp ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHH
T ss_pred EeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHH
Confidence 9999999854322 22334579999999999998887666 89999999999999999998754332211 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ... .. .........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~-~~~-~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LS-VKY-SI-------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HT-TCC-CC-------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hc-CCC-CC-------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 000 00 0000123567889999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.59 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=203.5
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
..++|.+.+.||+|+||.||++.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457889999999999999999976 468999999987543 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec---CCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDM 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~ 315 (496)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++
T Consensus 89 ~E~~~gg~L~~~i~~---------------~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---------------REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp ECCCBCCBHHHHHHH---------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTC
T ss_pred EEeCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCC
Confidence 999999999998853 345899999999999999999999998 99999999999998 567
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .......
T Consensus 151 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i- 225 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQI- 225 (444)
T ss_dssp CEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH-
T ss_pred cEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHH-
Confidence 89999999998765432 223446899999999999999999999999999999999999999864321 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.. ....+. .......+.+++.+||+.||.+|||+.|++++
T Consensus 226 ---~~~~~-~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 226 ---KAGAY-DFPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---HHTCC-CCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HhCCC-CCCccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10100 011110 11123567789999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=341.23 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=208.4
Q ss_pred cCCCccc-cccccCCeeEEEEEec---CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEEN-KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+ .||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999753 57789999997643 33467899999999999999999999999 55678999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 88 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp EECCTTEEHHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEE
T ss_pred EEeCCCCCHHHHHHh--------------CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEE
Confidence 999999999999842 3346899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i-- 226 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI-- 226 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHH--
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH--
Confidence 999999987754322 122233456889999999998999999999999999999998 99988643321 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSP 458 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p 458 (496)
..... +. ........+.+++..||+.+|++||++.++++.|+.++.....+
T Consensus 227 --~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 227 --EQGKR-----ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp --HTTCC-----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred --hcCCc-----CC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 11110 01 11122356788999999999999999999999999876554433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=345.03 Aligned_cols=264 Identities=20% Similarity=0.242 Sum_probs=206.3
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 236 (496)
..++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999987 5789999999976655667789999999999999999999999873 34789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+|+||+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLK-----------DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEEECCTTCBHHHHHHHHH-----------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred EEEEeCCCCcHHHHHHHHH-----------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCC
Confidence 9999999999999996532 23456899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccc-------cccccccccccccChhhhccCC---CCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 317 PKISDFGIARMFGGDELQ-------SNMNRIVGTYGYMSPEYALHGL---FSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+||+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 999999998765321110 0112345799999999987654 689999999999999999999998532111
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
........ .. .... .........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 253 ~~~~~~~~----~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 253 GDSVALAV----QN--QLSI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp TSCHHHHH----HC--C--C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred cchhhHHh----hc--cCCC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11111000 00 0000 011122356888999999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=339.48 Aligned_cols=261 Identities=27% Similarity=0.347 Sum_probs=205.2
Q ss_pred CCCccccccccCCeeEEEEEecC-C---CEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee-EEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN-G---EEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK-ILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lv 238 (496)
.|...+.||+|+||.||+|...+ + ..||||.+..... ...+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45556899999999999998643 2 2799999975432 3457889999999999999999999999877655 999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--------------PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp ECCCTTCBHHHHHHC--------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred EecccCCCHHHHHhc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 999999999999952 3456899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccc--cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..........
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~ 243 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQ 243 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHT
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhc
Confidence 9999999876543321 223345778999999999999999999999999999999997666432221 1111111110
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
.. ... ........+.+++.+||+.||.+|||+.++++.|++++..+.
T Consensus 244 ----~~--~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 244 ----GR--RLP-------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ----TC--CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ----CC--CCC-------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00 000 011123467889999999999999999999999999766554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.84 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=200.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999875 58899999997543 22345688999999998 899999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 89 ~e~~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---------------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp ECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred EeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEE
Confidence 999999999999853 245899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc---hhhHhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL---TLLGHAW 395 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~---~~~~~~~ 395 (496)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 151 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 228 (345)
T 3a8x_A 151 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228 (345)
T ss_dssp ECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH
T ss_pred EEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH
Confidence 99999998643221 223456899999999999999999999999999999999999999864322110 0001111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM------SEVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~ 446 (496)
........ . .+......+.+++.+||+.||.+||++ .++++
T Consensus 229 ~~i~~~~~------~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 229 QVILEKQI------R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHHHCCC------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHHHcCCC------C----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11111100 0 111123567789999999999999995 56654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=346.41 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=201.5
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+|.+.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999987 57899999998643 2233467899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 89 E~~-~g~l~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl 149 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---------------KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149 (336)
T ss_dssp CCC-CEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEE
T ss_pred ECC-CCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEE
Confidence 999 7899888853 345899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..........
T Consensus 150 ~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------- 218 (336)
T 3h4j_B 150 ADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------- 218 (336)
T ss_dssp CCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------
T ss_pred EEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------
Confidence 9999998765432 2344679999999999988776 789999999999999999999987533221100
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ .+......+.+++.+||+.||.+|||++|++++
T Consensus 219 -~i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 -KVNSCVYV-------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCSSCCC-------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHHcCCCC-------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000000 011123467789999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=355.65 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=196.8
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhc--CCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv 238 (496)
..+|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 34689999999999999999998889999999987543 334578999999999996 59999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+|
T Consensus 135 ~E-~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---------------KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EE-CCSEEHHHHHHH---------------CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEE
T ss_pred Ee-cCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEE
Confidence 99 568999999953 235888899999999999999999998 99999999999995 58999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhcc-----------CCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
|+|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987754433333345689999999999875 468999999999999999999999986432111
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..... ++++.............+.+++.+||+.||.+|||+.|++++-
T Consensus 275 ----~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 ----SKLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ----HHHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----HHHHH---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111 1111111011111134677899999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.86 Aligned_cols=270 Identities=18% Similarity=0.238 Sum_probs=204.8
Q ss_pred HhcCCCcccccccc--CCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEG--GFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
..++|.+.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45678999999999 99999999875 68999999997543 233567888999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 103 lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICT-------------HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGK 166 (389)
T ss_dssp EEEECCTTCBHHHHHHH-------------TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred EEEEccCCCCHHHHHhh-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 99999999999999964 22345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCc-----cccccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 317 PKISDFGIARMFGGDE-----LQSNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
+||+|||.+....... .........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999987543211 1111233478999999999987 67999999999999999999999998754332211
Q ss_pred hhHhhhhh---hc-----ccc-------------ccccc---Cccc------cccCCHHHHHHHHHHHHHhcccCCCCCC
Q 040910 390 LLGHAWNL---WK-----DDR-------------AWKLL---DPTL------QNEALYPMVKRYIKVALLCVQENAADRP 439 (496)
Q Consensus 390 ~~~~~~~~---~~-----~~~-------------~~~~~---d~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RP 439 (496)
........ .. ... ..... .+.. ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 326 (389)
T 3gni_B 247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326 (389)
T ss_dssp HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence 10000000 00 000 00000 0000 0001112235688999999999999999
Q ss_pred CHHHHHHH
Q 040910 440 TMSEVVSM 447 (496)
Q Consensus 440 s~~evl~~ 447 (496)
|+.|++++
T Consensus 327 ta~ell~h 334 (389)
T 3gni_B 327 SASTLLNH 334 (389)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.13 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=191.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999864 58999999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|++ |+|.+++...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~-~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG---------NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp CCC-CBHHHHHHHHHSS---------SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred ecC-CCHHHHHHhcccc---------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 997 6999998653211 22345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~ 226 (317)
T 2pmi_A 151 DFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMG 226 (317)
T ss_dssp CCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred cCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhC
Confidence 999998764321 22334578999999999986 468999999999999999999999987543211 1111110000
Q ss_pred c--cccc----c--ccCccc------------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 D--DRAW----K--LLDPTL------------QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~--~~~~----~--~~d~~~------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ...+ . ...+.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000 0 000000 000001123468899999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=340.42 Aligned_cols=270 Identities=25% Similarity=0.312 Sum_probs=202.1
Q ss_pred HHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh--cCCceeeeeeeeeec----C
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL--HHRNLVRLFGCCIEQ----G 233 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~ 233 (496)
....++|.+.+.||+|+||.||+|+. .++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34557899999999999999999987 5899999998643 234555666666555 899999999999887 6
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS-----RLRVIHRDLKASN 308 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlk~~N 308 (496)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred ceEEEEeccCCCcHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence 89999999999999999952 24899999999999999999999871 1129999999999
Q ss_pred EEecCCCceEEeccccccccCCCcccc--ccccccccccccChhhhccCCCCcc------ccchhhhHHHHHHHhCC---
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQS--NMNRIVGTYGYMSPEYALHGLFSIK------SDVFSFGVLLLETLSSK--- 377 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gvvl~elltg~--- 377 (496)
||++.++.+||+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|.
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999999998765432211 1234579999999999988776665 99999999999999994
Q ss_pred -------CCCCCCCCCcchhhHhhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 040910 378 -------KNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449 (496)
Q Consensus 378 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 449 (496)
.|+............ ........ ...+..... ........+.+++.+||+.||.+|||+.+|+++|+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYED-MREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHH-HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchhh-hHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 444332222111110 11101001 111111110 11255677899999999999999999999999999
Q ss_pred ccccC
Q 040910 450 NEIVN 454 (496)
Q Consensus 450 ~~~~~ 454 (496)
.+...
T Consensus 328 ~l~~~ 332 (337)
T 3mdy_A 328 KMSES 332 (337)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 87543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.83 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=205.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999875 6889999999765545556899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--CCceEE
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--DMNPKI 319 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl 319 (496)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 130 ~~gg~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 130 LSGGELFDRIAA--------------EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp CCCCBHHHHTTC--------------TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEE
T ss_pred CCCCcHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEE
Confidence 999999988842 2346899999999999999999999998 999999999999974 578999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .........
T Consensus 193 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~--- 264 (387)
T 1kob_A 193 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKR--- 264 (387)
T ss_dssp CCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHH---
T ss_pred EecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHh---
Confidence 9999998765432 22345789999999999999999999999999999999999999864321 111111110
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. . ..++.. .......+.+++.+||+.||.+|||+.+++++
T Consensus 265 -~~-~-~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 -CD-W-EFDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CC-C-CCCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CC-C-CCCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0 011111 11223567889999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.53 Aligned_cols=276 Identities=13% Similarity=0.144 Sum_probs=212.3
Q ss_pred hcCCCccccccccCCeeEEEEEecC---------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceee---------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN---------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR--------- 224 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 224 (496)
.++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678899999999999999998753 789999998753 36789999999999999998
Q ss_pred ------eeeeeee-cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 040910 225 ------LFGCCIE-QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRL 297 (496)
Q Consensus 225 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 297 (496)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 179 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-------------PKHVLSERSVLQVACRLLDALEFLHENE-- 179 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-------------CcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5667765 67889999999 99999999641 2356999999999999999999999998
Q ss_pred CeeecCCCCCCEEecCCC--ceEEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHH
Q 040910 298 RVIHRDLKASNVLLDGDM--NPKISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370 (496)
Q Consensus 298 ~ivH~Dlk~~NIll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl 370 (496)
|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++
T Consensus 180 -ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp -CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 99999999999999998 8999999999876533211 112345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 371 LETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 371 ~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
|||++|+.||.................. .....+.++...... ....+.+++.+||+.||++||++++|++.|++
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFV--DKPGPFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHH--HSCCCEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhcc--CChhhhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 9999999998765433222221111110 111111111111011 12567889999999999999999999999999
Q ss_pred cccCCCCCCCCcchh
Q 040910 451 EIVNLPSPQQPAFSY 465 (496)
Q Consensus 451 ~~~~~~~p~~~~~~~ 465 (496)
++..........+.|
T Consensus 334 ~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 334 LLQDLRVSPYDPIGL 348 (352)
T ss_dssp HHHHTTCCTTSCCCC
T ss_pred HHHhcCCCcCccccC
Confidence 877665544433433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.42 Aligned_cols=275 Identities=19% Similarity=0.230 Sum_probs=213.1
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeee-eecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC-IEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|+.++.+++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56889999999999999999986 5789999999875433 24689999999999988877766665 56678899999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ 317 (496)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 86 ~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCE
T ss_pred ec-CCCHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeE
Confidence 99 9999999953 2345899999999999999999999998 9999999999999 588999
Q ss_pred EEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc-chhh
Q 040910 318 KISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-LTLL 391 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~-~~~~ 391 (496)
||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 99999999876543321 11244679999999999999999999999999999999999999987643321 1111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchhh
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYV 466 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~~ 466 (496)
...... .. ....+.+... ....+.+++.+||+.||.+|||+.+|++.|+.+......+..-.+.|.
T Consensus 228 ~~~~~~----~~-~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 228 ERISEK----KM-STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHHHH----HH-HSCHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred hhhccc----cc-CCchHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 111000 00 0000001111 135678899999999999999999999999998776655544444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=334.17 Aligned_cols=276 Identities=19% Similarity=0.236 Sum_probs=208.9
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeee-eecCeeEEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC-IEQGEKILI 238 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv 238 (496)
...++|.+.+.||+|+||.||+|+. .+++.||||.+...... ..+.+|+.++.+++|++++..++++ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999986 57889999987654322 4578899999999988877777665 566788999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDM 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~ 315 (496)
|||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 84 ~e~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF--------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp EECC-CCBHHHHHHH--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTT
T ss_pred EEcc-CCCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCC
Confidence 9999 9999999853 2345899999999999999999999998 9999999999999 7899
Q ss_pred ceEEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-h
Q 040910 316 NPKISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-T 389 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~ 389 (496)
.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .
T Consensus 146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 9999999999876543221 122346789999999999999999999999999999999999999976443221 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchh
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~ 465 (496)
........ .. ....+..... ....+.+++..||+.||++|||+++|++.|++.+.....+..-.+.|
T Consensus 226 ~~~~~~~~----~~-~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 226 KYERISEK----KM-STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp HHHHHHHH----HH-HSCHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred hhhhhhcc----cc-cchhhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 11111000 00 0000000011 13567889999999999999999999999999876655544333333
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.07 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=203.4
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec--CeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ--GEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|+. +++.||||.+.... ....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35788899999999999999998 58999999997543 23456799999999999999999999999887 788999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ .+++||||||+|||++.++.++
T Consensus 88 ~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE-------------GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp EECCTTCBHHHHHHS-------------CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEE
T ss_pred ecccCCCcHHHHHhh-------------cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCccee
Confidence 999999999999953 22336899999999999999999999864 3499999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCc---cccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSI---KSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
|+|||++..... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ..
T Consensus 154 l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~--- 221 (271)
T 3kmu_A 154 ISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--GM--- 221 (271)
T ss_dssp EEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--HH---
T ss_pred EEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--HH---
Confidence 999998764322 2346899999999998765554 79999999999999999999864322111 11
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
...... ..+.. .......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 222 ~~~~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 222 KVALEG-----LRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHSC-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHhcC-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111 11111 1112356788999999999999999999999998853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=347.33 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=188.7
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567889999999999999999885 57899999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---CCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~ 317 (496)
|+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 129 ~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 129 LVTGGELFDRIV---------------EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp CCCSCBHHHHHT---------------TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCE
T ss_pred eCCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCE
Confidence 999999999984 2345899999999999999999999998 999999999999975 8899
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .....
T Consensus 191 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~i--- 263 (349)
T 2w4o_A 191 KIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFRRI--- 263 (349)
T ss_dssp EECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHHHH---
T ss_pred EEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHHHH---
Confidence 999999998764322 22346789999999999999999999999999999999999999864332211 11111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ....+ ........+.+++.+||+.||++|||+.+++++
T Consensus 264 -~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 264 -LNCEY-YFISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -HTTCC-CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HhCCC-ccCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01111 111223567889999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=352.92 Aligned_cols=260 Identities=30% Similarity=0.435 Sum_probs=194.9
Q ss_pred CCCccccccccCCeeEEEEEecC--C--CEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeee-cCeeEEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLN--G--EEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-QGEKILI 238 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv 238 (496)
.|...+.||+|+||.||+|.+.+ + ..||||.+.... ....+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 45667899999999999998642 2 368999987543 3446789999999999999999999998765 4578999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 170 ~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~k 232 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--------------ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVK 232 (373)
T ss_dssp EECCTTCBHHHHHHC--------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred EECCCCCCHHHHHhh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEE
Confidence 999999999999952 2345889999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCcccc--ccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 319 ISDFGIARMFGGDELQS--NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
|+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+........ .....
T Consensus 233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~ 310 (373)
T 3c1x_A 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL 310 (373)
T ss_dssp ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHH
T ss_pred EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHH
Confidence 99999998764332211 2233467889999999999999999999999999999999 5556554332221 11110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
... ....+. .....+.+++.+||+.||++|||+.++++.|+.++..+.
T Consensus 311 ----~~~--~~~~p~-------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 311 ----QGR--RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----TTC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----cCC--CCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011 111111 123467889999999999999999999999999766554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.78 Aligned_cols=264 Identities=17% Similarity=0.198 Sum_probs=198.5
Q ss_pred hcCCCccccccccCCeeEEEEEec----CCCEEEEEEeccCCcc-----------CHHHHHHHHHHHHHhcCCceeeeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNKSGQ-----------GVEEFKNEMILIAKLHHRNLVRLFG 227 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~ 227 (496)
.++|.+.+.||+|+||.||+|... ++..||||.+...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467888999999999999999875 5789999998754321 1234667888888899999999999
Q ss_pred eeee----cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040910 228 CCIE----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRD 303 (496)
Q Consensus 228 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 303 (496)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 176 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---------------NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGD 176 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---------------GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 9988 67899999999 9999999842 236899999999999999999999998 99999
Q ss_pred CCCCCEEecCCC--ceEEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhC
Q 040910 304 LKASNVLLDGDM--NPKISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS 376 (496)
Q Consensus 304 lk~~NIll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg 376 (496)
|||+|||++.++ .+||+|||+++.+...... .......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999887 9999999999876432211 112345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 377 KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
+.||................ .. ..+.+.+... ........+.+++..||+.||++||++.+|++.|++.
T Consensus 257 ~~pf~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQTAKTN-LL-----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp SCTTGGGTTCHHHHHHHHHH-HH-----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCCccccccccHHHHHHHHh-hc-----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 99986433222111111100 00 0011100000 0001234688899999999999999999999999885
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=348.08 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=203.4
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 235 (496)
...++|.+.+.||+|+||.||+|+.. +|+.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35678999999999999999999875 58899999997532 34567788999999987 999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 94 ~lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---------------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 155 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred EEEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCC
Confidence 999999999999999853 345899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i- 230 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSI- 230 (345)
T ss_dssp CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-
T ss_pred CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-
Confidence 99999999998643221 2234568999999999999999999999999999999999999998643321 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS-EVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 446 (496)
.... +.. +......+.+++.+||+.||++||++. +|++
T Consensus 231 ---~~~~------~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 231 ---RMDN------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---HHCC------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---HhCC------CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0010 011 111235677899999999999999997 6653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.42 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=195.7
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
.+.||+|+||.||+|... +|+.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999874 6899999999876555667899999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe--cCCCceEEeccccc
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL--DGDMNPKISDFGIA 325 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DFgla 325 (496)
.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 174 ~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 174 FDRIID--------------ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp HHHHHH--------------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred HHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 998853 2345889999999999999999999998 9999999999999 67789999999999
Q ss_pred cccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccccc
Q 040910 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWK 405 (496)
Q Consensus 326 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (496)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ . ...
T Consensus 237 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~---~--~~~ 306 (373)
T 2x4f_A 237 RRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILA---C--RWD 306 (373)
T ss_dssp EECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH---T--CCC
T ss_pred eecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh---c--cCC
Confidence 9765432 223357999999999999999999999999999999999999998643321 11111100 0 000
Q ss_pred ccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 406 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... ... ......+.+++.+||+.||.+|||+.|+++
T Consensus 307 ~~~-~~~----~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 LED-EEF----QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCS-GGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCh-hhh----ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 111 112356788999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.22 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=199.4
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC-----ccCHHHHHHHHHHHHHhc---CCceeeeeeeeeec
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS-----GQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 232 (496)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 468999999986432 122356778888887775 99999999999876
Q ss_pred C-----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 233 G-----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 233 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
. ..++||||+. |+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~ 149 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK-------------APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPE 149 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT-------------CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 5 5799999996 699999853 22344899999999999999999999998 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
|||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 150 Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 150 NILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp TEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred HEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999876432 22345678999999999999999999999999999999999999986533221
Q ss_pred chhhHhhhhhhcccccc------c----ccCcc---ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 388 LTLLGHAWNLWKDDRAW------K----LLDPT---LQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~------~----~~d~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
............... . ...+. ............+.+++.+||+.||++|||+.|++++
T Consensus 227 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 227 --QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp --HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111110000000 0 00000 0000011223567889999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=342.55 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=203.0
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+++.. +|+.||||.+... .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999875 6899999999753 2345678889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 e~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL 147 (318)
T 1fot_A 86 DYIEGGELFSLLRK---------------SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI 147 (318)
T ss_dssp CCCCSCBHHHHHHH---------------TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEE
T ss_pred eCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEE
Confidence 99999999999953 345889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...
T Consensus 148 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~---i~~ 217 (318)
T 1fot_A 148 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEK---ILN 217 (318)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHH---HHH
T ss_pred eecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH---HHh
Confidence 999999875432 2346799999999999999999999999999999999999999864321 111111 111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.. . .. +......+.+++.+||+.||++|| ++++++++
T Consensus 218 -~~---~---~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 218 -AE---L---RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CC---C---CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CC---C---CC----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 10 0 00 111234677899999999999999 88898853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.71 Aligned_cols=271 Identities=25% Similarity=0.398 Sum_probs=213.1
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
....++|.+.+.||+|+||.||+|... +++.||||.+..... .....|.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999764 367899999975432 3345789999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
+..++||||+++|+|.+++....... ........+++..+++++.||+.||+|||+.+ |+||||||+|||++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAM-----ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHH-----HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhh-----ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 99999999999999999996532110 00112245789999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~ 391 (496)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...... ...
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~ 250 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVL 250 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHH
Confidence 999999999999987654433333344567889999999999999999999999999999999 77777543211 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. ....... .........+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus 251 ~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RF----VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH----HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 1111110 0111223567889999999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.05 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=194.8
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCcc---CHHHHHHHHHHHHHhcCCceeeeeeeeeecCe----
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQ---GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE---- 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 234 (496)
.++|.+.+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999986 57889999999764322 24578899999999999999999999876653
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~ 152 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---------------EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 152 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCC
Confidence 4999999999999999953 345899999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+.+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 153 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----- 227 (311)
T 3ork_A 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV----- 227 (311)
T ss_dssp SCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----
T ss_pred CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----
Confidence 99999999999876543211 223345789999999999999999999999999999999999999864332111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH-HHHHhcc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV-VSMIKNE 451 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev-l~~L~~~ 451 (496)
........ ...+.... ......+.+++.+||+.||++||+..++ ...|...
T Consensus 228 ~~~~~~~~----~~~~~~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 228 AYQHVRED----PIPPSARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHCC----CCCHHHHS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhcCC----CCCccccc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11111110 01111100 1123567789999999999999965554 4555554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.42 Aligned_cols=263 Identities=29% Similarity=0.414 Sum_probs=204.0
Q ss_pred hcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeee-ecCeeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCI-EQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~ 236 (496)
..+|.+.+.||+|+||.||+|...+ ...||||.+.... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467788999999999999998643 2368999987543 234567999999999999999999999865 456789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 104 ~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--------------ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp EEEECCTTCBHHHHHHC--------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCC
T ss_pred EEEeCCCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCC
Confidence 99999999999999952 3345889999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccc--cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhhHh
Q 040910 317 PKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLLGH 393 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~~~ 393 (496)
+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+........ ...
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~ 244 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY 244 (298)
T ss_dssp EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHH
T ss_pred EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHH
Confidence 999999999876543321 12334567889999999999999999999999999999999554 4443222111 111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCC
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPS 457 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 457 (496)
.. . .. ....+. .....+.+++.+||+.||.+|||+.++++.|+.++..+..
T Consensus 245 ~~---~-~~--~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 245 LL---Q-GR--RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HH---T-TC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred Hh---c-CC--CCCCCc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 10 0 00 111111 1124678899999999999999999999999998765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.58 Aligned_cols=266 Identities=24% Similarity=0.397 Sum_probs=200.1
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
..+|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788899999999999999986 478999999997532 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 111 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFK-----------KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EECCCSCBHHHHHHHHH-----------HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred EecCCCCCHHHHHHHhc-----------ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEE
Confidence 99999999999996432 12456899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..............
T Consensus 177 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---- 250 (310)
T 2wqm_A 177 LGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---- 250 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----
T ss_pred EEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----
Confidence 99999998764322 122345789999999999999999999999999999999999999864332211111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
..... +.... ......+.+++.+||+.||.+|||+.+|++.|+++.....
T Consensus 251 ~~~~~-----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 251 EQCDY-----PPLPS---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HTTCS-----CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hcccC-----CCCcc---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11110 01100 1123467789999999999999999999999998644333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=345.90 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=200.1
Q ss_pred cCCCccccccccCCeeEEEEEecC-----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
++|...+.||+|+||.||+|.... +..||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466778899999999999998643 2359999997543 2335578999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 124 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--------------KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp EEECCTTEEHHHHHHH--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEeCCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcE
Confidence 9999999999999963 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 318 KISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~- 263 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI- 263 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH-
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH-
Confidence 99999999876543211 11223456789999999999999999999999999999999 9988854321 1111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
.... ... ........+.+++.+||+.+|.+||++.++++.|+.++..
T Consensus 264 ---~~~~--~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 264 ---NDGF--RLP-------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---HTTC--CCC-------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HCCC--cCC-------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1110 000 1112235678899999999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.35 Aligned_cols=263 Identities=19% Similarity=0.233 Sum_probs=207.3
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 231 (496)
+.++....++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999886 4789999999642 12233458899999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.+..++||||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--------------~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl 208 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--------------FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 208 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHH--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeE
Confidence 9999999999999999999952 2356899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+.++.+||+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 9999999999999987654322 2233468999999999997 567899999999999999999999998743321
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAAD--RPTMSEVVSM 447 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 447 (496)
. ...... .... ...-|.... .....+.+++.+||+.+|++ ||+++|++++
T Consensus 288 ~--~~~~i~---~~~~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 E--TYGKIM---NHKE--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp H--HHHHHH---THHH--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred H--HHHhhh---hccc--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 111110 0000 011111111 12345778888999888877 9999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=371.87 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=198.2
Q ss_pred cccccCCeeEEEEEec---CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 171 KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 45679999997643 3457889999999999999999999999976 56899999999999
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 422 L~~~l~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 422 LHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp HHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred HHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 9999952 2456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccccc
Q 040910 327 MFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404 (496)
Q Consensus 327 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (496)
....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ..+.
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i----~~~~-- 556 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI----EQGK-- 556 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHH----HTTC--
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC--
Confidence 7653321 112223346789999999999999999999999999999998 99998754322 111111 1111
Q ss_pred cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 405 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.. ..+......+.+++..||+.+|++||++.+|++.|+....
T Consensus 557 ~~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 557 RM-------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CC-------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01 1111233567889999999999999999999999998543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.51 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=205.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999875 68999999997543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+
T Consensus 86 ~~~~~~L~~~l~---------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 86 YCSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp CCTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCcHHHHHh---------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEe
Confidence 999999988873 2346899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||++................||..|+|||.+.+..+ +.++||||||+++|||++|+.||............+.
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 222 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----- 222 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----
Confidence 9999987643332233445678999999999987765 7899999999999999999999876543322221111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ...+ .......+.+++.+||+.||.+|||+.|++++
T Consensus 223 ~~~~--~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 223 EKKT--YLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTCT--TSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hccc--ccCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1100 0000 01123457789999999999999999998763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=353.79 Aligned_cols=275 Identities=21% Similarity=0.259 Sum_probs=213.7
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG 233 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 233 (496)
++....++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++..++|||||++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999875 5889999998642 1233456889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~ 203 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDK 203 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred EEEEEEeCCCCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECC
Confidence 99999999999999998852 24889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCC----CCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL----FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
++.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .
T Consensus 204 ~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~ 280 (410)
T 3v8s_A 204 SGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G 280 (410)
T ss_dssp TSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--H
T ss_pred CCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--h
Confidence 99999999999987654322 1234568999999999998765 889999999999999999999998743321 1
Q ss_pred hhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH--hc------cccCCCCCC
Q 040910 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAAD--RPTMSEVVSMI--KN------EIVNLPSPQ 459 (496)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L--~~------~~~~~~~p~ 459 (496)
..... ..... .+.-|. .......+.+++.+||+.+|.+ ||+++||+++- ++ .....++|.
T Consensus 281 ~~~~i---~~~~~--~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~ 350 (410)
T 3v8s_A 281 TYSKI---MNHKN--SLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV 350 (410)
T ss_dssp HHHHH---HTHHH--HCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSC
T ss_pred HHHHH---Hhccc--cccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCC
Confidence 11111 00000 000010 0012356778899999988988 99999999763 21 123456676
Q ss_pred CCcch
Q 040910 460 QPAFS 464 (496)
Q Consensus 460 ~~~~~ 464 (496)
.|...
T Consensus 351 ~p~~~ 355 (410)
T 3v8s_A 351 VPDLS 355 (410)
T ss_dssp CCCCS
T ss_pred CCcCC
Confidence 66653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.52 Aligned_cols=257 Identities=14% Similarity=0.153 Sum_probs=207.8
Q ss_pred HhcCCCccccccccCCeeEEEEE------ecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc---CCceeeeeeeeeec
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGK------LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 232 (496)
..++|.+.+.||+|+||.||+|. ..+++.||||++... ...++..|+.++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45778999999999999999994 456899999999653 4567888999998886 99999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
+..++||||+++|+|.+++..... .....++|..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKN----------TPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG 206 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHT----------STTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC
T ss_pred CCcEEEEeccCCCcHHHHHHHhhc----------ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEec
Confidence 999999999999999999975321 13456999999999999999999999988 99999999999999
Q ss_pred C-----------CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 313 G-----------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 313 ~-----------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
. ++.+||+|||+|+...............||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999976543222333455689999999999999999999999999999999999999875
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhccccC
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR-PTMSEVVSMIKNEIVN 454 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~evl~~L~~~~~~ 454 (496)
........ +...+..... ...+.+++..|++.+|.+| |+++++.+.|++.+..
T Consensus 287 ~~~~~~~~-----------------~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 287 KNEGGECK-----------------PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EEETTEEE-----------------ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCcee-----------------echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 33221110 1111111111 3445678888999999998 5899999999887553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=341.17 Aligned_cols=268 Identities=23% Similarity=0.297 Sum_probs=208.5
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHH--hcCCceeeeeeeeeecC--
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAK--LHHRNLVRLFGCCIEQG-- 233 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~-- 233 (496)
......++|.+.+.||+|+||.||+|+. +|+.||||.+... ....+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3445667899999999999999999988 6899999999643 34678889999988 68999999999998876
Q ss_pred --eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhh--------hcCCCCeeecC
Q 040910 234 --EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH--------QYSRLRVIHRD 303 (496)
Q Consensus 234 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~D 303 (496)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+|||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~D 172 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRD 172 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSC
T ss_pred cceeEEEEeecCCCcHHHHHhc----------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCC
Confidence 78999999999999999953 24889999999999999999999 666 99999
Q ss_pred CCCCCEEecCCCceEEeccccccccCCCccc--cccccccccccccChhhhccC------CCCccccchhhhHHHHHHHh
Q 040910 304 LKASNVLLDGDMNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHG------LFSIKSDVFSFGVLLLETLS 375 (496)
Q Consensus 304 lk~~NIll~~~~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~ellt 375 (496)
|||+|||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++
T Consensus 173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 9999999999999999999999876543211 123445799999999999875 33478999999999999999
Q ss_pred C----------CCCCCCCCCCcchhhHhhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040910 376 S----------KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEV 444 (496)
Q Consensus 376 g----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 444 (496)
| ..||.............. ...... ...+.+... ........+.+++.+||+.||++|||+.+|
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCcCCcccccccCccccCcCcccHHHHH-HHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 9 555543322221111111 111111 111111111 123556788999999999999999999999
Q ss_pred HHHHhcccc
Q 040910 445 VSMIKNEIV 453 (496)
Q Consensus 445 l~~L~~~~~ 453 (496)
+++|+.+..
T Consensus 328 ~~~L~~i~~ 336 (342)
T 1b6c_B 328 KKTLSQLSQ 336 (342)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=344.60 Aligned_cols=266 Identities=27% Similarity=0.393 Sum_probs=205.7
Q ss_pred HhcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
..++|.+.+.||+|+||.||+|+. .+++.||||.+.... .....++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356899999999999999999974 357789999996442 3345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
.++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPR--------PSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCC--------SSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred cEEEEecCCCCcHHHHHHhhccc--------ccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence 99999999999999999753211 122356899999999999999999999998 999999999999984
Q ss_pred --CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 314 --DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 314 --~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
+..+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 254 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV 254 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHH
Confidence 45699999999986544333333445578899999999999999999999999999999998 8888764321 111
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.... ..... +. ........+.+++.+||+.||.+||++.++++.|+....
T Consensus 255 ~~~~----~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 255 LEFV----TSGGR-----MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHH----HTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----hcCCC-----CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111 11110 00 011123467889999999999999999999999988644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=354.24 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=205.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+|.+.+.||+|+||.||+|+.. +|+.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999875 7899999999643 2234578899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 96 E~~~gg~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 96 EYVSGGELFDYIC---------------KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp ECCSSEEHHHHTT---------------SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEE
T ss_pred eCCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEE
Confidence 9999999999983 3456899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i---- 228 (476)
T 2y94_A 158 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKI---- 228 (476)
T ss_dssp CCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHH----
T ss_pred Eeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHH----
Confidence 9999998765432 2334679999999999998765 78999999999999999999998743321 111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNE 451 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 451 (496)
..+. ...| ......+.+++.+||+.||.+|||+.+++++ +...
T Consensus 229 ~~~~---~~~p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 229 CDGI---FYTP-------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HTTC---CCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred hcCC---cCCC-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1110 0001 1112457789999999999999999999973 5443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=331.64 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=204.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467889999999999999999875 467999999987666678899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ 317 (496)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 87 ~~~~~~L~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 87 LCTGGELFERVVH---------------KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp CCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred ccCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcE
Confidence 9999999998853 345899999999999999999999998 9999999999999 888999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||++....... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||....... .....
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~--- 219 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKI--- 219 (277)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---
T ss_pred EEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHH---
Confidence 999999998765432 23345789999999988764 8999999999999999999999986433211 11110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... ...+... .......+.+++.+||+.||.+|||+.++++
T Consensus 220 -~~~~---~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 220 -REGT---FTFPEKD---WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHCC---CCCCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -HhCC---CCCCchh---hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000000 0012356788999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.70 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=198.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999875 589999999865432 224678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~l~~~~~---------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 144 (311)
T 4agu_A 83 YCDHTVLHELDR---------------YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLC 144 (311)
T ss_dssp CCSEEHHHHHHH---------------TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCCchHHHHHh---------------hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEe
Confidence 999999988874 2345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh-Hhh----
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL-GHA---- 394 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~-~~~---- 394 (496)
|||++....... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||........... ...
T Consensus 145 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 145 DFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 999998765332 22334578999999999976 6789999999999999999999999865432211100 000
Q ss_pred ----hhhhccccc---ccccCccccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 ----WNLWKDDRA---WKLLDPTLQN---EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ----~~~~~~~~~---~~~~d~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...+..... ..+.++.... .........+.+++.+||+.||.+|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 0011110000 0001223457889999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=346.20 Aligned_cols=268 Identities=25% Similarity=0.343 Sum_probs=197.6
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHH--HHhcCCceeeeeeeeee-----cCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILI--AKLHHRNLVRLFGCCIE-----QGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~-----~~~~ 235 (496)
.++|.+.+.||+|+||.||+|+. +++.||||++.... ...+..|.++. ..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 78999999996432 34455555554 44799999999985542 2367
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc---------CCCCeeecCCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY---------SRLRVIHRDLKA 306 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~ivH~Dlk~ 306 (496)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||
T Consensus 88 ~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp 148 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNS 148 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSG
T ss_pred EEEEecCCCCcHHHHHhh----------------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeeccccc
Confidence 899999999999999953 2358899999999999999999998 6 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCcc------ccccccccccccccChhhhcc-------CCCCccccchhhhHHHHHH
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDEL------QSNMNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLET 373 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el 373 (496)
+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 149 ~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~el 228 (336)
T 3g2f_A 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228 (336)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHH
Confidence 999999999999999999987654321 112234579999999999987 4567899999999999999
Q ss_pred HhCCCCCCCCCCCcchhh------------HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 374 LSSKKNTRFYNIDSLTLL------------GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 374 ltg~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
++|..|+........... ...............+... ..........+.+++.+||+.||++|||+
T Consensus 229 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (336)
T 3g2f_A 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTA 306 (336)
T ss_dssp HTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcch
Confidence 999877643222111000 0000000000000000000 01123355678999999999999999999
Q ss_pred HHHHHHHhccccCC
Q 040910 442 SEVVSMIKNEIVNL 455 (496)
Q Consensus 442 ~evl~~L~~~~~~~ 455 (496)
+|+++.|++++...
T Consensus 307 ~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 307 QXAEERMAELMMIW 320 (336)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999976543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.92 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=202.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
..++|.+.+.||+|+||.||+|...+ +..||||.+.... ....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678889999999999999998643 2369999987542 3345789999999999999999999999865 4578
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 89 ~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--------------NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPEC 151 (281)
T ss_dssp EEEECCTTCBHHHHHHH--------------HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTE
T ss_pred EEEecCCCCCHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCc
Confidence 99999999999999963 2345889999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||++......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ......
T Consensus 152 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~ 228 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLE 228 (281)
T ss_dssp EEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHH
T ss_pred EEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHh
Confidence 999999999876543221 1233467889999999999999999999999999999998 999886433221 111110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
. .. ....+ ......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 229 ~----~~--~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 229 K----GD--RLPKP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp H----TC--CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c----CC--CCCCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0 00 00011 112356788999999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.64 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=203.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee---------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--------- 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 231 (496)
...+|...+.||+|+||.||+|... +++.||||.+.... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567888999999999999999885 78999999997543 457889999999999999999998864
Q ss_pred -------cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 040910 232 -------QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDL 304 (496)
Q Consensus 232 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 304 (496)
....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 148 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-------------RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDL 148 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-------------GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 44689999999999999999642 2346899999999999999999999998 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
||+|||++.++.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 224 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET- 224 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-
T ss_pred CHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-
Confidence 9999999999999999999998765432 223457899999999999999999999999999999999999875311
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
........... +... ....+.+++.+||+.||.+|||+.+++++|+....
T Consensus 225 -------~~~~~~~~~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 -------SKFFTDLRDGI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -------HHHHHHHHTTC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -------HHHHHHhhccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00111111111 1111 12456789999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=342.13 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=192.9
Q ss_pred hcCCCccccccccCCeeEEEEEe----cCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL----LNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||.||+++. .+|+.||||++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999987 478999999997542 2344568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---------------EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ 157 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTT
T ss_pred EEEEEeCCCCCcHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCC
Confidence 9999999999999999853 345888999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i 233 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKI 233 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 999999999998643221 2233457999999999999999999999999999999999999998643221 111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
. . .. . . .+......+.+++.+||+.||.+|| ++.+++++
T Consensus 234 ~---~-~~---~---~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 L---K-CK---L---N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp H---H-TC---C---C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred H---h-CC---C---C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 0 00 0 0 0111235677899999999999999 67787753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=337.35 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=204.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457888999999999999999875 689999999975432 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~lv~e~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---------------QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKN 152 (321)
T ss_dssp EEEECCCCSCBHHHHHH---------------TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTT
T ss_pred EEEEEcCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCC
Confidence 99999999999999994 2346899999999999999999999998 99999999999999888
Q ss_pred ----ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 316 ----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||...... ...
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 227 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL 227 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH
T ss_pred CCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHH
Confidence 79999999998765432 223457899999999999999999999999999999999999998643211 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ... ...++..... ....+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~i~----~~~--~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 228 ANIT----SVS--YDFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHH----TTC--CCCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHH----hcc--cccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 000 0011111111 12457789999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.84 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=198.3
Q ss_pred hcCCCcc-ccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEE-NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+.|.+. +.||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567664 68999999999999864 6899999999876666678899999999995 7999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc---
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN--- 316 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--- 316 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---------------RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp ECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCS
T ss_pred EcCCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCc
Confidence 99999999999953 245889999999999999999999998 999999999999998776
Q ss_pred eEEeccccccccCCCcc-----ccccccccccccccChhhhcc-----CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 317 PKISDFGIARMFGGDEL-----QSNMNRIVGTYGYMSPEYALH-----GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+||+|||++........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999986542211 111233569999999999875 56889999999999999999999998764432
Q ss_pred cchhh---------HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 387 SLTLL---------GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 387 ~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ............ .. ...... .....+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGKY-EF-PDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCCC-CC-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccchhHHHHHHHHHhccCc-cc-Cchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 21000 000000000000 00 000000 123467889999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.39 Aligned_cols=245 Identities=21% Similarity=0.258 Sum_probs=203.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|...+.||+|+||.||+++.. +|+.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 6899999999643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 121 e~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---------------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp ECCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred cCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEE
Confidence 99999999999953 235889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ....... .
T Consensus 183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i----~ 251 (350)
T 1rdq_E 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKI----V 251 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----H
T ss_pred cccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHH----H
Confidence 999999876432 2346799999999999999999999999999999999999999864321 1111111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
.... .+ +......+.+++.+||+.||.+||+ +++|+++
T Consensus 252 ~~~~------~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 SGKV------RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HCCC------CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred cCCC------CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1110 00 1112356788999999999999998 8888754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.10 Aligned_cols=274 Identities=21% Similarity=0.224 Sum_probs=203.8
Q ss_pred HHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-----CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 159 ISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-----SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 159 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
+....++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4567788999999999999999999874 6789999998643 334567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCccccc-------------------------CCCCCCCCChhhHHHHHHHHHHH
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVT-------------------------DPASKGILDWTTRVRIIEGIAQG 287 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-------------------------~~~~~~~l~~~~~~~i~~~ia~~ 287 (496)
+..++||||+++|+|.+++............. .......+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985432211100000 00012235677889999999999
Q ss_pred HHHhhhcCCCCeeecCCCCCCEEecCCC--ceEEeccccccccCCCc--cccccccccccccccChhhhcc--CCCCccc
Q 040910 288 LLYLHQYSRLRVIHRDLKASNVLLDGDM--NPKISDFGIARMFGGDE--LQSNMNRIVGTYGYMSPEYALH--GLFSIKS 361 (496)
Q Consensus 288 L~yLH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 361 (496)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+.... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 89999999998653221 1112345679999999999975 6789999
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040910 362 DVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 362 Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
||||||+++|||++|+.||....... ... ....... ....+.. ......+.+++.+||+.||.+||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~--~~~---~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD--TIS---QVLNKKL--CFENPNY-----NVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HHHHCCC--CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH--HHH---HHHhccc--ccCCccc-----ccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999999999999986433211 111 1111000 0111111 1123567789999999999999999
Q ss_pred HHHHHH
Q 040910 442 SEVVSM 447 (496)
Q Consensus 442 ~evl~~ 447 (496)
.+++++
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=347.86 Aligned_cols=273 Identities=21% Similarity=0.293 Sum_probs=212.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC--eeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG--EKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 238 (496)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457888999999999999999875 48999999997543 345678899999999999999999999998765 77999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe----cCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGD 314 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~ 314 (496)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.+
T Consensus 88 ~e~~~~g~L~~~l~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEP------------SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (396)
T ss_dssp ECCCTTEEHHHHTTSG------------GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSC
T ss_pred EecCCCCCHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCc
Confidence 9999999999998531 12234899999999999999999999998 9999999999999 788
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhcc--------CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
+.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 153 SVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp EEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred eeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 889999999998765432 2234579999999999875 56788999999999999999999998754332
Q ss_pred cchhhHhhhhhhcccc---c---cccc--------CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 387 SLTLLGHAWNLWKDDR---A---WKLL--------DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~---~---~~~~--------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..... .......... . .... +..............+.+++..||+.||++||++.++++.+++++
T Consensus 230 ~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 230 RRNKE-VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TTCHH-HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cchHH-HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11111 1111111000 0 0000 000111234566778889999999999999999999999998876
Q ss_pred cC
Q 040910 453 VN 454 (496)
Q Consensus 453 ~~ 454 (496)
..
T Consensus 309 ~~ 310 (396)
T 4eut_A 309 HR 310 (396)
T ss_dssp TC
T ss_pred hc
Confidence 53
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=347.04 Aligned_cols=273 Identities=25% Similarity=0.392 Sum_probs=207.5
Q ss_pred hcCCCccccccccCCeeEEEEEe-----cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC--ee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-----LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG--EK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~ 235 (496)
.++|.+.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688889999999999999984 368899999998766666778999999999999999999999987654 78
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 120 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 182 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--------------HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENEN 182 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--------------STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred EEEEECCCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCC
Confidence 999999999999999963 2345899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+..............
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 9999999999877543221 122334577889999999999999999999999999999999988653210000000000
Q ss_pred -hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 395 -WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 395 -~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..........+.+...............+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000000000000000000111122356888999999999999999999999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=348.62 Aligned_cols=207 Identities=28% Similarity=0.315 Sum_probs=179.1
Q ss_pred eCHHHHHHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-----CCceeeeee
Q 040910 154 FSLASISTATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-----HRNLVRLFG 227 (496)
Q Consensus 154 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~ 227 (496)
+++.+.....++|.+.++||+|+||.||+|+. .+++.||||++... ......+..|+.++.+++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44444445678999999999999999999987 46889999999642 234567788999999996 999999999
Q ss_pred eeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 228 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITR-------------NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 999999999999999 9999999964 22345899999999999999999999998 999999999
Q ss_pred CEEecC-------------------------CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCcccc
Q 040910 308 NVLLDG-------------------------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSD 362 (496)
Q Consensus 308 NIll~~-------------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 362 (496)
|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccc
Confidence 999976 789999999999865422 23457899999999999999999999
Q ss_pred chhhhHHHHHHHhCCCCCCCC
Q 040910 363 VFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 363 v~S~Gvvl~elltg~~~~~~~ 383 (496)
||||||++|||++|+.||...
T Consensus 242 iwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.67 Aligned_cols=247 Identities=30% Similarity=0.448 Sum_probs=199.1
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
+.|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 5789999999975432 23457899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+. |+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 134 e~~~-g~l~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp ECCS-EEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEE
T ss_pred ecCC-CCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence 9997 788777743 2346899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||+++..... ....||+.|+|||++. +..++.++|||||||++|||++|+.|+...... . ....
T Consensus 196 ~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~---~~~~ 264 (348)
T 1u5q_A 196 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S---ALYH 264 (348)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H---HHHH
T ss_pred eeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H---HHHH
Confidence 999999865422 2357899999999985 567899999999999999999999998643211 1 1111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
..... .+..... .....+.+++.+||+.||++|||+.+++++.
T Consensus 265 ~~~~~------~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 265 IAQNE------SPALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHSC------CCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHhcC------CCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11111 1111111 1234577899999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.19 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=203.2
Q ss_pred hcCCCccc-cccccCCeeEEEEEec---CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 163 THNFSEEN-KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 163 ~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
.++|.+.+ .||+|+||.||+|... +++.||||.+..... ...+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999653 467899999975432 2357899999999999999999999999 667789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 94 lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~ 155 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---------------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHY 155 (291)
T ss_dssp EEEECCTTEEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred EEEEeCCCCCHHHHHHh---------------CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCc
Confidence 99999999999999953 235889999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
+||+|||++........ ........+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~- 232 (291)
T 1xbb_A 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM- 232 (291)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH-
T ss_pred EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH-
Confidence 99999999987654322 122233456789999999999999999999999999999999 99988643321 11111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
...... +. ........+.+++.+||+.||.+||++.+|++.|++....
T Consensus 233 ---~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 233 ---LEKGER-----MG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ---HHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---HHcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111110 01 1112235678899999999999999999999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.92 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=201.4
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc--------cCHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG--------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
..++|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 4688999999975431 1334678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 GEKILIYEYMPNK-SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+..++||||+.+| +|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 163 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---------------RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVI 163 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---------------TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CEEEEEEEeCCCCccHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEE
Confidence 9999999999877 9999984 2345899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--- 237 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--- 237 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---
T ss_pred cCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---
Confidence 999999999999998765432 2234579999999999998877 889999999999999999999986321100
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
......+. .....+.+++..||+.||++|||+.+++++
T Consensus 238 ------------~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ------------EAAIHPPY-------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------------TTCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------------hhccCCCc-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011 123467889999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=330.33 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=203.0
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468899999999999999999874 58899999996543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc---
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN--- 316 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--- 316 (496)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 e~~~~~~l~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---------------REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp CCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCC
T ss_pred ecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCc
Confidence 99999999888853 345899999999999999999999998 999999999999987665
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 147 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~- 220 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIK- 220 (284)
T ss_dssp EEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-
T ss_pred EEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHH-
Confidence 9999999998765332 223467899999999999999999999999999999999999998643221 1111110
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .....+. .......+.+++.+||+.||++|||+.|++++
T Consensus 221 ---~~~-~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 221 ---AGA-YDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---HTC-CCCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---hcc-ccCCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 0011110 01123457789999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.26 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=198.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc---CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ---GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
..++|.+.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999875 6889999999754322 24678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 112 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---------------QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EEECCCCEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred EEEecCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCE
Confidence 9999999999999953 245899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||++........ .......||..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ...
T Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~---~~~ 246 (309)
T 2h34_A 174 YLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM---GAH 246 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH---HHH
T ss_pred EEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH---HHH
Confidence 9999999987653321 2233457899999999999999999999999999999999999998643211 11 000
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhccccCCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEVVSMIKNEIVNLPS 457 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~~~~ 457 (496)
.... ...+.. ........+.+++.+||+.||++|| +++++++.|+..+.....
T Consensus 247 ~~~~----~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 247 INQA----IPRPST---VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHSC----CCCGGG---TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred hccC----CCCccc---cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0000 000100 1111234677899999999999999 999999999997655443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.22 Aligned_cols=250 Identities=24% Similarity=0.297 Sum_probs=202.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 236 (496)
..++|.+.+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999875 4789999999753 234567788999999888 8999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 98 lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---------------VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCc
Confidence 99999999999999853 245899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 160 vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~- 234 (353)
T 2i0e_A 160 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIM- 234 (353)
T ss_dssp EEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-
T ss_pred EEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHH-
Confidence 9999999998643221 223456899999999999999999999999999999999999999864322 11111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
. .. . . .+......+.+++.+||+.||.+||+ +++++++
T Consensus 235 --~-~~---~---~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 --E-HN---V---A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --H-CC---C---C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --h-CC---C---C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 10 0 0 11122356788999999999999995 4777654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=358.81 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=193.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 6899999999743 334456788899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+
T Consensus 227 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---------------ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp ECCCSSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCE
T ss_pred EeeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCE
Confidence 999999999999853 3458999999999999999999998 77 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~-- 362 (446)
T 4ejn_A 289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL-- 362 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH--
T ss_pred EEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHH--
Confidence 999999998643221 2234568999999999999999999999999999999999999998643321 1111110
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
. .. . .. +......+.+++..||+.||.+|| +++|++++
T Consensus 363 -~-~~---~---~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 -M-EE---I---RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -H-CC---C---CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -h-CC---C---CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0 00 0 00 111235677899999999999999 99999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=357.59 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=206.3
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|...+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999875 6899999999643 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 263 mEy~~gg~L~~~l~~-------------~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH-------------MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp ECCCCSCBHHHHHHS-------------SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred EEcCCCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeE
Confidence 999999999999853 22345899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......
T Consensus 327 L~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i 401 (576)
T 2acx_A 327 ISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLV 401 (576)
T ss_dssp ECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHH
T ss_pred EEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHh
Confidence 99999998765432 223458999999999999999999999999999999999999999754332111 0011100
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
... ... ........+.+++.+||+.||.+|| +++||+++
T Consensus 402 ~~~------~~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 402 KEV------PEE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHC------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hcc------ccc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 000 000 1111235678899999999999999 77888754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.03 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=196.7
Q ss_pred ccccccCCeeEEEEEec---CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
++||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 46789999997543 2346789999999999999999999999964 568899999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 454 g~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 454 GPLNKYLQQ---------------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp EEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred CCHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 999999953 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 325 ARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 325 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .....
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~----i~~~~ 589 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM----LEKGE 589 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----HHTTC
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC
Confidence 997754322 222334457889999999999999999999999999999998 99998643321 11111 11111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
. . .........+.+++..||+.||++||++.+|++.|++..
T Consensus 590 ~--~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 590 R--M-------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp C--C-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C--C-------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0 0 111122356788999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.03 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=196.5
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-CeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-GEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~ 241 (496)
.++|.+.+.||+|+||.||+++. +|+.||||.+... ...+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999987 6899999998753 3457899999999999999999999997655 478999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 97 ~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 97 MAKGSLVDYLRSR-------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp CTTEEHHHHHHHH-------------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred CCCCCHHHHHHhc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEee
Confidence 9999999999641 1234788999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..... ..
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~----~~ 229 (278)
T 1byg_A 161 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----EK 229 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH----TT
T ss_pred cccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----hc
Confidence 9999865432 223467889999999999999999999999999999998 998876433211 11111 10
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.. .+.. .......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 230 ~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 230 GY-----KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp TC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-----CCCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 10 0111 112235678899999999999999999999999885
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=329.26 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=182.6
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999987 478999999996432 23457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
+||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 90 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--------------RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EECCTTEEHHHHHHT--------------CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEE
T ss_pred EecCCCCcHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 999999999999852 2356899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... .. .
T Consensus 153 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~- 224 (278)
T 3cok_A 153 IADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--NK---V- 224 (278)
T ss_dssp ECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C-
T ss_pred EEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--HH---H-
Confidence 99999998764322 1223357899999999999999999999999999999999999998754322110 00 0
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. .+... +......+.+++.+||+.||++|||+.++++
T Consensus 225 ---~~---~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 225 ---VL---ADYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CS---SCCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---hh---cccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 00001 1112346778999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=331.19 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=198.3
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..++|.+.++||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467888999999999999999874 68899999987543 345688999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCCc
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMN 316 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~ 316 (496)
||+++|+|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.
T Consensus 100 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~ 165 (285)
T 3is5_A 100 ETCEGGELLERIVSAQ-----------ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSP 165 (285)
T ss_dssp CCCSCCBHHHHHHHHH-----------HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCC
T ss_pred EeCCCCcHHHHHHhhh-----------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCC
Confidence 9999999999986422 12356899999999999999999999998 9999999999999 55688
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||+++...... ......||..|+|||.+. ..++.++||||||+++|||++|+.||........ .....
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~- 238 (285)
T 3is5_A 166 IKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKAT- 238 (285)
T ss_dssp EEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-
T ss_pred EEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhhc-
Confidence 9999999998765332 233457899999999875 5689999999999999999999999864332111 11000
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
...... +..... ....+.+++.+||+.||++|||+.|+++
T Consensus 239 -~~~~~~-----~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 -YKEPNY-----AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HCCCCC-----CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cCCccc-----ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000001 1246778999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=355.57 Aligned_cols=262 Identities=19% Similarity=0.228 Sum_probs=205.5
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 231 (496)
+.+.....++|.+.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444456789999999999999999999875 68999999996421 2234568899999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.+..++||||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl 195 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--------------GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILL 195 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeee
Confidence 99999999999999999999631 235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhc-------cCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
+.++++||+|||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654322 1223468999999999997 4578999999999999999999999986533
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR---PTMSEVVSM 447 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~~ 447 (496)
... ...... .... ....|... ......+.+++.+||+ +|.+| |+++|++++
T Consensus 275 ~~~--~~~~i~---~~~~--~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 275 TAE--TYGKIV---HYKE--HLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHH--HHHHHH---THHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHH--HHHHHH---hccc--CcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 211 111110 0000 01111111 1123567789999999 99998 589998765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=337.92 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=201.5
Q ss_pred HHHhcCCCcc-ccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe
Q 040910 160 STATHNFSEE-NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 160 ~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 234 (496)
....+.|.+. +.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445566666 78999999999999875 58999999987532 34467899999999999 57999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
.++||||+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLP-------------ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSI 167 (327)
T ss_dssp EEEEEECCTTEEGGGGGSS-------------CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCB
T ss_pred EEEEEEecCCCcHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecC
Confidence 9999999999999988832 23456999999999999999999999998 999999999999998
Q ss_pred --CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 314 --DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 314 --~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~ 242 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--Y 242 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H
T ss_pred CCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H
Confidence 7899999999998765332 22345799999999999999999999999999999999999999864332111 1
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... . ..............+.+++.+||+.||.+|||+++++++
T Consensus 243 ~~i~~~----~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 LNISQV----N------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHT----C------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHhc----c------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111000 0 000011111223567789999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.87 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=191.4
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecC--e
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQG--E 234 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~ 234 (496)
...++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999864 6899999998643 2334567889999999997 999999999997554 7
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||++ |+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~ 145 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred EEEEecccC-cCHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCC
Confidence 899999997 689888842 35889999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCc-------------------cccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHH
Q 040910 315 MNPKISDFGIARMFGGDE-------------------LQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETL 374 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~ell 374 (496)
+.+||+|||+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 999999999998764311 1112344579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCCCcchhhHhhhhhhcccc---cccccCc-----------------cccccC-------------CHHHHH
Q 040910 375 SSKKNTRFYNIDSLTLLGHAWNLWKDDR---AWKLLDP-----------------TLQNEA-------------LYPMVK 421 (496)
Q Consensus 375 tg~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~-----------------~~~~~~-------------~~~~~~ 421 (496)
+|+.||....... ............. ...+..+ ...... ......
T Consensus 226 ~g~~pf~~~~~~~--~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (388)
T 3oz6_A 226 CGKPIFPGSSTMN--QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303 (388)
T ss_dssp HSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCH
T ss_pred hCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCH
Confidence 9999987543211 1111100000000 0000000 000000 001134
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 422 RYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 422 ~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.+.+++.+||+.||++|||++|++++
T Consensus 304 ~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 304 EALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhhccCcccCCCHHHHhCC
Confidence 67899999999999999999999887
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=339.96 Aligned_cols=250 Identities=23% Similarity=0.254 Sum_probs=178.9
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 6899999999643 3467889999999996 9999999999999999999999999999
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC---ceEEeccc
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM---NPKISDFG 323 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFg 323 (496)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 93 L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 93 LFERIKK---------------KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp HHHHHHH---------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCT
T ss_pred HHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999953 346899999999999999999999998 99999999999997665 89999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-hhhHhhhhhhcccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLGHAWNLWKDDR 402 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~~~~~~~~~~~~~~ 402 (496)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............+.
T Consensus 155 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 155 FARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp TCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred cceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 998664332 223445789999999999999999999999999999999999999875433210 00011111111111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. .............+.+++..||+.||.+|||+++++++
T Consensus 233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 F------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp C------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred C------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 00000011123567889999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.79 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=190.8
Q ss_pred cCCCcc-ccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee----cCeeE
Q 040910 164 HNFSEE-NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE----QGEKI 236 (496)
Q Consensus 164 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~ 236 (496)
++|.+. +.||+|+||.||++... +|+.||||++.. ...+.+|+.++.++ +||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 68999999999999875 688999999863 24678899887655 89999999999875 56789
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--- 313 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--- 313 (496)
+||||+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 199 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD-------------RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 199 (400)
T ss_dssp EEEECCCSEEHHHHHHC-------------C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSST
T ss_pred EEEEeCCCCcHHHHHHH-------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCC
Confidence 99999999999999953 22346999999999999999999999998 999999999999998
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch--hh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT--LL 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~--~~ 391 (496)
++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 200 ~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 200 NAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp TCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred CccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 789999999999865432 2234567899999999999999999999999999999999999998754332211 11
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
... ..+.. ....+ ........+.+++..||+.||++|||+.+++++-
T Consensus 277 ~~i----~~~~~-~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 277 TRI----RMGQY-EFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHH----HHTCC-CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHH----HcCcc-cCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 110 00000 00000 0111235678899999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=339.44 Aligned_cols=272 Identities=25% Similarity=0.371 Sum_probs=205.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCE--EEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEE--VAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+.||+|+||.||+|+.. ++.. ||||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999874 4554 499998753 234456789999999999 999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCc-ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGF-DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|||+++|+|.+++......... ...........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 9999999999999642100000 00000022356899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++.... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 253 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHH---
Confidence 9999999974321 112233466889999999999999999999999999999998 999886432211 1111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
..... .+. ........+.+++.+||+.||.+|||+.++++.|+.++....
T Consensus 254 -~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 254 -LPQGY-----RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -GGGTC-----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -hhcCC-----CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11110 000 111223567889999999999999999999999998766543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.58 Aligned_cols=266 Identities=23% Similarity=0.274 Sum_probs=192.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeee--------e
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCI--------E 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~ 231 (496)
...+|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457889999999999999999864 68999999997666556678999999999995 999999999984 3
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
....++|+||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||||+|||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME------------SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLL 171 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH------------TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEE
T ss_pred CceEEEEEEecC-CCHHHHHHHhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEE
Confidence 345899999995 89999886421 2346999999999999999999999874 349999999999999
Q ss_pred cCCCceEEeccccccccCCCcccc----------ccccccccccccChhhh---ccCCCCccccchhhhHHHHHHHhCCC
Q 040910 312 DGDMNPKISDFGIARMFGGDELQS----------NMNRIVGTYGYMSPEYA---LHGLFSIKSDVFSFGVLLLETLSSKK 378 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~elltg~~ 378 (496)
+.++.+||+|||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998765432111 11234689999999998 56778999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCC
Q 040910 379 NTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSP 458 (496)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p 458 (496)
||........ .. .. .....+ ......+.+++.+||+.||.+|||+.|+++.|+.+....+.+
T Consensus 252 p~~~~~~~~~--~~--------~~-~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 252 PFEDGAKLRI--VN--------GK-YSIPPH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp CC-----------------------CCCCTT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcchhHHHh--hc--------Cc-ccCCcc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 9864322110 00 00 000000 011133678899999999999999999999999876544433
Q ss_pred C
Q 040910 459 Q 459 (496)
Q Consensus 459 ~ 459 (496)
+
T Consensus 314 ~ 314 (337)
T 3ll6_A 314 P 314 (337)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.40 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=191.9
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--------ccCHHHHHHHHHHHHHhcCCceeeeeeeeee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--------GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE 231 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 231 (496)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999874 57899999986432 122335889999999999999999999975
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll 272 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---------------GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 272 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred cCceEEEEEcCCCCcHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEE
Confidence 456899999999999988873 3456899999999999999999999998 9999999999999
Q ss_pred cCC---CceEEeccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 312 DGD---MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 312 ~~~---~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
+.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 654 45999999999876533 22344679999999999863 6788999999999999999999999875432
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ..... ..... ...+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 350 ~~~-~~~~i----~~~~~--~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 350 QVS-LKDQI----TSGKY--NFIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SCC-HHHHH----HTTCC--CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHH-HHHHH----hcCCC--CCCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 221 11111 00000 00011111 123567889999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.58 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=198.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc--CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ--GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999875 4899999998654322 2456789999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 104 e~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 104 EFVDHTILDDLEL---------------FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp ECCSEEHHHHHHH---------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ecCCcchHHHHHh---------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEE
Confidence 9999999988863 2345899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH------
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG------ 392 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~------ 392 (496)
+|||+++...... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||............
T Consensus 166 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 166 CDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 9999998664322 223345789999999999875 7899999999999999999999998754322110000
Q ss_pred ---hhhhhhccc-ccccccCccccccC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 393 ---HAWNLWKDD-RAWKLLDPTLQNEA-----LYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 393 ---~~~~~~~~~-~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.....+... .......+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 00011111111111 1122457889999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.56 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888999999999999999875 689999999875421 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---------------KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKN 145 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEEeecCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCC
Confidence 999999999999999953 345899999999999999999999998 99999999999998877
Q ss_pred ----ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 316 ----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||...... ...
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~ 220 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETL 220 (283)
T ss_dssp SSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH
T ss_pred CCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHH
Confidence 89999999998764332 223456899999999999999999999999999999999999998643221 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... .... ....+.... .....+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~----~~~~--~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 221 TNI----SAVN--YDFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHH----HTTC--CCCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHh----Hhcc--cCCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 110 0000 001111111 11346788999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.23 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=204.9
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|...+.||+|+||.||+++.. +|+.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999875 6899999999643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 265 E~~~gg~L~~~l~~~~-----------~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVD-----------EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp CCCTTCBHHHHHHTSS-----------TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCHHHHHHHhh-----------cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEE
Confidence 9999999999986421 22456999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 331 ~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~~ 407 (543)
T 3c4z_A 331 SDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLE 407 (543)
T ss_dssp CCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHHH
T ss_pred eecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHhh
Confidence 9999998765432 1223458999999999999999999999999999999999999999754322111 000000000
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM-----SEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 446 (496)
.. . ..+......+.+++.+||+.||.+||++ ++|++
T Consensus 408 -~~---~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 -QA---V-------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CC---C-------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -cc---c-------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00 0 0111223567789999999999999975 56654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.67 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=190.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHH-HHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMIL-IAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+++.. +++.||||.+.... ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467889999999999999999875 57899999997543 2233456667666 466799999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++
T Consensus 117 v~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---------------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp EEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EEeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCE
Confidence 9999999999999853 345888999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...... ......
T Consensus 179 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i--- 251 (373)
T 2r5t_A 179 VLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNI--- 251 (373)
T ss_dssp EECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHH---
T ss_pred EEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH---
Confidence 999999998643221 2334568999999999999999999999999999999999999998643221 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.. ... .+.. .....+.+++.+||+.||.+||++.+.+
T Consensus 252 ~~-~~~------~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 252 LN-KPL------QLKP----NITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HH-SCC------CCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred Hh-ccc------CCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 10 100 0111 1234577899999999999999985433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.79 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=198.4
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999986 4688999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-CCceEEecc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKISDF 322 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DF 322 (496)
+++|.+++... .....+++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.+||+||
T Consensus 103 ~~~L~~~l~~~------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 103 GGSLSALLRSK------------WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEEHHHHHHHT------------TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCT
T ss_pred CCCHHHHHHhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeec
Confidence 99999999642 12234678899999999999999999998 999999999999987 899999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCC--CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|++....... .......||..|+|||++.+.. ++.++||||||+++|||++|+.||.............. .
T Consensus 168 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~--- 240 (295)
T 2clq_A 168 GTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--M--- 240 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--H---
T ss_pred ccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--c---
Confidence 9998764322 1223457899999999997654 88999999999999999999999864322111111000 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
....+.+. ......+.+++.+||+.||++||++.+++++
T Consensus 241 ----~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 ----FKVHPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----HCCCCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----cccccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111111 1223567789999999999999999999763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=340.74 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=202.2
Q ss_pred hcCCCccccccccCCeeEEEEEe----cCCCEEEEEEeccCC----ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL----LNGEEVAVKRLSNKS----GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 233 (496)
.++|.+.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999987 378999999986432 23456778899999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---------------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDS 194 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEeecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 99999999999999999953 235889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
++.+||+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~- 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA- 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-
T ss_pred CCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-
Confidence 99999999999987643322 22334679999999999986 357899999999999999999999987543322111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSMI 448 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~L 448 (496)
......... .+. ........+.+++.+||+.||.+|| ++++++++.
T Consensus 273 ~~~~~~~~~-------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EISRRILKS-------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHC-------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHhcc-------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111000000 011 1112235677899999999999999 999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=352.53 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=194.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------C
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------G 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 233 (496)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999764 6889999999754 333456788999999999999999999999654 3
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~ 199 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEEeCCCCC-HHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeC
Confidence 579999999754 555552 23889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....
T Consensus 200 ~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~ 274 (464)
T 3ttj_A 200 DCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNK 274 (464)
T ss_dssp TSCEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred CCCEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 999999999999876432 22345689999999999999999999999999999999999999997543211 0000
Q ss_pred hhhh-------------------hccc------ccccccCcccccc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 394 AWNL-------------------WKDD------RAWKLLDPTLQNE---ALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 394 ~~~~-------------------~~~~------~~~~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.... .... .........+... ........+.+++.+||+.||++|||++|++
T Consensus 275 i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp HHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000 0000 0000000000000 0111245688999999999999999999998
Q ss_pred HH
Q 040910 446 SM 447 (496)
Q Consensus 446 ~~ 447 (496)
++
T Consensus 355 ~H 356 (464)
T 3ttj_A 355 QH 356 (464)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.25 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=199.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
+.++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999875 5779999998643 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 v~e~~~~~~l~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---------------LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp EECCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCE
T ss_pred EEecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCE
Confidence 9999999999999853 245889999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||++...... ......||..|+|||.+.+..++.++||||||+++|||++|..||....... .......
T Consensus 149 ~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~- 221 (279)
T 3fdn_A 149 KIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISR- 221 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH-
T ss_pred EEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHh-
Confidence 99999998754332 1234578999999999999999999999999999999999999986432111 1111000
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ... ........+.+++.+||+.||.+|||+.|++++
T Consensus 222 ---~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---V------EFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---T------CCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---C------CCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 011123457789999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.35 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=205.8
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..+.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3456888999999999999999864 68899999997543 345688999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 100 e~~~~~~L~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 100 EYLGGGSALDLLE----------------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp ECCTTEEHHHHHT----------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EeCCCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEE
Confidence 9999999999983 245899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... .
T Consensus 161 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~ 232 (303)
T 3a7i_A 161 ADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLI----P 232 (303)
T ss_dssp CCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH----H
T ss_pred eecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHh----h
Confidence 9999998765432 1223457899999999999999999999999999999999999998643211 111110 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.. ..+.+.... ...+.+++..||+.||.+|||+.+++++.
T Consensus 233 ~~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 233 KN-----NPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HS-----CCCCCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cC-----CCCCCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00 011111111 24577899999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=353.12 Aligned_cols=195 Identities=23% Similarity=0.379 Sum_probs=154.3
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Ce
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 234 (496)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999764 68999999996532 23456789999999999999999999998543 57
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+ +|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~ 192 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---------------TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT
T ss_pred EEEEEecc-ccchhhhcc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCC
Confidence 89999998 578988884 2356999999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCcc-------------------------ccccccccccccccChhhh-ccCCCCccccchhhhH
Q 040910 315 MNPKISDFGIARMFGGDEL-------------------------QSNMNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGV 368 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gv 368 (496)
+.+||+|||+++....... .......+||+.|+|||++ .+..++.++|||||||
T Consensus 193 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272 (458)
T ss_dssp CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence 9999999999987643211 0123445789999999986 4667999999999999
Q ss_pred HHHHHHhC
Q 040910 369 LLLETLSS 376 (496)
Q Consensus 369 vl~elltg 376 (496)
++|||++|
T Consensus 273 il~elltg 280 (458)
T 3rp9_A 273 IFAELLNM 280 (458)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=331.47 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=198.6
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 237 (496)
..++|.+.+.||+|+||.||+|... +++.||||.+.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567889999999999999999875 78999999997542 23456788999999999 99999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC----
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---- 313 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---- 313 (496)
||||+++++|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENY-----------RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp EEECCTTCBHHHHHHHHH-----------HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----
T ss_pred EEEecCCCcHHHHHHhhc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCC
Confidence 999999999999996422 12256899999999999999999999998 999999999999984
Q ss_pred ---------------CCceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCC
Q 040910 314 ---------------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSK 377 (496)
Q Consensus 314 ---------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~ 377 (496)
...+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|||++|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 228 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence 4479999999998765332 23589999999999876 6678999999999999999998
Q ss_pred CCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 378 KNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+++.... ... ....... +.+.. .....+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~-----~~~----~~~~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 229 PLPRNGD-----QWH----EIRQGRL-----PRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCSSSH-----HHH----HHHTTCC-----CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCcchh-----HHH----HHHcCCC-----CCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 7653211 110 0111111 11111 123567889999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.25 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=199.5
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..++|.+.+.||+|+||.||++... +|+.||||.+..... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567889999999999999999875 688999999975443 235688888888 7999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC----C
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD----M 315 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~----~ 315 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +
T Consensus 96 E~~~gg~L~~~i~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 96 ELMKGGELLDKILR---------------QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp CCCCSCBHHHHHHT---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGG
T ss_pred eCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcC
Confidence 99999999999852 345899999999999999999999998 9999999999998443 3
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-hhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~~~~~~ 394 (496)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||........ .....
T Consensus 158 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~- 234 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR- 234 (342)
T ss_dssp GEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH-
T ss_pred eEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH-
Confidence 59999999998764332 223446789999999999988899999999999999999999999875332211 11111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...+.. .............+.+++.+||+.||++||++.+++++
T Consensus 235 ---i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 235 ---IGSGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---HHHCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---HccCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111110 00011111223567789999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=336.20 Aligned_cols=257 Identities=20% Similarity=0.328 Sum_probs=204.5
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc--------CHHHHHHHHHHHHHh-cCCceeeeee
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ--------GVEEFKNEMILIAKL-HHRNLVRLFG 227 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~~ 227 (496)
.......+|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999885 6999999998754321 145678999999999 8999999999
Q ss_pred eeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 228 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~ 229 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE---------------KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE 229 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 99999999999999999999999853 345899999999999999999999998 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc------CCCCccccchhhhHHHHHHHhCCCCCC
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH------GLFSIKSDVFSFGVLLLETLSSKKNTR 381 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~elltg~~~~~ 381 (496)
|||++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999998765432 2344679999999999863 368899999999999999999999986
Q ss_pred CCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 382 FYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....... ..... ....+.. . .....+.+++.+||+.||++|||+.+++++
T Consensus 307 ~~~~--~~~~~~i----~~~~~-~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 307 HRRQ--ILMLRMI----MEGQY-QFSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CSSH--HHHHHHH----HHTCC-CCCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCH--HHHHHHH----HhCCC-CCCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4321 1111111 00000 0000000 0 112457889999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.18 Aligned_cols=258 Identities=28% Similarity=0.384 Sum_probs=196.5
Q ss_pred hcCCCccccccccCCeeEEEEEec--CCC--EEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL--NGE--EVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.+.||+|+||.||+|++. +++ .||||.+... .....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467888999999999999999863 233 6899998754 2334578999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++
T Consensus 96 ~~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--------------HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 158 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--------------HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred eeeEecccCCCHHHHHHh--------------ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCC
Confidence 899999999999999963 2245889999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~ 393 (496)
.+||+|||++......... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~ 236 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHK 236 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHH
Confidence 9999999999876543221 12234567889999999999999999999999999999999 99888643221 11111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
...... .. .........+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 237 ---~~~~~~--~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 237 ---IDKEGE--RL-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---HHTSCC--CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---HHccCC--CC-------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111100 00 011122356788999999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.08 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=205.9
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC-CceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH-RNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.++||+|+||.||+|+. .+++.||||++..... ..++..|++++..++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999986 4689999998865432 2457899999999976 566666677778889999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ 317 (496)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 84 ~~-g~sL~~ll~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~v 145 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--------------CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQV 145 (483)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCE
T ss_pred CC-CCCHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeE
Confidence 99 9999999953 2345999999999999999999999998 9999999999999 688999
Q ss_pred EEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc-hhh
Q 040910 318 KISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLL 391 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~-~~~ 391 (496)
||+|||+++.+...... .......||..|+|||.+.+..++.++|||||||+||||++|+.||........ ...
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence 99999999876543321 122356799999999999999999999999999999999999999976443321 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
..... ......+ ..+.... ...+.+++..||+.+|++||++.+|+++|++++.
T Consensus 226 ~~i~~----~~~~~~~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 226 EKISE----KKVATSI-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHH----HHHHSCH-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhh----ccccccH-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11100 0000000 0011111 3567899999999999999999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.30 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=203.2
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 237 (496)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999875 68999999997543 2345678999999999999999999998854 568999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEecCCC
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~ 315 (496)
||||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGT-----------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEECCTTEEHHHHHHHHH-----------HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS
T ss_pred EEeCCCCCCHHHHHHhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC
Confidence 999999999999996532 22345899999999999999999999976 23499999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i- 228 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI- 228 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH-
Confidence 99999999998764322 1123357899999999999999999999999999999999999998643321 111111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
...... .+ .......+.+++.+||+.||++||++.+|++.+..
T Consensus 229 ---~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 229 ---REGKFR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---HHTCCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---hhcccc-----cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111110 11 11123567889999999999999999999987754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.75 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=197.2
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc-----CHHHHHHHHHHHHHhcCCceeeeeeeeeecCe
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ-----GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 234 (496)
...++|.+.+.||+|+||.||+|... +|+.||||.+...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999875 5899999998643211 12468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--------------NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN 148 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--------------CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eEEEEEcCCC-CHHHHHHh--------------cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCC
Confidence 9999999975 88888742 2346889999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+.+||+|||+++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+|+...... .....
T Consensus 149 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~ 224 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTR 224 (346)
T ss_dssp CCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred CCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHH
Confidence 999999999998764332 223446789999999999764 5899999999999999999999887643321 11111
Q ss_pred hhhhhcccccc---------cccCccccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 394 AWNLWKDDRAW---------KLLDPTLQNEAL-----YPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 394 ~~~~~~~~~~~---------~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
........... +.+......... ......+.+++.+||+.||++|||+.|++++-
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 11110000000 000000000001 11235688999999999999999999998863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.99 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=193.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999875 6889999999754322 122456799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
++ |+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 82 LD-KDLKQYLDD--------------CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp CS-EEHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECS
T ss_pred cc-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEcc
Confidence 97 689888853 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+++...... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 144 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~ 219 (324)
T 3mtl_A 144 FGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGT 219 (324)
T ss_dssp SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred CcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 99998654321 22334578999999999886 568999999999999999999999987543221 11111111000
Q ss_pred cc------------cccccCccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DR------------AWKLLDPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~------------~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ......+.... .........+.+++.+||+.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 00000000000 0011123467889999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=351.31 Aligned_cols=246 Identities=13% Similarity=0.170 Sum_probs=190.5
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHH---HHHHHhcCCceeeee-------ee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEM---ILIAKLHHRNLVRLF-------GC 228 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 228 (496)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999986 46899999999743 334457889999 455556899999998 55
Q ss_pred eeecC-----------------eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHh
Q 040910 229 CIEQG-----------------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYL 291 (496)
Q Consensus 229 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 291 (496)
+.+.+ ..++||||+ +|+|.+++...... ......+++..++.++.||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH--------SSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT--------TTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc--------ccccccccHHHHHHHHHHHHHHHHHH
Confidence 44442 278999999 68999999753211 11234567789999999999999999
Q ss_pred hhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccC-----------CCCcc
Q 040910 292 HQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-----------LFSIK 360 (496)
Q Consensus 292 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 360 (496)
|+.+ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 223 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 223 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 9998 99999999999999999999999999986432 2334567 999999999887 89999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 361 SDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 361 ~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
+|||||||++|||++|+.||......... . .+.. .. . .....+.+++.+||+.||++|||
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~--~------------~~~~-~~-~----~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGS--E------------WIFR-SC-K----NIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCS--G------------GGGS-SC-C----CCCHHHHHHHHHHTCSSGGGCCC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccch--h------------hhhh-hc-c----CCCHHHHHHHHHHcCCCchhCCC
Confidence 99999999999999999998643322110 0 0000 00 1 11256778999999999999999
Q ss_pred HHHHHH
Q 040910 441 MSEVVS 446 (496)
Q Consensus 441 ~~evl~ 446 (496)
+.++++
T Consensus 354 ~~e~l~ 359 (377)
T 3byv_A 354 PLQAME 359 (377)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.75 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=198.2
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4567889999999999999999885 588999999987766778899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|..++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 97 ~~~~~~l~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--------------LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp CCTTEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred eCCCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEE
Confidence 9999999999853 2345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
|||++...... ........||..|+|||++. +..++.++||||||+++|||++|..|+....... ...
T Consensus 160 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~--- 232 (302)
T 2j7t_A 160 DFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL--- 232 (302)
T ss_dssp CCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---
T ss_pred ECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH---
Confidence 99998643211 11123357899999999984 6778999999999999999999999986433211 111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... ........+ ......+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~-~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 233 KIAK-SDPPTLLTP-------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHH-SCCCCCSSG-------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHhc-cCCcccCCc-------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 110011111 112346788999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.05 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=201.6
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+++.. +|+.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467888999999999999999875 689999999986554455678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ 317 (496)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+
T Consensus 87 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 87 LVSGGELFDRILE---------------RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp CCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCE
T ss_pred cCCCccHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCE
Confidence 9999999999853 235889999999999999999999998 9999999999999 788999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|..||...... ......
T Consensus 149 kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i--- 219 (304)
T 2jam_A 149 MITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKI--- 219 (304)
T ss_dssp EBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH---
T ss_pred EEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---
Confidence 99999999765432 223356899999999999999999999999999999999999998643211 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .. ... ........+.+++.+||+.||++|||+.+++++
T Consensus 220 -~~~~~-~~-~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 220 -KEGYY-EF-ESP----FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -HHCCC-CC-CTT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -HcCCC-CC-Ccc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00100 00 001 111223567889999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=344.78 Aligned_cols=254 Identities=11% Similarity=0.058 Sum_probs=182.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---cCHHHHHHHHHHHHHh--cCCceeeee-------eee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNEMILIAKL--HHRNLVRLF-------GCC 229 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 229 (496)
..+|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999865 789999999986542 3355778887666666 599988755 333
Q ss_pred eec-----------------CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhH------HHHHHHHHH
Q 040910 230 IEQ-----------------GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR------VRIIEGIAQ 286 (496)
Q Consensus 230 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~ 286 (496)
... ...++||||++ |+|.+++... ...+++..+ ..++.||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------------~~~~~~~~~~~~~vk~~i~~qi~~ 205 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--------------DFVYVFRGDEGILALHILTAQLIR 205 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--------------HHSCCCCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--------------ccccchhhhhhhhhHHHHHHHHHH
Confidence 322 34799999998 9999999642 223455566 788899999
Q ss_pred HHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc--CCCCccccch
Q 040910 287 GLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH--GLFSIKSDVF 364 (496)
Q Consensus 287 ~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~ 364 (496)
||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||
T Consensus 206 aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 206 LAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 999999998 999999999999999999999999999876432 113466799999999987 7899999999
Q ss_pred hhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040910 365 SFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444 (496)
Q Consensus 365 S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 444 (496)
||||++|||++|+.||........... ........................+.+++.+||+.||++|||+.++
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGSW-------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTCC-------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccch-------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 999999999999999876533211100 0000000000011001111223567889999999999999999998
Q ss_pred HH
Q 040910 445 VS 446 (496)
Q Consensus 445 l~ 446 (496)
++
T Consensus 351 l~ 352 (371)
T 3q60_A 351 ME 352 (371)
T ss_dssp TT
T ss_pred hc
Confidence 74
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=333.08 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=199.4
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee--------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-------- 231 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 231 (496)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788999999999999999987 478999999986543 2335678899999999999999999999987
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--------------VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CceEEEEEeccCC-CHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEE
Confidence 4468999999974 77777642 2345899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCc--cccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcc
Q 040910 312 DGDMNPKISDFGIARMFGGDE--LQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~ 388 (496)
+.++.+||+|||+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999998765322 1222345678999999999876 5689999999999999999999999875432211
Q ss_pred hhhHhhhhhh-----------cccccccccCcccccc-CCHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 389 TLLGHAWNLW-----------KDDRAWKLLDPTLQNE-ALYPM------VKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 389 ~~~~~~~~~~-----------~~~~~~~~~d~~~~~~-~~~~~------~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ ......+.+....... ..... ...+.+++.+||+.||++|||++|++++
T Consensus 238 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 --LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp --HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11110000 0000000000000000 00111 2347889999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.43 Aligned_cols=269 Identities=22% Similarity=0.281 Sum_probs=198.9
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCcc-----------CHHHHHHHHHHHHHhcCCceee
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ-----------GVEEFKNEMILIAKLHHRNLVR 224 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~ 224 (496)
..++....++|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 56777889999999999999999999999888999999998643221 1378999999999999999999
Q ss_pred eeeeeeec-----CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCe
Q 040910 225 LFGCCIEQ-----GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRV 299 (496)
Q Consensus 225 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 299 (496)
+++++... ...++||||++ |+|..++.. ....+++..+..++.||+.||+|||+.+ |
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 155 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--------------QRIVISPQHIQYFMYHILLGLHVLHEAG---V 155 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 99998543 36899999997 688888752 3346899999999999999999999998 9
Q ss_pred eecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCC
Q 040910 300 IHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKK 378 (496)
Q Consensus 300 vH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~ 378 (496)
+||||||+|||++.++.+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999854432 22334578999999999887 679999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhccc-----------ccccccCccc-------cccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 379 NTRFYNIDSLTLLGHAWNLWKDD-----------RAWKLLDPTL-------QNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
||....... ............ .....+.... ...........+.+++.+||+.||.+|||
T Consensus 233 pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 233 LFRGSTFYN--QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp SCCCSSHHH--HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCHHH--HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 987533211 111111000000 0000000000 00001112346788999999999999999
Q ss_pred HHHHHHH
Q 040910 441 MSEVVSM 447 (496)
Q Consensus 441 ~~evl~~ 447 (496)
+.|++++
T Consensus 311 ~~ell~h 317 (362)
T 3pg1_A 311 TEQALRH 317 (362)
T ss_dssp HHHHHTS
T ss_pred HHHHHcC
Confidence 9999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.58 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=201.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 5779999998643 2234578999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 94 e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 155 (284)
T 2vgo_A 94 EFAPRGELYKELQK---------------HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155 (284)
T ss_dssp CCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEE
T ss_pred EeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEE
Confidence 99999999999853 235889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|..||....... ..... ..
T Consensus 156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---~~ 226 (284)
T 2vgo_A 156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRI---VN 226 (284)
T ss_dssp CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---HT
T ss_pred ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHHH---hc
Confidence 9999997654321 234578999999999999999999999999999999999999986432211 11100 00
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. +... .......+.+++.+||+.||.+||++.++++
T Consensus 227 -~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 227 -V------DLKF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -T------CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c------ccCC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 0011 1112346778999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=334.79 Aligned_cols=271 Identities=24% Similarity=0.360 Sum_probs=188.5
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999764 68899999986442 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++...... .......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 92 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAK-------GEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EECCTTCBHHHHHHHHHHT-------TTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ehhccCCchHHHHHHHhhc-------cccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEE
Confidence 9999999999999653221 1123456899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCcc---ccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 319 ISDFGIARMFGGDEL---QSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
|+|||++........ ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLT 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHH
Confidence 999999987643211 111234578999999999876 56899999999999999999999998754332211 000
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.............++.... .....+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000000011111111 123467789999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=339.16 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=192.1
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc--cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG--QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
....++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999764 688999999975432 23456789999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe-----
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----- 311 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----- 311 (496)
+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK---------------NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEEECCS-EEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC---
T ss_pred EEEecCC-CCHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCC
Confidence 9999997 599999853 235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+.++.+||+|||+++...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~ 246 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--Q 246 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H
T ss_pred CccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--H
Confidence 455569999999998764322 223445789999999999874 58999999999999999999999986533211 1
Q ss_pred hHhhhhhhcc--cc---------cccccCccccccCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 391 LGHAWNLWKD--DR---------AWKLLDPTLQNEALY-----PMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 391 ~~~~~~~~~~--~~---------~~~~~d~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.......... .. .+....+........ .....+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1111000000 00 000000000000000 02356789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.57 Aligned_cols=271 Identities=24% Similarity=0.394 Sum_probs=198.6
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..++|.+.+.||+|+||.||+|+..+ .||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..++|+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45788899999999999999998743 59999987432 334466888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||
T Consensus 109 e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l 170 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--------------AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVI 170 (319)
T ss_dssp BCCCSEEHHHHTTS--------------SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEE
T ss_pred ecccCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEE
Confidence 99999999999842 2346899999999999999999999998 99999999999998 679999
Q ss_pred eccccccccCCCc---cccccccccccccccChhhhcc---------CCCCccccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040910 320 SDFGIARMFGGDE---LQSNMNRIVGTYGYMSPEYALH---------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387 (496)
Q Consensus 320 ~DFgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~ 387 (496)
+|||+++...... .........||..|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999987653221 1122334568999999999874 457899999999999999999999986432211
Q ss_pred chhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchhh
Q 040910 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSYV 466 (496)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~~ 466 (496)
..... ... ..+..... .....+.+++..||+.||++|||+.+++++|+.+.........|..+|.
T Consensus 251 --~~~~~----~~~-----~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 251 --IIWQM----GTG-----MKPNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp --HHHHH----HTT-----CCCCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred --HHHHh----ccC-----CCCCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 11111 111 11111110 1123577899999999999999999999999998766666666665554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.07 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999875 68899999997543 3335678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp CCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEE
T ss_pred CCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEE
Confidence 9999999999953 23588999999999999999999985 7 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh------
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH------ 393 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~------ 393 (496)
+|||++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 174 ~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 174 CDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp CCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred EECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 99999975432 12234578999999999999999999999999999999999999987543221110000
Q ss_pred ----hhhhhc--------------ccccccccCccc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 ----AWNLWK--------------DDRAWKLLDPTL----QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ----~~~~~~--------------~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... .....+.++... ...........+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 000000000000 000001123467889999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=349.44 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=202.0
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
..++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567899999999999999999875 6899999998643 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec---CCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDM 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~ 315 (496)
+||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++
T Consensus 100 ~e~~~~~~L~~~~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---------------RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp ECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTC
T ss_pred EEcCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCC
Confidence 999999999988853 345899999999999999999999998 99999999999995 566
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .......
T Consensus 162 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~ 235 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVE 235 (486)
T ss_dssp CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred CEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence 79999999998765332 2344679999999999876 5999999999999999999999998643321 1111110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....+. .......+.+++.+||+.||.+|||+.+++++
T Consensus 236 ----~~~~-~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 236 ----TGKY-AFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----HTCC-CSCSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----hCCC-CCCCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000011 01123467789999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.88 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=203.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999875 78999999996442 34577899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---cCCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL---DGDM 315 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~ 315 (496)
+||+.+|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 105 ~e~~~~~~L~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 105 GEVYTGGELFDEII---------------SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp ECCCCSCBHHHHHH---------------TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTC
T ss_pred EecCCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCC
Confidence 99999999999885 2346899999999999999999999998 9999999999999 5678
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .......
T Consensus 167 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~ 240 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVE 240 (484)
T ss_dssp CEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred cEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
Confidence 99999999998765432 2344579999999999876 6999999999999999999999998753321 1111110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....+. .......+.+++.+||+.||.+|||+.+++++
T Consensus 241 ----~~~~-~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 ----KGKY-TFELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----HCCC-CCCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cCCC-CCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0100 000010 01123567789999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.50 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=203.3
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888999999999999999875 57899999986542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~e~~~~~~L~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 94 LELCRRRSLLELHKR---------------RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EECCTTCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEE
Confidence 999999999998853 345899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+........ . ...
T Consensus 156 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~ 227 (294)
T 2rku_A 156 IGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--Y----LRI 227 (294)
T ss_dssp ECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHH
T ss_pred EEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHH
Confidence 99999998764322 223345789999999999999999999999999999999999999864332111 0 000
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... . .+ .......+.+++.+||+.||++|||+.+++++
T Consensus 228 ~~~~---~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 KKNE---Y---SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HTTC---C---CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhcc---C---CC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1010 0 00 01112457789999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.42 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=195.0
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|... +|+.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999875 6899999998643 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 90 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---------------HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EECCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEE
T ss_pred EeccCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEE
Confidence 999999999999953 235889999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|||++....... ......+|+.|+|||.+.+..+ +.++||||||+++|||++|+.|+...... ......
T Consensus 152 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~--- 223 (276)
T 2h6d_A 152 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKI--- 223 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---
T ss_pred EeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHh---
Confidence 99999998765432 1234578999999999988765 68999999999999999999998643211 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ...+ ......+.+++.+||+.||.+|||+.+++++
T Consensus 224 -~~~~---~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 224 -RGGV---FYIP-------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -HHCC---CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hcCc---ccCc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1010 0001 1112457789999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=332.75 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=185.6
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc-cC-HHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG-QG-VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.++|++.+.||+|+||.||++.. .+|+.||||++..... .. .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999987 4789999999975422 22 233444555577779999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
||++ |+|.+++.... .....+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+|
T Consensus 86 e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVI-----------DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp ECCS-EEHHHHHHHHH-----------HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEE
T ss_pred ehhc-cchHHHHHHHH-----------hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEE
Confidence 9997 68888875422 2345699999999999999999999998 7 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhh----ccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA----LHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
|+|||+++...... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.|+.............
T Consensus 151 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~- 226 (290)
T 3fme_A 151 MCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV- 226 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH-
T ss_pred EeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH-
Confidence 99999998765332 22334789999999996 56678999999999999999999999986433221111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
..... +.... ......+.+++.+||+.||++|||+.|+++
T Consensus 227 ---~~~~~------~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 ---VEEPS------PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---HHSCC------CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---hccCC------CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11100 11101 112356788999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=331.71 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=199.3
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeee--cCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIE--QGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv 238 (496)
.++|++.+.||+|+||.||+|.. .+++.||||.+.. ...+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46788999999999999999976 4789999999864 33578999999999997 9999999999988 5678999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ce
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ 317 (496)
|||+++++|..++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 112 ~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp EECCCCCCHHHHGG------------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EeccCchhHHHHHH------------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEE
Confidence 99999999988873 2788899999999999999999998 99999999999999776 89
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++...... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.... .
T Consensus 171 kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~-~ 246 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-K 246 (330)
T ss_dssp EECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-H
T ss_pred EEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH-H
Confidence 999999998765432 2334578999999999987 6799999999999999999999999854332211111100 0
Q ss_pred hhccccccc-------ccCc----------------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWK-------LLDP----------------TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~-------~~d~----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........+ ..++ .............+.+++.+||+.||.+|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 0000 00001111124567889999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.76 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=199.4
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
..++|.+.+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568899999999999999999875 58999999997543 45788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 105 ~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 105 YCGAGSVSDIIRL--------------RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp CCTTEEHHHHHHH--------------HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred cCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEe
Confidence 9999999999852 2345899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||++....... .......||..|+|||.+.+..++.++||||||+++|||++|..||....... . .... ..
T Consensus 168 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~-~~ 239 (314)
T 3com_A 168 DFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--A---IFMI-PT 239 (314)
T ss_dssp CCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHH-HH
T ss_pred ecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--H---HHHH-hc
Confidence 999998764332 22334578999999999999999999999999999999999999986432111 0 0000 00
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........+ ......+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 NPPPTFRKP-------ELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SCCCCCSSG-------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCcccCCc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111 1123567889999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.81 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=193.9
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999987 468999999986432 223567889999999999999999999998663
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+ +++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 163 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred eEEEEEecC-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcC
Confidence 469999999 8999999842 34889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++..... .....+|..|+|||++.+ ..++.++|||||||+++||++|+.||....... ...
T Consensus 164 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~ 236 (367)
T 1cm8_A 164 DCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLK 236 (367)
T ss_dssp TCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH
T ss_pred CCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999875432 334578999999999987 689999999999999999999999987543211 111
Q ss_pred hhhhh-----------hcccccc-------cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNL-----------WKDDRAW-------KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~-----------~~~~~~~-------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... +...... ......+ ..........+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 10000 0000000 0000000 01111223567889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=337.51 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=204.2
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccC-----------------HHHHHHHHHHHHHhcCCceeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQG-----------------VEEFKNEMILIAKLHHRNLVRL 225 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 225 (496)
.++|.+.+.||+|+||.||+|.. +|+.||||.+....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999998 99999999986432111 1789999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCC
Q 040910 226 FGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDL 304 (496)
Q Consensus 226 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dl 304 (496)
++++.+.+..++||||+++|+|.+++...... .......+++..+..++.||+.||+|||+ .+ |+||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l-------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl 178 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVL-------DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV 178 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESS-------CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhh-------hhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence 99999999999999999999999884211100 11225679999999999999999999998 87 999999
Q ss_pred CCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccC-CCCc-cccchhhhHHHHHHHhCCCCCCC
Q 040910 305 KASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSI-KSDVFSFGVLLLETLSSKKNTRF 382 (496)
Q Consensus 305 k~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gvvl~elltg~~~~~~ 382 (496)
||+|||++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|..||..
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999876433 23446789999999999887 6766 99999999999999999999875
Q ss_pred CCCCcchhhHhhhhh-hccc-ccccccCc---cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 383 YNIDSLTLLGHAWNL-WKDD-RAWKLLDP---TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~-~~~~-~~~~~~d~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ......... .... .......+ .............+.+++.+||+.||.+|||+.|++++
T Consensus 255 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLV-ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSH-HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHH-HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 44321 111111000 0000 00000000 00000012223567889999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=349.92 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=197.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+.|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999875 68899999997542 344678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---CCc
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG---DMN 316 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~ 316 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.
T Consensus 116 e~~~~g~L~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 116 ECYKGGELFDEIIH---------------RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp ECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred ecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCc
Confidence 99999999988853 345889999999999999999999998 999999999999976 455
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .......
T Consensus 178 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~- 250 (494)
T 3lij_A 178 IKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVE- 250 (494)
T ss_dssp EEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-
T ss_pred EEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-
Confidence 9999999998765432 234467999999999886 56999999999999999999999998753321 1111110
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ....+.. ......+.+++.+||+.||.+|||+.+++++
T Consensus 251 ---~~~~-~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 251 ---KGKY-TFDSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---HTCC-CCCSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---hCCC-CCCchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000 0111111 1123467789999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=334.88 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=203.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999999999875 57899999986542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 120 ~e~~~~~~L~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 120 LELCRRRSLLELHKR---------------RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp ECCCTTCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEE
Confidence 999999999998853 345899999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||........ .. ..
T Consensus 182 l~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~ 253 (335)
T 2owb_A 182 IGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--YL----RI 253 (335)
T ss_dssp ECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HH
T ss_pred EeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--HH----HH
Confidence 99999998764322 223345789999999999999999999999999999999999999864332111 00 00
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... ..+.. .....+.+++.+||+.||++|||+.+++++
T Consensus 254 ~~~~------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 KKNE------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHTC------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hcCC------CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00101 112456789999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=360.17 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=211.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467889999999999999999875 5789999999743 234567788899999988 79999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++
T Consensus 420 V~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~i 481 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---------------VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHI 481 (674)
T ss_dssp EEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCE
T ss_pred EEeCcCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcE
Confidence 9999999999999953 245899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 482 kL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i--- 554 (674)
T 3pfq_A 482 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSI--- 554 (674)
T ss_dssp EECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---
T ss_pred EEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHH---
Confidence 999999998643222 2344568999999999999999999999999999999999999998753321 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH--Hhc------cccCCCCCCCCcch
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM-----SEVVSM--IKN------EIVNLPSPQQPAFS 464 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~~--L~~------~~~~~~~p~~~~~~ 464 (496)
.. .. . ..+......+.+++..||+.||++||++ +||+++ +++ ....+++|..|...
T Consensus 555 ~~-~~---~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 555 ME-HN---V-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp HS-SC---C-------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred Hh-CC---C-------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 11 11 0 0111223567889999999999999997 676643 111 11345667777654
Q ss_pred h
Q 040910 465 Y 465 (496)
Q Consensus 465 ~ 465 (496)
.
T Consensus 624 ~ 624 (674)
T 3pfq_A 624 G 624 (674)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.18 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=197.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC----ccCHHHHHHHHHHHHHhcCCceeeeeeeee--ecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS----GQGVEEFKNEMILIAKLHHRNLVRLFGCCI--EQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 235 (496)
.++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 68899999996432 234578999999999999999999999984 45688
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||++++ |.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 84 ~lv~e~~~~~-l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~ 146 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-------------VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGG 146 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-------------STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEehhccCC-HHHHHHh-------------CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCC
Confidence 9999999876 7677643 23456899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCC--CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
.+||+|||++................||..|+|||++.+.. ++.++||||||+++|||++|+.||...... .....
T Consensus 147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~ 224 (305)
T 2wtk_C 147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFEN 224 (305)
T ss_dssp CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHH
Confidence 99999999998765433333344567899999999998654 478999999999999999999998643211 11111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ..... .....+.+++.+||+.||.+|||+.+++++
T Consensus 225 ----i~~~~------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 ----IGKGS------YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----HHHCC------CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HhcCC------CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11010 00111 123467789999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.85 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=166.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Ce
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 234 (496)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999874 57899999997532 23456789999999999999999999999876 57
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+. |+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---------------~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~ 165 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---------------TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred EEEEEecCC-cCHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCC
Confidence 899999986 69999884 2356899999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccc--------------------cccccccccccccChhhh-ccCCCCccccchhhhHHHHHH
Q 040910 315 MNPKISDFGIARMFGGDELQ--------------------SNMNRIVGTYGYMSPEYA-LHGLFSIKSDVFSFGVLLLET 373 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el 373 (496)
+.+||+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||
T Consensus 166 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~el 245 (432)
T 3n9x_A 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245 (432)
T ss_dssp CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHH
Confidence 99999999999976543211 123556899999999986 566799999999999999999
Q ss_pred HhCCCCC
Q 040910 374 LSSKKNT 380 (496)
Q Consensus 374 ltg~~~~ 380 (496)
++|..|+
T Consensus 246 l~g~~p~ 252 (432)
T 3n9x_A 246 LNMLQSH 252 (432)
T ss_dssp HTTCTTT
T ss_pred Hhccccc
Confidence 9865544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.78 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=200.1
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-------------cCHHHHHHHHHHHHHhcCCceeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-------------QGVEEFKNEMILIAKLHHRNLVRLFG 227 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~ 227 (496)
..++|.+.++||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 578999999875321 34578899999999999999999999
Q ss_pred eeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 228 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---------------RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE 175 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHH
Confidence 99999999999999999999998853 345899999999999999999999998 999999999
Q ss_pred CEEecCCC---ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 308 NVLLDGDM---NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 308 NIll~~~~---~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
|||++.++ .+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998776 69999999998765432 234467999999999987 469999999999999999999999987533
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ...... ..... ..+..... .....+.+++.+||+.||.+|||+.|++++
T Consensus 252 ~~--~~~~~i----~~~~~--~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 252 DQ--DIIKKV----EKGKY--YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH--HHHHHH----HHCCC--CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--HHHHHH----HcCCC--CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21 111111 00100 00000000 113567889999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=331.34 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=195.7
Q ss_pred HHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhc--CCceeeeeeeeeecCeeE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~ 236 (496)
...++|.+.+.||+|+||.||++...+++.||||.+.... ....+.+.+|+.++.+++ ||||+++++++.+.+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3457789999999999999999998889999999997543 334578899999999997 599999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++ +.
T Consensus 105 lv~e-~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK---------------KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EEEC-CCSEEHHHHHHH---------------CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TE
T ss_pred EEEe-cCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-Ce
Confidence 9999 568999999953 346889999999999999999999998 999999999999965 89
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhcc-----------CCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-----------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
+||+|||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 99999999987654433223344578999999999875 4788999999999999999999999864322
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 448 (496)
.... .... +++.............+.+++.+||+.||.+||++.+++++-
T Consensus 245 ~~~~----~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 245 QISK----LHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHH----HHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHH----HHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111 1111 111110011111124677899999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=326.41 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=196.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 236 (496)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999874 5789999998743 23345678999999999999999999999875 35689
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCC
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDM 315 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~ 315 (496)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++
T Consensus 106 lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTS
T ss_pred EEEEecCCCCHHHHHHH---------------ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCC
Confidence 99999999999999953 245889999999999999999999875 3499999999999998 889
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||++...... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||........ ....
T Consensus 170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~-- 241 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRR-- 241 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHH--
T ss_pred CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-HHHH--
Confidence 9999999999765432 223457899999999876 4599999999999999999999999864332111 1111
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... ........ ...+.+++.+||+.||.+|||+.+++++
T Consensus 242 --~~~~~~----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 242 --VTSGVK----PASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --HTTTCC----CGGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HhccCC----ccccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111100 01111111 2457889999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=338.85 Aligned_cols=263 Identities=21% Similarity=0.225 Sum_probs=195.5
Q ss_pred HHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------ 232 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 232 (496)
....++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34667899999999999999999986 4789999999865432 234699999999999999999998543
Q ss_pred --------------------------------CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHH
Q 040910 233 --------------------------------GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280 (496)
Q Consensus 233 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 280 (496)
...++||||++ |+|.+.+..+. .....+++..+..+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~l~~~~~~~i 146 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-----------RSGRSIPMNLISIY 146 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHH-----------HTTCCCCHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-----------hcCCCCCHHHHHHH
Confidence 34889999997 68888876432 23456899999999
Q ss_pred HHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCCceEEeccccccccCCCccccccccccccccccChhhhccC-CCC
Q 040910 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFS 358 (496)
Q Consensus 281 ~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 358 (496)
+.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|..|+|||++.+. .++
T Consensus 147 ~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 147 IYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCC
Confidence 999999999999998 99999999999998 68999999999998764432 22345789999999998875 489
Q ss_pred ccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc----------ccccccCccc-----cccCCHHHHHHH
Q 040910 359 IKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD----------RAWKLLDPTL-----QNEALYPMVKRY 423 (496)
Q Consensus 359 ~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~~-----~~~~~~~~~~~l 423 (496)
.++|||||||++|||++|+.||....... ............ ...+..-+.. ...........+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 99999999999999999999987533211 111110000000 0000000110 000111123567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 040910 424 IKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 424 ~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.+++.+||+.||.+|||+.|+++
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=334.34 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=197.6
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee----
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE---- 231 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---- 231 (496)
++....++|.+.+.||+|+||.||+|+.. +++.||||.+.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33446788999999999999999999874 68999999996543 3457889999999999 89999999999987
Q ss_pred --cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 232 --QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 232 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
.+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NI 160 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-------------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 160 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHE
Confidence 46889999999999999999641 2346889999999999999999999998 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
|++.++.+||+|||++....... .......||..|+|||++. +..++.++||||||+++|||++|..|+....
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999998764321 1223457899999999987 5678999999999999999999999986432
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... . ...... .. .+..... .....+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~--~---~~~~~~-~~-----~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 239 PMR--A---LFLIPR-NP-----APRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHH--H---HHHHHH-SC-----CCCCSCS---CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH--H---HHHhhc-Cc-----cccCCcc---ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 1 110000 10 1111111 113467789999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.83 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=200.6
Q ss_pred HhcCCCccccccccCCeeEEEEEe--cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHh---cCCceeeeeeeee----
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL--LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKL---HHRNLVRLFGCCI---- 230 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 230 (496)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 567899999999999999999987 367899999986432 22234667788888777 8999999999987
Q ss_pred -ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 040910 231 -EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNV 309 (496)
Q Consensus 231 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NI 309 (496)
.....++||||++ |+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Ni 151 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDK-------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 151 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHH-------------SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CCCceEEEEEecCC-CCHHHHHHh-------------cccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHe
Confidence 5567899999997 799999864 22345899999999999999999999998 99999999999
Q ss_pred EecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch
Q 040910 310 LLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389 (496)
Q Consensus 310 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~ 389 (496)
|++.++.+||+|||+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 152 li~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 226 (326)
T 1blx_A 152 LVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--D 226 (326)
T ss_dssp EECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred EEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--H
Confidence 9999999999999999876432 2234467899999999999999999999999999999999999998754321 1
Q ss_pred hhHhhhhhhccc---ccc-------ccc---CccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 390 LLGHAWNLWKDD---RAW-------KLL---DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 390 ~~~~~~~~~~~~---~~~-------~~~---d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
............ ... ... ...............+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111000000 000 000 0000001111223567789999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=342.31 Aligned_cols=199 Identities=21% Similarity=0.261 Sum_probs=172.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHh------cCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKL------HHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 235 (496)
..+|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457899999999999999999764 5889999999643 23346788899999888 567999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+. ++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 175 ~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKK-------------NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQG 237 (429)
T ss_dssp EEEECCCC-CBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTT
T ss_pred EEEEeccC-CCHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCC
Confidence 99999995 799888864 22345899999999999999999999998 99999999999999998
Q ss_pred c--eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 316 N--PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 316 ~--~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7 999999999765422 334578999999999999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=330.97 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=195.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--------ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--------GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467899999999999999999874 57899999986432 12234688999999999999999999998765
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
+ .++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---------------GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 148 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEES
T ss_pred c-eEEEEecCCCCcHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEe
Confidence 5 899999999999999883 2346899999999999999999999998 99999999999998
Q ss_pred CCCc---eEEeccccccccCCCccccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 313 GDMN---PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 313 ~~~~---~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
.++. +||+|||+++...... ......||..|+|||++. +..++.++||||||+++|||++|..||......
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 7664 9999999998765332 123457899999999974 567899999999999999999999998754332
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. +..... .... ...+.... .....+.+++.+||+.||++||++.++++
T Consensus 226 ~~-~~~~~~----~~~~--~~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 VS-LKDQIT----SGKY--NFIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SC-HHHHHH----HTCC--CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHHHHH----hCcc--ccCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11 111110 0000 00111111 12356788999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=338.23 Aligned_cols=262 Identities=19% Similarity=0.214 Sum_probs=201.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc--------CCceeeeeeeee---
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH--------HRNLVRLFGCCI--- 230 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--- 230 (496)
.++|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999764 6889999999643 334567899999999995 788999999988
Q ss_pred -ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCC
Q 040910 231 -EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASN 308 (496)
Q Consensus 231 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~N 308 (496)
+....++||||+ +++|..++.. .....+++..+..++.||+.||+|||+. + |+||||||+|
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~N 177 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK-------------SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPEN 177 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH-------------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGG
T ss_pred CCCceEEEEEecc-CccHHHHHHh-------------cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 556899999999 6666666643 2234689999999999999999999998 7 9999999999
Q ss_pred EEecCCC-------------------------------------------------ceEEeccccccccCCCcccccccc
Q 040910 309 VLLDGDM-------------------------------------------------NPKISDFGIARMFGGDELQSNMNR 339 (496)
Q Consensus 309 Ill~~~~-------------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~ 339 (496)
||++.++ .+||+|||+++..... ...
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~ 252 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTE 252 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----Ccc
Confidence 9999775 7999999999876422 334
Q ss_pred ccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch----hhHhhhhhhcc---------------
Q 040910 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT----LLGHAWNLWKD--------------- 400 (496)
Q Consensus 340 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~----~~~~~~~~~~~--------------- 400 (496)
..||..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 57899999999999999999999999999999999999999754433211 00000000000
Q ss_pred ----cccccccCcc---------ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 ----DRAWKLLDPT---------LQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ----~~~~~~~d~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.....+.+.. -...........+.+++.+||+.||++|||+.|++++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000000000 0012345666788999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=336.51 Aligned_cols=259 Identities=22% Similarity=0.240 Sum_probs=191.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468899999999999999999764 68899999997532 233467889999999999999999999997665
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||++ |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~ 162 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred ceEEEEEcCC-CCHHHHHh-----------------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcC
Confidence 7899999996 57877773 23789999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 163 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~ 237 (371)
T 2xrw_A 163 DCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNK 237 (371)
T ss_dssp TSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred CCCEEEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 999999999999866432 12334678999999999999999999999999999999999999987543211 0000
Q ss_pred hhhh-------------------hccc------ccccccCcccccc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 394 AWNL-------------------WKDD------RAWKLLDPTLQNE---ALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 394 ~~~~-------------------~~~~------~~~~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.... .... ...+.......+. ........+.+++.+||+.||++|||++|++
T Consensus 238 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 317 (371)
T 2xrw_A 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317 (371)
T ss_dssp HHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHh
Confidence 0000 0000 0000000000000 0112356788999999999999999999998
Q ss_pred HH
Q 040910 446 SM 447 (496)
Q Consensus 446 ~~ 447 (496)
++
T Consensus 318 ~h 319 (371)
T 2xrw_A 318 QH 319 (371)
T ss_dssp HS
T ss_pred CC
Confidence 75
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.42 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=201.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc---------cCHHHHHHHHHHHHHhc-CCceeeeeeeee
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---------QGVEEFKNEMILIAKLH-HRNLVRLFGCCI 230 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 230 (496)
..++|.+.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 688999999975431 12456889999999995 999999999999
Q ss_pred ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 231 EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 231 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil 156 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---------------KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENIL 156 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEE
Confidence 99999999999999999999953 345899999999999999999999998 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhc------cCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
++.++.+||+|||++....... ......||..|+|||++. ...++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999999999998765432 233457899999999985 4568899999999999999999999986432
Q ss_pred CCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 385 IDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.. ...... ..... ....+. .......+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~--~~~~~~----~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 QM--LMLRMI----MSGNY-QFGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH--HHHHHH----HHTCC-CCCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH--HHHHHH----hcCCc-ccCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 111111 00000 011110 1122356788999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=339.33 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=193.5
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe------eEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE------KIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~l 237 (496)
.+|...+.||+|+||.||+|+...+..||+|++...... ..+|+.+++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999877777999998654322 2469999999999999999999965543 789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCCc
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMN 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~ 316 (496)
||||++++.+..... +. .....+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.
T Consensus 116 v~e~~~~~l~~~~~~-~~-----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 116 VLEYVPETVYRASRH-YA-----------KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp EEECCSEEHHHHHHH-HH-----------HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred EeeccCccHHHHHHH-HH-----------hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCc
Confidence 999998655443332 11 23456899999999999999999999998 99999999999999 7999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ .....
T Consensus 181 ~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~ 255 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEII 255 (394)
T ss_dssp EEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999998764332 22345789999999999765 589999999999999999999999875432111 11110
Q ss_pred hhhcc----------cccccccCcccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 396 NLWKD----------DRAWKLLDPTLQ-----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 396 ~~~~~----------~~~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ....+..-+... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 000000000000 00111123568899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.26 Aligned_cols=269 Identities=23% Similarity=0.264 Sum_probs=190.9
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe--
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE-- 234 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 234 (496)
......++|.+.+.||+|+||.||+|+.. +|+.||||++.... .....+.+++..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34567789999999999999999999874 68999999986543 333466788899999999999999999976543
Q ss_pred -----eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCC
Q 040910 235 -----KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLH--QYSRLRVIHRDLKAS 307 (496)
Q Consensus 235 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlk~~ 307 (496)
.++||||+++ +|...+.... .....+++..+..++.|++.||.||| +.+ |+||||||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~ 160 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYY-----------RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPH 160 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHH-----------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGG
T ss_pred ccceeEEEEeecccc-cHHHHHHHHh-----------hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHH
Confidence 7899999975 5554443221 23456889999999999999999999 777 999999999
Q ss_pred CEEecC-CCceEEeccccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 308 NVLLDG-DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 308 NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
|||++. ++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999997 8999999999998765432 223457899999999987654 89999999999999999999999875432
Q ss_pred CcchhhHhhhhhhccc--ccccccCc----------------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 386 DSLTLLGHAWNLWKDD--RAWKLLDP----------------TLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~--~~~~~~d~----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ............ .....+++ .............+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 238 AG--QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HH--HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HH--HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 21 111111000000 00000000 00011111235678899999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=335.05 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=200.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Cee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 235 (496)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 688999999975332 3346789999999999999999999998765 368
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+. |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 106 ~iv~e~~~-~~L~~~l~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~ 165 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 165 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred EEEEcccC-cCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCC
Confidence 99999996 689888842 34899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCccc-cccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 316 NPKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~ 243 (364)
T 3qyz_A 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNH 243 (364)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHH
T ss_pred CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHH
Confidence 9999999999876533221 12344689999999998764 5589999999999999999999999875433221 111
Q ss_pred hhhhhcccc---c------------ccccCcccc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDR---A------------WKLLDPTLQ--NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~---~------------~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
......... . .....+... ..........+.+++.+||+.||++|||+.|++++
T Consensus 244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110000000 0 000000000 00001123467899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=327.07 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=202.1
Q ss_pred hcCCCccccccccCCeeEEEEEe--cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc------eeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL--LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN------LVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++..++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999986 36889999999643 234567899999999997654 9999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG- 313 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~- 313 (496)
.++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKE-------------NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQS 154 (339)
T ss_dssp EEEEEECC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCC
T ss_pred EEEEEcCC-CCCHHHHHHh-------------cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecc
Confidence 99999999 8999999864 22345889999999999999999999998 999999999999987
Q ss_pred ------------------CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh
Q 040910 314 ------------------DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375 (496)
Q Consensus 314 ------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt 375 (496)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 678999999999865422 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhh-----------ccccc------------------ccccCccc-cccCCHHHHHHHHH
Q 040910 376 SKKNTRFYNIDSLTLLGHAWNLW-----------KDDRA------------------WKLLDPTL-QNEALYPMVKRYIK 425 (496)
Q Consensus 376 g~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~------------------~~~~d~~~-~~~~~~~~~~~l~~ 425 (496)
|..||........ ........ ..... .+...+.. ...........+.+
T Consensus 230 g~~pf~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 230 GFTVFPTHDSKEH--LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp SSCSCCCSCHHHH--HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 9999875432211 00000000 00000 00000000 01112344577889
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 040910 426 VALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 426 l~~~cl~~~p~~RPs~~evl~~ 447 (496)
++.+||+.||.+|||+.|++++
T Consensus 308 li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCcCcccccCHHHHhcC
Confidence 9999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.02 Aligned_cols=271 Identities=22% Similarity=0.313 Sum_probs=182.7
Q ss_pred CCCc-cccccccCCeeEEEEEec---CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEEE
Q 040910 165 NFSE-ENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKILI 238 (496)
Q Consensus 165 ~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 238 (496)
.|.+ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 458999999999999875 57899999996532 23578899999999999999999999954 6789999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe----cCC
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL----DGD 314 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~ 314 (496)
|||+. |+|..++....... .......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASK------ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTT
T ss_pred EeCCC-CCHHHHHHHhcccc------ccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCC
Confidence 99996 57877775432110 1112335899999999999999999999998 9999999999999 778
Q ss_pred CceEEeccccccccCCCc-cccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCc-----
Q 040910 315 MNPKISDFGIARMFGGDE-LQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS----- 387 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~----- 387 (496)
+.+||+|||+++.+.... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+.
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 999999999998765332 11223456889999999999874 58999999999999999999999996543321
Q ss_pred --chhhHhhhhhhccc--ccccc-------------cCccccccCCH---------HHHHHHHHHHHHhcccCCCCCCCH
Q 040910 388 --LTLLGHAWNLWKDD--RAWKL-------------LDPTLQNEALY---------PMVKRYIKVALLCVQENAADRPTM 441 (496)
Q Consensus 388 --~~~~~~~~~~~~~~--~~~~~-------------~d~~~~~~~~~---------~~~~~l~~l~~~cl~~~p~~RPs~ 441 (496)
.............. ..+.. +.......... .....+.+|+.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 01111110000000 00000 00000000000 002457789999999999999999
Q ss_pred HHHHHH
Q 040910 442 SEVVSM 447 (496)
Q Consensus 442 ~evl~~ 447 (496)
+|++++
T Consensus 329 ~e~L~h 334 (405)
T 3rgf_A 329 EQAMQD 334 (405)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=337.39 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=182.5
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------C
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------G 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 233 (496)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999986 468899999986532 23456788999999999999999999998754 5
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++|+||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~ 167 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 167 (367)
T ss_dssp CCEEEEECC-CEECC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEeccc-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECC
Confidence 679999999 789988873 245899999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 168 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~ 240 (367)
T 2fst_X 168 DCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLK 240 (367)
T ss_dssp TCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred CCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 999999999999865422 334578999999999987 68999999999999999999999998754321 1111
Q ss_pred hhhhhhcc-----------cccccccC--ccccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNLWKD-----------DRAWKLLD--PTLQNEAL-----YPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~~~~-----------~~~~~~~d--~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ ......+. +.. .... ......+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 241 LILRLVGTPGAELLKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC-CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC-CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11110000 00000000 000 0000 0113457889999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=359.65 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred HhcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998742 4579999987543 233468999999999999999999999985 45689
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 467 lv~E~~~~g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--------------RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp EEEECCTTCBHHHHHHH--------------TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEEEcCCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCC
Confidence 99999999999999953 2345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .......
T Consensus 530 vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~ 606 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE 606 (656)
T ss_dssp EEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred EEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH
Confidence 999999999876543221 2233467889999999999999999999999999999997 88887643221 1111110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.... +. ........+.+++.+||+.||++|||+.+|++.|+.++
T Consensus 607 ----~~~~-----~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 607 ----NGER-----LP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ----HTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCC-----CC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0100 00 11122356788999999999999999999999998864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=329.34 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=193.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeee-----------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCI----------- 230 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----------- 230 (496)
.++|.+.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467888999999999999999875 48999999998666566778999999999999999999998873
Q ss_pred ---ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 231 ---EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 231 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
+....++||||++ |+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 149 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----------------QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG
T ss_pred cccccCceeEEeeccC-CCHHHHhh----------------cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 4467899999997 79999883 235889999999999999999999998 999999999
Q ss_pred CEEec-CCCceEEeccccccccCCCcc-ccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 308 NVLLD-GDMNPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 308 NIll~-~~~~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
|||++ +++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99997 577999999999987643211 122334567899999998875 678999999999999999999999987543
Q ss_pred CCcchhhHhhhhhhc---cccccc---cc---------Cccc-cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 385 IDSLTLLGHAWNLWK---DDRAWK---LL---------DPTL-QNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 385 ~~~~~~~~~~~~~~~---~~~~~~---~~---------d~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .......... .....+ .+ .+.. ...........+.+++.+||+.||++|||+++++++
T Consensus 230 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 230 ELE--QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHH--HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHH--HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 211 1111000000 000000 00 0000 000001123568899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.96 Aligned_cols=260 Identities=24% Similarity=0.297 Sum_probs=192.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------eeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------EKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~ 236 (496)
.+|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|||||++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999885 589999999865332 2346999999999999999999986432 367
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC-C
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-M 315 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~ 315 (496)
+||||+++ +|..++..+. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +
T Consensus 130 lv~e~~~~-~l~~~~~~~~-----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~ 194 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS-----------RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTA 194 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH-----------HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTT
T ss_pred eehhcccc-cHHHHHHHHh-----------hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCC
Confidence 99999975 6666654321 23456899999999999999999999988 9999999999999965 5
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
.+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 195 ~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i 269 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEI 269 (420)
T ss_dssp EEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH
T ss_pred eEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 68999999998764332 12345789999999999765 79999999999999999999999987543211 11111
Q ss_pred hhhhc----------ccccccccCcccccc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWK----------DDRAWKLLDPTLQNE-----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~----------~~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... .....+...+.+... ........+.+|+.+||+.||.+||++.|++++
T Consensus 270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11000 000001111111100 111123568899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.06 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=194.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee---
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK--- 235 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 235 (496)
..++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468889999999999999999864 68999999997542 22356788999999999999999999999877655
Q ss_pred ---EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 236 ---ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 236 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
++||||+. ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 178 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 178 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eeEEEEEcccc-ccHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEEC
Confidence 99999996 68877762 23899999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..
T Consensus 179 ~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~ 251 (371)
T 4exu_A 179 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QL 251 (371)
T ss_dssp TTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH
T ss_pred CCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 9999999999999865422 334578999999999987 789999999999999999999999987533211 11
Q ss_pred Hhhhhhhc-----------cccccc---ccCcccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWK-----------DDRAWK---LLDPTLQ---NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~-----------~~~~~~---~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........ ...... .+..... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11100000 000000 0000000 00011123568899999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.70 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=190.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee---------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--------- 231 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 231 (496)
..++|++.+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467888999999999999999874 7899999999643 3345788999999999999999999998865
Q ss_pred ----cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 232 ----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 232 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~ 145 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--------------ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPM 145 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--------------SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--------------cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHH
Confidence 4578999999999999999963 2345788899999999999999999998 999999999
Q ss_pred CEEecCCCceEEeccccccccCCCcc------------ccccccccccccccChhhhccC-CCCccccchhhhHHHHHHH
Q 040910 308 NVLLDGDMNPKISDFGIARMFGGDEL------------QSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETL 374 (496)
Q Consensus 308 NIll~~~~~~kl~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~ell 374 (496)
|||++.++.+||+|||++........ ........||..|+|||.+.+. .++.++||||||+++|||+
T Consensus 146 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp GEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred hEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 99999999999999999987643210 1122345789999999999865 7899999999999999999
Q ss_pred hCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 375 SSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 375 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
+ |+.... ....... ..... ...............+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~---p~~~~~-~~~~~~~----~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 226 Y---PFSTGM-ERVNILK----KLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp S---CCSSHH-HHHHHHH----HHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---ccCCch-hHHHHHH----hcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 8 332110 0001110 01000 0111111222233567789999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=336.60 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=187.0
Q ss_pred CCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEEecC
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34446789999999998776668999999998643 245678999999987 89999999999999999999999995
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC---------
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD--------- 314 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--------- 314 (496)
|+|.+++....... ......++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 93 -gsL~~~l~~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 93 -LNLQDLVESKNVSD--------ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp -EEHHHHHHTC--------------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred -CCHHHHHhccCCCc--------hhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccccccc
Confidence 79999996422110 01112345567889999999999999998 9999999999999754
Q ss_pred ----CceEEeccccccccCCCccc--cccccccccccccChhhhcc-------CCCCccccchhhhHHHHHHHh-CCCCC
Q 040910 315 ----MNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALH-------GLFSIKSDVFSFGVLLLETLS-SKKNT 380 (496)
Q Consensus 315 ----~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~ellt-g~~~~ 380 (496)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999977543211 12334679999999999976 678999999999999999999 88888
Q ss_pred CCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 381 RFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
........... ..... .+.............+.+++.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~i~---~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRESNII---RGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHHHHHH---HTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhHHHHh---cCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 54322111110 00000 011111123455678899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.20 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=201.8
Q ss_pred HHhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
...++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 6899999998643 23456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC---
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD--- 314 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--- 314 (496)
|+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.+
T Consensus 99 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---------------RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD 160 (287)
T ss_dssp EECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTT
T ss_pred EEEccCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCc
Confidence 9999999999988853 235889999999999999999999998 9999999999999754
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+.+||+|||++....... ......+|..|+|||.+.+ .++.++||||||+++|+|++|..|+...... ......
T Consensus 161 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~ 234 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRV 234 (287)
T ss_dssp CCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred ccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 479999999998764332 2233468999999998876 4899999999999999999999998643221 111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ....+.. ......+.+++.+||+.||++|||+.+++++
T Consensus 235 ----~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 235 ----ETGKY-AFDLPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----HHCCC-CCCSGGG-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HcCCC-CCCchhh-----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11110 0000000 1123467889999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.27 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=197.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Cee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 235 (496)
.++|.+.+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468889999999999999999875 68899999996433 23346788999999999999999999988764 678
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++|+||+. |+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 90 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~ 149 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNC 149 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTC
T ss_pred EEEEeccC-ccHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCC
Confidence 99999996 689888842 35899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccccccCCCcccc--------ccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 316 NPKISDFGIARMFGGDELQS--------NMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
.+||+|||+++......... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 150 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 229 (353)
T 2b9h_A 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229 (353)
T ss_dssp CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999998765322111 1223578999999998764 77899999999999999999999998754321
Q ss_pred cchhhHhhhhhhcccc---ccccc-Cc----------ccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDR---AWKLL-DP----------TLQ----NEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~---~~~~~-d~----------~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ............ ....+ .+ ... ..........+.+++.+||+.||++|||+.+++++
T Consensus 230 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 230 HQ--LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HH--HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HH--HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11 000000000000 00000 00 000 00001223567889999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.11 Aligned_cols=202 Identities=25% Similarity=0.323 Sum_probs=170.9
Q ss_pred HhcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CC-----ceeeeeeeeeecCe
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HR-----NLVRLFGCCIEQGE 234 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~ 234 (496)
..++|.+.+.||+|+||.||+|... +++.||||++... .....++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999875 6789999999643 233567788999999885 55 49999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec--
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-- 312 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-- 312 (496)
.++||||++ |+|.+++.. .....+++..+..++.||+.||+|||.. ..+|+||||||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRN-------------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp EEEEEECCC-CBHHHHHHH-------------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred eEEEEecCC-CCHHHHHhh-------------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence 999999995 699999864 2234589999999999999999999952 12399999999999994
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5788999999999876432 234678999999999999999999999999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.64 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=177.6
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHH-HHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMI-LIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.++|...+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999874 689999999975432 23345566666 566679999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
||++ |+|.+++..... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+|
T Consensus 101 e~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYS----------VLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp CCCS-EEHHHHHHHHHH----------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred eecC-CChHHHHHHHHh----------hhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence 9997 488777753211 1245689999999999999999999998 7 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhh----ccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA----LHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
|+|||+++...... ......||..|+|||++ .+..++.++||||||+++|||++|+.||..........
T Consensus 167 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---- 239 (327)
T 3aln_A 167 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL---- 239 (327)
T ss_dssp ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred EccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----
Confidence 99999998764322 12334789999999998 46678999999999999999999999986432211100
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... .... .+.+...........+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~-~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQV-VKGD-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-CCSC-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHH-hcCC-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 0000 011111111122356788999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=326.75 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=194.0
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe-----
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE----- 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 234 (496)
.++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999874 68999999997532 2234678899999999999999999999987654
Q ss_pred -eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 235 -KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 235 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
.++||||+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECT
T ss_pred eEEEEecccc-CCHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECC
Confidence 499999997 68876652 23899999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 162 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~ 234 (353)
T 3coi_A 162 DCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLT 234 (353)
T ss_dssp TCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHH
T ss_pred CCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999865422 234578999999999987 678999999999999999999999987543211 111
Q ss_pred hhhhhh-----------ccccc-------ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNLW-----------KDDRA-------WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~~-----------~~~~~-------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... ..... .....+.. ..........+.+++.+||+.||++|||+.+++++
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110000 00000 00000000 01111234578889999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.47 Aligned_cols=258 Identities=17% Similarity=0.206 Sum_probs=174.3
Q ss_pred HhcCCCccc-cccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCee
Q 040910 162 ATHNFSEEN-KLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEK 235 (496)
Q Consensus 162 ~~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 235 (496)
..++|.+.+ .||+|+||.||+|... +|+.||||++.... ....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456788755 5999999999999875 68999999986421 222223334566699999999999876 4458
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-- 313 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-- 313 (496)
++||||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 102 ~lv~e~~~gg~L~~~l~~-------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQE-------------RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEEECCTTEEHHHHHHT-------------C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEEeccCCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecC
Confidence 999999999999999953 22346999999999999999999999998 999999999999976
Q ss_pred -CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 -DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 -~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+++..... ......+|+.|+|||++.+..++.++||||||+++|||++|..||...........
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~- 240 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG- 240 (336)
T ss_dssp TTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred CCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-
Confidence 455999999999865432 22345789999999999989999999999999999999999999864432211000
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcc
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS--MIKNE 451 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~ 451 (496)
........ ..... ..........+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 241 -~~~~~~~~-~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 241 -MKRRIRLG-QYGFP-----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------------CCC-----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -HHHhhhcc-ccccC-----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00000000 00000 0011122356788999999999999999999998 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.69 Aligned_cols=262 Identities=20% Similarity=0.281 Sum_probs=199.4
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-----------CCceeeeeeeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-----------HRNLVRLFGCCI 230 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~ 230 (496)
..+|.+.+.||+|+||.||+|+. .+++.||||.+... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46788999999999999999986 46889999999643 234567889999999886 899999999998
Q ss_pred ecC----eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCC
Q 040910 231 EQG----EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLK 305 (496)
Q Consensus 231 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk 305 (496)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. + |+|||||
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dik 159 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-------------EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIK 159 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCS
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-------------hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCC
Confidence 654 789999999 99999999642 234589999999999999999999997 7 9999999
Q ss_pred CCCEEec------CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCC
Q 040910 306 ASNVLLD------GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379 (496)
Q Consensus 306 ~~NIll~------~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~ 379 (496)
|+|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 9999994 4458999999999876432 3345789999999999999999999999999999999999999
Q ss_pred CCCCCCCcc----hhhHhhhhhh------------------cccccccccCc----------cccccCCHHHHHHHHHHH
Q 040910 380 TRFYNIDSL----TLLGHAWNLW------------------KDDRAWKLLDP----------TLQNEALYPMVKRYIKVA 427 (496)
Q Consensus 380 ~~~~~~~~~----~~~~~~~~~~------------------~~~~~~~~~d~----------~~~~~~~~~~~~~l~~l~ 427 (496)
|........ .......... ......+.+.. .............+.+++
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 875432210 0000000000 00000000000 001123456677889999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 040910 428 LLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 428 ~~cl~~~p~~RPs~~evl~~ 447 (496)
.+||+.||++|||++|++++
T Consensus 315 ~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GGGGCSSTTTCBCHHHHHTC
T ss_pred HHHhccCccccCCHHHHhhC
Confidence 99999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.52 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=186.2
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
...+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+.+++++ +|||||++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456888899999999997655556899999999965332 3457899999999 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-----CC
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-----DM 315 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-----~~ 315 (496)
|+. |+|.+++.. ....+.+..+..++.||+.||+|||+.+ |+||||||+|||++. ..
T Consensus 99 ~~~-g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 99 LCA-ATLQEYVEQ--------------KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp CCS-EEHHHHHHS--------------SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBC
T ss_pred CCC-CCHHHHHHh--------------cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCce
Confidence 995 699999863 2223445567899999999999999998 999999999999943 34
Q ss_pred ceEEeccccccccCCCcc-ccccccccccccccChhhhc---cCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 316 NPKISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
.+||+|||+++....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||..........
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~ 240 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH
Confidence 688999999987653321 12234467999999999997 4567889999999999999999 888875322111110
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... ........ ........+.+++.+||+.||.+|||+.+|++
T Consensus 241 ------~~~-~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 ------LLG-ACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------HTT-CCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------Hhc-cCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 00001111 11223445778999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.19 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=198.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CC-CEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc------eeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NG-EEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN------LVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.++.+++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468899999999999999999874 34 68999999643 234567889999999997766 9999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe---
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL--- 311 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll--- 311 (496)
.++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-------------NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNS 159 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCC
T ss_pred EEEEEecc-CCChHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecc
Confidence 99999999 6777777753 22346899999999999999999999998 9999999999999
Q ss_pred ----------------cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh
Q 040910 312 ----------------DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375 (496)
Q Consensus 312 ----------------~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt 375 (496)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 67889999999999864322 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhh-----------ccccc-------c-----------cccCc-cccccCCHHHHHHHHH
Q 040910 376 SKKNTRFYNIDSLTLLGHAWNLW-----------KDDRA-------W-----------KLLDP-TLQNEALYPMVKRYIK 425 (496)
Q Consensus 376 g~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-------~-----------~~~d~-~~~~~~~~~~~~~l~~ 425 (496)
|+.||........ ........ ..... + +...+ .............+.+
T Consensus 235 g~~pf~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 235 GFTLFQTHENREH--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp SSCSCCCSSHHHH--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCCHHHH--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 9999875432211 00000000 00000 0 00000 0000112234567889
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 040910 426 VALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 426 l~~~cl~~~p~~RPs~~evl~ 446 (496)
++.+||+.||++|||+.|+++
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.47 Aligned_cols=244 Identities=22% Similarity=0.365 Sum_probs=190.2
Q ss_pred HHHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc------cCHHHHHHHHHHHHHh----cCCceeeeeee
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG------QGVEEFKNEMILIAKL----HHRNLVRLFGC 228 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~ 228 (496)
....++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44567899999999999999999976 4688999999965432 1233566799999999 89999999999
Q ss_pred eeecCeeEEEEEe-cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 040910 229 CIEQGEKILIYEY-MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKAS 307 (496)
Q Consensus 229 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~ 307 (496)
+.+.+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 168 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---------------KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh
Confidence 9999999999999 789999999953 335899999999999999999999998 999999999
Q ss_pred CEEec-CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCC-ccccchhhhHHHHHHHhCCCCCCCCCC
Q 040910 308 NVLLD-GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFS-IKSDVFSFGVLLLETLSSKKNTRFYNI 385 (496)
Q Consensus 308 NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~~~~~~~~ 385 (496)
||+++ .++.+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 243 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ- 243 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-
Confidence 99999 89999999999998765432 2345689999999999877664 58999999999999999999885311
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... . .. . .. .......+.+++.+||+.||++|||+.|++++
T Consensus 244 ---~~~-------~-~~---~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ---EIL-------E-AE---L---HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHH-------H-TC---C---CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---HHh-------h-hc---c---CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 00 0 00 11123467789999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=324.91 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=198.1
Q ss_pred HHhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCcc------CHHHHHHHHHHHHHhc--CCceeeeeeeeee
Q 040910 161 TATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQ------GVEEFKNEMILIAKLH--HRNLVRLFGCCIE 231 (496)
Q Consensus 161 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~ 231 (496)
...++|.+.+.||+|+||.||+|.. .+++.||||.+...... ..+.+.+|+.++.+++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999976 46889999999754321 2356778999999996 5999999999999
Q ss_pred cCeeEEEEEecCC-CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 QGEKILIYEYMPN-KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
.+..++|+||+.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 181 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---------------RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENIL 181 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEE
Confidence 9999999999976 899999853 345889999999999999999999998 999999999999
Q ss_pred ec-CCCceEEeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcc
Q 040910 311 LD-GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388 (496)
Q Consensus 311 l~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~ 388 (496)
++ +++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 99 78999999999998765332 234578999999999987765 788999999999999999999985321
Q ss_pred hhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... . .. .... .. ....+.+++.+||+.||++|||+.+++++
T Consensus 254 ~~~-------~-~~--~~~~----~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 EII-------R-GQ--VFFR----QR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHH-------H-CC--CCCS----SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhh-------c-cc--cccc----cc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 00 0000 11 12467789999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=316.40 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=177.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc-C-HHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ-G-VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
.++|...+.||+|+||.||+|... +|+.||||.+...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999875 6899999999754322 2 233444555677789999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
||+ ++.+..+... ....+++..+..++.||+.||+|||+. + |+|+||||+|||++.++.+|
T Consensus 104 e~~-~~~~~~l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~k 165 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--------------MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIK 165 (318)
T ss_dssp CCC-SEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEE
T ss_pred ecc-CCcHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEE
Confidence 999 4555544421 234588999999999999999999985 7 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
|+|||++....... ......+|+.|+|||++. +..++.++||||||+++|||++|+.||........ ....
T Consensus 166 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~ 241 (318)
T 2dyl_A 166 LCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTK 241 (318)
T ss_dssp ECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHH
T ss_pred EEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHH
Confidence 99999998664322 223457899999999994 56788999999999999999999999864322111 1111
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. .. ... +.... .......+.+++.+||+.||.+||++.+++++
T Consensus 242 ~---~~-~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 242 V---LQ-EEP-----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp H---HH-SCC-----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred H---hc-cCC-----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 01 000 00000 00123467789999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=339.56 Aligned_cols=267 Identities=23% Similarity=0.298 Sum_probs=199.8
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeee------cCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE------QGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 234 (496)
..+|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 6899999998754 33345679999999999999999999998765 667
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~------------~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF------------ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPG 157 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS------------SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECC
T ss_pred EEEEEEeCCCCCHHHHHHhc------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecC
Confidence 89999999999999999631 22345889999999999999999999998 9999999999999977
Q ss_pred Cc---eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 315 MN---PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 315 ~~---~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+. +||+|||++....... ......||..|+|||.+.+..++.++||||||+++|||++|..||...... .
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~ 230 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----V 230 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----H
T ss_pred CCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----h
Confidence 65 8999999998765432 223467899999999999999999999999999999999999998642110 0
Q ss_pred Hhhhhhhcc--------ccccc-c-cCcc--ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHhcc
Q 040910 392 GHAWNLWKD--------DRAWK-L-LDPT--LQNEALYPMVKRYIKVALLCVQENAADRPTMSE-----VVSMIKNE 451 (496)
Q Consensus 392 ~~~~~~~~~--------~~~~~-~-~d~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-----vl~~L~~~ 451 (496)
.+....... ..... . .... ............+.+++..||+.||++|||+.+ +.+.++.+
T Consensus 231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 000000000 00000 0 0000 011122335677889999999999999999977 44555554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.52 Aligned_cols=238 Identities=20% Similarity=0.311 Sum_probs=191.9
Q ss_pred cCCCccccccccCCeeEEEEEec--CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCe-----e
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL--NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGE-----K 235 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~ 235 (496)
++|.+.+.||+|+||.||+|... +|+.||||.+.... ....+.|.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999875 58999999986433 2345678999999999999999999999988765 7
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++++|.+++. ..++|..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 160 ~lv~E~~~g~~L~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~- 218 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-----------------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE- 218 (681)
T ss_dssp EEEEECCCCEECC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-
T ss_pred EEEEEeCCCCcHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-
Confidence 99999999999987662 15899999999999999999999998 9999999999999986
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
.+||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........
T Consensus 219 ~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------- 284 (681)
T 2pzi_A 219 QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------- 284 (681)
T ss_dssp CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------
T ss_pred cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------
Confidence 8999999999876432 3457999999999987654 8999999999999999999877653111100
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcc
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEVVSMIKNE 451 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~ 451 (496)
.. ..........+.+++.+||+.||.+|| +++++...|...
T Consensus 285 -----------~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 -----------PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----------CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----------cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 000112235678899999999999999 566676666653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.58 Aligned_cols=232 Identities=13% Similarity=0.043 Sum_probs=181.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCcc---CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ---GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
.++|.+.+.||+|+||.||+|... +++.||||.+...... ..+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367899999999999999999875 4899999999755332 246899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. . .....+.+++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 110 ~e~~~g~~L~~~l~~----------------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----------------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EECCCEEEHHHHHTT----------------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEE
T ss_pred EEecCCCCHHHHHhc----------------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEE
Confidence 999999999999831 1 244568889999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+++| |++ .++.++|||||||++|||++|+.||........... .....
T Consensus 170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~ 218 (286)
T 3uqc_A 170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDT 218 (286)
T ss_dssp ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCT
T ss_pred EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHh
Confidence 98543 333 368899999999999999999999875443221000 00000
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
. . ....+.. ........+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 219 ~-~---~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 A-G---QPIEPAD---IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp T-S---CBCCHHH---HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred c-c---CCCChhh---cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0 0 0000000 011123467889999999999999 99999999998643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=318.74 Aligned_cols=246 Identities=14% Similarity=0.150 Sum_probs=181.0
Q ss_pred HhcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcC-Cceeeeee---------
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHH-RNLVRLFG--------- 227 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~~--------- 227 (496)
.+.+|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|+.++..++| +|......
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344577788999999999999985 4699999999874332 336789999999999977 32211111
Q ss_pred ------------eeee-----cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHH
Q 040910 228 ------------CCIE-----QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290 (496)
Q Consensus 228 ------------~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 290 (496)
+... ....+++|+++ +++|.+++..... .......+++..++.++.||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~--------~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--------HSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH--------HTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc--------ccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 1111 12356666655 7899988853221 01234568899999999999999999
Q ss_pred hhhcCCCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhh----------ccCCCCcc
Q 040910 291 LHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYA----------LHGLFSIK 360 (496)
Q Consensus 291 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~ 360 (496)
||+.+ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.+
T Consensus 227 LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred HHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 99998 999999999999999999999999999865422 344567 999999999 55568899
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040910 361 SDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT 440 (496)
Q Consensus 361 ~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 440 (496)
+|||||||++|||++|+.||......... . .++... .. ....+.+++..||+.||++||+
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~~--~------------~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGGS--E------------WIFRSC--KN----IPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSCS--G------------GGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhhH--H------------HHHhhc--cc----CCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999998643321110 0 000000 01 1256788999999999999999
Q ss_pred HHHHH
Q 040910 441 MSEVV 445 (496)
Q Consensus 441 ~~evl 445 (496)
+.+++
T Consensus 358 ~~~~l 362 (413)
T 3dzo_A 358 PLQAM 362 (413)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 76664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.33 Aligned_cols=231 Identities=18% Similarity=0.206 Sum_probs=176.7
Q ss_pred cCCCcc-ccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHH-HhcCCceeeeeeeeee----cCeeE
Q 040910 164 HNFSEE-NKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIA-KLHHRNLVRLFGCCIE----QGEKI 236 (496)
Q Consensus 164 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~----~~~~~ 236 (496)
++|.+. +.||+|+||.||++.. .+++.||||.+.. ...+.+|+.++. .++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 6799999999999987 4689999999864 246788998884 4599999999999987 67889
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC---
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--- 313 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--- 313 (496)
+||||+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD-------------RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp EEECCCCSCBHHHHHHH-------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST
T ss_pred EEEeecCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCC
Confidence 99999999999999964 22346899999999999999999999998 999999999999998
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
++.+||+|||++.... +..++.++|||||||++|||++|+.||.......... .
T Consensus 156 ~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~ 209 (299)
T 3m2w_A 156 NAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G 209 (299)
T ss_dssp TCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C
T ss_pred CCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H
Confidence 7899999999997543 2346788999999999999999999986433211100 0
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ..........+.. ........+.+++.+||+.||++|||+.|++++
T Consensus 210 ~~---~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 MK---TRIRMGQYEFPNP---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SC---CSSCTTCCSSCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---HHHhhccccCCch---hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0000000000000 001123567889999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=310.39 Aligned_cols=242 Identities=15% Similarity=0.150 Sum_probs=181.4
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--------ccCHHHHHHHHHHHHHhc---------CCceeee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--------GQGVEEFKNEMILIAKLH---------HRNLVRL 225 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 225 (496)
.++|.+.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788899999999999999987 78999999997542 233578999999999996 5555555
Q ss_pred eee-----------------eee-------------cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChh
Q 040910 226 FGC-----------------CIE-------------QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275 (496)
Q Consensus 226 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~ 275 (496)
.++ +.+ .+..++||||+++|++.+.+. +..+++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----------------~~~~~~~ 161 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----------------TKLSSLA 161 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----------------TTCCCHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----------------hcCCCHH
Confidence 554 443 678999999999997766652 1457899
Q ss_pred hHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCCEEecCCC--------------------ceEEeccccccccCCCccc
Q 040910 276 TRVRIIEGIAQGLLYLH-QYSRLRVIHRDLKASNVLLDGDM--------------------NPKISDFGIARMFGGDELQ 334 (496)
Q Consensus 276 ~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DFgla~~~~~~~~~ 334 (496)
.+..++.||+.||+||| +.+ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--- 235 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---
Confidence 99999999999999999 888 99999999999999887 8999999999876422
Q ss_pred cccccccccccccChhhhccCCCCccccchhhhHH-HHHHHhCCCCCCCCCCCcchhhHhhhhhhcccccccccCccccc
Q 040910 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVL-LLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQN 413 (496)
Q Consensus 335 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv-l~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 413 (496)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..|+... .............. ........
T Consensus 236 ----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~---~~~~~~~~ 302 (336)
T 2vuw_A 236 ----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQM---TFKTKCNT 302 (336)
T ss_dssp ----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTC---CCSSCCCS
T ss_pred ----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhh---ccCcccch
Confidence 347999999999998776 899999998777 77788888876420 00000000000000 00001111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040910 414 EALYPMVKRYIKVALLCVQENAADRPTMSEVV 445 (496)
Q Consensus 414 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 445 (496)
.........+.+++.+||+.| |++|++
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 122345678899999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-31 Score=278.01 Aligned_cols=185 Identities=17% Similarity=0.134 Sum_probs=130.8
Q ss_pred cccccCCeeEEEEE-ecCCCEEEEEEeccCC----------ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKS----------GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 171 ~lG~G~~g~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
..+.|++|.+..++ ...|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666553 3468999999997542 22346799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||++|++|.++|.. .+.++. .+|+.||+.||+|||+.+ ||||||||+|||+++++.+|
T Consensus 321 MEyv~G~~L~d~i~~---------------~~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---------------GEEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EECCCSEEHHHHHHT---------------TCCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEE
T ss_pred EecCCCCcHHHHHHh---------------CCCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEE
Confidence 999999999999953 234544 358999999999999999 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCC
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKN 379 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~ 379 (496)
|+|||+|+...... ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 380 L~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 99999999765432 23445789999999999875 467789999999999887666543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=252.80 Aligned_cols=185 Identities=18% Similarity=0.193 Sum_probs=146.7
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCcc--------CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQ--------GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
...+.||+|+||.||+|.. .++.+|+|+....... ..+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 6789999987543211 134589999999999999999777777788888999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++++|.+++.. +..++.||++||+|||+.+ |+||||||+|||++. .+|
T Consensus 418 mE~~~ggsL~~~l~~-----------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~k 469 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLY 469 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEE
T ss_pred EECCCCCCHHHHHHH-----------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEE
Confidence 999999999999831 4589999999999999998 999999999999999 999
Q ss_pred EeccccccccCCCcccc-----ccccccccccccChhhhcc--CCCCccccchhhhHHHHHHHhCCCCC
Q 040910 319 ISDFGIARMFGGDELQS-----NMNRIVGTYGYMSPEYALH--GLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
|+|||+++......... ......||+.|||||++.. ..|+..+|+||..+-.++-+.++.++
T Consensus 470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999876432211 1235689999999999987 67888999999999888887776543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=208.22 Aligned_cols=154 Identities=17% Similarity=0.101 Sum_probs=123.2
Q ss_pred HHHHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCc------------------cCHHHHHHHHHHHHHh
Q 040910 156 LASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG------------------QGVEEFKNEMILIAKL 217 (496)
Q Consensus 156 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 217 (496)
+..+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667777899999999999999987799999999964321 1245689999999999
Q ss_pred cCCceeeeeeeeeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 040910 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRL 297 (496)
Q Consensus 218 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 297 (496)
+ | +++.+++.. +..++||||+++|+|.+ +. ......++.||+.||.|||+.+
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------------------~~~~~~i~~qi~~~l~~lH~~g-- 213 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------------------VENPDEVLDMILEEVAKFYHRG-- 213 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------------------CSCHHHHHHHHHHHHHHHHHTT--
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------------------hhhHHHHHHHHHHHHHHHHHCC--
Confidence 8 5 666665543 56799999999999976 31 1234579999999999999998
Q ss_pred CeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhcc
Q 040910 298 RVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH 354 (496)
Q Consensus 298 ~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 354 (496)
|+||||||+|||++ ++.+||+|||+|+.. ..++|||++..
T Consensus 214 -iiHrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 214 -IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp -EECSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred -CEeCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 99999999999999 999999999999743 34788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=176.97 Aligned_cols=138 Identities=14% Similarity=0.173 Sum_probs=107.2
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCE--EEEEEeccCCcc------------------------CHHHHHHHHHHHHHh
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEE--VAVKRLSNKSGQ------------------------GVEEFKNEMILIAKL 217 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 217 (496)
-|.+.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999987 68888 999987543111 013678999999999
Q ss_pred cCCce--eeeeeeeeecCeeEEEEEecC-CC----ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHH
Q 040910 218 HHRNL--VRLFGCCIEQGEKILIYEYMP-NK----SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLY 290 (496)
Q Consensus 218 ~H~ni--v~l~~~~~~~~~~~lv~e~~~-~g----sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 290 (496)
.|+++ ..++++ +..+|||||+. +| +|.++... .++..+..++.|++.||.|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------------~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------------LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------------GGGSCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------------cChHHHHHHHHHHHHHHHH
Confidence 88764 334432 35689999995 24 56554421 2355778999999999999
Q ss_pred hh-hcCCCCeeecCCCCCCEEecCCCceEEeccccccccC
Q 040910 291 LH-QYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG 329 (496)
Q Consensus 291 LH-~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~ 329 (496)
|| +.+ |+||||||+|||+++ .++|+|||+|....
T Consensus 186 lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 186 LYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 99 887 999999999999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=9.1e-18 Score=166.07 Aligned_cols=142 Identities=13% Similarity=0.141 Sum_probs=99.4
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--------------ccCHHHHHHHHHHHHHhcCCceeeeeeee
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--------------GQGVEEFKNEMILIAKLHHRNLVRLFGCC 229 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 229 (496)
.-|++.+.||+|+||.||+|...+|+.||||.++... .........++++.....|+|++++....
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488999999999999999998899999999875321 01112223333333333344444433221
Q ss_pred e------ecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040910 230 I------EQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRD 303 (496)
Q Consensus 230 ~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 303 (496)
. .....+|||||+++++|..+. .......++.||+.+|.|||..+ |||||
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~---------------------~~~~~~~l~~qll~~l~~lH~~g---IVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVS---------------------SVPDPASLYADLIALILRLAKHG---LIHGD 230 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCC---------------------CCSCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhc---------------------ccHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 1 111236999999988885432 11234678899999999999988 99999
Q ss_pred CCCCCEEecCCC----------ceEEeccccccccC
Q 040910 304 LKASNVLLDGDM----------NPKISDFGIARMFG 329 (496)
Q Consensus 304 lk~~NIll~~~~----------~~kl~DFgla~~~~ 329 (496)
|||.|||+++++ .+.|+||+-+....
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999998877 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-12 Score=123.85 Aligned_cols=145 Identities=16% Similarity=0.090 Sum_probs=114.3
Q ss_pred HhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEEEE
Q 040910 162 ATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 162 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.-..|.....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+ .|.++.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345687778889899999999975 4789999998753223335689999999999 47788899999998889999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC-------------------------
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS------------------------- 295 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------- 295 (496)
|+++.+|...+. +......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~--------------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 91 EADGVLCSEEYE--------------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp CCSSEEHHHHCC--------------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred ecCCeehhhccC--------------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 999999976531 11234578899999999999811
Q ss_pred -------------------------------CCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 296 -------------------------------RLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 296 -------------------------------~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
...++|+|+++.||+++++..+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=116.09 Aligned_cols=131 Identities=16% Similarity=0.171 Sum_probs=97.4
Q ss_pred ccc-ccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc--eeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 171 KLG-EGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN--LVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 171 ~lG-~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
.++ .|..+.||+....+|+.++||..... ....+..|+.+++.+.+.+ +.+++++...++..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 454 55569999998777888999997643 2346788999999996544 55688888887889999999999888
Q ss_pred hHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--------------------------------
Q 040910 248 DFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS-------------------------------- 295 (496)
Q Consensus 248 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------- 295 (496)
. ... .....++.++++.|+.||+..
T Consensus 103 ~--~~~---------------------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 103 L--SSH---------------------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp T--TSC---------------------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred C--cCc---------------------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 4 210 012356666667777777532
Q ss_pred -----------------------CCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 296 -----------------------RLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 296 -----------------------~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.8e-10 Score=114.28 Aligned_cols=142 Identities=13% Similarity=0.255 Sum_probs=107.1
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEEec--cCC-ccCHHHHHHHHHHHHHhc--CCceeeeeeeeeec---CeeEEEE
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLS--NKS-GQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQ---GEKILIY 239 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 239 (496)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +.++.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3568999999999999874 5678888875 322 123457888999999996 56688899988776 4589999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC------------------------
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS------------------------ 295 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------ 295 (496)
||+++..+.+. ....++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~-----------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 121 EFVSGRVLWDQ-----------------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp ECCCCBCCCCT-----------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred EecCCeecCCC-----------------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 99998877321 1223677888899999999999999731
Q ss_pred -------------------------------CCCeeecCCCCCCEEecCCCc--eEEeccccccc
Q 040910 296 -------------------------------RLRVIHRDLKASNVLLDGDMN--PKISDFGIARM 327 (496)
Q Consensus 296 -------------------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DFgla~~ 327 (496)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=4e-10 Score=109.12 Aligned_cols=187 Identities=18% Similarity=0.215 Sum_probs=117.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCc--eeeeeeeeeecC---eeEEEEEec
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRN--LVRLFGCCIEQG---EKILIYEYM 242 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lv~e~~ 242 (496)
.+.++.|....||+.. ..+++|..... .....+.+|+.+++.+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56889986432 3356789999999998 4333 344555443333 358899999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc----------------------------
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY---------------------------- 294 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------- 294 (496)
++.+|..... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~-----------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 99 KGVPLTPLLL-----------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp CCEECCHHHH-----------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred CCeECCcccc-----------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 9988865331 1244555566666666666666641
Q ss_pred ---------------------------CCCCeeecCCCCCCEEecC--CCceEEeccccccccCCCc-ccccccc-----
Q 040910 295 ---------------------------SRLRVIHRDLKASNVLLDG--DMNPKISDFGIARMFGGDE-LQSNMNR----- 339 (496)
Q Consensus 295 ---------------------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DFgla~~~~~~~-~~~~~~~----- 339 (496)
..+.++|+|+++.||++++ +..+.|+||+.+..-.... .......
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~ 241 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYG 241 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCC
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccC
Confidence 1245899999999999998 4567899999987543210 0000000
Q ss_pred ------ccccccccC-hhhhccCCCCccccchhhhHHHHHHHhCCCCC
Q 040910 340 ------IVGTYGYMS-PEYALHGLFSIKSDVFSFGVLLLETLSSKKNT 380 (496)
Q Consensus 340 ------~~gt~~y~a-PE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~ 380 (496)
.....+... |+.... .....+.|++|.++|.+.+|..++
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000001111 222111 112258899999999999998653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=7.5e-07 Score=84.24 Aligned_cols=136 Identities=20% Similarity=0.197 Sum_probs=95.3
Q ss_pred ccccccCCe-eEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 170 NKLGEGGFG-PVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 170 ~~lG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
+.+..|..| .||+.... ++..++||+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 58987654 4668999986532 3457888999999883 4457788999999999999999999988
Q ss_pred hhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc--------------------------------
Q 040910 247 LDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-------------------------------- 294 (496)
Q Consensus 247 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------- 294 (496)
+.+..... ......+..+++..|+-||..
T Consensus 107 ~~~~~~~~-------------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (272)
T 4gkh_A 107 AFQVLEEY-------------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF 167 (272)
T ss_dssp HHHHHHHC-------------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred ccccccCC-------------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence 86654210 112233444444444444431
Q ss_pred -----------------------CCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 295 -----------------------SRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 295 -----------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=6.9e-07 Score=86.32 Aligned_cols=75 Identities=20% Similarity=0.177 Sum_probs=55.5
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCC---ceeeeeeeee-ecCeeEEEEEecCC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHR---NLVRLFGCCI-EQGEKILIYEYMPN 244 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~ 244 (496)
.+.++.|....||+. |..++||.-. .......+..|+.++..+.+. .+.+.+.+.. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 5678888843 223356789999999999642 3556666664 34567899999999
Q ss_pred CChhH
Q 040910 245 KSLDF 249 (496)
Q Consensus 245 gsL~~ 249 (496)
.+|..
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 88865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.3e-06 Score=86.29 Aligned_cols=80 Identities=6% Similarity=-0.030 Sum_probs=57.3
Q ss_pred ccc-cccCCeeEEEEEec-------CCCEEEEEEeccCC---ccCHHHHHHHHHHHHHhc-C--Cceeeeeeeeeec---
Q 040910 170 NKL-GEGGFGPVYKGKLL-------NGEEVAVKRLSNKS---GQGVEEFKNEMILIAKLH-H--RNLVRLFGCCIEQ--- 232 (496)
Q Consensus 170 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--- 232 (496)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999998764 26788999865432 111246788999998884 3 4577788887665
Q ss_pred CeeEEEEEecCCCChhH
Q 040910 233 GEKILIYEYMPNKSLDF 249 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~ 249 (496)
+..++||||+++..+..
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=9.1e-06 Score=79.36 Aligned_cols=151 Identities=15% Similarity=0.179 Sum_probs=84.1
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc--CCceeeeee------eeeecCeeEEEEEe
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH--HRNLVRLFG------CCIEQGEKILIYEY 241 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~------~~~~~~~~~lv~e~ 241 (496)
+.|+.|..+.||+....+| .+++|+... ....+..|+.++..|. .-.+.+++. +....+..++|+||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987544 589998864 2244455666666663 223444443 12345678999999
Q ss_pred cCCCChhH--------------HHhhcccCCCccccc-CCCCCCCCChhhH-----------------------------
Q 040910 242 MPNKSLDF--------------FLFDYKYSSGFDMVT-DPASKGILDWTTR----------------------------- 277 (496)
Q Consensus 242 ~~~gsL~~--------------~l~~~~~~~~~~~~~-~~~~~~~l~~~~~----------------------------- 277 (496)
+++.++.. -++.... ...... .......-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASV--GYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHT--TCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCC--CCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 99876530 1111110 000000 0000111233221
Q ss_pred --HHHHHHHHHHHHHhhh----------cCCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 278 --VRIIEGIAQGLLYLHQ----------YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 278 --~~i~~~ia~~L~yLH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
..+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234446667763 1245699999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=5.5e-06 Score=83.01 Aligned_cols=75 Identities=12% Similarity=0.185 Sum_probs=50.8
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccCCc-------cCHHHHHHHHHHHHHhcC--Cce-eeeeeeeeecCeeEE
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-------QGVEEFKNEMILIAKLHH--RNL-VRLFGCCIEQGEKIL 237 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~ni-v~l~~~~~~~~~~~l 237 (496)
.+.||.|..+.||++... +++.++||....... ...+.+..|.+++..+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899998653211 233567889999988842 333 345543 3455689
Q ss_pred EEEecCCC
Q 040910 238 IYEYMPNK 245 (496)
Q Consensus 238 v~e~~~~g 245 (496)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.09 E-value=2.3e-05 Score=74.76 Aligned_cols=80 Identities=16% Similarity=0.216 Sum_probs=59.6
Q ss_pred CCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-C--CceeeeeeeeeecCeeEEEEEe
Q 040910 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-H--RNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.....+.+|.|..+.||+.++.+|+.|+||+-..........|..|+..|+.|. . -.+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 344567899999999999999999999999876554444557889999999984 2 2344555542 34789999
Q ss_pred cCCCChh
Q 040910 242 MPNKSLD 248 (496)
Q Consensus 242 ~~~gsL~ 248 (496)
++.+...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9876543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.01 E-value=5.5e-05 Score=72.87 Aligned_cols=151 Identities=19% Similarity=0.147 Sum_probs=95.7
Q ss_pred ccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc---CCceeeeeeeeeecCeeEEEEEecCC
Q 040910 168 EENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH---HRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
..+.|+.|....+|+... ++..++||+.... ....|..|+..|+.|. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999976 5778899987542 3567899999999883 36788899988888889999999998
Q ss_pred CChhH-----------HHhhcccCCCcccccC-------CCCCCCCChhhHH---HHHH----------------HHHH-
Q 040910 245 KSLDF-----------FLFDYKYSSGFDMVTD-------PASKGILDWTTRV---RIIE----------------GIAQ- 286 (496)
Q Consensus 245 gsL~~-----------~l~~~~~~~~~~~~~~-------~~~~~~l~~~~~~---~i~~----------------~ia~- 286 (496)
..+.. -|+.......+....+ ......-+|.... ++.. .+..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87531 1111111011110000 0011123454322 1111 1111
Q ss_pred HHHHhhh-cCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 287 GLLYLHQ-YSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 287 ~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
....|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223432 2356799999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=6e-05 Score=76.02 Aligned_cols=78 Identities=10% Similarity=0.071 Sum_probs=47.4
Q ss_pred CCCeeecCCCCCCEEecCCCceEEeccccccccCCCcccccccccc--ccccccChhhhccC---CCCccccchhhhHHH
Q 040910 296 RLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV--GTYGYMSPEYALHG---LFSIKSDVFSFGVLL 370 (496)
Q Consensus 296 ~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl 370 (496)
...++|+|+++.|||++.++ ++|+||+.+..-... .. ..... -...|.+|+..... ......++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 44699999999999998876 999999998753211 00 00011 12346666654311 112234455777777
Q ss_pred HHHHhCC
Q 040910 371 LETLSSK 377 (496)
Q Consensus 371 ~elltg~ 377 (496)
|+.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7776653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00029 Score=71.08 Aligned_cols=72 Identities=19% Similarity=0.338 Sum_probs=50.6
Q ss_pred ccccccCCeeEEEEEecC--------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCce-eeeeeeeeecCeeEEEEE
Q 040910 170 NKLGEGGFGPVYKGKLLN--------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL-VRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e 240 (496)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578888889999998753 478999987432 122566789999998843333 567766543 28999
Q ss_pred ecCCCCh
Q 040910 241 YMPNKSL 247 (496)
Q Consensus 241 ~~~~gsL 247 (496)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00062 Score=65.64 Aligned_cols=166 Identities=16% Similarity=0.170 Sum_probs=88.7
Q ss_pred CHHHHHHHhcCCCc-----cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc--eeeeee
Q 040910 155 SLASISTATHNFSE-----ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN--LVRLFG 227 (496)
Q Consensus 155 ~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~ 227 (496)
+..++...-..|.. .+.|+.|....+|+....+| .+++|...... ..+.+..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34444444444543 34567788899999987555 68899886521 2235667888888874222 334442
Q ss_pred e------eeecCeeEEEEEecCCCChhH----H----------HhhcccCCCcccccCCCCCCCCChhhHHH--------
Q 040910 228 C------CIEQGEKILIYEYMPNKSLDF----F----------LFDYKYSSGFDMVTDPASKGILDWTTRVR-------- 279 (496)
Q Consensus 228 ~------~~~~~~~~lv~e~~~~gsL~~----~----------l~~~~~~~~~~~~~~~~~~~~l~~~~~~~-------- 279 (496)
. ....+..+++++|+++..+.. . ++.. ...+.... ........|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~--~~~~~~~~-~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLA--SEGFEIKR-PNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHH--TTTCCCCC-BCTTSHHHHHHHHHHHGGGGGG
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHH--hccCCCcc-cCccChHHHHHHHHHHHHHHHh
Confidence 2 122356789999998866421 1 1110 00110000 00011112322111
Q ss_pred ----HHHHHHHHHHHhhhc----CCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 280 ----IIEGIAQGLLYLHQY----SRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 280 ----i~~~ia~~L~yLH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
+...+...++.++.. .+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23459999999999999987666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00045 Score=66.10 Aligned_cols=72 Identities=7% Similarity=0.117 Sum_probs=46.3
Q ss_pred cccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCce-eeeeeeeeecCeeEEEEEec-CCCC
Q 040910 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL-VRLFGCCIEQGEKILIYEYM-PNKS 246 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 246 (496)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .+++++. .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 568999999999998 568889876432221 223568888888743233 4555543 33457899999 6655
Q ss_pred hh
Q 040910 247 LD 248 (496)
Q Consensus 247 L~ 248 (496)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00048 Score=68.14 Aligned_cols=153 Identities=18% Similarity=0.183 Sum_probs=85.2
Q ss_pred ccccccCCeeEEEEEec--------CCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEE
Q 040910 170 NKLGEGGFGPVYKGKLL--------NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 240 (496)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.|. +.-..++++++.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 46777888889998764 2478999986332 234567788999999884 33345677766542 8999
Q ss_pred ecCCCChhHHH-hhc-----ccCCCccccc-CCCCCCCC--ChhhHHHHHHHHHH-------------------HHHHhh
Q 040910 241 YMPNKSLDFFL-FDY-----KYSSGFDMVT-DPASKGIL--DWTTRVRIIEGIAQ-------------------GLLYLH 292 (496)
Q Consensus 241 ~~~~gsL~~~l-~~~-----~~~~~~~~~~-~~~~~~~l--~~~~~~~i~~~ia~-------------------~L~yLH 292 (496)
|+++.+|..-- .+. .......+.. +....+.. -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99987664210 000 0000000000 00001112 24455555444322 223332
Q ss_pred ----hc-CCCCeeecCCCCCCEEecCC----CceEEeccccccc
Q 040910 293 ----QY-SRLRVIHRDLKASNVLLDGD----MNPKISDFGIARM 327 (496)
Q Consensus 293 ----~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~DFgla~~ 327 (496)
.. .+..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23469999999999999876 7899999998863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0013 Score=63.69 Aligned_cols=153 Identities=14% Similarity=0.130 Sum_probs=75.9
Q ss_pred ccccccCCee-EEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-C-CceeeeeeeeeecCeeEEEEEecCCCC
Q 040910 170 NKLGEGGFGP-VYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-H-RNLVRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 170 ~~lG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
+.|+.|+... +|+....+|+.+++|....... +.+..|+.++..+. + -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555444 6677654477788876543221 23455777777773 2 34556776643333 78999998777
Q ss_pred hhHHHhhcccC--CCc--------ccccCCC-CCCCCChhhH---------------H-----HHHHHHHHHHHHhh---
Q 040910 247 LDFFLFDYKYS--SGF--------DMVTDPA-SKGILDWTTR---------------V-----RIIEGIAQGLLYLH--- 292 (496)
Q Consensus 247 L~~~l~~~~~~--~~~--------~~~~~~~-~~~~l~~~~~---------------~-----~i~~~ia~~L~yLH--- 292 (496)
+..++...... ... .+..... ....++.... . .....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 76655421110 000 0000000 0000110000 0 00011112222221
Q ss_pred hcCCCCeeecCCCCCCEEecCC----CceEEeccccccc
Q 040910 293 QYSRLRVIHRDLKASNVLLDGD----MNPKISDFGIARM 327 (496)
Q Consensus 293 ~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFgla~~ 327 (496)
......++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1224569999999999999875 6789999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.001 Score=64.31 Aligned_cols=76 Identities=12% Similarity=0.072 Sum_probs=51.9
Q ss_pred ccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC--Cceeeeeee-----eeecCeeEEEEEec
Q 040910 170 NKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH--RNLVRLFGC-----CIEQGEKILIYEYM 242 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~-----~~~~~~~~lv~e~~ 242 (496)
..++ |....||+....+|+.+++|...... ...+.+..|..++..+.. -.+.+++.. ....+..++|++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999877677789999986332 235677788988888842 234555543 12244567899999
Q ss_pred CCCCh
Q 040910 243 PNKSL 247 (496)
Q Consensus 243 ~~gsL 247 (496)
++..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 87654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.001 Score=67.50 Aligned_cols=75 Identities=15% Similarity=0.111 Sum_probs=49.1
Q ss_pred cccccccCCeeEEEEEecC-CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCce-eeeeeeeeecCeeEEEEEecCCCC
Q 040910 169 ENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL-VRLFGCCIEQGEKILIYEYMPNKS 246 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gs 246 (496)
.+.|+.|-...+|+....+ +..+++|+........ -.-..|..++..|...++ .++++++. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888899999998754 4788888875432221 122579999999965444 46777663 2 25999998766
Q ss_pred hh
Q 040910 247 LD 248 (496)
Q Consensus 247 L~ 248 (496)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0029 Score=61.59 Aligned_cols=68 Identities=13% Similarity=0.123 Sum_probs=44.8
Q ss_pred cccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-C--Cceeeeeee------eeecCeeEEEEEecC
Q 040910 173 GEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-H--RNLVRLFGC------CIEQGEKILIYEYMP 243 (496)
Q Consensus 173 G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~------~~~~~~~~lv~e~~~ 243 (496)
|.|....||+....+| .+++|+...... ..|+.++..|. + |++.+.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444688999987666 899998765331 35666676663 1 225555532 233567899999999
Q ss_pred CCCh
Q 040910 244 NKSL 247 (496)
Q Consensus 244 ~gsL 247 (496)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0021 Score=63.35 Aligned_cols=73 Identities=11% Similarity=0.115 Sum_probs=44.4
Q ss_pred ccccccCCeeEEEEEecC---------CCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc-eeeeeeeeeecCeeEEEE
Q 040910 170 NKLGEGGFGPVYKGKLLN---------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN-LVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~ 239 (496)
+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888888999987643 267888886543221 123467888888884333 34666544 2 36899
Q ss_pred EecCCCCh
Q 040910 240 EYMPNKSL 247 (496)
Q Consensus 240 e~~~~gsL 247 (496)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0029 Score=56.58 Aligned_cols=103 Identities=12% Similarity=0.021 Sum_probs=66.0
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
.-||.+.|.. ...++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ +
T Consensus 32 ~vSL~eIL~~--------------~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~ 94 (229)
T 2yle_A 32 ALSLEEILRL--------------YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-A 94 (229)
T ss_dssp EEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C
T ss_pred cccHHHHHHH--------------cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-c
Confidence 3478888863 45789999999999999999877621110 1 1233456899999999988764 1
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~ 378 (496)
.+. .....+.|||... ...+.+.-|||+|+++|.-+--..
T Consensus 95 ~s~--------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 95 ADD--------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccc--------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 110 1122456888653 455678899999999999875443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0084 Score=60.06 Aligned_cols=74 Identities=12% Similarity=0.119 Sum_probs=49.1
Q ss_pred cccccccCCeeEEEEEecC--------CCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEE
Q 040910 169 ENKLGEGGFGPVYKGKLLN--------GEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 239 (496)
.+.|..|-...+|+....+ ++.+++|+....... ...-.+|..+++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998753 578999986543322 123367888888884 333445565432 26899
Q ss_pred EecCCCCh
Q 040910 240 EYMPNKSL 247 (496)
Q Consensus 240 e~~~~gsL 247 (496)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.02 E-value=0.13 Score=51.05 Aligned_cols=30 Identities=23% Similarity=0.351 Sum_probs=25.2
Q ss_pred CeeecCCCCCCEEe------cCCCceEEeccccccc
Q 040910 298 RVIHRDLKASNVLL------DGDMNPKISDFGIARM 327 (496)
Q Consensus 298 ~ivH~Dlk~~NIll------~~~~~~kl~DFgla~~ 327 (496)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998863
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=89.84 E-value=0.23 Score=36.68 Aligned_cols=34 Identities=26% Similarity=0.477 Sum_probs=27.4
Q ss_pred cCChHHHHHHhhccCceEEEeeecccCCCcccccccc
Q 040910 29 SVNLKECEAECLKNCTCRAYGNSNLIGGGSGCLMWFG 65 (496)
Q Consensus 29 ~~~~~~C~~~Cl~ncsC~a~~~~~~~~~~~~C~~w~~ 65 (496)
.+++++|+..|+.+-.|+||.|. .....|.+..+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN---~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYN---VKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEE---TTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEec---cCCCceEcccC
Confidence 45799999999999999999995 23456886654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.13 E-value=0.056 Score=54.79 Aligned_cols=60 Identities=5% Similarity=0.063 Sum_probs=17.9
Q ss_pred ccccccccCCeeEEEEEecC-CCEEEE------EEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeee
Q 040910 168 EENKLGEGGFGPVYKGKLLN-GEEVAV------KRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCI 230 (496)
Q Consensus 168 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 230 (496)
..++|| ||.||+|.+.. ..+||| |..+... .+....|.+|..++..++|||+++..++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 346777 99999998854 368899 7765422 233457888999999999999999987754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.03 E-value=0.25 Score=31.60 Aligned_cols=6 Identities=33% Similarity=0.888 Sum_probs=2.3
Q ss_pred Hhhhhh
Q 040910 115 IFYGRK 120 (496)
Q Consensus 115 ~~~~~~ 120 (496)
++++++
T Consensus 33 ~~~RRr 38 (44)
T 2ks1_B 33 LFMRRR 38 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.13 E-value=0.23 Score=31.73 Aligned_cols=6 Identities=33% Similarity=0.778 Sum_probs=2.4
Q ss_pred Hhhhhh
Q 040910 115 IFYGRK 120 (496)
Q Consensus 115 ~~~~~~ 120 (496)
++++++
T Consensus 32 ~~~RRR 37 (44)
T 2l2t_A 32 VYVRRK 37 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 344443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.26 E-value=0.26 Score=31.44 Aligned_cols=6 Identities=33% Similarity=0.645 Sum_probs=2.2
Q ss_pred Hhhhhh
Q 040910 115 IFYGRK 120 (496)
Q Consensus 115 ~~~~~~ 120 (496)
+|++|+
T Consensus 33 ~~~RRR 38 (44)
T 2jwa_A 33 ILIKRR 38 (44)
T ss_dssp HHHHHH
T ss_pred hheehh
Confidence 333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.60 E-value=5.5 Score=35.40 Aligned_cols=114 Identities=9% Similarity=0.056 Sum_probs=73.7
Q ss_pred cCCceeeeeeeeeecCeeEEEEEecCCC-ChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHH-HhhhcC
Q 040910 218 HHRNLVRLFGCCIEQGEKILIYEYMPNK-SLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL-YLHQYS 295 (496)
Q Consensus 218 ~H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~ 295 (496)
.||++ -...-.+.+...+.|+--+++ ++. .+ ..++...+++++.+|+.... +++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------------------~~~~~~eKlrll~nl~~L~~~~~~~-- 104 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------------------RKTTLLSRIRAAIHLVSKVKHHSAR-- 104 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------------------HTSCHHHHHHHHHHHHHHHSSCCSS--
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------------------HhcCHHHHHHHHHHHHHHHHHhhhC--
Confidence 68887 333335666666666654332 222 22 24777889999999888776 5554
Q ss_pred CCCeeecCCCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh
Q 040910 296 RLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS 375 (496)
Q Consensus 296 ~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt 375 (496)
-+|--|.|+|+++|.++.++|.=.|+-..+.+-. +.+|- =.-++=+++..++.
T Consensus 105 ---r~tf~l~P~NL~f~~~~~p~i~hRGi~~~lpP~e--------------~~ee~----------fl~qyKali~all~ 157 (219)
T 4ano_A 105 ---RLIFIVCPENLMFNRALEPFFLHVGVKESLPPDE--------------WDDER----------LLREVKATVLALTE 157 (219)
T ss_dssp ---SEECCCCGGGEEECTTCCEEESCCEETTTBSSCS--------------CCHHH----------HHHHHHHHHHHHTT
T ss_pred ---ceeEEEeCceEEEeCCCcEEEEEcCCcccCCCCC--------------CCHHH----------HHHHHHHHHHHHHc
Confidence 5788899999999999999998887754332111 11121 12256677888888
Q ss_pred CCCCCC
Q 040910 376 SKKNTR 381 (496)
Q Consensus 376 g~~~~~ 381 (496)
++..|.
T Consensus 158 ~K~~Fe 163 (219)
T 4ano_A 158 GEYRFD 163 (219)
T ss_dssp CSSCHH
T ss_pred CCCCHH
Confidence 877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 496 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 5e-71
Identities = 64/295 (21%), Positives = 125/295 (42%), Gaps = 31/295 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ ++G G FG VYKGK V + ++ + Q ++ FKNE+ ++ K H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
G + ++ ++ SL L + + + I
Sbjct: 69 FMGYS-TAPQLAIVTQWCEGSSLYHHLHI--------------IETKFEMIKLIDIARQT 113
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
AQG+ YLH +IHRDLK++N+ L D+ KI DFG+A + ++ G+
Sbjct: 114 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 345 GYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
+M+PE +S +SDV++FG++L E ++ + + NI++ +
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLS 228
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456
+ ++ C+++ +RP ++++ I+ +LP
Sbjct: 229 PDLSKVRSNCPKAM--------KRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-67
Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 33/285 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ ++G G FG V+ G LN ++VA+K + + E+F E ++ KL H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L+G C+EQ L++E+M + L +L + + T + + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--------------LFAAETLLGMCLDV 110
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+G+ YL + VIHRDL A N L+ + K+SDFG+ R D+ ++
Sbjct: 111 CEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPV 166
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404
+ SPE +S KSDV+SFGVL+ E S K ++ + +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDISTGF 219
Query: 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
+L P L + +Y ++ C +E DRP S ++ +
Sbjct: 220 RLYKPRLASTHVY-------QIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 8e-67
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 33/287 (11%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
+LG G FG V+ G +VAVK L + + F E L+ +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
RL+ + +I EYM N SL FL L + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-------------GIKLTINKLLDMAAQ 117
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
IA+G+ ++ + IHRDL+A+N+L+ ++ KI+DFG+AR+ +E +
Sbjct: 118 IAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFP 173
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
+ +PE +G F+IKSDV+SFG+LL E ++ + Y + + + +R
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEV-----IQNLERG 226
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
++++ P E LY ++ LC +E DRPT + S++++
Sbjct: 227 YRMVRPDNCPEELY-------QLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-67
Identities = 75/319 (23%), Positives = 130/319 (40%), Gaps = 42/319 (13%)
Query: 144 GKSKESWFIFFSLASISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQG 203
G +K++W I + E KLG+G FG V+ G VA+K L
Sbjct: 6 GLAKDAWEIPRE---------SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMS 55
Query: 204 VEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMV 263
E F E ++ KL H LV+L+ + ++ EYM SL FL
Sbjct: 56 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--- 111
Query: 264 TDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323
V + IA G+ Y+ + +HRDL+A+N+L+ ++ K++DFG
Sbjct: 112 ----------LPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 158
Query: 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383
+AR+ +E + + +PE AL+G F+IKSDV+SFG+LL E + +
Sbjct: 159 LARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR----- 212
Query: 384 NIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
+ + ++ + + + C ++ +RPT
Sbjct: 213 ---------VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 263
Query: 444 VVSMIKNEIVNLPSPQQPA 462
+ + +++ + QP
Sbjct: 264 LQAFLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-65
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+ + +LG G FG V GK +VA+K + + +EF E ++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 225 LFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
L+G C +Q +I EYM N L +L + + + + + +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLRE--------------MRHRFQTQQLLEMCKDV 109
Query: 285 AQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTY 344
+ + YL + +HRDL A N L++ K+SDFG++R DE S
Sbjct: 110 CEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPV 165
Query: 345 GYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAW 404
+ PE ++ FS KSD+++FGVL+ E S K + + +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSET------AEHIAQGL 218
Query: 405 KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+L P L +E +Y + C E A +RPT ++S I +
Sbjct: 219 RLYRPHLASEKVY-------TIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 3e-64
Identities = 71/321 (22%), Positives = 133/321 (41%), Gaps = 49/321 (15%)
Query: 154 FSLASISTATHNFSEE---------NKLGEGGFGPVYKGKLL----NGEEVAVKRL-SNK 199
F+ + A F++E +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 200 SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSG 259
+ + +F +E ++ + H N++ L G + ++I E+M N SLD FL
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ------ 120
Query: 260 FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319
+ G V ++ GIA G+ YL +HRDL A N+L++ ++ K+
Sbjct: 121 --------NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKV 169
Query: 320 SDFGIARMFGGDELQSNMNRIVG---TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSS 376
SDFG++R D +G + +PE + F+ SDV+S+G+++ E +S
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 377 KKNTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAA 436
+ + + ++ + ++ L C Q++
Sbjct: 230 GE--------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275
Query: 437 DRPTMSEVVSMIKNEIVNLPS 457
RP ++V+ + ++++ P+
Sbjct: 276 HRPKFGQIVNTL-DKMIRNPN 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 27/300 (9%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQG-VEEFKNEMILIAK 216
+ S LG G FG V + VAVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 217 L-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYS---SGFDMVTDPASKGIL 272
L +H N+V L G C G ++I EY L FL + S S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
D + +A+G+ +L IHRDL A N+LL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 333 LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
+M+PE + +++ +SDV+S+G+ L E S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
+ D + +K++ + + + C + RPT ++V +I+ +I
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 1e-63
Identities = 63/305 (20%), Positives = 114/305 (37%), Gaps = 41/305 (13%)
Query: 169 ENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+ +G+G FG V++GK GEEVAVK S++ + + E+ L H N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 229 CIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGI 284
+ L+ +Y + SL +L ++ + +++
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----------------NRYTVTVEGMIKLALST 109
Query: 285 AQGLLYLHQ-----YSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF--GGDELQSNM 337
A GL +LH + + HRDLK+ N+L+ + I+D G+A D +
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 338 NRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS---- 387
N VGT YM+PE H ++D+++ G++ E +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 388 -LTLLGHAWNLWKDDRAWKLLDPTLQNEALYP-MVKRYIKVALLCVQENAADRPTMSEVV 445
L + + + L P + N ++ K+ C N A R T +
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 446 SMIKN 450
+
Sbjct: 290 KTLSQ 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-63
Identities = 74/304 (24%), Positives = 119/304 (39%), Gaps = 32/304 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLSNKSGQG-VEEFKNEMILIAKL 217
N LG G FG V +VAVK L K+ E +E+ ++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 218 -HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK------- 269
H N+V L G C G LI+EY L +L + D + K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 270 -GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMF 328
+L + + +A+G+ +L +HRDL A NVL+ KI DFG+AR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 329 GGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388
D +M+PE G+++IKSDV+S+G+LL E S N + I
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVD 273
Query: 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMI 448
+KL+ + + + + + C ++ RP+ + S +
Sbjct: 274 ANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 449 KNEI 452
++
Sbjct: 322 GCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 3e-63
Identities = 69/312 (22%), Positives = 123/312 (39%), Gaps = 33/312 (10%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLS-NKSGQGVEEF 207
L S+ +N +GEG FG V++ + VAVK L S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 208 KNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPA 267
+ E L+A+ + N+V+L G C L++EYM L+ FL + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 268 S---------KGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318
S L ++ I +A G+ YL + + +HRDL N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
I+DFG++R + +M PE + ++ +SDV+++GV+L E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 379 NTRFYNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADR 438
+ + ++ + + D + + LC + ADR
Sbjct: 241 Q-------------PYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADR 286
Query: 439 PTMSEVVSMIKN 450
P+ + +++
Sbjct: 287 PSFCSIHRILQR 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 3e-63
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ + ++KLG G +G VY+G VAVK L + VEEF E ++ ++ H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V+L G C + +I E+M +L +L + + + + +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-------------RQEVSAVVLLYMAT 122
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKF 178
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402
+ +PE + FSIKSDV++FGVLL E + + + +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQ 224
Query: 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
++LL+ + E ++ ++ C Q N +DRP+ +E+ +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-62
Identities = 68/308 (22%), Positives = 114/308 (37%), Gaps = 38/308 (12%)
Query: 162 ATHNFS-EENKLGEGGFGPVYKGKLL---NGEEVAVKRLSNKSGQG-VEEFKNEMILIAK 216
N + +LG G FG V +G +VA+K L + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
L + +VRL G C + +L+ E L FL + + +
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--------------EEIPVSN 110
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
++ ++ G+ YL + +HRDL A NVLL KISDFG+++ G D+
Sbjct: 111 VAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167
Query: 337 -MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395
+ + +PE FS +SDV+S+GV + E LS + +
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPY 213
Query: 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455
K ++ + E + C DRP V ++ +L
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
Query: 456 PSPQQPAF 463
S +
Sbjct: 274 ASKVEGHH 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-61
Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVR 224
+G+G FG V G G +VAVK + N + + F E ++ +L H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 225 LFGCCIEQGEKI-LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L G +E+ + ++ EYM SL +L + +L ++
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-------------RSVLGGDCLLKFSLD 111
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+ + + YL +HRDL A NVL+ D K+SDFG+ + E S +
Sbjct: 112 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 163
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
+ +PE FS KSDV+SFG+LL E S + Y L + + + ++
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDV-----VPRVEKG 216
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+K+ P A+Y ++K C +AA RP+ ++ +++
Sbjct: 217 YKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEH 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 2e-61
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 45/288 (15%)
Query: 166 FSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQG---VEEFKNEMILIAKLHHRN 221
FS+ ++G G FG VY + + N E VA+K++S Q ++ E+ + KL H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ GC + + L+ EY + D K L +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---------------HKKPLQEVEIAAVT 121
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
G QGL YLH +IHRD+KA N+LL K+ DFG A + + N V
Sbjct: 122 HGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFV 172
Query: 342 GTYGYMSPEYAL---HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
GT +M+PE L G + K DV+S G+ +E K +N+++++ L +++
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---YHIA 227
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
+++ P LQ+ + ++ C+Q+ DRPT ++
Sbjct: 228 QNES------PALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-61
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 42/296 (14%)
Query: 168 EENKLGEGGFGPVYKGKLLN---GEEVAVKRLSNKSGQG--VEEFKNEMILIAKLHHRNL 222
E+ +LG G FG V KG + VAVK L N++ +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
VR+ G C E +L+ E L+ +L + + ++
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ---------------NRHVKDKNIIELVH 114
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD-ELQSNMNRIV 341
++ G+ YL + +HRDL A NVLL KISDFG+++ D
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
+ +PE + FS KSDV+SFGVL+ E S + + K
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGS 217
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN---EIVN 454
+L+ + + + LC + +RP + V ++N ++VN
Sbjct: 218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-61
Identities = 83/300 (27%), Positives = 126/300 (42%), Gaps = 41/300 (13%)
Query: 158 SISTATHNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKSGQG-VEEFKNEMI 212
S+ +F+E +G G FG VY G LL+ AVK L+ + G V +F E I
Sbjct: 23 GPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 213 LIAKLHHRNLVRLFGCCIE-QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGI 271
++ H N++ L G C+ +G +++ YM + L F+ +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--------------ETHN 126
Query: 272 LDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGD 331
+ +A+G+ + + +HRDL A N +LD K++DFG+AR
Sbjct: 127 PTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 332 ELQS--NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT 389
E S N +M+ E F+ KSDV+SFGVLL E ++ Y +
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPY--PDVN 239
Query: 390 LLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
L + R LL P + LY +V L C A RP+ SE+VS I
Sbjct: 240 TFDITVYLLQGRR---LLQPEYCPDPLY-------EVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-61
Identities = 62/310 (20%), Positives = 116/310 (37%), Gaps = 51/310 (16%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGV-EEFKNEMILIAKLHHRNL 222
+F + ++LG G G V+K +G +A K + + + + E+ ++ + + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V +G GE + E+M SLD L G + ++
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------------AGRIPEQILGKVSI 111
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+ +GL YL + +++HRD+K SN+L++ K+ DFG++ S N VG
Sbjct: 112 AVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 165
Query: 343 TYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK--------------KNTRFYNIDSL 388
T YMSPE +S++SD++S G+ L+E + + +
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALL--------------CVQEN 434
T P + L + L C+ +N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 435 AADRPTMSEV 444
A+R + ++
Sbjct: 286 PAERADLKQL 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-60
Identities = 76/315 (24%), Positives = 141/315 (44%), Gaps = 30/315 (9%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLNG---EEVAVKRLS-NKSGQGVEEFKNEMILIAKL-H 218
++ ++ +GEG FG V K ++ + A+KR+ S +F E+ ++ KL H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKY-SSGFDMVTDPASKGILDWTTR 277
H N++ L G C +G L EY P+ +L FL + + ++ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
+ +A+G+ YL Q + IHRDL A N+L+ + KI+DFG++R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397
+M+ E + +++ SDV+S+GVLL E +S T + + L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTCAEL------Y 236
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS----MIKNEIV 453
K + ++L P ++ +Y + C +E +RP+ ++++ M++
Sbjct: 237 EKLPQGYRLEKPLNCDDEVY-------DLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 454 NLPSPQQPAFSYVRI 468
+ + F+Y I
Sbjct: 290 YVNTTLYEKFTYAGI 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 70/301 (23%), Positives = 131/301 (43%), Gaps = 39/301 (12%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLNGEE-----VAVKRLSNKSGQG-VEEFKNEMILIAKL 217
+ + +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
H N++RL G + ++I EYM N +LD FL + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--------------KDGEFSVLQL 112
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN- 336
V ++ GIA G+ YL + +HRDL A N+L++ ++ K+SDFG++R+ D +
Sbjct: 113 VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
+ + +PE + F+ SDV+SFG+++ E ++ + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYW 215
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456
+ K ++ + ++ + C Q+ A RP +++VS++ ++++ P
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAP 274
Query: 457 S 457
Sbjct: 275 D 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 73/309 (23%), Positives = 132/309 (42%), Gaps = 31/309 (10%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLN------GEEVAVKRLS-NKSGQGVEEFKNEMILIAK 216
+ +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 217 LHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTT 276
+ ++VRL G + ++I E M L +L + + + V P +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP-----PSLSK 134
Query: 277 RVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN 336
+++ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
+ + +MSPE G+F+ SDV+SFGV+L E + + +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQ 237
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456
+++ + + + ++ +C Q N RP+ E++S IK E+ P
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM--EP 295
Query: 457 SPQQPAFSY 465
++ +F Y
Sbjct: 296 GFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 6e-59
Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLS-NKSGQGVEEFKNEMILIAKLHHRNL 222
++ LGEG +G V E VAVK + ++ E K E+ + L+H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V+ +G E + L EY L + + R
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE---------------PDIGMPEPDAQRFFH 110
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+ G++YLH + + HRD+K N+LLD N KISDFG+A +F + + +N++ G
Sbjct: 111 QLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 343 TYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
T Y++PE F + DV+S G++L L+ + + DS
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYL 226
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
WK +D ++ + + EN + R T+ ++
Sbjct: 227 NPWKKIDSAPLA-----LLHK-------ILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-58
Identities = 74/319 (23%), Positives = 131/319 (41%), Gaps = 52/319 (16%)
Query: 166 FSEENKLGEGGFGPVYKGKLLNGEE-----VAVKRLS-NKSGQGVEEFKNEMILIAKLHH 219
F + LG G FG VYKG + E VA+K L S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
++ RL G C+ LI + MP L ++ ++K + +
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK--------------DNIGSQYLLN 115
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
IA+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 116 WCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
+M+ E LH +++ +SDV+S+GV + E ++ ++
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIP 218
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK---------- 449
+L+ + + + C +A RP E++
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278
Query: 450 ----NEIVNLPSPQQPAFS 464
+E ++LPSP F
Sbjct: 279 VIQGDERMHLPSPTDSNFY 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-58
Identities = 61/281 (21%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 170 NKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGC 228
+LG+G FG VYK + A K + KS + +E++ E+ ++A H N+V+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGL 288
+ ++ E+ ++D + + + L + + + L
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLEL--------------ERPLTESQIQVVCKQTLDAL 123
Query: 289 LYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMS 348
YLH ++IHRDLKA N+L D + K++DFG++ + +GT +M+
Sbjct: 124 NYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMA 178
Query: 349 PEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
PE + + K+DV+S G+ L+E + + ++ + +L
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVL----LKIAKSEP 232
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
L P+ + +K+ C+++N R T S++
Sbjct: 233 PTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 6e-58
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 35/288 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRN 221
++ +G G +G K + +G+ + K L + + + +E+ L+ +L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 222 LVRLFGCCIEQGEKIL--IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
+VR + I++ L + EY L + + LD +R
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-----------KERQYLDEEFVLR 113
Query: 280 IIEGIAQGLLYLHQYSR--LRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
++ + L H+ S V+HRDLK +NV LDG N K+ DFG+AR+ D S
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFA 171
Query: 338 NRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397
VGT YMSPE ++ KSD++S G LL E + + S L
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGKIRE 228
Query: 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVV 445
K R L + + RP++ E++
Sbjct: 229 GKFRRIPYRYSDELNE------------IITRMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-57
Identities = 61/287 (21%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRL 225
+ ++G G F VYKG EVA L ++ + + FK E ++ L H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 226 FGCCIEQGEK----ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+ + +L+ E M + +L +L ++
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---------------RFKVMKIKVLRSWC 118
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-DMNPKISDFGIARMFGGDELQSNMNRI 340
I +GL +LH + +IHRDLK N+ + G + KI D G+A + S +
Sbjct: 119 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAV 173
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL-TLLGHAWNLWK 399
+GT +M+PE + DV++FG+ +LE +S+ + + + + K
Sbjct: 174 IGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVK 230
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
K+ P ++ + C+++N +R ++ ++++
Sbjct: 231 PASFDKVAIPEVKE------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-57
Identities = 73/297 (24%), Positives = 111/297 (37%), Gaps = 26/297 (8%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQG--VEEFKNEMILIA 215
LG G FG V + VAVK L + ILI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 216 KLHHRNLVRLFGCCIEQGEKILI-YEYMPNKSLDFFLFDYK-YSSGFDMVTDPASKGILD 273
HH N+V L G C + G +++ E+ +L +L + + + + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ +A+G+ +L + IHRDL A N+LL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
+M+PE +++I+SDV+SFGVLL E S + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEE 245
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
K+ + D + L C + RPT SE+V + N
Sbjct: 246 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 64/291 (21%), Positives = 124/291 (42%), Gaps = 35/291 (12%)
Query: 155 SLASISTATHNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMIL 213
S+ S+ ++ K+G+G G VY + G+EVA+++++ + E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 214 IAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
+ + + N+V + E ++ EY+ SL + + D
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------------D 114
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+ Q L +LH +VIHRD+K+ N+LL D + K++DFG +
Sbjct: 115 EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169
Query: 334 QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
QS + +VGT +M+PE + K D++S G++ +E + + + N + L L
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL-- 225
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
L + +L +P + + R C+ + R + E+
Sbjct: 226 --YLIATNGTPELQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 4e-56
Identities = 68/286 (23%), Positives = 104/286 (36%), Gaps = 42/286 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHR 220
+F LG+G FG VY + + +A+K L + + E+ + + L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N++RL+G + LI EY P ++ L D
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---------------SKFDEQRTATY 111
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
I +A L Y H RVIHRD+K N+LL KI+DFG + +
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTL 164
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400
GT Y+ PE + K D++S GVL E L K F +
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRV--- 219
Query: 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446
+ P E ++ R ++ N + RP + EV+
Sbjct: 220 ----EFTFPDFVTEGARDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-56
Identities = 74/305 (24%), Positives = 123/305 (40%), Gaps = 29/305 (9%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLL--------NGEEVAVKRL-SNKSGQGVEEFKNEMILI 214
LGEG FG V + + +VAVK L S+ + + + + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 215 AKL-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSS-GFDMVTDPASKGIL 272
+ H+N++ L G C + G +I EY +L +L + + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 273 DWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDE 332
V +A+G+ YL + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 333 LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------------- 235
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452
+ + +KLL + + + C + RPT ++V + + I
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-DRI 294
Query: 453 VNLPS 457
V L S
Sbjct: 295 VALTS 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-55
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 39/293 (13%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKL 217
+ KLG+G FG V +G+ VAVK L + +++F E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 218 HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
HRNL+RL+G + ++ E P SL L ++ G T
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--------------GHFLLGTL 113
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
R +A+G+ YL R IHRDL A N+LL KI DFG+ R ++ M
Sbjct: 114 SRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 338 N-RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
+ + +PE FS SD + FGV L E + + + ++ +L
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-EPWIGLNGSQIL----- 224
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIK 449
K+ + + V + C DRPT + +
Sbjct: 225 -------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-52
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 38/292 (13%)
Query: 164 HNFSEENKLGEGGFGPVYKGKLLNGEE----VAVKRLSNKSGQGV-EEFKNEMILIAKLH 218
+GEG FG V++G ++ E VA+K N + V E+F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 219 HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRV 278
H ++V+L G E +I E L FL KYS LD + +
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--------------LDLASLI 111
Query: 279 RIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMN 338
++ L YL R +HRD+ A NVL+ + K+ DFG++R +
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-AS 167
Query: 339 RIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398
+ +M+PE F+ SDV+ FGV + E L + + +
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-------VKNNDVIG 220
Query: 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450
+ + +L P LY ++ + C + + RP +E+ + +
Sbjct: 221 RIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (446), Expect = 2e-51
Identities = 55/283 (19%), Positives = 103/283 (36%), Gaps = 35/283 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
++ +LG G FG V++ G A K + E + E+ ++ L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L + E ++IYE+M L + D + V +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD--------------EHNKMSEDEAVEYMRQ 132
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP--KISDFGIARMFGGDELQSNMNRIV 341
+ +GL ++H +H DLK N++ + K+ DFG+ + ++
Sbjct: 133 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTT 186
Query: 342 GTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401
GT + +PE A +D++S GVL LS N D + + DD
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
A+ + ++ +++ + + R T+ +
Sbjct: 247 SAFSGISEDGKD-----FIRK-------LLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 42/286 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHR 220
+F LGEG F V + L E A+K L + V E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
V+L+ + + Y N L ++ G D T
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---------------GSFDETCTRFY 113
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
I L YLH +IHRDLK N+LL+ DM+ +I+DFG A++ + Q+ N
Sbjct: 114 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400
VGT Y+SPE SD+++ G ++ + ++ ++
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRA 212
Query: 401 DRAWKLLDPTLQNEALYP--MVKRYIKVALLCVQENAADRPTMSEV 444
+ + ++ E +P + + + +A R E+
Sbjct: 213 GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 9e-50
Identities = 63/323 (19%), Positives = 121/323 (37%), Gaps = 43/323 (13%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
+LG G FG V++ G K ++ KNE+ ++ +LHH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
++ E +LI E++ L + Y + + + +GL
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK--------------MSEAEVINYMRQACEGLK 141
Query: 290 YLHQYSRLRVIHRDLKASNVLLDGDMNP--KISDFGIARMFGGDELQSNMNRIVGTYGYM 347
++H ++H D+K N++ + KI DFG+A DE+ + T +
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFA 195
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH--AWNLWKDDRAWK 405
+PE +D+++ GVL LS + F D L L + + D+ A+
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 406 LLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPS--PQQP 461
+ P ++ +K +Q+ R T+ + + +K + NL S P
Sbjct: 254 SVSPEAKD-----FIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301
Query: 462 AFSYVRIVEKSVLLENSEAEASS 484
+ +++ + A
Sbjct: 302 YNKIRQKIKEKYADWPAPQPAIG 324
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (408), Expect = 1e-45
Identities = 65/287 (22%), Positives = 107/287 (37%), Gaps = 43/287 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLH-- 218
+FS +G GGFG VY + G+ A+K L K QG NE I+++ +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 219 -HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+V + + I + M L + L G+
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---------------HGVFSEADM 109
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNM 337
I GL ++H V++RDLK +N+LLD + +ISD G+A F +
Sbjct: 110 RFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKP 162
Query: 338 NRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
+ VGT+GYM+PE G+ + +D FS G +L + L R + +
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT- 221
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
L P L++ +++ +Q + R
Sbjct: 222 LTMAVELPDSFSPELRS-----LLEG-------LLQRDVNRRLGCLG 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 55/319 (17%), Positives = 111/319 (34%), Gaps = 38/319 (11%)
Query: 171 KLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCC 229
LG G FG V++ + + K + G K E+ ++ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 230 IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLL 289
E ++I+E++ + + + L+ V + + + L
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--------------LNEREIVSYVHQVCEALQ 116
Query: 290 YLHQYSRLRVIHRDLKASNVLLD--GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYM 347
+LH + H D++ N++ KI +FG AR + N + Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170
Query: 348 SPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRAWKLL 407
+PE H + S +D++S G L+ LS + D+ A+K +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 408 DPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPSPQQPAFSY 465
+ V R + + R T SE + +K +I + + +
Sbjct: 231 SIEAMD-----FVDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKH 278
Query: 466 VRIVEKSVLLENSEAEASS 484
R + + + +++
Sbjct: 279 RRYYHTLIKKDLNMVVSAA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 5e-45
Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 32/281 (11%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEE-FKNEMILIAKLHHRNLV 223
+ + LG G F V + + VA+K ++ K+ +G E +NE+ ++ K+ H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L G LI + + L + KG R+I
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRI---------------VEKGFYTERDASRLIFQ 115
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
+ + YLH + + LD D ISDFG+++M + ++ GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
Query: 344 YGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403
GY++PE +S D +S GV+ L FY+ + L + K +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLF---EQILKAEYE 227
Query: 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ +++ ++ ++++ R T +
Sbjct: 228 FDSPYWDDISDSAKDFIRH-------LMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (396), Expect = 7e-45
Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 40/289 (13%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQG---VEEFKNEMILIAKLHHRN 221
+ LG GG V+ + L +VAVK L + F+ E A L+H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 222 LVRLFGCCIEQGEKI----LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
+V ++ + ++ EY+ +L + G +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---------------GPMTPKRA 113
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG-GDELQSN 336
+ +I Q L + H + +IHRD+K +N+++ K+ DFGIAR +
Sbjct: 114 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 337 MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396
++GT Y+SPE A +SDV+S G +L E L+ + F +++ +
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVA---YQ 225
Query: 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEV 444
++D + L +V + + +N +R T +E+
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEM 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 8e-44
Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 50/297 (16%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSG---------QGVEEFKNEMILI 214
N+ + LG G V + +E AVK + G + E E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 215 AKLH-HRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILD 273
K+ H N+++L L+++ M L +L K L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------------TEKVTLS 108
Query: 274 WTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDEL 333
+I+ + + + LH +L ++HRDLK N+LLD DMN K++DFG + E
Sbjct: 109 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE- 164
Query: 334 QSNMNRIVGTYGYMSPEYAL------HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDS 387
+ + GT Y++PE H + + D++S GV++ L+ F++
Sbjct: 165 --KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQ 220
Query: 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ +L + + + + ++ + +V R + R T E
Sbjct: 221 MLML---RMIMSGNYQFGSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 63/284 (22%), Positives = 102/284 (35%), Gaps = 41/284 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG---QGVEEFKNE-MILIAKLHH 219
+F LG+G FG V+ + + A+K L VE E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
L +F + + EY+ L + + S D +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---------------SCHKFDLSRATF 107
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
I GL +LH +++RDLK N+LLD D + KI+DFG+ + + + N
Sbjct: 108 YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNT 162
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
GT Y++PE L ++ D +SFGVLL E L + + F+ D L+
Sbjct: 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE-------ELFH 213
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
R P + ++ + R +
Sbjct: 214 SIRMDNPFYPRWLEKEAKDLLVK-------LFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 2e-43
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHR 220
+F LG G FG V+ + NG A+K L + + VE +E ++++ + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
++R++G + + +I +Y+ L L +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------------PNPVAKFY 109
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ L YLH +I+RDLK N+LLD + + KI+DFG A+ + +
Sbjct: 110 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 161
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK 378
GT Y++PE ++ D +SFG+L+ E L+
Sbjct: 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 5e-43
Identities = 52/296 (17%), Positives = 94/296 (31%), Gaps = 36/296 (12%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
K+G G FG +Y G + GEEVA+K K+ + E + + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIR 69
Query: 228 CCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQG 287
C +G+ ++ + SL+ T + + + +
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFC--------------SRKFSLKTVLLLADQMISR 115
Query: 288 LLYLHQYSRLRVIHRDLKASNVL---LDGDMNPKISDFGIARMFGGDELQSNM-----NR 339
+ Y+H IHRD+K N L I DFG+A+ + ++
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
+ GT Y S L S + D+ S G +L+ + + + K
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455
++L +E C D+P S + + +N
Sbjct: 233 MSTPIEVLCKGYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-42
Identities = 56/298 (18%), Positives = 104/298 (34%), Gaps = 34/298 (11%)
Query: 166 FSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQG-VEEFKNEMILIAKLHHRNLV 223
++ + +GEG +G V +N VA+K++S Q + E+ ++ + H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
+ + + Y+ + L+ L +
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKL------------LKTQHLSNDHICYFLYQ 117
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSN-MNRIVG 342
I +GL Y+H V+HRDLK SN+LL+ + KI DFG+AR+ D + + V
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 343 TYGYMSPEYALHGLFSIKS-DVFSFGVLLL---------------ETLSSKKNTRFYNID 386
T Y +PE L+ KS D++S G +L + L+
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ + N + + + + N R + +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 4e-42
Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 40/314 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRN 221
NF + K+GEG +G VYK + L GE VA+K RL ++ E+ L+ +L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V+L + + L++E++ F + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--------------TGIPLPLIKSYL 108
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+ QGL + H + RV+HRDLK N+L++ + K++DFG+AR FG V
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEV 163
Query: 342 GTYGYMSPE-YALHGLFSIKSDVFSFGVLLLETLSSKK-------NTRFYNIDSL--TLL 391
T Y +PE +S D++S G + E ++ + + + I T
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVAL----LCVQENAADRPTMSEVVSM 447
W +K P + +V + + + R + ++
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 448 --IKNEIVNLPSPQ 459
++ V P P
Sbjct: 284 PFFQD--VTKPVPH 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 5e-42
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 33/301 (10%)
Query: 162 ATHNFSEENKLGEGGFGPVYKGKLL--NGEEVAVKRLSNKSGQGVEEFK-----NEMILI 214
A + ++GEG +G V+K + L G VA+KR+ ++G+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 215 AKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDW 274
H N+VRLF C + + +D L Y D + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL---------DKVPEPGVPT 115
Query: 275 TTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQ 334
T ++ + +GL +LH RV+HRDLK N+L+ K++DFG+AR++ Q
Sbjct: 116 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 169
Query: 335 SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-------KNTRFYNIDS 387
+ +V T Y +PE L ++ D++S G + E K + I
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 388 LTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVAL----LCVQENAADRPTMSE 443
+ L + +D + + + + V ++ C+ N A R +
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 444 V 444
Sbjct: 290 A 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-42
Identities = 69/323 (21%), Positives = 121/323 (37%), Gaps = 49/323 (15%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
++++ +G G FG VY+ KL +GE VA+K++ E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 224 RLFGCCIEQGEK------ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTR 277
RL GEK L+ +Y+P + +K L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR------------AKQTLPVIYV 124
Query: 278 VRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQSN 336
+ + + L Y+H + HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 125 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 337 MNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDS-----LTL 390
+ + Y +PE ++ DV+S G +L E L + + + +
Sbjct: 182 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIK------VALL--CVQENAADRPTMS 442
LG + + +P K + +AL ++ R T
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 443 EV-----VSMIKNEIVNLPSPQQ 460
E +++ V LP+ +
Sbjct: 299 EACAHSFFDELRDPNVKLPNGRD 321
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-41
Identities = 67/314 (21%), Positives = 117/314 (37%), Gaps = 43/314 (13%)
Query: 170 NKLGEGGFGPVYKGKLLN-GEEVAVKRLSNKSGQGVEE-----FKNEMILIAKLHHRNLV 223
+ LGEG F VYK + N + VA+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
L + L++++M + +L + +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---------------KDNSLVLTPSHIKAYMLM 108
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGT 343
QGL YLHQ+ ++HRDLK +N+LLD + K++DFG+A+ FG V T
Sbjct: 109 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVT 163
Query: 344 YGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK-------KNTRFYNIDSL--TLLGH 393
Y +PE ++ + D+++ G +L E L + I T
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 394 AWNLWKDDRAWKLLD--PTLQNEALYPMVKRYIKVALL--CVQENAADRPTMSEVVSM-- 447
W + P + ++ + L+ N R T ++ + M
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL-DLIQGLFLFNPCARITATQALKMKY 282
Query: 448 IKNEIVNLPSPQQP 461
N P Q P
Sbjct: 283 FSNRPGPTPGCQLP 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 4e-41
Identities = 63/296 (21%), Positives = 117/296 (39%), Gaps = 36/296 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLLNGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRNL 222
+ K+GEG +G VYK + GE A+K RL + E+ ++ +L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 223 VRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
V+L+ + +L++E++ +G L+ T +
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---------------CEGGLESVTAKSFLL 107
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVG 342
+ G+ Y H RV+HRDLK N+L++ + KI+DFG+AR FG +
Sbjct: 108 QLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIV 162
Query: 343 TYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK-------------KNTRFYNIDSL 388
T Y +P+ + +S D++S G + E ++ + R +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 389 TLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
+ L K D + + +P L + + I + ++ + R T +
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 1e-40
Identities = 47/302 (15%), Positives = 100/302 (33%), Gaps = 38/302 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLV 223
++ ++GEG FG +++G LLN ++VA+K +S + ++E L +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63
Query: 224 RLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEG 283
++G ++ + SL+ L T +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--------------GRKFSVKTVAMAAKQ 109
Query: 284 IAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP-----KISDFGIARMFGGDELQSN-- 336
+ + +H+ +++RD+K N L+ + + DFG+ + + + +
Sbjct: 110 MLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 337 ---MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
+ GT YMS L S + D+ + G + + L + +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT------ 220
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453
N K +R + T E + + K P + + +
Sbjct: 221 --NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
Query: 454 NL 455
L
Sbjct: 279 RL 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-40
Identities = 61/299 (20%), Positives = 111/299 (37%), Gaps = 53/299 (17%)
Query: 166 FSEEN---------KLGEGGFGPVYKGKLL-NGEEVAVKRL------SNKSGQGVEEFKN 209
F +EN +LG G F V K + G + A K + S++ G E+ +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 210 EMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASK 269
E+ ++ ++ H N++ L + + ILI E + L FL + K
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---------------K 107
Query: 270 GILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP----KISDFGIA 325
L ++ I G ++ L++ H DLK N++L P KI DFG+A
Sbjct: 108 ESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 326 RMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNI 385
I GT +++PE + +++D++S GV+ LS
Sbjct: 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEV 444
A N +D + ++ ++R + ++ R T+ +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKD-----FIRR-------LLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 4e-39
Identities = 57/305 (18%), Positives = 105/305 (34%), Gaps = 60/305 (19%)
Query: 171 KLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEE------FKNEMILIAKLH--HRN 221
LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++RL +LI E F +G L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--------------ERGALQEELARSFF 116
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQSNMNRI 340
+ + + + H V+HRD+K N+L+D + K+ DFG + +
Sbjct: 117 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 169
Query: 341 VGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
GT Y PE+ H + V+S G+LL + + + +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD---------------IPFEHDE 214
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPS 457
+ ++ + +++ C+ +DRPT E+ + ++ ++
Sbjct: 215 EIIRGQVFFRQRVSSECQHLIRW-------CLALRPSDRPTFEEIQNHPWMQ----DVLL 263
Query: 458 PQQPA 462
PQ+ A
Sbjct: 264 PQETA 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-38
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 32/302 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRL--SNKSGQGVEEFKNEMILIAKLHHRN 221
+ + K+G+G FG V+K + G++VA+K++ N+ E+ ++ L H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+V L C + Y K + +FD+ ++++ K L RV
Sbjct: 71 VVNLIEICRTKA-----SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--- 122
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFG--GDELQSNMNR 339
+ L L+ R +++HRD+KA+NVL+ D K++DFG+AR F + +
Sbjct: 123 --MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 340 IVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLS------SKKNTRFYNIDSLTLLG 392
V T Y PE L + D++ G ++ E + + S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALL----------CVQENAADRPTMS 442
+W + ++L + + VK +K + + + A R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 443 EV 444
+
Sbjct: 301 DA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-38
Identities = 58/327 (17%), Positives = 114/327 (34%), Gaps = 46/327 (14%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLF 226
LG G G V + E+ A+K L + + + E+ L + ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 227 GCC----IEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIE 282
+ +++ E + L + D I++
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-------------DQAFTEREASEIMK 118
Query: 283 GIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP---KISDFGIARMFGGDELQSNMNR 339
I + + YLH + + HRD+K N+L K++DFG A+ ++
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTT 172
Query: 340 IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399
T Y++PE + D++S GV++ + S L + +
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKT 227
Query: 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPS 457
R + P + + VK I+ ++ R T++E ++ I +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQ---STKV 281
Query: 458 PQQPAFSYVRIVEKSVLLENSEAEASS 484
PQ P + + E E+ + E +S
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTS 308
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-37
Identities = 59/281 (20%), Positives = 101/281 (35%), Gaps = 40/281 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHR 220
+F LG+G FG V + G A+K L + + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
L L + EY L F L S+ + R R
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL----------------SRERVFTEERARF 109
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
A+ + L V++RD+K N++LD D + KI+DFG+ + D + M
Sbjct: 110 Y--GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTF 165
Query: 341 VGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400
GT Y++PE + D + GV++ E + + FYN D L ++
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILM--EE 221
Query: 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTM 441
R + L P ++ ++ ++++ R
Sbjct: 222 IRFPRTLSPEAKS-----LLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-36
Identities = 63/298 (21%), Positives = 109/298 (36%), Gaps = 38/298 (12%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVK--RLSNKSGQGVEEFKNEMILIAKLHHRN 221
+ + K+GEG +G V+K K E VA+K RL + E+ L+ +L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
+VRL + L++E+ +F +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------------------DLDPEIVK 104
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
+ Q L L V+HRDLK N+L++ + K+++FG+AR FG + V
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEV 162
Query: 342 GTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKK--------NTRFYNIDSL--TL 390
T Y P+ L+S D++S G + E ++ + + + I L T
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVAL----LCVQENAADRPTMSEV 444
W +K +L +V + ++ N R + E
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 38/300 (12%)
Query: 164 HNFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHR 220
+ + +G G +G V G +VA+K+L S + E+ L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 221 NLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
N++ L ++ + + + + ++ L +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDF-------YLVMPFMGTDLGKLM----KHEKLGEDRIQFL 126
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRI 340
+ + +GL Y+H +IHRDLK N+ ++ D KI DFG+AR + S M
Sbjct: 127 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGY 178
Query: 341 VGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL---------TL 390
V T Y +PE L+ + ++ D++S G ++ E ++ K + + T
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 391 LGHAWNLWKDDRAWKLLD--PTLQNEALYPMVKRYIKVAL----LCVQENAADRPTMSEV 444
+ D A + P L+ + ++ +A+ + +A R T E
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 8e-34
Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 30/258 (11%)
Query: 127 GNMTRAKEFCEGDSAAK--GKSKESWFIFFSLASISTAT-HNFSEENKLGEGGFGPVYKG 183
GN AK+ E +S + K+KE + + S +TA F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 184 K-LLNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239
K +G A+K L + + +E NE ++ ++ LV+L + ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRV 299
EY+ + L G I YLH L +
Sbjct: 121 EYVAGGEMFSHLRR---------------IGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 300 IHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSI 359
I+RDLK N+L+D +++DFG A+ + + GT ++PE L ++
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 360 KSDVFSFGVLLLETLSSK 377
D ++ GVL+ E +
Sbjct: 218 AVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-32
Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 42/290 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLS----NKSGQGVEEFKNEMILIAK 216
NF LG G +G V+ + + G+ A+K L + + E + E ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 217 L-HHRNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
+ LV L + + LI +Y+ L L +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------------------ERF 126
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS 335
T + + + +L L +L +I+RD+K N+LLD + + ++DFG+++ F DE
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TE 185
Query: 336 NMNRIVGTYGYMSPEYALHGL--FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393
GT YM+P+ G D +S GVL+ E L+ + F
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQ-- 241
Query: 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSE 443
+ + + P + +++R + ++ R
Sbjct: 242 -AEISRRILKSEPPYPQEMSALAKDLIQR-------LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (303), Expect = 3e-31
Identities = 54/308 (17%), Positives = 109/308 (35%), Gaps = 55/308 (17%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNL 222
++ KLG G + V++ + N E+V VK L ++ K E+ ++ L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92
Query: 223 VRLFGCCIEQGEK--ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRI 280
+ L + + L++E++ N L
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------------QTLTDYDIRFY 134
Query: 281 IEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD-MNPKISDFGIARMFGGDELQSNMNR 339
+ I + L Y H + ++HRD+K NV++D + ++ D+G+A + + N
Sbjct: 135 MYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 188
Query: 340 IVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSK------KNTRFYNIDSLTLLG 392
V + + PE + + ++ D++S G +L + K + + +LG
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALL----------------CVQENAA 436
D+ LDP + KR+ + ++ +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 437 DRPTMSEV 444
R T E
Sbjct: 309 SRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 3e-31
Identities = 42/212 (19%), Positives = 83/212 (39%), Gaps = 6/212 (2%)
Query: 169 ENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFG 227
KLG G F V+ K ++N VA+K + E ++E+ L+ +++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 228 CCIEQGEKILIY-EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQ 286
K+L + + + + + + +I + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 287 GLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPKISDFGIARMFGGDELQSNMNRIVGTYG 345
GL Y+H+ R +IH D+K NVL++ D + IA + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 346 YMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
Y SPE L + +D++S L+ E ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-30
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRN 221
+ +G G G V + VA+K+LS + + E++L+ ++H+N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 222 LVRLFGCCIEQG------EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWT 275
++ L Q + L+ E M + D
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------------DHE 119
Query: 276 TRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQS 335
++ + G+ +LH +IHRDLK SN+++ D KI DFG+AR G +
Sbjct: 120 RMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 174
Query: 336 NMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK 377
M V T Y +PE L + D++S G ++ E + K
Sbjct: 175 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 165 NFSEENKLGEGGFGPVYKGK-LLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRN 221
+ + +G G +G V G VAVK+LS S + E+ L+ + H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 222 LVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRII 281
++ L + D +L + + + + L +I
Sbjct: 79 VIGLLDVFTP--------ARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLI 127
Query: 282 EGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIV 341
I +GL Y+H +IHRDLK SN+ ++ D KI DFG+AR M V
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYV 179
Query: 342 GTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSK 377
T Y +PE L+ + ++ D++S G ++ E L+ +
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.0 bits (238), Expect = 1e-23
Identities = 37/214 (17%), Positives = 70/214 (32%), Gaps = 39/214 (18%)
Query: 170 NKLGEGGFGPVYKGKLLNGEEVAVK--RLSNKSGQGV--------EEFKNEMILIAKLHH 219
+GEG V+ E VK ++ + S + V F I A+
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 220 RNLVRLFGCCIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVR 279
R L +L G + + +Y + N L + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVR-------------VENPDE 107
Query: 280 IIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNR 339
+++ I + + + ++H DL NVL+ + I DF + G + + + R
Sbjct: 108 VLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILER 163
Query: 340 -IVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLE 372
+ Y S Y + D+ S +L+
Sbjct: 164 DVRNIITYFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 496 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.92 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 87.93 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-55 Score=417.72 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=204.8
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|++. ..||||+++.. +....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999863 36999998744 34456789999999999999999999999765 56899999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+++|+|.+++.. .+..++|..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 84 y~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--------------IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp CCCEEEHHHHHHT--------------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEEC
T ss_pred cCCCCCHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEc
Confidence 9999999999953 3346999999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||........ .......
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~- 224 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGR- 224 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHH-
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhc-
Confidence 9999987765443444556789999999999964 3589999999999999999999999864332111 1111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCC
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLP 456 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 456 (496)
+ ...|.+ ..........+.+++.+||+.||++||||+||+++|+.+...+|
T Consensus 225 ---~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 225 ---G----YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---T----SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---C----CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1 111111 01111223567889999999999999999999999998765554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=415.67 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=200.9
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|+..+.||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578888999999999999999988899999999753 4556889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|.+++.. ....++|..++.++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 84 ~g~L~~~l~~--------------~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 84 HGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp TCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC
T ss_pred CCcHHHHhhc--------------cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccc
Confidence 9999999852 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.|+.... ........... .
T Consensus 147 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~------~ 218 (263)
T d1sm2a_ 147 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST------G 218 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHH------T
T ss_pred hheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHh------c
Confidence 9987654322 22234578999999999999999999999999999999999655543221 11111111111 1
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.+...|.. ....+.+++.+||+.||++||||+||+++|+++.
T Consensus 219 ~~~~~p~~-------~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRL-------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccc-------cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11222222 1256788999999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=411.96 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=207.5
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|++.++||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988889999999754 3456789999999999999999999998865 5679999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. .....++|..+++++.||++||+|||+.+ |+||||||+||||++++.+||+||
T Consensus 90 ~~g~L~~~~~~-------------~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 90 ENGSLVDFLKT-------------PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp TTCBHHHHTTS-------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCCcHHHHHhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence 99999988742 22345899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+|+....... .......||+.|||||++.+..++.++|||||||++|||+||+.|+..... ........ ..+
T Consensus 154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i----~~~- 226 (272)
T d1qpca_ 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNL----ERG- 226 (272)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----HTT-
T ss_pred cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHH----Hhc-
Confidence 99998764432 223446789999999999999999999999999999999997766542221 11111111 111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.+...| ......+.+++.+||+.||++||||++|+++|++.
T Consensus 227 -~~~~~p-------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 227 -YRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCc-------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111111 11234678899999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-54 Score=413.08 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=211.9
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|++.++||+|+||+||+|.+. +|+.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888899999999999999875 5889999998654 34578899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|..++.. .....++|..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|
T Consensus 95 ~~~g~l~~~l~~-------------~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 95 MTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp CTTCBHHHHHHH-------------SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred ccCcchHHHhhh-------------ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcc
Confidence 999999999964 23456999999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..... .....+
T Consensus 159 FG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~----~~i~~~ 232 (287)
T d1opja_ 159 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVY----ELLEKD 232 (287)
T ss_dssp CCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH----HHHHTT
T ss_pred ccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHH----HHHhcC
Confidence 999997754332 223345689999999999999999999999999999999998776542221 11111 111111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
. .+ ..+......+.+++..||+.||++||||+||++.|+.+..
T Consensus 233 ~-----~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 Y-----RM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp C-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred C-----CC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 01 1111223568889999999999999999999999988643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-54 Score=418.72 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=197.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CC---CEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NG---EEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
++|++.+.||+|+||+||+|++. ++ ..||||.+... .....++|.+|+.++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34566789999999999999874 23 26899998654 334456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++.. ....++|.++.+++.||++||+|||+.+ |+||||||+||||+.++.+|
T Consensus 106 ~Ey~~~g~L~~~~~~--------------~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--------------NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp EECCTTEEHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred EEecCCCcceeeecc--------------ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEE
Confidence 999999999998852 3456999999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCccccc---cccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 319 ISDFGIARMFGGDELQSN---MNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
|+|||+|+.+........ .....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 999999997754432221 222457999999999999999999999999999999998 7888764322 1111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
..+. +. .........+.+++.+||+.||++||||.||++.|+.++..
T Consensus 247 ----~~~~--~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 247 ----EQDY--RL-------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----HTTC--CC-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HcCC--CC-------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1110 00 11122345678899999999999999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=409.26 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=203.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999874 68999999997543 23456799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 85 ~~gg~L~~~l~---------------~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~D 146 (271)
T d1nvra_ 85 CSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 146 (271)
T ss_dssp CTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred cCCCcHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEcc
Confidence 99999998883 3456999999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||+|+.+............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.............. .
T Consensus 147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-----~ 221 (271)
T d1nvra_ 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----E 221 (271)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----T
T ss_pred chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-----c
Confidence 999998754443444556789999999999988876 6789999999999999999999975443322211111 0
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... ... ........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~--~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 KKT--YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TCT--TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--CCC------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 000 00111245678899999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=402.11 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=212.7
Q ss_pred hcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
.++|+..++||+|+||+||+|++++++.||||.++... ...++|.+|+.++++++|||||+++|+|.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36889999999999999999999888899999997543 45678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 82 ~~g~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 82 ANGCLLNYLRE--------------MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp TTEEHHHHHHS--------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCCcHHHhhhc--------------cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcc
Confidence 99999999752 3456889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ...... ..+
T Consensus 145 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i----~~~ 217 (258)
T d1k2pa_ 145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHI----AQG 217 (258)
T ss_dssp SSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH----HTT
T ss_pred hhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHH----HhC
Confidence 999876544322 2334678999999999999999999999999999999998 78787644321 111111 111
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.+...|.. ....+.+++.+||+.||++|||+++|+++|.++
T Consensus 218 --~~~~~p~~-------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 --LRLYRPHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCCCCTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCCCCccc-------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11222222 225678899999999999999999999999763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=409.37 Aligned_cols=266 Identities=28% Similarity=0.420 Sum_probs=210.2
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecC
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMP 243 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 243 (496)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578999999999999999999988889999999644 4556889999999999999999999999855 56899999999
Q ss_pred CCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEeccc
Q 040910 244 NKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFG 323 (496)
Q Consensus 244 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFg 323 (496)
+|+|..++.. .....++|..++.++.||+.||+|||+.+ |+||||||+|||||.++++||+|||
T Consensus 95 ~g~l~~~~~~-------------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 95 KGSLLDFLKG-------------ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp TCBHHHHHSH-------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCchhhhhhh-------------cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccc
Confidence 9999999853 23346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccccc
Q 040910 324 IARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDRA 403 (496)
Q Consensus 324 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (496)
+|+....... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .....+. .+.
T Consensus 159 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~----~~~- 231 (285)
T d1fmka3 159 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE----RGY- 231 (285)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH----TTC-
T ss_pred hhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH----hcC-
Confidence 9987654332 22344678999999999999999999999999999999999877654332211 1111111 110
Q ss_pred ccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCc
Q 040910 404 WKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPA 462 (496)
Q Consensus 404 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~ 462 (496)
.+. ........+.+++.+||+.||++||||++|+++|++.....+++.+|.
T Consensus 232 ----~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 232 ----RMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp ----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred ----CCC----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 011 111223567889999999999999999999999999877776666654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=400.93 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=207.3
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 469999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 100 ~gg~L~~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 100 AGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp TTCBHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred CCCcHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccc
Confidence 99999988742 35899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
|+|+.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 161 G~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~---~~~~~~~- 232 (293)
T d1yhwa1 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RAL---YLIATNG- 232 (293)
T ss_dssp TTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HHHHHHC-
T ss_pred hhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHH---HHHHhCC-
Confidence 9999775432 2234568999999999999999999999999999999999999998643221 111 1111111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...+.. .......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 TPELQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCCCSS-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCC-------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 11123567789999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=407.14 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=200.9
Q ss_pred cCCCccccccccCCeeEEEEEecCC-----CEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNG-----EEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
+.|+..+.||+|+||.||+|.+.++ ..||||++.... .....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987542 379999997543 2334579999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+.+|+|..++.. ....++|..+++++.||+.||+|||+.+ |+||||||+||||+.++.+
T Consensus 87 v~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--------------KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp EEECCTTEEHHHHHHH--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEEecccCcchhhhhc--------------ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeE
Confidence 9999999999988753 3356999999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++........ .......||+.|||||++.+..++.++|||||||++|||++|+.|+...... ......
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~--- 225 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKA--- 225 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH---
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHH---
Confidence 99999999976543222 2233456899999999999999999999999999999999977665432211 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
...+. ....+...+..+.+|+.+||+.||++||||.||+++|+.++.
T Consensus 226 -i~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 226 -INDGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -HHTTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HhccC---------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 011112233568889999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=411.98 Aligned_cols=271 Identities=26% Similarity=0.392 Sum_probs=207.5
Q ss_pred hcCCCccccccccCCeeEEEEEecC-C-----CEEEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN-G-----EEVAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 234 (496)
.++|.+.+.||+|+||+||+|+... + ..||||.+... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998743 2 36999998654 334456899999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCc--------ccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGF--------DMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKA 306 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~ 306 (496)
.++||||+++|+|.+++......... ...........++|..++.++.||++||+|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 99999999999999999754321100 00011123356999999999999999999999998 99999999
Q ss_pred CCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCC
Q 040910 307 SNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNI 385 (496)
Q Consensus 307 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~ 385 (496)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333445678999999999999999999999999999999998 8888865433
Q ss_pred CcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 040910 386 DSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKN 450 (496)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 450 (496)
... +... ...+. +. ..+......+.+|+.+||+.||++|||++||+++|..
T Consensus 273 ~~~-~~~~----~~~~~--~~-------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DAN-FYKL----IQNGF--KM-------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHH-HHHH----HHTTC--CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HHHH----HhcCC--CC-------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 221 1111 11110 01 1111223567889999999999999999999999953
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=403.51 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=205.3
Q ss_pred cCCCccc-cccccCCeeEEEEEec---CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEEN-KLGEGGFGPVYKGKLL---NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+ +||+|+||.||+|.+. ++..||||.++... ....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 4999999999999763 34579999997543 3346789999999999999999999999865 568999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|.+++.. .+..+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 87 mE~~~~g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp EECCTTEEHHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEE
T ss_pred EEeCCCCcHHHHhhc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCcee
Confidence 999999999999842 3456999999999999999999999988 99999999999999999999
Q ss_pred EeccccccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 319 ISDFGIARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 319 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
|+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~--- 224 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAF--- 224 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHH---
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH---
Confidence 999999998764432 222344578999999999999999999999999999999998 8998875332 111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
...+... . .+...+..+.+++.+||+.||++||||.+|++.|+...
T Consensus 225 -i~~~~~~-----~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 225 -IEQGKRM-----E----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -HHTTCCC-----C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHcCCCC-----C----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111111 1 11122356788999999999999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=396.58 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=204.5
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999875 6889999998642 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 Ey~~~g~L~~~l~~---------------~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 86 EYAPLGTVYRELQK---------------LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp ECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eecCCCcHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEee
Confidence 99999999999953 345899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 148 ~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i----~ 217 (263)
T d2j4za1 148 ADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRI----S 217 (263)
T ss_dssp CCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH----H
T ss_pred cccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHHHH----H
Confidence 999999876533 234468999999999999999999999999999999999999998643221 111111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
... . .+ +......+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~---~---~~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 RVE---F---TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTC---C---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC---C---CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 0 01 1112356778999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=400.76 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=197.3
Q ss_pred ccccccCCeeEEEEEecC---CCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEecCC
Q 040910 170 NKLGEGGFGPVYKGKLLN---GEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYMPN 244 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 244 (496)
++||+|+||.||+|.+.+ ++.||||+++... ....++|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 4689999996532 2335689999999999999999999999865 567899999999
Q ss_pred CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecccc
Q 040910 245 KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDFGI 324 (496)
Q Consensus 245 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFgl 324 (496)
|+|.+++.. ...++|..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 92 g~L~~~l~~---------------~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 92 GPLNKYLQQ---------------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp EEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcHHHHHhh---------------ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhh
Confidence 999999853 345999999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcc-ccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhcccc
Q 040910 325 ARMFGGDEL-QSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDDR 402 (496)
Q Consensus 325 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (496)
++.+..... ........||+.|||||.+.+..++.++|||||||++|||++ |+.||..... ...... ...+.
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~----i~~~~ 227 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAM----LEKGE 227 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTC
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHH----HHcCC
Confidence 997654322 223344678999999999999999999999999999999998 8988864322 111111 11111
Q ss_pred cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 403 AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 403 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
. . ..+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus 228 ~--~-------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 R--M-------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp C--C-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C--C-------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1 1 11112235678899999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=399.97 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=206.2
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
+.|++.+.||+|+||.||+|+.. +|+.||||++........+.|.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999874 68999999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 92 ~~g~L~~~~~~--------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 92 AGGAVDAVMLE--------------LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp TTEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEec
Confidence 99999998853 2346999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhc-----cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYAL-----HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
|+|+..... ........||+.|||||++. +..++.++|||||||++|||++|+.||....... .....
T Consensus 155 G~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i--- 227 (288)
T d2jfla1 155 GVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKI--- 227 (288)
T ss_dssp TTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHH---
T ss_pred hhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHH---
Confidence 999865322 12234568999999999984 4568999999999999999999999987543222 11111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .....+..+ ......+.+++.+||+.||++|||++|++++
T Consensus 228 ~~-~~~~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 228 AK-SEPPTLAQP-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HH-SCCCCCSSG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Hc-CCCCCCCcc-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 111111111 1223567889999999999999999998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=403.43 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=193.5
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee--cCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE--QGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 238 (496)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.|.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999874 68999999997543 2345678999999999999999999999865 4568999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEecCCCc
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYS--RLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~ 316 (496)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.
T Consensus 84 mEy~~~g~L~~~i~~~~-----------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~ 152 (269)
T d2java1 84 MEYCEGGDLASVITKGT-----------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 152 (269)
T ss_dssp EECCTTEEHHHHHHHHH-----------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC
T ss_pred EecCCCCcHHHHHHhcc-----------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc
Confidence 99999999999986422 23456999999999999999999999865 235999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+||+|||+|+.+.... .......||+.|||||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 153 vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i-- 226 (269)
T d2java1 153 VKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI-- 226 (269)
T ss_dssp EEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH--
T ss_pred EEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHH--
Confidence 9999999999875432 223456899999999999999999999999999999999999999864322 1111111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
....... + +......+.+++.+||+.||++|||++|+++
T Consensus 227 --~~~~~~~-----~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 --REGKFRR-----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHTCCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HcCCCCC-----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111 1 1112346788999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=399.91 Aligned_cols=249 Identities=25% Similarity=0.327 Sum_probs=202.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+|+.. +|+.||||.+... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999874 6899999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 88 Ey~~gg~L~~~~~~---------------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---------------IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp CCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred EccCCCCHHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEe
Confidence 99999999998853 356999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||++|+.||..... ....... .
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i----~ 223 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKI----I 223 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----H
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHH----H
Confidence 999999987654434444557899999999999999999999999999999999999999874322 1111111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... .+ +......+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~------~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 224 KLEY------DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCC------CC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cCCC------CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1110 01 1112346778999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-52 Score=404.36 Aligned_cols=274 Identities=24% Similarity=0.364 Sum_probs=212.5
Q ss_pred HHHhcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCCcc-CHHHHHHHHHHHHHhcCCceeeeeeeeeec
Q 040910 160 STATHNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKSGQ-GVEEFKNEMILIAKLHHRNLVRLFGCCIEQ 232 (496)
Q Consensus 160 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 232 (496)
+...++|++.+.||+|+||.||+|++. +++.||||+++..... ..++|.+|+.++++++||||++++++|.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 335678999999999999999999864 3578999999754333 356799999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCccc---------ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDM---------VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRD 303 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 303 (496)
+..++||||+++|+|.+++........... .........++|..++.++.||+.||+|||+.+ |+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 999999999999999999976433211110 011223456999999999999999999999998 99999
Q ss_pred CCCCCEEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCC
Q 040910 304 LKASNVLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRF 382 (496)
Q Consensus 304 lk~~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~ 382 (496)
|||+|||+|.++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|.. |+..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999999987655444444455678999999999999999999999999999999999975 4543
Q ss_pred CCCCcchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 383 YNIDSLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
.. .......+ ..+.... .+...+..+.+|+.+||+.+|++||||.||+++|+++
T Consensus 246 ~~--~~e~~~~v----~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 246 MA--HEEVIYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp SC--HHHHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CC--HHHHHHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22 11111111 1111111 1112235678899999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=405.67 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=204.1
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|++.++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999874 689999999975433 335689999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEE
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||
T Consensus 85 y~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp CCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEE
T ss_pred cCCCCcHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEE
Confidence 9999999999953 34589999999999999999999974 6 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh--
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL-- 397 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~-- 397 (496)
+|||+|+.+.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.................
T Consensus 147 ~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 222 (322)
T d1s9ja_ 147 CDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222 (322)
T ss_dssp CCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred eeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence 99999986532 223456899999999999999999999999999999999999999976443221110000000
Q ss_pred ---------h---------ccc----ccccc-------cCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 ---------W---------KDD----RAWKL-------LDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ---------~---------~~~----~~~~~-------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ... ...+. ..+.+.. ......+.+++.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 000 00000 0000000 0112467889999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=389.85 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=194.7
Q ss_pred CccccccccCCeeEEEEEec-CCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeee----cCeeEEEE
Q 040910 167 SEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE----QGEKILIY 239 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 239 (496)
...++||+|+||+||+|... +++.||||.+... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999875 6889999998754 23345679999999999999999999999865 34679999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec-CCCceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD-GDMNPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~k 318 (496)
||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||||||+|||++ +++.+|
T Consensus 92 E~~~~g~L~~~l~~---------------~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~K 155 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 155 (270)
T ss_dssp ECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred eCCCCCcHHHHHhc---------------cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEE
Confidence 99999999999953 346899999999999999999999875 3599999999999996 589999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+|+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||....... ......
T Consensus 156 l~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i---- 225 (270)
T d1t4ha_ 156 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRV---- 225 (270)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHH----
T ss_pred EeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHH----
Confidence 9999999865432 2334689999999998865 59999999999999999999999986432111 111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+.. .+...... ...+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~----~~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TSGVK----PASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTTCC----CGGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCC----CcccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11100 11111111 2356789999999999999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=399.89 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=201.4
Q ss_pred cCCCccccccccCCeeEEEEEec-CCC----EEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGE----EVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.+|++.+.||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999874 343 6899998643 345678899999999999999999999999875 5678
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
++||+.+|+|.+++.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 88 v~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp EEECCTTCBHHHHHHH--------------TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEE
T ss_pred EEEeccCCcccccccc--------------cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCe
Confidence 8999999999988863 3456899999999999999999999988 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |..|+....... .....
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i-- 226 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL-- 226 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH--
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH--
Confidence 9999999998765544444455678999999999999999999999999999999998 677765433221 11111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..+. +... +......+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 227 --~~~~--~~~~-------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 227 --EKGE--RLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp --HHTC--CCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HcCC--CCCC-------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1111 1122356788999999999999999999999987753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-50 Score=397.80 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=207.3
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999874 68999999997666556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec--CCCceEEe
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD--GDMNPKIS 320 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~ 320 (496)
++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+
T Consensus 106 ~gg~L~~~l~~--------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~ 168 (350)
T d1koaa2 106 SGGELFEKVAD--------------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 168 (350)
T ss_dssp CSCBHHHHHTC--------------TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEEC
T ss_pred CCCCHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEe
Confidence 99999999842 3346999999999999999999999998 99999999999995 46789999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+.+.... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 169 DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~---- 239 (350)
T d1koaa2 169 DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS---- 239 (350)
T ss_dssp CCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH----
T ss_pred ecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHh----
Confidence 999999775432 23446899999999999999999999999999999999999999864322 111111110
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. .. ..+... ......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~-~~-~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 CD-WN-MDDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp TC-CC-SCCGGG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CC-CC-CCcccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 011111 1123467789999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=389.11 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=195.7
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-CeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-GEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~ 242 (496)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4677789999999999999998 6889999999653 3457899999999999999999999998654 5689999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++... ....++|..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 84 ~~g~L~~~l~~~-------------~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 84 AKGSLVDYLRSR-------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp TTEEHHHHHHHH-------------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCCHHHHHHhc-------------CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccc
Confidence 999999999641 2335899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+++..... .....+|..|+|||++.+..++.++|||||||++|||+| |+.|+..... ........ .+
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~----~~ 216 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE----KG 216 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHT----TT
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----cC
Confidence 999865432 233567899999999999999999999999999999998 5665543222 12222211 11
Q ss_pred ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 402 RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 402 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
. .+. .+......+.+++.+||+.||++||||.+|+++|+.+
T Consensus 217 ~-----~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 217 Y-----KMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp C-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CCC----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 111 1112235678899999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-51 Score=395.52 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=189.4
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
.+.|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999874 68999999997543 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec---CCCce
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDMNP 317 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~ 317 (496)
|+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+
T Consensus 88 ~~~gg~L~~~l~---------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 88 LVSGGELFDRIV---------------EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp CCCSCBHHHHHH---------------TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCE
T ss_pred ccCCCcHHHhhh---------------cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceE
Confidence 999999999995 2456999999999999999999999998 99999999999994 57899
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNL 397 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~ 397 (496)
||+|||+|+...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 150 kl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i--- 221 (307)
T d1a06a_ 150 MISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQI--- 221 (307)
T ss_dssp EECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH---
T ss_pred EEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH---
Confidence 999999998765332 234468999999999999999999999999999999999999998643221 111111
Q ss_pred hcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 398 WKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 398 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.. ... . ... .........+.+++.+||+.||++|||++|++++
T Consensus 222 ~~-~~~-~-~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 222 LK-AEY-E-FDS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HT-TCC-C-CCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hc-cCC-C-CCC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 000 0 000 1111223567889999999999999999999885
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-51 Score=397.08 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=200.2
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
..|+..++||+|+||.||+|+. .+|+.||||++..... ...+.|.+|+.++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999986 4688999999975432 23457899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 95 E~~~~g~l~~~~~---------------~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp ECCSEEHHHHHHH---------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEE
T ss_pred EecCCCchHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEE
Confidence 9999999987763 2356999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhcc---CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhh
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH---GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~ 396 (496)
+|||+|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ... ..
T Consensus 157 ~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~---~~ 225 (309)
T d1u5ra_ 157 GDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL---YH 225 (309)
T ss_dssp CCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HH
T ss_pred eecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHH---HH
Confidence 99999986542 234579999999999864 46899999999999999999999998643211 111 11
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... ... +..... .....+.+++.+||+.||.+|||++|++++
T Consensus 226 i~~-~~~-----~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 226 IAQ-NES-----PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHH-SCC-----CCCSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHh-CCC-----CCCCCC---CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 111 111111 123567789999999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=394.06 Aligned_cols=273 Identities=27% Similarity=0.381 Sum_probs=200.8
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecC-
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQG- 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 233 (496)
.++|.+.++||+|+||.||+|... +++.||||+++... ....+.+.+|...+.++ +|+|||++++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467888999999999999999863 34689999997543 23456788899988888 6899999999987654
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
..++||||+++|+|.+++........ ............++|..+..++.||++||+|||+.+ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999976432111 111111223456999999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhh
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLL 391 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~ 391 (496)
+++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|.. |+....... ...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence 999999999999997765444444556789999999999999999999999999999999999764 554332221 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
.. ...+.. +.. +......+.+++.+||+.||++|||++||+++|++++
T Consensus 248 ~~----~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 248 RR----LKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HH----HHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 111111 111 1112346788999999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=388.17 Aligned_cols=256 Identities=28% Similarity=0.371 Sum_probs=195.9
Q ss_pred cCCCccccccccCCeeEEEEEecC--C--CEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN--G--EEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
++|++.+.||+|+||.||+|++.. + ..||||++... .....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998642 2 37899998653 23345789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|.+++.. ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 87 lv~e~~~~~~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--------------HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDL 149 (273)
T ss_dssp EEEECCTTCBHHHHHHH--------------HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTE
T ss_pred eeeeeecCcchhhhhhc--------------ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccc
Confidence 99999999999988853 2345999999999999999999999988 999999999999999999
Q ss_pred eEEeccccccccCCCccc-cccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~ 394 (496)
+||+|||+++.+...... .......||..|+|||.+.+..++.++|||||||++|||+| |..||..... .......
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i 227 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKI 227 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHHHHH
Confidence 999999999987544322 22334567889999999999999999999999999999998 8888764322 1111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNE 451 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 451 (496)
...+.. . ......+..+.+++.+||+.||++||||.+|++.|+++
T Consensus 228 ---~~~~~~--~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 ---DKEGER--L-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---HTSCCC--C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HhCCCC--C-------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 1 11112235678899999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-50 Score=396.98 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=209.2
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5789999999999999999986 479999999998665555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec--CCCceEEe
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD--GDMNPKIS 320 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~ 320 (496)
++|+|.+++. .....+++..+..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+
T Consensus 109 ~gg~L~~~~~--------------~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 109 SGGELFDRIA--------------AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp CCCBHHHHTT--------------CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEEC
T ss_pred CCChHHHHHH--------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEe
Confidence 9999988763 23446999999999999999999999998 99999999999998 67899999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 172 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~---- 242 (352)
T d1koba_ 172 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKR---- 242 (352)
T ss_dssp CCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH----
T ss_pred ecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh----
Confidence 999999876432 234467899999999999999999999999999999999999998643321 11111110
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNE 451 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 451 (496)
.. ..............+.+++.+||+.||.+|||++|++++ +++.
T Consensus 243 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 243 CD------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CC------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CC------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 00 000011111223567889999999999999999999885 5543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=392.83 Aligned_cols=275 Identities=26% Similarity=0.344 Sum_probs=214.0
Q ss_pred hcCCCccccccccCCeeEEEEEe------cCCCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL------LNGEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 234 (496)
.++|++.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788889999999999999986 2456899999975432 3456799999999999 79999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCccc---ccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDM---VTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
.++||||+++|+|..++........... .........+++..+.+++.||++||+|||+.+ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999986543211110 011123457999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999987655444445567899999999999999999999999999999999996555432222221111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
... ..+. +.. ........+.+|+.+||+.||++||||.+|+++|++.+.
T Consensus 259 ~~i----~~~~--~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 KMI----KEGF--RML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHH----HHTC--CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----hcCC--CCC-------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111 1110 111 111223568899999999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=388.17 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=195.8
Q ss_pred hcCCCccccccccCCeeEEEEEecC----CCEEEEEEeccCCc-cCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN----GEEVAVKRLSNKSG-QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 237 (496)
.++|.+.+.||+|+||.||+|++.. +..||||.++.... ...+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998743 34689999865433 33567999999999999999999999986 467899
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
||||+++|+|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+
T Consensus 85 v~E~~~~g~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--------------RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp EEECCTTEEHHHHHHH--------------TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred EEEeccCCcHHhhhhc--------------cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcE
Confidence 9999999999998753 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+|+...... .......
T Consensus 148 Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~- 223 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE- 223 (273)
T ss_dssp EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH-
T ss_pred EEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHH-
Confidence 9999999987654322 22344678999999999999999999999999999999998 78777644322 1211111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
.+... . .+......+.+++.+||+.||++|||+.||++.|+.++.
T Consensus 224 ---~~~~~-----~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 ---NGERL-----P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---TTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCC-----C----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11110 1 111223567889999999999999999999999987643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=384.71 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=204.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC------ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS------GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.+.|.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35789999999999999999987 468999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 89 ~iv~E~~~gg~L~~~i~~---------------~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---------------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRN 150 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSS
T ss_pred EEEEEcCCCccccchhcc---------------ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCC
Confidence 999999999999999953 346999999999999999999999998 99999999999998776
Q ss_pred ----ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhh
Q 040910 316 ----NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLL 391 (496)
Q Consensus 316 ----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~ 391 (496)
.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~ 225 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL 225 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred CcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHH
Confidence 49999999998775432 233467899999999999999999999999999999999999998743321 111
Q ss_pred HhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 GHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
.... .... -..+.... .....+.+++.+||+.||++|||++|++++
T Consensus 226 ~~i~----~~~~--~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 226 ANVS----AVNY--EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHH----TTCC--CCCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHH----hcCC--CCCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110 0000 00001111 123467789999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=387.84 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=203.0
Q ss_pred cccccccCCeeEEEEEecCC----CEEEEEEeccC-CccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-CeeEEEEEec
Q 040910 169 ENKLGEGGFGPVYKGKLLNG----EEVAVKRLSNK-SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-GEKILIYEYM 242 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~ 242 (496)
.++||+|+||+||+|.+.++ ..||||+++.. +....++|.+|++++++++|||||+++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987542 26899999743 344567899999999999999999999998764 5889999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
++|+|.+++.. ....+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 112 ~~g~l~~~~~~--------------~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DF 174 (311)
T d1r0pa_ 112 KHGDLRNFIRN--------------ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 174 (311)
T ss_dssp TTCBHHHHHHC--------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSS
T ss_pred ecCchhhhhcc--------------ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecc
Confidence 99999999852 3446788899999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccc--cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 323 GIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 323 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
|+++........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ .
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~---~- 249 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL---Q- 249 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH---T-
T ss_pred cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHH---c-
Confidence 999976544322 2233457899999999999999999999999999999999988876542211 11111111 1
Q ss_pred cccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 401 DRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 401 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
+. +...|. .....+.+++.+||+.||++||+|.||+++|+.++..
T Consensus 250 g~--~~~~p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 250 GR--RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TC--CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC--CCCCcc-------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11 111221 1234678899999999999999999999999997654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=389.66 Aligned_cols=273 Identities=25% Similarity=0.385 Sum_probs=209.0
Q ss_pred hcCCCccccccccCCeeEEEEEecC--------CCEEEEEEeccCCc-cCHHHHHHHHHHHHHh-cCCceeeeeeeeeec
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLLN--------GEEVAVKRLSNKSG-QGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQ 232 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 232 (496)
.++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578888999999999999997632 24799999975443 3457889999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCC-cccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSG-FDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
+..++||||+++|+|.+++........ ............+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975432111 011111233567999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCcchh
Q 040910 312 DGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLS-SKKNTRFYNIDSLTL 390 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~~~~~~~~~~~~~ 390 (496)
+.++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||++ |..|+...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H-
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--H-
Confidence 9999999999999998765554455566789999999999999999999999999999999998 56666532221 1
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIV 453 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 453 (496)
....+..+.. . . .+......+.+++.+||+.||++|||+.||++.|++++.
T Consensus 246 ---~~~~i~~~~~--~---~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ---LFKLLKEGHR--M---D----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHTTCC--C---C----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCC--C---C----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111211111 1 1 111123568899999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=390.73 Aligned_cols=271 Identities=25% Similarity=0.379 Sum_probs=206.4
Q ss_pred cCCCccccccccCCeeEEEEEecC-CC--EEEEEEeccC-CccCHHHHHHHHHHHHHh-cCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLN-GE--EVAVKRLSNK-SGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 238 (496)
++|++.+.||+|+||.||+|++.+ |. .||||+++.. .....++|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999998754 43 5788988643 334566899999999999 799999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCC-CcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCce
Q 040910 239 YEYMPNKSLDFFLFDYKYSS-GFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNP 317 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 317 (496)
|||+++|+|.+++....... .............++|..+.+++.|||.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999996421100 0000001134567999999999999999999999998 9999999999999999999
Q ss_pred EEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCC-CCCCCCCCcchhhHhhhh
Q 040910 318 KISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKK-NTRFYNIDSLTLLGHAWN 396 (496)
Q Consensus 318 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-~~~~~~~~~~~~~~~~~~ 396 (496)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. |+.... ...+...+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHG--
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHH--
Confidence 99999999865422 12234578999999999999999999999999999999999875 454322 11221111
Q ss_pred hhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCC
Q 040910 397 LWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNL 455 (496)
Q Consensus 397 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 455 (496)
..+. + + .........+.+++.+||+.||++||||+||++.|+.++.+.
T Consensus 240 --~~~~--~---~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 --PQGY--R---L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --GGTC--C---C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --HhcC--C---C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111 1 1 111122356888999999999999999999999999976543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=392.25 Aligned_cols=267 Identities=25% Similarity=0.393 Sum_probs=212.2
Q ss_pred hcCCCccccccccCCeeEEEEEec------CCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCee
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL------NGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEK 235 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 235 (496)
.++|.+.++||+|+||.||+|.+. +++.||||+++... ......|.+|+.++++++|||||+++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999763 35789999997543 23345789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM 315 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 315 (496)
++||||+++|+|.+++....... ........++|..+.+++.|+|+||+|||+.+ |+||||||+|||+++++
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAM-----ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHH-----HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred eEEEeecCCCCHHHHHHhccccc-----ccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 99999999999999987532110 01122345799999999999999999999987 99999999999999999
Q ss_pred ceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCC-CCCCCCCCCcchhhHhh
Q 040910 316 NPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSK-KNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~~~~~~~~~~~~~~~~~ 394 (496)
++||+|||+|+...............||+.|+|||.+.+..++.++||||||+++|||+||. .|+.... .......+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~~~~i 248 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFV 248 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HHHHHHHH
Confidence 99999999999776554444455567899999999999999999999999999999999996 4444321 11111111
Q ss_pred hhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 395 WNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 395 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
..+... ..+......+.+++.+||+.+|++||||++|+++|++.+
T Consensus 249 ----~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 ----MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ----HhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111110 011122356889999999999999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=388.64 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=198.8
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHH--HHHHHHhcCCceeeeeeeeeecC----eeEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNE--MILIAKLHHRNLVRLFGCCIEQG----EKIL 237 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E--~~~l~~l~H~niv~l~~~~~~~~----~~~l 237 (496)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... .+++..| +..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566788999999999999997 78999999996432 3344444 44555679999999999998764 5799
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCCEEec
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY-----SRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlk~~NIll~ 312 (496)
||||+++|+|..++.. ..++|..+++++.|+|.||+|||+. ...+|+||||||+||||+
T Consensus 79 v~Ey~~~g~L~~~l~~----------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~ 142 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp EEECCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred EEecccCCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence 9999999999999953 2489999999999999999999974 123599999999999999
Q ss_pred CCCceEEeccccccccCCCcc--ccccccccccccccChhhhccCC------CCccccchhhhHHHHHHHhCCCCCCCCC
Q 040910 313 GDMNPKISDFGIARMFGGDEL--QSNMNRIVGTYGYMSPEYALHGL------FSIKSDVFSFGVLLLETLSSKKNTRFYN 384 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~elltg~~~~~~~~ 384 (496)
.++.+||+|||+++....... ........||+.|+|||++.+.. ++.++|||||||+||||+||..|+....
T Consensus 143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 999999999999997654321 22234568999999999987643 6789999999999999999988765433
Q ss_pred CCcchhh---------HhhhhhhcccccccccCcccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 040910 385 IDSLTLL---------GHAWNLWKDDRAWKLLDPTLQNE-ALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEI 452 (496)
Q Consensus 385 ~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 452 (496)
....... ....... ..+..+|.+... ...+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 223 DYQLPYYDLVPSDPSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchhhcccccchHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2211110 0111111 111122222111 12345567889999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=388.23 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=205.9
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|.+.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788999999999999999987 47999999999743 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 85 ey~~gg~L~~~~~~---------------~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 85 EYANGGELFFHLSR---------------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp ECCTTCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred eccCCCchhhhhhc---------------ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEE
Confidence 99999999999853 456889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... +.... .
T Consensus 147 ~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i----~ 218 (337)
T d1o6la_ 147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI----L 218 (337)
T ss_dssp CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----H
T ss_pred eecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHH----h
Confidence 9999998764322 23445789999999999999999999999999999999999999987544221 11111 1
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
... . .. +......+.+++.+||+.||.+||+ ++|++++
T Consensus 219 ~~~---~---~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 219 MEE---I---RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HCC---C---CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cCC---C---CC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111 0 01 1112345778999999999999995 7888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-49 Score=384.13 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=203.9
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999987 46899999999643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 84 E~~~gg~l~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 84 DYIEGGELFSLLR---------------KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp CCCCSCBHHHHHH---------------HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEE
T ss_pred eecCCcccccccc---------------ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEE
Confidence 9999999998885 3445788899999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 146 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i----~ 214 (316)
T d1fota_ 146 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKI----L 214 (316)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH----H
T ss_pred ecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHH----H
Confidence 999999876532 33468999999999999999999999999999999999999998743221 111111 0
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM 447 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 447 (496)
.... . .+......+.+++.+||+.||.+|| |+++++++
T Consensus 215 ~~~~------~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 215 NAEL------R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HCCC------C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred cCCC------C----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0110 0 0111234577899999999999996 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-48 Score=373.29 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCcc---------CHHHHHHHHHHHHHhc-CCceeeeeeeeeec
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQ---------GVEEFKNEMILIAKLH-HRNLVRLFGCCIEQ 232 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 232 (496)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999987 47899999999754321 1246889999999996 99999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 233 GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 233 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---------------~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~ 144 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---------------KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 144 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred cceEEEEEcCCCchHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEc
Confidence 999999999999999999953 346999999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccccccCCCccccccccccccccccChhhhcc------CCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 040910 313 GDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH------GLFSIKSDVFSFGVLLLETLSSKKNTRFYNID 386 (496)
Q Consensus 313 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~ 386 (496)
.++.+||+|||+++.+.... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp TTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999999999875432 2344679999999999863 35788999999999999999999998754321
Q ss_pred cchhhHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 387 SLTLLGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
...... ..+.. +...+ ........+.+++.+||+.||++|||++||+++
T Consensus 222 --~~~~~i----~~~~~-~~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 --LMLRMI----MSGNY-QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHHHHH----HHTCC-CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHHHHH----HhCCC-CCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 11110 11111 111223567889999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-48 Score=382.29 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=211.6
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 239 (496)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999874 6999999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKI 319 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 319 (496)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 121 e~~~~g~l~~~l~~---------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---------------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp ECCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred ccccccchhhhHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEe
Confidence 99999999999853 345899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+|+.+... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 183 ~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~---- 251 (350)
T d1rdqe_ 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIV---- 251 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----
T ss_pred eeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHh----
Confidence 999999976532 3346899999999999999999999999999999999999999864321 11111111
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--Hhc------cccCCCCCCCCcch
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-----TMSEVVSM--IKN------EIVNLPSPQQPAFS 464 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~--L~~------~~~~~~~p~~~~~~ 464 (496)
... . .. +......+.+++.+||+.||.+|+ |+++++++ +.+ ....+++|..|.+.
T Consensus 252 ~~~---~---~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 252 SGK---V---RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp HCC---C---CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred cCC---C---CC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence 010 0 00 111235677899999999999994 89999863 222 11345666666543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-48 Score=371.08 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=199.9
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCc---cCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----e
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSG---QGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG----E 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~ 234 (496)
.++|.+.+.||+|+||.||+|+. .+|+.||||.++.... ...+.|.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46789999999999999999986 4789999999975432 23457999999999999999999999988654 3
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++||||+++|+|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~ 147 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---------------EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 147 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EEEEEECCCCCEehhhhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcc
Confidence 7899999999999998853 346899999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCc-cccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDE-LQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+..+|+|||.+....... .........||+.|||||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 148 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~--- 222 (277)
T d1o6ya_ 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--V--- 222 (277)
T ss_dssp SCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---
T ss_pred ccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--H---
Confidence 999999999988654332 2223445689999999999999999999999999999999999999986432211 1
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcc
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRP-TMSEVVSMIKNE 451 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~ 451 (496)
......... ..+.... ......+.+++.+||+.||.+|| |++++++.|..+
T Consensus 223 ~~~~~~~~~----~~~~~~~---~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 223 AYQHVREDP----IPPSARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHCCC----CCGGGTS---SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHhcCC----CCCchhc---cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111111111 1111111 11235677899999999999999 899999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=377.85 Aligned_cols=260 Identities=23% Similarity=0.274 Sum_probs=195.7
Q ss_pred cccccccCCeeEEEEEec-CCCEEEEEEeccCCcc-----CHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEec
Q 040910 169 ENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQ-----GVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEYM 242 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 242 (496)
++.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999874 6899999998643221 1346889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEecc
Q 040910 243 PNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISDF 322 (496)
Q Consensus 243 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF 322 (496)
.++++..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~---------------~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 83 ETDLEVIIK---------------DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp SEEHHHHHT---------------TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred cchHHhhhh---------------hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccC
Confidence 888776554 23456889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhccc
Q 040910 323 GIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKDD 401 (496)
Q Consensus 323 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (496)
|+|+...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ ............
T Consensus 145 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 145 GLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTP 220 (299)
T ss_dssp GGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCC
T ss_pred ccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCC
Confidence 9998765432 223345799999999998754 67999999999999999999999886533211 111111100000
Q ss_pred ccc------cc---cCccccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 040910 402 RAW------KL---LDPTLQNEAL-----YPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKN 450 (496)
Q Consensus 402 ~~~------~~---~d~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~ 450 (496)
... .. .......... ......+.+++.+||+.||++|||++|++++ +++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000 00 0000000001 1123568899999999999999999999874 544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=375.80 Aligned_cols=267 Identities=23% Similarity=0.334 Sum_probs=201.8
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999987 468999999996432 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
|+.++.+ .++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~-~~~~~-------------~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-------------SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp CCSEEHH-HHHHH-------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred ecCCchh-hhhhh-------------hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceec
Confidence 9975544 44422 23456999999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||+|+...... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... ..........
T Consensus 145 DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~ 220 (298)
T d1gz8a_ 145 DFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLG 220 (298)
T ss_dssp STTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred cCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcC
Confidence 999998765332 2344568999999999987765 5789999999999999999999987533211 1111100000
Q ss_pred c-c-c----ccccc-----Ccccccc----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 040910 400 D-D-R----AWKLL-----DPTLQNE----ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNE 451 (496)
Q Consensus 400 ~-~-~----~~~~~-----d~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 451 (496)
. . . ..... .+..... ........+.+++.+||+.||++|||++|++++ ++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 0 0 00000 0000000 011223567889999999999999999999986 6554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=374.78 Aligned_cols=262 Identities=19% Similarity=0.263 Sum_probs=207.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
.++|.+.+.||+|+||+||+|... +|+.||||.++... .....+.+|++++++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 357889999999999999999874 68899999997543 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--CCceEE
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG--DMNPKI 319 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl 319 (496)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||
T Consensus 83 ~~gg~L~~~i~~--------------~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 83 ISGLDIFERINT--------------SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp CCCCBHHHHHTS--------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred CCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEE
Confidence 999999999842 2346899999999999999999999998 999999999999985 458999
Q ss_pred eccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 320 SDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 320 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
+|||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|..||...... ...... ..
T Consensus 146 ~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i---~~ 217 (321)
T d1tkia_ 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENI---MN 217 (321)
T ss_dssp CCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---HH
T ss_pred cccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hh
Confidence 9999998765432 233467899999999999999999999999999999999999998753321 111111 00
Q ss_pred ccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhccccCCCC
Q 040910 400 DDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNEIVNLPS 457 (496)
Q Consensus 400 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~~~~ 457 (496)
... .++..... .....+.+++.+||+.||++|||+.|++++ +.+.+.....
T Consensus 218 -~~~--~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~~ 270 (321)
T d1tkia_ 218 -AEY--TFDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270 (321)
T ss_dssp -TCC--CCCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCC
T ss_pred -CCC--CCChhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccccCh
Confidence 000 00111101 113457889999999999999999999984 5443333333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=377.45 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=201.8
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHHHHHHH-HhcCCceeeeeeeeeecCeeEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNEMILIA-KLHHRNLVRLFGCCIEQGEKILI 238 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv 238 (496)
++|.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999875 6899999999643 2345667777887766 57999999999999999999999
Q ss_pred EEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceE
Q 040910 239 YEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPK 318 (496)
Q Consensus 239 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 318 (496)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 82 mEy~~~g~L~~~i~~---------------~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---------------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred EeecCCCcHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCcee
Confidence 999999999999953 345888999999999999999999998 99999999999999999999
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhh
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLW 398 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~ 398 (496)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+....
T Consensus 144 l~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i---- 215 (320)
T d1xjda_ 144 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSI---- 215 (320)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----
T ss_pred ccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH----
Confidence 99999998765332 2344568999999999999999999999999999999999999999753321 111111
Q ss_pred cccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040910 399 KDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMS-EVVS 446 (496)
Q Consensus 399 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 446 (496)
.... +.. +......+.+++.+||+.||++||++. ++++
T Consensus 216 ~~~~------~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 RMDN------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHCC------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HcCC------CCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 111 111234578899999999999999996 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-48 Score=384.93 Aligned_cols=249 Identities=26% Similarity=0.321 Sum_probs=197.7
Q ss_pred cCCCccccccccCCeeEEEEEec-CCCEEEEEEeccC---CccCHHHHHHH---HHHHHHhcCCceeeeeeeeeecCeeE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNK---SGQGVEEFKNE---MILIAKLHHRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~~ 236 (496)
++|.+.+.||+|+||.||+|+.. +|+.||||++... .......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999874 6899999998642 12333445555 55555667999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 84 ivmE~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---------------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGH 145 (364)
T ss_dssp EEECCCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSC
T ss_pred EEEEecCCCcHHHHHHh---------------cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCc
Confidence 99999999999999953 345788999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhh
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAW 395 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~ 395 (496)
+||+|||+|+.+.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||............
T Consensus 146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--- 218 (364)
T d1omwa3 146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--- 218 (364)
T ss_dssp EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---
T ss_pred EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 9999999999765432 344689999999999974 56899999999999999999999999754433221110
Q ss_pred hhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040910 396 NLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM 447 (496)
Q Consensus 396 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 447 (496)
...... .+.... .....+.+++.+||+.||++||| ++|++++
T Consensus 219 ~~~~~~------~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 219 RMTLTM------AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHSSSC------CCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HhcccC------CCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000000 001111 12345788999999999999999 6888753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=378.13 Aligned_cols=253 Identities=18% Similarity=0.216 Sum_probs=198.3
Q ss_pred hcCCCccc-cccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHh-cCCceeeeeeeeee----cCee
Q 040910 163 THNFSEEN-KLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKL-HHRNLVRLFGCCIE----QGEK 235 (496)
Q Consensus 163 ~~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 235 (496)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787765 599999999999986 5689999999864 25678899987766 89999999999875 4578
Q ss_pred EEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC--
Q 040910 236 ILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-- 313 (496)
Q Consensus 236 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-- 313 (496)
++||||+++|+|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 85 ~ivmEy~~gg~L~~~i~~-------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~ 148 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQD-------------RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 148 (335)
T ss_dssp EEEEECCCSEEHHHHHHS-------------CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSS
T ss_pred EEEEECCCCCcHHHHHHh-------------cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccc
Confidence 999999999999999952 22346999999999999999999999998 999999999999985
Q ss_pred -CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 314 -DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 314 -~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 149 ~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~ 223 (335)
T d2ozaa1 149 PNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P 223 (335)
T ss_dssp TTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred ccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--H
Confidence 5679999999998765432 234568999999999999999999999999999999999999999754322110 0
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
......... +. .............+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~i~~~---~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 224 GMKTRIRMG---QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CCCSC---SS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcC---CC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000000 00 00001112234568899999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-47 Score=367.88 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=200.4
Q ss_pred cCCCccccccccCCeeEEEEEecCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 241 (496)
++|.+.++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999899999999996542 33467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEec
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKISD 321 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 321 (496)
+.++++..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~---------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~D 143 (286)
T d1ob3a_ 82 LDQDLKKLLD---------------VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIAD 143 (286)
T ss_dssp CSEEHHHHHH---------------TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ehhhhHHHHH---------------hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecc
Confidence 9887776665 23467999999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhcc
Q 040910 322 FGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWKD 400 (496)
Q Consensus 322 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~~ 400 (496)
||++....... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 144 fG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~ 219 (286)
T d1ob3a_ 144 FGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGT 219 (286)
T ss_dssp TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred cccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCC
Confidence 99998765432 22334568999999999876 457999999999999999999999986433211 11111110000
Q ss_pred c------------c---cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 401 D------------R---AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 401 ~------------~---~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
. + ......+.............+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 00000000001111122356788999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=366.81 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=197.7
Q ss_pred hcCCCccccccccCCeeEEEEEec-C-CCEEEEEEeccCC--ccCHHHHHHHHHHHHHh---cCCceeeeeeeeee----
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-N-GEEVAVKRLSNKS--GQGVEEFKNEMILIAKL---HHRNLVRLFGCCIE---- 231 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 231 (496)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999863 4 5679999986432 22334567788887776 79999999999863
Q ss_pred -cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 040910 232 -QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVL 310 (496)
Q Consensus 232 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIl 310 (496)
....++++||+.++++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NIL 148 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 148 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--------------SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cCceEEEEEEeccCCchhhhhh--------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEE
Confidence 347899999998887765543 24456899999999999999999999998 999999999999
Q ss_pred ecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 311 LDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 311 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
+++++.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~ 223 (305)
T d1blxa_ 149 VTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--Q 223 (305)
T ss_dssp ECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred EcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--H
Confidence 999999999999999865432 23455789999999999999999999999999999999999999987543211 1
Q ss_pred hHhhhhhhccc-------------ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 391 LGHAWNLWKDD-------------RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 391 ~~~~~~~~~~~-------------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........... .......+.............+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111000000 0000000000001111223457789999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=366.47 Aligned_cols=241 Identities=22% Similarity=0.362 Sum_probs=195.0
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCc------cCHHHHHHHHHHHHHhc--CCceeeeeeeeeecC
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSG------QGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQG 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 233 (496)
.++|.+.+.||+|+||.||+|+.. +|+.||||++..... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357899999999999999999874 689999999864321 12245678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec
Q 040910 234 EKILIYEYMPN-KSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD 312 (496)
Q Consensus 234 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~ 312 (496)
..++||||+.+ +++.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---------------~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---------------ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 144 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---------------HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred eEEEEEEeccCcchHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEe
Confidence 99999999975 57777774 2346899999999999999999999998 99999999999998
Q ss_pred C-CCceEEeccccccccCCCccccccccccccccccChhhhccCCC-CccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 313 G-DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLF-SIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 313 ~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
. ++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ..
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i 216 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI 216 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH
T ss_pred cCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH
Confidence 5 479999999999875432 2345689999999999987765 677899999999999999999986321 00
Q ss_pred hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 391 LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 391 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. . .. ..+.+ . ....+.+++.+||+.||++|||++|++++
T Consensus 217 ~-------~-~~--~~~~~----~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 217 I-------R-GQ--VFFRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp H-------H-CC--CCCSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-------h-cc--cCCCC----C----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0 00 00111 1 12467889999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-45 Score=350.94 Aligned_cols=274 Identities=16% Similarity=0.216 Sum_probs=212.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcC-CceeeeeeeeeecCeeEEEEE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHH-RNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 240 (496)
.++|.+.+.||+|+||.||+|+.. +|+.||||.+..... ...+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367899999999999999999864 689999999865432 2457889999999965 899999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC-----CC
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG-----DM 315 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~-----~~ 315 (496)
|+ +++|..++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++
T Consensus 82 ~~-~~~l~~~~~~--------------~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 82 LL-GPSLEDLLDL--------------CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred ec-CCCHHHHHHh--------------hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCC
Confidence 98 7899888853 2346899999999999999999999998 999999999999974 57
Q ss_pred ceEEeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh
Q 040910 316 NPKISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL 390 (496)
Q Consensus 316 ~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~ 390 (496)
.+||+|||+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 8999999999976533211 12334679999999999999999999999999999999999999997544432211
Q ss_pred -hHhhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccCCCCCCCCcchh
Q 040910 391 -LGHAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVNLPSPQQPAFSY 465 (496)
Q Consensus 391 -~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~p~~~~~~~ 465 (496)
....... +. ...-+.+.... +..+.+++..|++.+|++||+++.+.+.|++++........-.|.|
T Consensus 224 ~~~~i~~~----~~-~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 224 KYERIGEK----KQ-STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HHHHHHHH----HH-HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHHHHHhc----cC-CCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1111000 00 00001111112 2457788889999999999999999999998776665544333433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=357.56 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=196.0
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccC--CccCHHHHHHHHHHHHHhcCCceeeeeeeeee--------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNK--SGQGVEEFKNEMILIAKLHHRNLVRLFGCCIE-------- 231 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 231 (496)
.++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36889999999999999999987 47999999998643 33445778999999999999999999998865
Q ss_pred cCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEe
Q 040910 232 QGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLL 311 (496)
Q Consensus 232 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll 311 (496)
....++||||+.++++..+. .....++...+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl 150 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 150 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---------------CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CceEEEEEeccCCCccchhh---------------hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheee
Confidence 34689999999888776554 23456888999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccccccCCCccc--cccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcc
Q 040910 312 DGDMNPKISDFGIARMFGGDELQ--SNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSL 388 (496)
Q Consensus 312 ~~~~~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~ 388 (496)
+.++.+||+|||+++.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 151 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-- 228 (318)
T d3blha1 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-- 228 (318)
T ss_dssp CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--
Confidence 99999999999999877543322 222335799999999999865 6899999999999999999999998643221
Q ss_pred hhhHhhhhhhc-----------ccccccccCccccccCCH-H------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 389 TLLGHAWNLWK-----------DDRAWKLLDPTLQNEALY-P------MVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 389 ~~~~~~~~~~~-----------~~~~~~~~d~~~~~~~~~-~------~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
........... .......+.......... + ....+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111111000 000000000000001111 1 12356789999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-45 Score=352.58 Aligned_cols=263 Identities=19% Similarity=0.233 Sum_probs=198.1
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeee-eeeeeecCeeEEEEEe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRL-FGCCIEQGEKILIYEY 241 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~~~~~~~~~~~lv~e~ 241 (496)
++|++.+.||+|+||.||+|+. .+|+.||||.+..... .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5689999999999999999986 4689999999875433 2467889999999987765554 5555777888999999
Q ss_pred cCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEec---CCCceE
Q 040910 242 MPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLD---GDMNPK 318 (496)
Q Consensus 242 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~k 318 (496)
+ +++|...+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..+|
T Consensus 85 ~-~~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 85 L-GPSLEDLFNF--------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp C-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred c-CCchhhhhhh--------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceee
Confidence 9 5666666542 3456899999999999999999999998 99999999999985 456799
Q ss_pred EeccccccccCCCccc-----cccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 319 ISDFGIARMFGGDELQ-----SNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 319 l~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
|+|||+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 9999999987543221 22345689999999999999999999999999999999999999987644332211100
Q ss_pred hhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccC
Q 040910 394 AWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSMIKNEIVN 454 (496)
Q Consensus 394 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 454 (496)
... .... ....+.+... .+..+.+++..||+.+|++||+++++.+.|+.....
T Consensus 227 ~~~---~~~~-~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 227 RIS---EKKM-STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHH---HHHH-HSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred Hhh---cccC-CCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000 0000 0000111111 225677899999999999999999999999876443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=364.16 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=194.3
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC------
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG------ 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 233 (496)
.++|++.++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46889999999999999999986 469999999997532 233567899999999999999999999998665
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
+.++||||+ +.+|..+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----------------HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 156 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred eEEEEEecc-cccHHHHHH----------------hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccc
Confidence 579999999 667776663 235999999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcch-hh
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLT-LL 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~-~~ 391 (496)
++.+|++|||+|+..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ..
T Consensus 157 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 157 DCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp TCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 999999999999876432 345689999999999876 45789999999999999999999998654321100 00
Q ss_pred H--------hhhhhhcccc-------cccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 040910 392 G--------HAWNLWKDDR-------AWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKNE 451 (496)
Q Consensus 392 ~--------~~~~~~~~~~-------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 451 (496)
. ..+....... ..+.....+ ..........+.+++.+||+.||.+|||++|++++ ++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhccCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 0000000000 000000000 01111123456789999999999999999999986 6554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=361.90 Aligned_cols=260 Identities=23% Similarity=0.263 Sum_probs=192.8
Q ss_pred CCCccccccccCCeeEEEEEec-CCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCceeeeeeeeeec------CeeEE
Q 040910 165 NFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ------GEKIL 237 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 237 (496)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+.++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999874 689999999975432 234799999999999999999998643 24789
Q ss_pred EEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-c
Q 040910 238 IYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-N 316 (496)
Q Consensus 238 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~ 316 (496)
||||++++++..+... . .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 97 v~Ey~~~~~~~~l~~~-~-----------~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~ 161 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY-S-----------RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAV 161 (350)
T ss_dssp EEECCSEEHHHHHHHH-H-----------HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCC
T ss_pred EEeccCCccHHHHHhh-h-----------hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCc
Confidence 9999986654443321 1 23456999999999999999999999988 99999999999999775 8
Q ss_pred eEEeccccccccCCCccccccccccccccccChhhhcc-CCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH---
Q 040910 317 PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALH-GLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG--- 392 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~--- 392 (496)
+||+|||+++.+.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ +..
T Consensus 162 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~ 237 (350)
T d1q5ka_ 162 LKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIK 237 (350)
T ss_dssp EEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHH
T ss_pred eeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHH
Confidence 9999999998765432 2334689999999998875 5789999999999999999999999875432111 000
Q ss_pred -------hhhhhhccc----ccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 393 -------HAWNLWKDD----RAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 393 -------~~~~~~~~~----~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..+...... .....................+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0000000000011111223467889999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=360.43 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=197.6
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC-ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecC----eeE
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS-GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQG----EKI 236 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 236 (496)
+.+|++.++||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45789999999999999999976 479999999997543 233568899999999999999999999987653 335
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCc
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMN 316 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 316 (496)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 87 ~l~~~~~~g~L~~~l~~----------------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~ 147 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCD 147 (345)
T ss_dssp EEEEECCCEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred EEEEeecCCchhhhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCC
Confidence 56677789999999842 25899999999999999999999998 999999999999999999
Q ss_pred eEEeccccccccCCCccc-cccccccccccccChhhhc-cCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh
Q 040910 317 PKISDFGIARMFGGDELQ-SNMNRIVGTYGYMSPEYAL-HGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA 394 (496)
Q Consensus 317 ~kl~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~ 394 (496)
+||+|||+++........ .......||+.|+|||++. +..++.++||||+||+++||++|+.||........ ....
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~ 225 (345)
T d1pmea_ 148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHI 225 (345)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH
T ss_pred EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHH
Confidence 999999999876543222 2234567999999999985 45678999999999999999999999865432111 0000
Q ss_pred hhhhcccc-------------cccccCccccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 040910 395 WNLWKDDR-------------AWKLLDPTLQN----EALYPMVKRYIKVALLCVQENAADRPTMSEVVSM--IKN 450 (496)
Q Consensus 395 ~~~~~~~~-------------~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~ 450 (496)
........ ......+.... .........+.+++.+||+.||.+|||+.|++++ |+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00000000 00000000000 0001112467889999999999999999999986 544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=351.55 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=207.6
Q ss_pred cCCCccccccccCCeeEEEEEec----CCCEEEEEEeccC----CccCHHHHHHHHHHHHHhcC-CceeeeeeeeeecCe
Q 040910 164 HNFSEENKLGEGGFGPVYKGKLL----NGEEVAVKRLSNK----SGQGVEEFKNEMILIAKLHH-RNLVRLFGCCIEQGE 234 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 234 (496)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56899999999999999999752 4789999998643 22345678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.++|+||+.+|+|..++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---------------~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---------------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN 165 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeeecccccHHHHHHHh---------------cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCC
Confidence 9999999999999999853 345678889999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccC--CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhH
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG--LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLG 392 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~ 392 (496)
+.+||+|||+++.+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........
T Consensus 166 ~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~- 243 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE- 243 (322)
T ss_dssp SCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-
T ss_pred CCEEEeeccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 9999999999987654332 223446799999999999764 478899999999999999999999876544322111
Q ss_pred hhhhhhcccccccccCccccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH--Hhc------cccCCCCCC
Q 040910 393 HAWNLWKDDRAWKLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPT-----MSEVVSM--IKN------EIVNLPSPQ 459 (496)
Q Consensus 393 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~--L~~------~~~~~~~p~ 459 (496)
........ .+. .+......+.+++.+||+.||.+||| ++|++++ +++ ....+|+|-
T Consensus 244 -i~~~~~~~------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~ 312 (322)
T d1vzoa_ 244 -ISRRILKS------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 312 (322)
T ss_dssp -HHHHHHHC------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred -HHHhcccC------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCC
Confidence 11100000 001 11123457788999999999999994 7888763 222 123456666
Q ss_pred CCcc
Q 040910 460 QPAF 463 (496)
Q Consensus 460 ~~~~ 463 (496)
.|..
T Consensus 313 ~p~~ 316 (322)
T d1vzoa_ 313 KPVI 316 (322)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 6643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=347.77 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=202.7
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeecCeeEEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 240 (496)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999987 478899999996543 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCCceEEe
Q 040910 241 YMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDMNPKIS 320 (496)
Q Consensus 241 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 320 (496)
++.+++|..++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 82 FCDQDLKKYFDS---------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp CCSEEHHHHHHH---------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred eccccccccccc---------------cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeee
Confidence 999999988774 3456889999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccccccccccccccChhhhccCC-CCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhhhhhhc
Q 040910 321 DFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGL-FSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHAWNLWK 399 (496)
Q Consensus 321 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~~~~~~ 399 (496)
|||.++...... .......++..|+|||.+.+.. ++.++|||||||++|||++|+.|+....... ...........
T Consensus 144 DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~ 220 (292)
T d1unla_ 144 NFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLG 220 (292)
T ss_dssp CCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHC
T ss_pred ecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcC
Confidence 999999765432 2233346788999999988665 6899999999999999999999874322211 11111111110
Q ss_pred ccc------cccccC---------ccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 400 DDR------AWKLLD---------PTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 400 ~~~------~~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
... .....+ ..............+.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000 000001111223467789999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-44 Score=350.02 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=195.1
Q ss_pred cCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeec--CeeEEEE
Q 040910 164 HNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQ--GEKILIY 239 (496)
Q Consensus 164 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 239 (496)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+.++.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999987 46899999998643 3578899999999995 99999999998744 4689999
Q ss_pred EecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCCC-ceE
Q 040910 240 EYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGDM-NPK 318 (496)
Q Consensus 240 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~k 318 (496)
||+++++|..+. +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 112 e~~~~~~L~~~~------------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vk 170 (328)
T d3bqca1 112 EHVNNTDFKQLY------------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR 170 (328)
T ss_dssp ECCCSCBGGGTT------------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred eecCCCcHHHHh------------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeee
Confidence 999999986543 24889999999999999999999998 99999999999998655 689
Q ss_pred EeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHhh---
Q 040910 319 ISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGHA--- 394 (496)
Q Consensus 319 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~~--- 394 (496)
|+|||+|+...... ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..............
T Consensus 171 l~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 171 LIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp ECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 99999998765432 23446789999999998865 579999999999999999999999875443211100000
Q ss_pred -----hhhh---c---ccccccccC-------cc-ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040910 395 -----WNLW---K---DDRAWKLLD-------PT-LQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVS 446 (496)
Q Consensus 395 -----~~~~---~---~~~~~~~~d-------~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 446 (496)
.... . ......... .. ............+.+|+.+||+.||++|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 000000000 00 000011112346788999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=350.16 Aligned_cols=261 Identities=21% Similarity=0.226 Sum_probs=189.5
Q ss_pred hcCCCccccccccCCeeEEEEEec-CCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeee------cC
Q 040910 163 THNFSEENKLGEGGFGPVYKGKLL-NGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIE------QG 233 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 233 (496)
.++|.+.++||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999875 69999999997542 2334578899999999999999999999864 36
Q ss_pred eeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecC
Q 040910 234 EKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDG 313 (496)
Q Consensus 234 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 313 (496)
..++||||+.++++. .+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 154 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred eeEEEEeccchHHHH-hhh-----------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccc
Confidence 889999999765554 331 24789999999999999999999998 999999999999999
Q ss_pred CCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCCCCCcchh-h-
Q 040910 314 DMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTL-L- 391 (496)
Q Consensus 314 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~-~- 391 (496)
++.+|++|||+++..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||.......... .
T Consensus 155 ~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 155 DCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp TCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccceeeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 999999999999876533 23344578999999999999999999999999999999999999986443211000 0
Q ss_pred H-------hhhh--------hhcc------cccccccCcccccc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 392 G-------HAWN--------LWKD------DRAWKLLDPTLQNE---ALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 392 ~-------~~~~--------~~~~------~~~~~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
. ..+. .... .............. ........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000 0000 00011111111111 122345678899999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=349.57 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=193.7
Q ss_pred hcCCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCC--ccCHHHHHHHHHHHHHhcCCceeeeeeeeeec-----Ce
Q 040910 163 THNFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKS--GQGVEEFKNEMILIAKLHHRNLVRLFGCCIEQ-----GE 234 (496)
Q Consensus 163 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 234 (496)
+++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999986 479999999997543 23345788999999999999999999998643 34
Q ss_pred eEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEecCC
Q 040910 235 KILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASNVLLDGD 314 (496)
Q Consensus 235 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 314 (496)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~----------------~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~ 157 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 157 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eEEEEEeecCCchhhhcc----------------cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccc
Confidence 577788889999999883 235899999999999999999999998 9999999999999999
Q ss_pred CceEEeccccccccCCCccccccccccccccccChhhhccC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCcchhhHh
Q 040910 315 MNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHG-LFSIKSDVFSFGVLLLETLSSKKNTRFYNIDSLTLLGH 393 (496)
Q Consensus 315 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~~~~~~~~~~~~~~~~ 393 (496)
+.+|++|||++..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 158 ~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~ 230 (348)
T d2gfsa1 158 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL 230 (348)
T ss_dssp CCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH
T ss_pred ccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 9999999999976532 23446789999999987765 468999999999999999999999875432111 000
Q ss_pred hhhhh-----------cccccc-------cccCccccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040910 394 AWNLW-----------KDDRAW-------KLLDPTLQNEALYPMVKRYIKVALLCVQENAADRPTMSEVVSM 447 (496)
Q Consensus 394 ~~~~~-----------~~~~~~-------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 447 (496)
..... ...... +.....+. .........+.+++.+||+.||++|||++|++++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 000000 00000000 0001123457789999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-38 Score=315.58 Aligned_cols=278 Identities=19% Similarity=0.228 Sum_probs=197.1
Q ss_pred CCCccccccccCCeeEEEEEe-cCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-----------CCceeeeeeeeeec
Q 040910 165 NFSEENKLGEGGFGPVYKGKL-LNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-----------HRNLVRLFGCCIEQ 232 (496)
Q Consensus 165 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~ 232 (496)
+|.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588999999999999999987 479999999997542 23467788999998885 57899999988654
Q ss_pred --CeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCE
Q 040910 233 --GEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQ-YSRLRVIHRDLKASNV 309 (496)
Q Consensus 233 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlk~~NI 309 (496)
...+++++++..+........ ......+++..+..++.||+.||+|||+ .+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NI 157 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK------------KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 157 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH------------HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred cccceeeeeeecccccccccccc------------cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHe
Confidence 456677777665544333321 1344568889999999999999999997 66 99999999999
Q ss_pred EecCCCc------eEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 040910 310 LLDGDMN------PKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLLLETLSSKKNTRFY 383 (496)
Q Consensus 310 ll~~~~~------~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~~~~~~ 383 (496)
|++.++. ++++|||.+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 9986653 89999999986532 234467999999999999999999999999999999999999998643
Q ss_pred CCCcc-----hhhHhhhhh-----------------hcccccccccCc----------cccccCCHHHHHHHHHHHHHhc
Q 040910 384 NIDSL-----TLLGHAWNL-----------------WKDDRAWKLLDP----------TLQNEALYPMVKRYIKVALLCV 431 (496)
Q Consensus 384 ~~~~~-----~~~~~~~~~-----------------~~~~~~~~~~d~----------~~~~~~~~~~~~~l~~l~~~cl 431 (496)
..... ......... +........+.. .............+.+++.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 32110 000000000 000000000000 0011233556778999999999
Q ss_pred ccCCCCCCCHHHHHHH--Hhcc--ccCCCCCCCCcc
Q 040910 432 QENAADRPTMSEVVSM--IKNE--IVNLPSPQQPAF 463 (496)
Q Consensus 432 ~~~p~~RPs~~evl~~--L~~~--~~~~~~p~~~~~ 463 (496)
+.||.+|||++|++++ +++. ..+...|..|..
T Consensus 313 ~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred CCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 9999999999999986 5542 223444444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.2e-24 Score=193.31 Aligned_cols=169 Identities=17% Similarity=0.169 Sum_probs=120.5
Q ss_pred CccccccccCCeeEEEEEecCCCEEEEEEeccCCc------------------cCHHHHHHHHHHHHHhcCCceeeeeee
Q 040910 167 SEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSG------------------QGVEEFKNEMILIAKLHHRNLVRLFGC 228 (496)
Q Consensus 167 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 228 (496)
.+.++||+|+||.||+|...+|+.||||.++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988999999998753210 011234568888999999999988765
Q ss_pred eeecCeeEEEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 040910 229 CIEQGEKILIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQYSRLRVIHRDLKASN 308 (496)
Q Consensus 229 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk~~N 308 (496)
. ..+++|||++++.+. .++......++.|++++|+|||+.+ |+||||||+|
T Consensus 83 ~----~~~lvme~~~~~~~~----------------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~N 133 (191)
T d1zara2 83 E----GNAVLMELIDAKELY----------------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 133 (191)
T ss_dssp E----TTEEEEECCCCEEGG----------------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred c----CCEEEEEeecccccc----------------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhh
Confidence 3 237999999875542 2444566789999999999999998 9999999999
Q ss_pred EEecCCCceEEeccccccccCCCccccccccccccccccChhhhccCCCCccccchhhhHHH
Q 040910 309 VLLDGDMNPKISDFGIARMFGGDELQSNMNRIVGTYGYMSPEYALHGLFSIKSDVFSFGVLL 370 (496)
Q Consensus 309 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl 370 (496)
||++++ .++|+|||+|.....+........ .... -.+ .....|+.++|+||..--+
T Consensus 134 ILv~~~-~~~liDFG~a~~~~~~~~~~~l~r---d~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 134 VLVSEE-GIWIIDFPQSVEVGEEGWREILER---DVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEEETT-EEEECCCTTCEETTSTTHHHHHHH---HHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred eeeeCC-CEEEEECCCcccCCCCCcHHHHHH---HHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999965 489999999986543221110000 0000 011 1235678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=4.1e-08 Score=90.27 Aligned_cols=149 Identities=15% Similarity=0.098 Sum_probs=100.5
Q ss_pred HHHHHhcCCCccccccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeE
Q 040910 158 SISTATHNFSEENKLGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKI 236 (496)
Q Consensus 158 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 236 (496)
++...-..|+..+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556776655554455578999865 66778899887554445556788999988883 555677888888888999
Q ss_pred EEEEecCCCChhHHHhhcccCCCcccccCCCCCCCCChhhHHHHHHHHHHHHHHhhhc----------------------
Q 040910 237 LIYEYMPNKSLDFFLFDYKYSSGFDMVTDPASKGILDWTTRVRIIEGIAQGLLYLHQY---------------------- 294 (496)
Q Consensus 237 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------- 294 (496)
+||+++++.++...... ......++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~--------------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecccccccccccc--------------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 99999999887544311 011122333333333333321
Q ss_pred ----------------------------------CCCCeeecCCCCCCEEecCCCceEEeccccccc
Q 040910 295 ----------------------------------SRLRVIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 295 ----------------------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
....++|+|+.|.|||++++..+-|.||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112389999999999999877778999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=3.8e-06 Score=76.23 Aligned_cols=75 Identities=16% Similarity=0.139 Sum_probs=55.3
Q ss_pred cccccCC-eeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhc--CCceeeeeeeeeecCeeEEEEEecCCCCh
Q 040910 171 KLGEGGF-GPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLH--HRNLVRLFGCCIEQGEKILIYEYMPNKSL 247 (496)
Q Consensus 171 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL 247 (496)
.+..|.. +.||+....++..++||.-..... ..+..|+..++.+. ...+.+++++..+++..++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 678999887788889998654432 34677888888774 34466788888888889999999988766
Q ss_pred h
Q 040910 248 D 248 (496)
Q Consensus 248 ~ 248 (496)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=7e-05 Score=72.36 Aligned_cols=77 Identities=12% Similarity=0.174 Sum_probs=50.1
Q ss_pred cccccccCCeeEEEEEecC-CCEEEEEEeccC-------CccCHHHHHHHHHHHHHhc-C--CceeeeeeeeeecCeeEE
Q 040910 169 ENKLGEGGFGPVYKGKLLN-GEEVAVKRLSNK-------SGQGVEEFKNEMILIAKLH-H--RNLVRLFGCCIEQGEKIL 237 (496)
Q Consensus 169 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~l 237 (496)
.+.||.|....||+....+ ++.|+||.-... -....++...|++.+..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998654 678999964321 1123345567888888773 3 335555544 4556789
Q ss_pred EEEecCCCCh
Q 040910 238 IYEYMPNKSL 247 (496)
Q Consensus 238 v~e~~~~gsL 247 (496)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.13 E-value=0.0012 Score=63.40 Aligned_cols=73 Identities=15% Similarity=0.235 Sum_probs=50.2
Q ss_pred ccccccCCeeEEEEEecCC--------CEEEEEEeccCCccCHHHHHHHHHHHHHhc-CCceeeeeeeeeecCeeEEEEE
Q 040910 170 NKLGEGGFGPVYKGKLLNG--------EEVAVKRLSNKSGQGVEEFKNEMILIAKLH-HRNLVRLFGCCIEQGEKILIYE 240 (496)
Q Consensus 170 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 240 (496)
+.|+.|-.-.+|+....++ +.|.++... . ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5788888999999987543 456666654 2 233445678999999884 4434577777643 58999
Q ss_pred ecCCCChh
Q 040910 241 YMPNKSLD 248 (496)
Q Consensus 241 ~~~~gsL~ 248 (496)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.002 Score=60.03 Aligned_cols=148 Identities=12% Similarity=0.117 Sum_probs=81.3
Q ss_pred CeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc--eeeeee-----eeeecCeeEEEEEecCCCChhH
Q 040910 177 FGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN--LVRLFG-----CCIEQGEKILIYEYMPNKSLDF 249 (496)
Q Consensus 177 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 249 (496)
--.||+....+|+.+++|..+... ...+++..|...+..|.... ++..+. .....+..+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 357999999899999999986542 34577888999998884322 222221 2234556788999997644321
Q ss_pred ----HHhhc--------ccCCCcccccCCC---------------CCCCCChhhHHHHHHHHHHHHHHhhh----cCCCC
Q 040910 250 ----FLFDY--------KYSSGFDMVTDPA---------------SKGILDWTTRVRIIEGIAQGLLYLHQ----YSRLR 298 (496)
Q Consensus 250 ----~l~~~--------~~~~~~~~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~----~~~~~ 298 (496)
.+... ............. ....++-..+..+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11000 0000000000000 00111112222222223333333332 22446
Q ss_pred eeecCCCCCCEEecCCCceEEeccccccc
Q 040910 299 VIHRDLKASNVLLDGDMNPKISDFGIARM 327 (496)
Q Consensus 299 ivH~Dlk~~NIll~~~~~~kl~DFgla~~ 327 (496)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.92 E-value=0.14 Score=46.36 Aligned_cols=169 Identities=14% Similarity=0.041 Sum_probs=84.8
Q ss_pred CHHHHHHHhcCCCcccc-----ccccCCeeEEEEEecCCCEEEEEEeccCCccCHHHHHHHHHHHHHhcCCc--eeeeee
Q 040910 155 SLASISTATHNFSEENK-----LGEGGFGPVYKGKLLNGEEVAVKRLSNKSGQGVEEFKNEMILIAKLHHRN--LVRLFG 227 (496)
Q Consensus 155 ~~~~~~~~~~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~ 227 (496)
+..++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..++...|+.++..|...+ +...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 44566666677765433 34566677899987555 58999886432 2234555777788874322 222221
Q ss_pred ------eeeecCeeEEEEEecCCCChhHHHh-----------hc-ccCCCcccccCCCC--------------CCCCChh
Q 040910 228 ------CCIEQGEKILIYEYMPNKSLDFFLF-----------DY-KYSSGFDMVTDPAS--------------KGILDWT 275 (496)
Q Consensus 228 ------~~~~~~~~~lv~e~~~~gsL~~~l~-----------~~-~~~~~~~~~~~~~~--------------~~~l~~~ 275 (496)
+.........++.+..+......-. .. .............. .......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1122345666777766533321100 00 00000000000000 0001111
Q ss_pred hHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCCEEecCCCceEEecccccc
Q 040910 276 TRVRIIEGIAQGLLYLHQY-SRLRVIHRDLKASNVLLDGDMNPKISDFGIAR 326 (496)
Q Consensus 276 ~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFgla~ 326 (496)
.....+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2223333333333333322 23459999999999999998877899999886
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.93 E-value=0.076 Score=38.53 Aligned_cols=52 Identities=19% Similarity=0.397 Sum_probs=33.2
Q ss_pred CceEeccCCCCCCchhhhh---hccCChHHHHHHhhc----cCceEEEeeecccCCCccccc
Q 040910 8 SQFIKFDDMQVPDLLEVLL---NESVNLKECEAECLK----NCTCRAYGNSNLIGGGSGCLM 62 (496)
Q Consensus 8 ~~f~~~~~~~~p~~~~~~~---~~~~~~~~C~~~Cl~----ncsC~a~~~~~~~~~~~~C~~ 62 (496)
|+|.+..+..|...+.... ....+.++|...|+. +..|.+|.|.. ....|.+
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~---~~~~C~L 63 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK---ARKQCLW 63 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET---TTTEEEE
T ss_pred HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC---CCCeEEE
Confidence 4677776665544332111 123489999999987 45799999952 3446874
|